{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "gpt-oss-120b-reasoning",
    "experiment": "e3_page_window_distract",
    "pattern": "qualitative_3hop_cross_company_type1",
    "sample_size": null,
    "random_seed": null,
    "total_questions_in_experiment": 600,
    "successful_questions_in_experiment": 600,
    "failed_questions_in_experiment": 0,
    "questions_evaluated": 600,
    "completed": true,
    "input_file": "/Users/reeturajharsh/domyn/multihopQA-benchmarking/src/experiments/outputs/experiments/gpt-oss-120b-reasoning/e3_page_window_distract/qualitative_3hop_cross_company_type1.json",
    "timestamp": "2026-02-04T01:43:47.258620"
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "How does the number of securities remaining available for future issuance under equity compensation plans approved by security holders at Colgate-Palmolive (CL) compare to the total number of securities related to stock options, restricted stock units, and performance stock units available for future issuance at Procter & Gamble (PG)?",
      "original_answer": "Colgate-Palmolive (CL) reported 37,028,000 securities remaining available under equity compensation plans approved by security holders. Procter & Gamble (PG) disclosed that under similar plans, they had 133,185,995 total securities related to stock options, restricted stock units, and performance stock units available for future issuance. This indicates that PG has significantly more securities available for future issuance compared to CL.",
      "llm_answer": "Colgate‑Palmolive reports that equity‑compensation plans approved by security holders have **37,028 thousand securities** (≈37 million) still available for future issuance【page_61】.  \nProcter & Gamble indicates that the only plan that can grant new awards (the 2019 Stock and Incentive Compensation Plan) provides **about 119 million shares** available for future issuance of stock options, RSUs and PSUs【page_69】.  \n\nThus, PG’s pool of securities available for future issuance (~119 million) is roughly three times larger than CL’s (~37 million).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Colgate-Palmolive's available securities as 37,028,000 (rounded to 37 million), which matches the ground truth. However, it reports Procter & Gamble's total available securities as 'about 119 million', whereas the ground truth is 133,185,995—this is a significant numerical discrepancy (~14 million fewer). The LLM may have pulled data from a different section or used an outdated/incorrect figure. (2) Quantitative accuracy is compromised due to the incorrect number for PG; while the CL number is accurate (37,028 thousand = 37,028,000), the PG number is off by over 10%. The comparison stating PG’s pool is 'roughly three times larger' is approximately correct (133M / 37M ≈ 3.6), but based on incorrect input. (3) The multi-hop reasoning is sound: the model identifies both companies, the relevant equity compensation plans, and synthesizes the data to make a valid comparison. It correctly interprets that both figures relate to securities available for future issuance under shareholder-approved plans. (4) Contextual relevance is perfect—the answer directly addresses the comparison asked. Despite the reasoning and structure being strong, the incorrect PG number reduces quantitative and overall correctness scores. Minor formatting (thousands vs. full count) is acceptable, but the magnitude error in PG’s value prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 386,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the sensitivity of Google's foreign exchange forward contracts to a 10% weakening of the U.S. dollar compare with Disney's hedge coverage for forecasted foreign currency transactions in terms of notional exposure and risk mitigation horizon?",
      "original_answer": "Google's foreign exchange forward contracts would result in a $660 million impact on AOCI as of December 31, 2024, from a 10% weakening of the U.S. dollar, reflecting its net investment hedge strategy. In contrast, Disney hedges forecasted foreign currency transactions with a notional exposure of $9.9 billion as of September 28, 2024, and maintains coverage for periods generally not exceeding four years. While Google focuses on offsetting translation risk from foreign subsidiaries, Disney aims to stabilize earnings and cash flows by hedging forecasted transactions in major currencies like the euro and Japanese yen.",
      "llm_answer": "Google’s foreign‑exchange forward contracts would translate into a roughly $660 million (2024) – $946 million (2023) reduction in its cumulative translation adjustment if the U.S. dollar weakened by 10%, indicating a sub‑billion‑dollar sensitivity. By contrast, Disney has about $9.9 billion (2024) of net foreign‑exchange cash‑flow hedges (up from $8.3 billion in 2023) that are used to hedge forecasted foreign‑currency transactions for periods generally not to exceed four years, giving Disney a much larger notional exposure and a multi‑year risk‑mitigation horizon.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Google's $660 million sensitivity to a 10% weakening of the U.S. dollar as of 2024, which matches the ground truth. However, it introduces a figure of $946 million for 2023 that is not present in the original answer and is irrelevant to the question, potentially confusing the comparison. Disney's $9.9 billion notional exposure as of 2024 is accurately reported. The mention of $8.3 billion in 2023 is factually consistent with typical year-over-year disclosures but was not included in the ground truth, making it extraneous. (2) The core numbers ($660M for Google, $9.9B for Disney) are correct and properly attributed to their respective companies and years. However, the inclusion of unverified prior-year figures (Google’s $946M, Disney’s $8.3B) reduces quantitative accuracy. The 10% weakening scenario is correctly tied to Google’s impact on AOCI (though labeled as 'cumulative translation adjustment', which is part of AOCI—semantically acceptable). (3) The multi-hop reasoning is sound: the model correctly contrasts Google’s net investment hedge strategy (affecting AOCI/CTA) with Disney’s cash flow hedges of forecasted transactions, and correctly notes Disney’s up-to-four-year risk mitigation horizon. It captures the strategic difference in risk management focus—translation risk vs. earnings/cash flow stability—even if not explicitly stated in those terms. (4) The answer is contextually relevant and addresses both parts of the question: notional exposure and risk mitigation horizon. While it omits explicit mention of the currencies hedged (euro, yen), this is a minor omission. The main deduction is for introducing unsupported historical data, which risks misleading the reader despite correct core facts. Overall, the answer is substantially correct but less precise due to extra, unverified figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 507,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does the number of securities remaining available for future issuance under equity compensation plans approved by security holders at Procter & Gamble compare to Colgate-Palmolive’s available securities, considering both companies disclose these figures under similar categories?",
      "original_answer": "Procter & Gamble reports that there are 133,185,995 securities remaining available for future issuance under equity compensation plans approved by security holders, while Colgate-Palmolive discloses 37,028,000 securities remaining available under the same category. This indicates that P&G has a significantly larger pool of available securities for future equity compensation compared to Colgate-Palmolive.",
      "llm_answer": "Procter & Gamble reports that its equity‑compensation plans approved by security holders have **about 119 million shares** still available for future grants (see PG 10‑K p. 69 footnote 1). Colgate‑Palmolive reports **approximately 37.0 million shares** (37,028 thousand) available under the same category (see CL 10‑K p. 61). Thus, P&G’s pool of issuable securities is roughly three times larger than Colgate‑Palmolive’s.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies both companies and the relevant metric—securities remaining available for future issuance under equity compensation plans approved by security holders. The Colgate-Palmolive figure is accurate at 37,028,000 (reported as 37.0 million or 37,028 thousand), matching the ground truth. However, the Procter & Gamble number is reported as 'about 119 million' in the LLM answer, while the ground truth is 133,185,995, a significant difference of over 14 million shares. This discrepancy affects quantitative accuracy. (2) The calculation comparing P&G’s pool to Colgate’s as 'roughly three times larger' is approximately valid if using 119M vs 37M (~3.2x), but would be more accurate at ~3.6x using the true 133.2M figure. Thus, the comparison is directionally correct but based on an incorrect input. (3) The multi-hop reasoning is sound—LLM correctly synthesizes data from both 10-K filings and compares them appropriately. It cites specific footnotes and pages, indicating accurate source tracing. (4) Despite the numerical inaccuracy for P&G, the overall reasoning, entity identification, and contextual relevance are strong. The answer addresses the comparison aspect fully and uses semantically equivalent phrasing. The score is reduced primarily due to the material error in P&G's available securities count, which impacts factual correctness, but not enough to undermine the entire response.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 399,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does AbbVie's patent litigation against Sandoz Inc. over upadacitinib relate to Amgen's legal strategy in defending its own patents against Sandoz's counterclaims regarding denosumab biosimilar development?",
      "original_answer": "AbbVie is actively enforcing its patents for upadacitinib (Rinvoq) by suing Sandoz Inc. and other generic drug manufacturers, seeking injunctive relief to prevent premature market entry of generic versions. Meanwhile, Amgen faces litigation from Sandoz Inc., which has filed counterclaims asserting that Amgen's asserted patents for denosumab are invalid or unenforceable. Both companies are engaged in high-stakes patent battles involving Sandoz Inc., but while AbbVie is in the offensive position protecting its drug exclusivity, Amgen is defending its intellectual property against Sandoz's legal challenges, revealing contrasting legal dynamics in the biopharmaceutical patent ecosystem.",
      "llm_answer": "AbbVie has opened a direct infringement suit in the U.S. District Court for the District of Delaware (filed Nov 2023) alleging that Sandoz’s proposed generic upadacitinib products infringe AbbVie’s patents and is seeking declaratory and injunctive relief 【page_95】. Amgen is pursuing a parallel approach with its own BPCIA litigation in New Jersey – it sued Sandoz over a denosumab biosimilar and is now defending that case by moving to dismiss Sandoz’s counterclaims that the asserted patents are invalid/unenforceable and by seeking a preliminary (and eventual permanent) injunction 【page_155】【page_156】. Both companies therefore use patent litigation to block Sandoz’s generic entry, AbbVie by asserting infringement of upadacitinib, and Amgen by aggressively defending its denosumab patents against Sandoz’s challenges.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: AbbVie filed a patent infringement suit against Sandoz over upadacitinib in November 2023 in Delaware, seeking injunctive relief; Amgen is involved in BPCIA litigation in New Jersey over denosumab, defending against Sandoz’s counterclaims of patent invalidity/unenforceability. These details match the original answer’s characterization of AbbVie as the offensive party and Amgen as the defensive one. (2) Quantitative accuracy is perfect: the date (Nov 2023) is correctly stated, and no numerical errors exist. Format variations are not needed as all data is consistent. (3) Multi-hop reasoning is sound—LLM correctly synthesizes that both companies are engaged in patent litigation with Sandoz Inc., but in different procedural postures (AbbVie asserting patents, Amgen defending them), which reflects the contrasting legal dynamics described in the ground truth. The mention of specific pages (95, 155, 156) suggests proper sourcing from the filings. (4) Minor deduction in qualitative accuracy due to slightly stronger characterization of Amgen’s approach as 'aggressively defending'—while accurate in tone, this nuance isn’t present in the original answer, which sticks to a more neutral description. However, this does not affect factual correctness. Overall, the answer is semantically equivalent, contextually precise, and factually robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 399,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How does the voting power dilution mechanism in CMCSA's Class B to Class A common stock conversion compare with GOOGL's multi-class stock structure, particularly in light of the $62.2 billion in Class A and Class C shares repurchased by GOOGL in 2023?",
      "original_answer": "GOOGL repurchased $62.2 billion of its Class A and Class C shares in 2023, maintaining a multi-class structure where Class B shares carry 10 votes per share and convert automatically upon sale or transfer to Class A, which has 1 vote per share. In contrast, CMCSA's Class B shares carry 15 votes and are convertible share-for-share into Class A shares, with Class B's aggregate voting power capped at 33 1/3% and protected from dilution under its articles of incorporation. This means CMCSA has a stronger anti-dilution mechanism for its Class B shares compared to GOOGL, where Class B shares lose their enhanced voting rights upon conversion. Additionally, GOOGL's repurchase activity in 2023 may have concentrated voting control among remaining Class B shareholders by reducing the total number of Class A shares outstanding.",
      "llm_answer": "CMCSA’s charter fixes the voting split at roughly 66 % for Class A (1 vote) and 33 % for Class B (10 votes) and makes that proportion “generally non‑dilutable,” so when a holder converts a Class B share into a Class A share the overall voting balance is preserved rather than eroding the high‑vote bloc【page_91】. Alphabet also uses a 10‑vote Class B, 1‑vote Class A and non‑voting Class C structure, but its 2023 repurchase of $62.2 billion of Class A and C shares reduced the number of low‑ or non‑voting shares outstanding, thereby concentrating voting power even more in the 10‑vote Class B shares【page_81】.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct but contains a few key inaccuracies and omissions that affect the qualitative accuracy. (1) Quantitatively, all numbers are accurate: GOOGL's $62.2 billion share repurchase in 2023 is correctly cited, and the voting rights (10 votes for Class B, 1 for Class A) are correct for both companies. (2) However, the LLM misstates CMCSA's voting structure: it claims Class B has 10 votes, but the ground truth specifies 15 votes per share, not 10. Additionally, the LLM incorrectly states the voting split as 66% Class A and 33% Class B without clarifying that this is based on aggregate voting power capped at 33 1/3% for Class B, which is a critical anti-dilution protection. (3) The reasoning about GOOGL’s repurchase concentrating voting power in Class B is sound and correctly infers the indirect effect of reducing low-vote shares. (4) The LLM fails to mention that CMCSA’s Class B shares are convertible share-for-share into Class A and that the anti-dilution mechanism actively protects the 33 1/3% cap, making it stronger than GOOGL’s structure where conversion eliminates enhanced voting. This omission weakens the comparative analysis. (5) Despite these issues, the answer remains contextually relevant and captures the core dynamic of voting concentration via repurchases and structural differences. Minor wording differences are acceptable, but the misattribution of vote count (10 vs 15) and oversimplification of CMCSA’s mechanism justify a score of 7 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 419,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How does the number of shares reserved for future issuance under Nike's Equity Compensation Plan compare to the number of shares represented by outstanding warrants at Tesla, based on their respective 2023 filings?",
      "original_answer": "Nike reported 97,567,370 shares remaining available for future issuance under its Equity Compensation Plan, while Tesla disclosed that 11 million shares were represented by outstanding warrants in 2023. Therefore, Nike's available shares under its equity plan are significantly higher than Tesla's outstanding warrants.",
      "llm_answer": "The Nike excerpts (pages 94‑98) do not contain a disclosed figure for the shares “reserved for future issuance” under its Equity Compensation Plan, so that amount is not available from the provided material. Tesla’s 2023 filing, however, reports that its outstanding warrants represent roughly **11 million shares** (see the “Warrants” line in the diluted‑EPS reconciliation table on page 63). Because Nike’s reserved‑share number isn’t disclosed in the supplied pages, a direct numeric comparison cannot be made.",
      "correctness_score": 3,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that Nike's shares reserved for future issuance are not disclosed in the provided material, which contradicts the ground truth that Nike reported 97,567,370 shares available under its Equity Compensation Plan in its 2023 filing. This is a critical factual error. Tesla’s figure of 11 million shares from outstanding warrants is correctly identified and matches the ground truth. (2) Quantitatively, the Tesla number is accurate (11 million), but the Nike number is missing due to the incorrect assertion of non-disclosure, leading to incomplete quantitative analysis. The comparison fails because one side of the comparison is omitted. (3) The multi-hop reasoning is flawed: the model fails to retrieve or acknowledge the Nike figure, breaking the synthesis required between the two companies’ filings. The conclusion that a comparison cannot be made is incorrect, as the ground truth confirms both values are available. (4) Contextual relevance is moderate—the response addresses the right documents and metric types, and correctly interprets Tesla’s data, but the failure to recognize Nike’s disclosed figure severely undermines correctness and qualitative reasoning. A score of 3 reflects mostly incorrect output with one correct data point but a failed core task.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 367,
        "total_tokens": 1592
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the number of shares issuable upon exercise of outstanding warrants disclosed by Tesla in 2023 compare to the number of shares remaining available for future issuance under Nike's equity compensation plans, based on their respective disclosures?",
      "original_answer": "Tesla disclosed that in 2023, there were 11 million shares issuable upon exercise of outstanding warrants. In contrast, Nike, through its equity compensation plan disclosures, indicated that 97,567,370 shares were remaining available for future issuance under compensation plans. This highlights a significant difference in scale between Tesla's warrant-related share exposure and Nike's available equity compensation pool.",
      "llm_answer": "Tesla’s 2023 filing shows that about 11 million shares would be issued upon exercise of its outstanding warrants (see TSLA 10‑K, page 63). Nike’s 10‑K excerpts (pages 94‑98) do not provide a specific count of shares remaining available for future issuance under its equity‑compensation plans, so a direct numeric comparison cannot be made.",
      "correctness_score": 3,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Tesla's 11 million shares issuable upon exercise of outstanding warrants, which matches the ground truth. However, it incorrectly claims that Nike’s 10-K does not provide a specific count of shares remaining available for future issuance, when in fact the ground truth states that Nike disclosed 97,567,370 shares available under its equity compensation plans. This is a critical factual omission. (2) The quantitative accuracy is partially correct—Tesla’s number is accurate, but the complete absence of Nike’s figure undermines the comparison. The model fails to report a number that exists in the source material, leading to an incomplete and misleading conclusion. (3) The multi-hop reasoning is flawed: the question requires comparing two disclosed quantities across companies, but the LLM fails to retrieve and synthesize the Nike data, breaking the chain of reasoning. Instead of acknowledging the available data, it asserts a lack of information, which contradicts the ground truth. (4) Contextual relevance is moderate—the response addresses the right companies and topics (warrants, equity compensation), but the failure to report Nike’s disclosed shares severely limits usefulness. The conclusion that a comparison cannot be made is incorrect, as both figures are available. Thus, the correctness score is low due to a major factual gap despite partial numerical accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 395,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How does the differential voting power per share in GOOGL's Class B common stock impact its corporate governance structure, compared to NFLX's uniform voting rights model where each share carries one vote?",
      "original_answer": "GOOGL's Class B common stock provides 10 votes per share, significantly enhancing the voting influence of its holders compared to the 1 vote per share for Class A and no voting rights for Class C stock. This structure allows key stakeholders holding Class B shares to maintain disproportionate control over corporate decisions. In contrast, NFLX provides uniform voting rights, where each share of common stock entitles the holder to exactly one vote, promoting a more egalitarian governance model. The difference in voting rights structures reflects contrasting philosophies in corporate governance between the two companies.",
      "llm_answer": "Alphabet’s charter creates a dual‑class system in which each Class B share carries ten votes versus one vote for a Class A share, concentrating voting control in the hands of insiders who hold Class B stock and allowing them to steer board elections and major corporate actions even with a relatively small economic stake【page_82】. In contrast, Netflix grants every common share one vote, so voting power is proportional to share ownership and governance is more democratic and aligned with economic interest【page_60】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all numbers are correct: GOOGL's Class B shares carry 10 votes per share, Class A has 1 vote, and the contrast with NFLX's 1 vote per share is accurately stated. No calculations are required, and the numeric facts match exactly. (2) The answer is complete, addressing both the differential voting structure of GOOGL and the uniform voting model at NFLX, fulfilling the comparative aspect of the question. (3) Entities are correct—Alphabet (GOOGL) and Netflix (NFLX) are properly identified, and the stock classes and their voting rights are accurately described. (4) The reasoning is sound: the LLM correctly infers that the dual-class structure concentrates control with insiders, which is a valid interpretation of the governance impact, and contrasts it with Netflix’s more democratic, ownership-proportional model. The only minor shortcoming is that the LLM does not explicitly mention Class C shares (non-voting), which are referenced in the ground truth, but this omission does not undermine the overall correctness or completeness of the response. Semantic equivalence is maintained, and the answer is contextually fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 349,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "What percentage of Chevron's average daily net crude oil production in 2021 came from the QG3 project through its stake in Qatargas Operating Company Limited?",
      "original_answer": "Chevron's average daily net crude oil production from the QG3 project through its stake in Qatargas Operating Company Limited was 13 MBD in 2021. Since Chevron holds a 30% interest in Qatargas, this production volume reflects Chevron's proportional share of the crude oil output from the QG3 project.",
      "llm_answer": "Chevron’s 30 % interest in QG3 produced 13 thousand barrels of crude oil per day in 2021【page_11】.  With total average‑daily net crude oil production of roughly 1,825 thousand barrels per day for the company in 2021, the QG3 output represented about 0.7 % of Chevron’s overall crude production【page_61】.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer introduces information not present in the ground truth, leading to significant factual inaccuracies. While it correctly states that Chevron has a 30% interest in QG3 and that the project produced 13 thousand barrels per day (MBD) in 2021, it fabricates a total company-wide average daily net crude oil production figure of 1,825 thousand barrels per day and calculates a derived percentage of 0.7%, which is not supported by the original answer. The ground truth does not provide Chevron’s total crude oil production for 2021, nor does it state any percentage contribution of QG3 to overall production—only that the 13 MBD reflects Chevron’s proportional share through its 30% stake. Therefore, the quantitative accuracy is partially correct on the 13 MBD and 30% figures but incorrect in the derived percentage due to unsupported data. The reasoning is flawed because it performs a calculation based on external, unverified data, failing the multi-hop synthesis requirement—the question asks for a percentage, but the ground truth does not contain enough information to compute it. The contextual relevance is high because the answer addresses the right entities and time frame. However, the correctness score is low due to the fabricated total production number and the resulting incorrect percentage, which misrepresents the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 375,
        "total_tokens": 1528
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the adoption of ASU 2022-04 impact the transparency of supplier finance obligations for both 3M and Honeywell, particularly in terms of the new roll-forward disclosure requirements effective in 2024?",
      "original_answer": "The adoption of ASU 2022-04 enhances transparency for both 3M and Honeywell by mandating detailed annual disclosures about supplier finance program obligations, including a roll-forward of confirmed invoice amounts. For 3M, this includes reporting $1.5 billion of invoices confirmed and $1.5 billion of invoices paid or adjusted in 2024, which is now disclosed as part of the roll-forward requirement. Honeywell adopted the roll-forward provisions starting in 2024, aligning with the ASU’s phased implementation. Both companies now provide clearer visibility into their supplier finance activities, improving comparability and risk assessment for stakeholders.",
      "llm_answer": "ASU 2022‑04 does not change how either company records supplier‑finance liabilities, but it forces them to show a detailed roll‑forward of the program’s balances. 3M’s Note 16 now lists the confirmed‑invoice balance at year‑end and the year‑long activity (invoices confirmed, invoices paid and other adjustments), while Honeywell’s supply‑chain‑financing note presents a similar table of beginning balance, invoices confirmed, invoices paid and ending balance for 2024 (and 2023). The mandatory roll‑forward, effective in 2024, makes the size and flow of each firm’s supplier‑finance obligations far more transparent to investors.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core impact of ASU 2022-04 on transparency for both 3M and Honeywell. It correctly identifies that the standard does not change liability recognition but introduces a mandatory roll-forward disclosure starting in 2024, which aligns with the ground truth. The answer accurately describes the nature of the roll-forward (beginning balance, invoices confirmed, paid, adjustments, ending balance) and notes its inclusion in both companies' disclosures. However, it omits the specific dollar figures mentioned in the ground truth—3M’s $1.5 billion confirmed and $1.5 billion paid/adjusted—which are material details required for full quantitative completeness. While the structure and qualitative reasoning are sound, this omission prevents a perfect score. The entities (3M, Honeywell, ASU 2022-04, 2024 effective date) and multi-hop synthesis across both firms are correct. The explanation of improved transparency and investor relevance matches the original answer’s intent. Minor wording differences do not affect meaning, and the reasoning about enhanced comparability and risk assessment is implied. Overall, the answer is factually strong, contextually relevant, and semantically equivalent except for the missing numerical values.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 357,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How does LMT's revenue recognition approach for U.S. Government contracts regulated by FAR compare to RTX's financial exposure to U.S. Government contract risks, particularly in relation to fixed-price contract structures?",
      "original_answer": "LMT recognizes revenue for U.S. Government contracts regulated by the FAR using a cost-plus-fixed-fee model, where the standalone selling price is typically equal to the contract price due to FAR-mandated cost-plus structures. RTX, on the other hand, faces financial exposure from its reliance on fixed-price contracts, especially firm fixed-price (FFP) contracts, where it bears the full burden of cost overruns. Both companies are subject to U.S. Government contract risks, but LMT's FAR-regulated contracts provide more predictable revenue due to cost reimbursement with a reasonable profit margin, whereas RTX's FFP contracts carry higher risk of negative profit adjustments, particularly in development programs.",
      "llm_answer": "Lockheed Martin accounts for U.S. Government contracts (which are governed by the FAR) using a percentage‑of‑completion, cost‑to‑cost method that recognizes revenue over time as work‑in‑process is transferred to the customer and adjusts profit‑booking rates for risk retirements, recording a loss when estimated costs exceed the fixed‑price award 【page_76】【page_77】【page_78】.  Raytheon Technologies, by contrast, flags that a large share of its government business is on fixed‑price contracts, so any cost overruns or performance issues can generate direct losses and materially affect earnings, exposing the company to greater financial risk from the fixed‑price structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its description of both Lockheed Martin's (LMT) and Raytheon Technologies' (RTX) approaches to U.S. Government contracts and correctly identifies the financial risks associated with fixed-price structures. It accurately states that LMT uses a cost-to-cost percentage-of-completion method for revenue recognition on FAR-regulated contracts, which aligns with cost-plus-fixed-fee models where revenue is recognized over time based on costs incurred. The mention of adjusting profit-booking rates and recognizing losses when costs exceed fixed-price awards is consistent with accounting for long-term contracts under U.S. GAAP, especially when deviations occur.\n\nFor RTX, the LLM correctly highlights that a 'large share' of its government business is on fixed-price contracts, exposing it to cost overruns and potential losses—this matches the ground truth's emphasis on firm fixed-price (FFP) contracts and financial exposure. However, the original answer provides a clearer contrast by explicitly stating that LMT’s FAR-mandated cost-plus structures lead to more predictable revenue due to cost reimbursement, while RTX bears full risk of overruns under FFP contracts. The LLM answer implies this but does not make the regulatory distinction (FAR mandating cost-plus for LMT) as clearly, nor does it explicitly state that LMT’s model insulates it from cost overrun risk in the same way RTX is exposed.\n\nThere are no numerical values in the question or answers, so quantitative accuracy is not applicable in a strict sense—but since no numbers are misstated, it scores highly. Entity names (LMT, RTX, FAR) are correct. The reasoning is mostly sound and addresses the comparative financial exposure, though the multi-hop synthesis between regulatory framework (FAR), contract type (cost-plus vs FFP), and financial risk is slightly less precise than the original. Wording differences are acceptable under semantic equivalence, but the LLM omits the key point that FAR *mandates* cost-plus structures, which is central to why LMT has lower risk. This omission reduces qualitative accuracy slightly. Overall, the answer is relevant, correct in substance, but lacks full precision in explaining the regulatory and structural reasons behind the risk differential.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 611,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How does the expiration timeline of BMY's Eliquis patent rights in Europe compare to MRK's Januvia family patent expiration in the U.S., and what impact does this have on their respective market exclusivity strategies?",
      "original_answer": "BMY is actively litigating to extend the market exclusivity of Eliquis in Europe, having secured final positive decisions in Norway, Sweden, and Switzerland, while facing negative outcomes in the UK and ongoing appeals in several other countries. Despite these efforts, generic competition has already entered in some markets like Finland and Portugal. In contrast, MRK's Januvia family lost its key U.S. patent in January 2023, but due to court rulings and settlements, exclusivity is maintained until May 2026 for Januvia and Janumet and July 2026 for Janumet XR. This difference in timelines and enforcement success highlights how BMY's fragmented European patent strategy faces more immediate generic erosion, while MRK has extended exclusivity in the U.S. through secondary patents, delaying generic entry and preserving revenue longer.",
      "llm_answer": "BMS’s Eliquis composition‑of‑matter patent (and its SPCs) is still in force in Europe and is being defended through litigation across many countries, with only the UK already losing protection and generics on the market【page_121】. In contrast, Merck’s key U.S. patents covering the Januvia/Janumet sitagliptin family are slated to retain exclusivity until May 2026 for Januvia and Janumet and July 2026 for Janumet XR【page_58】. Thus, BMS must rely on aggressive court actions to extend its European market exclusivity, while Merck can count on a known pre‑2026 exclusivity period in the United States to drive sales before the expected generic entry.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all dates and exclusivity timelines are correct: MRK's Januvia/Janumet exclusivity until May 2026 and Janumet XR until July 2026 matches the original answer exactly. The mention of the UK losing protection for Eliquis aligns with the 'negative outcomes in the UK' in the ground truth. (2) The LLM correctly identifies BMS (BMY) and Merck (MRK) and their respective drugs, Eliquis and Januvia family, with proper geographic focus—Europe for Eliquis and U.S. for Januvia. (3) The reasoning is sound: it contrasts BMS's litigation-dependent, fragmented European strategy with Merck's more stable, court-extended U.S. exclusivity through secondary patents. (4) The only minor omission is that the original answer notes generic entry already occurred in Finland and Portugal and ongoing appeals in several countries, which the LLM does not mention—this slightly reduces completeness but does not affect core correctness. The LLM also correctly cites page references (121 and 58), indicating proper sourcing. Overall, the answer captures the key strategic difference in market exclusivity management, making it semantically equivalent with high contextual relevance and factual precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 356,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What is the total amount of appeal bonds posted by PM USA related to adverse verdicts on appeal, and how does this compare to the total payments made by PM USA for judgments and settlements in tobacco-related litigation since October 2004?",
      "original_answer": "PM USA has posted appeal bonds totaling $35 million related to adverse verdicts currently on appeal. Since October 2004, PM USA has paid approximately $1 billion in judgments and settlements (including related costs and fees) and approximately $241 million in interest related to tobacco litigation. This indicates that the current appeal bonds represent a small fraction of the total historical litigation-related payments made by PM USA.",
      "llm_answer": "PM USA has posted appeal bonds of roughly **$35 million** to secure stays of judgments while appeals are pending (see page 49 and page 92).  Since October 2004, PM USA has paid **about $1 billion** in judgments and settlements (plus about $241 million in interest) for tobacco‑related litigation (page 92).  Thus, the appeal‑bond amount is only a few percent of the total payments made.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $35 million in appeal bonds, $1 billion in judgments and settlements, and $241 million in interest are all accurately reported with acceptable formatting (e.g., 'about $1 billion' = 'approximately $1 billion'). (2) The answer addresses both parts of the multi-part question: the total appeal bonds posted and the comparison to historical payments. (3) Entities are correct—PM USA is the focus, and the time frame 'since October 2004' is properly applied. (4) The reasoning is sound: the LLM correctly synthesizes that the $35 million in bonds is a small fraction (a few percent) of the total payments (~$1.241 billion including interest), which aligns with the ground truth's conclusion. The mention of source pages adds contextual support without affecting factual accuracy. Semantic equivalence is maintained throughout.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 267,
        "total_tokens": 1497
      },
      "error": null
    },
    {
      "question_id": 205,
      "question": "How does the revenue contribution from Taiwan differ between Apple's Greater China segment in 2022 and NVIDIA's direct revenue reported from Taiwan in the same year?",
      "original_answer": "Apple's Greater China segment generated $74,200 million in net sales in 2022, which includes Taiwan along with China mainland and Hong Kong. In contrast, NVIDIA directly reported $8,544 million in revenue from Taiwan in 2022. Since Apple's figure for Taiwan is embedded within the broader Greater China segment, the exact revenue contribution from Taiwan alone for Apple cannot be determined precisely but is a subset of the $74,200 million. NVIDIA’s $8,544 million provides a direct and isolated measure of its Taiwan revenue.",
      "llm_answer": "Apple’s Greater China segment – which the filing says “includes China mainland, Hong Kong and Taiwan” – generated **$74.2 billion of net sales in 2022**【page_25†L7-L13】【page_52†L31-L38】. In contrast, NVIDIA’s 2022 10‑K does not break out any revenue attributable to Taiwan; the sections provided (pages 78‑82) contain no Taiwan‑specific revenue figure, indicating that NVIDIA reported no separate direct revenue from Taiwan for that year.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Apple's Greater China segment revenue as $74.2 billion in 2022, which matches the ground truth of $74,200 million (equivalent values, acceptable format variation). However, it incorrectly states that NVIDIA’s 10-K does not report any revenue from Taiwan, claiming 'no Taiwan-specific revenue figure' is provided. This contradicts the ground truth, which states NVIDIA directly reported $8,544 million in revenue from Taiwan in 2022. The LLM either failed to extract or misread the NVIDIA filing data, leading to a critical factual error. (2) Quantitatively, Apple’s number is accurate ($74.2B = $74,200M), but NVIDIA’s $8,544 million is entirely missing and falsely denied. No calculations were required, but the comparison fails due to incorrect data. (3) The reasoning is flawed in the multi-hop synthesis: the question asks to compare Apple’s embedded Taiwan contribution (within Greater China) with NVIDIA’s direct Taiwan revenue. The LLM fails this comparison by asserting NVIDIA has no such data, breaking the logical chain. (4) Contextual relevance is moderate—Apple’s segment definition and revenue are correctly cited with document references, but the core contrast with NVIDIA is invalid due to the omission of actual data. The answer would be strong if NVIDIA’s data were correctly included, but as it stands, it misrepresents a key fact, severely undermining correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 397,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 233,
      "question": "How has the growth in NVDA's revenue from Taiwan between fiscal years 2020 and 2022 compared to the growth in AAPL's revenue from the Greater China region, which includes Taiwan?",
      "original_answer": "NVDA's revenue from Taiwan grew from $3,025 million in 2020 to $8,544 million in 2022, representing a 182.5% increase over two years. AAPL's revenue from Greater China, which includes Taiwan, grew from $40,308 million in 2020 to $74,200 million in 2022, representing an 84.1% increase over the same period. Therefore, NVDA experienced significantly higher growth in revenue from Taiwan (as part of its broader regional exposure) compared to AAPL's growth in the broader Greater China region.",
      "llm_answer": "NVDA’s revenue from Taiwan rose from about **$2.2 billion in FY 2020 to roughly $5.1 billion in FY 2022**, a **≈134 % increase** (NVDA 10‑K, Note 5 Geographic Information, p. 78).  \nApple’s Greater‑China net sales (which include Taiwan) grew from **$40.3 billion in FY 2020 to $74.2 billion in FY 2022**, an **≈84 % increase** (Apple 10‑K, Segment Operating Performance, p. 25).  \n\nThus, NVDA’s Taiwan‑specific revenue grew faster than Apple’s Greater‑China revenue over the 2020‑2022 period.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, NVDA's revenue from Taiwan was $3,025 million in 2020 and $8,544 million in 2022, representing a 182.5% increase. However, the LLM reports $2.2 billion (i.e., $2,200 million) in 2020 and $5.1 billion (i.e., $5,100 million) in 2022, which is substantially lower than the actual figures. The calculated growth rate of ≈134% is also incorrect due to these wrong inputs. In contrast, the AAPL figures are correct: $40.3 billion in 2020 and $74.2 billion in 2022, with an accurate ≈84% increase. (2) The calculation for AAPL is correct: (74.2 - 40.3) / 40.3 ≈ 84.1%, matching the ground truth. But for NVDA, using the LLM's numbers: (5.1 - 2.2) / 2.2 ≈ 131.8%, rounded to 134%—still incorrect both numerically and due to wrong base data. The actual growth should be (8,544 - 3,025) / 3,025 ≈ 182.5%. (3) The multi-hop reasoning is logically sound—the model correctly compares revenue growth between NVDA (Taiwan-specific) and AAPL (Greater China, including Taiwan)—and draws the right qualitative conclusion that NVDA grew faster. However, this conclusion is based on incorrect data, undermining factual validity. (4) Despite incorrect numbers for NVDA, the answer structure is clear, cites appropriate sections of 10-Ks, and addresses all parts of the question. Hence, contextual relevance is high, qualitative reasoning is mostly sound, but quantitative accuracy is poor due to erroneous source data for NVDA, leading to a correctness score of 5—partially correct but with major factual flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 438,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 235,
      "question": "How does Microsoft's projected tax liability under the OECD's Pillar Two Model Rules compare to Broadcom's exposure from the global minimum tax, given their differing international tax structures?",
      "original_answer": "Microsoft projects no material impact from the OECD's Pillar Two Model Rules, which establish a 15% global minimum tax, as it begins applying to the company in fiscal year 2025. In contrast, Broadcom notes that global minimum tax provisions, such as Singapore's adoption effective for fiscal year 2026, may materially increase its effective tax rate and cash tax costs. This divergence reflects Microsoft's current lack of material operations in jurisdictions with tax rates below the 15% threshold, versus Broadcom's existing reliance on tax incentives in various jurisdictions that could be adversely affected by the global minimum tax.",
      "llm_answer": "Microsoft says the OECD Pillar‑Two rules will begin to apply to its worldwide operations in FY 2025, but it “does not currently estimate a material impact” to its consolidated statements, noting that a portion of its earnings is taxed at lower foreign rates (e.g., Ireland) and it will monitor the guidance 【page_47】. Broadcom, by contrast, notes that because it “does not have material operations in jurisdictions with tax rates lower than the Pillar Two minimum,” its exposure to the 15% global minimum tax is expected to be negligible and not materially increase its global tax costs 【page_75】. Thus, while both companies anticipate limited impact, Microsoft’s potential liability is tied to its foreign‑income mix, whereas Broadcom’s exposure is essentially minimal.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in its characterization of Broadcom's exposure. The original answer states that Broadcom expects a material increase in its effective tax rate and cash tax costs due to the global minimum tax, particularly because of Singapore's adoption in FY2026. However, the LLM answer incorrectly claims Broadcom expects 'negligible' impact and 'no material operations in jurisdictions with tax rates below the Pillar Two minimum,' which directly contradicts the ground truth. This reversal of Broadcom's actual position severely undermines the answer's correctness. Microsoft's portion is mostly accurate: it correctly notes no material impact projected starting FY2025 and references lower foreign tax rates (e.g., Ireland), aligning with the original. (2) Quantitatively, the fiscal years (2025 for Microsoft, 2026 for Singapore/Broadcom) are correctly cited, and the 15% minimum tax rate is accurately mentioned. No numerical calculations are required, so quantitative accuracy is acceptable. (3) The multi-hop reasoning fails because the model incorrectly synthesizes Broadcom's tax exposure. Instead of contrasting Microsoft's low risk with Broadcom's high risk due to tax incentives in low-rate jurisdictions, it falsely equates both as having limited impact, inverting the comparative logic required by the question. (4) Contextual relevance is fair because the answer addresses the OECD Pillar Two rules, mentions both companies, fiscal years, and tax structures, but the core qualitative inaccuracy in Broadcom's assessment leads to a low correctness and qualitative accuracy score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 449,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 245,
      "question": "How does the difference in voting rights structure between NFLX common stock and GOOGL Class B common stock impact shareholder influence, given that GOOGL Class B shares carry 10 votes per share while NFLX shares carry only one vote per share?",
      "original_answer": "NFLX common stock provides one vote per share to all shareholders, granting equal influence per share. In contrast, GOOGL has a multi-tiered voting rights structure where Class B common stockholders receive 10 votes per share, significantly amplifying their voting power compared to Class A shareholders who receive one vote per share. This structural difference means that GOOGL's Class B shareholders have disproportionately greater influence over corporate decisions than any single group of shareholders at NFLX, where voting power is uniformly distributed across all shares.",
      "llm_answer": "Netflix’s 2023 Form 10‑K states that “the holders of each share of common stock shall be entitled to one vote per share on all matters to be voted upon by the Company’s stockholders”【page_61】. Alphabet’s 2023 Form 10‑K notes that “each share of Class B common stock is entitled to 10 votes per share” (while Class A gets one vote)【page_81】. Thus, a GOOGL Class B holder wields ten‑times the voting power of a Netflix shareholder per share, concentrating influence in the hands of Class B owners and allowing them to dominate corporate decisions far more than a one‑vote‑per‑share structure like Netflix’s.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) Quantitative accuracy: The numbers are correct—NFLX has 1 vote per share, GOOGL Class B has 10 votes per share, and the comparison of ten-times voting power is accurate. The cited pages from the 2023 10-Ks are consistent with the data source. (2) Completeness: The answer addresses the core of the question—how the voting structure differences impact shareholder influence. It correctly contrasts the uniform voting at NFLX with the concentrated voting power at GOOGL. (3) Entity accuracy: Companies (NFLX, GOOGL), stock classes (Class B vs Class A), and document types (Form 10-K) are correctly identified. (4) Reasoning: The multi-hop synthesis—comparing two companies' voting structures using their respective 10-K filings—is sound. The conclusion that GOOGL Class B shareholders have significantly more influence per share than NFLX shareholders is logically derived. (5) Semantic equivalence: While the LLM emphasizes 'ten-times the voting power' more than the original, it captures the same essential meaning about disproportionate influence. Minor deduction in qualitative accuracy because it doesn't explicitly mention that NFLX has a single class of stock (implied but not stated), and the original answer more clearly articulates the uniform distribution of power at NFLX versus the tiered structure at GOOGL. Overall, the answer is highly accurate, well-supported, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 408,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does AMD's revenue from Taiwan in 2021 compare to Apple's 2022 revenue from the broader Greater China region, which includes Taiwan?",
      "original_answer": "AMD reported $1,187 million in revenue from Taiwan in 2021, while Apple reported $74,200 million in revenue from the Greater China region in 2022. Since Greater China includes Taiwan along with China mainland and Hong Kong, Apple's revenue from the broader region was significantly higher than AMD's revenue specifically from Taiwan.",
      "llm_answer": "AMD reported $2,091 million in revenue from Taiwan for 2021 (see the geographic‑sales table). Apple’s Greater China segment – which includes mainland China, Hong Kong and Taiwan – generated $74,200 million in net sales in 2022 (segment data). Thus AMD’s Taiwan revenue in 2021 was only about $2.1 billion, roughly 3 % of Apple’s 2022 Greater China revenue.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a major factual error in the AMD revenue figure. The ground truth states AMD reported $1,187 million in revenue from Taiwan in 2021, but the LLM incorrectly reports $2,091 million—a significant overstatement. Apple's revenue is correctly reported as $74,200 million from Greater China in 2022, which matches the ground truth. (2) The calculation comparing AMD’s revenue to Apple’s (stating AMD’s was 'roughly 3%') is based on the incorrect AMD number. With correct figures, $1,187M / $74,200M ≈ 1.6%, not 3%. Thus, the percentage comparison is also inaccurate due to the wrong input. (3) The multi-hop reasoning is structurally sound—the model correctly identifies that AMD’s Taiwan revenue must be compared to Apple’s broader Greater China revenue (which includes Taiwan, mainland China, and Hong Kong)—and it appropriately frames the comparison. However, the synthesis fails due to reliance on an incorrect data point. (4) Contextual relevance is high: the answer addresses both companies, correct years, and the geographic scope. The qualitative reasoning is logical and well-structured despite the data error. Final scores reflect high relevance and reasonable logic but severe penalty on quantitative and overall correctness due to the incorrect AMD revenue figure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 366,
        "total_tokens": 1535
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the availability of shares under Tesla's 2019 Equity Incentive Plan compare with Starbucks' remaining equity grant capacity, particularly in relation to their respective use of incentive stock options as a component of compensation strategy?",
      "original_answer": "Tesla's 2019 Equity Incentive Plan had 49.0 million shares reserved and available for issuance as of December 31, 2021, while Starbucks had 99.7 million shares available for future equity-based compensation awards as of October 2, 2022. Both companies utilize incentive stock options as part of their broader equity compensation structures, with Tesla's 2019 Plan explicitly including the provision for granting incentive stock options to employees, and Starbucks maintaining several equity incentive plans that include incentive stock options among other forms of equity compensation.",
      "llm_answer": "Tesla’s 2019 Equity Incentive Plan had 49.0 million shares reserved and available for issuance as of 12/31/2021 (​TSLA Note 13)​, whereas Starbucks reported roughly 99.7 million shares still available for future equity‑based compensation awards (​SBUX Note 13)​. Tesla’s plan expressly permits incentive stock options (grantable only to employees), while Starbucks’ stock‑option program consists of non‑qualified options and does not include incentive stock options as part of its compensation strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is quantitatively accurate: both share counts (49.0 million for Tesla as of December 31, 2021, and 99.7 million for Starbucks as of October 2, 2022) and dates are correct, matching the ground truth. The contextual relevance is high, as the response directly addresses the comparison of available shares and the role of incentive stock options in compensation strategy. However, there is a critical qualitative error: the LLM incorrectly states that Starbucks’ equity program 'does not include incentive stock options,' which contradicts the ground truth stating that Starbucks maintains plans that include incentive stock options among other forms. This misrepresents a key component of the multi-hop reasoning—synthesizing not just share availability but also the nature of equity instruments used. While Tesla's use of incentive stock options is correctly described, the erroneous claim about Starbucks undermines the comparative analysis, leading to a partially correct assessment. Thus, despite perfect numbers and good structure, the factual inaccuracy on a core qualitative point reduces the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 320,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the use of valuation models incorporating broker/dealer quotes impact the fair value determination of Level 2 assets for GD compared to BA's approach for available-for-sale debt investments?",
      "original_answer": "GD determines the fair value of its Level 2 fixed-income securities using valuation models that incorporate observable inputs such as quoted prices for similar assets and broker/dealer quotes. Similarly, BA values its available-for-sale debt investments using broker/dealer quotes for identical or comparable instruments. Both companies rely on these observable inputs through third-party pricing services and industry-standard models, indicating a parallel approach in determining fair value for Level 2 assets, despite being in different industries.",
      "llm_answer": "GD values its Level 2 assets (primarily fixed‑income securities in its pension plans) with a market‑approach valuation model that incorporates observable inputs such as interest rates, bond yields and quoted prices for comparable securities 【page_93】. In contrast, Boeing’s available‑for‑sale debt investments are measured at Level 2 using a market approach that relies directly on quoted market prices or broker/dealer quotes of identical or comparable instruments 【page_113】. Thus, GD’s fair‑value determination is model‑driven and estimates value from observable inputs, whereas BA’s approach uses actual broker/dealer price quotations, providing a more direct market reference for the assets.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that GD uses valuation models with observable inputs such as quoted prices for similar assets and broker/dealer quotes, and that BA uses broker/dealer quotes for identical or comparable instruments. However, it incorrectly frames the distinction by suggesting GD’s approach is 'model-driven' while BA’s is based on 'actual broker/dealer price quotations,' implying a meaningful divergence in methodology. The ground truth emphasizes that both companies use similar approaches—relying on third-party pricing services and industry-standard models incorporating broker/dealer quotes—indicating a parallel, not contrasting, methodology. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable; no errors in this regard. (3) The multi-hop reasoning is partially flawed: while the model correctly retrieves information about both companies’ fair value determinations, it fails to synthesize the key point of similarity emphasized in the original answer. Instead, it introduces a contrast (model-driven vs. direct quotes) not supported by the ground truth, misrepresenting the degree of difference between GD and BA. (4) The contextual relevance is high because the answer addresses the fair value determination for Level 2 assets at both companies and references appropriate inputs. However, the qualitative accuracy is reduced due to the incorrect comparative framing. The correctness score reflects that core facts are present but the synthesis and conclusion are misleading.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 431,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the current zero percent setting of the Countercyclical Capital Buffer (CCyB) impact the total capital buffer requirements for both Morgan Stanley and American Express under Basel III, considering Morgan Stanley's inclusion of the Stress Capital Buffer (SCB) in its Advanced Approach calculation and American Express's explicit subjectivity to the SCB?",
      "original_answer": "Under the current zero percent Countercyclical Capital Buffer (CCyB), Morgan Stanley's total capital buffer requirement under the Advanced Approach includes the 2.5% Capital Conservation Buffer (CCB), the G-SIB capital surcharge, and the Stress Capital Buffer (SCB). American Express is also subject to the SCB under Basel III, which contributes to its minimum capital requirements. Since the CCyB is currently set at zero, neither firm is required to add additional capital under this buffer. Therefore, the SCB plays a key role in both firms’ capital planning and distribution constraints, despite differing regulatory calculation approaches.",
      "llm_answer": "The Federal Reserve’s CCyB is set at 0 percent, so it contributes nothing to either firm’s buffer. Morgan Stanley therefore meets a total buffer of 5.4 % (SCB) + 3.0 % (G‑SIB) + 0 % (CCyB) = 8.4 % under the Standardized approach, and 2.5 % (capital‑conservation) + 3.0 % (G‑SIB) + 0 % (CCyB) = 5.5 % under the Advanced approach (the SCB is not counted in the Advanced calculation)【page_134】. American Express, which is explicitly subject to the SCB, adds only its SCB and the 3 % G‑SIB surcharge to the buffer, so its total requirement is SCB + 3 % + 0 % (CCyB) (e.g., 5.4 % + 3 % = 8.4 %)【AXP_10k_2023.pdf page 134】.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual and conceptual errors. While it correctly notes that the CCyB is 0%, which aligns with the ground truth, it incorrectly states that Morgan Stanley does not include the SCB in its Advanced Approach calculation—this directly contradicts the question and the ground truth, which explicitly states that Morgan Stanley *does* include the SCB in its Advanced Approach. The LLM claims the SCB is only used in the Standardized approach (8.4% total) and not in the Advanced approach (5.5%), but this is false: the SCB is a binding constraint under the Advanced Approach for large banks like Morgan Stanley. (2) The quantitative values are partially fabricated. The G-SIB surcharge is not universally 3.0% and varies by firm and year; the LLM assigns the same 3.0% to both Morgan Stanley and American Express without justification. American Express is not a G-SIB and therefore should not be subject to a G-SIB surcharge at all—this is a major error. The SCB value of 5.4% is cited without confirmation and applied incorrectly to both firms. (3) The multi-hop reasoning fails: the model does not correctly synthesize the regulatory frameworks for the two firms. It mischaracterizes American Express’s capital requirements by imposing a G-SIB surcharge on a non-G-SIB institution. It also creates a false dichotomy between Standardized and Advanced approaches for Morgan Stanley without acknowledging that the Advanced Approach is the relevant one, and that SCB is part of it. (4) Contextual relevance is moderate because the answer addresses capital buffers and mentions the correct regulatory components (CCyB, SCB, G-SIB, CCB), but the incorrect application of these to the firms undermines the response. Overall, the answer is mostly incorrect due to fundamental misunderstandings of Basel III implementation for these institutions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 509,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the $4.0 billion increased commitment under AMT's 2021 Credit Facility relate to its financing strategy for acquisitions, and how does this contrast with SPG's approach to financing through joint ventures as of December 31, 2021?",
      "original_answer": "AMT increased the commitment under its 2021 Credit Facility to $4.0 billion, which was used to finance acquisitions such as the CoreSite Acquisition, reflecting a strategy of leveraging large-scale credit facilities for major transactions. This contrasts with SPG's approach, where it provided $88.4 million in financing to joint ventures primarily in the form of interest-bearing construction loans, indicating a focus on internal financing and partnership structures to support real estate development and diversify risk.",
      "llm_answer": "American Tower’s $4.0 billion increase in the 2021 Credit Facility was an expansion of its revolving borrowing capacity that the company tapped to pay the cash consideration for its major purchases – the Telxius and CoreSite acquisitions – and to refinance existing debt, showing a debt‑driven, “borrow‑to‑buy” acquisition model【page_111†L1-L5】【page_111†L6-L9】.  \n\nIn contrast, Simon Property Group does not rely on a large credit line for acquisitions; instead it funds purchases and development through equity‑method joint‑venture investments and interest‑bearing construction loans to partners, using joint‑venture structures to share risk and finance property deals as of Dec. 31 2021【page_116†L1-L5】【page_117†L1-L4】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key figures are correct: the $4.0 billion commitment increase under AMT's 2021 Credit Facility is accurately stated, and while the original answer mentions $88.4 million in financing by SPG to joint ventures, this figure is not included in the LLM response—this is the only minor omission. However, no incorrect numbers are presented, and the dates (as of December 31, 2021) are correctly implied. (2) The LLM correctly identifies both companies (AMT and SPG), their respective financial instruments (credit facility vs. joint ventures and construction loans), and the strategic context. (3) The reasoning is sound: it correctly synthesizes that AMT uses large-scale debt financing (revolving credit) for acquisitions like CoreSite and Telxius, reflecting a 'borrow-to-buy' model, while SPG relies on joint ventures and internal financing structures to share risk—this directly contrasts the two strategies as required. (4) The LLM adds value by naming the Telxius acquisition, which is consistent with the filings and enriches the answer, even though not in the original answer. The only reason for not scoring a 10 is the omission of the specific $88.4 million figure from SPG’s joint venture financing, which was present in the ground truth and would have strengthened quantitative completeness. Otherwise, the answer is semantically equivalent, contextually precise, and demonstrates strong multi-hop reasoning across entities and strategies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 422,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does the growth in Starbucks' store count in Taiwan compare to Nike's revenue contribution from the Greater China region, considering Taiwan's inclusion within Greater China's geographic reporting?",
      "original_answer": "Starbucks added 21 net new stores in Taiwan from fiscal year 2021 to 2022, reflecting a growth in its operational footprint. Meanwhile, Nike reported $7,547 million in total revenues from the Greater China region in FY2022, which includes Taiwan. This indicates that while Starbucks is expanding its physical presence in Taiwan, Nike's revenue from the broader Greater China region—which encompasses Taiwan—represents a significant portion of its global revenue, highlighting different modes of market engagement and performance metrics across the two companies.",
      "llm_answer": "Starbucks added 21 net stores in Taiwan during the fiscal year (523 stores at Oct 3 2021 → 544 stores at Oct 2 2022) – roughly a 4 % increase【page_12】. In contrast, Nike’s Greater China segment (which includes Taiwan) generated $7.5 billion of revenue in FY 2022, representing a multi‑billion‑dollar contribution to the company【page_88】. Thus, the Taiwan store‑count growth is a modest numerical expansion, whereas Nike’s Greater China region delivers a far larger monetary impact.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Starbucks added 21 net new stores in Taiwan from FY2021 to FY2022, matching the ground truth. It provides additional detail (523 to 544 stores) that aligns with the 21-store increase and calculates a ~4% growth rate, which is accurate (21/523 ≈ 4.01%). Nike's Greater China revenue is reported as $7.5 billion, which is a rounded version of the exact $7,547 million in the original answer—this is acceptable under format variation. (2) All numeric values are correct or appropriately rounded. The store count progression and percentage increase are accurately derived. The $7.5 billion figure is a standard rounding of $7,547 million and does not misrepresent the data. (3) The multi-hop reasoning is sound: the model correctly synthesizes Starbucks' store growth in Taiwan with Nike's revenue from Greater China (which includes Taiwan), acknowledging different performance metrics (physical expansion vs. revenue contribution). The conclusion contrasting modest store-count growth with significant monetary impact is logically valid and consistent with the original answer. (4) The answer is contextually relevant, directly addressing the comparison between Starbucks' operational growth and Nike's financial performance in overlapping geography. The only minor shortcoming is the lack of explicit mention that Taiwan is included within Greater China in Nike’s reporting (though it is implied), which slightly reduces qualitative accuracy. Otherwise, the answer is factually correct, complete, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 430,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What percentage of Boeing's (BA) OPB plan assets are indirectly invested in equities through the balanced index fund, and how does this compare to the total fair value of equities held by 3M's (MMM) pension plan as of December 31, 2023?",
      "original_answer": "Boeing's OPB plan assets are approximately 60% invested in equities via the balanced index fund. Meanwhile, 3M's pension plan reported a total fair value of $785 million in equities as of December 31, 2023.",
      "llm_answer": "Boeing’s other‑post‑retirement benefit (OPB) plan invests the bulk of its assets in a balanced index fund that is roughly 60 % equities (the remainder being about 40 % debt)【page_96】.  \n\n3M’s pension plans reported equity holdings of $1.42 billion for U.S. plans and $0.785 billion for international plans, for a total fair‑value of about $2.2 billion of equities as of December 31 2023【page_72】【page_73】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Boeing's OPB plan assets are approximately 60% invested in equities through the balanced index fund, which matches the ground truth. However, it significantly misstates 3M's total fair value of equities. The ground truth reports $785 million total, but the LLM claims $2.2 billion by summing $1.42 billion (U.S.) and $0.785 billion (international), which contradicts the original answer. This calculation error leads to a major factual inaccuracy. (2) Quantitative accuracy is low because while the 60% figure is correct, the total equity value for 3M is wrong. The $785 million in the ground truth appears to refer to the international portion only in the LLM's answer, suggesting a misinterpretation of the data source. The LLM incorrectly assumes both U.S. and international amounts should be summed to get a total, whereas the ground truth implies $785 million is the total. (3) The multi-hop reasoning is partially sound—linking Boeing's asset allocation to 3M's equity holdings—but fails in synthesis because it uses incorrect source interpretation. The model adds two numbers that should not be added per the ground truth, indicating flawed logic in combining entities. (4) Contextual relevance is fair because the answer addresses both parts of the question and cites relevant pages, but the incorrect total undermines the comparison. The qualitative accuracy is moderate due to correct identification of companies, metrics, and time period, but flawed reasoning in aggregation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 422,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does AMT's utilization of the 2021 USD Delayed Draw Term Loans for financing compare to SPG's use of financing mechanisms for real estate joint ventures, particularly in terms of dollar amounts and financing structure?",
      "original_answer": "AMT utilized the 2021 USD Delayed Draw Term Loans as part of a $10.5 billion financing structure to support the CoreSite Acquisition, ensuring funding availability without drawing on bridge loans. In contrast, SPG provided $88.4 million in financing to joint ventures through interest-bearing construction loans and other advances as of December 31, 2021, primarily to support real estate development and investment activities. While AMT's financing was large-scale and acquisition-focused, SPG's approach was smaller in scale and oriented toward real estate joint ventures.",
      "llm_answer": "American Tower used the 2021 USD Delayed‑Draw Term Loans to borrow roughly $4.5 billion – a $3.0 billion 364‑day loan and a $1.5 billion two‑year loan – which were unsecured, LIBOR‑plus‑margin term facilities with no required amortization and were deployed to fund the CoreSite acquisition.  In contrast, Simon Property Group’s financing of its real‑estate joint ventures is limited to about $88.4 million of interest‑bearing construction loans and other advances to partners, a much smaller, short‑term loan arrangement recorded as deferred costs and other assets.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains a significant quantitative error: it states that American Tower borrowed 'roughly $4.5 billion' from the 2021 USD Delayed-Draw Term Loans, breaking it down into $3.0 billion and $1.5 billion tranches. However, the ground truth specifies a $10.5 billion financing structure, not $4.5 billion. This major discrepancy in dollar amount undermines the factual accuracy of the response, even though the purpose (funding the CoreSite acquisition) and loan characteristics (unsecured, LIBOR-plus-margin, no amortization) are correctly described. The SPG portion is accurate: $88.4 million in interest-bearing construction loans and other advances as of December 31, 2021, is correctly reported, including the nature and classification of the financing. Entity accuracy is strong—AMT and SPG are correctly identified, as are the financial instruments and time frame. The reasoning and comparison are logically structured: the contrast between AMT’s large-scale, acquisition-focused financing and SPG’s smaller, development-oriented joint venture loans is qualitatively sound and contextually relevant. However, the incorrect total amount for AMT’s financing leads to a flawed quantitative foundation, which is critical in financial comparisons. While the LLM captures the structural differences and intent, the core numerical inaccuracy reduces confidence in the overall correctness. Semantic equivalence is partially achieved, but the magnitude of the dollar amount error prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 414,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does XOM's reliance on crude oil as a raw material intersect with CVX's 15% ownership in the Caspian Pipeline Consortium, considering the volume of crude oil transported through CPC from Chevron's operations in Kazakhstan?",
      "original_answer": "XOM depends on crude oil as a core raw material for its operations. Meanwhile, CVX holds a 15% interest in the Caspian Pipeline Consortium (CPC), which transports an average of 1.4 million barrels of crude oil per day, with 1.2 million barrels sourced from Kazakhstan—specifically from fields like Tengiz and Karachaganak in which Chevron operates or holds stakes. This means that a portion of the crude oil CVX produces or co-produces in Kazakhstan relies on CPC for export, linking upstream production to midstream logistics. Since crude oil is essential for XOM’s business, any disruption in supply chains like CPC could impact the availability or cost of crude oil for companies downstream, including XOM.",
      "llm_answer": "XOM’s upstream and downstream businesses are fundamentally built on crude oil – the company both produces the commodity and purchases large volumes of crude as the feedstock for its refineries (see the “Crude oil and product purchases” line in XOM’s segment tables). Chevron (CVX) holds a 15 % stake in the Caspian Pipeline Consortium, which in 2024 moved an average of 1.4 million barrels of crude per day, of which about 1.2 million barrels per day came from Chevron’s Tengiz and Karachaganak fields in Kazakhstan (CVX p. 16 & 85). Thus, CVX’s pipeline ownership secures a critical export route for the Kazakh crude that XOM relies on as a raw material, linking the two companies’ supply chains.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: CVX holds a 15% stake in the CPC, the pipeline transports 1.4 million barrels per day, and 1.2 million barrels per day originate from Chevron-operated fields in Kazakhstan (Tengiz and Karachaganak). These numbers match the original answer exactly. (2) The quantitative accuracy is perfect—no errors in values or units, and the 2024 reference is consistent with the data context. (3) The multi-hop reasoning is sound: it correctly links XOM’s reliance on crude oil as a raw material (both through production and procurement) with CVX’s ownership in CPC, which enables export of Kazakh crude that contributes to global supply. The synthesis across XOM’s refining needs and CVX’s midstream logistics is logically coherent. (4) The only minor limitation is that the LLM slightly overstates that the 1.2 million bpd are solely from 'Chevron’s Tengiz and Karachaganak fields'—while Chevron operates Tengiz and has a stake in Karachaganak, these are joint ventures, so 'Chevron-operated' or 'Chevron-held stakes in' would be more precise. However, this does not materially distort the fact that CVX benefits from this flow. The answer remains semantically equivalent and contextually fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 365,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the decommissioning funding shortfall risk at NEE's nuclear facilities compare to Duke Energy's exposure to nuclear decommissioning trust fund volatility, given the shared environmental and financial risks associated with nuclear power plant operations?",
      "original_answer": "NEE faces potential decommissioning funding shortfalls due to the risk that decommissioning costs could exceed the amount available in its decommissioning funds, which are subject to market and operational uncertainties. Similarly, Duke Energy Carolinas, Duke Energy Progress, and Duke Energy Florida maintain Nuclear Decommissioning Trust Funds (NDTFs) whose values are subject to market fluctuations. A decline in the market value of these NDTF assets could significantly increase Duke Energy's funding requirements for decommissioning. Both companies are exposed to the financial risks of nuclear power plant decommissioning, with NEE highlighting potential shortfalls and Duke Energy emphasizing the impact of capital market performance on its NDTF investments.",
      "llm_answer": "NEE warns that a decline in the market value of its nuclear decommissioning funds could create a funding shortfall that exceeds the amount held in its de‑commissioning trusts or insurance, potentially impairing liquidity, financial condition and results of operations (NEE 10‑K p.32). Duke Energy similarly notes that market fluctuations can reduce the value of its nuclear de‑commissioning trust‑fund (NDTF) assets, requiring additional funding and possibly hurting its results of operations, financial position and cash flows (Duke Energy 10‑K p.35), so while both face the same environmental and financial risks, NEE’s risk is framed as a possible shortfall versus Duke’s risk of trust‑fund volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) All factual information is correct: both NEE and Duke Energy face financial risks related to nuclear decommissioning due to market volatility affecting their trust funds. The LLM correctly identifies that NEE highlights potential funding shortfalls if costs exceed trust values, while Duke Energy emphasizes the impact of market fluctuations on its Nuclear Decommissioning Trust Funds (NDTFs), possibly requiring additional funding. (2) There are no numeric values (e.g., dollar amounts, percentages, years) in either the question or the ground truth, so quantitative accuracy is not compromised—no calculations or figures to verify. (3) Multi-hop reasoning is sound: the LLM synthesizes risk disclosures from both companies’ 10-K filings, correctly comparing NEE’s framing of 'funding shortfall' with Duke’s focus on 'trust fund volatility,' despite both facing similar underlying risks. The mention of specific page numbers (p.32 for NEE, p.35 for Duke) adds precision and supports the claims, even though these were not in the original answer—this is acceptable as long as they are consistent with source documents and do not introduce inaccuracies. (4) Semantic equivalence is strong: the LLM captures the core comparison—both firms are exposed to market-driven financial risks in decommissioning, with slightly different risk characterizations. The only minor limitation is that the original answer explicitly names Duke Energy Carolinas, Duke Energy Progress, and Duke Energy Florida as maintaining NDTFs, while the LLM uses the more general 'Duke Energy.' However, this does not detract from overall correctness, as the entity is still accurately represented. Contextual relevance is excellent, directly addressing the comparative risk exposure as requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 501,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does LOW's use of pricing models for Level 3 fair value measurements compare to GM's application of unobservable inputs in Level 3 valuations, particularly in light of the stated accounting policy that classifies valuations based on the observability of inputs?",
      "original_answer": "LOW applies pricing models to determine fair value for Level 2 assets and uses an income approach with significant unobservable inputs like volatility and expected term for its Level 3 contingent consideration related to the Canadian retail business sale. This aligns with the accounting policy that defines Level 3 valuations as those using significant unobservable inputs, often involving pricing models or discounted cash flow methodologies. GM similarly relies on unobservable inputs for Level 3 valuations, particularly in its GM Financial receivables, where static pool modeling and economic forecasts such as unemployment rates and GDP growth are used to estimate expected credit losses. Both companies follow the same accounting hierarchy but apply it differently depending on the nature of their assets and business operations.",
      "llm_answer": "Lowe’s filing explains that its Level 3 fair‑value amounts – for example the performance‑based contingent‑consideration – are measured with pricing models (an option‑pricing model) that depend on significant **unobservable** inputs such as total‑equity value, volatility and expected term (see LOW p. 53; the hierarchy definition is in p. 52). General Motors likewise classifies an instrument as Level 3 only when the valuation technique requires **significant unobservable inputs**, using pricing models (e.g., discounted‑cash‑flow or option models) when market quotes are unavailable, while observable inputs are used for Level 2 (see GM p. 63). Thus, both companies follow the policy that Level 3 is assigned when unobservable inputs dominate the model, but Lowe explicitly cites a specific pricing‑model approach for its Level 3 items, whereas GM describes the broader reliance on unobservable inputs across its Level 3 valuations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: LOW uses an option-pricing model with significant unobservable inputs (volatility, expected term, total equity value) for Level 3 contingent consideration, specifically tied to performance-based metrics from the Canadian retail business sale. GM similarly classifies Level 3 valuations based on significant unobservable inputs, using discounted cash flow and other models when observable inputs are lacking, particularly in GM Financial receivables. The accounting policy reference—that Level 3 is defined by dominance of unobservable inputs—is correctly stated by both. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or answers, so quantitative accuracy is not compromised. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies (LOW and GM), identifies their respective use of pricing models and unobservable inputs in Level 3 valuations, and compares them under the common FASB fair value hierarchy framework. The only minor shortcoming is that the LLM does not explicitly mention GM’s use of economic forecasts like unemployment and GDP growth in static pool modeling—this contextual detail from the original answer is omitted, slightly reducing completeness. However, the core reasoning and comparison remain intact. (4) The answer is contextually relevant, directly addressing the comparison of pricing model usage and unobservable inputs under the observability-based classification policy. Wording differs but semantic meaning matches. Thus, a score of 9 is justified—excellent accuracy with a minor omission in depth of GM's methodology.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 475,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the $10.5 billion in committed financing under AMT's 2021 Multicurrency Credit Facility compare with SPG's financing activities in joint ventures, particularly in terms of capital deployment strategy and risk diversification?",
      "original_answer": "AMT secured $10.5 billion in committed financing through its 2021 Multicurrency Credit Facility and related facilities, which were used to fund acquisitions like CoreSite and Telxius, while SPG provided $88.4 million in financing to joint ventures primarily in the form of interest-bearing construction loans, aligning with its strategy to diversify risk and finance property development. This shows that AMT leveraged large-scale credit facilities for major acquisitions, whereas SPG used smaller, targeted financings to support joint venture operations and risk-sharing.",
      "llm_answer": "American Tower’s $10.5 billion of committed financing under its 2021 Multicurrency Credit Facility (see page 113 / 52) is a large, multi‑currency revolving pool that underwrites its $5‑$6 billion CoreSite and Telxius acquisitions and provides broad liquidity for general corporate purposes, diversifying funding risk across several loan facilities and currencies. In contrast, Simon Property Group’s joint‑venture financing is modest—about $88.4 million of construction loans and other advances to JV partners (page 116) plus equity stakes in specific projects—focused on funding individual property developments and spreading risk through partnership structures rather than a massive revolving credit line.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AMT's $10.5 billion committed financing under its 2021 Multicurrency Credit Facility is accurately stated, as is SPG's $88.4 million in financing to joint ventures. The use of funds for CoreSite and Telxius acquisitions by AMT and for construction loans and property development by SPG is correctly represented. (2) Quantitative accuracy is perfect: both dollar amounts ($10.5 billion and $88.4 million) match the original answer exactly, and no calculations are required beyond accurate reporting. (3) Multi-hop reasoning is sound—LLM correctly synthesizes information across two companies (AMT and SPG), their respective financing instruments, strategic purposes, and risk diversification approaches. It contrasts large-scale revolving credit usage (AMT) versus targeted joint venture lending and equity (SPG), capturing the core strategic difference. (4) Minor deduction in qualitative accuracy due to slight over-elaboration (e.g., 'page 113 / 52' and 'page 116' references not in original and potentially hallucinated; also 'revolving pool' and 'liquidity for general corporate purposes' add detail not in ground truth, though not incorrect). However, the semantic meaning and strategic comparison remain fully aligned. Contextual relevance is excellent—directly addresses capital deployment strategy and risk diversification as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 398,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does AMD's revenue exposure to Taiwan in 2023 compare to QCOM's operational dependency on foundry partners in Taiwan, given the geopolitical risks associated with the region?",
      "original_answer": "AMD reported $1,841 million in sales to external customers from Taiwan in 2023, indicating a notable but declining revenue exposure compared to previous years. Meanwhile, QCOM explicitly states that its business depends on consistent and reliable chipset supply from foundry partners, particularly in Taiwan. A significant or prolonged military or geopolitical conflict involving China and Taiwan could severely limit or prevent QCOM from receiving chipset supply, which would have a material adverse impact on its business. Given that both companies are exposed to Taiwan—AMD through revenue and QCOM through critical supply chain dependencies—geopolitical instability in the region poses a dual risk, impacting both revenue streams and manufacturing continuity.",
      "llm_answer": "AMD generated $1.84 billion of sales to customers in Taiwan in 2023 – about 8 % of its total $22.68 billion revenue (AMD 10‑K, page 71). Qualcomm, however, states that its business “depends on our ability to receive consistent and reliable chipset supply from our foundry partners, particularly in Taiwan,” and that a conflict could “severely limit or prevent” that supply, creating a material operational risk (QCOM 10‑K, page 35).  Thus AMD’s Taiwan exposure is a modest revenue share, while Qualcomm’s reliance on Taiwanese foundries is a critical supply‑chain dependency.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states AMD's $1.84 billion in sales to Taiwan in 2023, which aligns with the ground truth of $1,841 million (equivalent values, minor rounding difference acceptable). It also accurately calculates this as approximately 8% of AMD’s total revenue ($22.68 billion), a detail not in the original answer but factually correct and adds value. The citation of QCOM’s 10-K page 35 for its foundry dependency is consistent with the original answer’s claim about supply chain risk. (2) All numeric values are accurate: $1.84 billion = $1,841 million, and $22.68 billion total revenue matches AMD’s 2023 reported revenue. The percentage calculation (1,841 / 22,680 ≈ 8.11%) is correctly rounded to 8%. (3) The multi-hop reasoning is sound—correctly distinguishing between AMD’s revenue exposure (downstream customer sales) and QCOM’s operational/supply chain dependency (upstream manufacturing reliance)—and synthesizes information across both companies’ filings. (4) The only minor shortcoming is that the LLM omits the point about AMD’s exposure being 'declining compared to previous years,' which is present in the original answer and adds context. However, this does not undermine the core accuracy. Otherwise, the answer is factually correct, well-reasoned, and directly addresses the geopolitical risk comparison. Thus, high scores across all categories with a 9/10 on correctness and qualitative accuracy due to the small omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 406,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does the expected impact of the 15% global minimum tax under OECD's Pillar 2 on SBUX's consolidated financial statements compare to MCD's assessment, given the phased implementation timelines across jurisdictions?",
      "original_answer": "SBUX notes that the global minimum tax under Pillar 2 will not be effective for the company until fiscal 2025 and is not expected to result in a material impact on its consolidated financial statements. Similarly, MCD states that while numerous countries have enacted Pillar 2 with an effective date for taxable years beginning after December 31, 2023, it also does not expect a material impact on its consolidated financial statements. Both companies are monitoring regulatory developments and await further guidance, as the implementation of Pillar 2 varies across jurisdictions and could evolve over time.",
      "llm_answer": "Starbucks says the 15 % global minimum‑tax rules under OECD Pillar 2 won’t become effective for it until fiscal 2025 and therefore are not expected to have a material impact on its consolidated financial statements. McDonald’s, by contrast, notes that a number of jurisdictions have already enacted Pillar 2 for tax years beginning after Dec 31 2023, but it likewise expects no material effect on its consolidated results and will keep monitoring the phased rollout.  The difference is mainly timing – Starbucks’ impact is pushed to 2025, while McDonald’s acknowledges earlier, staggered implementation yet still foresees no material impact.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: SBUX expects no material impact with Pillar 2 effective in fiscal 2025; MCD acknowledges implementation starting after December 31, 2023, in various jurisdictions but also expects no material impact. The 15% rate is correctly referenced. (2) Quantitative accuracy is perfect: dates (fiscal 2025, Dec 31 2023), percentages (15%), and company timelines are correctly reported with no calculation errors. (3) Multi-hop reasoning is sound—correctly compares SBUX and MCD’s assessments, noting the difference in timing (2025 vs. earlier staggered rollout) while concluding both expect no material impact. (4) The answer captures all elements of the original response, including monitoring of regulatory developments (implied in 'keep monitoring'). The only minor omission is that the original explicitly states both companies await further guidance, which is slightly underemphasized in the LLM version, but the core meaning and synthesis remain intact. Wording differs but is semantically equivalent. No factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 317,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does JPMorganChase's risk governance framework, which emphasizes firmwide ownership of risk assessment, influence its approach to stress testing methodologies compared to Goldman Sachs, which explicitly ties stress testing to capital adequacy assessments?",
      "original_answer": "JPMorganChase's risk governance framework emphasizes firmwide ownership of risk assessment, with Risk Management and Compliance functions overseeing risk identification and escalation across business lines and corporate functions. This structured governance leads to a comprehensive approach to risk, where stress testing is likely embedded within broader risk identification and mitigation processes. In contrast, Goldman Sachs explicitly uses stress testing to assess capital adequacy and quantify exposure to tail risks, performing firmwide stress tests regularly to evaluate vulnerabilities across financial and nonfinancial risks. The difference in emphasis—JPMorganChase’s governance-driven risk ownership versus Goldman Sachs’s scenario-based capital adequacy focus—suggests that while both firms use stress testing as a core risk tool, the integration and ultimate purpose of stress testing within their risk frameworks differ significantly.",
      "llm_answer": "JPMorgan Chase’s risk‑governance model puts the responsibility for identifying and assessing risk on each line‑of‑business and on corporate, with the Independent Risk Management (IRM) function, the CRO, and the Board Risk Committee providing firm‑wide oversight and challenge (see JPM page 93‑94). Because risk owners are expected to own the assessment process, stress‑testing is embedded in the day‑to‑day risk‑management activities of the businesses and is overseen centrally rather than being a stand‑alone capital‑adequacy exercise (see JPM page 95). Goldman Sachs, on the other hand, runs a firm‑wide stress‑testing program that is explicitly linked to its capital‑planning and regulatory capital assessments, using the results to gauge capital adequacy (see GS page 99) and employing a suite of scenario, sensitivity and earnings‑at‑risk analyses to support that purpose (see GS page 111).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: JPMorganChase's firmwide ownership model is accurately described, with risk embedded in business lines and overseen by IRM, CRO, and Board Risk Committee. The integration of stress testing into day-to-day risk management—rather than as a standalone capital adequacy exercise—is correctly contrasted with Goldman Sachs’ explicit linkage of stress testing to capital planning and regulatory capital assessments. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or answers, so quantitative accuracy is not applicable in a numerical sense; however, the citation of page numbers (e.g., JPM page 93-94, GS page 99) suggests precise sourcing and supports factual grounding, which is acceptable as contextual references rather than quantitative data. These are consistent with expected documentation practices and do not affect numerical accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes governance structure (JPMorganChase’s decentralized ownership with centralized oversight) and compares it to Goldman Sachs’ centralized, capital-focused stress testing program. The distinction in purpose—integration into broader risk processes vs. capital adequacy assessment—is clearly and correctly articulated. (4) Semantic equivalence is strong: while the LLM answer uses slightly different phrasing (e.g., 'oversight and challenge' vs. 'escalation'), the meaning is consistent with the original. The only minor shortcoming is that the LLM answer does not explicitly mention Goldman Sachs’ evaluation of 'nonfinancial risks' or 'tail risks' as in the original, which slightly reduces completeness in qualitative nuance. However, the core contrast in stress testing purpose and integration is preserved. Hence, a score of 9 is justified—excellent accuracy with only minor omissions in descriptive breadth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 536,
        "total_tokens": 2025
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does XOM's asset exposure in Kazakhstan compare to CVX's financial stake in Tengizchevroil, considering CVX's equity ownership and loan contributions to the joint venture?",
      "original_answer": "XOM had $8,463 million in long-lived assets in Kazakhstan as of 2021, while CVX holds a 50% equity interest in Tengizchevroil (TCO), which operates in the same country. In addition to its equity stake, CVX provided a $4,500 million loan to TCO to fund the Future Growth Project and Wellhead Pressure Management Project (FGP/WPMP). This indicates that CVX's financial exposure to Tengizchevroil in Kazakhstan includes both its proportional equity value and a significant direct loan, potentially exceeding the magnitude of XOM's reported asset base in the country when combined.",
      "llm_answer": "Exxon Mobil’s long‑lived assets in Kazakhstan total about **$8.5 billion** (2021)【page_123】.  By contrast, Chevron owns **50 % of Tengizchevroil** and records a **$23.7 billion investment** in the joint venture, which also includes a **$4.5 billion loan** to fund development【page_78】.  Thus Chevron’s financial stake in Tengizchevroil is roughly three times the size of Exxon’s Kazakhstan asset exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but introduces a critical factual error in the reported investment value. The ground truth states that XOM had $8,463 million (≈$8.5 billion) in long-lived assets in Kazakhstan as of 2021, which the LLM correctly approximates. It also correctly identifies CVX's 50% equity interest in Tengizchevroil and the $4.5 billion loan to fund the FGP/WPMP projects. However, the LLM claims CVX has a '$23.7 billion investment' in TCO, which is not supported by the original answer or any referenced data in the ground truth. This figure appears fabricated or misattributed, as the original answer only mentions the 50% equity stake and the $4.5 billion loan—no total investment value is given. (2) Quantitative accuracy is partially correct: $8.5 billion for XOM is a valid rounding of $8,463 million; $4.5 billion loan is accurate. But the $23.7 billion figure is unsupported, and the conclusion that CVX’s stake is 'roughly three times' XOM’s exposure relies on this erroneous number. Without knowing the full equity value of CVX’s 50% stake, such a comparison cannot be validly made. (3) The multi-hop reasoning is sound in structure—comparing asset exposure vs. financial stake via equity and loan—but fails due to the incorrect input data. The model attempts to synthesize across entities (XOM, CVX, TCO) and financial instruments (assets, equity, loans), which aligns with the question’s intent. (4) Contextual relevance is high, as the answer addresses all components of the question and uses appropriate financial terminology. However, the introduction of an unverified $23.7 billion investment severely undermines factual correctness, leading to a correctness score of 6—partially correct but with significant factual deficiency.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 487,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How might geopolitical tensions involving Taiwan impact both QCOM's chipset supply and NVDA's supply continuity, given their reliance on foundry partners operating in the region?",
      "original_answer": "QCOM's business depends on receiving consistent chipset supply from foundry partners, particularly in Taiwan, and a significant geopolitical conflict involving Taiwan could severely limit or prevent QCOM from receiving this supply, which would have a material adverse impact on its business. Similarly, NVDA notes that geopolitical tensions involving Taiwan and China, where it has critical suppliers, contract manufacturers, and assembly partners, could have a material adverse impact on its supply continuity. Both companies rely on foundry partners operating in Taiwan, and any disruption due to geopolitical instability could lead to supply constraints, affecting QCOM's ability to manufacture products and NVDA's ability to fulfill customer orders on time, ultimately harming their revenues and market positions.",
      "llm_answer": "Qualcomm says its business “depends on our ability to receive consistent and reliable chipset supply from our foundry partners, particularly in Taiwan,” and a “significant or prolonged military or other geopolitical conflict involving China and Taiwan could severely limit or prevent us from receiving chipset supply from Taiwan” – a material‑adverse hit to its operations【page_35】. Nvidia likewise warns that “geopolitical tensions, such as those involving Taiwan and China… where we have suppliers, contract manufacturers and assembly partners who are critical to our supply continuity, could have a material adverse impact on us”【page_17】.  In both cases, heightened Taiwan‑China tensions threaten the flow of chips from regional foundries and could disrupt each company’s supply chain.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the original answer. (1) All key facts are correct: both QCOM and NVDA rely on foundry partners in Taiwan, and geopolitical tensions involving Taiwan and China could materially disrupt their supply chains. The LLM correctly cites QCOM's dependency on consistent chipset supply and the risk of severe limitation due to conflict【page_35】, and NVDA's exposure through suppliers and contract manufacturers【page_17】. (2) There are no numerical values requiring verification (e.g., dollar amounts, percentages, dates), so quantitative accuracy is not applicable but does not detract. (3) Multi-hop reasoning is sound: the model synthesizes risks for both companies by connecting their reliance on Taiwanese foundries to potential geopolitical disruptions, accurately reflecting the interdependence described in the ground truth. (4) Wording differs slightly but preserves precise meaning, including the use of direct quotes and proper attribution to risk factors. All parts of the question are addressed: impact on QCOM's chipset supply and NVDA's supply continuity, given their regional dependencies. No omissions or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 338,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How might Southern Company's environmental compliance costs, driven by regulatory requirements, affect electricity demand from industrial customers, and how does this potential demand shift compare to Duke Energy's exposure to industrial customer demand volatility as outlined in their risk factors?",
      "original_answer": "Southern Company estimates that compliance with environmental regulations could result in increased costs that are recovered through regulated rates, but this may contribute to reduced demand for electricity and natural gas from industrial customers. Many of these industrial customers may also face their own compliance costs under the same environmental requirements, further reducing their energy consumption. Duke Energy, on the other hand, explicitly notes that declines in industrial production due to economic conditions will reduce electricity and natural gas consumption, directly impacting their revenues and cash flows. Both companies are exposed to industrial demand shifts, but Southern Company's exposure is tied to regulatory cost pass-through effects, while Duke Energy highlights direct economic sensitivity of industrial customers.",
      "llm_answer": "Southern Company warns that the large capital‑ and operating‑costs required to meet new environmental regulations – many of which must be recovered through retail rates – could depress electricity (and natural‑gas) usage, especially among commercial and industrial customers who may cut consumption in response to higher rates and regulatory constraints (SO 10‑K Item 1A, p. 26‑27; MD&A, p. 89). Duke Energy’s risk factors similarly note that an economic slowdown can cause industrial customers to reduce production, leading to volatile electricity and gas sales and lower overall revenue (DU 10‑K Operational Risks, p. 27). Thus, both companies face a potential decline in industrial demand, but Southern’s risk is tied specifically to regulatory‑driven cost recovery, whereas Duke’s exposure stems from broader economic and market‑demand volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: Southern Company's environmental compliance costs are tied to regulatory-driven rate increases that may reduce industrial demand, and Duke Energy's exposure is linked to economic conditions affecting industrial production. The LLM correctly identifies that both companies face industrial demand risks but through different mechanisms—regulatory cost pass-through for Southern and economic volatility for Duke. (2) There are no numeric values (e.g., dollar amounts, percentages, years) in either the question or the answers, so quantitative accuracy is not compromised; the absence of such figures is consistent with the source material. (3) The multi-hop reasoning is sound: the LLM synthesizes risk factors from both Southern Company (SO) and Duke Energy (DU) 10-K filings, correctly attributing the nature of demand risk to each company based on their disclosures. It references specific sections (Item 1A, MD&A, Operational Risks) which supports fidelity to source documents. (4) Semantic equivalence is strong—while the LLM uses slightly different phrasing (e.g., 'commercial and industrial customers' vs. 'industrial customers'), this does not distort meaning and may reflect actual wording in the filings. The only minor point is the inclusion of 'commercial' customers, which slightly broadens the scope beyond the original answer’s focus on industrial customers, but the core emphasis remains on industrial demand. Overall, the answer is factually correct, well-reasoned, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 445,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the $9.9 billion notional amount of foreign exchange cash flow hedges used by NKE compare to MCD's foreign currency net asset exposures in managing cross-border financial risk?",
      "original_answer": "NKE utilizes $9.9 billion in notional foreign exchange cash flow hedges to manage transactional exposures from product costs, external sales, and other foreign currency-denominated assets and liabilities. These hedges, primarily in euros, Canadian dollars, Japanese yen, British pounds, and Chinese yuan, are designed to offset earnings fluctuations from currency movements. Meanwhile, MCD manages its foreign currency risk by maintaining diversified net asset exposures across a broad basket of currencies. While NKE actively hedges forecasted transactions and exposures through derivatives, MCD's approach focuses on balancing foreign currency assets and liabilities directly on its balance sheet, reflecting differing strategies to mitigate cross-border financial risk.",
      "llm_answer": "Nike’s foreign‑exchange program designates about **$9.9 billion** of contracts as cash‑flow hedges (see the “Foreign Exchange Risk Management” section). By contrast, McDonald’s disclosed net foreign‑currency asset exposures of roughly **$3.8 billion** in aggregate (Australian $1.48 bn + British $1.15 bn + Polish $0.64 bn + Chinese $0.33 bn + Hong Kong $0.23 bn). Thus, Nike’s hedging notional is roughly two‑to‑three times larger than the total net asset exposure McDonald’s uses to manage its cross‑border currency risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported calculations. (1) The $3.8 billion net foreign-currency asset exposure for MCD is not present in the original answer (ground truth); the ground truth does not provide any specific dollar amount for MCD's net asset exposures. The listed breakdown (Australian $1.48 bn, British $1.15 bn, etc.) is entirely fabricated and not supported by the original answer. (2) The claim that Nike’s hedging notional is 'two-to-three times larger' than MCD’s net asset exposure is therefore based on false data and invalid arithmetic. (3) While the LLM correctly identifies that NKE uses $9.9 billion in notional foreign exchange cash flow hedges, it misrepresents MCD’s strategy by quantifying it numerically when the original answer only describes it qualitatively as relying on diversified net asset exposures without specifying amounts. (4) The qualitative comparison of strategies—active hedging via derivatives (NKE) vs. balance sheet netting through asset-liability management (MCD)—is partially aligned with the original answer, which saves some contextual relevance. However, the introduction of false quantitative data severely undermines correctness. The model fails the multi-hop synthesis by inventing numbers instead of accurately retrieving and contrasting the disclosed strategies. Overall, the answer is misleading due to hallucinated figures, though it attempts to address the comparative risk management question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 406,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the exposure of The Coca-Cola Company through Coca-Cola HBC's operations in Ukraine compare to Procter & Gamble's direct reliance on Ukraine for its manufacturing and supply chain stability?",
      "original_answer": "The Coca-Cola Company relies on Coca-Cola HBC for bottling and distribution operations in Ukraine, which is part of a broader network contributing to 41% of Coca-Cola's global unit case volume through its top five bottlers. Meanwhile, Procter & Gamble reports that its Ukraine-related assets account for less than 1% of net assets, with potential risks including physical damage to its two manufacturing facilities in Ukraine and disruptions in raw material sourcing or product distribution. While Coca-Cola's exposure is indirect through a key bottler, P&G's exposure is more direct but smaller in scale, with both companies facing similar regional supply chain risks tied to geopolitical instability.",
      "llm_answer": "The Coca‑Cola Company’s link to Ukraine is indirect – its bottling partner Coca‑Cola HBC lists Ukraine among the many countries where it bottles and distributes beverages, but Coca‑Cola does not quantify any material revenue or earnings contribution from that market【page_7】. In contrast, Procter & Gamble actually operates two manufacturing sites in Ukraine; those facilities account for less than 1 % of its consolidated net sales and earnings and are explicitly noted as a direct part of its supply‑chain, with the company warning that damage or disruption there could affect its manufacturing stability【page_23】【page_24】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key figures are correct: Procter & Gamble's Ukraine operations account for less than 1% of net sales and earnings, matching the original answer's 'less than 1% of net assets'—while the metric differs slightly (sales/earnings vs. net assets), this is a reasonable interpretation given that P&G’s disclosure typically frames exposure in terms of sales and earnings, and the magnitude (<1%) is consistent. The absence of quantified revenue from Ukraine for Coca-Cola HBC is correctly noted. (2) The answer correctly identifies the structural difference: Coca-Cola has indirect exposure via Coca-Cola HBC, while P&G has direct ownership of two manufacturing facilities in Ukraine. (3) Multi-hop reasoning is sound—synthesizing Coca-Cola’s reliance on bottlers (with HBC as a top five bottler contributing to 41% of global volume) and contrasting it with P&G’s direct but minimal footprint. The LLM does not explicitly mention the 41% figure from the top five bottlers, which slightly reduces completeness, but since the question focuses on Ukraine specifically and not the broader bottler network, this omission is minor. (4) Wording differs but semantic meaning is equivalent: 'less than 1%' exposure, direct vs. indirect operations, and supply chain risks are all accurately conveyed. The LLM cites page references, suggesting proper grounding. Final score reduced slightly (from 10 to 9) due to the unmentioned 41% contextual detail, but overall the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 439,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What is the combined exposure of MET and BAC to commercial mortgage-backed securities (CMBS), and how does MET's fair value of CMBS compare to BAC's amortized cost for the same category as of December 31, 2023?",
      "original_answer": "MET's fair value exposure to CMBS was $4,551 million as of December 31, 2023, while BAC's amortized cost for commercial mortgage-backed securities was $10,922 million. The combined exposure of both companies to CMBS totals $15,473 million. MET's CMBS, as part of its Structured Securities portfolio, are reported at fair value, whereas BAC reports its CMBS at amortized cost, reflecting different accounting treatments for similar asset classes.",
      "llm_answer": "MetLife’s fair‑value balance for structured securities (which includes CMBS) was **$4,551 million** at 12/31/2023【page_274】, while Bank of America’s amortized‑cost balance for commercial mortgage‑backed securities was **$10,909 million** on the same date【page_113】. Together the two firms hold about **$15,460 million** of CMBS exposure. MetLife’s CMBS fair‑value amount is therefore roughly **$6.3 billion lower – less than half –** of Bank of America’s amortized‑cost holding.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor numerical inaccuracy in BAC's amortized cost: the ground truth reports $10,922 million, while the LLM states $10,909 million—a difference of $13 million. This affects the combined exposure, which the LLM calculates as $15,460 million instead of the correct $15,473 million. These discrepancies, though small, impact quantitative accuracy. (2) The calculation of combined exposure is arithmetically correct based on the numbers provided ($4,551 + $10,909 = $15,460), but because one input is slightly off, the result is not fully accurate. The comparison stating MET's CMBS is 'roughly $6.3 billion lower' is approximately correct: the true difference is $10,922 - $4,551 = $6,371 million, so $6.3 billion is a reasonable rounding. (3) The multi-hop reasoning is sound: the model correctly identifies MET and BAC, retrieves their respective CMBS exposures under different accounting treatments (fair value vs. amortized cost), and synthesizes the total exposure. It also correctly contextualizes the difference in reporting methods. (4) The answer is semantically equivalent to the original in intent and structure, with only minor data variance. Contextual relevance is perfect—it directly addresses all parts of the question. However, due to the incorrect BAC value and resulting sum, the correctness and quantitative accuracy scores are reduced to 7. Qualitative accuracy remains high due to correct logic and synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 411,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How do cyber intrusion risks at nuclear power plants impact the financial obligations and operational strategies of both Duke Energy and Southern Company, given their respective exposures to decommissioning trusts and compliance costs?",
      "original_answer": "Duke Energy Carolinas, Duke Energy Progress, and Duke Energy Florida have significant obligations tied to decommissioning nuclear plants, with funded trusts subject to market fluctuations that could increase funding requirements if asset values decline. Southern Company's nuclear units, operated by Southern Nuclear, are subject to compliance costs related to cyber intrusion risks, which could increase licensing or security expenditures. Both companies face potential financial strain: Duke Energy may need to inject additional capital if decommissioning trusts underperform, while Southern Company could face higher operational costs due to mandatory cybersecurity standards and potential threats, both of which could materially affect their financial positions and cash flows.",
      "llm_answer": "Cyber‑intrusion threats to nuclear facilities push both utilities to spend more on security and regulatory compliance. For Duke Energy, a breach could trigger higher NRC‑mandated security upgrades that increase capital and operating costs and may force additional funding of its nuclear‑decommissioning trusts—pressuring cash flow and its ability to meet debt and dividend obligations (see DUK pages 34‑35). For Southern Company, the same cyber‑risk exposure can raise nuclear‑licensing and compliance expenses that could outstrip the assets in its decommissioning trusts, leading the company to allocate extra capital to cybersecurity and safety measures and to adjust its operational strategy toward heightened risk‑mitigation spending (see SO pages 29‑30).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: both Duke Energy and Southern Company face increased costs due to cyber intrusion risks, with Duke Energy potentially needing to fund decommissioning trusts more if market performance declines, and Southern Company facing higher compliance and licensing costs. The mention of NRC-mandated upgrades and impacts on cash flow, debt, and dividend obligations is consistent with the original answer's emphasis on financial strain. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not compromised—no calculations or figures to verify. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes cyber risks with financial obligations (decommissioning trusts) and operational strategies (increased security spending) for both companies, drawing appropriate connections across risk exposure and financial impact. (4) Semantic equivalence is strong; the LLM uses slightly different phrasing (e.g., 'force additional funding of its nuclear-decommissioning trusts' vs. 'inject additional capital') but conveys the same meaning. The only minor gap is that the LLM does not explicitly name Duke Energy Progress or Duke Energy Florida, nor Southern Nuclear as the operator, which are present in the original—hence a 9 instead of 10 on qualitative accuracy. However, the core entities (Duke Energy, Southern Company) and their exposures are correctly identified and linked. Contextual relevance is perfect—the response directly addresses all parts of the multi-faceted question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 441,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does the treatment of dividend equivalents on unvested restricted stock units at HD influence the issuance of additional shares, and how does this compare to LOW's delivery of additional shares under its ASR agreements in fiscal 2021?",
      "original_answer": "At HD, dividend equivalents accrue on unvested restricted stock units and are paid out in the form of additional shares upon vesting. This mechanism increases the total number of shares ultimately delivered to employees. For example, HD's 2022 10-K shows that dividend equivalents are reinvested and paid out as additional shares when RSUs vest. This practice results in a higher share count over time, as unvested units continue to accrue dividends. In contrast, LOW delivered additional shares in the context of accelerated share repurchase (ASR) agreements. In fiscal 2021, LOW executed ASR agreements in Q1, Q4, and Q2, under which it received additional shares at settlement—0.2 million, 1.6 million, and 4 million shares respectively—depending on the final calculation of the stock price during the settlement period. Therefore, while HD's additional shares arise from reinvested dividend equivalents tied to employee compensation, LOW's additional shares are a byproduct of its capital return strategy through ASR agreements.",
      "llm_answer": "Home Depot’s restricted‑stock‑unit awards accrue dividend equivalents that are settled as **additional shares on the vesting date**, so each vesting event creates new shares to satisfy those dividend‑equivalent payments. Lowe’s accelerated‑share‑repurchase (ASR) agreements also generated extra shares, but they were delivered at settlement of the contracts – 0.2 million in Q1 2021, 4 million in Q2 2021, 1.7 million in Q3 2021 and 1.6 million in Q4 2021, totaling roughly 7.5 million additional shares for fiscal 2021.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the mechanism at HD—dividend equivalents on unvested RSUs are settled as additional shares upon vesting—which aligns with the ground truth. It also correctly frames LOW's additional shares as arising from ASR agreements, a capital return strategy. However, there are key quantitative inaccuracies: the LLM states that LOW received 4 million shares in Q2 2021 and 1.7 million in Q3 2021, but the ground truth specifies ASR settlements in Q1 (0.2M), Q4 (1.6M), and Q2 (4M)—with no mention of a Q3 settlement. The LLM incorrectly adds a 1.7 million share delivery in Q3, which is not in the original answer, and misorders the quarters. Additionally, the total of 'roughly 7.5 million' is incorrect—the correct sum from the three reported settlements (0.2M + 1.6M + 4M) is 5.8 million. (2) Number verification: HD portion has no specific numbers, so no error. LOW’s numbers: Q1 0.2M (correct), Q2 4M (correct), Q4 1.6M (correct), but Q3 1.7M is fabricated. Total should be 5.8M, not 7.5M. (3) Multi-hop reasoning is mostly sound: the model correctly distinguishes between HD’s employee-compensation-related share issuance and LOW’s capital-return-driven ASR share deliveries. It synthesizes across two companies and mechanisms appropriately. (4) The answer is contextually relevant and captures the conceptual contrast well, but the incorrect attribution of a Q3 settlement and wrong total undermines quantitative accuracy. Hence, correctness is reduced to 7 due to significant but not fundamental numerical errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 429,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does AT&T's use of sensitivity analyses in auditing its $67,854 million goodwill balance compare to Netflix's application of similar analyses in evaluating content amortization assumptions, given both companies are audited by the same firm?",
      "original_answer": "AT&T utilized sensitivity analyses to evaluate the goodwill impairment testing for its $67,854 million goodwill balance, focusing on assumptions like terminal growth rates and weighted average cost of capital. Netflix, on the other hand, applied sensitivity analyses to assess the impact of changes in estimated viewing patterns on content amortization, a key accounting estimate given its content licensing and production model. Both companies are audited by the same firm, which performed these sensitivity analyses as part of their audit procedures to evaluate the reasonableness and robustness of management’s assumptions in each case.",
      "llm_answer": "Both firms’ auditor, Ernst & Young, performed independent sensitivity analyses, but they were applied to different estimates. For AT&T, the analyses were used to test the goodwill‑impairment models—examining how changes in assumptions such as terminal growth rates, long‑term EBITDA margins and the weighted‑average cost of capital would affect the fair‑value of the $67,854 million goodwill balance. For Netflix, the same technique was used to gauge how variations in the historical and forecasted viewing‑hour assumptions would change the amount of content amortization recorded. In short, EY used sensitivity testing in both audits to address complex, judgment‑heavy estimates, but AT&T’s focus was goodwill valuation while Netflix’s focus was content‑amortization assumptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AT&T's $67,854 million goodwill balance is accurately cited, and the use of sensitivity analyses on assumptions like terminal growth rates and weighted average cost of capital (WACC) is correctly described. Netflix’s use of sensitivity analyses on viewing-hour assumptions for content amortization is also accurately represented. (2) Quantitative accuracy is perfect: the dollar amount ($67,854 million) is correctly stated, and no calculations are required beyond accurate representation of figures. (3) The multi-hop reasoning is sound—correctly linking both companies to the same auditor (implied as Ernst & Young, which is factually correct though not named in the original answer, but acceptable given public knowledge and context), and contrasting the application of the same audit technique (sensitivity analysis) to different accounting estimates (goodwill vs. content amortization). (4) The answer is contextually relevant and fully addresses the comparative aspect of the question. The only minor shortcoming is that the original answer explicitly states the auditor performed the analyses as part of audit procedures, while the LLM implies this by attributing the analyses to EY. However, this does not detract significantly from the overall correctness. Semantic equivalence is maintained, and the reasoning is robust and well-articulated.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 401,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does Mastercard's concern about disintermediation from fintech-developed payment platforms compare to Visa's strategic partnership approach with fintechs in the context of regulatory-driven competition in the digital payments ecosystem?",
      "original_answer": "Mastercard expresses concern that fintechs could develop platforms or networks that disintermediate them from digital payments, especially when sharing data under partnerships, which could give fintechs a competitive advantage. This aligns with the broader risk that fintechs may develop competitive products that replace Mastercard’s offerings. In contrast, Visa actively partners with fintechs and emphasizes leveraging local financial institutions and tailored solutions to maintain a competitive edge. Visa sees fintechs as both partners and potential competitors, but strategically integrates them into its 'network of networks' approach. The regulatory environment, particularly in the EEA with PSD2, exacerbates these dynamics by enabling third-party providers to route transactions away from traditional networks like Mastercard, while Visa adapts by strengthening partnerships to remain central in the evolving digital payments ecosystem.",
      "llm_answer": "Mastercard warns that fintechs could build their own payment platforms and bypass its network – a disintermediation risk heightened by regulations such as PSD2 that let issuers or processors route transactions directly away from Mastercard’s system【page_31】. In contrast, Visa frames regulatory‑driven competition as an opportunity to embed fintechs within its ecosystem, offering dedicated programs (Fintech Fast Track, Fintech Partner Connect) and strategic acquisitions (Currencycloud, Tink) to partner with and accelerate fintech services on Visa’s network【page_14】【page_15】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core contrast between Mastercard's concern about disintermediation and Visa's strategic partnership approach. It correctly identifies regulatory pressures like PSD2 in the EEA as a driver of disintermediation risk for Mastercard, citing transaction routing away from its network (aligns with ground truth). For Visa, it accurately highlights the 'network of networks' strategy through programs like Fintech Fast Track and acquisitions like Currencycloud and Tink, which are concrete examples of integration (not in ground truth but factually correct and enhance answer). No numeric data is present in either answer, so quantitative accuracy is 10 by default. The only minor shortcoming is that the LLM does not explicitly state that Visa sees fintechs as both partners *and* competitors—a nuance in the original answer—but it implies this by framing regulatory competition as an opportunity through embedding fintechs. The multi-hop reasoning across regulatory environment, company strategies, and fintech dynamics is sound. Semantic equivalence is strong, with slightly more specific program names enhancing clarity without distorting meaning. Contextual relevance is excellent, directly addressing all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 355,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does the expected impact of the 15% global minimum tax under Pillar 2 differ between MCD and SBUX, considering the OECD's framework and the earliest effective dates for implementation?",
      "original_answer": "MCD stated that while the global minimum tax under Pillar 2 was enacted in several countries with the earliest effective date for taxable years beginning after December 31, 2023, it does not expect a material impact on its consolidated financial statements. SBUX, on the other hand, noted that Pillar 2 will not be effective for the company until fiscal 2025 and also does not expect a material impact to its consolidated financial statements. The OECD's framework proposes a 15% global minimum tax applied on a country-by-country basis, and although many countries are incorporating Pillar 2 model rule concepts into domestic laws, differences in implementation timelines and domestic tax adjustments may affect the tax's impact on multinational companies like MCD and SBUX differently.",
      "llm_answer": "McDonald’s notes that many jurisdictions have already adopted the OECD’s Pillar 2 rules, with the first taxable‑year effective dates set for periods beginning after 31 December 2023, but the company does not expect the 15 % global minimum tax to have a material impact on its consolidated financial statements【page_20】. Starbucks likewise says that although some countries have enacted Pillar 2 for fiscal years starting after 31 December 2023, the tax will not become effective for Starbucks until fiscal 2025 and is also not expected to be material【page_28】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that MCD does not expect a material impact from the 15% global minimum tax under Pillar 2, with implementation starting after December 31, 2023, and that SBUX will not be affected until fiscal 2025 and also does not expect a material impact. All key facts—percentages, effective dates, company-specific timelines, and qualitative impacts—are consistent with the ground truth. (2) Quantitative accuracy is perfect: the 15% rate, December 31, 2023, and fiscal 2025 are all correctly reported. Format variations (e.g., '31 December 2023' vs 'December 31, 2023') are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound—comparing two companies' exposure to Pillar 2, synthesizing their disclosures, and contextualizing within OECD implementation timelines. The only minor omission is that the LLM answer does not explicitly mention the OECD’s country-by-country application or differences in domestic implementation that may lead to divergent impacts, which is included in the original answer and adds context to why impacts may differ. This slightly reduces qualitative accuracy but does not undermine the core correctness. (4) The answer is highly relevant, directly addressing the comparative impact of Pillar 2 on MCD and SBUX, including timing and materiality. The inclusion of citation markers ['page_20', 'page_28'] suggests grounding in source documents, enhancing credibility. Overall, the answer is factually correct and complete in substance, missing only a small amount of contextual nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 432,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does the capital adequacy position of BlackRock Institutional Trust Company (BTC) as of December 31, 2024, compare to American Express's (AXP) regulatory capital ratios, given both entities are subject to U.S. banking regulatory requirements?",
      "original_answer": "As of December 31, 2024, BlackRock Institutional Trust Company (BTC) exceeded its applicable capital adequacy requirements, including minimum Common Equity Tier 1 (CET1), Tier 1 leverage, and risk-based capital ratios. Similarly, American Express (AXP) met all capital requirements and maintained regulatory capital ratios above the thresholds to qualify as 'well capitalized' under Federal Reserve and OCC guidelines. Both entities are subject to U.S. banking regulatory capital requirements, with BTC regulated by the Office of the Comptroller of the Currency (OCC) and AXP supervised by the Federal Reserve and its subsidiary AENB also regulated by the OCC.",
      "llm_answer": "BlackRock Institutional Trust Company’s capital ratios as of 31 Dec 2024 were extraordinarily high – total‑capital‑to‑risk‑weighted‑assets 153.2 % (CET1 151.9 %, Tier 1 151.9 %) and a Tier 1‑leverage ratio of 71.3 %, far above the minimum (8 % total, 4 % Tier 1, 4 % leverage) and the “well‑capitalized” thresholds. American Express Company reported CET1 10.5 %, Tier 1 11.2 % and a Tier 1‑leverage ratio of 9.8 % (its bank subsidiary similar), which also exceed the required minima but are an order of magnitude lower than BTC’s figures. Thus, while both entities meet U.S. banking capital requirements, BTC’s capital adequacy position is substantially stronger than American Express’s.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in quantitative data. According to the ground truth, both BTC and AXP met regulatory capital requirements and were 'well capitalized,' but the LLM reports implausibly high capital ratios for BTC—CET1 and Tier 1 at 151.9%, total capital at 153.2%, and Tier 1 leverage at 71.3%. These figures are orders of magnitude higher than typical for any U.S. bank, especially compared to standard regulatory thresholds (e.g., CET1 minimum ~4.5%, well-capitalized >6.5%). No bank, including trust companies, reports a CET1 ratio above 150%. Such numbers are likely hallucinated. For AXP, the LLM provides specific ratios (CET1 10.5%, Tier 1 11.2%, leverage 9.8%), which are plausible and align broadly with American Express’s historical capital levels, though not verifiable from the ground truth provided. (2) The original answer does not include specific numerical values—only qualitative statements that both firms exceeded requirements and were well capitalized. Thus, the LLM introduced precise numbers not present in the source, making them unsupported. Even if intended as inference, the BTC figures are so extreme they invalidate the quantitative accuracy. (3) The multi-hop reasoning—comparing BTC and AXP’s capital positions under U.S. banking rules—is sound in structure and relevant. The model correctly identifies that both entities are subject to U.S. banking regulation, with appropriate supervisors (OCC for BTC, Fed/OCC for AXP), showing good qualitative synthesis. However, the conclusion that BTC’s position is 'substantially stronger' rests on fabricated data, undermining the logic. (4) Correctness score is 4 due to plausible structure and correct entities/timeframe, but major factual errors in numbers. Quantitative accuracy is low (2) due to grossly inflated and unrealistic capital ratios. Qualitative accuracy is moderate (6) because the reasoning framework and entity identification are correct, but conclusions are based on false data. Contextual relevance is high (9) as the response directly addresses the comparison asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 567,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does the $88.4 million in construction loans provided by SPG to joint ventures compare to AMT's utilization of the 2021 Multicurrency Credit Facility for acquisitions, and what does this reveal about their respective financing strategies for growth?",
      "original_answer": "SPG provided $88.4 million in construction loans to joint ventures as of December 31, 2021, indicating a strategy of internally financing development through joint ventures. In contrast, AMT borrowed $7.8 billion under the 2021 Multicurrency Credit Facility, including €2.4 billion ($2.9 billion), to fund major acquisitions like the Telxius and CoreSite deals. This reveals that AMT pursued a more aggressive, acquisition-driven growth strategy backed by large-scale credit facilities, while SPG focused on smaller-scale development financing through joint venture partnerships.",
      "llm_answer": "Simon Property Group reported that it had $88.4 million of interest‑bearing construction loans to joint‑venture partners at year‑end 2021 (​page 116​). In contrast, American Tower borrowed about $7.8 billion under its 2021 Multicurrency Credit Facility during 2021, using the proceeds primarily to fund the Telxius and CoreSite acquisitions (​page 111​). The comparison shows SPG’s financing is modest and partnership‑focused, while AMT employs a large revolving credit facility to finance major acquisition‑driven growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: SPG's $88.4 million in construction loans to joint ventures as of year-end 2021 and AMT's $7.8 billion borrowing under the 2021 Multicurrency Credit Facility are accurately reported. The LLM correctly identifies that AMT used the funds for the Telxius and CoreSite acquisitions. (2) Quantitative accuracy is perfect: both dollar amounts and the time frame (2021) match the original answer. The LLM does not mention the €2.4 billion ($2.9 billion) component of AMT's borrowing, which is a minor omission but does not affect the overall correctness of the core financial figures or the strategic interpretation. (3) Reasoning and synthesis are sound: the contrast between SPG’s partnership-focused, development-oriented financing and AMT’s large-scale, acquisition-driven strategy using a revolving credit facility is logically derived and well-articulated. (4) The answer is contextually relevant and directly addresses both parts of the question—comparing the financing amounts and interpreting the strategic implications. The only reason for not scoring a 10 is the omission of the euro-denominated portion of AMT’s borrowing, which adds granularity but does not undermine the central conclusion. Semantic equivalence is maintained, and the LLM effectively conveys the same strategic insight as the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 391,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does the $0.5 billion interest rate swap held by CSCO to hedge its fixed-rate senior notes compare with AVGO's exposure to $56.3 billion in fixed-rate senior notes in terms of sensitivity to interest rate fluctuations?",
      "original_answer": "CSCO uses a $0.5 billion interest rate swap to hedge a portion of its fixed-rate senior notes, converting the fixed interest rate to a floating rate based on SOFR, thereby reducing interest rate risk for that specific liability. In contrast, AVGO holds $56.3 billion in fixed-rate senior notes as of November 3, 2024, and a 50 basis point interest rate increase would decrease the fair value of these notes by $1.7 billion. This indicates that AVGO has significant interest rate exposure on its fixed-rate debt, while CSCO has mitigated part of its exposure through active hedging.",
      "llm_answer": "Cisco’s $0.5 billion interest‑rate swap is a fair‑value hedge that converts a small, $0.5 billion portion of its fixed‑rate senior notes to a floating rate, so the gain or loss on the swap largely offsets any market‑rate‑driven change in the fair value of that limited debt exposure【page_89】. In contrast, Broadcom carries $56.3 billion of fixed‑rate senior notes, and a 50‑basis‑point shift in market rates would alter the fair value of those notes by about $1.7 billion, indicating a much larger sensitivity to interest‑rate fluctuations【page_49】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: CSCO's $0.5 billion interest rate swap hedges a portion of its fixed-rate debt by converting it to floating rate, and AVGO (referred to as Broadcom, which is accurate) has $56.3 billion in fixed-rate senior notes with a $1.7 billion fair value sensitivity to a 50 bps rate change. These numbers match the original answer exactly. (2) Quantitative accuracy is perfect—dollar amounts, percentages, and the implied interest rate sensitivity are all correctly reported. The $1.7 billion impact from a 50 bps move aligns with the duration-like sensitivity of AVGO’s debt, and no calculation errors are present. (3) The reasoning is sound: the LLM correctly contrasts CSCO’s active hedging (reducing interest rate risk on $0.5B) with AVGO’s large unhedged exposure, thereby addressing the comparative sensitivity to interest rate fluctuations. It correctly identifies the swap as a fair-value hedge and explains offsetting gains/losses, which adds technical accuracy. (4) Minor point: the LLM refers to 'Broadcom' instead of 'AVGO', but this is semantically acceptable as AVGO is the ticker for Broadcom Inc. No meaningful information is missing, and the answer fully addresses the multi-hop comparison between the two firms’ interest rate risk exposures. Wording differs slightly but meaning is preserved. Thus, the answer earns a 9/10 for correctness—excellent, but not verbatim in entity naming convention (though not incorrect).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 424,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does the use of option contracts by NKE to hedge foreign currency exposures compare to TSLA's exposure to foreign currency assets, given the impact of such hedging instruments on deferred gains and losses in other comprehensive income?",
      "original_answer": "NKE actively uses option contracts as part of its foreign currency risk management program to hedge exposures from product costs, external sales, and other costs, with $9.9 billion in notional amounts of net foreign exchange cash flow hedges as of September 28, 2024. These contracts are designated as cash flow hedges, with mark-to-market gains and losses deferred in AOCI, including $99 million in net deferred gains expected to mature in the next twelve months. In contrast, TSLA does not typically hedge foreign currency risk and instead experiences significant fluctuations in foreign exchange gains and losses from period to period, particularly on intercompany balances, which flow through 'Other income (expense), net.' This highlights a more proactive hedging strategy by NKE versus TSLA’s reactive exposure to foreign currency assets.",
      "llm_answer": "Nike (NKE) actively hedges its transactional foreign‑currency risk with forward and **option contracts** that are designated as cash‑flow hedges; under U.S. GAAP the fair‑value changes on those hedges are recorded in **other‑comprehensive income (OCI) and deferred until the hedged cash flows occur**【page_48】. Tesla (TSLA), by contrast, holds foreign‑currency‑denominated monetary assets and intercompany balances that it **does not hedge**, so foreign‑exchange gains and losses are recognized immediately in other income (and ultimately net income) rather than being deferred in OCI【page_44】. Thus, Nike’s use of options smooths earnings by postponing gains/losses to OCI, whereas Tesla’s exposure creates direct, non‑deferred earnings volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core contrast between NKE and TSLA regarding foreign currency hedging and its impact on financial reporting. It correctly identifies that NKE uses option contracts designated as cash flow hedges, with gains/losses deferred in other comprehensive income (OCI), while TSLA does not hedge and recognizes FX gains/losses directly in earnings through 'Other income (expense), net.' The qualitative reasoning and multi-hop synthesis across companies and accounting treatments are sound and semantically equivalent to the ground truth. However, the LLM omits specific quantitative details present in the original answer: the $9.9 billion in notional amount of NKE's hedges and the $99 million in net deferred gains expected to mature in the next twelve months. These numbers are material to full completeness, especially since the question emphasizes 'impact of such hedging instruments on deferred gains and losses in other comprehensive income.' While the absence of these figures does not invalidate the conceptual accuracy, it reduces quantitative precision. All non-numeric elements—entities (NKE, TSLA), instruments (options), accounting treatment (OCI deferral), and logic (proactive vs. reactive strategy)—are correctly identified and synthesized. The answer is contextually relevant and effectively communicates the key difference in financial reporting impact.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 390,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does Boeing's use of Citibank, N.A. as administrative agent in its Five-Year Credit Agreement compare with Caterpillar's use of Citibank in its 5-Year Facility, particularly in terms of Citibank's role and the amendment timelines?",
      "original_answer": "Boeing's Five-Year Credit Agreement, dated October 30, 2019, and amended on August 25, 2022, lists Citibank, N.A. as the administrative agent. Similarly, Caterpillar's Third Amended and Restated Credit Agreement (5-Year Facility), dated September 1, 2022, also names Citibank, N.A. as the Agent. Both companies rely on Citibank in a leadership capacity—Boeing in a dual role as administrative agent and joint lead arranger, and Caterpillar as Agent. Boeing’s amendment occurred in August 2022, while Caterpillar’s Amendment No. 1 to the 5-Year Facility was dated August 31, 2023, showing staggered but comparable timelines for credit agreement adjustments.",
      "llm_answer": "Boeing’s October 30 2019 Five‑Year Credit Agreement names **Citibank, N.A. as the administrative agent** (with JPMorgan Chase as syndication agent and joint lead arranger) and was **amended once on August 25 2022** (Amendment No. 1). Caterpillar’s 5‑Year/2023 credit facility, dated **August 31 2023**, lists **Citibank, N.A. simply as the agent** (with Citibank Europe as local‑currency agent and MUFG as Japan agent) and the filing shows **no amendment to that facility**. Thus, Boeing’s Citibank role is specifically “administrative agent” and has an amendment history, whereas Caterpillar’s Citibank role is a general “agent” on a newer agreement with no amendment noted.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct but contains a key discrepancy regarding Caterpillar's amendment timeline. The ground truth states that Caterpillar’s Amendment No. 1 to the 5-Year Facility was dated August 31, 2023, while the LLM claims 'no amendment to that facility' as of the August 31, 2023 agreement. This is incorrect—Amendment No. 1 is part of the facility's evolution and was executed on that date. The LLM likely misinterpreted the effective date of the amended agreement as the original agreement date and failed to recognize it as an amendment. Boeing’s details are accurate: Citibank, N.A. as administrative agent, amendment on August 25, 2022. Caterpillar’s use of Citibank, N.A. as 'Agent' (not administrative agent) is correctly noted, though the distinction in title ('agent' vs 'administrative agent') is minor and contextually acceptable. The comparison of roles is qualitatively sound—Boeing gives Citibank a more specified leadership role, including joint lead arranger, while Caterpillar does not. However, the failure to acknowledge Caterpillar’s 2023 amendment as such breaks the multi-hop comparison on amendment timelines, which is a core part of the question. Quantitatively, all dates and roles are correctly cited except for the misinterpretation of the amendment status. Contextual relevance is strong—the response directly addresses the question’s focus on Citibank’s role and amendment timelines. Reasoning is logical but flawed in synthesis due to the amendment oversight.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 412,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does the difference in voting rights per share between Netflix's common stock and Meta's Class B common stock compare, given the structure of voting rights tied to different stock classes as disclosed by both companies?",
      "original_answer": "Netflix's common stock provides one vote per share, while Meta's Class B common stock provides 10 votes per share, reflecting a significant disparity in shareholder voting power between the two companies' stock structures.",
      "llm_answer": "Netflix’s common stock carries **one vote per share** (see Netflix 10‑K, “Voting Rights” – each share of common stock shall be entitled to one vote per share)【page_60】.  \n\nMeta’s Class B common stock carries **ten votes per share** (see Meta 10‑K, “Class A and Class B Common Stock and Class C Capital Stock” – each share of Class B common stock is entitled to 10 votes per share)【page_82】.  \n\nThus, a Meta Class B share has **nine additional votes (or ten‑times the voting power)** compared with a Netflix common share.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the voting rights per share are accurately reported: Netflix's common stock has 1 vote per share, and Meta's Class B common stock has 10 votes per share. The comparison correctly notes that Meta Class B shares have ten times the voting power, or nine additional votes, relative to Netflix shares—this calculation is accurate. (2) The answer is complete, addressing both companies' voting structures and directly comparing them as required by the question. (3) Entities are correctly identified: Netflix common stock and Meta Class B common stock are accurately referenced with proper context from their respective 10-K filings. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly pulled and compared data from two different companies' disclosures to form a valid cross-company comparison. (5) The semantic meaning is equivalent to the ground truth, with slightly more detailed phrasing but no deviation in factual content. All criteria for high scores are met.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 310,
        "total_tokens": 1515
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does BMY's reliance on Cardinal Health for 23% of its distribution in 2023 intersect with CVS’s financial consolidation of Red Oak Sourcing, given Cardinal Health’s 50% ownership stake in the same generic pharmaceutical sourcing entity?",
      "original_answer": "BMY relies on Cardinal Health, Inc. for 23% of its distribution network as of 2023, making Cardinal a critical third-party logistics partner. At the same time, CVS co-owns Red Oak Sourcing, LLC with Cardinal Health (each holding a 50% stake), and consolidates Red Oak’s operations into its financial statements due to its role as the primary beneficiary. This creates a complex interdependency where BMY’s supply chain is partially dependent on a company (Cardinal Health) that is structurally and financially tied to CVS through Red Oak Sourcing. The quarterly payments from Cardinal to CVS, totaling $183 million annually, influence CVS’s cost of goods sold, which could indirectly affect the pricing or efficiency of Cardinal’s distribution services to BMY.",
      "llm_answer": "BMY’s 2023 filing shows that 23 % of its U.S. product sales were shipped through Cardinal Health (see the GTN‑adjustments table [page 78]). CVS’s 10‑K notes that CVS and Cardinal each own 50 % of Red Oak Sourcing, a generic‑drug sourcing VIE that CVS consolidates because it is the primary beneficiary (see the Generic Sourcing Venture description [page 20] and the VIE‑consolidation discussion [page 136]). Thus, a sizable portion of BMY’s distribution passes through Cardinal Health—the same partner that co‑owns the Red Oak venture that CVS reports as a consolidated entity—linking BMY’s supply‑chain reliance to CVS’s consolidated financial results.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and percentages are correct: BMY's 23% reliance on Cardinal Health in 2023 and the 50% ownership stakes in Red Oak Sourcing are accurately reported. No dollar amounts or dates are misstated. (2) The LLM correctly identifies the key entities—BMY, Cardinal Health, CVS, and Red Oak Sourcing—and their relationships, including the VIE (variable interest entity) structure and CVS’s consolidation due to being the primary beneficiary. (3) The multi-hop reasoning is sound: it connects BMY’s distribution dependency on Cardinal Health to the financial consolidation of Red Oak Sourcing by CVS, despite the shared ownership. This captures the core interdependency highlighted in the original answer. (4) The only minor omission is the absence of the $183 million annual payment from Cardinal to CVS and its potential impact on CVS’s cost of goods sold and, by extension, Cardinal’s service efficiency or pricing to BMY. While this detail enriches the original answer, its absence does not undermine the central factual or logical structure. Wording differs but maintains semantic equivalence. Overall, the answer is factually correct, contextually relevant, and demonstrates strong synthesis across filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 363,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does MetLife's exposure to interest rate scenarios in its Retirement and Income Solutions segment affect its Life Insurance product line, and how does this compare to AIG's experience with Life Insurance reserve updates under similar interest rate dynamics?",
      "original_answer": "MetLife's Retirement and Income Solutions segment includes life insurance products and is exposed to interest rate scenarios that could compress gross margins due to minimum crediting rate guarantees and reinvestment risks. In declining rate environments, this leads to margin compression, while rising rates allow for reinvestment in higher-yielding assets. Similarly, AIG experienced a $106 million favorable impact in 2021 from actuarial assumption updates in Life Insurance, driven by policy fee modeling, but also faced margin pressures from lower projected investment earnings. Both companies show sensitivity in their Life Insurance lines to interest rate dynamics, with MetLife managing through ALM strategies and AIG adjusting reserves and assumptions.",
      "llm_answer": "MetLife’s Retirement & Income Solutions (RIS) business is highly sensitive to U.S. interest‑rate moves; its scenario analysis shows a $15 million adjusted‑earnings hit for RIS in 2022 under a declining‑rate scenario and a $15 million gain in 2023 under a rising‑rate scenario (see MetLife 10‑K p. 60). Those earnings swings translate into reserve and margin pressure on the company’s Life‑Insurance line—lower rates increase policy‑holder reserves and compress margins, while higher rates reduce reserves and improve profitability (MetLife 10‑K p. 59). By contrast, AIG’s Life‑Insurance reserves are re‑measured directly when interest‑rate assumptions change, producing large reserve updates such as a $166 million net‑unfavorable adjustment in 2021 (driven by lower earned rates) and a $106 million net‑favorable adjustment in 2021 from policy‑fee modeling (see AIG 10‑K p. 134; also note projected yield cuts of up to 42 bps on life deposits on p. 133). Thus MetLife feels rate changes through RIS‑segment earnings and indirect reserve effects, whereas AIG experiences the impact through explicit Life‑Insurance reserve updates.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes several correct qualitative insights about MetLife and AIG's sensitivity to interest rates in their Life Insurance lines, with accurate mechanisms described—MetLife’s margin compression in declining rates due to minimum crediting rate guarantees and reinvestment risks, and AIG’s direct reserve updates from assumption changes. However, there are significant quantitative discrepancies. The ground truth states AIG had a $106 million favorable impact in 2021 from actuarial updates due to policy fee modeling. The LLM answer correctly cites this $106 million favorable update but incorrectly adds a $166 million net-unfavorable adjustment in the same year (2021), which is not in the original answer and introduces a conflicting detail. Additionally, the LLM introduces specific MetLife scenario figures—$15 million earnings hit in 2022 and $15 million gain in 2023 under rate scenarios—which are absent from the ground truth and not supported by the provided knowledge. These numbers, while plausible, are factually unverifiable against the original answer and represent a deviation. (2) The years referenced (2021 for AIG) are correct, but the additional 2022/2023 MetLife figures are extraneous and unsupported. The $106 million favorable adjustment for AIG matches, but the $166 million unfavorable adjustment does not appear in the ground truth, making it an error. (3) The multi-hop reasoning is strong: the model correctly distinguishes between MetLife’s indirect margin/reserve impacts via its RIS segment and AIG’s direct reserve re-measurement, showing synthesis across companies and mechanisms. This reflects sound understanding of how interest rate dynamics propagate differently through each company’s financial structure. (4) The contextual relevance is high—the answer directly addresses both parts of the question and draws a meaningful comparison. Due to the inclusion of unsupported numerical figures and an extra, conflicting reserve adjustment for AIG, the quantitative accuracy is reduced. However, the core qualitative analysis and logical structure are solid, warranting a correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 578,
        "total_tokens": 2079
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What specific battery supply agreements exist between Tesla and Panasonic Corporation, and how do these agreements compare to known battery sourcing dependencies reported by General Motors?",
      "original_answer": "Tesla has multiple agreements with Panasonic Corporation for battery supply, including the 2011 Supply Agreement, its 2019 and 2021 Pricing Agreements for Japan-sourced cells, and the 2020 Pricing Agreement for Gigafactory 2170 cells. These agreements are supported by ongoing amendments, investment letters, and shared facility leases that indicate a deep strategic partnership. In contrast, General Motors’ filings only state a general dependency on batteries without specifying agreements or suppliers, making Tesla’s battery sourcing strategy with Panasonic more explicitly defined and contractually secured.",
      "llm_answer": "Tesla’s 10‑K lists a long‑standing, multi‑year supply relationship with Panasonic Corporation.  The filings disclose a original “Supply Agreement” dated Oct 5 2011 (Exhibit 10.25) and a series of follow‑on amendments and pricing contracts – Amendment No. 1 (Oct 29 2013, Ex 10.26), a 2014 agreement (Ex 10.27), General Terms & Conditions (Oct 1 2014, Ex 10.28), a 2015 Letter Agreement (Feb 24 2015, Ex 10.29), a 2016 Gigafactory amendment (Mar 1 2016, Ex 10.30), an amended‑and‑restated Gigafactory terms (Jun 10 2020, Ex 10.31), and specific pricing agreements for Japan‑cell and Gigafactory‑2170 cells in 2019 (Ex 10.35), 2020 (Ex 10.36) and 2021 (Ex 10.37) (see pages 106‑107).\n\nGeneral Motors, by contrast, reports that its EV battery supply is tied to its own joint‑venture, Ultium Cells Holdings LLC, which provides battery cells for GM vehicles and to which GM has committed capital and records equity earnings (see Note 8/Note 12, pages 76‑80).  Thus Tesla relies on a series of formal contracts with an external supplier (Panasonic), whereas GM’s battery sourcing is dependent on an internal JV (Ultium Cells) rather than a single outside supplier.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) It correctly identifies Tesla's battery supply agreements with Panasonic, including the 2011 Supply Agreement and subsequent amendments and pricing agreements in 2013, 2014, 2015, 2016, 2019, 2020, and 2021, with specific exhibit numbers and dates that align with the ground truth. The mention of the 2020 amended-and-restated Gigafactory terms and pricing agreements for Japan-sourced and 2170 cells matches the original answer’s key points. (2) All dates and exhibit numbers are factually correct and consistent with SEC filing disclosures; no calculation errors exist. (3) The multi-hop reasoning is sound: the LLM correctly contrasts Tesla’s external contractual dependencies with Panasonic against GM’s internal reliance on Ultium Cells LLC, a joint venture. While the original answer emphasizes that GM does not specify suppliers and only reports general dependency, the LLM adds value by naming Ultium Cells and referencing GM’s capital commitments and equity earnings, which is consistent with GM’s 10-K disclosures and provides deeper context without contradicting the ground truth. (4) The only minor shortcoming is that the original answer highlights the lack of specific supplier agreements in GM’s filings, while the LLM frames GM’s dependency as being on an internal JV—this is accurate but slightly reframes the contrast. However, this does not reduce factual correctness, as Ultium is indeed GM’s primary battery sourcing mechanism. Overall, the answer is semantically equivalent, factually precise, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 437,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How does MDLZ's use of commodity futures, which are classified as Level 1 financial assets, compare to COST's disclosure about holding no Level 1 financial assets, in the context of their respective risk management strategies involving financial instruments?",
      "original_answer": "MDLZ actively uses commodity futures, which are categorized as Level 1 financial assets based on quoted market prices, as part of its hedging strategy to manage exposure to input cost fluctuations such as cocoa, sugar, and energy. In contrast, COST disclosed that as of August 28, 2022, it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis, indicating a different approach to financial risk management that does not involve exchange-traded futures. This contrast highlights that while MDLZ relies on Level 1 commodity futures for price risk mitigation, COST does not utilize such instruments in its financial strategy.",
      "llm_answer": "Mondelez International explicitly uses exchange‑traded commodity futures and options to hedge the price of key inputs (e.g., cocoa, sugar, wheat) and classifies those contracts as Level 1 financial assets – $46 million of its $77 million commodity‑derivative exposure is measured at Level 1 (see MDLZ pages 94, 112 & 111). Costco, by contrast, reports that it held no Level 1 (or Level 3) financial assets or liabilities on a recurring‑fair‑value basis (see COST pages 50‑51), indicating that its risk‑management program does not rely on exchange‑traded commodity futures.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that MDLZ uses commodity futures classified as Level 1 financial assets for hedging key input costs like cocoa, sugar, and wheat, and notes COST’s disclosure of holding no Level 1 or Level 3 financial assets. The core comparison between MDLZ’s active use of exchange-traded derivatives and COST’s non-use is accurately conveyed. (2) Quantitatively, the LLM adds specific figures not in the original answer: $46 million of MDLZ’s $77 million commodity-derivative exposure being Level 1. While these numbers are plausible and consistent with the knowledge graph (and cited to specific pages), they were not part of the ground truth answer, so their inclusion is an enhancement rather than an error. No incorrect calculations are made. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (MDLZ and COST), their use (or non-use) of Level 1 instruments, and links this to their risk management strategies. (4) The answer is contextually excellent, directly addressing the comparative risk management strategies involving financial instruments. The only reason for not scoring a 10 is that the original ground truth did not include the $46M/$77M detail, and while not incorrect, it introduces specificity beyond the verified answer without confirming if that level of detail was required. Overall, the semantic meaning, factual accuracy, and reasoning are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 415,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How does the adoption of Rule 10b5-1(c) trading plans by Apple executives compare with Broadcom's use of similar plans in terms of volume and timing of potential stock sales?",
      "original_answer": "Apple executives Deirdre O'Brien and Jeff Williams entered into Rule 10b5-1(c) trading plans in August 2024, covering the sale of shares vesting between April 1, 2025, and October 1, 2026 (O'Brien) and up to 100,000 shares plus additional vesting shares through October 1, 2025 (Williams), with expiration dates in 2025 and 2026. Broadcom director Diane M. Bryant adopted a similar plan in September 2024, allowing for the sale of up to 15,000 shares of Broadcom common stock contingent on market price thresholds, expiring September 12, 2025. Both companies utilize Rule 10b5-1(c) plans to structure insider trading in compliance with SEC regulations, but Apple’s plans involve significantly larger volumes and longer time horizons.",
      "llm_answer": "Apple’s senior executives have entered Rule 10b5‑1(c) plans that could sell a much larger amount of stock – Jeff Williams’ plan authorizes up to 100,000 shares (and Deirdre O’Brien’s plan covers an unspecified but comparable pool of shares) – and the sales are tied to shares vesting from April 2025 through October 2026, with the plans expiring at the end of 2025 or 2026. Broadcom’s board member Diane Bryant adopted a plan on September 23 2024 that allows the sale of up to 15,000 shares only while the price meets set thresholds, and it expires on September 12 2025, reflecting a smaller volume and a shorter, more immediate sales window.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, most numbers and dates are correct: Jeff Williams' plan covers up to 100,000 shares with vesting through October 1, 2025, and expiration in 2025/2026; Diane Bryant’s plan allows sale of up to 15,000 shares and expires September 12, 2025. However, the LLM incorrectly states Bryant adopted the plan on September 23, 2024, while the ground truth specifies September 2024 without a day—this minor date discrepancy prevents a perfect score. (2) The LLM correctly notes Apple’s plans involve larger volumes and longer time horizons, aligning with the comparative conclusion in the original answer. (3) Multi-hop reasoning is sound: the model synthesizes data across Apple and Broadcom executives, compares volume (100k vs 15k shares), timing (vesting from 2025–2026), and plan duration, correctly inferring Apple's broader scope. (4) The mention of 'unspecified but comparable pool' for O'Brien is a slight softening of the original (which specifies her plan covers shares vesting between April 1, 2025, and October 1, 2026), but does not misrepresent. Overall, the answer is factually strong, contextually relevant, and semantically equivalent with only minor precision loss on the exact adoption date for Bryant’s plan.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 368,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How does the involvement of JPMorgan Chase Bank, N.A. as syndication agent in both 3M's May 11, 2023 Five-Year Credit Agreement and Honeywell’s March 20, 2023 Amended and Restated Five-Year Credit Agreement reflect a shared banking relationship in their respective credit facilities?",
      "original_answer": "JPMorgan Chase Bank, N.A. serves as syndication agent in both 3M’s May 11, 2023 Five-Year Credit Agreement and Honeywell’s March 20, 2023 Amended and Restated Five-Year Credit Agreement, indicating a shared banking relationship where JPMorgan plays a key coordinating role in managing the syndicate of lenders for both companies’ credit facilities. This suggests that both companies rely on JPMorgan Chase Bank, N.A. to help structure and administer large-scale financing arrangements, potentially reflecting a strategic alignment in how they access syndicated credit markets.",
      "llm_answer": "Both 3M’s May 11, 2023 five‑year credit agreement (exhibit 10.29) and Honeywell’s March 20, 2023 amended and restated five‑year credit agreement (exhibit 10.68) list JPMorgan Chase Bank, N.A. as the syndication agent, showing that each company turned to the same major bank to structure and distribute its revolving credit facility and thus share a common banking partner in their credit arrangements【page_114】【page_125】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) All entities—JPMorgan Chase Bank, N.A., 3M, Honeywell, and the respective credit agreements with correct dates (May 11, 2023, and March 20, 2023)—are accurately identified. The role of JPMorgan as syndication agent in both agreements is correctly stated. (2) There are no numerical values requiring calculation (e.g., dollar amounts), but the dates and exhibit references (exhibit 10.29 and 10.68) are consistent with typical SEC filing details and do not contradict the ground truth; their inclusion adds precision. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two separate companies’ credit agreements to infer a shared banking relationship through JPMorgan’s role. (4) The answer captures the core implication—that both companies use the same bank to structure and distribute their credit facilities—though it is slightly less detailed than the original answer in articulating JPMorgan’s 'key coordinating role' or 'strategic alignment' in syndicated credit markets. However, the omission is minor and does not detract from factual correctness. Wording differs but semantic meaning is equivalent. No factual errors; high contextual relevance and accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 356,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How might the EU and U.S. sanctions targeting the tobacco sector in Belarus impact Coca-Cola HBC's operations in the country, and what implications could this have for The Coca-Cola Company's overall unit case volume given its reliance on Coca-Cola HBC as a key bottler?",
      "original_answer": "The EU and U.S. sanctions targeting the tobacco sector in Belarus, including restrictions on trade of goods used for tobacco production, could disrupt local supply chains and economic activity, potentially affecting Coca-Cola HBC's operations in the country. Since Coca-Cola HBC is a major independent bottler representing 41% of The Coca-Cola Company’s total worldwide unit case volume in 2021 and operates in Belarus, any operational constraints or economic instability in Belarus could reduce its production and distribution capacity. This, in turn, could negatively impact The Coca-Cola Company’s overall unit case volume, especially since non-U.S. markets accounted for 83% of the company’s total volume in 2021 and bottlers like Coca-Cola HBC are contractually required to purchase concentrates from KO, forming a critical link in the supply chain.",
      "llm_answer": "The EU‑ and U.S. sanctions that bar trade in goods used for tobacco production and block persons operating in Belarus’s tobacco sector force Coca‑Cola HBC to avoid any dealings with sanctioned entities, which could compel it to suspend or sharply curtail bottling and distribution in Belarus to remain compliant 【page 52】. Because Coca‑Cola HBC is one of the five largest independent bottlers – together the top five generate roughly 41 % of the Coca‑Cola system’s worldwide unit‑case volume – a disruption to HBC’s Belarus operations would shave a modest but material amount off The Coca‑Cola Company’s total unit‑case volume.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that EU and U.S. sanctions on Belarus's tobacco sector could force Coca-Cola HBC to suspend or curtail operations in Belarus to remain compliant, which aligns with the ground truth's implication of operational disruption. The key quantitative figure — 41% of The Coca-Cola Company’s total worldwide unit case volume — is accurately cited, though the LLM slightly rephrases it as 'roughly 41% of the Coca-Cola system’s worldwide unit-case volume', which is semantically equivalent. (2) All numbers and percentages are correct: 41% is accurately reported from the ground truth and matches known data for 2021. No calculations are required, and the reference to page 52 supports the compliance risk. (3) The multi-hop reasoning is sound: the model correctly links sanctions → impact on Coca-Cola HBC’s operations in Belarus → effect on The Coca-Cola Company’s total unit case volume via its reliance on HBC as a major bottler. It correctly identifies the contractual supply chain dependency, though this is implied rather than explicitly stated. (4) The only minor shortcoming is that the LLM does not explicitly mention that non-U.S. markets accounted for 83% of KO’s volume (context that strengthens the global reliance argument), nor does it clarify that Coca-Cola HBC is a contract bottler required to purchase concentrates — a detail present in the original. However, the core causal chain and quantitative impact are preserved. Wording differences do not affect factual accuracy. Thus, the answer is highly accurate with only slight omissions in contextual depth, warranting a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 452,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How might the proposed 28%-30% reduction in U.S. debit interchange rate caps impact Capital One’s interchange fee income, given its exposure to Mastercard’s four-party network and the ongoing legal challenges involving interchange fees that Visa and Mastercard face?",
      "original_answer": "The proposed 28%-30% reduction in U.S. debit interchange rate caps by the Federal Reserve could significantly lower Capital One’s interchange fee income, as COF relies on interchange fees from transactions processed through four-party networks like Mastercard. This impact could be exacerbated by the fact that merchants continue to pursue legal actions against Mastercard and Visa, as seen in the ongoing multidistrict litigation where interchange fee practices remain under scrutiny. Mastercard, being subject to regulatory oversight and interchange fee limitations, may be forced to further reduce fees or face additional settlements, which would directly affect Capital One’s revenue model tied to those networks.",
      "llm_answer": "The Federal Reserve’s October 2023 proposal to cut the U.S. debit‑card interchange cap by roughly 28%‑30% (based on a $50 ticket) would directly shrink the fees Capital One earns on debit purchases that run on Mastercard’s four‑party network, trimming a material portion of its interchange‑fee revenue【page_38】.  That impact is amplified by the broader antitrust and multidistrict litigation facing Visa and Mastercard—ongoing consumer‑interchange and MDL actions that could force further fee reductions or costly settlements—adding uncertainty and additional downside to Capital One’s interchange‑fee income【page_22】【page_101】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 28%-30% reduction in debit interchange caps is correctly cited, with the clarification that it is based on a $50 ticket size, which matches the context of the Federal Reserve’s proposal. The October 2023 date is an acceptable addition not contradicted by the original answer and consistent with public regulatory timelines. (2) All entities are correct: Capital One (COF), Mastercard’s four-party network, Visa and Mastercard litigation, and the multidistrict litigation (MDL) are accurately referenced. (3) The reasoning correctly synthesizes the multi-hop logic: the regulatory cap reduction directly impacts Capital One’s interchange income due to its reliance on Mastercard’s network; this is compounded by ongoing legal challenges that could lead to further fee reductions or settlements. The use of citations (e.g., page_38, page_22, page_101) suggests grounding in source material. (4) The only minor shortcoming is that the original answer emphasizes Mastercard’s regulatory exposure more explicitly, while the LLM focuses slightly more on litigation; however, both convey the same core risk and downstream impact on Capital One. Wording differs but semantic meaning and factual content are equivalent. No calculation errors. The answer is fully contextually relevant and addresses all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 390,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does Duke Energy's exposure to LIBOR-indexed financial contracts influence its adoption timeline for ASU 2020-04 compared to Southern Company's approach, given both companies' assessments of the regulation's financial impact?",
      "original_answer": "Duke Energy is assessing LIBOR-indexed financial arrangements and evaluating the optional expedients in ASU 2020-04 for contracts extending beyond the LIBOR phase-out in 2023, with the transition not expected to have a material impact on its financial statements. Southern Company, similarly, is evaluating the provisions of ASU 2020-04 and the impact of transitioning to alternative rates, though the ultimate outcome remains uncertain. Both companies are applying the guidance as it relates to contract modifications and hedge accounting under the reform, but Duke Energy had until December 31, 2022, to apply the optional expedients, suggesting a time-bound evaluation window compared to Southern Company's ongoing assessment.",
      "llm_answer": "Duke Energy notes that a sizable portion of its variable‑rate debt and interest‑rate swaps are tied to LIBOR, and it is still evaluating the transition and the optional expedients in ASU 2020‑04; the standard has not been adopted as of year‑end 2021 and the company expects to decide on adoption within the elective window (see DUK page 137). In contrast, Southern Company, which also references LIBOR in debt, hedging and certain PPAs, has already elected to apply the ASU 2020‑04 amendments prospectively to qualifying modifications and expects no material impact (see Southern page 194), indicating a sooner, more definitive adoption.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key facts are correct: Duke Energy had not adopted ASU 2020-04 as of year-end 2021 and was evaluating it within the elective window, which matches the ground truth noting Duke’s evaluation period extending until December 31, 2022. Southern Company’s prospective application of the ASU and expectation of no material impact are correctly stated. (2) The LLM correctly identifies both companies’ exposure to LIBOR in debt and hedging instruments, and in Southern’s case, adds PPAs—a detail not in the ground truth but not contradictory. (3) The multi-hop reasoning is sound: the LLM contrasts Duke’s pending evaluation with Southern’s definitive adoption decision, accurately reflecting different adoption timelines influenced by their respective assessments. (4) The only minor gap is that the LLM does not explicitly mention the 2023 LIBOR phase-out as a driver, though it is implied in the transition context. Also, the ground truth emphasizes Duke’s time-bound window versus Southern’s ongoing assessment, while the LLM frames Southern’s approach as more 'definitive'—a valid interpretation. Overall, the answer is factually correct, contextually relevant, and synthesizes cross-company information accurately, warranting a high score with only slight room for added nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 379,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does the application of the Black-Scholes-Merton model for stock option valuation at KO compare to the use of weighted-average assumptions in pension plan cost calculations at CL, particularly in terms of the specific inputs and their financial reporting implications?",
      "original_answer": "KO uses the Black-Scholes-Merton model to estimate the fair value of stock option awards, with the weighted-average fair value of options granted in 2023 being calculated using assumptions such as volatility, risk-free interest rate, and expected term. These weighted-average assumptions are a key input in the model. CL also utilizes weighted-average assumptions, but in the context of pension plan cost calculations, where factors like discount rate (5.66% in 2023), expected long-term rate of return on plan assets (6.25% in 2023), and compensation increase (3.50% in 2023) directly impact the reported net periodic benefit cost. While both companies rely on weighted-average assumptions, KO applies them in equity compensation valuation using a formal pricing model, whereas CL integrates them into actuarial estimates for pension liabilities, highlighting different financial reporting applications of similar statistical inputs.",
      "llm_answer": "The Coca‑Cola Company values its stock‑option awards with a Black‑Scholes‑Merton model, using weighted‑average market inputs – a dividend yield of about 3 % (2023), expected volatility of roughly 17‑18 %, a risk‑free rate that rose to 4.1 % in 2023, and a six‑year expected term – to arrive at a fair‑value of $9.84 per option, which is then expensed on a straight‑line basis over the vesting period and shown as stock‑based compensation expense (recorded in SG&A and reflected in the tax benefit)【page_95】. Colgate‑Palmolive, by contrast, calculates its pension cost using weighted‑average actuarial assumptions – a discount rate of about 5.4 % (U.S. plans), an expected long‑term return on plan assets of 6.5 %, a compensation‑increase rate of 3.5 % (plus ESOP growth, medical‑cost trend and interest‑crediting rates) – to determine service cost, interest cost, expected return on assets and amortization of actuarial gains/losses, which together form the net periodic benefit cost and total pension expense reported in operating profit【page_105】【page_107】. Thus, KO relies on market‑based option‑pricing inputs that drive compensation expense, whereas CL relies on actuarial discount‑rate and return assumptions that drive pension expense and the measurement of pension liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) It correctly identifies KO's use of the Black-Scholes-Merton model for stock option valuation and CL's use of weighted-average assumptions in pension cost calculations. The key inputs for both companies are accurately described. (2) Quantitatively, most numbers align closely with the ground truth: KO's risk-free rate of 4.1% in 2023 is plausible and consistent with market conditions, though the original answer does not specify exact values for volatility, dividend yield, or fair value per option—these are reasonable elaborations based on typical disclosures and do not contradict the ground truth. For CL, the LLM reports a discount rate of ~5.4% (vs. 5.66% in ground truth), expected return of 6.5% (vs. 6.25%), and compensation increase of 3.5% (exact match). These slight variances may reflect rounding or plan-specific subsets (e.g., U.S. vs. global plans) and are within acceptable range for SEC filing interpretations. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both firms use weighted-average assumptions but in different contexts—KO for equity compensation via a financial pricing model, CL for actuarial pension liabilities. The financial reporting implications (expensing methods, impact on SG&A, tax effects, and operating profit) are well articulated. (4) The answer goes beyond the ground truth with specific dollar value ($9.84 per option) and expense classification details, which enhances precision without introducing error. Only minor deviations in CL’s reported rates prevent a perfect 10 on quantitative accuracy. Overall, the response demonstrates strong factual grounding, correct entity identification (KO, CL, correct fiscal year 2023), and excellent semantic equivalence with added contextual depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1586,
        "completion_tokens": 491,
        "total_tokens": 2077
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does AMT's use of subsidiary equity interests as collateral for the $525.0 million Series 2015-2 Notes compare with SPG's strategy of monetizing equity interests through disposals, particularly in light of SPG's $18.8 million gain from such transactions?",
      "original_answer": "AMT utilized the equity interests in its subsidiary GTP Acquisition Partners as part of the collateral structure for the $525.0 million Series 2015-2 Notes, which were secured by a security interest in substantially all of the personal property of the GTP Entities, including GTP Acquisition Partners' equity interests in its subsidiaries. This approach allowed AMT to securitize cash flows from specific communications sites while retaining control over excess cash flows. In contrast, SPG pursued a strategy of actively monetizing its equity interests through disposals, as evidenced by a $18.8 million gain from the sale of equity interests in 2021, indicating a more direct capital realization approach. The comparison highlights different financial strategies: AMT leveraged equity interests for secured financing, while SPG liquidated equity interests for immediate financial gain.",
      "llm_answer": "American Tower pledged the equity interests it holds in GTP Acquisition Partners (and its subsidiaries) as collateral for the $525 million Series 2015‑2 Notes, meaning the equity remains owned but is pledged to secure the debt【page_117】【page_118】. In contrast, Simon Property Group actually disposes of equity stakes, realizing a $18.8 million gain from those sales in 2021【page_63】. Thus, AMT leverages equity to back borrowing, while SPG monetizes equity through outright sales, generating a modest profit rather than using it as loan security.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: AMT pledged equity interests in GTP Acquisition Partners as collateral for the $525.0 million Series 2015-2 Notes, and SPG realized an $18.8 million gain from disposals of equity interests in 2021. The dollar amounts ($525 million and $18.8 million) and year (2021) match the original answer. (2) Quantitative accuracy is perfect—numbers are correctly reported with acceptable format variation ($525 million vs $525.0 million). (3) The multi-hop reasoning is sound: the model correctly contrasts AMT’s secured financing strategy (using equity as collateral while retaining ownership) with SPG’s monetization via outright sales. The synthesis across two companies and financial strategies is accurate. (4) The only minor shortcoming is that the LLM omits a brief detail from the original about AMT retaining control over excess cash flows, which adds nuance to the securitization structure. However, this does not detract from the overall correctness. The comparison is logically structured and semantically equivalent. Contextual relevance is excellent, directly addressing the comparative financial strategies posed in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 350,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does ConocoPhillips' operational exposure in Nigeria compare to ExxonMobil's reliance on production-sharing contracts in terms of reserve reporting and contractual term structures?",
      "original_answer": "ConocoPhillips operates in Nigeria, where exploration and production activities are governed by production-sharing contracts (PSCs) with a typical term of 30 years, including a 10-year exploration period and a 20-year production period that may be extended under the Petroleum Industry Act. ExxonMobil reports that 12% of its total proved reserves (on an oil-equivalent basis) in 2021 were associated with PSC arrangements, where reserve volumes fluctuate inversely with price changes due to the fiscal terms of these contracts. This indicates that while both companies are exposed to PSCs in Nigeria, ExxonMobil's reserve reporting methodology must account for the dynamic nature of PSC-based reserves, whereas ConocoPhillips must manage its operations under fixed-term contractual obligations that include partial relinquishment requirements.",
      "llm_answer": "ConocoPhillips’ 2021 filing shows that only a small slice of its proved reserves – roughly 4 % – is reported under production‑sharing contracts, and it does not break out any Nigeria‑specific acreage, suggesting that its operational exposure in Nigeria is minimal and not material to its reserve reporting. In contrast, ExxonMobil’s Nigerian deep‑water assets are expressly held under PSCs that carry a 30‑year term (a 10‑year exploration phase, convertible to an OML, followed by a 20‑year production period with possible extensions), indicating that PSCs are a core, contract‑defined framework for its Nigerian operations.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but introduces a significant factual discrepancy. The original answer states that ExxonMobil reports 12% of its total proved reserves in 2021 were associated with PSC arrangements, while the LLM incorrectly attributes the 4% PSC reserve figure to ConocoPhillips in 2021 — this number is not present in the ground truth and cannot be verified from the provided data. This is a critical quantitative error. (2) The LLM correctly identifies the 30-year PSC term structure (10-year exploration, 20-year production with possible extensions) for Nigerian operations, which aligns with the ground truth description applicable to ConocoPhillips, but incorrectly frames it as specific to ExxonMobil’s deep-water assets without confirming that structure for Exxon in the source. The ground truth does not specify that the 30-year term applies exclusively or specifically to ExxonMobil, only that such terms exist in Nigeria where both companies operate. (3) The multi-hop reasoning is partially sound — the model attempts to compare contractual structures and reserve reporting implications — but fails to correctly attribute reserve percentage data and misaligns entity-specific details. It incorrectly suggests ConocoPhillips has only 4% reserves under PSCs, which is not in the original answer, and omits the key point that ExxonMobil’s PSC reserves fluctuate inversely with prices due to fiscal terms — a central element of the original comparison. (4) Contextual relevance is high because the answer addresses reserve reporting and contractual terms for both companies in Nigeria, but correctness and qualitative accuracy are reduced due to unsupported numbers and misattributed contractual details. The model fabricates a specific percentage (4%) not present in the ground truth and misassigns term structure details, undermining factual reliability despite plausible reasoning structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 527,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does IBM's focus on generative AI innovation compare with QCOM's investment in edge-based generative AI and cloud computing, particularly in terms of their respective strategies for commercializing AI technologies in high-performance, low-power computing environments?",
      "original_answer": "IBM is actively investing in generative AI as part of its broader innovation initiatives, emphasizing cutting-edge R&D to differentiate itself in hybrid cloud and AI markets, with the goal of attracting a developer ecosystem and maintaining market share. In contrast, QCOM is embedding generative AI capabilities directly into edge devices, such as smartphones and PCs, to optimize performance, privacy, and personalization while coordinating with cloud applications. QCOM's cloud computing processing initiative supports this strategy by enabling intelligent data sharing between edge devices and cloud systems. While IBM focuses on enterprise-level AI innovation and ecosystem development, QCOM is commercializing generative AI through high-performance, low-power mobile platforms, projecting that 46% of smartphones sold in 2027 will be generative AI capable, up from 19% in 2024.",
      "llm_answer": "IBM is positioning generative‑AI as a cloud‑centric capability, embedding it in its hybrid‑cloud platform and enterprise software/consulting services so that AI can be delivered at scale to business workflows (IBM 10‑K p.3‑5). Qualcomm, by contrast, is building generative‑AI into the silicon itself—its AI Engine and Hexagon NPU deliver high‑performance, low‑power inference on Snapdragon SoCs for edge devices, while the same technology is tied into cloud‑computing services through its ecosystem (QCOM 10‑K p.7‑9). Thus IBM’s commercialization path relies on cloud‑based AI services for enterprises, whereas Qualcomm’s strategy centers on on‑device, low‑power AI hardware that powers edge use cases and complements cloud workloads.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its qualitative description of IBM and Qualcomm's strategies and correctly identifies the core distinction: IBM focuses on cloud-centric, enterprise-level generative AI delivered via hybrid cloud platforms and services, while QCOM integrates generative AI directly into edge hardware (e.g., Snapdragon SoCs) for low-power, high-performance on-device inference, complemented by cloud integration. The answer cites appropriate sections of the 10-K filings (IBM p.3-5, QCOM p.7-9), supporting its claims with document context. However, it omits a key quantitative projection from the ground truth: QCOM's forecast that 46% of smartphones sold in 2027 will be generative AI-capable, up from 19% in 2024. This is a significant omission in completeness, as the question specifically asks about commercialization strategies in high-performance, low-power environments, and this statistic directly supports QCOM's market trajectory and strategic impact. Despite this, all other factual elements—such as IBM’s ecosystem and enterprise focus, and QCOM’s silicon-level AI integration with NPUs and edge-cloud coordination—are correctly represented. There are no errors in entity identification, reasoning, or financial/technical terminology. The multi-hop synthesis between the two companies’ strategies is sound and relevant. The answer is semantically aligned with the ground truth but lacks the specific forward-looking metric that strengthens QCOM’s commercialization narrative. Hence, full marks for quantitative accuracy (no incorrect numbers, just a missing one), high marks for qualitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 451,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does Duke Energy's exposure to nuclear decommissioning funding risks compare to NextEra Energy's financial risk management for nuclear generation, given both companies' reliance on market performance for trust-funded obligations?",
      "original_answer": "Duke Energy Carolinas, Progress, and Florida have significant obligations tied to decommissioning nuclear plants, with trust assets subject to market fluctuations that could increase funding requirements if returns fall below projections. Similarly, NextEra Energy and FPL maintain decommissioning funds and insurance coverage, but the cost of decommissioning could exceed available funds. Both companies are exposed to financial risks stemming from nuclear power plants, particularly as market performance directly affects their ability to meet long-term decommissioning obligations.",
      "llm_answer": "Duke Energy’s nuclear decommissioning risk is tied almost entirely to the market value of its nuclear‑decommissioning trust‑fund assets – a decline in those assets would raise funding needs and could hurt cash flow (DUK page 35). NextEra Energy also relies on market‑based decommissioning funds, but it cushions that exposure with maximum private liability insurance, participation in a secondary financial‑protection system, and active hedging and risk‑management tools that limit the impact of market volatility (NEE pages 31‑32, 30). Thus, Duke’s risk is more directly linked to trust‑fund performance, whereas NextEra uses broader insurance and hedging mechanisms to manage similar market‑linked obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: both Duke Energy and NextEra Energy face nuclear decommissioning funding risks tied to market performance of trust-funded obligations. The LLM correctly identifies that Duke Energy's exposure is directly linked to trust fund performance, which could impact cash flow if market returns decline. For NextEra, it accurately notes the use of insurance, secondary financial protection, and risk management tools to mitigate market volatility—details not explicitly in the ground truth but consistent with and elaborating upon it. (2) There are no numeric values (e.g., dollar amounts, percentages, years) in either the original or LLM answer, so quantitative accuracy is not compromised; the response avoids making up figures and sticks to qualitative risk descriptions. (3) Multi-hop reasoning is sound: the model synthesizes comparative risk management approaches across two companies, correctly contrasting Duke’s direct market exposure with NextEra’s broader mitigation strategies. This goes slightly beyond the original answer by citing specific risk management mechanisms (e.g., hedging, insurance layers), which are plausible and supported by the cited document pages. (4) Semantic equivalence is strong—the core message matches: both firms are exposed to market-linked decommissioning risks, but NextEra employs additional financial safeguards. The only reason for not scoring a 10 is that the original answer emphasizes mutual exposure without contrasting mitigation strategies in detail, so the LLM adds nuance not present in the ground truth, which, while reasonable, slightly exceeds the confirmed facts. However, this does not constitute an error, just a more detailed interpretation. Overall, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 508,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does CAT's application of hedging relationship accounting under ASU 2020-04 compare to UPS's adoption of the same standard, particularly in terms of their respective derivative contract management strategies and transition timelines?",
      "original_answer": "CAT formally documents and designates derivatives as either fair value or cash flow hedges, using foreign currency forward and option contracts to manage up to five years of anticipated foreign currency cash flow exposure. Under ASU 2020-04, CAT applied optional expedients for contract modifications affected by reference rate reform through December 31, 2024, though the adoption did not have a material impact. In contrast, UPS transitioned its affected debt instruments and contracts to SOFR as the alternative reference rate by December 31, 2023, but did not elect to apply the practical expedients provided under ASU 2020-04, continuing to assess potential impacts through 2024. Both companies applied the standard to manage derivative and debt contract modifications, but CAT leveraged the extended relief period while UPS opted for direct transition without using the optional relief.",
      "llm_answer": "CAT applies ASU 2020‑04 with a detailed hedge‑accounting framework: it formally documents each hedge, designates foreign‑currency forwards as cash‑flow hedges, uses fixed‑to‑floating interest‑rate swaps as fair‑value hedges (floating‑to‑fixed swaps as cash‑flow hedges), keeps commodity contracts undesignated, and even runs a match‑funding policy to align assets and liabilities – and it completed its transition of affected debt and contracts to SOFR by 12/31/2023, opting not to use the practical expedients. UPS also adopted ASU 2020‑04 and moved its debt and contracts to SOFR as of 12/31/2023 without electing the expedients, but its filing only notes the use of foreign‑currency, interest‑rate and commodity derivatives for risk management without the granular hedge designations that CAT describes.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, CAT applied the optional expedients under ASU 2020-04 through December 31, 2024, and the adoption did not have a material impact. However, the LLM incorrectly states that CAT completed its transition to SOFR by December 31, 2023 and opted *not* to use the practical expedients—this directly contradicts the original answer, which states CAT *did* apply the expedients and used the extended relief period. Conversely, the LLM claims UPS moved to SOFR by 12/31/2023 without electing expedients, which aligns with the ground truth. However, it omits that UPS continued to assess potential impacts through 2024, a key detail. (2) The date for CAT’s use of expedients is wrong: ground truth specifies relief through 12/31/2024, but LLM says CAT transitioned by 12/31/2023—this is a critical error in both timeline and interpretation of expedient usage. (3) The multi-hop reasoning fails because the LLM reverses the core contrast: the original answer hinges on CAT using the expedients while UPS did not, but the LLM incorrectly states both companies avoided the expedients. This undermines the comparative analysis. Additionally, the LLM adds unsupported details (e.g., fixed-to-floating swaps, match-funding policy, commodity contracts undesignated) not present in the ground truth, introducing hallucinated information. (4) Correctness is low (3/10) due to major factual and directional errors in both companies’ strategies and timelines. Quantitative accuracy is poor due to incorrect dates and mischaracterized transitions. Qualitative accuracy is low due to flawed reasoning and invented details. Contextual relevance is moderate as the answer addresses derivative management and transition timelines, but with incorrect substance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 497,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does Comcast's lack of voting rights in Atairos compare to Alphabet's dual-class stock structure, particularly in terms of control implications given Alphabet's significant share repurchase activity in Classes A and C?",
      "original_answer": "Comcast has no voting rights in Atairos and only certain consent rights, which means it lacks control over Atairos’s activities despite a remaining unfunded capital commitment of $1.4 billion as of December 31, 2024. In contrast, Alphabet maintains a dual-class stock structure where Class B shares have 10 votes per share, allowing key stakeholders to retain outsized voting power. Despite repurchasing $62.0 billion in Class A and Class C shares in 2024 alone, Alphabet has preserved the Class B structure, which ensures concentrated control while reducing public float in the lower-vote and no-vote classes.",
      "llm_answer": "Comcast’s investment in Atairos is an equity‑method investment that carries no voting rights – the company “does not have the power to direct the activities that most significantly impact the economic performance of Atairos” (CMCSA 10‑K p. 85). Alphabet, by contrast, operates a dual‑class system in which Class B shares carry ten votes each while Class A has one vote and Class C has none, and it has repurchased large amounts of Class A and C stock (over $62 billion in 2022‑2024), thereby shrinking the pool of non‑voting shares and concentrating voting power in the Class B hands (GOOGL 10‑K p. 82). Thus, Comcast has no control over Atairos, whereas Alphabet’s structure and share‑repurchase activity consolidate control among its voting shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core comparison between Comcast's lack of voting rights in Atairos and Alphabet's dual-class structure with concentrated control. It correctly identifies that Comcast has no voting rights and lacks control over Atairos, citing the appropriate qualitative language from the 10-K. It accurately describes Alphabet’s dual-class structure (Class B: 10 votes, Class A: 1 vote, Class C: 0 votes) and notes the repurchase of over $62 billion in Class A and C shares from 2022–2024. However, the original answer specifies that Alphabet repurchased $62.0 billion in 2024 *alone*, while the LLM answer states 'over $62 billion in 2022–2024', which misrepresents the timeframe and aggregates across three years—this is a material quantitative discrepancy. Despite this, the reasoning is sound: the LLM correctly infers that repurchasing non-voting shares increases the relative influence of voting shareholders, thus concentrating control. The entities (Comcast, Alphabet, Atairos), stock classes, and control implications are all correctly identified and synthesized across sources. The answer addresses all parts of the multi-hop question: ownership structure, voting rights, share repurchases, and control implications. Wording differs but meaning is semantically equivalent in most aspects, except for the time period of repurchases. Hence, correctness is slightly reduced due to the date/amount misstatement, but qualitative and contextual accuracy remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 412,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How does the extension of reference rate reform accounting relief under ASU 2022-06 impact the transition timelines for both UPS and FedEx, given that UPS had already transitioned its affected debt to SOFR by December 31, 2023, while FedEx continued monitoring its contracts through May 31, 2024?",
      "original_answer": "The deferral of the sunset date of ASU 2020-04 from December 31, 2022, to December 31, 2024, via ASU 2022-06, allowed both UPS and FedEx to extend their evaluation and application of reference rate reform accounting relief. UPS had already transitioned its affected debt instruments and contracts to SOFR by December 31, 2023, and did not elect to apply the practical expedients under Topic 848, but continued to assess potential impacts through 2024. FedEx, on the other hand, had not experienced any material effect from reference rate reform as of May 31, 2024, and continued to monitor its contracts and transactions for potential application of ASUs 2020-04 and 2022-06. The extension provided FedEx additional time to evaluate whether to apply the optional expedients, while UPS used the period to ensure full alignment with the new rates and assess any residual effects.",
      "llm_answer": "The ASU 2022‑06 relief can be used on eligible LIBOR‑linked contracts through Dec. 31 2024, giving companies an extra year to apply the optional expedients. UPS already finished moving its affected debt to SOFR as of Dec. 31 2023 and will simply continue to watch for any residual impacts during 2024 (UPS 10‑K p. 74). FedEx, by contrast, is still evaluating its contracts and has not completed a transition, so it will remain in a monitoring phase through May 31 2024 and can rely on the extended relief period to finish any required changes before the 2024 deadline (FedEx 10‑K p. 93).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: ASU 2022-06 extends the relief to December 31, 2024; UPS completed its transition to SOFR by December 31, 2023, and continues monitoring for residual impacts; FedEx was still evaluating contracts as of May 31, 2024. These dates and timelines match the original answer exactly. (2) Quantitative accuracy is perfect: all dates (Dec 31, 2023, May 31, 2024, Dec 31, 2024) are correctly stated and contextually applied. (3) Multi-hop reasoning is sound—correctly synthesizes UPS’s completed transition versus FedEx’s ongoing monitoring, and how the extension benefits each differently. (4) The only minor omission is that the original answer notes UPS did not elect to apply Topic 848 expedients, which the LLM answer does not explicitly mention, though it implies UPS did not rely on the relief by stating it 'already finished moving' its debt. This nuance is not critical to the core question about transition timelines but adds depth. Otherwise, the LLM answer captures the impact of the extension on both companies accurately and concisely. Wording differs slightly but maintains semantic equivalence. Contextual relevance is excellent—directly addresses the question with appropriate detail and source references.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 366,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How does PepsiCo's beverage revenue concentration in Africa, Middle East, and South Asia (29% in 2023) compare with Target's beverage sales geographic exposure, given that Target's merchandise segments only describe domestic operations in the U.S.?",
      "original_answer": "PepsiCo generated 29% of its beverage revenue from the Africa, Middle East, and South Asia (AMESA) region in 2023, indicating a significant international presence in this sector. In contrast, Target's 2023 10-K filing only describes its beverage offerings as part of grocery sales within its U.S. operations, with no mention of international retail presence or beverage sales outside the United States. This suggests that Target's beverage sales are entirely domestic, while PepsiCo maintains a substantial international footprint in beverages, particularly in the AMESA region.",
      "llm_answer": "PepsiCo reports that 29 % of its 2023 beverage revenue comes from its Africa‑Middle East‑South Asia (AMESA) division, indicating a sizable share of its beverage sales is generated outside the United States【page_72】. By contrast, Target’s filing notes that it operates as a single domestic segment and “nearly all of our revenues are generated in the United States,” so its food‑and‑beverage sales have essentially no comparable international exposure【page_46】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 29% beverage revenue figure for PepsiCo in the AMESA region in 2023 is correctly reported, and the characterization of Target’s revenue as 'nearly all... generated in the United States' matches the original answer’s assertion that Target has no international beverage sales presence. (2) The citation of page numbers (72 for PepsiCo, 46 for Target) suggests proper sourcing from the 10-K filings, though these are not part of the ground truth verification but add credibility. (3) The multi-hop reasoning is sound: the model correctly contrasts PepsiCo’s explicit international beverage revenue concentration with Target’s domestic-only operations, synthesizing information across two companies and their respective geographic exposures. (4) The only minor shortcoming is that the LLM answer refers to 'food-and-beverage sales' rather than specifically 'beverage sales' within grocery, slightly broadening the scope, but this does not distort the core conclusion. Semantically, the answer conveys the same key point: PepsiCo has significant international beverage exposure in AMESA, while Target’s are entirely domestic. Thus, the answer is factually correct, well-reasoned, and contextually appropriate, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 394,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How does the absence of the Countercyclical Capital Buffer impact the minimum capital requirements for SCHW compared to GS's TLAC to RWAs requirement, given both are subject to multi-layered regulatory buffers?",
      "original_answer": "For SCHW, the absence of the Countercyclical Capital Buffer (which was set to zero) still results in a minimum Common Equity Tier 1 Risk-Based Capital ratio of 7.0%, Tier 1 Risk-Based Capital ratio of 8.5%, and Total Risk-Based Capital ratio of 10.5%, inclusive of other buffers like the 2.5% stress capital buffer. For GS, the TLAC to RWAs requirement includes a 18% minimum, a 2.5% buffer, and also incorporates the Countercyclical Capital Buffer (also set to zero), along with a 1.5% G-SIB surcharge. Therefore, even without the Countercyclical Capital Buffer, both firms face layered capital requirements, but GS's baseline (18%) is significantly higher due to its global systemic importance and TLAC framework.",
      "llm_answer": "Schwab’s banking subsidiaries face a minimum capital‑ratio floor of 7.0 % CET1 (8.5 % Tier 1 and 10.5 % total), which reflects only the regulatory minimum plus the stress‑capital and capital‑conservation buffers because the counter‑cyclical capital buffer is set to 0 % (see SCHW page 118). Goldman Sachs’s TLAC‑to‑RWAs requirement is 22.0 % – a figure that already incorporates the 18 % TLAC minimum, a 2.5 % buffer and a 1.5 % G‑SIB surcharge, with the counter‑cyclical buffer also at 0 % (see GS page 93). Thus, the absence of a counter‑cyclical buffer leaves Schwab with a much lower minimum capital requirement than Goldman’s TLAC‑to‑RWAs target, even though both calculations exclude that buffer.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct but contains a minor quantitative inaccuracy in the presentation of GS's TLAC-to-RWAs requirement. The original answer states that GS's requirement includes an 18% minimum, a 2.5% buffer, a 1.5% G-SIB surcharge, and a zero-countercyclical buffer, implying a total of 22% (18 + 2.5 + 1.5), which the LLM correctly calculates and reports as 22.0%. However, the original answer does not explicitly state that 22% is the final requirement—it only lists the components—while the LLM presents 22.0% as a consolidated figure, which is reasonable but slightly extrapolated. The LLM correctly notes that both firms exclude the countercyclical buffer (set to 0%), and accurately contrasts SCHW’s 7.0% CET1 with GS’s higher baseline due to TLAC and G-SIB status. The SCHW capital ratios (7.0%, 8.5%, 10.5%) are correctly reported and attributed to stress capital and conservation buffers. The reasoning correctly synthesizes multi-hop elements: regulatory buffers, exclusion of countercyclical buffer, and systemic importance driving higher GS requirements. Entity names (SCHW, GS), metrics (CET1, TLAC, RWAs), and buffer types are accurate. The answer is contextually relevant and addresses all parts of the question. The minor issue is that the original answer emphasizes that GS’s *baseline* (18%) is higher, while the LLM emphasizes the *total* (22%), which shifts focus slightly but does not invalidate the comparison. No calculation errors; formatting variations (e.g., % spacing) are acceptable. Overall, core facts and synthesis are correct with minor presentational over-precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 439,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How does Dalton's $5.3 million reimbursement from Georgia Power for Plant Vogtle construction reflect its involvement in self-owned generation facilities, and how does this ownership model contrast with NEE's approach to revenue generation through long-term contracts covering 94% of its capacity?",
      "original_answer": "Dalton receives $5.3 million in reimbursements from Georgia Power for its share of Plant Vogtle Units 3 and 4 construction costs, indicating its partial ownership stake in this nuclear generation facility. This aligns with Dalton’s broader strategy of serving its energy requirements through self-owned generation assets, some of which are jointly owned with Georgia Power. In contrast, NEE generates revenue by contracting 94% of its net generating capacity under long-term bilateral agreements, focusing on full-output commitments rather than joint ownership of facilities. This highlights a structural difference: Dalton participates in shared infrastructure ownership to meet its load needs, while NEE monetizes its generation assets through extensive contractual commitments in competitive markets.",
      "llm_answer": "Dalton’s $5.3 million reimbursement (page 189) is a cost‑sharing payment from Georgia Power for Dalton’s proportional share of Plant Vogtle construction, reflecting Dalton’s role as a joint‑owner that supplies its members from self‑owned (and partly jointly‑owned) generation assets (page 18). In contrast, NextEra Energy Resources (NEER) does not rely on self‑consumption; it earns almost all of its revenue by selling the output of its owned plants under long‑term power‑purchase agreements that lock in about 94 % of its capacity (page 19).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the $5.3 million reimbursement and the 94% long-term contract coverage are accurately reported. Format variations (e.g., $5.3 million vs $5.3M) are acceptable and do not affect accuracy. (2) The answer correctly identifies Dalton’s partial ownership in Plant Vogtle via cost reimbursement, linking it to its self-owned generation strategy, and contrasts this with NEE’s (specifically NEER’s) revenue model based on long-term contracts covering 94% of capacity. (3) The multi-hop reasoning is sound: it synthesizes Dalton’s ownership model (involving joint ownership and cost reimbursement) with NEE’s contractual monetization approach. The only minor limitation is that the LLM refers to 'NextEra Energy Resources (NEER)' rather than 'NEE' as in the original, but NEER is a subsidiary of NEE and the context of long-term contracts for 94% of capacity is correctly attributed to the appropriate business segment. This does not constitute a factual error but slightly narrows the scope compared to the broader NEE reference. (4) The answer is contextually relevant, directly addressing both parts of the question—Dalton’s ownership model and NEE’s contrasting revenue strategy—with precise and meaningful comparison. Wording differs slightly but maintains semantic equivalence. No calculation errors or entity misidentifications are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 401,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How do RTX and BA differ in their approaches to managing customer financing obligations, particularly regarding RTX's $7.0 billion in credit facilities versus BA's long-term lease structures?",
      "original_answer": "RTX manages its customer financing obligations by leveraging its strong liquidity position, including $7.0 billion in available credit facilities, which provides flexibility for funding such obligations without relying on short-term commercial paper borrowings. In contrast, BA structures its customer financing through long-term lease arrangements, with terms ranging from 1 to 12 years, often including options to extend, terminate, or purchase the underlying asset. These lease-based financing strategies reflect BA's capital-intensive model, particularly in its BCC segment, and are accounted for under operating or finance leases, impacting both asset and liability balances on its balance sheet. The differing approaches highlight RTX's reliance on liquidity buffers versus BA's use of extended lease terms to manage financing commitments.",
      "llm_answer": "RTX manages its customer‑financing needs primarily through external liquidity sources – it maintains $7.0 billion of revolving credit facilities (a $5 billion and a $2 billion line) that can be drawn to fund operating, investing and financing activities, including any customer‑financing requirements (see RTX 10‑K p. 52). In contrast, Boeing finances its customers by structuring long‑term leases: it records sales‑type/finance leases and operating leases on its balance sheet, recognizes the associated financing receivables and lease income, and controls risk with allowances for losses and residual‑value estimates (see BA 10‑K p. 93‑94).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all numbers are correct: RTX's $7.0 billion in credit facilities (broken into $5B and $2B lines) matches the ground truth amount, and the reference to Boeing's long-term lease structures with durations up to 12 years is consistent in both. No calculations were required, but the dollar amounts are precisely reported. (2) The answer addresses all parts of the question: it contrasts RTX’s use of credit facilities for customer financing with Boeing’s reliance on long-term lease structures. It correctly identifies that RTX uses external liquidity (credit lines) while BA uses lease-based financing models, including sales-type/finance and operating leases. (3) Entity accuracy is strong: RTX and BA are correctly identified, and the financial instruments (revolving credit, finance leases, operating leases) are accurately named. The 10-K page references (p.52 for RTX, pp.93–94 for BA) add verifiability and align with typical disclosure locations. (4) Reasoning is sound and reflects multi-hop synthesis: the model correctly infers different strategic approaches—RTX relying on liquidity buffers versus BA embedding financing in lease accounting. The only minor omission is that the original answer notes lease terms range from 1 to 12 years and may include extension/purchase options, which the LLM answer does not explicitly mention. Additionally, the ground truth highlights that BA’s model impacts both asset and liability balances, a point slightly underdeveloped in the LLM response. However, these are minor gaps that do not undermine the overall correctness. Semantic equivalence is maintained, and the LLM provides contextually relevant, factually accurate, and well-synthesized information.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 490,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How do Coca-Cola and Philip Morris differ in their application of weighted-average assumptions within their financial reporting frameworks?",
      "original_answer": "Coca-Cola uses the Black-Scholes-Merton option-pricing model to estimate the fair value of stock option awards, with the weighted-average assumptions applied specifically to these stock options granted during the years ended December 31, 2023, 2022, and 2021. In contrast, Philip Morris applies weighted-average assumptions to determine net pension and postretirement healthcare costs, which is a different financial reporting framework focused on employee benefits beyond stock compensation. The difference in application highlights how the same accounting methodology is used for distinct compensation components—equity-based incentives at Coca-Cola versus retirement and healthcare liabilities at Philip Morris.",
      "llm_answer": "Coca‑Cola applies weighted‑average assumptions only to its equity‑compensation valuation – the Black‑Scholes‑Merton model for stock options (using dividend yield, expected volatility, risk‑free rate and expected term) and the fair‑value calculations for performance‑share awards. In contrast, Philip Morris uses weighted‑average assumptions in its actuarial calculations for pension and post‑retirement benefit plans, such as discount rates, compensation‑increase rates, interest‑crediting rates and health‑care cost‑trend rates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that Coca-Cola applies weighted-average assumptions to equity compensation—specifically using the Black-Scholes-Merton model for stock options and fair-value calculations for performance-share awards—while Philip Morris uses these assumptions for pension and post-retirement benefit plans. This aligns with the original answer’s emphasis on different financial reporting frameworks: stock-based compensation vs. employee benefits. (2) There are no numeric values, dates, or financial figures in either answer that conflict; both correctly reference the relevant models and assumptions without introducing incorrect data. The LLM adds slightly more detail (e.g., naming specific assumptions like dividend yield, expected volatility, etc.), but these are consistent with standard Black-Scholes inputs and do not contradict the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies and distinguishes their use of weighted-average assumptions within different accounting contexts. The only minor shortcoming is that the original answer specifies the years (2023, 2022, 2021) and explicitly frames the contrast in terms of 'financial reporting frameworks,' which the LLM implies but does not state as clearly. However, this does not detract from factual correctness. (4) The answer is contextually precise, directly addressing how the two firms differ in application. Thus, the correctness score is 9 due to slightly less explicit framing of the conceptual contrast, though all facts are accurate and complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 460,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How does the expiration timeline of regulatory exclusivity for Merck's Januvia family of products compare to Gilead's U.S. regulatory exclusivity expiration in 2032, and what impact might this have on their respective market positions given the role of exclusivity in delaying generic competition?",
      "original_answer": "Merck's Januvia family of products is expected to lose U.S. market exclusivity in May 2026 (Januvia and Janumet) and July 2026 (Janumet XR), while Gilead has a U.S. regulatory exclusivity that expires in 2032. According to the evidence, regulatory exclusivity provides a period during which generic competitors cannot rely on the innovator’s data for approval, thus delaying market entry of generics. Since Gilead benefits from a significantly longer exclusivity period, it may maintain a more protected market position through 2032, whereas Merck will face substantial sales declines starting in 2026 due to generic competition and pricing pressures, as seen in other markets post-expiry.",
      "llm_answer": "Merck’s Januvia/Janumet portfolio is projected to lose U.S. market exclusivity by May 2026 for Januvia and Janumet (July 2026 for Janumet XR)【page_58】, whereas Gilead’s key products retain U.S. regulatory exclusivity until 2032【page_9】. Because exclusivity blocks generic approvals, Merck will confront generic competition roughly six years earlier, putting pressure on its sales and market share, while Gilead’s later expiration gives it a longer protected window to sustain its market position.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the U.S. market exclusivity expiration dates for Merck's Januvia family: May 2026 for Januvia and Janumet, and July 2026 for Janumet XR, matching the ground truth. It also accurately states that Gilead’s U.S. regulatory exclusivity extends until 2032. These dates are factually correct and properly attributed to the respective companies and products. (2) All quantitative elements—specific months and years—are accurate. The comparison of a roughly six-year difference in exclusivity timelines is a reasonable approximation (2032 vs. 2026 is a six-year gap), and no calculations are required beyond this temporal comparison, which is sound. (3) The reasoning correctly synthesizes the impact of regulatory exclusivity on generic competition: it notes that exclusivity blocks generic approvals, leading to earlier sales and market share pressure for Merck, while Gilead benefits from a longer protected period. This reflects accurate multi-hop reasoning across the two companies and the broader regulatory context. (4) The answer is semantically equivalent to the ground truth, though it omits a minor detail about 'substantial sales declines starting in 2026 due to generic competition and pricing pressures, as seen in other markets post-expiry'—a contextual nuance present in the original. However, the core impact (pressure on sales and market share) is conveyed. Wording differences are acceptable and do not affect factual accuracy. Thus, the answer is highly accurate, with only a slight deduction for minor incompleteness in elaborating the full extent of Merck’s expected post-patent challenges.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 453,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How does Intel's amortization expense for developed technology used in cybersecurity compare with Cisco's revenue recognition timing for its cloud security offerings?",
      "original_answer": "Intel reported $1,283 million in amortization expenses for developed technology in 2021, which includes technology used for cybersecurity solutions like cloud security. Cisco recognizes revenue for its cloud security offerings ratably over the contract term, aligning with the ongoing delivery of updates and upgrades critical to the software’s performance. This contrasts with Intel’s cost recognition pattern, where developed technology is amortized over a 9-year weighted average useful life, reflecting a more fixed cost structure compared to Cisco’s recurring revenue model.",
      "llm_answer": "Intel records a sizable amortization charge on its cybersecurity‑related developed‑technology intangibles – $1.283 billion for the year ended Dec 25 2021 (and $1.211 billion for 2020) 【page_95】. By contrast, Cisco treats its cloud‑security (End‑to‑End Security) offerings as a single distinct performance obligation and recognises the related revenue ratably over the contract term, i.e., over time rather than upfront 【page_75】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the amortization expense for Intel is correctly stated as $1.283 billion for 2021 (equivalent to $1,283 million in the original answer), and the inclusion of the 2020 figure ($1.211 billion) is an acceptable addition not contradicting the ground truth. The citation of page_95 and page_75 supports the data provenance. (2) The revenue recognition method for Cisco is accurately described as ratable (over time) over the contract term, which matches the original answer’s claim. (3) The multi-hop reasoning is sound: the model correctly contrasts Intel’s cost amortization pattern (a fixed, backward-looking cost allocation) with Cisco’s forward-looking, recurring revenue model for cloud security, even if it doesn’t explicitly mention the 9-year useful life or use the phrase 'weighted average'—a minor omission. (4) The core entities—Intel, Cisco, developed technology amortization, cloud security revenue recognition, and the relevant fiscal year (2021)—are all correctly identified and contextualized. The only slight gap is the lack of explicit comparison language about cost vs. revenue recognition structures, but the contrast is implied through accurate descriptions. Semantic equivalence is maintained, and all critical facts are correct. Hence, a high score across all dimensions with a minor deduction in qualitative accuracy for incomplete elaboration on the structural contrast.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 407,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has the adoption of ASU 2022-02 affected MET's loan modification disclosures compared to JPM's reporting under the legacy TDR guidance, particularly in terms of the types and financial impact of modifications made to borrowers experiencing financial difficulty?",
      "original_answer": "MET adopted ASU 2022-02 on January 1, 2023, which eliminated the TDR accounting framework and introduced the concept of Financial Difficulty Modifications (FDMs), requiring expanded disclosures. MET reported that the adoption did not have a material impact on its financial statements, but it now discloses FDMs instead of TDRs. JPM, under the legacy TDR guidance prior to 2023, reported $362 million in new TDRs for 2022, with modifications typically involving interest rate reductions, term extensions, and payment delays. In 2023, under FDM reporting, JPM noted $136 million in FDMs, predominantly term extensions and rate reductions, which extended the weighted-average life of loans by 20 years and reduced the weighted-average interest rate from 7.21% to 4.44%. This shift reflects a more principles-based approach under ASU 2022-02, focusing on financial difficulty rather than concession-based criteria, resulting in more consistent and transparent reporting of loan modifications across both institutions.",
      "llm_answer": "MetLife’s 2023 filing shows that, after adopting ASU 2022‑02, it now reports “financial‑difficulty modifications” (FDMs) instead of legacy TDRs and provides a detailed breakdown of the concessions granted—interest‑rate cuts, term extensions, principal deferrals or forgiveness—and quantifies their impact (e.g., $136 million of residential‑real‑estate FDMs, a drop in weighted‑average rate from 7.21 % to 4.44 %, a 20‑year life‑extension, $1 million of charge‑offs, $16 million deferred, $2 million forgiven and $147 million of re‑defaults). JPMorgan’s disclosures, by contrast, still reference the pre‑ASU TDR framework and simply state that auto and other loan modifications were “not material” (both before and after the change), offering no granular data on modification types or their financial effect.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misattributes data. (1) Quantitative Accuracy: The $136 million in FDMs is correctly attributed to JPM in 2023 in the ground truth, but the LLM incorrectly assigns this figure to MetLife (MET), which is false. The detailed breakdown of $1 million charge-offs, $16 million deferred, $2 million forgiven, and $147 million re-defaults is not present in the original answer and appears fabricated. The 20-year extension and rate drop from 7.21% to 4.44% are correctly cited in magnitude but wrongly attributed to MetLife instead of JPM. (2) Completeness: The LLM fails to mention MET’s statement that adoption of ASU 2022-02 had no material impact on its financials, a key point in the original. It also omits JPM’s $362 million in TDRs for 2022 under legacy guidance. (3) Entity Accuracy: The LLM swaps key data between MET and JPM—JPM reported the $136 million FDMs and associated metrics in 2023, not MET. Additionally, the claim that JPM’s disclosures state modifications were 'not material' contradicts the ground truth, which provides specific figures and types of modifications for JPM. (4) Reasoning: The multi-hop synthesis is flawed—instead of contrasting MET’s post-ASU FDM disclosures with JPM’s pre- and post-ASU reporting, the LLM incorrectly portrays MET as providing granular FDM data while falsely claiming JPM offers none. This reverses the actual flow of information. (5) Semantic Equivalence: Despite using similar terminology (FDMs, TDRs, rate reductions), the answer conveys a meaning that is factually opposite to the ground truth in key aspects. The contextual relevance is moderate because it addresses loan modifications and ASU 2022-02, but the misattribution of data severely undermines correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 482,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How does CVX's upstream position in South American natural gas reserves compare with XOM's downstream footprint across the broader Americas region?",
      "original_answer": "CVX reported 329 billion cubic feet of natural gas reserves in South America as of December 31, 2022, reflecting its upstream exposure in the region. South America is geographically included within the broader 'Americas' reporting segment, which encompasses both North and South America. XOM maintains a large downstream presence across the Americas, with integrated refining, marketing, and logistics operations focused on delivering refined products like gasoline, diesel, and synthetic motor oils. While CVX's position centers on upstream resource extraction in South America, XOM's downstream operations span the entire Americas region, highlighting complementary but distinct strategic focuses within the energy value chain.",
      "llm_answer": "CVX’s upstream exposure in South America is modest – it held about 462 billion cubic feet of proven natural‑gas reserves in the region at the end of 2021 【page_108】. In contrast, ExxonMobil’s downstream business is one of the largest integrated operations worldwide, with a well‑established, region‑wide footprint across the Americas that includes extensive refining, marketing, logistics and trading assets 【page_63】.  Thus, CVX’s South‑American gas reserve position is relatively small compared with XOM’s broad, diversified downstream presence throughout the entire Americas region.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key quantitative data. The ground truth states CVX held 329 billion cubic feet of natural gas reserves in South America as of December 31, 2022, but the LLM claims 462 billion cubic feet as of end-2021. This is both a numerical and temporal error—wrong amount and wrong year. These discrepancies affect the reliability of the comparison. (2) The quantitative accuracy is low because the reserve figure is off by over 130 billion cubic feet, and the reporting year is incorrect (2021 vs 2022). No acceptable format variation explains this gap. (3) Qualitatively, the reasoning is sound in framing CVX’s upstream position against XOM’s downstream footprint, and correctly identifies the geographic scope (South America vs broader Americas). It also accurately characterizes XOM’s downstream operations as integrated and region-wide. However, it fails to note that South America is part of the broader 'Americas' segment, missing a key contextual link present in the original. (4) Contextual relevance is high—the answer addresses the core contrast between upstream and downstream strategies and focuses on the correct companies and regions. Despite incorrect numbers, the overall structure and intent align with the question. Final correctness score is low due to major quantitative and temporal inaccuracies, which are critical in financial and resource reporting.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 398,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does the $25 million commercial paper exposure of Duke Energy Ohio compare with Tesla's $470 million commercial paper holdings in terms of their short-term liquidity strategies?",
      "original_answer": "Duke Energy Ohio reports a $25 million commercial paper exposure as part of its short-term liabilities, reflecting its reliance on modest short-term borrowing for operational needs. In contrast, Tesla holds $470 million in commercial paper as part of its short-term investments, indicating a cash deployment strategy rather than a funding need. This comparison highlights two distinct uses of commercial paper: Duke Energy utilizes it as a financing tool, while Tesla treats it as an investment to optimize liquidity returns.",
      "llm_answer": "Duke Energy Ohio’s $25 million of commercial paper is a modest, short‑term exposure that the company classifies as long‑term debt because it backs the paper with a master credit facility and intends to refinance it, using those facilities to meet any near‑term cash needs【page_165】. Tesla, on the other hand, holds $470 million of commercial paper as part of its cash‑and‑cash‑equivalents portfolio, reflecting a much larger reliance on short‑term marketable securities to provide immediate liquidity【page_72】.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the $25 million commercial paper exposure for Duke Energy Ohio and Tesla's $470 million holdings, matching the ground truth numerically. These values are accurately cited and contextually placed. (2) Quantitative accuracy is perfect—both dollar amounts are correct, with acceptable formatting ($25 million, $470 million). No calculations were required, and the numbers align with the original answer. (3) The multi-hop reasoning is partially sound: the model correctly identifies Duke Energy Ohio’s commercial paper as a liability and Tesla’s as an investment (via cash-equivalents). However, it introduces a detail not in the ground truth—classifying Duke’s commercial paper as long-term debt due to refinancing intent—which, while possibly accurate from the filing, shifts focus from the core contrast in liquidity strategies. The original answer emphasizes Duke’s use of commercial paper as a financing tool versus Tesla’s use as an investment for returns; the LLM downplays this strategic contrast by focusing on debt classification rather than purpose. (4) The answer remains contextually relevant and mostly factually aligned, but misses the deeper qualitative insight about opposing roles of commercial paper (liability vs. asset), reducing the qualitative accuracy. Hence, correctness is scored 7 for accurate numbers but incomplete conceptual synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 389,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does the voting power structure of META's Class A common stock compare to GOOGL's Class B common stock in terms of shareholder influence, given the dual-class stock structures described in their filings?",
      "original_answer": "META's Class A common stock has limited voting power compared to its Class B common stock, where a single shareholder (Mr. Zuckerberg) retains significant control, with Class B shares requiring majority approval for change-in-control transactions until they represent less than 35% of combined voting power. In contrast, GOOGL's Class B common stock provides 10 votes per share, significantly more than the 1 vote per share for Class A, though Class B shares automatically convert to Class A upon sale or transfer. CMCSA's example shows a similar dual-class structure where Class A holds 66 2/3% of voting power with 1 vote per share and Class B holds 33 1/3% with 15 votes per share, illustrating a pattern of concentrated voting control in dual-class structures like those of META and GOOGL.",
      "llm_answer": "Meta’s Class A common stock carries only one vote per share, so ordinary shareholders have relatively modest voting power (Meta’s filing notes that “Our Class B common stock has ten votes per share and our Class A common stock has one vote per share”【page_49】). In contrast, Alphabet’s Class B shares are the high‑voting shares, each entitled to ten votes per share, giving their holders (founders and insiders) roughly ten‑fold greater influence over corporate matters (“Each share of Class B common stock is entitled to 10 votes per share”【page_81】). Consequently, Meta’s Class A shareholders have far less voting leverage than Alphabet’s Class B shareholders.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the voting rights for META Class A (1 vote per share) and Class B (10 votes per share), as well as GOOGL's Class B shares having 10 votes per share, which aligns with the ground truth. These quantitative details are accurate and properly cited from the filings. (2) All numeric values — one vote for Class A and ten votes for Class B in both companies — are correct. There are no calculation errors. (3) However, the LLM answer misses key qualitative and multi-hop elements from the original answer. Specifically, it omits the structural detail about Mr. Zuckerberg’s sustained control until Class B shares fall below 35% of combined voting power, which is a critical aspect of META’s governance. It also fails to mention the automatic conversion of GOOGL Class B shares to Class A upon sale or transfer, a key limitation on long-term control. Additionally, while the comparison between the two companies’ voting power is directionally correct, the LLM does not fully synthesize the broader pattern of dual-class structures illustrated by the CMCSA example in the ground truth, which provides context for concentrated voting control. (4) The answer is factually sound in its core claims and highly relevant to the question, earning strong scores in quantitative accuracy and contextual relevance. However, the lack of key structural details from both companies’ filings reduces the qualitative accuracy and overall correctness, warranting a score of 7 rather than higher.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 417,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does the dividend structure for non-voting share classes at Mastercard and Charles Schwab impact the alignment of shareholder returns between voting and non-voting equity holders, given Mastercard's explicit distinction in dividend rights for B Class Shares and Charles Schwab's statement that dividend rights are identical across voting and nonvoting stock classes?",
      "original_answer": "At Mastercard, both A Class (voting) and B Class (non-voting) shares have dividend rights, indicating equal treatment in shareholder returns through dividends despite differences in voting power. In contrast, Charles Schwab explicitly states that dividend and liquidation rights are identical between its voting and nonvoting stock classes, ensuring full alignment in shareholder returns across share types. This means that while both companies provide dividend rights to non-voting shares, Charles Schwab maintains a stronger structural alignment in returns between share classes, whereas Mastercard preserves dividend parity but separates voting control.",
      "llm_answer": "Mastercard’s charter creates two equity classes: voting Class A shares and non‑voting Class B shares. Both classes are granted “Dividend rights” (see Note 16, Classes of Capital Stock – Class B: “Non‑voting Dividend rights”) so the cash dividend per share is the same for voting and non‑voting holders, but the non‑voting holders do not participate in corporate governance. Charles Schwab, by contrast, states that “the participation rights, including dividend and liquidation rights, are identical between the voting and nonvoting stock classes” (see Consolidated Statements of Income note), meaning both classes receive the same dividend per share; the only distinction between the classes is voting power. Thus, in both firms cash returns are aligned across share classes, but Mastercard separates voting rights from dividend rights explicitly, whereas Schwab emphasizes that the dividend rights are identical.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly identifies that both Mastercard and Charles Schwab provide equal dividend rights to voting and non-voting shares, with Mastercard explicitly distinguishing voting but not dividend rights between Class A and B shares, and Schwab stating identical participation rights including dividends and liquidation. (2) There are no numerical values in the question or answer requiring calculation, so quantitative accuracy is not applicable in terms of figures; however, the absence of any incorrect numbers or misstatements earns a perfect score. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies and compares their dividend structures, noting that both align cash returns but differ in how they frame the structural separation—Mastercard separates voting from dividend rights explicitly, while Schwab emphasizes identity across classes. (4) The only minor shortcoming is that the LLM slightly underemphasizes the conclusion in the original answer that Charles Schwab maintains 'stronger structural alignment' due to identical liquidation *and* dividend rights, whereas Mastercard only ensures dividend parity. This nuance is present in the source but could have been more explicitly highlighted. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 399,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How might the implementation of the OECD's Pillar Two global minimum tax differently affect Microsoft's and Oracle's effective tax rates, given Microsoft's expectation of no material impact and Oracle's concern about materially increased international tax costs?",
      "original_answer": "Microsoft expects no material impact from the OECD's Pillar Two global minimum tax due to its current operations not being concentrated in jurisdictions with tax rates below the 15% threshold. In contrast, Oracle explicitly notes that the adoption of Pillar Two in many jurisdictions could materially increase its international tax costs. While both companies are subject to the same global regulatory framework, their differing geographic footprints and tax planning strategies appear to lead to divergent expectations about the financial impact of the new rules.",
      "llm_answer": "Microsoft says that, although the OECD Pillar Two rules (a 15% global minimum tax) will begin to apply to it in FY 2025, it does not expect a material impact on its consolidated effective tax rate because it has little exposure to jurisdictions with rates below the floor (see MSFT page 47). In contrast, Oracle warns that the same Pillar Two regime could “materially increase the level of income tax on our international profits,” potentially raising its effective tax rate through higher international tax costs (see ORCL page 29).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that Microsoft expects no material impact on its effective tax rate due to limited exposure to jurisdictions with tax rates below the 15% Pillar Two threshold, while Oracle explicitly warns of materially increased international tax costs. (2) There are no numerical values requiring calculation (e.g., percentages, dollar amounts, or dates) beyond the 15% rate and FY2025 applicability, both of which are correctly stated and contextually accurate. The mention of 'FY2025' aligns with Microsoft's timeline and is consistent with Pillar Two implementation expectations. (3) The multi-hop reasoning is sound: the model correctly synthesizes contrasting disclosures from two different companies (Microsoft and Oracle) regarding the same regulatory framework (OECD Pillar Two), drawing a valid comparison based on geographic tax exposure and strategic implications. (4) The answer is fully contextually relevant, directly addressing how Pillar Two might differentially affect the two companies' effective tax rates, as asked. Minor stylistic differences (e.g., citation of page numbers, use of 'consolidated effective tax rate') do not detract from accuracy and in fact add precision. All entities—Microsoft (MSFT), Oracle (ORCL), OECD Pillar Two, effective tax rates, international tax costs—are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 398,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How do GM's and LOW's applications of Level 3 valuation techniques differ in their financial reporting, particularly regarding the unobservable inputs and methodologies used for fair value measurements?",
      "original_answer": "GM utilizes Level 3 valuation techniques primarily for marketable debt securities and finance receivables, relying on pricing models, discounted cash flow models, and industry-standard pricing models with unobservable inputs such as economic forecasts, including unemployment rates, interest rate spreads, disposable personal income, and GDP growth rates. LOW, on the other hand, applies Level 3 valuation specifically to contingent consideration from the fiscal 2022 sale of its Canadian retail business, using an income approach with unobservable inputs like total equity value, volatility, and expected term. While both companies use Level 3 valuations, GM focuses on macroeconomic assumptions across a range of financial instruments, whereas LOW applies it to a specific long-term investment with performance-based metrics.",
      "llm_answer": "GM uses Level 3 valuation for a range of assets—primarily equity‑method investments and long‑lived asset groups—by applying discounted‑cash‑flow or cash‑flow‑discount models that require unobservable assumptions about future cash flows, residual values and discount rates (GM’s Note 3 describes Level 3 as “instruments whose significant inputs are unobservable” and the fair‑value discussion notes that fair value is “determined primarily using the anticipated cash flows, including estimated residual values”) 【page_63】【page_64】. In contrast, Lowe’s only classifies its performance‑based contingent consideration as Level 3, measuring it with an income‑approach/option‑pricing model that relies on unobservable inputs such as total equity value, volatility, expected term and a risk‑adjusted discount rate (Lowe’s Note 3 and the contingent‑consideration paragraph describe this Level 3 treatment) 【page_52】【page_53】. Thus, GM’s Level 3 application is broader and uses cash‑flow‑based models for various assets, whereas Lowe’s Level 3 use is limited to contingent consideration and employs an option‑pricing model with specific unobservable market‑assumption inputs.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of entities, methodologies, and unobservable inputs used by GM and LOW (Lowe’s) for Level 3 valuations. It accurately identifies that GM applies Level 3 techniques broadly across assets such as equity-method investments and long-lived asset groups using discounted cash flow models with unobservable inputs like future cash flows, residual values, and discount rates. The mention of GM’s Note 3 and page references supports this. For Lowe’s, the answer correctly states that Level 3 is applied only to performance-based contingent consideration from the Canadian retail business sale, using an income/option-pricing model with inputs like total equity value, volatility, expected term, and risk-adjusted discount rate—consistent with the original answer. However, the original answer specifies the contingent consideration relates to the fiscal 2022 sale, a detail omitted in the LLM response. Additionally, the original highlights GM’s use of macroeconomic forecasts (e.g., unemployment, GDP growth), while the LLM focuses on cash flow assumptions without explicitly naming those broader economic inputs. These are minor but relevant omissions affecting completeness and qualitative accuracy. No numeric inaccuracies are present—there are no explicit numbers to verify, but all descriptive financial concepts are correctly represented. The reasoning is sound and multi-hop, correctly contrasting the scope and methodology differences between the two companies. Contextual relevance is high as all content directly addresses the question. Thus, the answer earns a high score but not perfect due to missing specificity on timing (fiscal 2022) and GM’s macroeconomic inputs.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 474,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA influence the potential conversion dynamics of Class A shares, especially in light of Alphabet's aggressive share repurchase strategy involving Class A and Class C shares?",
      "original_answer": "At CMCSA, Class B common stock holds 33 1/3% of the voting power, with each share entitled to 15 votes, and this voting power is non-dilutable under the company's articles of incorporation. This structure creates a concentrated voting control that could influence decisions regarding potential conversions of Class A shares, as Class B shares can be converted share-for-share into Class A under certain restrictions. Meanwhile, Alphabet (GOOGL) has been actively repurchasing Class A and Class C shares, spending $62.2 billion in 2023 alone and maintaining $36.3 billion in remaining authorization as of year-end. This aggressive repurchase strategy could reduce the number of outstanding shares in similar classes, potentially increasing the proportional influence of remaining shareholders, including those holding voting shares like CMCSA's Class B. The combination suggests that while CMCSA's Class A shareholders may see increased influence through potential Class B conversion, GOOGL's repurchase activity could further concentrate ownership and influence within its own capital structure.",
      "llm_answer": "CMCSA’s charter gives Class B shareholders a fixed one‑third of the total voting power (33.3 % of all votes, 15 votes per share) that cannot be diluted, so when Class B is converted share‑for‑share into Class A it adds to the pool of Class A shares but leaves the protected Class B voting block unchanged, limiting any shift in control (CMCSA 10‑K p. 91). Alphabet, by contrast, is aggressively buying back its voting Class A and non‑voting Class C shares (repurchasing $62.2 bn in 2023 and authorizing an additional $70 bn) while its high‑vote Class B shares remain untouched (Alphabet 10‑K p. 81). Consequently, any conversion of Class B to Class A would represent a larger slice of the reduced Class A base, but the unchanged Class B voting power means the overall voting dynamics remain tempered.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is largely correct in its factual content and reasoning. It accurately states that CMCSA's Class B shares hold 33 1/3% (or 33.3%) of voting power with 15 votes per share and that this voting power is non-dilutable, which aligns with the ground truth. It correctly notes that Class B shares can be converted share-for-share into Class A, affecting the share pool but not diluting the protected voting block. Regarding Alphabet, it correctly reports the $62.2 billion in share repurchases in 2023. However, it introduces an inaccuracy by stating Alphabet authorized an 'additional $70 billion' in repurchases, whereas the ground truth specifies $36.3 billion remained authorized as of year-end—this figure is not an additional authorization and contradicts the original answer. 2) Quantitative accuracy is high: $62.2 billion in repurchases is correct; 33.3% and 15 votes per share are accurate. The $70 billion figure is incorrect and unsupported by the ground truth, which mentions $36.3 billion remaining authorization without specifying new authorization. This is a significant but isolated error. 3) The multi-hop reasoning is sound: the model correctly connects CMCSA’s voting structure to potential conversion dynamics and contrasts it with Alphabet’s repurchase strategy. It logically infers that repurchases reduce the Class A base, increasing the relative weight of any converted shares, while CMCSA’s Class B voting power remains insulated. However, it overstates Alphabet’s repurchase authorization, weakening the precision of the cross-company comparison. 4) Contextual relevance is excellent—the response directly addresses the interplay between voting power, conversion, and repurchase strategies. Despite the error in the repurchase authorization amount, the core insights about ownership concentration and control dynamics are preserved, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 514,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What is the difference in remaining securities available for future issuance under equity compensation plans between MDLZ and CL, based on their 2022 10-K disclosures?",
      "original_answer": "MDLZ reported 48,932,017 securities remaining available for future issuance under equity compensation plans, while CL reported 37,028,000 securities (in thousands). The difference between the two companies' remaining issuance capacity is 11,904,017 securities.",
      "llm_answer": "The Colgate‑Palmolive 2022 10‑K reports that 37,028 thousand securities remain available for future issuance under its equity‑compensation plans. The Mondelēz International excerpts do not contain a comparable “remaining available” figure, so a numeric difference between the two companies cannot be calculated from the disclosed information.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect. (1) It falsely claims that MDLZ's 10-K does not contain a 'remaining available' figure, when in fact the ground truth confirms MDLZ reported 48,932,017 securities available for future issuance in its 2022 10-K. This information was available and correctly extracted in the original answer. (2) The LLM correctly reports CL's figure as 37,028 thousand (i.e., 37,028,000), which matches the ground truth. However, it fails to report the MDLZ number and incorrectly concludes the difference cannot be calculated. The correct difference is 48,932,017 - 37,028,000 = 11,904,017, as stated in the original answer. (3) The multi-hop reasoning is flawed: the model should have retrieved and compared the two disclosed figures from each company’s 10-K, but instead it erroneously asserts data is missing for MDLZ. (4) Due to the complete failure to report a correct difference and the false assertion of missing data, the correctness and quantitative accuracy scores are very low. Contextual relevance is slightly higher because the answer addresses the right topic and correctly cites CL’s number, but it fails the core task.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1155,
        "completion_tokens": 326,
        "total_tokens": 1481
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does the impact of Illinois' Clean Energy Law on ComEd's transmission rate structure compare to Tesla's exposure to state-level regulatory challenges in markets with direct sales restrictions?",
      "original_answer": "Illinois' Clean Energy Law directly affects ComEd's transmission rate structure by requiring a new four-year multi-year plan to establish rates after the expiration of its performance-based distribution formula rate, and accelerating the amortization of ComEd's unprotected excess deferred income taxes over approximately 39.5 years. These regulatory changes introduce uncertainty around ComEd’s rate of return on equity, which is currently set at 11.50% with a 50-basis-point incentive adder as a RTO member. In contrast, Tesla faces state-level regulatory challenges related to its direct-to-consumer sales model, where certain U.S. states have laws interpreted to restrict its ability to sell vehicles through company-owned stores or obtain dealer licenses. While ComEd’s exposure centers on rate-setting mechanisms and compliance with decarbonization mandates, Tesla’s risk is tied to legal interpretations of motor vehicle industry laws and potential legislative pushback from dealer associations. Both face significant regulatory uncertainty, but the financial implications differ: ComEd’s are embedded in its cost recovery and capital structure, while Tesla’s affect its go-to-market strategy and expansion potential.",
      "llm_answer": "The Illinois Clean Energy Law reshapes ComEd’s transmission‑rate framework by adding a new rider to recover the cost of nuclear carbon‑mitigation credits, imposing a decoupling mechanism and obligating the utility to file a new general‑rate case or multi‑year plan once the existing performance‑based distribution formula sunsets (see pages 219‑220). Tesla’s exposure, by contrast, is a broader state‑level regulatory risk that could limit the company’s ability to operate its own stores in certain states and trigger legal challenges, but it does not alter a regulated rate‑setting formula—its impact is chiefly on market access and sales‑channel strategy (see page 27).",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core regulatory impacts on both ComEd and Tesla but omits key factual details present in the ground truth, particularly regarding the financial and structural specifics of ComEd's rate treatment. (1) Correct elements: The LLM correctly identifies that Illinois' Clean Energy Law affects ComEd’s transmission rate structure through a new multi-year plan after the expiration of its performance-based distribution formula rate, and mentions decoupling and cost recovery mechanisms. It also accurately contrasts this with Tesla’s state-level regulatory challenges around direct sales, noting the difference in nature (rate-setting vs. market access). (2) Quantitative accuracy: No explicit numbers (e.g., 11.50% ROE, 50-basis-point adder, 39.5-year amortization) are mentioned in the LLM answer, so while it doesn’t contradict them, it fails to include critical quantitative details from the ground truth. The absence of these figures—especially the ROE and amortization period—reduces factual completeness. (3) Multi-hop reasoning: The model synthesizes across entities (ComEd vs. Tesla) and regulatory domains (utility rate design vs. auto sales laws), showing sound comparative logic. However, it misses the deeper financial implications: ComEd’s exposure to return on equity uncertainty and the specific treatment of deferred income taxes, which are central to the original answer. (4) The LLM cites page numbers (219–220, 27), suggesting document grounding, but the content summarized is incomplete. While semantically aligned in broad strokes, the lack of specificity on ComEd’s financial mechanisms and Tesla’s legislative pushback from dealer associations limits qualitative accuracy. Contextual relevance is high as the response stays focused on regulatory comparisons. Overall, partially correct but lacks key multi-hop details needed for full accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 508,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How will the IRA-driven Medicare Part D redesign, which imposes manufacturer discounts and price caps starting in 2025, affect the gross-to-net rebate accruals for both AMGN's ENBREL and BMY's Medicare Part D-dependent products, given AMGN's regulatory exposure and BMY's accounting for GTN adjustments based on payer channel mix and contract prices?",
      "original_answer": "The IRA-driven Medicare Part D redesign, which introduces manufacturer discounts and caps beneficiary out-of-pocket costs starting in 2025, will increase the gross-to-net (GTN) rebate accruals for both AMGN and BMY. For AMGN, the redesign compounds the impact of the set price for ENBREL starting in 2026, which is significantly lower than current pricing, and the potential inclusion of Otezla in the next round of Medicare price setting in 2027. This will likely reduce profitability and necessitate larger GTN adjustments. For BMY, which depends on Medicare Part D and accounts for GTN rebates using assumptions like payer channel mix and contract prices, the new obligations under the IRA will increase rebate liabilities, particularly in the catastrophic phase where manufacturers absorb more costs. The combined effect will be a material adverse impact on both companies' revenues and financial reporting accuracy, as they must adjust accruals to reflect the new regulatory environment and pricing pressures.",
      "llm_answer": "The IRA’s Medicare Part D redesign forces manufacturers to provide mandatory discounts and accept price caps starting in 2025, so Amgen expects ENBREL’s gross‑to‑net rebate accruals to rise as the lower CMS‑set price and inflation‑penalty rebates increase its regulatory exposure (see p. 36). Bristol‑Myers Squibb will likewise record higher GTN accruals for its Part D‑dependent products because its GTN calculations are driven by payer‑channel mix and contract‑price assumptions, and the new required discounts and caps reduce contract prices and boost the estimated rebate liability (see p. 125‑126).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the IRA's Medicare Part D redesign starts in 2025, imposes manufacturer discounts and price caps, and increases gross-to-net (GTN) rebate accruals for both AMGN and BMY. The answer correctly identifies that AMGN’s ENBREL faces increased regulatory exposure due to the CMS-set price and inflation penalties, and that BMY’s GTN accruals are affected through payer channel mix and contract price assumptions. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; dates (2025) are correct. (3) Multi-hop reasoning is sound: the model correctly links the IRA policy change to its financial impact on GTN accruals, connects AMGN’s exposure to regulatory pricing mechanisms, and explains BMY’s accounting methodology in light of new rebate obligations. The only minor omission is that the original answer includes forward-looking impacts for AMGN beyond 2025—specifically the 2026 price setting for ENBREL and potential 2027 inclusion of Otezla—which the LLM answer does not mention. This slightly reduces completeness but does not invalidate the core correctness. (4) The LLM answer uses different wording (e.g., 'inflation-penalty rebates', 'CMS-set price') but maintains semantic equivalence and contextual relevance. Overall, the response is factually correct, well-reasoned, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 409,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How do AIG's and MET's differing accounting treatments for structured securities impact the valuation and reporting of ABS & CLO assets in their respective financial statements?",
      "original_answer": "AIG applies the effective yield method to structured securities, recalculating yields based on expected cash flows and adjusting amortized cost accordingly, with changes in expected cash flows either charged or credited to net investment income. MET, on the other hand, classifies ABS & CLO as available-for-sale (AFS) and measures them at estimated fair value, including those valued using Level 3 inputs, which are disclosed in recurring fair value measurements. These differing approaches—AIG's yield-based adjustments versus MET's fair value measurement—result in different financial statement presentations and sensitivity to market changes, affecting how investors assess the valuation and risk profile of each company's structured securities portfolio.",
      "llm_answer": "AIG treats its ABS & CLO holdings as available‑for‑sale fixed‑maturity securities measured at fair value; changes in their fair value flow through OCI and, for high‑credit‑quality securities, the effective yield is reset and the amortized‑cost basis is adjusted, which directly impacts net investment income (AIG p.169‑171; p.167). MetLife also measures ABS & CLO exposures at fair value but classifies them mainly in Level 3 of the fair‑value hierarchy and reports them in the “Other” category of fixed‑maturity securities, providing a detailed Level‑3 roll‑forward of balances, unrealized gains/losses and transfers while keeping non‑credit‑related unrealized losses out of earnings (MET p.93‑94; p.308‑309).",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains no explicit numerical data (e.g., dollar amounts, percentages, dates), so quantitative accuracy is not applicable in a traditional sense; however, since no numbers were misstated, it is scored as 10. Contextually, the response is relevant and addresses the accounting treatments of ABS & CLO assets for both AIG and MET, citing appropriate sections of their filings. However, there is a significant factual inaccuracy in the characterization of AIG's accounting treatment: the LLM claims AIG measures ABS & CLO at fair value and adjusts effective yield upon fair value changes, which conflates AIG's actual method. According to the ground truth, AIG applies the effective yield method based on expected cash flows (not fair value), with yield recalculations adjusting amortized cost and impacting net investment income directly—this is a form of amortized cost accounting under dynamic yield assumptions, not fair value through OCI. In contrast, the LLM incorrectly states AIG treats these as available-for-sale (AFS) securities, which is false; AFS treatment implies fair value measurement with unrealized gains/losses in OCI, which is MET's approach, not AIG's. MET's classification as AFS and Level 3 fair value measurement is correctly described, including the Level 3 roll-forward and exclusion of non-credit losses from earnings. The core distinction—AIG’s cash flow-driven yield adjustment vs. MET’s fair value reporting—is therefore misrepresented, undermining the qualitative accuracy. This is a critical error in multi-hop reasoning, as the comparison hinges on correctly identifying each firm's accounting model. While the LLM references correct document pages and appears to draw from valid sources, the synthesis is flawed. Thus, despite good structure and contextual relevance, the answer earns only a 5 for correctness and qualitative accuracy due to this central misrepresentation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 516,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does the percentage of Chevron's (CVX) reserves tied to production-sharing contracts (PSCs) compare with ExxonMobil's (XOM) operational exposure in Nigeria, given Nigeria's reliance on PSCs for deepwater offshore exploration and production?",
      "original_answer": "Chevron's (CVX) reserves tied to production-sharing contracts (PSCs) accounted for 8% of its consolidated reserves in 2021. ExxonMobil (XOM) operates in Nigeria, where deepwater offshore exploration and production are governed by PSCs with terms typically lasting 30 years, including a 10-year exploration period and a 20-year production period. This indicates that both companies are exposed to PSC frameworks, but while CVX quantifies its PSC exposure directly in terms of reserves, XOM's exposure in Nigeria is structural and long-term, embedded in the regulatory framework of a key operational region.",
      "llm_answer": "Chevron reports that PSC‑related reserves make up only 7 percent of its total proved reserves for 2021 (9 % in 2020 and 11 % in 2019)【page_106】.  By contrast, ExxonMobil’s deep‑water offshore assets in Nigeria are “typically governed by production‑sharing contracts (PSCs)” – meaning its entire Nigerian operating base is subject to PSCs【page_31】.  Thus Chevron’s PSC exposure is modest (≈7 % of reserves), whereas ExxonMobil’s exposure in Nigeria is effectively 100 % of its Nigerian operations.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Chevron's PSC-related reserves as 7% in 2021, which is close to the ground truth value of 8%. This minor discrepancy (7% vs 8%) likely stems from a source variation or rounding difference, but it affects quantitative accuracy. The trend (9% in 2020, 11% in 2019) is additional context not in the original answer but does not contradict it. (2) For ExxonMobil, the LLM correctly states that its Nigerian deepwater operations are governed by PSCs and interprets this as 100% exposure of its Nigerian operations to PSCs, which aligns with the original answer’s claim of structural, long-term exposure embedded in the regulatory framework. While the original answer does not quantify XOM’s exposure as '100%', the LLM’s interpretation is reasonable and semantically consistent. (3) The multi-hop reasoning is sound: the model connects Chevron’s quantified reserve exposure with ExxonMobil’s operational structure in Nigeria, and correctly contrasts direct reserve-based exposure with structural contractual exposure. It synthesizes information across companies and contract types appropriately. (4) The answer is contextually excellent—directly addressing the comparison asked, using correct entities (CVX, XOM, Nigeria, PSCs), and maintaining focus on the regulatory and operational implications. The slight numerical deviation prevents a top score in correctness and quantitative accuracy, but qualitative and contextual performance is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 412,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How does Tesla's fixed share reservation under the 2019 Plan compare with HD's approach to stock appreciation rights in terms of long-term equity compensation flexibility, given Tesla's 49.0 million reserved shares and HD's forfeiture-adjusted vesting methodology?",
      "original_answer": "Tesla's 2019 Plan establishes a fixed reservation of 49.0 million shares for equity incentives including stock appreciation rights (SARs), indicating a structured long-term approach to compensation with defined capacity. In contrast, HD's SAR program incorporates estimated forfeitures into its compensation expense calculation and recognizes value on a straight-line basis as restrictions lapse, allowing for dynamic adjustment based on actual retention of talent. While both companies utilize SARs, Tesla's approach suggests greater predictability and constraint in equity issuance, whereas HD's method provides flexibility in response to workforce attrition and vesting outcomes.",
      "llm_answer": "Tesla’s 2019 Equity Incentive Plan reserves a fixed pool of 49.0 million shares that can be issued for stock options, RSUs and SARs, establishing a set ceiling for future equity awards (TSLA 10‑K 2022, p. 83). Home Depot, however, accounts for its SAR awards using a forfeiture‑adjusted vesting methodology—estimated forfeitures are built into the expense calculation—so the number of SARs that actually vest can shrink over time, giving the company more flexibility to tailor long‑term equity compensation to employee retention and performance (HD 10‑K 2022, p. 53).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 49.0 million share reservation for Tesla's 2019 Plan is correctly stated, and the description of HD's forfeiture-adjusted methodology matches the original. No calculations were required, but the numbers and their contexts are precise. (2) The answer addresses all parts of the multi-hop question: Tesla’s fixed share reservation, HD’s forfeiture-adjusted vesting, and the comparative impact on long-term equity compensation flexibility. (3) Entity accuracy is strong: Tesla (TSLA), Home Depot (HD), the 2019 Plan, SARs, and correct 10-K references (2022 filings, pp. 83 and 53) are properly cited. (4) The reasoning is sound—LLM correctly infers that Tesla’s fixed pool implies predictability and constraint, while HD’s approach allows dynamic adjustment based on retention, which is a valid interpretation of the forfeiture methodology. The only minor shortcoming is that the LLM does not explicitly mention 'straight-line recognition' of value as in the original, slightly reducing qualitative completeness. However, the core insight about flexibility due to forfeiture adjustments is preserved. Overall, the answer is factually correct, well-synthesized, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 358,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How does Chevron's financial exposure to Tengizchevroil in Kazakhstan, including its $4,500 million loan for the FGP/WPMP development, compare to ExxonMobil's reported long-lived asset value in Kazakhstan of $8,463 million as of 2021?",
      "original_answer": "Chevron holds a 50% equity stake in Tengizchevroil (TCO), which operates major oil fields in Kazakhstan, and has extended a $4,500 million loan to TCO specifically for the FGP/WPMP development. In 2021, Chevron's upstream earnings from TCO contributed positively to its income from equity affiliates. Meanwhile, ExxonMobil reported a total long-lived asset value in Kazakhstan of $8,463 million as of 2021. This suggests that while Chevron's exposure is primarily through equity investment and project-specific financing, ExxonMobil's presence is reflected in substantial asset holdings, indicating differing capital deployment strategies in the same geographic region.",
      "llm_answer": "Chevron’s equity investment in its 50 % stake in Tengizchevroil was $23.7 billion at the end of 2021, and that amount includes a $4.5 billion loan to fund the FGP/WPMP development 【page_78】. That exposure is roughly three‑times larger than ExxonMobil’s Kazakhstan long‑lived‑asset balance of $8.463 billion reported for 2021 【page_123】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in asserting that Chevron's total equity investment in Tengizchevroil was $23.7 billion as of 2021, which is not supported by the ground truth. The original answer only confirms a $4.5 billion loan and a 50% equity stake, but does not specify the total value of Chevron's equity investment. This $23.7 billion figure is a critical error that undermines the quantitative comparison. (2) The LLM claims Chevron's exposure is 'roughly three-times larger' than ExxonMobil's $8.463 billion, based on the unsupported $23.7 billion figure. However, the ground truth does not provide a total exposure value for Chevron that would allow such a comparison—only a $4.5 billion loan and equity stake without a dollar valuation. Therefore, the calculation and comparison are invalid. The $4.5 billion loan alone is less than half of ExxonMobil's $8.463 billion asset value, so the conclusion is factually incorrect. (3) The multi-hop reasoning is partially sound in that the model attempts to compare Chevron's financial exposure with ExxonMobil's asset value in Kazakhstan, and correctly identifies the 50% stake and the purpose of the loan. However, it fabricates a total investment figure that enables an erroneous conclusion, failing to accurately synthesize the available data. (4) Contextual relevance is high because the answer addresses the right companies, project (FGP/WPMP), and geographic focus (Kazakhstan), and cites appropriate financial metrics. However, the quantitative inaccuracy severely reduces correctness. The qualitative score reflects correct entity identification but flawed reasoning due to the invented figure. The correctness score is 4 due to partial factual alignment but major errors in key financial figures and the resulting comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 499,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How do Duke Energy's PPA negotiations for renewable facilities compare to Southern Power's PPA structures in wind facilities, particularly in terms of cash flow implications given Southern Power's utilization of production tax credits through 2024?",
      "original_answer": "Duke Energy negotiates PPAs as part of its commercial renewables strategy, where these agreements significantly influence the economic performance of its renewable energy VIEs. Southern Power, on the other hand, acts as a lessor in PPAs related to wind facilities, which are accounted for as operating leases with terms up to 25 years. These PPAs directly affect Southern Power's cash flows through lease income, which is further enhanced by production tax credits (PTCs) tied to the first 10 years of energy production from these wind facilities. Southern Power had approximately $0.8 billion in unutilized PTCs at the end of 2021, expected to be fully utilized by 2024. This creates a distinct cash flow dynamic: while Duke's PPAs are central to the performance of its consolidated VIEs, Southern Power's PPAs are structured to align with tax credit monetization strategies, directly shaping its lease income and tax equity partnership returns.",
      "llm_answer": "Duke Energy’s renewable projects are held in VIEs and the 10‑K notes that the company “negotiates PPAs” (see Commercial Renewables – DUK pages 204‑202) focus only on securing the contracts; the filing does not describe a specific cash‑flow structure or credit benefit tied to those PPAs. In contrast, Southern Power’s wind PPAs are long‑term, energy‑only agreements that rely on the production tax credit (PTC) for the first ten years of output, and the filing states that those PTCs have a material impact on cash flow and net income and are expected to be fully utilized by 2024 (see Southern Power PPAs – SO pages 96‑97). Thus, while Duke’s PPAs are still being negotiated with no explicit cash‑flow effect disclosed, Southern Power’s wind PPAs already embed a predictable cash‑flow benefit from the PTCs through 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key distinction between Duke Energy's and Southern Power's PPA structures and their respective cash flow implications. It correctly identifies that Duke Energy negotiates PPAs within VIEs without disclosing specific cash flow structures or tax credit benefits, while Southern Power's wind PPAs are long-term and tied to production tax credits (PTCs) that materially impact cash flow and net income. The statement that PTCs are expected to be fully utilized by 2024 aligns with the ground truth. However, the LLM omits the specific figure of approximately $0.8 billion in unutilized PTCs at the end of 2021, which is a quantitatively relevant detail from the original answer. This omission slightly reduces completeness and quantitative accuracy. The LLM also characterizes Duke’s PPAs as having 'no explicit cash-flow effect disclosed,' which, while not incorrect, understates the original answer’s point that Duke’s PPAs influence the economic performance of its VIEs—implying indirect cash flow relevance. The qualitative reasoning is sound in comparing structural differences and tax credit utilization, and the multi-hop synthesis across companies and financial mechanisms is appropriate. Wording differs but meaning is semantically close. Contextual relevance is strong as all aspects of the question are addressed, albeit with minor detail gaps.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 386,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How does LOW's receipt of additional shares through ASR agreements compare to HD's issuance of additional shares via dividend equivalents in deferred share awards for non-employee directors?",
      "original_answer": "LOW receives additional shares from third-party financial institutions as part of variable notional ASR agreements, where the final share delivery depends on the difference between the maximum notional amount paid and the final notional value of shares repurchased. In contrast, HD issues additional shares to non-employee directors through dividend equivalents that accrue on deferred shares and are paid out in stock upon termination of board service. While LOW's additional shares result from share repurchase efficiency, HD's additional shares are a structured compensation element tied to deferred share awards.",
      "llm_answer": "LOW’s Accelerated Share Repurchase agreements resulted in the company receiving roughly 15.4 million shares of its common stock【page_61】. In contrast, Home Depot’s deferred‑share awards for non‑employee directors involve only about 19 thousand shares that accrue dividend equivalents and are paid out as additional shares【page_68】—a share‑receipt that is orders of magnitude smaller than LOW’s ASR‑derived shares.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies that LOW receives shares through ASR agreements and HD issues shares via dividend equivalents on deferred share awards, it misrepresents the nature and scale of these mechanisms. The ground truth emphasizes qualitative differences in purpose and structure—LOW’s shares come from repurchase efficiency in variable notional ASRs, while HD’s are part of director compensation—but the LLM reduces this to a quantitative comparison. (2) The numbers cited—15.4 million for LOW and 19 thousand for HD—are not present in the original answer and appear to be fabricated or extracted from document pages not validated against the knowledge graph. The original answer does not provide specific share quantities, so asserting these figures undermines quantitative accuracy. Additionally, no calculation or comparison of magnitude (e.g., 'orders of magnitude smaller') can be justified without verified inputs. (3) The multi-hop reasoning is partially sound: the model connects ASR outcomes for LOW and dividend equivalents for HD to their respective share movements. However, it fails to synthesize the correct conceptual contrast—mechanism (repurchase settlement vs. compensation accrual)—and instead invents a numerical comparison absent from the source. This reflects flawed reasoning despite correct entity identification. (4) Contextual relevance is high because the response addresses both companies and the correct mechanisms (ASR, dividend equivalents on deferred shares), but correctness is low due to unsupported numbers and oversimplification of a structural comparison into a misleading quantitative claim.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 466,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How does Boeing's equity income from ULA in 2024 correlate with Lockheed Martin's commercial satellite launch revenue, given ULA's role in serving both government and commercial customers?",
      "original_answer": "Boeing reported equity income of $125 million from ULA in 2024, reflecting its stake in the joint venture. ULA, co-owned by Boeing and Lockheed Martin, provides expendable launch services to both the U.S. Government and commercial customers. Lockheed Martin’s Space segment includes revenue from commercial satellite launches facilitated through ULA. Additionally, Lockheed Martin reported $665 million in receivables from commercial customers as of December 31, 2024, which includes payments related to ULA’s commercial launch services. Therefore, Boeing’s equity income from ULA is directly tied to the revenue Lockheed Martin recognizes from commercial satellite launches via ULA’s dual customer base.",
      "llm_answer": "Boeing’s 50 % equity stake in United Launch Alliance generated $125 million of equity income in 2024 (BA 10‑K p. 42). Lockheed Martin’s Space segment recorded only about $20 million of commercial‑satellite‑launch revenue in 2024 (LMT 10‑K p. 74), and ULA provides launch services to both U.S. government and commercial customers (LMT 10‑K p. 71). Thus, Boeing’s equity income reflects ULA’s total earnings (government + commercial), which is far larger than the modest commercial‑only launch revenue that Lockheed reports.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states Boeing's $125 million equity income from ULA in 2024, it incorrectly claims Lockheed Martin reported only $20 million in commercial satellite launch revenue in 2024. The ground truth states that Lockheed Martin reported $665 million in receivables from commercial customers as of December 31, 2024, which includes payments related to ULA’s commercial launch services. The $20 million figure does not appear in the ground truth and contradicts it. This is a major quantitative error. (2) The LLM cites specific 10-K page numbers (BA 10-K p.42, LMT 10-K p.74), but these are not verifiable from the provided ground truth and introduce unconfirmed data. The ground truth does not mention a $20 million figure or page references, making this a fabrication or misattribution. The $665 million receivable — a key financial figure — is entirely omitted. (3) The reasoning partially captures the multi-hop structure: it acknowledges ULA’s dual role (government and commercial), Boeing’s 50% stake, and that Boeing’s equity income reflects total ULA earnings. However, it fails to connect Boeing’s income to Lockheed Martin’s commercial revenue through ULA’s joint ownership and revenue flow, instead creating a false contrast between Boeing’s income and Lockheed’s 'modest' commercial revenue. The conclusion misrepresents the correlation as a discrepancy rather than a linkage. (4) The contextual relevance is fair because the answer addresses ULA’s role and the relationship between the companies, but the core quantitative inaccuracy and omission of the $665 million receivable severely undermine correctness. The qualitative reasoning is partially sound but based on incorrect data. Thus, the correctness score is low due to major factual and numerical errors despite some structural understanding.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 512,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How does the loss of market exclusivity for LLY's pharmaceutical products, influenced by patent rights and regulatory data protection, compare to MRK's exposure to patent-related risks, particularly in light of the varying durations of exclusivity in major markets such as the U.S., Europe, and Japan?",
      "original_answer": "LLY faces a severe and rapid revenue decline when pharmaceutical products lose effective market exclusivity, which is often tied to patent expiration. However, LLY may retain exclusivity through later-expiring patents on formulations or methods of use, or through regulatory data protection, such as 12 years for biologics in the U.S., 10 years in Europe, and 8 years in Japan. This market exclusivity is determined by both patent rights and regulatory protections, as noted in the BMY evidence, which explains that patent coverage and data exclusivity (e.g., orphan drug exclusivity for 7 years or pediatric exclusivity for 6 months) are the two key determinants of exclusivity. MRK similarly depends on patent rights for market exclusivity and faces material adverse impacts if those rights are invalidated or circumvented. MRK frequently engages in patent litigation to defend its exclusivity, especially against generic manufacturers seeking to enter the market before patent expiration. Thus, both companies are highly exposed to patent-related risks, but LLY may have more nuanced opportunities to extend exclusivity through regulatory mechanisms, while MRK emphasizes legal defense of its patents as a core strategy.",
      "llm_answer": "LLY explains that loss of effective patent protection ends market exclusivity and can cause a rapid revenue decline, but the company may retain exclusivity through later‑expiring patents or regulatory data protection that lasts about five years in the United States (twelve years for biologics), roughly ten years in Europe, and eight years in Japan (LLY 10‑K p.10; p.8). Merck similarly warns that its business depends on patent rights and that the loss of exclusivity—illustrated by upcoming U.S., EU and China expirations for Januvia/Janumet—triggers swift sales drops, yet its filing focuses on the general risk of patent invalidation, compulsory licensing and generic entry without specifying the statutory exclusivity periods (MRK 10‑K p.30‑33).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) It correctly identifies that LLY faces rapid revenue decline upon loss of market exclusivity due to patent expiration, and may extend exclusivity via later-expiring patents or regulatory data protection. It accurately notes the 12-year biologics exclusivity in the U.S., 10 years in Europe, and 8 years in Japan. However, it adds a claim that general regulatory data protection lasts 'about five years' in the U.S., which is not present in the original answer and could be misleading—this is a minor inaccuracy, as the original only specifies biologics (12 years) and does not generalize. (2) Quantitatively, all specified durations (12, 10, 8 years) are correct. The 'five years' reference lacks support in the ground truth and may conflate small molecule exclusivity rules not explicitly discussed, slightly reducing quantitative accuracy. (3) The reasoning correctly synthesizes multi-hop information: it contrasts LLY’s reliance on both patent and regulatory mechanisms with MRK’s emphasis on patent rights and litigation risk, citing specific examples like Januvia/Janumet and referencing general risks (invalidation, compulsory licensing). It correctly infers that MRK does not emphasize statutory exclusivity periods in its filing, aligning with the original. (4) The answer is contextually excellent—directly addressing the comparison between LLY and MRK across major markets and regulatory frameworks. The minor overgeneralization about U.S. data protection duration prevents a perfect score, but core facts, entities, and synthesis are sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1532,
        "completion_tokens": 443,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How do the potential financial impacts of cyber intrusion-related compliance costs at Southern Company's nuclear facilities compare to Duke Energy's decommissioning trust fund funding risks given both companies' exposure to nuclear power plant operations?",
      "original_answer": "Southern Company highlights that cyber intrusions could result in increased nuclear licensing or compliance costs that are difficult to predict, particularly at its nuclear facilities where Alabama Power and Georgia Power hold ownership interests representing 26% and 28% of their total KWH generation in 2021, respectively. These compliance costs could rise unpredictably due to threats of cyber intrusions or physical attacks. Meanwhile, Duke Energy notes that a decline in the market value of assets in its Nuclear Decommissioning Trust Funds (NDTF) could increase funding requirements for decommissioning its nuclear plants. Both companies face distinct financial risks tied to nuclear power plant operations—Southern Company through potential cyber-related compliance costs and Duke Energy through market-dependent decommissioning funding obligations.",
      "llm_answer": "Southern Company warns that “actual or potential threats of cyber intrusions… could result in increased nuclear licensing or compliance costs that are difficult to predict” and that “the cost and operational consequences of implementing, maintaining, and enhancing system protection measures are significant” (Southern Co. 10‑K pp. 29‑30). By contrast, Duke Energy flags a concrete funding risk: a decline in the market value of its nuclear de‑commissioning trust‑fund assets could “require significant additional funding” and “negatively affect… results of operations, financial position and cash flows” (Duke Energy 10‑K pp. 34‑35). Thus, Southern’s exposure is to uncertain, potentially large cyber‑related compliance outlays, while Duke’s exposure is to a measurable shortfall in de‑commissioning trust funding that could strain liquidity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Southern Company faces uncertain cyber intrusion-related compliance costs, citing increased licensing and system protection expenses, while Duke Energy faces decommissioning trust fund risks due to market value declines. The LLM correctly identifies the nature of each risk—Southern's as uncertain and potentially large, Duke's as measurable and liquidity-impacting. (2) There are no numeric values (e.g., percentages, dollar amounts) in the LLM answer that contradict the original; the original mentions Alabama Power and Georgia Power’s 26% and 28% KWH generation from nuclear in 2021, but the LLM omits these specifics. However, since the question does not explicitly ask for those percentages and the LLM focuses on the qualitative risk comparison, this omission does not undermine the core correctness. (3) The multi-hop reasoning is sound: the model correctly synthesizes risk types (compliance vs. funding), sources (cyber threats vs. market performance), and financial implications (unpredictable costs vs. required additional funding) across two companies’ 10-Ks. (4) The answer is contextually precise, directly comparing the two companies’ distinct nuclear-related financial risks as asked. The only minor shortcoming is the omission of the specific ownership percentages from Southern’s subsidiaries, which were present in the ground truth but not critical to the central comparison. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 448,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does the treatment of dividend equivalents on deferred stock units granted to non-employee directors in 2023 by Lowe's compare with Home Depot's policy on dividend equivalents related to deferred shares, particularly in terms of vesting schedules and payout structure?",
      "original_answer": "Lowe's provides dividend equivalents on deferred stock units granted to non-employee directors, which vest either on the first anniversary of the grant date or the day before the next Annual Meeting of Shareholders, with immediate vesting for awards granted prior to 2022. In contrast, Home Depot pays dividend equivalents on deferred shares granted to non-employee directors that accrue and are paid out in additional shares upon termination of service, with the fair value expensed immediately upon grant. This shows differences in both vesting timing and payout mechanisms between the two companies’ deferred compensation structures.",
      "llm_answer": "Lowe’s 2023 filing says its deferred‑stock units for non‑employee directors “earn dividend equivalents” and **vest on the earlier of the first anniversary of the grant date or the day immediately preceding the next annual meeting of shareholders (subject to acceleration)**; the equivalents are settled in shares when the units vest【page_64】. Home Depot’s 2023 filing states that its deferred‑share awards “receive dividend equivalents that accrue and are paid out in the form of additional shares of stock upon payout of the underlying shares following termination of Board service” – i.e., they vest only when the director’s service ends【page_68】. Thus Lowe’s units have a time‑based vesting schedule with payout at vesting, while Home Depot’s awards vest on termination of service and pay the equivalents at that later date.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Lowe's dividend equivalents on deferred stock units vest on the earlier of the first anniversary of the grant date or the day before the next Annual Meeting, with payout upon vesting. This matches the original answer, including the nuance of acceleration (implied by 'subject to acceleration'). (2) It accurately states that Home Depot’s dividend equivalents accrue and are paid in additional shares upon termination of service, which corresponds to the ground truth’s description of payout occurring 'upon payout of the underlying shares following termination of Board service'. (3) The comparison correctly highlights the difference in vesting timing—time-based with earlier trigger for Lowe’s vs. service termination for Home Depot—and payout structure (at vesting vs. at termination). (4) The only minor omission is that the original answer notes immediate vesting for Lowe’s awards granted prior to 2022, which the LLM answer does not mention; however, the question specifically asks about 2023 grants, making this detail less critical. All entities (Lowe’s, Home Depot, non-employee directors, deferred stock units/shares, dividend equivalents), years (2023), and financial terms are correct. Wording differs slightly but maintains semantic equivalence. Calculations are not involved, so quantitative accuracy is 10. Reasoning is sound and synthesizes information correctly across both companies’ filings. Contextual relevance is perfect as it directly addresses vesting schedules and payout structures as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 443,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does the potential loss of 12-year biologic data exclusivity in the U.S. impact AMGN's competitive position compared to MRK's strategy of leveraging compound patents and pediatric exclusivity extensions?",
      "original_answer": "The potential removal of the 12-year biologic data exclusivity in the U.S., as highlighted in AMGN's 10-K, could expose AMGN to earlier biosimilar competition, particularly for products like EPOGEN, which is sold almost exclusively to a concentrated customer base. In contrast, MRK's strategy, as outlined in its 10-K, relies on a layered approach to market exclusivity, including compound patents, pediatric exclusivity extensions (which can add six months), and regulatory data protection. This layered approach allows MRK to maintain commercial control even after initial patent expiration, giving it a more diversified defense against generic erosion compared to AMGN's reliance on regulatory exclusivity.",
      "llm_answer": "Amgen notes that its biologics rely on a 12‑year data‑exclusivity period, and if that protection is shortened or lost—e.g., through “umbrella‑exclusivity” changes or regulatory pressure—biosimilar competitors could enter the market earlier, eroding Amgen’s pricing power and market share (AMGN 10‑K pp. 44‑46). Merck, however, builds its protection on a suite of compound patents that can be extended by up to five years plus a six‑month pediatric exclusivity extension, giving it a layered, patent‑driven shield that can offset any reduction in data‑exclusivity (MRK 10‑K pp. 16‑18).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: AMGN's reliance on 12-year biologic data exclusivity and the risk of earlier biosimilar entry if that is lost; MRK's use of compound patents (with up to five years extension, though the ground truth emphasizes 'layered' protection without specifying the 5-year term) and six-month pediatric exclusivity. The cited page numbers (AMGN pp. 44–46; MRK pp. 16–18) match the expected source locations. (2) Quantitative accuracy is perfect: '12-year', 'six-month', and 'up to five years' are all correctly stated (note: the original answer mentions pediatric exclusivity but not patent term extension length; the LLM adds 'up to five years' which is factually plausible and consistent with patent term restoration under Hatch-Waxman, though not explicitly in the ground truth—this is a minor addition, not an error). (3) Multi-hop reasoning is sound: the model correctly contrasts AMGN’s regulatory exclusivity dependence with MRK’s patent-based, layered strategy, synthesizing across both 10-Ks. (4) Semantic equivalence is strong: while the LLM does not mention EPOGEN or the 'concentrated customer base' detail from the original, these are contextual nuances rather than core factual omissions. The central comparison of strategic vulnerability vs. diversified protection is preserved. The answer is fully relevant and accurately reflects the competitive dynamics described. Minor deduction in qualitative accuracy due to the slight expansion on patent term length not present in the original, but this does not undermine correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 445,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does the treatment of the countercyclical capital buffer under TLAC requirements for GS compare with SCHW's application of the same buffer, particularly in light of GS's 18% minimum TLAC to RWAs threshold and SCHW's 2.5% stress capital buffer?",
      "original_answer": "Goldman Sachs (GS) includes the countercyclical capital buffer as part of its TLAC to RWAs requirement, which the Federal Reserve has set to zero percent, within the broader 18% minimum TLAC threshold (as stated in GS's 10-K filing). In contrast, Schwab (SCHW) is also subject to a countercyclical capital buffer above the minimum risk-based capital ratios, which was zero percent as of December 31, 2024 (as disclosed in SCHW's 10-K). However, SCHW specifically maintains a 2.5% stress capital buffer, indicating a differentiated approach to regulatory capital planning despite both institutions operating under a zero percent countercyclical buffer.",
      "llm_answer": "Goldman Sachs’ TLAC calculation treats the counter‑cyclical buffer as **zero percent** – the TLAC‑to‑RWAs rule is an 18 % minimum plus a 2.5 % capital‑conservation buffer and a 1.5 % G‑SIB surcharge (22 % required, actual 40 %+). Charles Schwab, by contrast, is required to hold a **2.5 % stress capital buffer** above its regulatory minimum, so the buffer adds a real capital charge for Schwab that does not affect GS’s TLAC requirement.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information, with significant factual inaccuracies affecting the overall correctness. (1) Quantitatively, the LLM incorrectly states that Goldman Sachs has a 2.5% capital-conservation buffer and a 1.5% G-SIB surcharge, and that the total TLAC requirement is 22% (18% + 2.5% + 1.5%), which is not supported by the ground truth. The original answer states only that GS has an 18% minimum TLAC threshold that includes the countercyclical buffer (set at 0%), with no mention of these additional buffers or a 40%+ actual ratio. These numbers are either fabricated or misattributed. (2) The LLM correctly notes that the countercyclical buffer is zero for GS and that SCHW has a 2.5% stress capital buffer, which aligns with the ground truth. However, it misrepresents the nature of the TLAC framework by implying that the stress capital buffer imposes a 'real capital charge' on SCHW that does not affect GS, without clarifying that SCHW is not a GSIB and thus not subject to TLAC—this is a critical regulatory distinction missing in the response. (3) The reasoning is flawed in the multi-hop synthesis: the model conflates TLAC requirements (applicable to GSIBs like GS) with stress capital buffers (applicable to non-GSIBs like SCHW), failing to recognize that these are different regulatory regimes. The comparison should focus on how each firm treats the countercyclical buffer within its respective capital framework, not imply direct comparability of buffers. (4) Despite these errors, the answer addresses the core contrast in buffer treatment and identifies the correct zero percent countercyclical buffer for GS and the 2.5% buffer for SCHW, maintaining some contextual relevance. However, the incorrect numerical breakdowns and regulatory mischaracterizations reduce quantitative and qualitative accuracy significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 505,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does XOM's asset exposure in Kazakhstan compare with CVX's stake in TCO's operations in the region?",
      "original_answer": "XOM reported $7,728 million in long-lived assets in Kazakhstan in 2023, reflecting its operational exposure in the region. Meanwhile, CVX holds a significant stake in TCO, which operates major oil fields like Tengiz and Korolev under a concession agreement expiring in 2033. TCO achieved mechanical completion of the Future Growth Project (FGP) in 2023, with start-up expected in the first half of 2025, and is also advancing the Karachaganak Expansion Project, with Stage 1A expected to complete in 2024. CVX’s involvement through TCO demonstrates its strategic positioning in Kazakhstan’s upstream sector, despite not directly owning long-lived assets like XOM.",
      "llm_answer": "Exxon Mobil’s 2023 10‑K shows it has about **$7.7 billion of long‑lived assets in Kazakhstan** (see XOM page 114).  In contrast, Chevron’s filing states it holds a **50 percent interest in the Tengizchevroil (TCO) affiliate**, which runs the Tengiz and Korolev fields in Kazakhstan (see CVX page 15).  Thus XOM’s exposure is expressed as a $7.7 bn asset base, while CVX’s exposure is a half‑ownership stake in the TCO operation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies XOM's $7.7 billion (i.e., $7,728 million) in long-lived assets in Kazakhstan from its 2023 10-K, which matches the ground truth. It also accurately states CVX's 50% interest in Tengizchevroil (TCO), which operates the Tengiz and Korolev fields—this aligns with the original answer’s description of CVX’s stake via TCO. The comparison between XOM’s direct asset exposure and CVX’s equity stake in TCO is logically sound and factually correct.\n\n2) Quantitatively, the $7.7 billion figure is a rounded version of $7,728 million—this is acceptable and common in financial reporting. The 50% stake in TCO is accurate per Chevron’s disclosures. No calculations were required, but the representation of financial exposure is precise.\n\n3) The multi-hop reasoning is strong: the model correctly synthesizes information from two different companies’ filings (XOM and CVX), distinguishes between direct asset ownership (XOM) and indirect equity participation (CVX via TCO), and draws a valid comparative conclusion. However, the LLM omits some forward-looking operational details mentioned in the ground truth—specifically, the TCO Future Growth Project (FGP) mechanical completion in 2023 and start-up expected in H1 2025, as well as the Karachaganak Expansion Project with Stage 1A completion in 2024. While these are not central to the core comparison of asset exposure, they add strategic context about CVX’s involvement that the LLM answer leaves out.\n\n4) Despite the omission of project timelines, the LLM answer captures the essential contrast in exposure types (direct assets vs. joint venture stake) and supports it with accurate numbers and entities. The response is contextually relevant, clearly addressing the question’s focus on comparing exposure types. The minor lack of completeness on TCO’s project status prevents a perfect 10, but the core factual and reasoning content is highly accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 522,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How does Southern Company's uncertainty around the financial impact of transitioning from LIBOR to alternative rates under ASU 2020-04 compare with NextEra Energy's disclosure that it is applying the same standard to its interest rate contracts, given that both companies rely on reference rate reform guidance to manage derivative exposures?",
      "original_answer": "Southern Company explicitly states that the 'ultimate outcome of the transition [from LIBOR] cannot be determined at this time,' indicating uncertainty in assessing the financial impact of ASU 2020-04. In contrast, NextEra Energy affirms that it is applying the guidance under ASU 2020-04 to manage its interest rate contracts affected by reference rate reform. Both companies are subject to the same regulatory framework and are actively navigating the transition from LIBOR to alternative rates, but NEE demonstrates a more definitive implementation stance compared to SO's ongoing evaluation.",
      "llm_answer": "Southern Company notes that, while it has elected to apply ASU 2020‑04 to its LIBOR‑referenced debt and hedging arrangements, “the ultimate outcome of the transition cannot be determined at this time” and the financial impact remains uncertain (see pages 194‑195). NextEra Energy, by contrast, states it is also applying the ASU 2020‑04 guidance to its interest‑rate contracts, has begun using the permitted options, and to date has seen no material impact—though it acknowledges the full effect is still unknown (see page 79). Thus, both rely on the same reference‑rate reform guidance, but Southern Company expresses greater uncertainty about the result, whereas NextEra Energy reports a more definitive, non‑material impact so far.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: Southern Company acknowledges uncertainty about the financial impact of transitioning from LIBOR under ASU 2020-04, explicitly stating the 'ultimate outcome cannot be determined at this time.' NextEra Energy confirms it is applying ASU 2020-04 to its interest rate contracts and reports no material impact to date, while acknowledging ongoing uncertainty. These points match the original answer's core claims. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or answers, so quantitative accuracy is not compromised—no errors in this dimension. (3) The multi-hop reasoning is sound: the model correctly synthesizes disclosures from two companies (SO and NEE), compares their stances on ASU 2020-04 implementation, and draws a valid contrast—Southern expresses greater uncertainty, while NextEra demonstrates more definitive application with no material impact observed so far. The LLM adds slightly more detail (e.g., reference to pages, mention of 'hedging arrangements' and 'permitted options'), which is consistent with likely source text but not present in the ground truth; however, this does not introduce inaccuracies. (4) Semantic equivalence is maintained: the key conclusion—that both companies use the same guidance but differ in the certainty of their implementation—is preserved. The only minor gap is that the LLM answer slightly downplays NEE’s acknowledgment of unknown future effects when saying it reports a 'non-material impact so far,' which is accurate but could risk implying full resolution if read superficially. Still, it includes the caveat that 'the full effect is still unknown,' preserving accuracy. Thus, the answer earns a 9 for correctness and qualitative accuracy due to excellent fidelity with minor room for interpretive clarity, 10 for contextual relevance and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 532,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How does the dual-class stock structure and voting rights limitations in META's Class A Common Stock compare to GOOGL's governance framework under their respective Certificates of Incorporation, particularly in terms of protecting minority shareholder interests?",
      "original_answer": "GOOGL's Certificate of Incorporation ensures equal dividend and liquidation rights across all stock classes and mandates unanimous board approval before amendments affecting stockholder rights can be proposed, with affected classes requiring to approve such changes. This provides a structural safeguard for minority shareholders. In contrast, META's Class A Common Stock is subject to a controlled company structure where the board is not required to be majority independent, and key governance decisions require approval from Class B stockholders, who hold superior voting rights. META's Certificate of Incorporation also includes anti-takeover provisions that require a two-thirds majority vote for certain amendments once Class B voting power drops below 35%, further entrenching control and potentially limiting minority shareholder influence.",
      "llm_answer": "META’s dual‑class structure gives its Class B shares ten votes per share and its Class A shares only one vote, and the company’s certificate of incorporation and Nasdaq‑controlled‑company status embed anti‑takeover provisions that require separate Class B approval for mergers, board changes, special meetings and other corporate actions—effectively concentrating control with Mr. Zuckerberg and limiting the ability of Class A (minority) shareholders to influence decisions (META 10‑K pp. 49‑50). Alphabet also uses a dual‑class system (Class A 1‑vote, Class B 10‑vote, Class C non‑voting) but its charter includes explicit safeguards—class‑specific approval for any amendment that would adversely affect a class and a requirement that the board unanimously consent before such amendments are voted on—providing a procedural check that can help protect minority shareholders despite the voting concentration (GOOGL 10‑K p. 81).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: META's Class B shares have 10 votes vs. Class A's 1 vote, and GOOGL has a similar dual-class (and triple-class) structure with Class B holding superior voting rights. These numbers match the ground truth and are consistent with the cited 10-Ks. (2) The answer correctly identifies that META operates under a controlled company structure (citing Nasdaq rules), which allows it to avoid requirements for a majority-independent board, and that key decisions require Class B approval—concentrating control with Zuckerberg and limiting minority shareholder influence. This matches the original answer’s point about META’s board not needing to be majority independent and Class B dominance. (3) For GOOGL, the LLM correctly notes the procedural safeguards: class-specific approval for amendments that adversely affect a class and a requirement for unanimous board consent before such amendments are proposed—directly reflecting the ground truth’s description of GOOGL’s charter protections. (4) The only minor omission is that the LLM does not mention META’s two-thirds supermajority requirement for certain charter amendments once Class B voting power falls below 35%, which is a specific anti-takeover provision highlighted in the ground truth. This is a meaningful detail related to entrenchment, so its absence prevents a perfect score. However, the core comparative governance framework—GOOGL’s procedural checks vs. META’s structural concentration of power—is accurately synthesized. (5) The reasoning is sound, multi-hop (comparing two companies’ charter provisions on shareholder rights), and contextually relevant. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9/10 for correctness—excellent but missing one specific structural safeguard in META’s charter.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 514,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How might the implementation of the OECD's global minimum tax framework impact the effective tax rates of both PepsiCo and Altria, given their differing U.S. tax burdens and exposure to international tax changes?",
      "original_answer": "The implementation of the OECD's global minimum tax framework could increase PepsiCo's effective tax rate due to its international operations and exposure to countries implementing the 15% minimum tax, as noted in PepsiCo's 10-K. Altria, which reported $2,346 million in federal tax payments in the U.S. and minimal foreign tax liabilities, may not face the same upward pressure on its effective tax rate, as its tax burden is more concentrated domestically. The U.S. tax legislation context suggests that multinational corporations with significant overseas earnings, like PepsiCo, are more likely to see tax increases under the new framework, while companies like Altria with limited international exposure may remain relatively unaffected.",
      "llm_answer": "PepsiCo warns that the OECD‑backed 15 % global minimum tax could raise its tax bill because a sizable share of its earnings is earned abroad at rates that may fall below that floor, and the filing notes that “our taxes could increase and negatively impact our provision for income taxes” once the rules take effect. Altria’s effective tax rate (about 25.6 % in 2023) is driven largely by U.S. federal, state and corporate‑AMT liabilities and it has only modest foreign earnings, so the Pillar Two minimum‑tax regime would affect it only marginally—potentially nudging its overall rate up slightly if any low‑tax foreign income is re‑taxed.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that PepsiCo is exposed to the OECD's global minimum tax due to its international operations, citing the risk of increased taxes as stated in its 10-K—this matches the original answer's claim. Altria's minimal foreign exposure and predominantly domestic tax burden are also accurately portrayed. (2) The LLM includes a specific effective tax rate of 25.6% for Altria in 2023, which is not in the original answer but is plausible and does not contradict it; no dollar figures from the original (e.g., $2,346 million in federal taxes) are repeated, but the omission is not material as the focus is on relative exposure. The 15% minimum tax rate is correctly cited. (3) The multi-hop reasoning is sound: the model synthesizes the differential impact of Pillar Two based on international vs. domestic earnings, correctly linking PepsiCo’s foreign income exposure to potential tax increases and Altria’s limited foreign activity to minimal impact. (4) The answer is contextually excellent, directly addressing how the OECD framework affects each company’s effective tax rate based on their differing tax structures. The only minor shortcoming is the lack of explicit mention of Altria’s $2,346 million federal tax payment, which adds granularity to the original answer, but this does not detract from the overall correctness. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9 for correctness, with high marks across all dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 425,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How does the extension of market exclusivity through orphan drug designation in the U.S. impact AbbVie's risk of generic competition, given Eli Lilly's reliance on the same regulatory mechanism to protect its products beyond compound patent expiration?",
      "original_answer": "In the U.S., orphan drug designation grants seven years of market exclusivity, which runs in parallel with any applicable patents and can extend beyond the expiration of compound patents, as noted in Eli Lilly's 2023 10-K. This exclusivity period prevents the FDA from approving another application for the same drug product for the same orphan use, as described in the regulatory overview. For AbbVie, the loss or weakening of such exclusivity—whether through patent challenges, regulatory changes, or compulsory licensing—could accelerate generic competition and significantly reduce revenues, as stated in AbbVie's 2023 10-K. Therefore, the strength and duration of orphan drug exclusivity directly influence AbbVie’s exposure to market erosion, especially in the context of competitors like Eli Lilly leveraging the same protections to maintain market control beyond traditional patent life.",
      "llm_answer": "U.S. orphan‑drug designation gives a product or a specific indication seven years of market exclusivity that runs alongside any existing patents, thereby extending the period before a generic can be launched (AbbVie 10‑K p. 10). Eli Lilly likewise leans on orphan exclusivity to protect its drugs beyond the expiration of the underlying compound patents (LLY 10‑K p. 8‑12), so when AbbVie obtains orphan status it similarly postpones generic entry and reduces its exposure to generic competition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information in the ground truth. (1) Quantitatively, it correctly identifies the seven-year exclusivity period for orphan drugs in the U.S., which aligns with the ground truth. No specific dates or dollar amounts are involved, so numerical accuracy is fully preserved. (2) The answer correctly cites both AbbVie and Eli Lilly's use of orphan drug exclusivity to delay generic competition beyond compound patent expiration, referencing their respective 10-Ks appropriately. (3) The multi-hop reasoning is sound: it connects Eli Lilly's use of the mechanism to AbbVie’s strategic benefit, showing how orphan exclusivity reduces exposure to generics. (4) While the LLM answer captures the essential logic and facts, it omits a minor but relevant point from the ground truth: the risk to AbbVie if exclusivity is weakened (e.g., via regulatory changes or patent challenges), which is explicitly mentioned in AbbVie’s 10-K and central to the risk assessment. This omission slightly reduces completeness and qualitative depth, but does not undermine the overall correctness. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent as it directly addresses the impact of orphan exclusivity on generic competition for AbbVie in light of Eli Lilly's practices.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 370,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Coca-Cola FEMSA's operational footprint in Argentina in 2021 influence KO's equity investee sales exposure compared to PEP's direct exposure to Argentina's economic volatility during the same period?",
      "original_answer": "KO reported net sales to equity method investees, including Coca-Cola FEMSA, of $14,471 million in 2021, which were influenced by recovery from the pandemic. Coca-Cola FEMSA operated in Argentina's federal capital and surrounding areas in 2021, contributing to KO's indirect exposure in that market. Meanwhile, PEP directly operated in Argentina and faced economic volatility, including currency controls and inflationary pressures, which posed risks to their financial results. Therefore, while KO's exposure to Argentina was indirect through Coca-Cola FEMSA's operations and tied to equity investee sales, PEP faced direct exposure to Argentina's macroeconomic instability in 2021.",
      "llm_answer": "Coca‑Cola FEMSA’s 2021 bottling footprint included Argentina (the federal capital of Buenos Aires and surrounding areas)【page_7】, so The Coca‑Cola Company’s exposure to Argentine demand was indirect—channeled through its equity‑method investment in FEMSA, which generated $14.5 bn of net sales to equity‑method investees and a $3.2 bn fair‑value stake in FEMSA in 2021【page_89】. PepsiCo, on the other hand, lists “volatile economic, political and social conditions … in Argentina” as a direct risk to its own operations and sales【page_41】. Thus KO’s Argentine exposure is mediated through its equity investee, whereas PEP’s exposure is a direct market‑risk to its own business.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $14.5 billion figure matches the original $14,471 million (rounded appropriately), and the $3.2 billion fair-value stake in FEMSA is consistent with reported data. The year 2021 is correctly used. (2) The answer correctly identifies Coca-Cola FEMSA's operational footprint in Argentina (Buenos Aires and surrounding areas), which supports KO's indirect exposure via equity investee sales. (3) It contrasts this with PEP’s direct exposure by citing Argentina's volatile conditions as a risk factor from their filing, accurately reflecting PEP's direct operational presence and associated macroeconomic risks. (4) The multi-hop reasoning—linking KO’s indirect exposure through FEMSA’s local operations to equity investee sales, while contrasting with PEP’s direct market risk—is logically sound and well-synthesized across entities and sources. The only minor shortcoming is that the original answer emphasizes pandemic recovery as a factor in KO’s equity investee sales, which the LLM omits; however, this does not undermine the core comparison. Wording differs but semantic meaning and factual content are equivalent. All entities (KO, PEP, Coca-Cola FEMSA), years (2021), and financial metrics (equity investee sales, fair value stake) are correct. The contextual relevance is perfect, directly addressing the comparative exposure question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 396,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How does AbbVie's reliance on patent rights for emraclidine through its acquisition of Cerevel Therapeutics influence its market exclusivity strategy compared to Merck's experience with Januvia's patent expiration and regulatory exclusivity timeline?",
      "original_answer": "AbbVie's acquisition of Cerevel Therapeutics included an exclusive global license under certain Pfizer patent rights, which were critical for developing and commercializing emraclidine. However, despite this licensing arrangement, AbbVie recorded a $4.5 billion intangible asset impairment charge related to emraclidine, suggesting that the expected market exclusivity or commercial viability did not materialize as anticipated. Patent rights are a key determinant of market exclusivity in the pharmaceutical industry, often supplemented by regulatory exclusivity periods that can extend beyond patent terms. In contrast, Merck was able to extend its market exclusivity for Januvia and Janumet in the U.S. until May 2026 and for Janumet XR until July 2026 due to favorable court rulings and settlement agreements around a later-expiring patent on the sitagliptin salt form, despite the core compound patent expiring in January 2023. This demonstrates that while AbbVie's strategy relied heavily on patent licensing to secure exclusivity, it faced significant financial consequences when that exclusivity or market uptake failed to deliver expected returns, unlike Merck, which successfully leveraged later-stage intellectual property strategies to delay generic competition.",
      "llm_answer": "AbbVie’s exclusivity for emraclidine is built on the exclusive global license it inherited when it bought Cerevel Therapeutics – a license to Pfizer‑held patents that lets AbbVie develop, manufacture and commercialize the drug and obliges it to pay milestones and royalties (see page 68, 66). The company therefore counts emraclidine as a high‑value, patent‑protected intangible (though recently impaired) to sustain market protection. In contrast, Merck’s Januvia/Janumet has already lost its core compound patent (January 2023) and now relies only on later‑expiring patents and the residual regulatory exclusivity that extends protection only until mid‑2026, after which generic competition is expected (see page 58). This reflects Merck’s much shorter, waning exclusivity horizon versus AbbVie’s patent‑driven strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct but has some key omissions and minor inaccuracies that affect the overall correctness. (1) Quantitatively, the dates for Merck's exclusivity (mid-2026) align with the ground truth (May 2026 for Januvia/Janumet, July 2026 for Janumet XR), and the mention of the core patent expiration in January 2023 is accurate. However, the LLM omits the specific dollar amount of AbbVie's $4.5 billion impairment charge, which is a significant financial detail in the original answer and critical to understanding the consequence of failed exclusivity expectations. (2) The entity identification is correct: AbbVie, Cerevel Therapeutics, Pfizer patent rights, Merck, Januvia, Janumet are all accurately referenced. (3) The reasoning captures the contrast between AbbVie’s reliance on licensed patent rights and Merck’s extension via later-expiring patents, but it underrepresents the multi-hop synthesis by failing to explicitly connect the impairment charge to the failure of the exclusivity strategy, which is central to the original answer’s conclusion. The LLM notes the impairment but does not explain its implication—that the expected market exclusivity or commercial success did not materialize. (4) The answer is contextually relevant and addresses the core comparison between the two companies’ exclusivity strategies. However, it lacks the depth of analysis regarding how Merck actively extended exclusivity through litigation and settlements, instead framing it as reliance on 'residual' protections. This downplays Merck’s strategic IP management. Overall, the answer is factually sound on major points but misses nuanced, critical details affecting completeness and reasoning quality, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1550,
        "completion_tokens": 475,
        "total_tokens": 2025
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How does Chevron's investment in the Caspian Pipeline Consortium (CPC) influence its crude oil export capacity, and how does this compare to ConocoPhillips' reliance on crude oil production for its upstream operations?",
      "original_answer": "Chevron's 15% interest in the Caspian Pipeline Consortium (CPC) enables it to export approximately 1.2 million barrels of crude oil per day from Kazakhstan, which is critical for transporting output from the Tengiz and Karachaganak fields. The CPC pipeline's debottlenecking project, completed in January 2023, increased throughput capacity, directly supporting Chevron's Future Growth Project (FGP) expected to ramp up in early 2025. In contrast, ConocoPhillips' upstream operations are fundamentally dependent on crude oil production, as evidenced by its 2023 filings, where crude oil remains a core component of its asset base and revenue generation. Therefore, Chevron's exposure to crude oil export capacity is mediated through its stake in CPC, while ConocoPhillips has a more direct operational dependency on crude oil production.",
      "llm_answer": "Chevron’s 15 % ownership of the Caspian Pipeline Consortium gives it a direct outlet for roughly 1.4 million barrels of crude oil per day – 1.2 million bpd from Kazakhstan and 0.2 million bpd from Russia – and the recent CPC debottlenecking project has further lifted that throughput capacity for new production (see CVX 10‑K p. 16). In contrast, ConocoPhillips’ 10‑K emphasizes that its upstream results are driven by oil and gas activities, with crude oil production forming the core of its upstream cash flow, indicating a reliance on producing crude rather than on a specific export‑pipeline asset (see COP 10‑K p. 143).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer is mostly correct but contains a quantitative inaccuracy: it states Chevron's CPC ownership enables 'roughly 1.4 million barrels per day' (1.2M bpd from Kazakhstan + 0.2M bpd from Russia), while the ground truth specifies only 1.2 million barrels per day from Kazakhstan with no mention of Russian volumes attributable to Chevron. This 1.4M bpd figure is unsupported in the original answer and introduces a factual error. The debottlenecking project completion in January 2023 and its relevance to Chevron’s Future Growth Project (FGP) in 2025 is omitted, which is a key multi-hop detail. 2) The quantitative accuracy is reduced due to the incorrect aggregation of 1.4M bpd. The 15% ownership stake is correctly stated, but the breakdown into Kazakhstan and Russia volumes is not present in the ground truth and appears speculative. The original answer does not attribute any specific Russian export volume to Chevron via CPC, so this addition is inaccurate. 3) The qualitative reasoning is strong: the contrast between Chevron’s indirect exposure via pipeline infrastructure and ConocoPhillips’ direct reliance on crude production is correctly interpreted and well-articulated. The use of 10-K references (p.16 for CVX, p.143 for COP) adds credibility and shows proper sourcing. The core logic of comparing asset-type dependency (export infrastructure vs. production) is sound and aligns with the original answer. 4) Contextual relevance is high—the response directly addresses both parts of the question, compares the two companies appropriately, and maintains focus on upstream operations and export capacity. The error in volume does not completely undermine the conceptual comparison, but it does weaken the factual foundation. Overall, the answer is semantically close but compromised by the incorrect barrel-per-day figure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 498,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does Oracle's integration of generative AI in MySQL HeatWave compare with Qualcomm's strategic vision for on-device generative AI in edge computing, given both companies' investments in cloud computing infrastructure?",
      "original_answer": "Oracle integrates generative AI into its MySQL HeatWave cloud service, combining transactions, real-time analytics, machine learning, and generative AI in one managed service to enhance data processing and decision-making capabilities. Meanwhile, Qualcomm envisions generative AI becoming ubiquitous across industries, with a focus on running complex models on edge devices such as smartphones and PCs to improve immediacy, privacy, and personalization. Qualcomm expects that 46% of smartphones sold in 2027 will be generative AI capable, up from 19% in 2024, and sees cloud computing as a complementary enabler of these edge AI capabilities. Both companies are investing in cloud computing—Oracle through its Oracle Cloud Infrastructure (OCI) and Autonomous Database offerings, while Qualcomm supports cloud-edge coordination through its cloud computing processing initiative within its QSI segment.",
      "llm_answer": "Oracle embeds generative AI as a built‑in capability of its MySQL HeatWave managed cloud service, coupling transactions, real‑time analytics, machine learning and generative AI on OCI’s AI‑infrastructure (ORCL page 12; OCI AI offerings on page 11). Qualcomm, by contrast, is positioning generative AI to run on‑device at the edge—using its Snapdragon AI Engine, NPU and 5G connectivity—to deliver low‑latency, privacy‑preserving AI for smartphones, PCs and IoT products (QCOM page 7). Although both are expanding cloud infrastructure (Oracle through OCI and AI services; Qualcomm through its cloud‑computing processing initiative and edge‑cloud integration), Oracle’s approach centralizes AI in the cloud database service, while Qualcomm’s vision decentralizes AI to edge hardware.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual content is correct: Oracle integrates generative AI into MySQL HeatWave on OCI, combining transactions, analytics, ML, and AI in a managed cloud service. Qualcomm focuses on on-device generative AI via Snapdragon AI Engine and NPUs for edge devices like smartphones and PCs, emphasizing low latency, privacy, and personalization. Both companies invest in cloud infrastructure—Oracle via OCI and Autonomous Database, Qualcomm through its cloud-computing processing initiative in QSI. (2) Quantitative accuracy is perfect: although the LLM answer does not explicitly mention the 19% (2024) and 46% (2027) smartphone adoption figures, this omission does not detract significantly from the core comparison, and no incorrect numbers are presented. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across Oracle and Qualcomm, contrasting centralized cloud AI (Oracle) vs decentralized edge AI (Qualcomm), while acknowledging both companies' cloud investments. (4) Semantic equivalence is strong—wording differs but meaning matches. The only minor gap is the absence of the specific forecast percentages from the original answer, which would have strengthened completeness. However, the core strategic contrast and technological directions are accurately conveyed, with proper entity and context alignment. Hence, a high score of 9 is justified.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 400,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does Walmart's use of firm commitments for inventory and utility purchases compare to Colgate-Palmolive's use of option contracts in managing financial exposure, given the role of such instruments in mitigating cash flow risks?",
      "original_answer": "Walmart has $15.9 billion in firm commitments due within one year, primarily for inventory, utilities, and capital expenditures, which represent legally binding contracts that lock in future cash outflows. These obligations are managed through operational cash flows and are not typically hedged with financial derivatives. In contrast, Colgate-Palmolive actively uses option contracts as part of its foreign exchange risk management strategy to hedge forecasted transactions, protecting against currency fluctuations. Both companies aim to reduce cash flow volatility, but Walmart focuses on operational liquidity planning while Colgate employs financial instruments like options to manage exposure. This distinction reflects differing approaches to financial risk mitigation aligned with their respective business models.",
      "llm_answer": "Walmart counts “firm commitments for inventory and utility purchases” among its legally‑binding purchase obligations, which lock in quantities and prices and therefore give the retailer a relatively fixed cash‑outflow schedule for those items (see WMT 10‑K p. 45). Colgate‑Palmolive, by contrast, uses option contracts as part of its foreign‑currency hedging program to protect the value of anticipated foreign‑currency purchases, giving it the right—but not the obligation—to lock in exchange rates and thus smooth cash‑flow volatility from currency movements (see CL 10‑K p. 90). Both tools are employed to mitigate cash‑flow risk, but Walmart does so with binding purchase contracts, while Colgate‑Palmolive does so with flexible financial options.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, while the LLM does not explicitly mention the $15.9 billion figure for Walmart's firm commitments, this omission does not appear to be an error but rather a choice to focus on qualitative distinctions. All other numerical and factual assertions (e.g., nature of contracts, use of options) are correct. (2) The LLM correctly identifies Walmart’s use of firm commitments for inventory and utilities as binding obligations and Colgate-Palmolive’s use of option contracts for foreign exchange hedging—both factually accurate and aligned with their 10-K disclosures (WMT p.45, CL p.90). (3) The multi-hop reasoning is sound: it compares two companies’ distinct approaches to cash flow risk mitigation—Walmart via operational, fixed-outflow contracts and Colgate via financial derivatives—correctly synthesizing information across filings. (4) The semantic meaning matches the original answer: both emphasize that Walmart locks in cash outflows through binding contracts while Colgate uses flexible options to hedge currency risk, with the shared goal of reducing cash flow volatility. The only minor shortcoming is the absence of the $15.9 billion figure, which slightly reduces completeness but does not impair the overall correctness. Hence, a 9 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 406,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does Morgan Stanley's use of credit default swaps (CDS) to hedge default risk relate to Capital One's reliance on default rate assumptions in valuing their net derivative assets, given the sensitivity of both institutions to credit event outcomes?",
      "original_answer": "Morgan Stanley actively uses credit default swaps (CDS) to hedge against the risk of default on debt obligations, entering into contracts where it receives or provides protection against credit events such as bankruptcy or failure to pay. The firm manages exposure through risk mitigation strategies and monitors aggregate market risk limits. Meanwhile, Capital One values its net derivative assets using discounted cash flow models that depend heavily on unobservable inputs, including a weighted average default rate assumption of 4% with a range of 53–163%. The connection between the two lies in the systemic sensitivity both institutions have to default outcomes: Morgan Stanley’s CDS contracts are triggered by defaults, directly affecting its derivative liabilities, while Capital One’s valuation models depend on projected default rates, meaning actual deviations from these assumptions would materially impact the fair value of its derivative assets. Thus, both firms are indirectly exposed to the same macroeconomic or sector-specific credit events that could simultaneously affect their derivative positions.",
      "llm_answer": "Morgan Stanley manages its credit‑event exposure by entering into credit‑default swaps that provide protection against a reference entity’s default – the firm both buys and sells CDS and uses the contracts as a primary hedge for its net derivative liabilities (MS 10‑K p.111). Capital One, on the other hand, does not hedge with CDS but values its net derivative assets using Level 3 fair‑value models that rely on a “default” assumption as a significant unobservable input (COF 10‑K p.208) and explicitly states that higher default rates would lower the fair value of those assets (COF 10‑K p.207). Thus, both institutions are highly sensitive to credit‑event outcomes: a default triggers CDS payouts for Morgan Stanley and simultaneously drives down the fair‑value of Capital One’s derivative positions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core relationship between Morgan Stanley's use of CDS and Capital One's reliance on default rate assumptions. (1) All factual elements are correct: Morgan Stanley uses CDS to hedge credit risk (citing MS 10-K p.111), both buys and sells protection, and manages net derivative liabilities through these instruments. Capital One uses Level 3 fair-value models with a significant unobservable 'default' assumption (citing COF 10-K p.208), and explicitly notes that higher default rates reduce the fair value of its derivative assets (COF 10-K p.207). (2) Quantitative accuracy is perfect: while the original answer specifies a 4% weighted average default rate with a range of 53–163%, the LLM correctly captures the qualitative importance of the assumption without misstating any numbers. The omission of the exact percentage and range is a minor gap but does not undermine the correctness, as the key point — that Capital One’s valuation is highly sensitive to default rate assumptions — is preserved. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes across both firms’ 10-K disclosures to highlight their shared sensitivity to credit events — direct for Morgan Stanley via CDS triggers, indirect for Capital One via valuation impacts. (4) Contextual relevance is excellent: the answer directly addresses the systemic sensitivity both institutions have to credit outcomes, aligning with the original answer’s central thesis. The only reason for not scoring a 10 is the omission of the specific 4% default rate and its range, which were present in the ground truth and add precision to Capital One’s modeling assumptions. However, since the LLM correctly identifies the conceptual dependence on default assumptions and their material impact, this is a minor omission rather than an error.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 499,
        "total_tokens": 2006
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How do Duke Energy's natural gas distribution assets in Georgia compare to Southern Company Gas's investment in SNG in terms of capital scale and contribution to regional infrastructure reliability, given their respective exposures to Georgia's energy market?",
      "original_answer": "Duke Energy operates 28,000 miles of natural gas distribution and transmission pipelines in Georgia, directly contributing to local infrastructure reliability by delivering gas to end-users. Southern Company Gas holds a 50% interest in SNG, a 7,000-mile pipeline system that connects supply basins in the Gulf Coast to markets including Georgia, underpinning supply-side reliability. While Duke’s assets are focused on distribution with direct customer delivery, SNG serves as a backbone transmission system feeding regional utilities, including those in Georgia like Duke, creating an integrated infrastructure network. Southern Power’s 97% investment coverage ratio through 2028 indicates strong contracted revenue stability for SNG-related assets, while Duke’s localized pipeline miles reflect a high dependency on regional demand and regulatory frameworks governing distribution rates and returns.",
      "llm_answer": "Duke Energy’s natural‑gas system in Georgia – delivered through its Piedmont subsidiary – consists of roughly 28,000 mi of distribution‑and‑transmission pipelines and about 22,100 mi of service lines, giving the company a large local‑distribution footprint that directly supports reliable service to Georgia customers【page_39†L1-L7】.  Southern Company Gas’s stake in the Southern Natural Gas (SNG) project is a 7,000‑mi interstate pipeline that is part of a $1.8 billion construction program for natural‑gas infrastructure【page_13†L1-L4】【page_14†L31-L38】.  While Duke’s assets are larger in total mileage and focus on end‑user delivery, SNG’s smaller‑scale but high‑value investment provides a critical supply corridor that enhances regional gas‑supply reliability for Georgia and the broader Southeast.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Duke Energy's 28,000 miles of natural gas pipelines in Georgia and Southern Company Gas's 7,000-mile SNG pipeline, which aligns with the ground truth. However, it introduces an additional figure of 22,100 miles of service lines not present in the original answer, which may conflate distribution infrastructure with service lines and lacks support in the ground truth. The $1.8 billion construction program for SNG is mentioned in the LLM answer but absent from the original, introducing a new financial figure that cannot be verified against the ground truth, thus reducing quantitative accuracy. (2) The core numbers—28,000 miles (Duke) and 7,000 miles (SNG)—are accurate and correctly attributed. However, the added $1.8B investment figure and 22,100 miles of service lines are not in the original answer and may be extraneous or misleading, though they might come from the cited pages. Without confirmation that these numbers directly relate to SNG’s capital scale in Georgia, this introduces uncertainty. (3) The reasoning is strong: the LLM correctly distinguishes Duke’s local distribution focus from SNG’s role as a supply backbone, noting that SNG enhances regional reliability—a key multi-hop synthesis. It captures the complementary nature of the two systems, even if it doesn’t mention Duke potentially being a customer of SNG, as implied in the original. The mention of Southern Power’s 97% investment coverage ratio through 2028 is missing, which is a notable omission in terms of financial stability context. (4) Despite missing the investment coverage ratio and adding unverified figures, the LLM answer conveys a semantically close and logically sound comparison, with high contextual relevance. The core multi-hop insight—Duke delivers locally, SNG supplies regionally—is preserved and well-articulated.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 507,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the enactment of Louisiana's corporate tax rate reduction legislation in 2024 impact Union Pacific's deferred tax expense, and how does this compare to the impact from similar legislation in Arkansas during the same year?",
      "original_answer": "Louisiana's enactment of corporate tax rate reduction legislation in 2024 resulted in a $34 million reduction in Union Pacific's deferred tax expense. This mirrors a similar impact from Arkansas, which also enacted tax rate reductions, contributing to a comparable adjustment. Together, these state-level legislative changes reflect a broader regional shift in corporate tax policy affecting Union Pacific's financial position.",
      "llm_answer": "Union Pacific says that the 2024 corporate‑tax‑rate reductions enacted by both Louisiana and Arkansas together lowered its deferred tax expense by **$34 million** 【page_29】. The filing does not break out the effect by state, so the Arkansas legislation is reflected in the same $34 million reduction and no separate amount is disclosed.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $34 million reduction in deferred tax expense due to Louisiana and Arkansas tax rate reductions, which matches the ground truth. The number is accurate and properly attributed to 2024 legislation. (2) Quantitative accuracy is perfect: the $34 million figure is correct, and no incorrect calculations are made. The format ($34 million) is consistent with acceptable variations. (3) However, the qualitative reasoning has a key discrepancy: the original answer states that Louisiana's legislation caused a $34 million reduction and that Arkansas had a 'comparable adjustment,' implying two separate but similar impacts. In contrast, the LLM interprets the $34 million as the combined effect and states that Arkansas's impact is included in that figure with no separate disclosure. This contradicts the original answer’s implication that both states contributed comparably, suggesting Arkansas also had a roughly $34 million effect. The LLM’s interpretation may be based on a more conservative reading of the source (page 29), but it fails to reflect the original answer’s intent that the impacts were individually comparable. (4) The contextual relevance is high because the response directly addresses the question and cites a specific document page. However, the failure to correctly synthesize the multi-hop detail — that Louisiana and Arkansas each had a similar, distinct impact — reduces the qualitative accuracy. Thus, while numbers are correct, the reasoning and completeness on the comparative aspect are partially flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 433,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How does the difference in voting rights between META's Class B Common Stock and GOOGL's Class A Common Stock influence their respective corporate governance structures, particularly in light of the specified voting limitations tied to Class B shares in merger scenarios?",
      "original_answer": "META's Class B Common Stock has no voting rights except in specified merger or consolidation scenarios, where they receive voting power proportional to their conversion rate. This limits shareholder influence outside of exceptional corporate actions. In contrast, GOOGL's Class A Common Stock provides one vote per share, offering more consistent voting influence to shareholders. This structural difference means that at META, decision-making control is more concentrated among holders of shares with superior voting rights (e.g., Class A), while at GOOGL, Class A shareholders have a steadier role in corporate governance. The specified voting limitations in META's charter for Class B shares in merger scenarios create a tailored influence mechanism that only activates under specific corporate events, unlike GOOGL's ongoing voting rights for Class A shares.",
      "llm_answer": "Alphabet’s charter gives each Class A share one vote (see GOOGL 10‑K p. 82) and limits its high‑vote Class B shares to voting only on specific matters—such as a merger—where they vote as a single class at the applicable conversion rate (see GOOGL 10‑K p. 90). The META 10‑K excerpts (pages 1‑5) do not disclose the voting rights of its Class B shares, but the company’s dual‑class structure traditionally grants Class B ten votes per share, concentrating control with insiders and allowing them to dominate key corporate actions, including mergers. Consequently, Alphabet’s governance includes a built‑in check on high‑vote shareholders in merger scenarios, whereas META’s governance is likely more centralized in the hands of Class B holders.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. First, it incorrectly states that Alphabet (GOOGL) limits its Class B shares to voting only on specific matters like mergers, with voting at the conversion rate—this is false. In reality, GOOGL’s Class B shares have superior voting rights (10 votes per share) and are held by insiders, while Class A shares have one vote per share and vote on all matters. The LLM reverses the governance structure: it is META (not GOOGL) where Class B shares have limited voting rights, only in specified merger or consolidation scenarios, as correctly stated in the ground truth. The LLM also incorrectly claims that META’s Class B shares traditionally have ten votes per share, which contradicts the ground truth stating they have *no* voting rights except in merger scenarios. This fundamental mix-up between the two companies’ dual-class structures invalidates the core comparison. While the LLM correctly notes that GOOGL Class A shares have one vote (quantitative accuracy is acceptable on that point), it misattributes the voting limitations to GOOGL instead of META. The reasoning is therefore flawed in both direction and entity assignment, failing the multi-hop synthesis required to compare the two firms’ governance implications accurately. Contextually, the answer addresses merger scenarios and governance concentration, so it remains relevant, but the reversed facts lead to an incorrect conclusion about which company has centralized control and when voting rights activate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 426,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How might U.S. payer restrictions on high-cost therapies like Repatha impact Pfizer's revenue recognition strategy for similar cardiovascular products, given both companies face challenges with formulary placement and patient affordability?",
      "original_answer": "U.S. commercial payer actions have significantly restricted access to high-cost therapies like Repatha through formulary exclusions, prior authorization requirements, and increased patient cost-sharing, which has directly limited sales despite price reductions. Pfizer faces similar risks, as it notes challenges in obtaining or maintaining favorable formulary placement and pricing for its products amid managed care and healthcare cost containment trends. Gilead's revenue recognition strategy accounts for these payer dynamics through complex gross-to-net deductions that factor in expected payer mix, rebate levels, and patient affordability trends. Therefore, if Pfizer markets similar high-cost cardiovascular therapies, it would likely face comparable pressures requiring careful estimation of rebates and chargebacks to align with payer realities and maintain revenue integrity.",
      "llm_answer": "Amgen explains that U.S. commercial payers are increasingly using step‑therapy, prior‑authorization and higher copay requirements for its high‑cost cholesterol drug Repatha, forcing deeper discounts and limiting patient access【page_41】. Pfizer’s filing says it records sales “net of estimated government and other rebates, chargebacks, cash discounts … and that trends toward managed‑care cost‑containment and formulary placement are a risk”【page_10】, and it explicitly estimates those gross‑to‑net deductions at the time of sale【page_48】. Thus, similar payer restrictions on Pfizer’s own high‑priced cardiovascular products would push the company to increase its rebate/discount assumptions, adjust its gross‑to‑net estimates more frequently and recognize revenue more conservatively (or defer recognition) to reflect the tighter formulary placement and patient‑affordability pressures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that U.S. commercial payers restrict access to high-cost therapies like Repatha through step-therapy, prior authorization, and higher copays, which matches the original answer's description of formulary exclusions and cost-sharing. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no numbers are misstated. (3) The multi-hop reasoning is sound: it connects Amgen’s experience with Repatha to Pfizer’s revenue recognition practices by citing Pfizer’s own disclosures about recording sales net of rebates and chargebacks, and notes the risk from managed care cost containment. It correctly infers that Pfizer would need to increase rebate assumptions and adjust gross-to-net estimates, which is consistent with Gilead’s strategy in the ground truth and logically extends to Pfizer. (4) The only minor shortcoming is that the LLM references Gilead in the original answer but does not explicitly mention it; instead, it focuses on Pfizer’s internal disclosures. However, the core logic—that companies must adjust revenue recognition via gross-to-net estimates due to payer pressures—is preserved and correctly applied. The answer is semantically equivalent, uses appropriate terminology, and addresses all parts of the question including formulary placement, patient affordability, and revenue recognition implications. Thus, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning with only a slight omission in cross-company synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 453,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How does Chevron's 15% ownership stake in TCO's Kazakhstan crude oil operations influence its exposure to TCO's planned production ramp-up from the FGP project starting in 2025, especially when compared to COP's broader dependence on crude oil as a raw material?",
      "original_answer": "Chevron's 15% ownership in TCO provides it with partial exposure to TCO's planned production ramp-up from the FGP project in Kazakhstan, which is expected to start-up in the first half of 2025 and ramp up to full production within three months. This production increase will flow through the Caspian Pipeline Consortium (CPC), in which Chevron also holds a 15% interest, enabling increased throughput capacity. In contrast, COP has a direct and full dependency on crude oil as a raw material, indicating a more concentrated exposure to crude oil supply dynamics. Chevron’s partial ownership in TCO creates a more indirect exposure to crude oil production volumes and timelines in Kazakhstan, as opposed to COP’s direct reliance on crude oil for its operations.",
      "llm_answer": "Chevron’s 15 percent working interest in the Caspian Pipeline Consortium (CPC) gives it only a proportional slice of the oil that TCO ships – roughly 15 percent of any extra volumes that flow once TCO’s Future‑Growth Project (FGP) ramps up to full production in the first half of 2025 (CPC moved about 1.2 MM bbl/d from Kazakhstan and Chevron owns 15 % of that pipeline). In contrast, ConocoPhillips’ operations are far more dependent on crude oil as a feedstock, as shown by its large proved bitumen reserves (410 MM bbl at year‑end 2023) and ongoing bitumen production, meaning its exposure to crude‑oil supply and price swings is broad and integral to its business rather than limited to a single 15 % share.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core of the ground truth, but has minor inaccuracies and omissions. (1) Quantitatively, the LLM correctly states Chevron's 15% interest in the CPC and the ~1.2 MM bbl/d throughput, which aligns with known data, and correctly identifies the FGP start-up in the first half of 2025. However, the ground truth specifies that the FGP ramp-up to full production will occur within three months, which the LLM omits. Also, the LLM introduces '410 MM bbl' of proved bitumen reserves for COP at year-end 2023—a specific number not present in the original answer and not confirmed by the knowledge graph provided, making it a potential hallucination. (2) The LLM correctly interprets Chevron’s partial (15%) exposure via ownership in TCO and the CPC, and contrasts it with COP’s broader crude oil dependence. However, it frames Chevron’s stake as a 'working interest in the CPC' rather than clarifying the 15% ownership in TCO (the production entity) as the primary exposure point—the CPC is a secondary conduit. This slightly misrepresents the chain of exposure. (3) The reasoning is sound in comparing indirect vs. direct exposure to crude oil, and the multi-hop synthesis between Chevron’s TCO/CPC stakes and COP’s operational model is logically presented. (4) Contextually, the answer is highly relevant and addresses the comparative exposure question. The inclusion of bitumen reserves adds detail but is unsupported by the ground truth and slightly distracts from the direct comparison on exposure mechanisms. Overall, the answer is factually strong with minor errors in entity emphasis and one unsupported number, warranting a score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 457,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How does Goldman Sachs' exposure to hotel-related commercial real estate loans compare to MetLife's investment in real estate funds focused on hotels, given the role of real estate funds in both companies' strategies?",
      "original_answer": "Goldman Sachs has significant credit exposure to commercial real estate loans secured by hotels, as detailed in their 2024 10-K filing, which highlights the importance of this asset class in their lending portfolio. These loans are often channeled through or connected to real estate funds, which are also a key vehicle for investment in hotel assets. MetLife, on the other hand, holds $13.3 billion in real estate investments as of December 31, 2024, including interests in real estate funds that invest in hotel properties. While both companies are exposed to hotel real estate, Goldman Sachs' involvement is primarily through lending, whereas MetLife participates through direct ownership stakes in funds. This distinction reflects different risk profiles and strategic approaches to the hotel sector within the broader commercial real estate market.",
      "llm_answer": "Goldman Sachs’ commercial‑real‑estate loan portfolio is $34.8 bn, and only about 5 % of it – roughly $1.7 bn – is allocated to hospitality (i.e., hotel‑related) loans【page_118】.  MetLife’s real‑estate fund holdings total $3.65 bn, and hotels make up $700 m (about 5 % of its $13.3 bn real‑estate assets)【page_94】.  Consequently, Goldman’s direct loan exposure to hotels is larger in absolute terms than MetLife’s hotel‑focused investment in real‑estate funds, even though both firms rely on real‑estate funds as a diversification component of their overall strategies.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. The ground truth states that MetLife holds $13.3 billion in total real estate investments, including hotel-focused real estate funds, but the LLM incorrectly claims that MetLife’s real estate fund holdings are $3.65 billion and that hotel investments are $700 million (5% of $13.3 billion). However, 5% of $13.3 billion is $665 million, not $700 million, and the original answer does not specify the exact dollar amount invested in hotel funds—only that such investments exist within the $13.3 billion portfolio. More critically, the LLM fabricates a $34.8 billion commercial real estate loan portfolio for Goldman Sachs with $1.7 billion (5%) in hospitality loans, which is not present in the original answer. The original answer mentions Goldman Sachs has 'significant credit exposure' to hotel-related CRE loans but provides no dollar figures. Thus, all quantitative claims in the LLM answer are unsupported and incorrect. (2) Calculations are internally consistent (5% of $34.8B ≈ $1.7B, 5% of $13.3B ≈ $665M), but they are based on fabricated data. The comparison of absolute exposure ($1.7B vs $700M) is therefore invalid. (3) The multi-hop reasoning is partially sound in structure—comparing lending exposure vs. investment via funds—but fails in execution because it invents precise figures not present in the source material. The qualitative distinction between Goldman’s lending role and MetLife’s ownership stake is correctly identified, showing understanding of strategic differences. (4) Correctness score is 4 due to major quantitative errors but partial credit for correct conceptual framing. Quantitative accuracy is low (3) due to fabricated numbers. Qualitative accuracy is moderate (5) as the strategic contrast is valid. Contextual relevance is high (8) because the response addresses the core comparison asked, despite factual inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 526,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How do the liquidity risk profiles of BA's limited partnership investments compare with UPS's pension fund commitments in real estate, particularly regarding the 10–15 year partnership terms and UPS's $3.3 billion in unfunded obligations?",
      "original_answer": "Both BA and UPS hold investments through limited partnerships, which expose them to long-term liquidity risks due to the structural characteristics of these vehicles. BA invests in limited partnerships that focus on real estate and private assets, with investment durations typically spanning 10–15 years, limiting liquidity until the end of the partnership term. Similarly, UPS has $3.3 billion in unfunded commitments to limited partnerships as of December 31, 2023, with redemption provisions restricted until the end of the fund’s life, also generally 10–15 years from inception. This shared structure implies both companies face limited short-term liquidity and are exposed to market risks over extended periods without the ability to exit early without discounts.",
      "llm_answer": "Boeing’s alternative‑investment portfolio is dominated by private‑equity ($4.1 bn) and real‑asset ($3.1 bn) positions that are held through limited‑partnership interests and therefore have long lock‑up periods that create a liquidity risk similar to other LP investments【page_94】.  UPS’s pension plan also invests in limited‑partnership real‑estate funds that cannot be redeemed until the end of a 10‑ to 15‑year partnership term, and the plan carries roughly $3.3 bn of unfunded commitments that must be funded over the next three to six years, making its liquidity exposure both long‑dated and quantitatively defined【page_89】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Boeing (BA) and UPS, their respective limited partnership structures, and the 10–15 year lock-up periods affecting liquidity. It accurately states UPS's $3.3 billion in unfunded commitments, matching the ground truth. The mention of Boeing’s $4.1B private equity and $3.1B real assets, while adding detail not in the original answer, does not contradict it and aligns with the broader context of illiquid alternative investments. (2) All numeric values—$4.1B, $3.1B, $3.3B, 10–15 year terms, 3–6 year funding window for UPS—are factually accurate and consistent with the knowledge graph. Format variations (e.g., $3.3 bn vs $3.3 billion) are acceptable. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies face long-term liquidity constraints due to LP structures, even though the specific funds differ (Boeing’s private equity and real assets vs UPS’s real estate LPs). It appropriately compares structural illiquidity and unfunded obligations across entities. (4) The only minor shortcoming is that the original answer emphasizes the parallelism in both companies’ exposure to 10–15 year terms and lack of early exit, while the LLM slightly deemphasizes Boeing’s term length beyond 'long lock-up periods'—though it is implied. Still, the core comparison is valid and well-reasoned. Scores reflect high accuracy with negligible omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 396,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How does the voting power distribution tied to Class A and Class B common stock at META compare to the voting structure at CMCSA, particularly in terms of control concentration and shareholder influence?",
      "original_answer": "At META, the dual-class structure gives Class B common stockholders, primarily Mark Zuckerberg, outsized control, requiring a majority of Class B shares to approve change-of-control transactions until they represent less than 35% of combined voting power. In contrast, CMCSA's structure grants Class A common stockholders 66 2/3% of the combined voting power, with each Class B share having 15 votes, but Class B stock is non-dilutable and owned entirely by Brian L. Roberts. This means both companies use dual-class structures to concentrate control, but META's governance rules and anti-takeover provisions make it harder for investors to influence corporate decisions compared to CMCSA, where Class A shareholders collectively hold significant voting influence.",
      "llm_answer": "Meta’s dual‑class structure gives its ten‑vote Class B shares (held by Mark Zuckerberg, the board chair and CEO) a majority of the combined voting power even though they represent only about 9 % of the total shares, concentrating control in a small group and limiting other shareholders’ influence【page_49】. In contrast, Comcast’s 15‑vote Class B shares are owned by a single holder but account for only roughly one‑third of total voting power, with the remaining two‑thirds held by the much larger base of one‑vote Class A shareholders, resulting in a less concentrated control structure【page_33】.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core contrast between META and CMCSA's voting structures. It accurately conveys that META's Class B shares (held by Zuckerberg) have 10 votes per share and maintain majority voting power despite representing only ~9% of total shares, which aligns with the ground truth's emphasis on outsized control and anti-takeover provisions. The statement that CMCSA’s Class B shares have 15 votes but account for only about one-third of voting power is consistent with the ground truth, as CMCSA’s Class A holds 66 2/3%, meaning Class B holds roughly one-third. The LLM correctly infers that CMCSA’s structure gives broader influence to Class A shareholders, resulting in less concentrated control than at META. However, the LLM omits specific governance mechanisms mentioned in the original answer, such as META’s 35% threshold for change-of-control approval and CMCSA’s non-dilutable Class B shares owned entirely by Brian L. Roberts. These are important qualitative details that enhance completeness, particularly for multi-hop reasoning. While the LLM captures the essence of control concentration and shareholder influence, the absence of these structural specifics slightly weakens the depth of comparison. Quantitatively, all percentages and vote ratios are plausibly aligned with the ground truth (e.g., 10 votes vs 15 votes, ~1/3 vs 2/3 split), though the exact source of the '9%' figure for META is not in the original answer (which focuses on voting power thresholds, not economic ownership). This introduces a minor discrepancy, but not a factual error per se. Overall, the reasoning is sound, the comparison is valid, and the answer is highly relevant, earning high marks with room for improvement in completeness of structural details.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 483,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How does the allocation of PEP's U.S. qualified defined benefit plan assets to government securities compare with the investment profile of COST's short-term holdings in government and agency securities, particularly in terms of risk management and expected return strategy?",
      "original_answer": "PEP's U.S. qualified defined benefit plans allocated $1.812 billion to government securities in 2023 as part of a diversified investment strategy aiming for a 7.4% long-term return, while COST holds short-term investments in government and agency securities primarily for capital preservation with a focus on low volatility and effective maturities of three months to five years. PEP's approach includes active management and use of derivatives to mitigate risk, whereas COST limits exposure to interest rate fluctuations by investing in fixed-rate, short-duration instruments.",
      "llm_answer": "PepsiCo’s U.S. qualified defined‑benefit plan holds about $1.8 billion of government securities – roughly 15 % of its $11.7 billion U.S. plan assets – as part of a diversified portfolio that targets a 7.4 % long‑term return and uses derivatives to hedge interest‑rate and currency risk (PEP 2023 10‑K, p. 99; expected return 7.4 % p. 98). Costco’s short‑term holdings, by contrast, are concentrated in U.S. government and agency securities (and related money‑market instruments) with maturities of three months to five years, where the primary objective is principal preservation and only a secondary goal of modest yield generation, reflecting a low‑risk, liquidity‑focused strategy (COST 2023 10‑K, p. 31).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies PEP's allocation of $1.812 billion to government securities (rounded to $1.8 billion, which is acceptable for reporting purposes) and accurately states the 7.4% long-term return target. It also correctly characterizes COST's short-term holdings in government and agency securities with maturities from three months to five years, emphasizing principal preservation and low risk. All key facts from the ground truth are present and factually accurate. (2) Quantitatively, the $1.8 billion figure is a valid rounding of $1.812 billion. The 15% allocation is consistent with PEP’s total U.S. plan assets of $11.7 billion (1.8 / 11.7 ≈ 15.4%), which is a reasonable inference not contradicted by the ground truth. The 7.4% expected return is exact. No calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes data from both PEP and COST 10-Ks, comparing their investment strategies across risk management (derivatives and active management for PEP vs. short-duration, fixed-rate instruments for COST) and return objectives (long-term return targeting vs. modest yield generation). The only minor omission is that the ground truth explicitly mentions COST’s focus on limiting interest rate exposure, which is implied but not directly stated in the LLM answer. (4) Scores reflect near-perfect factual accuracy, excellent quantitative precision, strong qualitative reasoning, and full contextual relevance to the comparative risk and return strategy question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 423,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How does Southern Company's actual allocation to mortgage-backed securities within its fixed income portfolio compare to NextEra Energy's target allocation framework for fixed income investments, given that both classify mortgage-backed securities under fixed income assets?",
      "original_answer": "Southern Company had only $9 million allocated to mortgage-backed securities as part of its $6,154 million in fixed income investments measured using significant other observable inputs (Level 2), representing less than 0.15% of its fixed income portfolio. In contrast, NextEra Energy's pension plan targets 32% allocation to fixed income investments as part of its broader pension asset strategy, which explicitly includes mortgage-backed securities under its fixed income classification. Both companies classify mortgage-backed securities under fixed income investments, with Southern Company valuing them at yields on comparable securities and NextEra Energy utilizing a combination of directly held securities and commingled investment arrangements.",
      "llm_answer": "Southern Company’s 2020 fair‑value table shows just **$9 million** of mortgage‑ and asset‑backed securities in its fixed‑income holdings – roughly **0.3 % of its $2.9 billion fixed‑income portfolio**【page_298】. In contrast, NextEra Energy’s pension‑plan policy targets **32 % of assets** to be invested in fixed‑income securities overall【page_101】. Thus, Southern’s actual mortgage‑backed‑security exposure is a tiny slice of its fixed‑income mix, while NextEra’s framework calls for a much larger, 32 % allocation to fixed‑income assets.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While it correctly states Southern Company's $9 million allocation to mortgage-backed securities, it incorrectly reports the total fixed income portfolio as $2.9 billion, whereas the ground truth specifies $6,154 million ($6.154 billion). This leads to an incorrect percentage calculation: the LLM claims ~0.3%, but the correct proportion is $9M / $6,154M ≈ 0.146%, which rounds to less than 0.15% as stated in the original answer. The LLM’s 0.3% figure is nearly double the accurate value due to the wrong denominator. (2) The mention of 'mortgage- and asset-backed securities' introduces ambiguity not present in the original, which specifically refers to mortgage-backed securities only. This could conflate distinct asset classes. (3) The LLM correctly identifies NextEra Energy’s 32% target allocation to fixed income and correctly notes that mortgage-backed securities are included within fixed income for both companies. However, it fails to mention that NextEra’s framework applies specifically to its pension plan and omits details about valuation methods (e.g., Southern using yields on comparable securities, NextEra using commingled arrangements), reducing completeness. (4) Despite these issues, the core multi-hop comparison — Southern’s actual small allocation vs. NextEra’s broader target — is conceptually sound and addresses the central question. The reasoning structure is logical, even if based on flawed data. (5) Contextual relevance is high, as the response directly compares the two companies’ allocations as requested. However, the incorrect portfolio size and resulting percentage undermine factual reliability. Minor formatting like '32 %' with a space is negligible. Overall, partial credit is warranted for correct identification of key figures like $9M and 32%, but significant deductions are necessary for the incorrect total portfolio value and derived percentage.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 532,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What specific pricing agreements and supply arrangements did Tesla and Panasonic Corporation formalize in their Gigafactory partnership, and how does GM’s dependency on batteries compare in terms of supplier integration and contractual depth?",
      "original_answer": "Tesla and Panasonic Corporation formalized multiple pricing agreements and supply arrangements under their Gigafactory partnership, including the Amended and Restated General Terms and Conditions for Gigafactory (June 10, 2020), the 2020 Pricing Agreement (Gigafactory 2170 Cells), and the 2021 Pricing Agreement (Japan Cells). These agreements establish detailed pricing mechanisms, production responsibilities, and shared facility leasing arrangements. In contrast, GM’s dependency on batteries is noted without equivalent supplier integration details or specific contractual commitments in the evidence provided, indicating a less transparent or structured supplier partnership compared to Tesla’s explicit agreements with Panasonic.",
      "llm_answer": "Tesla and Panasonic built a multi‑layered Gigafactory supply framework that began with a 2011 Supply Agreement (and its 2013 amendment) and was expanded by a 2014 General Terms and Conditions, a Production Pricing Agreement, and a Letter Agreement adding co‑parties to those contracts [page_106].  The partnership was then refined with explicit cell‑price contracts – a 2019 Japan‑cell pricing agreement, a 2020 Gigafactory 2170‑cell pricing agreement, and a 2021 Japan‑cell pricing agreement [page_107] – which lock in volumes and prices for Panasonic‑produced batteries.  \n\nGM’s battery reliance, by contrast, is tied to its equity stake in the Ultium Cells Holdings joint venture, which is described as an “integral” supplier of EV cells but is governed primarily by equity‑investment and joint‑venture arrangements rather than a series of detailed, long‑term pricing contracts [page_76].",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. It correctly identifies the core pricing agreements and supply arrangements between Tesla and Panasonic, including the 2020 and 2021 pricing agreements for Gigafactory 2170 and Japan cells, though it references a 2019 Japan-cell agreement instead of the 'Amended and Restated General Terms and Conditions' from June 10, 2020—this is a minor discrepancy in naming and dating but does not undermine the factual core. The LLM accurately captures the multi-layered contractual structure and references specific agreements with correct years and purposes (e.g., 2020 Gigafactory 2170-cell pricing agreement). Regarding GM, the LLM correctly contrasts its supplier integration model, emphasizing equity-based joint ventures (Ultium Cells Holdings) rather than detailed long-term pricing contracts, which matches the ground truth’s assertion of less explicit contractual depth. The reasoning is sound, multi-hop synthesis is appropriate (comparing Tesla-Panasonic contracts to GM’s JV model), and all entities (Panasonic, Tesla, GM, Ultium) are correctly identified. Quantitative elements (dates, agreement types) are mostly accurate, with only a slight variance in the naming/timing of one agreement. Wording differs but semantic equivalence is preserved. No major omissions or factual errors affect the conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 382,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How does Chevron's ongoing tax audit exposure in Nigeria compare to Exxon's production-sharing contract risk in the same country, given the specific terms of Nigeria's PSCs and Chevron's unresolved tax positions?",
      "original_answer": "Chevron faces unresolved tax audits in Nigeria with $5,288 million in unrecognized tax benefits at year-end 2021, where the latest audit finalized was for the year 2007, leaving over a decade of tax exposure open to scrutiny. Meanwhile, Exxon operates in Nigeria under production-sharing contracts (PSCs) that typically last 30 years, with a 10-year exploration period followed by a 20-year production period, which may be extended subject to relinquishment provisions. Exxon also reports that 12% of its total proved reserves in 2021 were under PSC arrangements, where production volumes fluctuate inversely with price changes. Therefore, while Chevron's risk in Nigeria is tied to legacy tax liabilities and regulatory uncertainty, Exxon's exposure is more operational and tied to the fiscal terms and duration of its PSCs, which are sensitive to commodity price volatility.",
      "llm_answer": "Chevron’s 2021 filing shows that a tax audit of its Nigerian operations is still open (the latest year under examination is 2007) and that $5.3 billion of “unrecognized tax benefits” – about 82 % of which would affect the effective tax rate if recognized – remain unresolved, leaving the potential tax impact in Nigeria highly uncertain. By contrast, Exxon’s risk in Nigeria stems from the structure of its deep‑water production‑sharing contracts, which are generally 30‑year agreements with a 10‑year exploration phase and a 20‑year production phase that can be relinquished or extended under the Petroleum Industry Act, so the exposure is contractual‑duration risk rather than a quantified tax liability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Quantitatively, all key figures are correct: Chevron's $5.3 billion in unrecognized tax benefits (matches $5,288 million, rounded appropriately), the latest audit year being 2007, and the 82% impact on effective tax rate are all factually consistent with the original answer. (2) The description of Exxon's PSCs—30-year duration, 10-year exploration, 20-year production, and potential for extension or relinquishment under Nigeria's Petroleum Industry Act—is accurate and aligns with the structural details in the ground truth. (3) The reasoning correctly distinguishes Chevron's tax liability risk from Exxon's operational/contractual risk, capturing the multi-hop comparison between tax exposure and PSC terms. (4) The only minor omission is that the original answer includes the detail that 12% of Exxon’s total proved reserves in 2021 were under PSCs and that production volumes under PSCs fluctuate inversely with prices—this contextualizes the financial sensitivity but is not central to the core comparison. The LLM answer captures the essence and key differentiators of the risks, with excellent synthesis and semantic equivalence. Thus, full marks for quantitative accuracy and contextual relevance, near-perfect qualitative accuracy, and a 9/10 overall for minor completeness gap.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 378,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How does Tesla's use of commercial paper compare to companies with significant operations in Ohio, such as Duke Energy Ohio?",
      "original_answer": "Tesla reported $470 million in commercial paper holdings as of December 31, 2023, as part of its short-term investment strategy. In contrast, Duke Energy Ohio, a major company operating in the state, had $25 million in commercial paper outstanding as disclosed in its financial details. This comparison highlights different approaches to short-term financing and liquidity management between Tesla, a technology and automotive company, and Duke Energy Ohio, a utility provider.",
      "llm_answer": "Tesla’s 2023 filing shows it held $470 million of commercial paper, classified as part of cash and cash equivalents (fair‑value $470 m)【page_72】.  \nDuke Energy Ohio, by contrast, reports only $25 million of commercial paper under short‑term notes payable【page_165】.  \n\nThus, Tesla’s commercial‑paper balance is roughly twenty‑fold larger and is treated as a cash‑equivalent asset, while Duke Energy Ohio’s commercial paper is a modest short‑term borrowing.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitative accuracy: The dollar amounts ($470 million for Tesla and $25 million for Duke Energy Ohio) are correctly reported, with no calculation errors. The comparison stating Tesla's balance is 'roughly twenty-fold larger' is accurate (470 / 25 = 18.8, which rounds to ~20x). (2) Completeness: The answer addresses both companies, their respective commercial paper positions, the classification (asset vs. liability), and the implied difference in financial strategy. (3) Entity accuracy: Tesla and Duke Energy Ohio are correctly identified, and the data is attributed to the correct fiscal period (2023). (4) Reasoning: The multi-hop synthesis across two different companies and filings is sound. The LLM correctly interprets that Tesla holds commercial paper as a cash-equivalent investment, while Duke Energy Ohio has commercial paper as a borrowing instrument, reflecting different financial strategies. (5) Semantic equivalence: The LLM conveys the same core information as the original answer, with added clarity on classification and magnitude. Minor wording differences do not affect factual accuracy. All evaluation criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 349,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How does JPMorgan's exposure to transition risk, as outlined in its climate risk management framework, influence its compliance risk profile compared to Morgan Stanley's experience with regulatory scrutiny tied to climate-related disclosures?",
      "original_answer": "JPMorgan acknowledges transition risk as a key component of climate risk, which may amplify compliance risk due to increased regulatory scrutiny tied to climate-related disclosures. JPMorgan has established a Climate Risk Management function that integrates climate risk into its broader risk management framework, including developing metrics and stress testing mechanisms to assess potential financial impacts. According to Morgan Stanley’s disclosures, compliance risk includes exposure to legal sanctions or reputational damage from failure to meet climate-related regulatory requirements, such as increased disclosure mandates or carbon taxes. Furthermore, Morgan Stanley notes that transition risk can lead to reputational, compliance, and litigation risks due to heightened legal and regulatory scrutiny. Therefore, both firms recognize that transition risk directly influences compliance risk, but JPMorgan emphasizes proactive integration into risk frameworks, whereas Morgan Stanley highlights the regulatory enforcement dimension.",
      "llm_answer": "JPMorgan treats transition risk as a core element of its Climate‑Risk Management function, which sets policies, metrics and stress‑testing and requires the business lines and Corporate to “adhere to applicable climate‑related laws, rules and regulations” (JPM 10‑K p.148‑146).  By embedding that oversight in its firm‑wide risk‑governance structure, JPMorgan’s compliance risk from transition‑risk exposures is managed internally, whereas Morgan Stanley explicitly warns that transition risk can “expose us to … compliance and/or litigation risk due to increased legal and regulatory scrutiny” of its climate‑related disclosures (MS 10‑K p.78).  Thus, JPMorgan’s proactive climate‑risk framework seeks to contain compliance risk, while Morgan Stanley’s experience reflects external regulatory pressure that heightens its compliance‑risk profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: JPMorgan's integration of transition risk into its Climate Risk Management function, its emphasis on internal governance and adherence to climate-related regulations, and Morgan Stanley's explicit linkage of transition risk to compliance and litigation risk due to regulatory scrutiny are all accurately represented. The citations to page numbers in the 10-Ks (e.g., JPM 10-K pp.148-146, MS 10-K p.78) are plausible and contextually appropriate, though minor page order inversion (148-146) is a negligible formatting issue. (2) There are no numeric values, dates, or financial figures in the question or ground truth, so quantitative accuracy is not applicable in a traditional sense—however, the absence of incorrect numbers and proper handling of non-numeric data earns full marks. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two firms, comparing how each links transition risk to compliance risk, and draws a valid contrast—JPMorgan’s proactive internal framework vs. Morgan Stanley’s focus on external regulatory pressure. (4) Semantic equivalence is strong: while the LLM uses slightly different phrasing (e.g., 'contain compliance risk' vs. 'managed internally'), the meaning matches the original. The only minor shortcoming is a slight omission of Morgan Stanley’s mention of reputational risk, which is noted in the ground truth but not in the LLM answer—this does not undermine the core comparison but prevents a perfect 10. Contextual relevance is excellent, directly addressing the comparative influence on compliance risk profiles as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 465,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What implications does Nigeria's 30-year production-sharing contract framework have for both ConocoPhillips' deepwater operations and Chevron's reserve accounting practices in the region?",
      "original_answer": "Nigeria's regulatory framework for deepwater offshore exploration establishes 30-year production-sharing contracts (PSCs) that include a 10-year exploration period followed by a 20-year production period, which may be extended under certain conditions. Since ConocoPhillips operates in Nigeria, this structure directly influences its long-term planning and investment decisions in the region. Chevron, which reports that 8-10% of its reserves are tied to PSCs like those in Nigeria, must align its reserve accounting and production forecasts with the specific terms of these contracts, including the partial relinquishment provisions under Nigeria's Petroleum Industry Act. Both companies must therefore manage exploration timelines, commercial discovery requirements, and reserve disclosures in accordance with this regulatory framework.",
      "llm_answer": "Nigeria’s production‑sharing contracts are 30‑year agreements – a 10‑year exploration phase (with optional extensions) followed by a 20‑year production phase that can be further extended, and they require partial relinquishment of acreage when the exploration period ends 【page_31】. For ConocoPhillips this means its deep‑water offshore projects must be structured around OPL‑to‑OML conversions and the relinquishment schedule dictated by the PSC framework, shaping the timing and risk of its operations. For Chevron, the same PSC framework means its Nigerian assets are accounted for as PSC‑related reserves, reported under the economic‑interest method and representing roughly 7‑11 % of its consolidated proved reserves, which directly affects its reserve disclosures and valuation 【page_106】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all key numbers and timeframes are correct: the 30-year PSC structure with a 10-year exploration phase and 20-year production phase is accurately described, including optional extensions. The percentage of Chevron's reserves tied to PSCs is reported as 7–11%, which is within the acceptable range of the ground truth's 8–10%; this minor variation is reasonable and semantically equivalent given reporting flexibility. (2) The mention of partial relinquishment at the end of the exploration period matches the ground truth's reference to Nigeria's Petroleum Industry Act provisions. (3) Entity accuracy is strong: ConocoPhillips and Chevron are correctly identified, and their respective operational and accounting implications are properly attributed. (4) Multi-hop reasoning is sound—LLM correctly synthesizes how the same regulatory framework impacts ConocoPhillips' operational planning (e.g., OPL-to-OML conversions, timing risks) and Chevron's reserve accounting (economic-interest method, reserve disclosures). The reference to reserve valuation effects adds contextual depth consistent with the original. (5) The answer is fully contextually relevant, addressing both companies and both aspects of the question (operations and accounting). The only minor shortfall is the lack of explicit mention of 'Petroleum Industry Act' by name in the Chevron context, though the relinquishment rule is correctly implied. Overall, the answer demonstrates strong factual correctness, synthesis, and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 436,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How does Boeing's exposure to U.S. government contract modifications influence its application of ASU 2022-06, and how does this compare to FedEx's use of the same standard in managing reference rate reform impacts on their contracts?",
      "original_answer": "Boeing faces significant risk from U.S. government contract modifications, which could impact 37% of its revenues earned under government contracts. While Boeing must apply accounting standards like ASU 2022-06, which extends relief for contract modifications related to reference rate reform (e.g., LIBOR), the evidence shows Boeing did not experience material impacts from such modifications. Similarly, FedEx, though not directly exposed to government contract risk like Boeing, also applies ASU 2022-06 to manage contract modifications related to reference rate reform, with no material effect on its financial condition or results of operations as of May 31, 2024. Both companies benefit from the extended sunset date of ASU 2022-06 through 2024, easing the burden of contract adjustments.",
      "llm_answer": "Boeing’s 2023 filing stresses that ≈ 37 % of its revenue comes from U.S. government contracts and that the government can modify, curtail or terminate those contracts, creating a material risk of contract‑modification impacts (see BA 10‑K page 14). The filing does not mention applying ASU 2022‑06 to those government‑contract changes; it merely highlights the exposure. In contrast, FedEx explicitly notes that it has adopted ASU 2022‑06 (the reference‑rate‑reform update) to use optional expedients for contracts and hedging relationships tied to LIBOR, and it is monitoring the impact, which to date has been immaterial (see FDX 10‑K page 93).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 37% revenue exposure for Boeing is correctly cited, and the fiscal year (2023) and page references (BA 10-K p.14, FDX 10-K p.93) are consistent with expected sourcing. No dollar amounts or dates are incorrect. (2) The LLM correctly identifies that Boeing does not apply ASU 2022-06 to government contract modifications—only that it faces material risk from such modifications—while FedEx explicitly adopts ASU 2022-06 for reference rate reform (e.g., LIBOR) with immaterial impact. This matches the ground truth that neither company experienced material effects, and both benefit from the standard’s extended application. (3) The multi-hop reasoning is sound: the model distinguishes between types of contract modifications (government-driven vs. reference rate reform), correctly attributes ASU 2022-06 application only where disclosed (FedEx), and avoids conflating risks. (4) The only minor gap is that the LLM does not explicitly mention the 'extended sunset date through 2024' as a shared benefit, though it implies FedEx is actively using the standard, which is contextually sufficient. Wording differs slightly but maintains semantic equivalence. No factual errors; high contextual relevance and precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 364,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How does ExxonMobil's offshore acreage in Angola compare to Chevron's stake in Angola LNG, given Chevron's reported upstream earnings contributions from that asset in 2021?",
      "original_answer": "ExxonMobil held 2.9 million net offshore acres in Angola at year-end 2021, while Chevron reported a stake in Angola LNG, which contributed to upstream-related earnings improvements in 2021 due to higher performance from equity affiliates like Angola LNG. Chevron's volumes in Angola reflect its share of production through affiliates, including Angola LNG.",
      "llm_answer": "ExxonMobil reported that it held 2.9 million offshore acres in Angola at the end of 2021【page_24】.  Chevron, by contrast, does not own land there but holds an equity interest in the Angola LNG joint‑venture; that interest helped lift its upstream earnings, contributing to the $5.657 billion of income from equity affiliates reported for 2021【page_42】.  Thus ExxonMobil’s presence is measured in millions of acres, while Chevron’s is a financial stake that generated a material earnings boost.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: ExxonMobil's 2.9 million offshore acres in Angola at year-end 2021 is accurately reported, and Chevron's $5.657 billion income from equity affiliates in 2021 (which includes Angola LNG) matches the source. The figure is not broken out specifically for Angola LNG, but the LLM correctly attributes it to equity affiliates generally, with Angola LNG as a contributing factor, which is consistent with the original answer's phrasing about upstream earnings improvements due to higher performance from equity affiliates. (2) The entity identification is correct—ExxonMobil (acreage), Chevron (equity stake), Angola LNG (joint venture), and the year 2021 are all properly referenced. (3) The reasoning is sound: the LLM correctly contrasts ExxonMobil’s physical asset (offshore acres) with Chevron’s financial stake in a joint venture, capturing the core of the multi-hop comparison. (4) The only minor shortcoming is that the original answer notes Chevron's 'volumes in Angola reflect its share of production through affiliates,' which the LLM omits—this contextual link between stake and production is slightly underdeveloped. However, the earnings contribution is correctly emphasized. Overall, the answer is factually correct, contextually relevant, and semantically equivalent, with only a slight gap in completeness regarding production linkage, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 417,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does Accenture's $6.6 billion investment in 46 strategic acquisitions in fiscal 2024, focused on scaling industry solutions, compare to Microsoft's revenue from enterprise and partner services—which includes industry solutions—in the same period?",
      "original_answer": "Accenture invested $6.6 billion across 46 strategic acquisitions in fiscal 2024 to scale its industry solutions, while Microsoft reported $7.594 billion in revenue from 'Enterprise and partner services'—a category that includes 'Industry Solutions'—during the same fiscal year. This indicates that while Accenture is heavily investing in expanding its industry-specific offerings through acquisitions, Microsoft is generating substantial revenue from its own industry solutions and enterprise services, suggesting differing strategic approaches to growth in the enterprise technology space.",
      "llm_answer": "Accenture spent about **$6.6 billion** on 46 strategic acquisitions in fiscal 2024 to scale its industry‑solution capabilities【page_6】.  In the same year, Microsoft reported **$7.6 billion** of revenue from “Enterprise and partner services” – a line that includes its industry‑solution offerings【page_93】.  Thus, Accenture’s acquisition outlay was roughly **$1 billion less** than Microsoft’s enterprise‑partner services revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Accenture's $6.6 billion investment in 46 acquisitions in fiscal 2024 and Microsoft's revenue from 'Enterprise and partner services' as $7.6 billion, which is a rounded version of the ground truth $7.594 billion—this minor rounding is acceptable and common in financial reporting. The comparison stating Accenture’s outlay was 'roughly $1 billion less' is accurate: $7.594B - $6.6B = $0.994B ≈ $1B. (2) All numeric values are correct or appropriately rounded; no calculation errors. The fiscal year (2024) and entities (Accenture, Microsoft) are correctly identified. The financial metrics—acquisition investment vs. revenue—are accurately attributed. (3) The multi-hop reasoning is sound: the model synthesizes data from two different companies and financial contexts (investment vs. revenue) to make a valid cross-company comparison focused on industry solutions. It correctly infers that Accenture is investing heavily while Microsoft is generating revenue, though it omits the slightly richer strategic interpretation in the original about differing growth approaches. (4) The answer is factually correct, contextually relevant, and semantically equivalent to the ground truth, with only a minor omission in strategic nuance. Hence, high scores across all categories with a 9 in correctness due to near-perfect accuracy and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 386,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How might Duke Energy's experience with maintaining a 30% equity threshold under FERC-approved dividend policies inform Southern Company's financial planning for its 50% cost share in the $3 billion SNG pipeline project requiring similar FERC approval?",
      "original_answer": "Duke Energy Ohio was required to maintain equity, adjusted to remove push-down accounting impacts, at no less than 30% of total capital as part of FERC and PUCO approval for dividend policies. Southern Company Gas has a 50% cost share in a $3 billion pipeline project through its stake in SNG, which also requires FERC approval. Given this regulatory overlap, Southern Company may reference Duke Energy's equity management strategies to structure its capital allocation and ensure compliance with potential FERC equity requirements for the SNG pipeline project.",
      "llm_answer": "Duke Energy’s Ohio subsidiary was required by FERC to keep its equity—after adjusting for push‑down accounting—no lower than 30 % of total capital, which forced it to limit dividend payouts and carefully balance retained earnings, debt and equity to stay above the regulator’s floor (see DUK pages 147‑148). Southern Company can apply the same discipline to its $1.5 billion (50 % of the $3 billion) SNG‑pipeline commitment by preserving a strong equity base—e.g., retaining earnings, moderating distributions and using a prudent mix of debt—so that its equity ratio remains comfortably above any FERC‑imposed threshold for the project (see SO page 92).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: Duke Energy Ohio's 30% equity threshold is accurately cited, and Southern Company's 50% share of the $3 billion SNG pipeline is correctly calculated as $1.5 billion. No date or percentage errors exist. Format variations (e.g., $1.5 billion) are acceptable. (2) The answer addresses all parts of the multi-hop question: it references Duke Energy’s FERC-related equity maintenance requirement, explains the financial implications (limiting dividends, managing capital structure), and applies this precedent to Southern Company’s SNG pipeline cost share. (3) Entity accuracy is strong: Duke Energy Ohio, Southern Company Gas, SNG pipeline, FERC, and the $3 billion project are all correctly identified. The reference to DUK pages 147–148 and SO page 92 suggests document grounding, though not verifiable here, does not detract. (4) Reasoning is sound: the model correctly infers that Southern Company may adopt similar capital discipline (retained earnings, moderated distributions, prudent debt use) to meet potential FERC equity thresholds. The only minor shortcoming is that the original answer emphasizes 'adjusting for push-down accounting' as a specific nuance in equity calculation, which the LLM mentions but does not fully integrate into the advice for Southern Company. This slight omission in technical depth prevents a perfect 10 on qualitative accuracy, but the core logic and synthesis remain robust. Overall, the answer is factually correct, contextually relevant, and demonstrates strong multi-hop reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 446,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the use of matrix pricing for corporate debt instruments differ between UPS's fair value hierarchy disclosures and MMM's valuation methodologies, given that both companies rely on this pricing technique when broker quotes are unavailable?",
      "original_answer": "UPS categorizes its corporate debt instruments under Level 2 inputs in the fair value hierarchy and utilizes matrix pricing when broker quotes are not available, as seen in its 2022 disclosures. Similarly, MMM also applies matrix pricing for corporate debt instruments when broker quotes are unavailable, valuing them based on yields from comparable securities or discounted cash flow models. Both companies depend on matrix pricing as a fallback method for valuing these instruments, though MMM specifically notes adjustments for non-observable risks like credit and liquidity, unlike UPS, which does not mention such adjustments. This reveals a nuanced difference in how each company applies matrix pricing depending on the complexity of risk factors considered.",
      "llm_answer": "UPS treats corporate debt that must be priced without a broker quote as a pure Level 2 fair‑value item – it is disclosed under “market‑corroborated pricing, matrix pricing or other models that use observable inputs such as yield curves,” and all of its corporate‑bond holdings fall in that Level 2 bucket. MMM also uses matrix pricing when quotes are unavailable, but it couples it with yield‑curve comparisons, discounted‑cash‑flow models and credit‑/liquidity‑risk adjustments, and its hierarchy separates a small amount of corporate bonds at Level 1 (quoted) with the bulk measured at Level 2 using those matrix‑pricing‑based techniques. Thus UPS’s matrix pricing is a straightforward Level‑2 observable‑input approach, whereas MMM’s matrix pricing is part of a broader, more nuanced valuation methodology that includes additional modeling and risk‑adjustments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: UPS categorizes corporate debt instruments under Level 2 when broker quotes are unavailable, using matrix pricing based on observable inputs like yield curves. MMM also uses matrix pricing in the absence of quotes but supplements it with yield comparisons, discounted cash flow models, and credit/liquidity risk adjustments, with most bonds at Level 2 and a small portion at Level 1. These details match the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages, years) in either answer beyond '2022' in the original, which the LLM omits—but since the question does not hinge on a specific year and both companies' practices are consistent over recent reporting periods, this omission does not affect correctness. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes across UPS and MMM’s disclosures, comparing their use of matrix pricing and highlighting the key difference—MMM’s inclusion of non-observable risk adjustments versus UPS’s reliance on purely observable inputs. (4) The semantic meaning is equivalent to the original answer, with slightly more structural clarity in distinguishing the two companies’ approaches. The only minor shortcoming is the lack of explicit mention that UPS does *not* disclose adjustments for non-observable risks (a nuance present in the original), but this is implied by stating UPS uses only observable inputs. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 449,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the $2.8 billion upfront payment from Vertical Bridge REIT, LLC to VZ in 2024 compare to T's prior tower transaction with Crown Castle in 2013, particularly in terms of the financing structure and the retained operational control over the towers?",
      "original_answer": "The $2.8 billion upfront payment from Vertical Bridge to VZ in 2024 was primarily recorded as prepaid rent ($2.0 billion) and a financing obligation ($830 million), reflecting the retained operational control and right-of-use for a portion of the towers. In contrast, T's 2013 transaction with Crown Castle resulted in a $4.827 billion cash payment, which was fully accounted for as a financing obligation, with T retaining control and continuing to depreciate the tower assets ($608 million at the end of 2024). Both companies maintained ownership on their balance sheets and depreciated the assets, but VZ's arrangement included a dual treatment of prepaid rent and financing, while T's was entirely structured as a financing obligation with interest at approximately 3.9%.",
      "llm_answer": "The 2024 Vertical Bridge deal was accounted for as a split‑payment: $2 bn of the $2.8 bn was recorded as prepaid rent (shown in operating cash flow) and the remaining $830 m was booked as a financing obligation (shown in financing cash flow). By contrast, the 2013 Crown Castle transaction treated the entire $4.827 bn cash receipt as a single financing liability, accruing interest at roughly 3.9 % under the effective‑interest method. In both transactions the towers stay on the seller’s books and the seller retains operational control—Verizon leases back capacity for a 10‑year term (with renewal options) and continues to occupy part of the sites, while AT&T subleases space on Crown Castle’s towers and remains the primary obligor for the underlying ground leases.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key numbers are correct: $2.8 billion total, $2.0 billion as prepaid rent, $830 million financing obligation, and $4.827 billion for the 2013 Crown Castle transaction. The interest rate of approximately 3.9% is correctly noted as 'roughly 3.9%'. (2) The accounting treatment is accurately described: VZ's split between prepaid rent (operating cash flow) and financing obligation (financing cash flow) vs. T's full treatment as a financing liability. (3) Entity accuracy is strong: Vertical Bridge, VZ (Verizon), Crown Castle, and T (AT&T) are correctly identified with proper transaction years (2024 and 2013). (4) Multi-hop reasoning is sound—correctly compares two different transactions across companies and time, synthesizing accounting treatment, retained control, and operational arrangements. (5) The LLM adds slightly more operational detail (e.g., 10-year term with renewal options, subleasing, ground lease obligations) not in the original answer, which is contextually valid and enhances completeness without introducing error. The only minor gap is that the original mentions T continued to depreciate tower assets ($608 million at end of 2024), which the LLM omits—this is a small but relevant detail about asset treatment on the balance sheet. Otherwise, semantic equivalence is strong, and all core facts and calculations are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 394,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the potential tax liability from MRK's TCJA-related IRS examination compare with MDT's BEAT-related tax impact in 2024, given the TCJA's introduction of BEAT as a minimum tax?",
      "original_answer": "MRK faces a potential significant tax liability if the IRS disagrees with its transition tax position under the TCJA, which includes BEAT as a component of its minimum tax framework. The TCJA introduced BEAT as a minimum tax based on cross-border service payments, directly linking it to the broader tax reform that both MRK and MDT are subject to. In 2024, MDT reported a 0.3% increase in effective tax rate due to BEAT, indicating a measurable but relatively small impact. Comparatively, MRK's exposure could be more substantial if the IRS challenges its TCJA transition tax calculations, potentially reversing unrecognized tax benefits that stood at $2.3 billion as of December 31, 2024. Thus, while MDT's BEAT impact is quantifiably modest, MRK's TCJA-related risk remains high and contingent on IRS resolution.",
      "llm_answer": "Merck (MRK) notes that the IRS is examining its 2017‑18 returns, including the one‑time transition‑tax provision under the TCJA, and warns that “if the IRS disagrees with the Company’s transition‑tax position, it may result in a significant tax liability” (​MRK 10‑K p. 127). In contrast, Medtronic (MDT) reports that the Base‑Erosion Anti‑Abuse Tax (BEAT) – a minimum tax created by the TCJA – only added 0.3 percentage points to its 2024 effective tax rate (​MDT 10‑K p. 87). Thus, Merck faces an uncertain, potentially large liability from the TCJA‑related audit, whereas MDT’s BEAT impact in 2024 is modest, amounting to a 0.3 % increase in its effective tax rate.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: MRK faces a potential significant tax liability from the IRS examination of its TCJA transition tax position (2017–18 returns), and MDT’s BEAT impact in 2024 was a 0.3 percentage point increase in effective tax rate. The dollar amount of $2.3 billion in unrecognized tax benefits from the original answer is not mentioned in the LLM response, which is a minor omission but does not contradict or misrepresent the data. (2) Quantitatively, the 0.3% increase for MDT is correctly cited, and the years (2017–18 for MRK audit, 2024 for MDT impact) are accurate. No calculations are required, but the comparison in magnitude (significant vs. modest) is appropriately conveyed. (3) The multi-hop reasoning is sound: the LLM correctly links TCJA to BEAT, identifies MRK’s exposure through audit risk, and contrasts it with MDT’s actual reported BEAT impact. It synthesizes information from both companies’ 10-Ks and contextualizes the TCJA’s role. (4) The answer is contextually relevant, directly addressing the comparison asked. The only reason for not scoring a 10 is the omission of the $2.3 billion unrecognized tax benefit figure, which adds specificity to MRK’s exposure in the original answer. However, the phrase 'significant tax liability' captures the essence, so the omission is minor. Overall, the response is factually correct, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 412,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does Nigeria's 30-year production sharing contract framework influence both ConocoPhillips' operational footprint and Chevron's reserve disclosures in Africa?",
      "original_answer": "Nigeria's regulatory framework establishes 30-year production sharing contracts (PSCs) with a 10-year exploration period followed by a 20-year production period, requiring partial relinquishment at the end of exploration (from hop2_evidence). ConocoPhillips operates in Nigeria under this framework (from hop1_evidence), which shapes its exploration timelines and asset management strategy. Chevron's 2021 reserves in Africa totaled 106 million barrels (from hop3_evidence), indicating continued exposure to jurisdictions like Nigeria where regulatory terms directly affect reserve life and development planning. The 30-year PSC duration influences both companies' capital allocation decisions, reserve booking practices, and long-term operational strategies in the region.",
      "llm_answer": "Nigeria’s deep‑water production‑sharing contracts are 30‑year agreements (a 10‑year exploration phase followed by a 20‑year production phase, with possible extensions) 【page_31】. ConocoPhillips’ African footprint is built around assets held under such PSCs – its 10‑K notes that a share of its proved reserves is reported under PSCs and that Africa is a disclosed geographic segment 【page_151】. Chevron’s reserve disclosure likewise reflects the impact of its Nigerian PSC‑based assets (the Sonam field), which contributed a 42‑million‑barrel increase to its African proved reserves 【page_105】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Nigeria's 30-year PSC framework with a 10-year exploration and 20-year production phase, aligning with the ground truth. It accurately links ConocoPhillips' operational footprint in Africa to PSCs and notes that Africa is a disclosed segment in its 10-K, which supports the influence of the regulatory framework. For Chevron, it references the Sonam field and a 42-million-barrel increase in African proved reserves. However, this conflicts with the ground truth, which states Chevron's total African reserves in 2021 were 106 million barrels — not a 42-million-barrel increase. The LLM does not provide the total reserve figure, and presenting 42 million barrels as an increase (rather than a component or total) introduces a significant quantitative inaccuracy. (2) The number 42 million barrels is not corroborated by the ground truth and appears to misrepresent the data; no source in the ground truth mentions a '42-million-barrel increase' tied to Sonam. The correct total African reserves for Chevron (106 million barrels) is omitted. (3) The multi-hop reasoning is partially sound: the model connects Nigeria’s PSC structure to both companies’ operations and reserve reporting. It correctly infers that PSCs influence reserve disclosures and operational strategies. However, it fails to fully synthesize the correct reserve magnitude for Chevron, weakening the conclusion. (4) The contextual relevance is high — the answer addresses both companies and the regulatory framework’s impact. Qualitative accuracy is good due to correct entity identification and logical flow, but quantitative accuracy is reduced due to the incorrect reserve figure and lack of verification against the known total. Correctness score is 7 because core facts about the PSC structure and company exposure are correct, but a key financial metric is misrepresented.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 513,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How does the limited voting rights structure attached to AT&T's Series C Preferred Stock influence potential restructuring decisions compared to Netflix's one-share-one-vote governance model?",
      "original_answer": "AT&T's Series C Preferred Stockholders have no voting rights except in specific restructuring scenarios such as mergers or consolidations where their equity treatment might change, requiring their separate approval. This constraint limits their influence on broader corporate decisions but protects their interests in defined high-impact events. In contrast, Netflix grants one vote per share to common stockholders on all matters, enabling broader shareholder participation in governance and strategic direction. This difference means Netflix’s shareholders have more consistent influence over corporate decisions, whereas AT&T’s Series C Preferred Stockholders only exert influence in narrowly defined restructuring contexts.",
      "llm_answer": "AT&T’s charter limits the voting power of its Series C preferred shareholders to a narrow set of actions – they can only vote on matters such as a merger, consolidation or amendment that would affect their conversion or liquidation preferences, and any restructuring that triggers those provisions must receive the affirmative vote of the entire Series C class 【page_90】. Netflix, on the other hand, gives every share one vote on all shareholder matters, so restructuring decisions are governed by a simple majority of common shareholders without a separate preferred‑stock consent requirement 【page_61】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. It correctly identifies that AT&T's Series C Preferred Stockholders have limited voting rights, exercisable only in specific restructuring events such as mergers, consolidations, or amendments affecting their conversion or liquidation preferences, and that such actions require approval by the entire Series C class. This matches the original answer's claim about their influence being restricted to defined high-impact scenarios. The comparison to Netflix is also accurate: Netflix operates under a one-share-one-vote model where common shareholders vote on all matters by simple majority, without separate preferred stockholder consent—correctly highlighting broader shareholder influence. There are no numeric values to verify, so quantitative accuracy is 10. The qualitative accuracy is slightly docked (9) because the LLM answer does not explicitly mention that AT&T's structure is designed to protect preferred shareholders' interests in those narrow events, a nuance present in the original. However, the core reasoning and multi-hop synthesis—comparing governance models across two companies and explaining implications for restructuring decisions—are sound and complete. Contextual relevance is perfect, as every part of the response directly addresses the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 375,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How does the expiration timeline of key patent protections for Enbrel impact Pfizer's long-term revenue strategy for the product, particularly given AbbVie's broader approach to patent term restoration and regulatory exclusivity for biologics?",
      "original_answer": "Enbrel (etanercept) has multiple U.S. patents expiring at different points: fusion protein composition in 2028, DNA encoding the fusion protein in 2029, and formulations in 2037. This staggered expiration allows Pfizer to maintain some level of market protection until 2037, though biosimilar competition could begin as early as 2028. AbbVie, in contrast, actively pursues patent protection and patent term restoration under the Hatch-Waxman Act, which can extend exclusivity by up to five years, with total post-approval exclusivity potentially reaching 14 years. Given that AbbVie emphasizes both patent and regulatory exclusivity strategies for its biologics, Pfizer may need to adopt a similarly aggressive lifecycle management approach—such as filing secondary patents or seeking regulatory extensions—to preserve Enbrel's revenue stream beyond its core patent expirations.",
      "llm_answer": "Pfizer’s Enbrel is protected by U.S. composition‑of‑matter patents that expire on 11/22/2028 (and a related method patent on 4/24/2029) and by a formulation patent that runs until 10/19/2037 (Pfizer 10‑K, p. 11). This schedule lets Pfizer count on strong sales through the late‑2020s, but once the composition patents lapse the product will face biosimilar competition, leaving only the later‑expiring formulation patent as a narrower barrier. AbbVie’s broader use of patent‑term restoration and the 12‑year BPCIA biologics exclusivity to extend protection (AbbVie 10‑K, p. 9) underscores that Pfizer must maximize its remaining patents, seek extensions or new indications, and plan for a transition to biosimilars to preserve long‑term revenue from Enbrel.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the dates provided—11/22/2028 (composition patent), 4/24/2029 (method patent), and 10/19/2037 (formulation patent)—are consistent with the staggered expiration timeline in the original answer, though the ground truth does not specify exact dates but rather years. The inclusion of exact dates may reflect additional detail from the 10-K not contradicted by the ground truth, so this does not constitute an error. (2) The answer correctly identifies that biosimilar competition could begin after 2028 upon expiration of core composition patents, while the 2037 formulation patent provides a narrower, later-expiring barrier—this matches the original answer’s implication of partial protection into the late 2030s. (3) The comparison to AbbVie’s strategy is sound: the LLM correctly references AbbVie’s use of patent-term restoration and the 12-year BPCIA exclusivity (aligned with Hatch-Waxman and biologics regulatory frameworks), and infers that Pfizer should pursue similar lifecycle management tactics like new indications or extensions. (4) The reasoning is multi-hop, synthesizing patent expiration data for Enbrel with comparative strategy analysis of AbbVie’s approach, and drawing a logical conclusion about Pfizer’s strategic imperatives. The only minor limitation is that the original answer explicitly mentions DNA patent expiration in 2029, while the LLM refers to a 'method patent'—a slight entity discrepancy, but not a critical factual error given that method patents can cover related processes. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth with high completeness and strong reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 477,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How does the ethylene production capacity of ExxonMobil's Singapore facility compare to the ethylene manufacturing capacity that Chevron indirectly supports through its ownership stake in the Map Ta Phut Olefins joint venture in Thailand?",
      "original_answer": "ExxonMobil's Singapore facility has an ethylene production capacity of 1.9 million metric tons per year. Chevron indirectly owns a 32.77% stake in the Map Ta Phut Olefins Company Limited in Thailand, which manufactures ethylene, although the exact ethylene capacity attributable to Chevron is not specified in the evidence provided.",
      "llm_answer": "ExxonMobil’s Singapore chemical complex is reported to have an ethylene capacity of **1.9 million metric tons per year**【page_24】.  Chevron’s exposure to ethylene in Thailand comes from its **32.77 % ownership (20.27 % direct + 12.5 % indirect) of the Map Ta Phut Olefins joint‑venture**, which “manufactures propylene and ethylene”【page_15】, but the filing does not disclose the joint‑venture’s ethylene output.  Consequently, while ExxonMobil’s Singapore capacity is quantified, Chevron’s indirect ethylene capacity is not provided, so a direct numeric comparison cannot be made.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitative accuracy: The ethylene capacity of ExxonMobil's Singapore facility is correctly stated as 1.9 million metric tons per year, and Chevron's ownership stake (32.77%, broken into 20.27% direct and 12.5% indirect) in the Map Ta Phut Olefins joint venture is accurately reported. (2) Completeness: The answer addresses both parts of the multi-hop question—ExxonMobil’s capacity and Chevron’s indirect stake—and correctly notes that while ExxonMobil’s capacity is quantified, the ethylene output attributable to Chevron is not disclosed, making a direct comparison impossible. (3) Entity accuracy: All companies (ExxonMobil, Chevron, Map Ta Phut Olefins), locations (Singapore, Thailand), and metrics (ethylene capacity, ownership percentages) are correctly identified. (4) Reasoning: The multi-hop synthesis across entities and filings is sound—the model correctly infers that without the total ethylene capacity of the joint venture, Chevron’s attributable capacity cannot be calculated. (5) Semantic equivalence: The LLM conveys the same information as the original answer, with added clarity on the ownership breakdown and source references, without introducing any inaccuracies. All scores are maximized due to full factual correctness, precise numbers, logical reasoning, and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 381,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How does the financial impact of Southern Company's disallowance of capital investments at Nicor Gas in Illinois compare to the scale of infrastructure assets that NextEra Energy operates in the same state?",
      "original_answer": "Southern Company recorded a pre-tax charge of $96 million related to the disallowance of capital investments at Nicor Gas, which operates in Illinois and serves approximately 2.3 million customers across 34.7 thousand miles of gas pipelines. Meanwhile, NextEra Energy operates 90 thousand miles of transmission lines in Illinois, Indiana, Kentucky, New Hampshire, and New York combined, with Illinois being a part of this footprint. This comparison highlights the relative scale of infrastructure assets under regulatory scrutiny versus those actively operated by NextEra in the same state.",
      "llm_answer": "Southern Company recorded pre‑tax charges of about **$96 million** (≈$72 million after tax) tied to the disallowance of certain capital investments at Nicor Gas in Illinois【page_300】. In contrast, NextEra Energy’s Illinois footprint is a **physical‑asset scale** of roughly **90 miles of rate‑regulated transmission lines and five substations** (part of its “Other” transmission holdings)【page_16】—a non‑monetary, infrastructure‑quantity comparison to Southern Company’s $96 million financial hit.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. While it correctly states Southern Company's $96 million pre-tax charge related to Nicor Gas in Illinois, it grossly misrepresents NextEra Energy's infrastructure scale. The LLM claims NextEra operates '90 miles of rate-regulated transmission lines' in Illinois, but the ground truth states NextEra operates 90 thousand miles of transmission lines across multiple states, including Illinois. The LLM's figure is off by a factor of 1,000 (90 vs 90,000). Additionally, the mention of 'five substations' and characterizing this as Illinois-specific is unsupported by the original answer, which only notes that Illinois is part of a broader multi-state footprint. (2) Quantitative accuracy is severely compromised: $96 million is correct, but '90 miles' is incorrect (should be 90,000 miles), and the after-tax calculation of $72 million, while plausible, is not in the original answer and introduces unverified detail. (3) Multi-hop reasoning fails: the model does not correctly synthesize the relative scale—Nicor Gas has 34.7k miles of gas pipelines serving 2.3M customers, while NextEra’s electric transmission footprint is much larger in scale but spread across multiple states. The LLM incorrectly narrows NextEra’s asset to a tiny 90-mile footprint in Illinois, undermining the comparison. (4) Contextual relevance is moderate because the answer attempts the right comparison (financial impact vs. infrastructure scale), but the factual inaccuracies in key metrics render the conclusion misleading. The qualitative reasoning is flawed due to incorrect entity scaling and unsupported specifics about substations and rate regulation in Illinois.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 467,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "What percentage of KO's equity method investments as of December 31, 2021, was represented by its stake in CCEP, and how does this relate to CCEP's operational presence in Iceland, where COST also operates?",
      "original_answer": "KO owned approximately 19% of CCEP as of December 31, 2021. CCEP operates in Iceland, which is also a market where COST operates through its wholly owned subsidiaries. This shared presence in Iceland indicates both companies have exposure to the same geographic market, with KO indirectly participating in the Icelandic beverage market through its equity stake in CCEP, while COST directly operates retail warehouses there.",
      "llm_answer": "KO owned roughly **19 %** of Coca‑Cola Europacific Partners plc (CCEP) – that share of its equity‑method portfolio was disclosed for the December 31 2021 balance sheet【page_88】. CCEP’s bottling and distribution network includes **Iceland**, a country where Costco (COST) also runs membership‑warehouse operations【page_7】【page_63】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that KO owned approximately 19% of CCEP as of December 31, 2021, which matches the ground truth exactly. This figure is properly attributed to the equity-method investments and the correct date. (2) All numeric and date-related information is accurate—19%, December 31, 2021, and the operational presence in Iceland are all factually correct. Format variations (e.g., '19 %' with a thin space) do not affect meaning or accuracy. (3) The multi-hop reasoning is sound: the LLM connects KO’s equity stake in CCEP to CCEP’s operations in Iceland, then correctly notes that COST also operates in Iceland—this synthesizes information across entities (KO → CCEP → Iceland; COST → Iceland). The conclusion about shared market exposure is implied through this linkage. (4) The only minor shortcoming is that the LLM does not explicitly articulate the distinction between KO’s indirect exposure (via equity investment) and COST’s direct retail operations, which is present in the original answer. However, the key facts and logical connections are all present, making the answer semantically equivalent with only slight loss in explanatory depth. Thus, the answer is highly accurate, fully relevant, and correctly sourced with page references.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 357,
        "total_tokens": 1560
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How does Duke Energy's direct exposure to electricity price volatility compare with Southern Company's indirect exposure through its subsidiaries' ownership stake in PowerSouth, which receives 100 MW of capacity from Alabama Power under a 2021 agreement?",
      "original_answer": "Duke Energy directly manages exposure to electricity price volatility through fuel adjustment clauses, formula-based contracts, and hedging programs that defer cost differences as regulatory assets or liabilities. In contrast, Southern Company's exposure is indirect through its subsidiaries' ownership stake in PowerSouth, which receives 100 MW of year-round capacity service from Alabama Power starting in 2024 under a 2021 agreement. This arrangement, combined with a 10-year coordinated planning and operations agreement, allows Southern Company to mitigate some volatility through shared dispatch and cost-offsetting mechanisms, rather than direct hedging. While Duke Energy actively hedges its exposure using financial instruments, Southern Company's risk is mediated through contractual agreements and operational coordination with PowerSouth.",
      "llm_answer": "Duke Energy’s registrants are **directly exposed** to electricity‑price volatility because they buy and sell bulk‑power in the market and hold commodity‑derivative contracts to hedge those price swings (DUK 10‑K p. 179). Southern Company’s exposure is **indirect** – its subsidiaries own an 8.16 % stake in PowerSouth, which under a 2021 agreement receives a fixed ≈ 100 MW of year‑round capacity from Alabama Power, so Southern’s price risk is limited to that ownership interest and the contracted capacity rather than market‑based price fluctuations (SO 10‑K p. 17).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Duke Energy has direct exposure via market transactions and hedging (supported by DUK 10-K p.179), while Southern Company's exposure is indirect through its 8.16% stake in PowerSouth, which receives ~100 MW of capacity from Alabama Power under a 2021 agreement. The LLM correctly identifies the nature of the exposure and supporting mechanisms. (2) Quantitative accuracy is excellent: the 8.16% ownership stake, ~100 MW capacity, and correct citation of the 2021 agreement are all factually correct and consistent with the knowledge graph. The start year '2024' mentioned in the original answer is not contradicted but simply omitted in the LLM response—this is a minor completeness gap, not an error. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across Duke Energy’s direct hedging practices and Southern Company’s indirect exposure via subsidiary and contractual arrangements. It distinguishes financial hedging (Duke) from structural/contractual risk mitigation (Southern). (4) Semantic equivalence is strong—while the LLM does not mention 'fuel adjustment clauses' or 'coordinated planning agreement', it captures the core contrast in exposure type and risk management approach. The omission of minor contextual details (e.g., regulatory assets, 10-year coordination) prevents a perfect 10, but the central comparison is accurate and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 409,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How does the growth in Starbucks' store count in Taiwan compare to Nike's revenue contribution from the Greater China region, considering that Taiwan is included within the Greater China geographic segment?",
      "original_answer": "Starbucks reported a net increase of 21 stores in Taiwan from fiscal year 2021 to 2022, bringing its total store count in Taiwan to 544. Nike, which includes Taiwan within its Greater China segment, reported total revenues of $7.547 billion from that region in fiscal year 2022. Given that Greater China includes mainland China, Hong Kong, and Taiwan, Starbucks’ store presence in Taiwan is a component of the broader regional market that contributes to Nike’s revenue, though the specific revenue contribution from Taiwan alone is not disclosed by Nike.",
      "llm_answer": "Starbucks added 21 net stores in Taiwan during fiscal 2022, increasing the count from 523 to 544 – roughly a 4 % year‑over‑year rise (see the licensed‑store table for Taiwan). By comparison, Nike’s Greater China geographic segment – which includes Taiwan – generated about **$7.5 billion** in revenue in FY 2022 (see the segment‑revenue table for Greater China). Thus, Starbucks’ Taiwan expansion was modest in absolute terms (a few dozen stores), while Nike’s contribution from the same broader region was measured in billions of dollars.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct in all key aspects. It correctly states that Starbucks added 21 net stores in Taiwan in fiscal year 2022, increasing the total to 544, which aligns with the ground truth. The starting count of 523 (implied by 544 - 21) is accurate. The approximate 4% year-over-year growth is a reasonable calculation (21/523 ≈ 4.02%), though not mentioned in the original answer, it is a correct inference. Nike’s Greater China revenue is reported as $7.5 billion, which is a rounded version of the exact $7.547 billion in the ground truth—this minor rounding is acceptable under format variation. (2) All numbers are accurate or appropriately approximated. The store count change and total are exact. The revenue figure is rounded but within acceptable limits for financial reporting context. No calculation errors. (3) The multi-hop reasoning is sound: the model correctly identifies that Starbucks’ Taiwan store growth is a local operational metric, while Nike’s revenue from Greater China (which includes Taiwan) is a financial metric from a broader region. It appropriately contrasts scale (store count vs. revenue) and acknowledges the geographic inclusion. (4) The answer is semantically equivalent to the ground truth, conveying the same core information: Starbucks’ modest physical expansion in Taiwan versus Nike’s large revenue from the broader region that includes Taiwan. The only minor omission is not explicitly stating that Taiwan’s individual revenue contribution is not disclosed by Nike, but this does not detract significantly from the overall correctness. Scores reflect high accuracy with a small deduction in quantitative accuracy due to rounding without qualification, and qualitative accuracy for the slight omission in disclosure nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 488,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How do the supplier finance disclosures required by ASU 2022-04 affect the visibility of 3M's $0.3 billion in confirmed invoice obligations, and how does FedEx's adoption of the same standard compare in terms of transparency?",
      "original_answer": "ASU 2022-04 significantly enhances the visibility of 3M's supplier finance obligations, which stood at $0.3 billion as of December 31, 2024, by mandating detailed disclosures such as key terms, balance sheet presentation, and roll-forward information. This requirement was adopted by 3M starting in 2023, with full roll-forward reporting effective in 2024. Similarly, FedEx adopted ASU 2022-04 effective June 1, 2023, and also included disclosures related to its supplier finance program obligations. Both companies now provide stakeholders with clearer insights into their supplier finance activities, aligning their reporting practices under the new standard to enhance transparency.",
      "llm_answer": "ASU 2022‑04 obliges 3M to surface its supplier‑finance liability, so the company now notes that roughly $0.3 billion of confirmed invoices sit inside accounts payable and gives a high‑level roll‑forward of the year’s activity. FedEx’s disclosure under the same rule is more granular—showing the $94 million balance at year‑end, the $686 million of invoices confirmed and the $678 million paid (plus the $83 million opening balance and translation adjustments)—which makes the size and flow of its supplier‑finance program far more transparent than 3M’s aggregated figure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While the ground truth confirms 3M's supplier finance obligation at $0.3 billion as of December 31, 2024, the LLM correctly notes this figure but incorrectly implies it is current and fully compliant with ASU 2022-04 roll-forward requirements without specifying the adoption timeline (2023 adoption, 2024 full roll-forward). More critically, the LLM introduces FedEx-specific figures—$94 million year-end balance, $686 million confirmed, $678 million paid, $83 million opening balance—that are not present in the original answer and are unverified by the ground truth. These numbers suggest a level of detail not confirmed in the source, making them factually unsupported. (2) Quantitative accuracy is low because the FedEx numbers appear fabricated or misattributed; there is no mention in the ground truth of FedEx’s specific balances or flows. The $0.3 billion for 3M is correct, but the rest of the numerical claims fail verification. (3) The reasoning is partially sound in recognizing that ASU 2022-04 improves transparency and that FedEx may provide more detailed disclosures, but the multi-hop synthesis fails because it invents data for FedEx rather than relying on confirmed facts. The comparison in transparency is speculative and not grounded in the provided truth. (4) Contextual relevance is high because the answer addresses both companies and the impact of ASU 2022-04 on transparency, aligning with the question’s intent. However, correctness score is low due to unsupported numerical claims and incomplete alignment with the verified timeline and disclosure content.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 453,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How might the dual-class stock structures at CMCSA and META, particularly the 15-vote-per-share advantage for Class B stockholders at CMCSA and the 35% Class B voting power threshold for blocking change-of-control transactions at META, similarly expose minority shareholders to governance risks?",
      "original_answer": "At CMCSA, Class B common stockholders, led by Brian L. Roberts, hold 33⅓% of the combined voting power due to a 15-vote-per-share advantage, which can influence corporate decisions disproportionately relative to their economic stake. Similarly, at META, Class B stockholders control key governance decisions, including blocking change-of-control transactions, as long as they hold at least 35% of the combined voting power. Both structures concentrate decision-making authority in a small group, potentially undermining minority shareholder influence and making the companies less attractive to investors, which could depress stock valuations.",
      "llm_answer": "Both Comcast and Meta give a tiny group of insiders outsized voting power – Comcast’s single Class B holder gets 15 votes per share, which together with the 33 % voting‑power share of Class B stock lets him control the outcome of all shareholder votes (see CMCSA page 33), and Meta’s Class B shares retain at least 35 % of the combined voting power, a level that automatically blocks any change‑of‑control transaction unless the Class B holders approve it (see META page 50). Because the Class B votes dominate, ordinary Class A investors cannot meaningfully influence director elections, mergers or other key corporate actions, exposing them to governance risk that decisions may be made without their consent or in the interests of the controlling insiders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: CMCSA's Class B shares have a 15-vote-per-share advantage and hold 33⅓% of voting power (correctly rounded to 33%); META's Class B shares maintain at least 35% of combined voting power, sufficient to block change-of-control transactions. These numbers match the original answer exactly in substance, with acceptable rounding. (2) Quantitative accuracy is perfect: percentages and voting rights are correctly reported, and no calculations are erroneous. (3) The multi-hop reasoning is sound—LLM correctly synthesizes governance risks across two companies, identifying disproportionate control by insiders and the resulting marginalization of minority shareholders. It links both structures to reduced influence over director elections, mergers, and other key actions. (4) The only minor shortcoming is that the LLM does not explicitly name Brian L. Roberts or state that the concentration of power 'could depress stock valuations,' which appears in the original. However, the omission does not detract from the core governance risk explanation. Wording differs slightly but maintains semantic equivalence. Contextual relevance is excellent—the response directly addresses how both dual-class structures expose minority shareholders to similar risks.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 379,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What percentage of V's U.S. pension plan assets classified as Level 2 in 2022 consists of investments in collective investment funds, and how does this allocation strategy compare to COF's use of 'other securities' in terms of investment focus and yield profile?",
      "original_answer": "In 2022, V reported $319 million in collective investment funds under Level 2 assets, out of a total of $960 million in U.S. pension plan assets, representing approximately 33.2%. These funds are described as unregistered investment vehicles that commingle assets from multiple fiduciary clients to invest in portfolios of stocks, bonds, or other securities, including equity and debt instruments. In contrast, COF held $2,834 million in 'other securities' as part of its available-for-sale securities, with a weighted-average yield of 1.57%. While V's collective investment funds focus on diversified portfolios for institutional investors, COF's 'other securities' likely reflect a different risk-return profile given the lower yield and potentially different asset composition.",
      "llm_answer": "Visa’s U.S. pension plan held $733 million of Level 2 assets in 2022, of which $319 million were in collective‑investment funds – about **44 % of its Level 2 holdings** (319 ÷ 733 ≈ 43.5 %)【page_87】.  \n\nCapital One’s “other securities” are a separate investment‑security category that, as of 12/31/2021, produced modest yields ranging from **0.31 % (≤1 yr) to 1.86 % (5‑10 yr)** and an overall weighted‑average yield of roughly **1.5 %**【page_162】, indicating a more income‑focused, lower‑return allocation compared with Visa’s equity‑oriented collective‑fund strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It states that Visa's total Level 2 assets were $733 million, but the ground truth indicates total U.S. pension plan assets were $960 million, not $733 million. The $319 million in collective investment funds is correct, but the percentage calculation (43.5%) is based on an incorrect denominator. The correct percentage of total U.S. pension assets is ~33.2%, not 44%. The LLM incorrectly frames the percentage as a share of Level 2 assets rather than total U.S. pension assets, misrepresenting the scope. (2) For COF, the yield data (0.31% to 1.86%) and weighted average of ~1.5% are close to the ground truth (1.57%), so this part is approximately correct, though the date is cited as 2021 instead of 2022, introducing a minor time inconsistency. (3) The reasoning partially captures the multi-hop comparison: it contrasts V’s collective funds (implied equity/debt diversification) with COF’s income-focused 'other securities'. However, it fails to correctly contextualize V’s allocation as a percentage of total U.S. pension assets, undermining the core quantitative claim. (4) The contextual relevance is high because the answer addresses both companies, the correct metrics, and attempts a strategic comparison. Qualitative accuracy is moderate due to correct terminology and logical comparison framework, despite flawed inputs. Quantitative accuracy is low due to incorrect asset totals and miscomputed percentage. Correctness score is 5 due to partially correct numbers and reasoning but major error in key calculation and reference base.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 444,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How do Adobe's compliance costs related to Saudi Arabia's data localization laws compare to Microsoft's financial exposure from similar regulations, and what does this reveal about their respective cloud service strategies?",
      "original_answer": "Adobe faces significant compliance costs due to its global operations, including exposure to Saudi Arabia's data localization requirements, which could 'adversely impact our business and our enterprise customers' business, our financial condition and our results of operations in those jurisdictions' (ADBE_10k_2024.pdf). Saudi Arabia is explicitly mentioned as one of the jurisdictions implementing data localization requirements that mandate data to remain stored within national borders (MA_10k_2024.pdf). Microsoft discloses that such localization laws globally 'may require changes in services, business practices, or internal systems that result in increased costs, lower revenue, reduced efficiency' and specifically references compliance engineering costs that 'involve substantial expense and the diversion of engineering resources from other projects' (MSFT_10k_2024.pdf). The comparison reveals Adobe's vulnerability through its enterprise customer contracts in Saudi Arabia, while Microsoft faces broader systemic challenges due to its cloud infrastructure and AI services that rely heavily on cross-border data flows.",
      "llm_answer": "Adobe warns that meeting Saudi Arabia’s data‑localisation rules could “involve significant costs” that would cut revenue and profitability (Adobe 10‑K p. 30). Microsoft, on the other hand, flags that similar cross‑border data rules create “financial exposure” – including potential fines and higher compliance costs – that could affect its results (Microsoft 10‑K p. 29). Thus Adobe is budgeting for the operational expense of localising data to keep its cloud services viable in Saudi Arabia, while Microsoft is emphasizing risk‑management and the broader financial risk of regulatory non‑compliance across its global cloud platform.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, though it omits some key nuances in the comparative analysis of Adobe and Microsoft's cloud service strategies. (1) Factual correctness: The LLM accurately captures both companies' disclosures about compliance costs related to data localization, citing appropriate risks from their 10-Ks. While the exact quote from Adobe in the ground truth does not include the phrase 'involve significant costs' verbatim (it refers to adverse impacts on business and operations), the sentiment and meaning are consistent, and the reference to enterprise customer impact is implied. Microsoft's 'financial exposure' and compliance engineering costs are correctly characterized, though the LLM does not explicitly mention the diversion of engineering resources or the impact on AI and cross-border data flows, which are central to the strategic contrast. (2) Quantitative accuracy: There are no numerical figures in this question, so this dimension is satisfied by absence of error—no incorrect numbers or miscalculations. (3) Multi-hop reasoning: The LLM correctly synthesizes information from both companies' filings and draws a reasonable comparison—Adobe focusing on operational costs to maintain service viability, Microsoft on broader financial and systemic risks. However, it misses the deeper strategic implication in the ground truth: that Adobe’s exposure is tied to enterprise customer contracts in specific jurisdictions like Saudi Arabia, whereas Microsoft’s challenge is structural due to its global cloud and AI infrastructure. This weakens the qualitative depth of the comparison. (4) Contextual relevance: The response directly addresses the question’s two parts—compliance cost comparison and what it reveals about cloud strategies—and remains focused and relevant throughout. Minor omission of strategic depth prevents a perfect score, but overall the answer is factually sound and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 529,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does Duke Energy's divestiture of KO Transmission's pipeline facilities impact its FERC regulatory exposure, and how does this contrast with Southern Company's ongoing capital expenditure risks tied to FERC rule changes?",
      "original_answer": "Duke Energy Ohio divested all of KO Transmission's pipeline facilities on February 1, 2023, for approximately book value, which reduces its direct exposure to FERC-regulated interstate pipeline operations. This contrasts with Southern Company’s ongoing capital expenditure programs, which are subject to FERC rule changes that could materially affect construction costs and recovery of investments. Southern Company specifically notes uncertainty in recovering costs related to capital expenditures due to potential changes in FERC regulations. While Duke Energy has mitigated its FERC-related risk in the pipeline business through divestiture, Southern Company remains exposed to regulatory shifts that could impact its construction programs and cost recovery.",
      "llm_answer": "Duke Energy eliminated a FERC‑regulated asset when KO Transmission sold its 90‑mile interstate gas pipeline to Columbia Gas Transmission on Feb 1 2023, thereby reducing the company’s direct exposure to FERC oversight and related compliance risk (DUK 10‑K p. 18). In contrast, Southern Company’s 2024‑2028 capital‑expenditure program is expressly called out as being vulnerable to “changes in FERC rules and regulations,” which could raise costs or cause delays to its construction projects (SO 10‑K p. 104).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key event — Duke Energy's divestiture of KO Transmission's pipeline facilities on February 1, 2023 — which matches the ground truth date and action. It accurately states that this reduces Duke Energy’s direct FERC exposure, aligning with the original answer’s conclusion. The contrast with Southern Company is also correctly framed: Southern Company’s capital expenditure program (2024–2028) is highlighted as vulnerable to FERC rule changes affecting costs and project timelines, which reflects the original answer’s emphasis on uncertainty in cost recovery due to regulatory shifts. (2) Quantitatively, the date (Feb 1, 2023) is correct and matches the ground truth. While the LLM adds specificity — '90-mile interstate gas pipeline' and 'sold to Columbia Gas Transmission' — these details are consistent with public filings and do not contradict the ground truth (which focuses on the financial and regulatory outcome). The absence of 'book value' in the LLM answer is a minor omission but does not affect factual correctness. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (Duke Energy and Southern Company), two timeframes (divestiture in 2023 vs. future capex 2024–2028), and two types of FERC risk (direct operational exposure vs. regulatory impact on cost recovery). The logic linking divestiture to reduced FERC oversight and contrasting it with ongoing regulatory risk for Southern Company is coherent and well-supported. (4) The LLM answer conveys the same core information as the original, with slightly more operational detail and slightly less emphasis on financial terms like 'book value' or 'materially affect'. However, the semantic meaning and factual substance are equivalent. The answer is highly contextually relevant, directly addressing both parts of the question with precise citations to 10-K pages (though not required, they enhance credibility). Minor deduction in qualitative accuracy due to omission of 'book value' and slightly narrower phrasing of cost recovery risk, but overall excellent performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 575,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does the $2.7 billion in unfunded commitments to private debt and private equity funds reported by UPS compare to Caterpillar's allocation of $55 million in NAV-measured assets for its other postretirement benefit plans, in terms of liquidity and investment strategy?",
      "original_answer": "UPS reports $2.7 billion in unfunded commitments to private debt and private equity funds, which are illiquid and typically have redemption restrictions for 10–15 year terms, indicating a long-term investment horizon. In contrast, Caterpillar allocates $55 million in NAV-measured assets for its other postretirement benefits, which include less complex instruments like U.S. corporate bonds and short-term instruments, suggesting a more liquid and conservative investment approach. The difference highlights UPS's focus on alternative investments for long-term growth versus Caterpillar's preference for liquidity and stability in managing postretirement obligations.",
      "llm_answer": "UPS reports that it has unfunded commitments of roughly **$2.7 billion** to private‑debt and private‑equity limited‑partnership funds, which will be called over the next three‑to‑six years and can only be redeemed after 10‑15 years, making them a large, future‑cash‑outflow and highly illiquid component of its pension‑plan strategy【page_93】.  \n\nCaterpillar’s “other post‑retirement benefit” plans show only **$55 million** of assets measured at NAV, a modest, already‑funded exposure to alternative investments that is a small slice of its overall plan and therefore far more liquid relative to its size【page_102】.  \n\nThus, UPS’s commitment is orders of magnitude larger and far less liquid, reflecting a long‑term, illiquid private‑market strategy, whereas Caterpillar’s $55 million NAV allocation is a limited, comparatively liquid alternative‑asset position within its broader benefit‑plan portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $2.7 billion unfunded commitments by UPS and Caterpillar's $55 million NAV-measured assets, both of which match the ground truth exactly. These figures are presented with appropriate formatting variations (e.g., $2.7 billion vs $2.7 billion) that do not affect accuracy. (2) All numeric values are accurate—no calculations are required beyond comparison, and the relative scale ('orders of magnitude larger') is a reasonable interpretation of the 49x difference between $2.7B and $55M. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across two companies (UPS and Caterpillar), two types of benefit plans (pension vs other postretirement), and contrasts liquidity profiles and investment strategies. It accurately notes the 10–15 year redemption restrictions for UPS’s commitments and implies Caterpillar’s greater liquidity due to smaller, already-funded NAV assets. One minor shortcoming is that the LLM does not explicitly name the more liquid instruments in Caterpillar’s portfolio (e.g., U.S. corporate bonds, short-term instruments) as stated in the ground truth, instead generalizing them as 'comparatively liquid alternative-asset position.' This omission slightly weakens the qualitative completeness but does not invalidate the conclusion. (4) The answer is contextually fully relevant, directly addressing the comparison in terms of liquidity and investment strategy. The core facts, entities, and financial magnitudes are correct, and the reasoning supports the correct inference: UPS employs a long-term, illiquid alternative investment strategy, while Caterpillar takes a more conservative, liquid approach. Thus, the answer earns a 9/10 for correctness—very close to perfect, with only a minor detail missing in the qualitative description.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 498,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does Alphabet's selective repurchase of Class A and Class C shares, while retaining Class B shares with enhanced voting rights, contrast with Netflix's uniform voting rights structure, and what might this imply about Alphabet's governance strategy?",
      "original_answer": "Alphabet selectively repurchased $62.2 billion of Class A and Class C shares in 2023 while retaining Class B shares, which carry 10 votes per share, suggesting a strategy to maintain concentrated voting control. In contrast, Netflix provides one vote per share across all common stock, indicating a more egalitarian governance approach. This contrast implies that Alphabet's repurchase strategy may be designed to preserve the influence of stakeholders holding Class B shares, which could include insiders or long-term investors, rather than diluting their control through broader ownership.",
      "llm_answer": "Alphabet’s board authorizes repurchases only of its Class A shares (one vote each) and its non‑voting Class C shares, while the high‑voting Class B shares (ten votes per share) are left untouched 【page_81】. Netflix, by contrast, has a single class of common stock in which every share carries one vote 【page_61】. This suggests Alphabet is using its dual‑class structure to retain concentrated control in the hands of insiders (via Class B) while returning cash to the market through lower‑vote or non‑voting shares, whereas Netflix follows a one‑share‑one‑vote, more egalitarian governance model.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, while the LLM does not explicitly mention the $62.2 billion repurchase amount from 2023, this is the only missing numeric detail. However, the absence does not distort the factual picture, as the focus is on the structural aspect of the repurchases rather than the exact dollar figure. All other entities—Alphabet, Netflix, Class A/B/C shares, voting rights (1, 10, and 0 votes)—are correctly identified. (2) The LLM correctly notes that Class B shares (10 votes) are retained while repurchasing only Class A (1 vote) and Class C (non-voting), which matches the ground truth’s implication of preserving insider control. (3) The comparison to Netflix’s single class with one vote per share is accurate and properly cited, supporting the contrast in governance models. (4) The reasoning is sound: the LLM correctly infers that Alphabet’s strategy maintains concentrated control among insiders (e.g., founders or long-term holders of Class B shares), while Netflix adopts a more egalitarian, one-share-one-vote structure. The only minor shortcoming is the omission of the $62.2 billion figure and the specific year (2023), which slightly reduces completeness but does not affect the core correctness. Thus, the answer earns a 9 for correctness and qualitative accuracy, a 10 for quantitative accuracy (as no stated numbers are wrong, only one omitted), and full marks for contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 407,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the Tax Reform Act's GILTI provisions impact Coca-Cola's 2022 effective tax rate, and how does this compare to Philip Morris International's 2021 effective tax rate benefit from the corporate income tax reduction enacted in the Philippines where it operates and completed business combinations?",
      "original_answer": "The Tax Reform Act's GILTI provisions impacted Coca-Cola's 2022 effective tax rate by requiring the company to account for these taxes in the period subject to such tax, contributing to a $431 million net tax expense (4.4% impact on effective tax rate). For Philip Morris International, the corporate income tax rate reduction enacted in the Philippines in Q1 2021 contributed to a 0.1 percentage point decrease in its 2021 effective tax rate, which stood at 21.8%. This tax benefit occurred in a jurisdiction where PMI completed business combinations, including in the Philippines, as part of its global expansion strategy.",
      "llm_answer": "The Tax Reform Act’s GILTI rules forced Coca‑Cola to include foreign earnings in its U.S. return, which pushed its effective tax rate higher in 2022 (the effect is reflected in the full‑year provision)【page_107】. By contrast, Philip Morris International’s 2021 effective tax rate was helped by a corporate‑income‑tax reduction in the Philippines, which partially offset GILTI‑related costs and left its effective tax rate at 21.8% (a modest 0.1‑point increase)【page_94】.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details and direction of tax rate impact. It correctly identifies that Coca-Cola was negatively impacted by GILTI provisions in 2022 and that Philip Morris International (PMI) benefited from a tax rate reduction in the Philippines in 2021. However, it incorrectly states that the Philippines tax change led to a '0.1-point increase' in PMI's effective tax rate, when in fact it caused a 0.1 percentage point *decrease* (i.e., a benefit). This reverses the meaning and is a critical error. Additionally, the LLM omits the $431 million net tax expense and the specific 4.4% impact on Coca-Cola’s effective tax rate, instead vaguely stating the rate was 'pushed higher.' (2) Quantitative accuracy is low: the $431 million expense and 4.4 percentage point impact for Coca-Cola are missing; for PMI, the 0.1 percentage point *decrease* is misrepresented as an *increase*, which is factually wrong. The 21.8% effective tax rate for PMI in 2021 is correctly cited. (3) The multi-hop reasoning is partially sound—linking GILTI to Coca-Cola and Philippine tax changes to PMI—but fails in synthesis by misrepresenting the direction of the tax impact and omitting key figures. The mention of business combinations in the Philippines, present in the ground truth as part of PMI’s strategy, is missing. (4) Contextual relevance is high as the answer addresses both companies and the relevant tax events, but the incorrect characterization of the tax benefit as an 'increase' in the rate undermines the conclusion. Overall, the answer captures the general context but fails on key facts and numerical accuracy, warranting a mid-low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 474,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does the $3.1 billion in mortgage loans sold by BAC to GSEs in 2023 influence the risk exposure of MET's $12.392 billion portfolio of pass-through mortgage-backed securities, given that these securities are directly secured by mortgage loans serviced by institutions like BAC?",
      "original_answer": "BAC sold $3.1 billion in mortgage loans to GSEs in 2023, which are part of the broader pool of loans that can be securitized into pass-through mortgage-backed securities (MBS). MET holds $12.392 billion in such pass-through MBS as of 2023, which are directly secured by mortgage loans—often serviced by institutions like BAC. If BAC, as a servicer, experiences issues in fulfilling its obligations (e.g., due to cybersecurity incidents or servicing breaches), this could lead to disruptions in cash flows or increased credit risk for the underlying loans, which in turn affects the value and performance of MET’s pass-through MBS portfolio.",
      "llm_answer": "BAC reported that it sold about $3.1 billion of mortgage loans to the GSEs (primarily Freddie Mac) in 2023 【page_18】. MET’s RMBS schedule shows a $12.392 billion pass‑through mortgage‑backed‑securities portfolio that is “secured by a mortgage loan or collection of mortgage loans” and whose cash flows pass through the originating bank or an intermediary such as a servicing institution like BAC 【page_98】. Because the loans BAC sold are now guaranteed by the GSEs, the credit‑risk on that roughly 25 % slice of MET’s underlying loan pool is shifted to the GSEs, lowering MET’s exposure for those securities, while the remaining ~75 % of the portfolio remains subject to the performance of the loans still serviced by BAC.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several critical inaccuracies that undermine its correctness. (1) Quantitative Accuracy: While the $3.1 billion in mortgage loans sold by BAC and MET’s $12.392 billion MBS portfolio are correctly stated, the LLM incorrectly calculates that this represents ~25% of MET’s portfolio. There is no evidence in the ground truth or logical basis to claim that the $3.1 billion sold by BAC constitutes 25% of MET’s $12.392 billion portfolio—this is an unsupported inference. The ground truth does not state or imply any proportional relationship between BAC’s loan sales and the composition of MET’s portfolio. (2) Completeness: The question asks how BAC’s loan sales influence MET’s risk exposure. The LLM incorrectly frames the risk transfer as reduced due to GSE guarantees on the $3.1 billion, but the original answer emphasizes potential risk *increase* if BAC, as servicer, fails in its obligations (e.g., due to cybersecurity or servicing issues). The LLM misses this key risk channel entirely. (3) Entity Accuracy: BAC and MET are correctly identified, as are GSEs and the nature of pass-through MBS. The years (2023) are correct. (4) Reasoning: The multi-hop logic is flawed. The LLM assumes that because BAC sold loans to GSEs, those loans are now part of MET’s MBS pool and their risk is transferred—however, the ground truth does not establish that these specific $3.1 billion in loans are in MET’s portfolio. It only states that MET’s securities are secured by loans often serviced by institutions like BAC. The LLM incorrectly infers direct inclusion and proportional impact. (5) Semantic Equivalence: The LLM’s conclusion (reduced risk due to GSE guarantee) contradicts the ground truth (potential increased risk due to servicer dependence). This is a fundamental divergence in meaning, not just wording. The contextual relevance is moderate because it discusses the right entities and structure, but the reasoning and conclusion are factually misaligned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 532,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How does the valuation complexity of NKE's embedded derivatives, which result in Level 3 classification, compare to LOW's use of unobservable inputs for fair value measurements, particularly in terms of reliance on non-market-based assumptions?",
      "original_answer": "NKE disclosed $5 million in embedded derivatives as of May 31, 2022, which resulted in Level 3 classification due to the use of significant unobservable inputs such as extrapolation beyond observable limits and policyholder behavior assumptions. Similarly, Level 3 classifications—as described in MET_10k_2022—rely on non-market-based assumptions like actuarial inputs for policyholder behavior and mortality, which cannot be corroborated by observable market data. LOW, however, reported no material fair value measurements on a nonrecurring basis and emphasized that its financial assets and liabilities not measured at fair value on a recurring basis (such as long-term debt) primarily use observable inputs like quoted market prices or discounted cash flow analyses with incremental borrowing rates, indicating a lesser reliance on unobservable assumptions compared to NKE's Level 3 embedded derivatives.",
      "llm_answer": "Nike’s embedded foreign‑currency contracts are treated as separate derivatives and are classified in Level 3 because their fair‑value is derived from pricing models that rely on inputs that cannot be observed in active markets, requiring significant management judgment and non‑market‑based assumptions (see NKE 10‑K pages 85‑84). By contrast, Lowe’s fair‑value disclosures acknowledge that unobservable inputs are used only where market data are unavailable, but the company’s assets and liabilities are largely measured at Level 1 or Level 2 and it explicitly seeks to minimize reliance on non‑observable, non‑market assumptions (see LOW 10‑K page 55). Thus, Nike’s embedded derivatives involve a higher valuation complexity and greater dependence on unobservable assumptions than Lowe’s more limited use of such inputs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, no specific dollar amounts or dates are incorrectly stated; the LLM does not include the $5 million figure for NKE's embedded derivatives as of May 31, 2022, which is present in the original answer, but this omission does not distort the comparison and is not critical to the core reasoning. All other financial concepts (Level 3 classification, use of unobservable inputs) are correctly represented. (2) The LLM correctly identifies that NKE uses significant unobservable inputs (e.g., pricing models requiring management judgment) for its embedded derivatives, leading to Level 3 classification—consistent with the ground truth mentioning extrapolation beyond observable limits and policyholder behavior assumptions (though the latter is actually from MET, not NKE). There is a minor conflation: the policyholder behavior assumption is attributed to NKE in the original answer via MET’s example, but the LLM does not repeat this error and instead focuses on foreign currency contracts, which is accurate to NKE’s disclosures. (3) The comparison with LOW is sound: the LLM correctly states that LOW minimizes use of unobservable inputs, relies primarily on Level 1/2 measurements, and uses observable inputs like quoted prices or discounted cash flows—consistent with the original answer’s claim that LOW reported no material nonrecurring fair value measurements and uses incremental borrowing rates. (4) The reasoning correctly synthesizes multi-hop information: it contrasts NKE’s higher reliance on non-market-based assumptions with LOW’s limited use, concluding that NKE has greater valuation complexity—this matches the original answer’s conclusion. The only minor shortcoming is the absence of the specific $5M figure and the misattribution of policyholder behavior to NKE in the original (which the LLM avoids), but the LLM’s focus on foreign currency derivatives is factually correct. Overall, the answer is semantically equivalent, contextually relevant, and logically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 556,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "As defense industry peers managing significant pension assets, how do GD's and LMT's approaches to Level 3 asset valuations differ, given GD's use of valuation models with observable inputs for fixed-rate notes versus LMT's reliance on unobservable inputs for its $4,951 million private equity fund holdings?",
      "original_answer": "GD values its Level 3 assets, including fixed-rate notes, using valuation models that incorporate observable inputs such as interest rates and quoted prices for similar assets. In contrast, LMT's $4,951 million in private equity funds, which are also Level 3 assets, are valued using NAV based on valuation models that rely on unobservable inputs not corroborated by verifiable market data. This highlights a key difference in their fair value accounting methodologies for similar asset classifications, with GD relying on more market-validated inputs while LMT uses internally-derived assumptions for its private equity investments.",
      "llm_answer": "General Dynamics values its fixed‑rate notes with market‑based models that use observable inputs—interest‑rate curves, bond yields and quoted prices for similar securities—so the fair value is derived from market data (GD 10‑K p. 83). Lockheed Martin, by contrast, measures its $4.951 billion of private‑equity fund holdings at NAV using valuation models that rely on unobservable inputs that cannot be corroborated with market data, classifying those assets as Level 3 (LMT 10‑K pp. 87‑88).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: GD uses observable inputs (interest-rate curves, bond yields, quoted prices) for valuing fixed-rate notes, while LMT relies on unobservable inputs via NAV for its $4,951 million private equity fund holdings, both classified as Level 3. The dollar amount is correctly reported as $4.951 billion (equivalent to $4,951 million), and the use of NAV and unobservable inputs for LMT is accurately described. (2) Quantitative accuracy is perfect—$4,951 million is correctly rendered as $4.951 billion, and no calculations are required beyond accurate representation. (3) Multi-hop reasoning is sound: the model correctly synthesizes valuation methodologies from two different companies (GD and LMT), links them to their respective Level 3 asset types, and contrasts their use of observable vs. unobservable inputs. The citation of specific 10-K pages adds precision, though not required. (4) The only minor shortcoming is that the LLM does not explicitly state the broader implication highlighted in the original answer—namely, that this reflects a difference in fair value accounting methodologies for the same classification (Level 3), with GD using more market-validated inputs and LMT relying on internal assumptions. This contextual nuance is implied but not articulated, justifying a 9 instead of 10 on qualitative accuracy. Otherwise, the answer is factually complete, semantically equivalent, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 418,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How does the legal exposure from Slack's shareholder litigation, including the timeline and procedural history of the motion to dismiss, compare to Disney's recent antitrust litigation strategy involving motions to dismiss in the Biddle and Fendelander actions?",
      "original_answer": "Slack faced a multi-year shareholder litigation process beginning in 2019, with the motion to dismiss filed in January 2020, partial denial in April 2020, and eventual reversal by the Ninth Circuit on February 10, 2025, leading to dismissal with prejudice. In contrast, Disney filed motions to dismiss in both the Biddle and Fendelander actions on January 31, 2023, which were granted in part and denied in part by September 30, 2023. Disney then filed another motion to dismiss the consolidated amended complaint on December 1, 2023, which was also granted in part and denied in part on June 25, 2024. While Slack’s litigation reached the U.S. Supreme Court and resulted in a definitive dismissal, Disney’s antitrust cases remain ongoing with class certification deadlines set for March 27, 2026.",
      "llm_answer": "Slack’s shareholder suits began in September 2019 and the company filed a motion to dismiss the federal class‑action in January 2020; the district court granted the motion in part, the order was appealed to the Ninth Circuit, then to the U.S. Supreme Court, which vacated the Ninth Circuit’s decision in June 2023 and sent the case back for further briefing, and the Ninth Circuit finally issued a February 10 2025 opinion reversing the district court and dismissing the complaint with prejudice (page 91). By contrast, Disney’s antitrust actions were filed in November 2022 and Disney moved to dismiss both the Biddle and Fendelander cases on January 31 2023; the court partially granted and partially denied those motions on September 30 2023, consolidated the cases, and then partially granted a motion to dismiss the consolidated complaint on June 25 2024, leaving the litigation in its early stages with exposure still uncertain (page 116).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key dates and events are correct: Slack's litigation began in 2019 (specified as September 2019), motion to dismiss filed January 2020, Ninth Circuit reversal on February 10, 2025, and dismissal with prejudice—all match. Disney filed motions on January 31, 2023, partial grant/denial on September 30, 2023, second motion December 1, 2023 (LLM says December 1 implicitly via 'after consolidation'), and partial grant/denial on June 25, 2024—all correct. The mention of the Supreme Court vacating and remanding in June 2023 adds detail not in the original but is factually accurate and enhances precision. (2) Quantitative accuracy is perfect: all dates and procedural milestones are correct. (3) Multi-hop reasoning is sound—correctly compares timeline, procedural posture, and outcomes across two companies and multiple cases. Only minor omission: LLM does not explicitly state that Disney’s class certification deadline is March 27, 2026, which is included in the original answer and relevant to 'ongoing' status. However, stating the litigation is 'in its early stages' captures the essence. (4) Contextual relevance is excellent—directly addresses comparison of legal exposure, timeline, and motions to dismiss. Wording differs slightly but semantic equivalence is strong. One point deducted from correctness for missing the class certification deadline detail, which is part of the forward-looking exposure assessment.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 412,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does Intel's tax benefit from operations in Hong Kong compare to Apple's revenue contribution from the Greater China region, considering the inclusion of Hong Kong within Apple's Greater China reporting?",
      "original_answer": "Intel reported deriving effective tax rate benefits from operations in Hong Kong, where statutory tax rates range from 12.5% to 24.0%, as part of its broader non-US tax strategy. Meanwhile, Apple reported $74.2 billion in net sales from the Greater China region in 2022, which includes Hong Kong. This indicates that while Intel leverages Hong Kong for tax optimization, Apple generates significant revenue from the broader Greater China region, which encompasses Hong Kong.",
      "llm_answer": "Intel says that the tax advantage it gets from its Hong Kong operations is reflected in a roughly 5.9‑percentage‑point reduction in its effective tax rate for 2021 (the company’s effective tax rate fell to 8.5% from 16.7% a year earlier)【page_90】. By contrast, Apple’s Greater China segment – which explicitly includes Hong Kong – contributed about $74.2 billion of net sales in 2022【page_52】. Thus Intel’s Hong Kong benefit is a modest tax‑rate improvement, whereas Apple’s Greater China (including Hong Kong) generates a multi‑billion‑dollar revenue amount.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $74.2 billion net sales figure for Apple's Greater China region in 2022 is correct and matches the original answer. The Intel tax benefit is specified as a 5.9-percentage-point reduction in effective tax rate (from 16.7% to 8.5%) in 2021, which is a precise detail not present in the original answer but factually consistent with Intel's 10-K filing and adds value. While the original answer only mentions statutory tax rates in Hong Kong (12.5%–24.0%) and general tax strategy, the LLM provides a more granular, correct figure on actual impact. (2) The years differ slightly—Intel's data is from 2021, Apple's from 2022—but this is acceptable as the question does not require the same fiscal year, and the LLM correctly attributes each figure to the right company and context. (3) Entity accuracy is strong: both Intel and Apple are correctly identified, with proper metrics (tax rate benefit vs. net sales), and the inclusion of Hong Kong in Apple’s Greater China reporting is accurately noted. (4) The reasoning is sound: the LLM correctly contrasts Intel’s tax optimization (a cost-side benefit) with Apple’s revenue generation (an income-side contribution), highlighting the different business implications despite both involving Hong Kong. The only minor limitation is that the original answer emphasizes the statutory tax rate range in Hong Kong, which the LLM omits—but since the LLM provides more specific effective tax rate impact, this omission does not reduce correctness. Overall, the answer is factually superior to the ground truth in specificity and remains semantically equivalent in intent and conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 466,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does the 70% CO₂ emissions reduction target set by North Carolina's HB 951 impact Duke Energy's Carolinas Resource Plan, and how does this regulatory requirement compare with NextEra Energy's operational exposure in North Carolina?",
      "original_answer": "North Carolina passed HB 951 in 2021, directing the NCUC to develop and approve a carbon reduction plan targeting a 70% reduction in CO₂ emissions from Duke Energy Progress' and Duke Energy Carolinas' electric generation by 2030. In response, Duke Energy filed its 2023 Carolinas Resource Plan, recommending Portfolio 3 as the most prudent path forward, which includes retiring coal by 2035 and leveraging nuclear and energy storage to meet the emissions targets. Meanwhile, NextEra Energy operates in North Carolina, exposing it to the same regulatory environment, though it is not directly subject to HB 951. This creates a differentiated regulatory burden and transition pathway between the two companies in the same state.",
      "llm_answer": "The 70 % CO₂‑reduction goal in North Carolina’s HB 951 drives Duke Energy to structure its 2023 Carolinas Resource Plan around “Portfolio 3,” which emphasizes early retirement of coal, extensions of nuclear and pumped‑hydro capacity and expanded demand‑response and energy‑efficiency to meet the mandated emissions cuts 【page 71】. In contrast, NextEra Energy’s exposure in North Carolina is limited to a modest amount of generation assets (primarily a few wind projects) and is not subject to a comparable state‑mandated carbon‑reduction target, so its regulatory burden in the state is far smaller 【page 44】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 70% CO₂ reduction target in North Carolina's HB 951 and its impact on Duke Energy's 2023 Carolinas Resource Plan, specifically naming Portfolio 3 as the recommended path. It accurately notes Duke Energy's actions such as coal retirement and use of nuclear and energy storage (referred to as pumped-hydro, which is a subset of storage). However, the original answer specifies coal retirement by 2035, which the LLM omits. The LLM correctly states that NextEra Energy is not subject to HB 951 and has limited exposure via wind projects, aligning with the ground truth. (2) Quantitatively, the 70% reduction target and 2030 deadline are correctly stated. The LLM does not introduce any incorrect numbers or miscalculations. The reference to page numbers (71, 44) suggests source alignment but are not factually verifiable in this context; however, they don't detract from accuracy. (3) The multi-hop reasoning is sound: the LLM connects HB 951 to Duke’s resource planning and contrasts Duke’s regulatory obligations with NextEra’s lighter burden due to operational scale and exemption from the mandate. It correctly differentiates regulatory impact based on utility status in the state. (4) The answer is contextually relevant and addresses both parts of the question—Duke’s response and NextEra’s exposure. The slight deduction in correctness and qualitative accuracy is due to the omission of the 2035 coal retirement date and slightly narrower mention of 'pumped-hydro' instead of the broader 'energy storage' and nuclear extensions as in the original. Still, the core facts and synthesis are accurate, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 459,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How do MDLZ's use of weighted-average assumptions for measuring postretirement healthcare costs differ from KO's application of these assumptions in the Black-Scholes-Merton model for stock option valuation?",
      "original_answer": "MDLZ uses weighted-average assumptions to determine its net periodic postretirement healthcare costs, which resulted in costs of $14 million in 2021, $12 million in 2022, and a benefit of $5 million in 2023. These assumptions are applied to liability cash flows using spot rates along a yield curve to measure service and interest costs. In contrast, KO uses weighted-average assumptions as inputs in the Black-Scholes-Merton option-pricing model to estimate the fair value of stock options granted, which are then expensed on a straight-line basis over a four-year vesting period. The key difference lies in the financial valuation context: MDLZ applies the assumptions for postretirement benefit accounting, while KO uses them for equity compensation valuation.",
      "llm_answer": "MDLZ’s weighted‑average assumptions are actuarial inputs used to value post‑retirement health‑care obligations – they apply a discount rate (5.53 % for U.S. plans and 6.07 % for non‑U.S. plans in 2023) and a health‑care cost‑trend rate (7.00 % U.S., 5.98 % non‑U.S.) to project future benefit cash flows【page_107】. In contrast, KO’s weighted‑average assumptions are market‑based inputs for the Black‑Scholes‑Merton option‑pricing model – they use a dividend yield (≈3 %), expected volatility (≈17‑18 %), a risk‑free rate (4.1 % in 2023) and a 6‑year expected term to calculate the fair value of stock options【page_95】. Thus MDLZ’s assumptions drive actuarial cost estimates, while KO’s drive financial option valuation.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core distinction as the ground truth, with strong factual support. (1) Quantitatively, the LLM provides specific and correct assumptions used by both companies: MDLZ's 2023 discount rates (5.53% U.S., 6.07% non-U.S.) and healthcare trend rates (7.00% U.S., 5.98% non-U.S.), and KO's Black-Scholes inputs (dividend yield ~3%, volatility ~17-18%, risk-free rate 4.1% in 2023, 6-year expected term). These align with typical disclosures in 10-K filings, though the original answer does not include these granular inputs, so their presence in the LLM answer is a value-add rather than an error. However, the LLM omits the actual postretirement cost figures ($14M, $12M, -$5M) from MDLZ’s disclosures mentioned in the ground truth, which is a minor completeness gap. (2) The LLM correctly identifies the distinct financial contexts: actuarial valuation of postretirement healthcare costs for MDLZ vs. equity compensation valuation using Black-Scholes-Merton for KO. (3) Multi-hop reasoning is sound—correctly linking MDLZ’s assumptions to liability cash flows and KO’s to option pricing and expensing over vesting (though vesting period is not mentioned in LLM answer, it is implied in 'fair value of stock options'). (4) The semantic meaning matches the original: both emphasize the difference in application context (benefit accounting vs. equity compensation). The LLM enhances the answer with more detailed inputs but slightly underreports the outcome metrics (costs/benefits). Thus, high scores across all dimensions, with a 9 on correctness due to the omission of the dollar-amount results for MDLZ.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 450,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does JPMorgan Chase's exposure to derivatives under the Dodd-Frank Act compare to Bank of America's resolution planning obligations under the Orderly Liquidation Authority, particularly in terms of liquidity risk management during financial distress?",
      "original_answer": "JPMorgan Chase is subject to Dodd-Frank regulations that govern its use of derivatives through enforceable set-off and close-out netting provisions under ISDA Master Agreements, which are constrained by the Orderly Liquidation Authority (OLA) under Title II of Dodd-Frank. Similarly, Bank of America must submit resolution plans under the OLA that outline a 'single point of entry' strategy, restricting liquidity flows from subsidiaries to the parent company during financial distress. Both firms face regulatory constraints on liquidity: JPMorgan through enforceable netting limitations and Bank of America through intercompany liquidity contribution arrangements that prioritize subsidiary solvency over parent company funding needs.",
      "llm_answer": "JPMorgan Chase’s derivative exposure is managed through ISDA master‑netting agreements, collateral and the ability to set‑off receivables against payables under the Orderly Liquidation Authority provision of the Dodd‑Frank Act, which helps preserve liquidity if a counter‑party defaults 【page_261】. By contrast, Bank of America’s resolution‑planning under the Orderly Liquidation Authority obliges it to hold separate capital and liquidity buffers for key subsidiaries and may bar the parent from drawing on subsidiary funding when resolution becomes imminent, creating tighter liquidity constraints in a distress scenario 【page_13】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that JPMorgan Chase relies on ISDA master netting agreements, set-off rights, and collateral under the Orderly Liquidation Authority (OLA) to manage derivatives exposure and preserve liquidity during distress. Similarly, it accurately states that Bank of America’s resolution planning under OLA restricts the parent from accessing subsidiary liquidity in resolution, aligning with the 'single point of entry' strategy. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes how Dodd-Frank’s OLA impacts both firms differently—JPMorgan through netting and collateral mechanisms, and Bank of America through structural liquidity constraints across subsidiaries. The only minor omission is not explicitly naming the 'single point of entry' strategy for Bank of America, though the concept is clearly described (bar on parent drawing subsidiary funds). (4) The answer is contextually precise, directly addressing the comparison of liquidity risk management under distress for both institutions. Wording differs slightly from the original but maintains semantic equivalence. No factual inaccuracies—thus, a high correctness score of 9 is warranted.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 399,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does Ohio's continued reliance on coal influence the contrasting energy transition strategies of XOM and CVX, particularly considering XOM's European coal tax burden and CVX's 2024 renewable natural gas investments in the state?",
      "original_answer": "XOM faced a significant $1.8 billion after-tax charge in 2022 due to the EU's new tax on coal and other energy sectors, which targeted companies with surplus profits, signaling regulatory pressure to reduce fossil fuel dependency. Meanwhile, Duke Energy Ohio, a subsidiary operating in the state, held only $23 million in coal inventory as of December 31, 2024, suggesting a cautious but ongoing reliance on coal. In contrast, CVX made targeted investments in Ohio through Brightmark RNG Holdings LLC, achieving commercial operations at renewable natural gas projects in 2024, aligning with a cleaner energy transition. This divergence highlights how regulatory penalties in Europe are pushing XOM toward compliance, while CVX is proactively investing in low-carbon alternatives like RNG in coal-reliant states such as Ohio.",
      "llm_answer": "Ohio’s electricity system still leans on coal – Duke Energy Ohio reported $23 million of coal inventory in 2024 (up from $28 million in 2023)【page_124】.  That coal dependence makes ExxonMobil’s (XOM) exposure to the fuel costly: the EU’s 33 % “surplus‑profits” tax on coal‑related earnings imposed a $1.8 billion after‑tax charge in 2022 and a $0.2 billion charge in 2023【page_115】, reinforcing XOM’s incentive to de‑emphasize coal in its global portfolio.  By contrast, Chevron (CVX) is using Ohio’s coal‑heavy market as a launchpad for low‑carbon alternatives, adding renewable natural‑gas (RNG) projects – including Brightmark dairy‑biomethane facilities that began commercial operation in Ohio in 2024【page_19】 – to replace coal with cleaner gas as part of its energy‑transition strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is mostly correct in conveying the core contrast between XOM and CVX in response to Ohio's coal reliance and broader energy transition strategies. Key facts such as the $1.8 billion after-tax charge on XOM from the EU coal-related surplus profits tax in 2022 and CVX’s 2024 renewable natural gas (RNG) projects via Brightmark in Ohio are accurately reported. However, there is a quantitative error regarding Duke Energy Ohio’s coal inventory: the LLM states it was $23 million in 2024 (which matches the ground truth), but incorrectly claims it was $28 million in 2023 — this figure is not present in the ground truth and contradicts it by implying an increase, when no such comparison is supported. This introduces a minor factual inaccuracy. 2) The $1.8 billion 2022 charge is correct; the additional $0.2 billion charge in 2023 for XOM is plausible but not mentioned in the original answer, so its inclusion may reflect overextrapolation, though not necessarily incorrect. The 33% tax rate is contextually reasonable but not specified in the ground truth, so its inclusion without sourcing weakens quantitative precision. 3) The multi-hop reasoning is strong: the model correctly links Ohio’s ongoing coal use (via Duke Energy) to regulatory pressure on XOM in Europe and contrasts it with CVX’s proactive RNG investments in the same state, demonstrating sound synthesis across geographic and strategic dimensions. 4) The answer is semantically very close to the original, with only minor embellishments (e.g., 'dairy-biomethane facilities') adding detail not in the ground truth but not contradicting it. The core narrative — regulatory penalty pushing XOM vs. CVX investing in low-carbon alternatives in coal-reliant Ohio — is preserved and well-articulated. Thus, while the answer is highly accurate and contextually relevant, the unsupported claim about 2023 coal inventory and unverified 2023 charge and tax rate prevent a top score in quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 532,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How does the structure of MS's CLNs, which embed credit protection sold by the issuer, compare with JPM's credit-related notes in terms of payout mechanics upon a credit event, given that both instruments involve the transfer of credit risk on reference entities?",
      "original_answer": "Morgan Stanley structures CLNs as hybrid instruments where it purchases credit protection from the issuer, and if a credit event occurs with the reference entity, the principal balance of the note may not be repaid in full. JPMorgan, on the other hand, sells credit protection through credit-related notes, where the issuer pays the investor the difference between the par value and the fair value of the defaulted reference obligation upon a credit event. Both instruments transfer credit risk on reference entities, but MS acts as the buyer of protection while JPM often acts as the seller, affecting payout obligations differently based on their respective positions in the transaction.",
      "llm_answer": "Morgan Stanley’s CLNs are structured as funded notes in which the SPE **sells credit protection** to the firm; if a credit event occurs the SPE **delivers securities collateral** to Morgan Stanley, so the firm’s payout is the market value of those securities (which may be less than the original principal) 【page_129】.  \nJPMorgan’s credit‑related notes are also funded, but the **issuer purchases protection from the investor**; on a credit event the issuer does not repay the full par‑value but instead **pays a cash shortfall equal to the difference between the note’s par and the fair‑value recovery of the defaulted reference obligation** 【page_224】.  \n\nThus, CLNs settle a credit event with delivery of collateral securities, whereas JPM’s credit‑related notes settle with a cash payment of the shortfall.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in the characterization of Morgan Stanley's CLN structure, which directly impacts the correctness of the comparison. According to the ground truth, Morgan Stanley *purchases* credit protection from the issuer in its CLNs, meaning MS is the buyer of protection and thus receives a payout upon a credit event. However, the LLM incorrectly states that the SPE *sells* credit protection to Morgan Stanley, reversing the direction of the risk transfer and misrepresenting MS's position. This error fundamentally undermines the payout mechanics: the LLM claims MS receives securities collateral upon a credit event, but in reality, if MS is the buyer of protection, it would receive compensation when the reference entity has a credit event, not deliver or receive collateral in the manner described. The settlement mechanism described (delivery of securities collateral) does not align with standard CLN mechanics as implied in the ground truth. In contrast, the description of JPMorgan’s notes is largely accurate: the issuer (JPM) sells protection, and upon a credit event, pays the investor the shortfall between par and the recovery value. This matches the ground truth where JPM acts as the seller of protection. There are no numerical values in the question or answers, so quantitative accuracy is not applicable in a traditional sense, but the logical relationships and directional flows of payments are treated as qualitative facts. The LLM does attempt multi-hop reasoning by comparing two instruments across firms and describing payout mechanics, but the reversal of MS’s position breaks the synthesis. The contextual relevance is high because the answer addresses the right instruments and the core question of payout mechanics. However, due to the critical error in the risk transfer direction for MS, the qualitative and overall correctness scores are significantly reduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 521,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does the application of the reduced disclosure format differ between Georgia Power Company (a subsidiary of Southern Company) and Florida Power & Light Company (a subsidiary of NextEra Energy) in their respective 2022 Form 10-K filings, particularly in terms of their compliance with General Instruction I.(1)(a) and (b) of Form 10-K?",
      "original_answer": "Georgia Power Company, as part of Southern Company's consolidated 10-K filing, explicitly states that it meets the conditions in General Instructions I(1)(a) and (b) of Form 10-K and therefore uses the reduced disclosure format specified in General Instructions I(2)(b), (c), and (d). Similarly, Florida Power & Light Company also asserts compliance with General Instruction I.(1)(a) and (b), qualifying for the reduced disclosure format in its 2022 Form 10-K filing. However, while Georgia Power is one of multiple registrants in a combined filing with Southern Company, Florida Power & Light Company is one of only two registrants in its combined filing, the other being NextEra Energy, Inc., which holds all 1,000 shares of its common stock. Both companies file information only on their own behalf and disclaim responsibility for the other registrants’ data.",
      "llm_answer": "Both subsidiaries qualify for the reduced‑disclosure filing under General Instruction I.(1)(a) and (b). Georgia Power (a non‑accelerated filer) is listed among the Southern Company subsidiaries that “meet the conditions … and is therefore filing this Form 10‑K with the reduced disclosure format” in the combined Southern Company filing【page_4】, while Florida Power & Light (a smaller reporting company) is separately identified as meeting the same conditions and filing with the reduced format in the combined NextEra Energy filing【page_2】. Thus, the reduced‑disclosure format is applied in both cases, but Georgia Power does so as a non‑accelerated filer within a Southern Company combined 10‑K, whereas Florida Power & Light does so as a smaller reporting company within a NextEra Energy combined 10‑K.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that both Georgia Power Company and Florida Power & Light Company qualify for the reduced disclosure format under General Instruction I.(1)(a) and (b) of Form 10-K in their 2022 filings. The answer accurately notes that both are part of combined filings—Georgia Power within Southern Company’s and Florida Power & Light within NextEra Energy’s—and that each files only on its own behalf. The additional detail about Georgia Power being a non-accelerated filer and Florida Power & Light being a smaller reporting company is consistent with SEC categorizations and adds useful context not contradicted by the ground truth. The only minor omission is that the ground truth specifies Florida Power & Light’s common stock structure (1,000 shares held entirely by NextEra Energy, Inc.), which the LLM answer does not mention. However, this detail is not central to the question about application of the reduced disclosure format. All entities, instructions, and filing structures are correctly identified. There are no numerical inaccuracies (quantitative accuracy is perfect), and the reasoning correctly synthesizes multi-hop information across subsidiaries and parent companies. The answer is semantically equivalent to the original and highly relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 378,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does RTX's revenue recognition timing on U.S. government fixed-price contracts, influenced by FAR guidelines, compare to GD's cost allocation practices under the same regulatory framework, particularly in relation to performance-based payments and contract modifications?",
      "original_answer": "RTX recognizes revenue in excess of billings on U.S. government fixed-price contracts due to performance-based payments (PBPs) or progress payments, where the customer retains a portion of the contract price until completion. This practice is guided by the Federal Acquisition Regulation (FAR), which outlines allowable cost structures and payment mechanisms. Similarly, GD operates under the FAR and Cost Accounting Standards (CAS), which regulate cost allowability and allocation across contracts. GD's cost allocation practices are subject to audits and reviews by the government, ensuring that costs charged to contracts comply with FAR stipulations. Both companies must manage contract modifications and revenue or cost adjustments in response to FAR-mandated acquisition phases, including planning, competition, and contractor qualifications, though RTX specifically highlights the impact of these regulations on contract assets and liabilities, while GD emphasizes compliance and auditability under FAR and CAS.",
      "llm_answer": "RTX records revenue on U.S. government fixed‑price contracts as the performance obligations are satisfied, using performance‑based payments (PBPs) or progress payments that often cause revenue to be recognized before the customer bills and appear as contract‑asset balances; contract modifications are accounted for either on a cumulative catch‑up or prospective basis (RTX 10‑K p. 79). GD, by contrast, follows the FAR for cost allowability and the Cost Accounting Standards for allocating those allowable costs to contracts, billing as work progresses and adjusting the cost allocation when a contract is modified, rather than front‑loading revenue recognition (GD 10‑K p. 19; p. 64).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies RTX's revenue recognition practice on U.S. government fixed-price contracts, noting that revenue is recognized as performance obligations are satisfied, often leading to revenue in excess of billings (recorded as contract assets), driven by performance-based or progress payments—consistent with FAR guidelines. It also accurately notes that contract modifications are accounted for on a cumulative catch-up or prospective basis, citing RTX’s 10-K page 79. For GD, it correctly states that the company follows FAR for cost allowability and Cost Accounting Standards (CAS) for cost allocation, with billing occurring as work progresses and cost allocations adjusted upon contract modification, citing GD’s 10-K pages 19 and 64. (2) There are no numeric values in the question or answers requiring verification; thus, quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (RTX and GD), two regulatory frameworks (FAR and CAS), and two accounting practices (revenue recognition vs. cost allocation), drawing a clear contrast in timing and methodology under the same regulatory umbrella. (4) The LLM omits minor contextual details present in the original answer—such as government audits of GD’s cost allocations or RTX’s emphasis on contract assets/liabilities in relation to FAR acquisition phases—but the core factual comparison is correct and semantically equivalent. The inclusion of specific 10-K page references enhances credibility. No factual errors; only slight incompleteness prevents a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 461,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does the difference in voting rights structure between Class A and Class B shares at GOOGL compare to CMCSA's disclosure regarding its lack of voting rights in Atairos, and what implications does this have for corporate governance control in both entities?",
      "original_answer": "At GOOGL, Class A shares carry one vote per share while Class B shares carry ten votes per share, creating a dual-class structure that concentrates voting power among holders of Class B shares. This structure allows certain shareholders to maintain control over corporate decisions despite owning a minority of shares. In contrast, CMCSA explicitly discloses that it has no voting rights in Atairos, which is accounted for as an equity method investment, limiting its influence over Atairos’s operations. While GOOGL uses differentiated voting rights to preserve control through a structured share class system, CMCSA lacks such control mechanisms entirely in its investment in Atairos, affecting its corporate governance influence in that entity.",
      "llm_answer": "Alphabet’s capital structure gives each Class A share one vote and each Class B share ten votes (Class C has none)【page_82】, concentrating voting power and board‑level control in the hands of the relatively few Class B holders.  By contrast, Comcast’s investment in Atairos carries no voting rights – its economic interest “does not carry voting rights” and it “does not have the power to direct” the VIE’s activities【page_84】【page_85】.  Thus, Alphabet’s dual‑class shares enable a small group to dominate corporate governance, whereas Comcast’s stake in Atairos provides only economic exposure with no ability to influence governance decisions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all key facts are correct: Class A shares have one vote, Class B have ten votes at GOOGL; CMCSA has no voting rights in Atairos. The mention of Class C shares with no votes, while not in the original answer, is factually accurate and adds context without distorting the truth. (2) The citations to 'page_82', 'page_84', 'page_85' suggest document grounding, though their presence doesn't affect factual scoring. (3) The multi-hop reasoning is sound: it correctly contrasts GOOGL’s dual-class voting structure (concentrating control) with CMCSA’s lack of voting rights in Atairos (limiting governance influence). (4) The answer fully addresses both parts of the question: the structural comparison and the implications for corporate governance. The only minor shortcoming is slightly less explicit emphasis on the 'minority control' aspect at GOOGL compared to the original, but the implication is clearly conveyed through 'concentrating voting power' and 'dominate corporate governance'. Thus, the answer is semantically equivalent, with excellent reasoning and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 335,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does Amgen's reliance on McKesson Corporation for 33% of its gross product sales in 2021 compare to Merck's risk disclosures about pharmaceutical product distribution concentration, given Amgen's specific exposure to wholesaler distribution risks outlined in its 2022 filing?",
      "original_answer": "Amgen's 2022 filing reveals that McKesson Corporation accounted for 33% of its gross product sales in 2021, highlighting a significant dependency on a single wholesaler. This concentration risk is explicitly acknowledged in Amgen's disclosure that the substantial majority of its U.S. product sales are made to just three distributors, including McKesson, and that financial or operational difficulties at any of these could significantly disrupt its business. Merck's 2022 filing similarly warns that 'pharmaceutical products can develop unexpected safety or efficacy concerns' and that 'reliance on third-party relationships and outsourcing arrangements could materially adversely affect the business,' reinforcing the industry-wide sensitivity to distribution chain vulnerabilities. Together, these disclosures underscore the material financial and operational risk both companies face from overreliance on a concentrated pharmaceutical distribution network.",
      "llm_answer": "Amgen’s 2022 filing shows that McKesson accounted for 33 percent of Amgen’s gross product sales in 2021 and warns that a problem with a major wholesaler (e.g., financial distress or insolvency) could materially disrupt its business (see page 46 and the McKesson sales table on page 113). In contrast, Merck’s 10‑K only contains a generic risk statement that it is “reliant on third‑party relationships and outsourcing arrangements” (see page 31) and does not quantify any single distributor’s share, making Merck’s disclosure of distribution concentration far less specific than Amgen’s explicit, quantified exposure.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its quantitative claims: Amgen's 2022 filing does state that McKesson accounted for 33% of its gross product sales in 2021, and this figure is correctly cited. The reference to page 113 for the sales table and page 46 for the risk disclosure aligns with typical 10-K structures, though exact page numbers may vary by filing version. The entity names (Amgen, Merck, McKesson), time period (2021 sales, 2022 filings), and metric (gross product sales) are all correct. The reasoning correctly identifies that Amgen provides a specific, quantified concentration risk while Merck’s disclosure is more generic, which is consistent with the ground truth. However, the LLM answer omits a key point from the original answer: Merck’s additional risk disclosure about 'unexpected safety or efficacy concerns' in pharmaceutical products, which the ground truth uses to draw a broader industry comparison. While the core comparison on distribution concentration is valid and well-reasoned, this omission reduces completeness in the multi-hop synthesis between the two companies’ risk profiles. The answer is highly contextually relevant and conveys a substantively correct, though slightly less comprehensive, interpretation of the comparative risk disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 358,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "What is ConocoPhillips' financial exposure from its ownership in Alba Plant LLC, given Chevron's production of condensate and the plant's role in processing natural gas from the Alba Unit in Equatorial Guinea?",
      "original_answer": "ConocoPhillips has a 56.0% ownership interest in EG LNG and a 52.2% interest in Alba Plant LLC, which processes natural gas from the Alba Unit and extracts condensate and LPG for sale at market prices. According to COP's 2024 10-K, ConocoPhillips has $116 million in maximum potential future payments related to guarantees for Alba Plant LLC’s agreements to process third-party gas. This exposure is tied to Chevron’s upstream production of condensate, which feeds into the Alba Unit’s gas stream, and the downstream monetization through the LPG plant and EG LNG’s liquefaction facility.",
      "llm_answer": "ConocoPhillips’ only quantified exposure to its 52.2 % stake in Alba Plant LLC is the guarantee it has issued for the joint‑venture – it could be called on for as much as **$116 million** in future payments, with a recorded carrying value of roughly **$4 million** at December 31 2024【page_102】. This exposure reflects the plant’s role in processing natural gas from the Alba Unit (and extracting condensate that Chevron also produces) under a fixed‑rate contract.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: $116 million maximum potential future payments and $4 million carrying value (implied in LLM answer as 'recorded carrying value') are consistent with typical disclosures in 10-K filings, and the 52.2% ownership in Alba Plant LLC is accurately stated. The reference to page 102 supports the sourcing. (2) The LLM correctly identifies the key financial exposure—guarantees tied to Alba Plant LLC—and links it to ConocoPhillips’ ownership stake. (3) The multi-hop reasoning is sound: it connects ConocoPhillips’ ownership, the financial guarantee, the plant’s role in processing gas from the Alba Unit, and the relevance of condensate production (noted as also produced by Chevron). While the original answer explicitly names EG LNG (56.0% ownership) and ties in downstream monetization via EG LNG’s liquefaction, the LLM answer focuses narrowly on Alba Plant LLC, which is the focus of the question. The mention of a 'fixed-rate contract' is a minor addition not in the original but plausible and not contradicted. (4) The only slight gap is the omission of EG LNG’s role in the broader monetization chain, but since the question specifically asks about exposure from Alba Plant LLC, this does not detract significantly from correctness. Overall, the answer is factually precise, contextually relevant, and synthesizes the required multi-hop information accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 406,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How does the use of valuation models incorporating observable market inputs by General Dynamics' Level 2 assets compare with Union Pacific's disclosure of real estate funds at NAV, given that real estate funds are typically valued using unobservable inputs over 8-10 year terms?",
      "original_answer": "General Dynamics values its Level 2 fixed-income assets using valuation models with observable inputs like interest rates and bond yields, contrasting with Union Pacific's $30 million allocation to real estate funds that are valued at NAV based on unobservable inputs according to LMT's explanation of real estate fund valuation practices which involve long-term valuations over 8-10 year periods.",
      "llm_answer": "General Dynamics’ Level 2 assets are measured using a market‑approach valuation model that incorporates observable inputs such as interest‑rate curves, bond yields and quoted prices for comparable securities (Lockheed Martin 10‑K p. 84‑85). Union Pacific, however, values its real‑estate funds at net‑asset value based on valuation models and periodic appraisals that rely on unobservable inputs and have typical terms of eight‑to‑ten years (Union Pacific 10‑K p. 88). Thus, GD’s Level 2 valuations are grounded in readily observable market data, while Union Pacific’s real‑estate NAV valuations depend on less observable, longer‑term assumptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: General Dynamics uses observable market inputs (e.g., interest rates, bond yields) for Level 2 assets, and Union Pacific values its real estate funds at NAV using unobservable inputs over 8-10 year terms. The dollar amount ($30 million) from the original answer is missing in the LLM response, which is a minor omission but does not undermine the core comparison. (2) No numerical calculations are required, and all referenced inputs (8-10 year terms, use of unobservable inputs) are correctly stated. Format variations are acceptable and not an issue. (3) The multi-hop reasoning is sound—correctly linking General Dynamics’ valuation approach (via Lockheed Martin’s 10-K as source) with Union Pacific’s real estate fund disclosures, and contrasting observable vs. unobservable inputs. The synthesis across companies and valuation methodologies is logically presented. (4) The answer is contextually relevant, directly addressing the comparison between Level 2 valuation practices and NAV-based real estate fund valuation. The only reason for not scoring a 10 is the omission of the specific $30 million figure from Union Pacific’s allocation, which was present in the original answer and adds quantitative precision. Otherwise, the reasoning, entity identification, and semantic equivalence are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 390,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "Given Citibank's co-branding role in Costco's credit card program and its administrative role in Colgate's five-year credit agreement, how does the nature of Citibank's involvement differ in these two financial arrangements?",
      "original_answer": "Citibank's involvement with Costco is characterized by a co-branded credit card program that has undergone twelve amendments since 2015, most recently on October 11, 2023, indicating an ongoing consumer financial product partnership. In contrast, Citibank's role with Colgate is as administrative agent and arranger for a five-year credit agreement most recently amended on November 4, 2022, which represents a corporate lending facility rather than a consumer credit product. The Costco relationship centers on a retail financial service partnership while the Colgate arrangement involves managing a syndicated corporate credit facility.",
      "llm_answer": "Citibank’s role with Costco is that of a co‑branded credit‑card partner – it issues and services the Costco‑branded consumer credit cards under a “Citibank, N.A. Co‑Branded Credit Card Agreement” (see Exhibit 10.8)【page_68】. In the Colgate arrangement, Citibank is not a card issuer but serves as the “Administrative Agent and Arranger” for Colgate’s five‑year corporate credit facility (see the Amended and Restated Five‑Year Credit Agreement)【page_67】. Thus, with Costco Citibank is a co‑branding, consumer‑card provider, whereas with Colgate it is a loan‑administration intermediary handling the structuring and ongoing management of a corporate loan.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Citibank's role in the Costco relationship is accurately described as a co-branded credit card partnership involving consumer credit products, while its role with Colgate is correctly identified as Administrative Agent and Arranger for a five-year corporate credit facility. The distinction between consumer financial services (Costco) and corporate lending (Colgate) is clearly and correctly articulated. (2) There are no numeric values, dates, or financial figures in the LLM answer that conflict with the ground truth; while the ground truth mentions specific amendment dates (October 11, 2023 for Costco, November 4, 2022 for Colgate) and the number of amendments (twelve since 2015), the LLM answer does not include these details. However, since the question does not explicitly ask for dates or amendment counts, their omission does not constitute a critical error but represents a minor gap in completeness. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two distinct financial arrangements (retail co-branding vs. corporate credit facility) and draws a valid contrast in the nature of Citibank’s involvement. (4) Semantic equivalence is strong—wording differs but meaning aligns closely with the original answer. The use of terms like 'co-branded credit-card partner' and 'loan-administration intermediary' effectively captures the essence of the two roles. The inclusion of exhibit references (e.g., Exhibit 10.8) adds precision and sourcing, enhancing credibility. Final scores reflect high accuracy with a slight deduction in qualitative accuracy due to the omission of amendment history, which provides context about the ongoing nature of the Costco relationship, though it does not undermine the correctness of the core comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 515,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "What is Chevron's net daily crude oil production contribution from its stake in QatarEnergy LNG, considering the average daily net production and Chevron's ownership percentage in 2023?",
      "original_answer": "Chevron's net daily crude oil production from its stake in QatarEnergy LNG in 2023 was 3.9 MBD (thousand barrels per day), calculated as 30% ownership of the 13 MBD average daily net crude oil production from QatarEnergy LNG.",
      "llm_answer": "Chevron does not own a working interest in the QatarEnergy LNG (N3) joint venture – the 2023 filing shows the venture is owned by QatarEnergy (68.5 %), ConocoPhillips (30 %) and Mitsui (1.5 %) with no Chevron stake listed【page_12】. Because Chevron’s ownership percentage is effectively 0 %, its net daily crude‑oil contribution from QatarEnergy LNG is 0 million barrels per day.",
      "correctness_score": 0,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 1,
      "detailed_feedback": "The LLM answer is completely incorrect and contradicts the ground truth. (1) The original answer states that Chevron has a 30% ownership stake in QatarEnergy LNG, resulting in a net daily crude oil production of 3.9 MBD (30% of 13 MBD). However, the LLM claims Chevron has no stake, asserting ownership by QatarEnergy (68.5%), ConocoPhillips (30%), and Mitsui (1.5%) with no mention of Chevron. This directly conflicts with the ground truth. (2) Quantitatively, the LLM reports 0 million barrels per day, which is factually wrong per the correct calculation of 3.9 MBD from 30% of 13 MBD. The numbers and percentages are entirely inaccurate. (3) The reasoning is flawed: the LLM fails to perform the correct multi-hop synthesis—Chevron’s ownership percentage and its application to average daily production—and instead incorrectly asserts zero ownership without supporting the claim against the known truth. (4) Contextual relevance is minimal because the answer misidentifies key entities (ownership structure) and provides a confidently incorrect conclusion. The citation of 'page_12' does not override the established ground truth from the knowledge graph, which reflects actual filing data. The LLM likely hallucinated or misread the ownership structure, leading to a fully incorrect response.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1160,
        "completion_tokens": 360,
        "total_tokens": 1520
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How does Caterpillar's use of pricing models for valuing Level 3 non-U.S. pension assets compare to Lockheed Martin's valuation methodology for fixed income investments categorized as Level 3, particularly in terms of the inputs and approaches used?",
      "original_answer": "Caterpillar values its Level 3 non-U.S. pension assets, which include insurance contracts, using pricing models that reflect management's judgment of assumptions a market participant would use. In contrast, Lockheed Martin categorizes fixed income investments as Level 3 when observable inputs are unavailable and uses discounted cash flow approaches or indicative quotes from vendors and brokers, with significant inputs including projected annuity payments and discount rates. Both companies rely on unobservable inputs for Level 3 assets, but Caterpillar focuses on pricing models based on management assumptions, while Lockheed Martin employs a broader set of valuation techniques including discounted cash flows and third-party indicative quotes.",
      "llm_answer": "Caterpillar’s Level 3 non‑U.S. pension assets are primarily insurance contracts, and the company values them with internal pricing models that incorporate the assumptions a market participant would use (e.g., market‑based insurance‑pricing factors, inflation and interest‑rate assumptions). Lockheed Martin’s Level 3 fixed‑income investments, by contrast, are valued mainly from indicative quotes or bid evaluations from vendors or brokers, and for some securities a discounted‑cash‑flow approach is used that relies on projected annuity‑type cash flows and a discount rate. Thus, Caterpillar leans on model‑driven market‑participant assumptions, while Lockheed Martin depends on external price quotes and cash‑flow‑discounting inputs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: Caterpillar uses internal pricing models based on management's judgment of market-participant assumptions for its Level 3 non-U.S. pension assets (insurance contracts), while Lockheed Martin uses indicative quotes from vendors/brokers and discounted cash flow models for its Level 3 fixed income investments, relying on inputs like projected annuity payments and discount rates. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a traditional sense—however, the absence of any numerical inaccuracies supports a score of 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes valuation methodologies across two different companies, asset types, and input categories. It accurately contrasts Caterpillar’s model-driven, assumption-based approach with Lockheed Martin’s use of external quotes and cash flow models. (4) The only minor shortcoming is that the LLM slightly downplays the emphasis in the original answer on 'unobservable inputs' as a commonality between both firms—though this is implied, it is not explicitly stated. Otherwise, the semantic meaning, entity accuracy (Caterpillar, Lockheed Martin, Level 3 assets, non-U.S. pension assets, fixed income), and contextual relevance are fully preserved. The answer directly addresses the comparison in inputs and approaches as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 413,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How might the expiration of Enbrel's formulation patents in 2037 impact Pfizer's Specialty Care segment revenue concentration risk, especially considering Bristol Myers Squibb's external innovation strategy focused on future pipeline assets?",
      "original_answer": "Enbrel remains a key product in Pfizer's Specialty Care segment, where it is listed among major inflammation & immunology offerings. The expiration of its formulation patents in 2037 could expose Pfizer to increased generic competition, potentially exacerbating revenue concentration risk if other pipeline or partnered products have not sufficiently diversified the segment's portfolio by then. Meanwhile, Bristol Myers Squibb's external innovation strategy, which emphasizes acquiring and developing disruptive therapies beyond internal R&D, may position it to enter the post-patent market with new assets, assuming favorable clinical and regulatory outcomes. This dynamic could shift competitive positioning in the inflammation & immunology space if BMY successfully brings alternative therapies to market ahead of the 2037 timeline.",
      "llm_answer": "Enbrel’s formulation patents run out in 2037 (Pfizer 10‑K p. 10), which will invite biosimilar entry and cut the drug’s share of the Specialty Care (inflammation & immunology) revenue mix. Although the loss of a single, high‑earning product can lower the segment’s reliance on Enbrel, it also creates a revenue gap that must be filled; if Pfizer’s pipeline does not replace those sales, the Specialty Care segment could become more dependent on a smaller set of remaining products, a risk amplified by Bristol‑Myers Squibb’s external‑innovation strategy that is targeting new immunology pipeline assets (BMS 10‑K pp. 9‑13) and thus heightening competitive pressure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Enbrel's formulation patent expiration in 2037 is accurately cited, and the impact on Pfizer's Specialty Care segment—specifically the risk of revenue concentration due to potential revenue gaps and reliance on fewer products—is correctly interpreted. The mention of biosimilar entry post-patent expiration is consistent with industry dynamics and adds context not in the original but is factually sound. (2) Quantitative accuracy is perfect: the date 2037 is correctly stated, and no other numbers (e.g., revenue figures) are claimed, so there are no discrepancies. Format and citation (Pfizer 10-K p.10, BMS 10-K pp.9-13) support accuracy, though exact page numbers are not part of the knowledge graph truth, they do not contradict it. (3) Multi-hop reasoning is strong: the answer synthesizes Enbrel’s patent cliff, its effect on revenue concentration risk (not just decline but potential shift in dependency), and connects it to Bristol Myers Squibb’s external innovation strategy in immunology, correctly identifying that BMS’s pipeline-focused approach could increase competitive pressure. This mirrors the original answer’s logic about BMS potentially entering the market with new assets. (4) Semantic equivalence is high: while the LLM frames the risk slightly differently—emphasizing that reduced reliance on Enbrel could paradoxically increase concentration risk on fewer remaining products—it captures the nuanced dynamic in the ground truth. The only minor gap is that the original emphasizes BMS’s potential to shift competitive positioning *by bringing alternatives to market before 2037*, which the LLM implies but does not explicitly state. This slight omission prevents a perfect 10, but the core reasoning and facts are sound. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 522,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How do AIG's market risk stress testing practices compare with COF's credit loss forecasting methods in terms of their reliance on scenario-based modeling and sensitivity analysis?",
      "original_answer": "AIG employs stress testing as part of its market risk management to evaluate the impact of adverse market developments, including through sensitivity analysis and scenario analysis, which are aligned with its corporate risk appetite. This includes analyzing the effects of hypothetical shocks to interest rates, credit spreads, and equity prices. On the other hand, COF uses scenario-based forecasting models to estimate its allowance for credit losses (ACL), which totaled $13.0 billion as of December 31, 2024, incorporating both quantitative forecasts and qualitative adjustments for current and forward-looking economic conditions. Both firms rely on scenario and sensitivity analysis, but AIG applies these techniques to market risk exposures while COF integrates them into credit risk modeling for consumer loan portfolios.",
      "llm_answer": "AIG’s market‑risk framework is built around explicit scenario‑based and sensitivity‑based testing – it “uses a number of approaches to measure market risk exposure including sensitivity analysis, scenario analysis and stress testing” (AIG p. 82‑83) and quantifies the impact of defined shocks (e.g., a 10 % decline in equity values, 100‑bp yield‑curve moves) in its sensitivity tables (AIG p. 84). In contrast, Capital One’s credit‑loss methodology for its credit‑card portfolio relies on quantitative loss‑forecasting models and qualitative judgment of economic conditions, rather than formal scenario or sensitivity analyses (“the allowance…represents management’s current estimate…based upon various statistical analyses…and a qualitative element…judgment of current and forward‑looking conditions”) (COF p. 135). Thus, AIG’s stress testing is heavily scenario‑ and sensitivity‑driven, whereas COF’s credit‑loss forecasting is model‑ and judgment‑driven with limited explicit use of scenario‑based or sensitivity analysis.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct in its description of AIG's market risk practices, accurately noting the use of scenario analysis, sensitivity analysis, and stress testing with specific examples (e.g., 10% equity decline, 100-bp yield curve moves), which aligns with the ground truth. The quantitative accuracy is high—no numbers are incorrect, and the references to page numbers and hypothetical shocks are consistent with typical disclosures. However, the LLM incorrectly characterizes COF's credit loss forecasting as not using scenario or sensitivity analysis. The ground truth explicitly states that COF *does* use scenario-based forecasting models for its allowance for credit losses (ACL), incorporating forward-looking economic conditions—this is a core component of CECL (Current Expected Credit Loss) modeling, which is scenario-driven. The LLM contradicts this by claiming COF relies only on 'model- and judgment-driven' methods with 'limited explicit use' of scenario or sensitivity analysis, which is factually inaccurate. This represents a critical error in multi-hop reasoning: the model failed to recognize that scenario-based forecasting in credit loss estimation (especially for ACL) inherently involves scenario and sensitivity analysis. While the contrast between AIG (market risk) and COF (credit risk) is contextually relevant and well-framed, the conclusion misrepresents COF's methodology, undermining the qualitative accuracy. Thus, despite correct entities and no numeric errors, the answer fails on a key factual dimension of the comparison, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 438,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How does Qualcomm's exposure to EAR regulations on advanced semiconductor technologies compare with AMD's specific constraints on exporting Versal VC2602 and VE2602 FPGAs to China, given both companies' involvement in high-performance computing markets?",
      "original_answer": "Qualcomm's business and products, including those of its customers and licensees, are subject to a broad range of regulations, including the U.S. Export Administration Regulations (EAR), which govern the export and re-export of advanced technologies, potentially affecting its business operations and results. In contrast, AMD faces specific export constraints under EAR, including requirements to file a Notified Advanced Computing (NAC) notification 25 days before shipping certain Versal VC2602 and VE2602 FPGAs to China or to customers outside the U.S. whose ultimate parent is headquartered in a D5 country, including China. These FPGAs are part of AMD's Data Center segment, which includes Field Programmable Gate Arrays (FPGAs) and other adaptive computing products. While both companies are impacted by EAR regulations, AMD's exposure is more directly constrained in terms of specific product lines and geographic markets, particularly affecting its ability to serve Chinese customers without prior regulatory approval, whereas Qualcomm's exposure is more diffuse across its broader regulatory risk profile.",
      "llm_answer": "Qualcomm notes that its chips and related services are covered by the U.S. Export Administration Regulations (EAR) – the company must maintain a compliance program and obtain export licences for advanced semiconductor technologies whenever required by the Commerce Department 【page 37】. AMD’s filing, by contrast, spells out product‑specific export limits: BIS rules now force AMD to file a Notified Advanced Computing (NAC) notice (and potentially obtain a licence) before shipping its Versal VC2602 and VE2602 FPGAs to China or to customers whose ultimate parent is in a D5 country 【page 33】. Thus Qualcomm’s exposure is a broad, portfolio‑wide EAR compliance risk, while AMD faces a narrower, model‑specific restriction that directly curtails shipments of its high‑performance FPGA offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Qualcomm's broad exposure to EAR regulations is accurately described as portfolio-wide compliance risk, while AMD's specific constraints on Versal VC2602 and VE2602 FPGAs are correctly identified, including the requirement to file a Notified Advanced Computing (NAC) notification before shipping to China or customers with ultimate parents in D5 countries. (2) There are no numeric values (e.g., dollar amounts, dates, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across both companies’ regulatory disclosures, contrasting Qualcomm’s general EAR compliance obligations with AMD’s product-specific restrictions. The mention of 'page 37' and 'page 33' references suggests grounding in source documents, enhancing credibility. (4) Semantic equivalence is strong: while the LLM uses slightly different phrasing (e.g., 'model-specific restriction' vs 'narrower, model-specific restriction'), the meaning matches the original answer. One minor point preventing a perfect 10 is the omission of explicit mention that AMD’s affected products fall under its Data Center segment and are part of adaptive computing—contextual detail present in the original that adds completeness. However, this does not undermine the core accuracy. Overall, the response is factually correct, well-reasoned, and directly relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 428,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How does CMCSA's relinquishment of voting rights in Hulu contrast with META's dual-class stock structure in terms of control retention strategies?",
      "original_answer": "CMCSA relinquished substantially all voting rights associated with its investment in Hulu in 2019, including board seats, in exchange for a put/call arrangement with Disney that guaranteed a minimum equity value of $27.5 billion for its interest and resulted in an $8.6 billion payment from Disney in 2023. This contrasts with META's dual-class stock structure where Class B shares carry 10 votes per share compared to 1 vote for Class A shares, allowing certain stockholders to maintain significant voting power while owning a minority of economic interests. CMCSA's approach involved transferring control to Disney in exchange for financial guarantees, whereas META retains internal control differentiation through its stock classification framework.",
      "llm_answer": "Comcast’s 2019 agreements with Disney required it to give up its board seats and “substantially all voting rights” in Hulu, leaving Disney with full operational control of the joint‑venture (CMCSA 10‑K p. 85). By contrast, Meta’s capital‑structure creates three share classes – Class A (one vote), Class B (ten votes) and Class C (no votes) – so that insiders who hold the high‑voting Class B stock retain disproportionate voting power and therefore control of the company (Meta 10‑K p. 82). Thus, Comcast voluntarily ceded control of an investment, while Meta deliberately preserves control through a super‑voting dual‑class share design.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core contrast between CMCSA's relinquishment of Hulu voting rights and META's dual-class structure. (1) All entities (CMCSA, Disney, Hulu, META), years (2019), and actions (giving up board seats, voting rights) are correct. The LLM correctly identifies that CMCSA ceded control to Disney, while META maintains control via super-voting shares. (2) Quantitative accuracy is perfect: although the LLM does not mention the $27.5 billion guaranteed equity value or the $8.6 billion payment from Disney in 2023, these specific figures are not required to answer the qualitative contrast in control strategies. Their omission does not impair the factual correctness of the comparison. (3) The multi-hop reasoning is sound—correctly synthesizing information from CMCSA’s and Meta’s 10-Ks to contrast external control surrender vs. internal control preservation. (4) The LLM slightly simplifies Meta’s structure by referring to 'three share classes' and calling it a 'dual-class' design, but this is semantically acceptable as the key point—Class B shares have 10x voting power—is accurate (per Meta 10-K p. 82). The answer is fully contextually relevant and directly addresses the control retention contrast. Minor omission of financial terms from the original prevents a perfect 10, but the reasoning and factual core are solid.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 379,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How does Goldman Sachs' $113.9 billion in broker-dealer assets influence its approach to managing conflicts of interest under Regulation Best Interest, compared to Morgan Stanley's compliance framework for the same regulatory obligations?",
      "original_answer": "Goldman Sachs manages $113.9 billion in broker-dealer assets as of December 2024, which necessitates a robust compliance framework under Regulation Best Interest to ensure recommendations align with retail customers' best interests, especially given the SEC's requirement that broker-dealers avoid placing their own interests ahead of clients. This asset size increases the complexity of conflict management, particularly in areas like variable insurance product sales and investment strategy recommendations. Similarly, Morgan Stanley explicitly states it is subject to Regulation Best Interest, which governs its broker-dealer sales practices and customer relationships, including conflict mitigation. Both firms must maintain stringent internal controls, but Goldman's larger broker-dealer asset base may require more extensive monitoring and disclosure protocols to satisfy the same impartial conduct standards outlined in the regulation, particularly as both firms face potential litigation and regulatory scrutiny tied to compliance.",
      "llm_answer": "Goldman Sachs points out that its major broker‑dealer subsidiaries hold roughly $113.9 billion of assets (see the GCLA table on page 106) and, because of that scale, it weaves conflict‑of‑interest controls and Regulation Best Interest disclosures into the liquidity‑ and capital‑management framework that monitors those broker‑dealer balances (see the SEC‑disclosure discussion on page 22). Morgan Stanley’s compliance program, by contrast, is described as a firm‑wide set of policies, training and oversight that requires its broker‑dealer units (MS&Co. and MSSB) to act in the best interest of retail customers under RBI, without a similarly quantified asset‑level focus (see the RBI description on page 9 and broker‑dealer regulation on page 8).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, the $113.9 billion in broker-dealer assets for Goldman Sachs is accurately reported, matching the original answer's figure and time reference (December 2024 implied by context). No other numerical values are present, and there are no calculation errors. (2) The LLM correctly identifies both Goldman Sachs and Morgan Stanley as subject to Regulation Best Interest (RBI), and accurately contrasts their compliance approaches: Goldman integrates conflict-of-interest controls into its capital and liquidity management frameworks due to asset scale, while Morgan Stanley employs a firm-wide policy, training, and oversight model. These distinctions are consistent with the ground truth’s emphasis on Goldman’s larger asset base requiring more extensive monitoring. (3) The multi-hop reasoning is sound—linking asset size to regulatory complexity and contrasting implementation frameworks across firms. However, the LLM answer introduces specific document references (e.g., 'page 106', 'page 22') not present in the original answer or question, which may imply fabricated sourcing, slightly undermining reliability. Additionally, while the core idea of Goldman’s asset-driven compliance intensity is preserved, the LLM omits explicit mention of shared SEC impartial conduct standards, potential litigation risks, and specific conflict areas like variable insurance products noted in the ground truth. (4) Despite minor omissions and the addition of unverified page citations, the answer captures the essential comparison and factual core, warranting a high correctness score but not perfect due to incomplete contextual depth and potential hallucination of source locations.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 477,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How might Intel's IDM 2.0 strategy, which includes expanding manufacturing capacity with the aim of attracting foundry customers, be affected by Samsung's development of in-house integrated circuits, and what implications could this have for Qualcomm's semiconductor business given its reliance on external integrated circuit customers?",
      "original_answer": "Intel's IDM 2.0 strategy involves significant capital expenditures to expand manufacturing capacity with the goal of attracting foundry customers (chunk 1). However, Samsung, a key potential customer for Intel's foundry services, is developing its own integrated circuit products, which it may increasingly use in its own devices and potentially sell to third parties in competition with others in the market (chunk 2). This vertical integration by Samsung could limit Intel's ability to secure foundry business from Samsung, making Intel's IDM 2.0 capacity investments riskier and potentially leading to underutilized facilities or increased pricing pressure to attract other customers. Qualcomm, which derives a significant portion of its revenues from sales of its own integrated circuit products to OEMs (chunk 3), could face intensified competition if Samsung's in-house chips gain market traction, particularly in segments like mobile and automotive. Additionally, if Intel responds by lowering prices to attract other foundry clients, it could indirectly affect the broader semiconductor pricing environment, potentially impacting Qualcomm's cost structure or competitive positioning.",
      "llm_answer": "Intel’s IDM 2.0 plan hinges on building extra fab capacity to sell “foundry‑as‑a‑service” (IFS) to other chip makers, but Samsung’s move to design and produce its own integrated circuits means a key potential customer is likely to keep work in‑house rather than outsource to Intel. That competition from Samsung (and other established foundries) raises the risk that Intel’s new capacity could be under‑utilized, as noted in its 10‑K (e.g., “our IDM 2.0 investments… may heighten under‑utilization risks” and “IFS faces competition from … Samsung”) 【page_53】【page_55】. For Qualcomm, which depends on external IC customers and already flags Samsung’s vertical integration as a risk (“certain of our largest integrated‑circuit customers (for example, Samsung) develop their own IC products… rather than our products”) 【page_19】, Samsung’s in‑house strategy could further shrink Qualcomm’s addressable market and pressure its QCT semiconductor revenues.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Intel's IDM 2.0 strategy involves expanding manufacturing capacity to attract foundry customers; Samsung's in-house IC development reduces its likelihood of using Intel's foundry services; this increases underutilization risk for Intel; and Qualcomm faces competitive pressure as Samsung vertically integrates. These points are supported by accurate citations from the 10-K (e.g., page 53, 55, 19), which strengthens credibility. (2) There are no numeric values, dates, or calculations in the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly links Intel’s foundry ambitions → Samsung as a potential customer that is now self-sufficient → reduced demand for Intel’s capacity → risk of underutilization → competitive pressure on Qualcomm due to Samsung’s in-house chips. It also correctly identifies Qualcomm’s reliance on external customers and cites the relevant risk disclosure. (4) The only minor shortcoming is that the LLM does not explicitly mention the broader pricing pressure Intel might exert on the foundry market to attract other clients, which could indirectly affect Qualcomm’s cost structure—a nuance in the original answer. However, this omission is minor and doesn’t undermine the core correctness. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent, directly addressing all parts of the multi-entity, multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1582,
        "completion_tokens": 431,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How does VZ's monetization of wireless tower infrastructure through exclusive arrangements with American Tower Corporation compare to NFLX's reliance on exclusive content rights in terms of upfront capital impact and long-term strategic control?",
      "original_answer": "VZ received an upfront payment of $5.0 billion from American Tower Corporation in 2015 for exclusive rights to 11,300 wireless towers, while retaining operational control through subleased capacity and continuing depreciation of the towers. This allowed VZ to monetize infrastructure assets while maintaining network usage flexibility. In contrast, NFLX pursues exclusive content rights to differentiate its service, which requires ongoing licensing costs and exposes the company to risks of content withdrawal and increased programming expenses. Unlike VZ's capital-generating tower arrangement, NFLX's exclusive content strategy represents a cost center rather than a revenue source, with no upfront payments received and instead involves financial commitments to secure programming advantages.",
      "llm_answer": "Verizon turned its tower base into a cash‑generating asset by selling the exclusive lease‑and‑operate rights on about 11,300 towers to American Tower for a $5 billion upfront payment; the cash is recorded as prepaid rent and a financing obligation while Verizon keeps the towers on its balance sheet, subleases capacity and retains a future purchase option (see page 73). Netflix, by contrast, spends cash up‑front to lock in exclusive licensing and to produce original titles—costs that are reflected as content‑acquisition and production expenses rather than cash inflows—and the resulting exclusive rights give it only time‑limited control over the programming that drives subscriber growth (see page 10). Thus, Verizon’s tower deal provides a large immediate cash infusion and shifts operational control but preserves long‑term strategic options, whereas Netflix’s exclusive‑content model consumes cash up front and secures strategic differentiation only for the term of the rights.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key figures are correct: the $5 billion upfront payment from American Tower Corporation and the 11,300 towers are accurately reported, with no discrepancies in numbers or dates. The format variation ($5 billion vs $5.0 billion) is acceptable. (2) The answer correctly contrasts VZ's capital-generating tower monetization—highlighting the upfront cash inflow, retained balance sheet ownership, subleasing, and future purchase option—with NFLX's cash-outflow model for exclusive content, including licensing and production costs treated as expenses. (3) The multi-hop reasoning is sound: it synthesizes VZ’s infrastructure strategy (financial engineering with operational retention) and NFLX’s content-driven differentiation (cost center with time-limited control), directly addressing the comparison on upfront capital impact and long-term strategic control. (4) Minor deduction in qualitative accuracy due to the mention of 'prepaid rent and financing obligation' and 'future purchase option,' which, while plausible accounting treatments, are not present in the ground truth and introduce slight over-specificity not supported by the original answer. However, these do not contradict the core facts and may reflect additional context from the cited page 73. Overall, the semantic meaning, comparison structure, and strategic implications are fully aligned with the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 407,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the Tax Reform Act's GILTI provisions impact KO's effective tax rate in 2022, and how does this contrast with the effect of the corporate income tax rate reduction in the Philippines on PEP's operations in that market?",
      "original_answer": "KO's effective tax rate in 2022 was impacted by the Tax Reform Act's GILTI provisions, which required the inclusion of foreign subsidiaries' excess earnings in U.S. income tax returns, contributing to a 1.2% impact on KO's effective tax rate through pretax charges of $710 million related to equity method investee impairments. In contrast, PEP's operations in the Philippines experienced low-single-digit growth, and the corporate income tax rate reduction enacted in the Philippines in Q1 2021 contributed to a favorable impact on PEP's effective tax rate, lowering it by an unspecified but notable amount. This illustrates how the same U.S. tax reform had divergent effects—raising KO's tax burden through GILTI while enabling PEP to benefit from lower local corporate taxes.",
      "llm_answer": "The GILTI rules in the Tax Reform Act required Coca‑Cola to include foreign‑subsidiary earnings in its U.S. return, which pushed its effective tax rate higher – the company’s most recent effective‑tax‑rate figure (21.1%) reflects that GILTI impact 【page_107】. In contrast, PepsiCo’s corporate‑income‑tax cut in the Philippines lowered its tax burden, partially offsetting other tax‑rate pressures and bolstering the profitability of its Philippine operations 【page_94】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general direction of the impact of GILTI on KO and the tax rate reduction in the Philippines on PEP, but misses key quantitative details from the ground truth. It correctly states that GILTI increased KO's effective tax rate but fails to specify the exact 1.2% impact or the $710 million pretax charge related to equity method investee impairments, instead vaguely referencing a 21.1% effective tax rate without attributing the precise GILTI contribution. The ground truth specifies a 1.2% impact from a $710M charge, which the LLM omits. (2) For PEP, the LLM correctly notes the favorable effect of the Philippine corporate tax cut but does not mention that the reduction occurred in Q1 2021 or that it contributed to low-single-digit growth in the market—details present in the original answer. It also fails to convey the contrast in mechanisms: GILTI as a U.S. global minimum tax affecting KO’s U.S. liability vs. a local rate cut benefiting PEP’s local profitability. (3) The multi-hop reasoning is partially sound—linking U.S. tax policy to KO’s rate and local policy to PEP’s benefit—but lacks synthesis of the comparative effect as divergent outcomes of different tax changes (U.S. vs. foreign). The LLM does not clarify that the Tax Reform Act (U.S.) caused GILTI, while the Philippine rate cut was a separate local reform, not part of the same act. This weakens the contrast implied in the question. (4) Despite missing key numbers and causal clarity, the answer remains contextually relevant and directionally accurate, earning moderate scores in qualitative accuracy and high in relevance. Quantitative accuracy is penalized due to omission of specific figures ($710M, 1.2%) and misplacement of the 21.1% rate without proper context.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 485,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How does the $1.3 billion in restricted retained earnings at Nicor Gas impact Southern Company's ability to receive dividends from its subsidiaries, given that Nicor Gas is a key subsidiary under Southern Company Gas?",
      "original_answer": "Nicor Gas, as a regulated subsidiary under Southern Company Gas, has $1.3 billion in retained earnings that are restricted from being distributed as dividends or loans to affiliates. This restriction directly limits Southern Company's ability to receive dividend payments from Nicor Gas, which in turn affects the consolidated cash flows and financial flexibility of Southern Company, especially since Southern Company relies on equity earnings and dividends from its subsidiaries for a significant portion of its income.",
      "llm_answer": "The $1.3 billion of retained earnings that Nicor Gas must keep “restricted” means that, by regulation, Nicor Gas cannot pay dividends or loans to affiliates beyond the portion of earnings that is unrestricted. Consequently, that $1.3 billion cannot be distributed up through Southern Company Gas to Southern Company, limiting the total dividend cash flow Southern Company can receive from its subsidiaries.【page 261】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $1.3 billion in restricted retained earnings at Nicor Gas and explains that these funds cannot be distributed as dividends or loans to affiliates, which aligns with the ground truth. The impact on Southern Company's dividend inflows is accurately conveyed. (2) Quantitative accuracy is perfect: the $1.3 billion figure is correctly cited, and no other numerical values or calculations are involved. Format is consistent and clear. (3) The multi-hop reasoning is sound—Nicor Gas is a subsidiary under Southern Company Gas, which is part of Southern Company; the restriction at the subsidiary level affects upstream cash flow. The LLM correctly synthesizes the regulatory restriction with its implications for parent company dividends. Only minor omission is not explicitly stating that Southern Company relies significantly on subsidiary dividends for income, which is in the original answer and adds context about financial flexibility. (4) All entities—Nicor Gas, Southern Company Gas, Southern Company—are correctly identified and hierarchically placed. The reasoning is logical, and the source reference [page 261] supports the claim. The answer is semantically equivalent to the ground truth with slightly less elaboration on the broader financial impact, but core facts and implications are preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 379,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How do Tesla's and GM's compliance costs related to evolving vehicle safety standards compare, given the increasing regulatory complexity under the National Traffic and Motor Vehicle Safety Act?",
      "original_answer": "Tesla faces rising compliance costs due to evolving international vehicle safety standards, particularly for its Autopilot and FSD (Supervised) features, which must meet varying requirements across jurisdictions and may delay or restrict functionality. GM similarly notes that compliance with the National Traffic and Motor Vehicle Safety Act is costly, with global regulatory divergence—especially between North American and UN-ECE based standards—adding complexity and expense to vehicle development. Both companies emphasize the financial burden of maintaining compliance as safety standards evolve and expand globally, with GM specifically highlighting the lack of harmonization as a key driver of increased costs.",
      "llm_answer": "Tesla’s 2024 filing only warns that the growing complexity of vehicle‑safety rules under the National Traffic and Motor Vehicle Safety Act may increase its compliance expenses, but it does not disclose a specific dollar amount (see Tesla pages 26‑30). In contrast, GM explicitly states that meeting the Safety Act’s standards and any resulting recall campaigns “could be substantial” and it reports $1 billion of compliance‑related costs in 2024 for related regulatory obligations (see GM pages 13 and 12), indicating a materially larger and quantified cost burden than Tesla’s undisclosed estimate.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative inaccuracy: The claim that GM reported '$1 billion of compliance-related costs in 2024' is not supported by the original answer (ground truth), which does not provide any specific dollar amounts for either Tesla or GM. This figure is fabricated or misattributed, failing the quantitative accuracy check. (2) The original answer emphasizes both companies face rising compliance costs due to global regulatory divergence—Tesla due to Autopilot/FSD international standards, GM due to lack of harmonization between North American and UN-ECE standards—but the LLM incorrectly frames GM as having a 'materially larger and quantified cost burden' based on a number not present in the ground truth. (3) The LLM introduces specific document page numbers (e.g., 'Tesla pages 26-30', 'GM pages 13 and 12') and a 2024 fiscal year, which are not mentioned or verifiable from the original answer, introducing unsupported specifics. (4) While the LLM correctly identifies that both companies face compliance costs under evolving safety regulations, it fails to accurately represent the nature of the multi-hop comparison: both are affected by global regulatory complexity, not a domestic U.S.-only framework, and the core issue is lack of harmonization, not just cost magnitude. (5) The reasoning is flawed because it draws a conclusion (GM has higher, quantified costs vs. Tesla's unspecified) not supported by the source data. Despite this, the answer is contextually relevant to the question’s domain and attempts a comparative analysis, earning partial credit for relevance and qualitative structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 459,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How does General Dynamics' deferral of $305 million in other contract costs under FAR regulations compare to Raytheon Technologies' exposure to cost overruns under its fixed-price U.S. government contracts, given the differing financial risk profiles associated with these contract cost management approaches?",
      "original_answer": "General Dynamics defers $305 million in other contract costs under FAR regulations that govern cost allowability and allocation to U.S. government contracts, with recovery expected through existing backlog and follow-on contracts. These costs are not currently allocable but are maintained as assets pending future allocation. In contrast, Raytheon Technologies faces financial risk on its fixed-price contracts, particularly firm fixed-price (FFP) contracts, where it bears the full burden of cost overruns without reimbursement. This creates a more direct financial exposure compared to General Dynamics’ deferred cost model. The difference in risk stems from the fact that FAR-regulated cost recovery allows General Dynamics to defer recognition of certain costs until allocable, while Raytheon must absorb overruns on fixed-price contracts, which constitute a significant portion of its U.S. government contract portfolio.",
      "llm_answer": "General Dynamics reports a specific $305 million of “other contract costs” that must be deferred under FAR rules and is expected to recover that amount through future work (GD 10‑K, Note K). Raytheon Technologies, by contrast, warns that its fixed‑price U.S. government contracts expose it to cost‑overrun risk that could directly reduce earnings, but it does not quantify that exposure (RTX 10‑K, Item 1A – Risk Factors). Thus, GD’s risk is a known, deferred liability, whereas RTX’s risk is an uncertain, potentially larger liability that would be borne if contract costs exceed the fixed price.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $305 million deferral by General Dynamics is correctly stated, and the absence of a quantified exposure for Raytheon is accurately noted—consistent with the original answer. No calculations are required, and all financial figures match. (2) The answer addresses both parts of the multi-hop question: General Dynamics’ deferral under FAR and Raytheon’s exposure under fixed-price contracts. It correctly identifies that GD’s costs are deferred assets expected to be recovered through future work, while RTX bears overrun risk without reimbursement. (3) Entities are accurate—General Dynamics (GD) and Raytheon Technologies (RTX) are correctly named and linked to their respective contract risk models and 10-K disclosures. (4) The reasoning is sound: it contrasts a known, deferred cost (GD) with an uncertain, potentially larger liability (RTX), capturing the core difference in financial risk profiles. The only minor shortcoming is that it does not explicitly mention that FAR regulations govern cost allowability and allocation, or that fixed-price contracts—especially firm fixed-price (FFP)—constitute a significant portion of RTX’s portfolio, which adds slight contextual depth in the original. However, the semantic meaning and risk comparison are preserved. Wording differs but meaning is equivalent, and all critical facts are present and correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 400,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does the compound annual growth rate (CAGR) of Intel's Taiwan revenue from 2019 to 2021 compare to Apple's Greater China segment revenue growth over the same period, given that Taiwan is included within Apple's Greater China reporting?",
      "original_answer": "Intel's Taiwan revenue grew from $10,058 million in 2019 to $13,461 million in 2021, representing a CAGR of approximately 15.6%. Apple's Greater China revenue increased from $40,308 million in 2019 to $68,366 million in 2021, yielding a CAGR of approximately 30.8%. Therefore, Apple's Greater China segment revenue grew at more than double the rate of Intel's Taiwan-specific revenue during this period.",
      "llm_answer": "Intel’s Taiwan revenue rose from $10,058 million in 2019 to $13,461 million in 2021, giving a compound‑annual‑growth‑rate of roughly 15.7 % per year (INTC 10‑K, page 86). Apple’s Greater China segment – which includes Taiwan – increased from $40,308 million in 2020 to $68,366 million in 2021, a jump of about 70 % (Apple 10‑K, page 52), so Apple’s regional growth far outpaced Intel’s Taiwan‑only growth.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Intel's Taiwan revenue figures ($10,058M in 2019 and $13,461M in 2021) and calculates a CAGR close to the ground truth (15.7% vs actual 15.6%), which is acceptable within rounding. However, it makes a critical error in Apple's time frame: it uses 2020–2021 instead of 2019–2021 as required by the question. Apple's Greater China revenue is reported as $40,308M in 2020, but the original answer states this was the 2019 figure. This misalignment leads to an incorrect CAGR calculation. The LLM reports a '70% jump' from 2020 to 2021, which is factually correct for that period (from $40,308M to $68,366M), but fails to compute the full 2019–2021 CAGR of ~30.8% as required. (2) The quantitative accuracy is compromised because the comparison period is wrong. While the final Apple revenue number is correct, the starting point should be 2019, not 2020. The ground truth uses $40,308M in 2019, so the LLM incorrectly assumes this was 2020 data. This breaks the multi-hop comparison across the same time horizon. (3) The reasoning is partially sound—Apple’s growth outpacing Intel’s is correct—but the conclusion lacks valid support due to mismatched time periods. The claim that Apple’s growth 'far outpaced' Intel’s is directionally correct but quantitatively unsupported in the given context. (4) Scores reflect that core data points are mostly accurate (hence not below 5), but the failure to align the correct years for Apple undermines the CAGR comparison, which is central to the question. Contextual relevance is high because the answer addresses the right companies, regions, and metric (CAGR), even if execution is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 458,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "Given Alphabet's $70 billion share repurchase authorization targeting Class A and Class C shares in 2024, how might the repurchase activity influence Class B shareholders' decisions to convert shares to Class A, especially in light of Meta's disclosure of a significantly larger Class A share base compared to Class B outstanding shares?",
      "original_answer": "Alphabet's $70 billion share repurchase program, which includes Class A shares, could reduce the supply of Class A shares in the market, potentially increasing their relative value. This may incentivize Class B shareholders—who hold shares with 10x voting rights but often face restrictions on holding Class A shares after conversion—to convert and sell Class A shares before further scarcity and price appreciation occur. However, Meta's 2024 disclosure shows that it has 2,189,898,148 Class A shares and only 343,761,117 Class B shares outstanding, indicating a much larger float of Class A shares in the market. This abundance of Class A shares at Meta may temper conversion urgency compared to Alphabet, as Class A shares at Meta are likely more liquid and less affected by repurchase-induced scarcity.",
      "llm_answer": "Alphabet’s $70 billion authorization to repurchase Class A and Class C shares will shrink the outstanding pool of voting‑class shares, likely boosting the market price of Class A stock and giving Class B holders (who have ten votes per share) a premium incentive to convert to the more liquid, lower‑voting Class A shares. By contrast, Meta’s 10‑K discloses a far larger Class A base (≈2.19 billion shares) versus its Class B shares (≈0.34 billion), showing that a larger Class A pool can dilute price gains; therefore, Alphabet’s tighter Class A supply from the repurchase program makes conversion more appealing for Class B shareholders than it would be in Meta’s situation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Alphabet's $70 billion share repurchase includes Class A and Class C shares, which reduces supply and may increase Class A share value, incentivizing Class B shareholders to convert. The Meta data is accurately represented: ~2.19 billion Class A shares and ~0.34 billion Class B shares (matching the original 2,189,898,148 and 343,761,117), with proper rounding. (2) Quantitative accuracy is excellent—numbers match exactly when rounded appropriately, and no calculations are incorrect. (3) Reasoning is sound: the model correctly infers that reduced Class A supply at Alphabet increases conversion appeal for Class B holders, while Meta’s larger Class A float would dilute such effects, making conversion less urgent. The multi-hop synthesis between Alphabet’s repurchase program and Meta’s capital structure is logically coherent. (4) Minor deduction in qualitative accuracy due to slightly stronger emphasis on 'premium incentive' and 'price gains' without fully elaborating on Meta’s liquidity point as a moderating factor, though the core insight is preserved. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect—directly addresses all parts of the question with appropriate financial logic and entity linkage.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 374,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does the treatment of dividend equivalents in RSU awards differ between PepsiCo and Philip Morris International in terms of vesting conditions and financial obligations as of 2023?",
      "original_answer": "PepsiCo accrues dividend equivalents during the vesting period for both RSUs and PSUs, which are paid out in cash when the award vests. Philip Morris International also accrues dividend equivalents on RSU awards, but its RSUs generally vest on the third anniversary of the grant date and do not carry voting rights. As of December 31, 2023, PMI had $160 million of total unrecognized compensation costs related to non-vested RSU awards, which are being amortized over the restriction period or upon specific life events.",
      "llm_answer": "PepsiCo’s RSUs only **accrue dividend equivalents that are paid in cash when the award actually vests** – i.e., after the three‑year service period ends – so the company does not record a dividend‑equivalent liability until vesting 【page_92】. By contrast, PMI’s RSUs **earn dividend equivalents that are treated as non‑forfeitable rights** (participating securities) and are therefore reflected as a financial obligation in earnings‑per‑share calculations even while the awards are still unvested; the RSUs generally vest on the third anniversary of the grant date, subject to forfeiture if employment conditions are not met 【page_110】【page_112】.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, with high factual accuracy and strong contextual relevance. (1) Quantitatively, there are no numeric inaccuracies: while the LLM does not explicitly mention the $160 million unrecognized compensation cost for PMI, this omission does not introduce an error but rather a minor gap in completeness. All other referenced facts (e.g., vesting on the third anniversary, cash payout upon vesting for PepsiCo, non-forfeitable dividend equivalents for PMI) are accurate. (2) The LLM correctly identifies both companies and the relevant treatment of dividend equivalents in RSUs as of 2023, satisfying entity and time period accuracy. (3) The reasoning is sound: it correctly contrasts PepsiCo’s approach (dividend equivalents paid in cash at vesting, no liability accrued earlier) with PMI’s treatment (dividend equivalents as non-forfeitable, participating securities affecting EPS calculations pre-vesting), which represents valid multi-hop synthesis across the two companies’ policies. (4) The main difference from the original answer is that the LLM adds a detail not in the ground truth — that PMI treats dividend equivalents as participating securities affecting EPS — which is consistent with the source citations and enhances accuracy. However, it omits the specific $160 million unrecognized cost figure from PMI’s filing, which is a notable but not critical omission since the question focuses on treatment differences rather than exact financial figures. Thus, the answer earns a high score but not perfect due to this partial incompleteness on financial obligations. Semantic equivalence is maintained, and wording differences do not affect meaning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 467,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does DHR's use of NAV and discounted cash flow in valuing private investments compare to LLY's reliance on fair value estimation for acquired intangible assets, considering the inherent subjectivity in both approaches as highlighted in their respective disclosures?",
      "original_answer": "DHR utilizes NAV based on fund manager inputs and applies discounted cash flows, earnings multiples, and third-party appraisals to estimate the fair value of private investments, acknowledging that these methods may not reflect net realizable value or future fair values. LLY, on the other hand, applies fair value estimation to acquired intangible assets such as IPR&D, which required $3.80 billion in charges in 2023 alone, and admits that final valuations may change significantly as fair values are finalized within one year post-acquisition. Both companies recognize the subjectivity involved in fair value estimation, with DHR noting that different methodologies can yield materially different results and LLY emphasizing the need for considerable judgment in determining the fair value of acquired assets, especially under limited access to pre-acquisition data.",
      "llm_answer": "Danaher values its private‑equity, venture‑capital and partnership holdings by using a net‑asset‑value “practical expedient” that relies on fund‑manager reports and, when appropriate, discounted‑cash‑flow, earnings multiples, third‑party appraisals or quoted market prices—methods the company says involve judgment and may not reflect net‑realizable or future values. Eli Lilly, on the other hand, records acquired intangible assets at fair value using market, income and cost approaches, noting that the fair‑value determination also requires significant estimates and assumptions; thus both firms acknowledge that their valuation techniques are inherently subjective, though Danaher’s is applied to private‑investment NAVs while Lilly’s is applied to acquisition‑related intangibles.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core comparison between DHR and LLY regarding their use of valuation methods and the inherent subjectivity involved. (1) All factual elements are correct: DHR uses NAV with fund manager inputs, applying discounted cash flows, earnings multiples, and third-party appraisals, while acknowledging judgment and uncertainty in net realizable or future values. LLY applies fair value estimation to acquired intangibles using market, income, and cost approaches, with recognition of significant assumptions. The LLM correctly identifies that both companies acknowledge subjectivity—DHR in methodology potentially yielding materially different results, and LLY in requiring considerable judgment, especially with limited pre-acquisition data. (2) Quantitative accuracy is perfect: although the original answer mentions LLY’s $3.80 billion in charges in 2023, this specific figure is absent in the LLM response. However, this omission does not distort the factual comparison or core reasoning, and the question does not explicitly require inclusion of the dollar amount—only a comparison of subjectivity in valuation approaches. Thus, the absence is a minor completeness gap but not a factual error. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across two companies, two distinct valuation contexts (private investments vs. acquired intangibles), and aligns their disclosures on subjectivity. The distinction in application (DHR on private-investment NAVs, LLY on acquisition-related intangibles) is clearly and correctly drawn. (4) Semantic equivalence is strong—wording differs but meaning matches. The LLM uses 'judgment' and 'significant estimates' in place of 'considerable judgment' and 'subjectivity,' which are equivalent in context. Overall, the answer is factually correct, well-reasoned, and fully relevant, meriting a 9 due to the omission of the $3.80 billion charge detail, which slightly reduces completeness but not correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 540,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How does NVIDIA's revenue from Taiwan in 2022 compare to Apple's reported revenue from the Greater China segment, given that Apple's geographic reporting includes Taiwan within Greater China?",
      "original_answer": "NVIDIA reported $8,544 million in revenue from Taiwan in 2022, while Apple reported $74,200 million in net sales from the Greater China segment in the same year. Since Apple explicitly includes Taiwan within its Greater China geographic reporting, NVIDIA's Taiwan-specific revenue constitutes a subset of the broader regional revenue that Apple reports, reflecting different levels of geographic granularity in their respective segment disclosures.",
      "llm_answer": "NVIDIA’s 2022 filing does not break out revenue by country, and none of the disclosed NVIDIA notes (pages 78‑82) provide a separate figure for Taiwan – so a Taiwan‑specific amount is not reported. In contrast, Apple’s Greater China segment – which the company defines as “China (including Hong Kong and Taiwan)” – generated $74.2 billion of net sales in 2022【page_52】. Thus, Apple’s reported Greater China revenue (including Taiwan) far exceeds any disclosed NVIDIA Taiwan revenue, which is not separately disclosed.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that NVIDIA does not report revenue from Taiwan in 2022. The ground truth confirms that NVIDIA reported $8,544 million in revenue from Taiwan in 2022. The LLM incorrectly claims this data is not disclosed, which contradicts the verified knowledge. (2) Quantitatively, the Apple figure ($74.2 billion) is correctly reported and matches the ground truth of $74,200 million. However, the NVIDIA figure is entirely missing due to the erroneous claim of non-disclosure, making the quantitative accuracy very low despite one correct number. (3) The reasoning is flawed because it fails the core multi-hop requirement: comparing NVIDIA’s Taiwan-specific revenue to Apple’s Greater China revenue that includes Taiwan. Instead, the LLM denies the existence of the NVIDIA data, breaking the logical chain. While it correctly notes Apple includes Taiwan in Greater China, it does not make the required comparison. (4) Contextual relevance is moderate because the answer addresses the right companies, year, and geographic segments, and correctly cites Apple’s definition of Greater China. However, the central error — denying the availability of NVIDIA’s Taiwan revenue — undermines the factual foundation of the response. The answer would have been stronger if it acknowledged the $8.5 billion figure and contextualized it within Apple’s broader regional reporting, as the ground truth does.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 400,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How does the concentrated voting power in CMCSA's Class B common stock compare to the shareholder structure disclosed for GOOGL's Class A common stock in terms of control and ownership distribution?",
      "original_answer": "CMCSA's Class B common stock, held entirely by Brian L. Roberts, represents 33⅓% of the combined voting power with each share carrying 15 votes, creating significant control concentration. In contrast, GOOGL's Class A common stock, with 300,754,904 shares outstanding as of January 25, 2022, is broadly distributed among non-affiliates, with voting rights presumably more dispersed given the large number of shares and absence of similar super-voting structures described for CMCSA. This indicates a stark difference in governance dynamics, with CMCSA maintaining centralized control through Class B shares, while GOOGL's structure suggests more distributed shareholder influence.",
      "llm_answer": "CMCSA’s Class B shares concentrate roughly one‑third of the company’s voting power (33 ⅓ %) in a single holder – Brian L. Roberts owns all of the Class B stock (see CMCSA page 38). Alphabet’s filing shows about 300.8 million Class A shares outstanding with no single shareholder identified as holding a dominant block, indicating that voting power for the Class A stock is broadly distributed among many investors (see GOOGL page 2).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all numbers are correct: the 33⅓% voting power concentration for CMCSA and the ~300.8 million GOOGL Class A shares (matching the ground truth 300,754,904, rounded appropriately) are accurate. The ownership by Brian L. Roberts and the absence of a dominant holder in GOOGL are correctly stated. (2) The answer correctly identifies the super-voting nature of CMCSA’s Class B shares (implied by the 33⅓% concentration with full ownership by one individual) and contrasts it with the broadly distributed Class A shares of GOOGL. (3) Multi-hop reasoning is sound: the model synthesizes ownership structure from both CMCSA and GOOGL filings, correctly inferring control concentration vs. dispersion. (4) Minor deduction in qualitative accuracy because the LLM does not explicitly mention the 15 votes per share for CMCSA Class B stock, which is part of the structural explanation for the voting power concentration. However, the implication of disproportionate voting power is still clearly conveyed. Wording differences (e.g., 'roughly one-third' vs '33⅓%') are semantically equivalent. Overall, the answer is factually correct, relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 352,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How does the ratio of securities remaining available for future issuance to those issuable upon exercise of outstanding options differ between UnitedHealth Group and Johnson & Johnson under their respective equity compensation plans approved by security holders?",
      "original_answer": "For UnitedHealth Group, the ratio is approximately 9.64 (241 million remaining available / 25 million issuable upon exercise), while for Johnson & Johnson, the ratio is approximately 1.79 (240,344,013 remaining available / 133,794,708 issuable upon exercise). This indicates that UnitedHealth Group has a significantly higher proportion of remaining available securities compared to those already issuable, relative to Johnson & Johnson.",
      "llm_answer": "UnitedHealth Group’s approved plans show ≈ 241 million shares available versus ≈ 25 million exercisable, a ratio of about **9.6 to 1**【page_77】.  \nJohnson & Johnson’s approved plans show ≈ 240.3 million shares available versus ≈ 133.8 million exercisable, a ratio of about **1.8 to 1**【page_118】.  \n\nThus UnitedHealth Group’s “available‑to‑exercisable” ratio is roughly five‑fold higher than Johnson & Johnson’s.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers provided are accurate: UnitedHealth Group has approximately 241 million shares remaining available and 25 million issuable upon exercise, yielding a ratio of 9.64, which the LLM correctly rounds to ~9.6. Johnson & Johnson has 240,344,013 available and 133,794,708 exercisable, resulting in a ratio of ~1.79, which the LLM accurately rounds to 1.8. The use of '≈' and rounded figures is appropriate and preserves precision. (2) The answer is complete, addressing both companies, their respective equity plan metrics, and the computed ratios. It also includes a correct comparative conclusion that UnitedHealth Group's ratio is roughly five times higher, which is logically sound (9.6 / 1.8 ≈ 5.3). (3) Entity accuracy is perfect: both companies are correctly identified, and the metrics ('shares available for future issuance' and 'issuable upon exercise of outstanding options') are correctly attributed to their respective equity compensation plans approved by security holders. (4) The multi-hop reasoning—extracting data from two different companies, computing ratios, and comparing them—is flawlessly executed. The semantic meaning fully aligns with the original answer, despite slightly more concise wording. Minor formatting differences (e.g., '240.3 million' vs '240,344,013') are acceptable and do not affect factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 397,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How does AMD's reliance on third-party motherboard suppliers compare to Intel's dependency on Dell Inc. as a major customer, particularly in terms of revenue concentration risk?",
      "original_answer": "AMD depends on third-party companies for the design, manufacture, and supply of motherboards that support its microprocessor, GPU, and APU offerings, making it vulnerable to supply chain disruptions. In contrast, Intel reports that Dell Inc. accounted for 21% of its net revenue in 2021, highlighting a significant revenue concentration risk tied to a single customer. While AMD's risk centers on supply chain limitations that could prevent product delivery, Intel's exposure is tied directly to customer dependency, with Dell representing a substantial portion of both revenue and accounts receivable.",
      "llm_answer": "AMD warns that it “depends on third‑party companies for the design, manufacture and supply of motherboards, graphics cards, software, memory and other components” and that a loss or reduction of those suppliers “could materially adversely affect” its business (AMD 10‑K p. 28). In contrast, Intel’s filing shows that its three largest customers generated 43 % of net revenue in 2021, with Dell alone accounting for about 21 % of revenue (Intel 10‑K p. 87). Thus AMD’s exposure is a broad supply‑chain reliance across many partners, whereas Intel faces a more concentrated revenue risk tied to a single major customer.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the 21% of Intel's revenue from Dell in 2021 is accurately cited, and the mention of Intel’s top three customers accounting for 43% of revenue (with Dell as a major component) is consistent with the source data. No calculation errors. (2) The entity accuracy is strong: AMD, Intel, and Dell Inc. are correctly identified, and the years (2021) and financial metrics (revenue concentration, supply chain reliance) are accurate. (3) The multi-hop reasoning is sound—LLM correctly contrasts AMD’s supply-side risk (reliance on third-party motherboard and component suppliers) with Intel’s demand-side risk (customer concentration, specifically Dell). It synthesizes information from both AMD’s and Intel’s 10-K filings appropriately. (4) The answer is semantically equivalent to the original: while the LLM adds a minor detail about Intel’s top three customers (43%), this contextualizes the 21% figure and does not contradict the ground truth. The core contrast—AMD’s supply chain vulnerability vs. Intel’s customer concentration risk—is clearly and correctly articulated. One minor point preventing a perfect 10 is that the original answer also notes Dell’s impact on Intel’s accounts receivable, which the LLM omits. This is a small but relevant detail in assessing revenue concentration risk. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 409,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How do Louisiana's corporate tax rate reductions impact the financial exposure of both Boeing and Union Pacific, given Boeing's dependence on federal appropriations influenced by broader legislative dynamics and Union Pacific's direct operations in the state?",
      "original_answer": "Louisiana enacted legislation to reduce its corporate income tax rate for future years, resulting in a $34 million reduction of Union Pacific’s deferred tax expense in 2024. Union Pacific directly benefits from this tax reduction due to its operational presence in Louisiana, as evidenced by its major classification yard in Livonia. Boeing, on the other hand, does not directly benefit from Louisiana’s tax changes but faces exposure to broader legislative uncertainty, particularly in terms of federal appropriations for the U.S. Department of Defense and other government agencies. A lapse or delay in federal funding could disrupt Boeing’s operations, delay aircraft certifications, or impact future orders. Therefore, while Union Pacific experiences a quantifiable financial benefit ($34 million reduction in deferred tax expense) from Louisiana’s tax legislation, Boeing’s exposure is indirect and tied to the uncertainty of federal budget dynamics influenced by the same legislative environment.",
      "llm_answer": "Louisiana’s corporate‑tax cuts directly benefit Union Pacific – the 2024 legislation lowered the railroad’s deferred tax expense by about $34 million, reducing its tax burden and easing its overall financial exposure【page_29】. By contrast, Boeing’s exposure is tied to the timing and level of federal appropriations and broader legislative dynamics rather than state‑level tax changes, so the Louisiana rate reduction has little direct impact on its financial position【page_10】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $34 million reduction in Union Pacific’s deferred tax expense in 2024 is correctly stated, matching the original answer exactly. No other numbers or dates are involved, and the figure is cited appropriately. (2) The answer correctly identifies that Union Pacific benefits directly due to its operations in Louisiana (with implicit support from its classification yard in Livonia, though not explicitly mentioned), while Boeing is unaffected by the state tax change but exposed to federal appropriations uncertainty. (3) The multi-hop reasoning is sound: it distinguishes between state-level tax impacts (Union Pacific) and federal funding dynamics (Boeing), correctly synthesizing that Louisiana’s tax policy affects companies based on operational presence versus reliance on federal contracts. (4) The only minor omission is the lack of explicit mention of Union Pacific’s Livonia facility as evidence of its operational footprint, which slightly reduces qualitative completeness but does not detract from the core factual accuracy. Wording differs slightly (e.g., 'little direct impact' vs 'does not directly benefit'), but semantic equivalence is preserved. All key entities—Louisiana, Union Pacific, Boeing, deferred tax expense, federal appropriations—are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 386,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How does Netflix's one-vote-per-share governance model contrast with Meta's dual-class stock structure, particularly in relation to Charter Communications' disclosure about the link between Class A common stock and voting rights?",
      "original_answer": "Netflix operates under a one-vote-per-share governance model for its common stock, as explicitly stated in its 2024 10-K filing. In contrast, Charter Communications' 2024 financial statements clarify that its Class A common stock carries one vote per share, while its Class B common stock has variable voting rights tied to A/N's economic interests. Meta's 2024 10-K filing discloses the existence of both Class A and Class B common stock, a dual-class structure that suggests differentiated voting rights similar to Charter's framework, though Meta does not specify the exact voting power of each class in the provided chunk. This creates a contrast between Netflix's egalitarian voting model and the more complex, tiered voting structures used by both Charter and Meta.",
      "llm_answer": "Netflix’s 10‑K states that “the holders of each share of common stock shall be entitled to one vote per share on all matters to be voted upon by the Company’s stockholders”【page_60】. Meta, however, has a dual‑class capital structure – it issues both Class A common stock (one vote per share) and Class B common stock that carries multiple votes per share, giving insiders greater voting power【page_1】. Charter’s filing similarly notes that its Class A common stock “are entitled to one vote per share,” showing that Netflix’s one‑vote‑per‑share model aligns with Charter’s Class A voting rights, while Meta’s dual‑class system creates a distinct split in voting power between its two share classes【page_95】.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its numerical and structural claims: Netflix has one vote per share (correctly cited from its 10-K), Charter's Class A common stock carries one vote per share (accurate per ground truth), and Meta has a dual-class structure. The quantitative accuracy is perfect—no numbers, share classes, or voting rights are misrepresented. However, the LLM makes a critical overstatement not supported by the provided ground truth: it claims Meta’s Class B shares carry 'multiple votes per share' and that this gives 'insiders greater voting power.' While this is generally true in public knowledge, the ground truth explicitly states that Meta's 2024 10-K 'does not specify the exact voting power of each class in the provided chunk.' Thus, the LLM introduces external knowledge or inference not verifiable from the given data, undermining the qualitative accuracy. The comparison to Charter is partially correct—both Netflix and Charter’s Class A shares have one vote per share—but the LLM implies alignment between Netflix and Charter without acknowledging Charter’s additional Class B shares with variable voting rights, which the original answer highlights. The reasoning is mostly sound and contextually relevant, addressing the contrast in governance models, but fails to fully capture the nuance in Charter’s variable voting rights or Meta’s unspecified voting breakdown as constrained by the source material. Hence, while the core facts are correct, the overreach in inference and slight oversimplification of Charter’s structure reduce the qualitative and overall correctness scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 441,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How does the daily cash-settlement mechanism for exchange-traded commodity futures described in PEP's 2022 filing impact the valuation methodology used by MDLZ for its Level 1 financial liabilities, given that both companies rely on quoted market prices from commodity exchanges?",
      "original_answer": "The daily cash-settlement mechanism for exchange-traded commodity futures described in PEP's 2022 filing aligns with the valuation methodology used by MDLZ for its Level 1 financial liabilities, which are also based on quoted market prices from commodity exchanges. PEP notes that exchange-traded commodity futures are 'cashsettled on a daily basis' and therefore not included in the balance sheet table as of year-end, indicating a standard market practice. MDLZ explicitly states that the fair value of its Level 1 financial assets and liabilities 'is determined based on quoted market prices on commodity exchanges.' This shows that the market standard of daily cash settlement directly informs MDLZ's valuation approach for Level 1 liabilities, as both companies are subject to the same pricing and settlement mechanisms in commodity futures markets.",
      "llm_answer": "PEP notes that its exchange‑traded commodity futures are “cash‑settled on a daily basis, therefore, not included in the table” of fair‑value amounts 【page_107】. Mondelez (MDLZ) classifies exchange‑traded commodity futures as Level 1 assets and liabilities and values them “based on quoted market prices on commodity exchanges” 【page_112】. Because the quoted market price already reflects the daily settlement value, MDLZ’s Level 1 valuation uses the same market‑based input that PEP’s cash‑settlement mechanism produces, so the daily settlement does not alter MDLZ’s methodology—it simply reinforces that the fair value is measured at the current exchange price.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All entities—PEP, MDLZ, exchange-traded commodity futures, Level 1 financial liabilities, quoted market prices, and daily cash settlement—are correctly identified and contextually accurate. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or the answers that conflict; the absence of specific figures is appropriate given the qualitative nature of the topic. Thus, quantitative accuracy is fully preserved. (3) The multi-hop reasoning is sound: the LLM correctly infers that because PEP’s futures are daily cash-settled and excluded from year-end fair value tables, and MDLZ uses quoted market prices on exchanges for Level 1 classification, the daily settlement mechanism inherently informs the valuation input used by MDLZ. The conclusion that the mechanism reinforces rather than alters MDLZ’s methodology is logically consistent with the source information. (4) The LLM captures the core insight from the ground truth—that the market standard of daily settlement underpins the use of exchange prices in fair value measurement—though it omits explicit mention that this reflects a broader 'market practice' as stated in the original answer. This minor omission in contextual framing does not detract from factual correctness but slightly reduces qualitative completeness. Overall, the answer is semantically equivalent, well-reasoned, and highly relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 409,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does Apple's 2022 net sales performance in the Greater China region, which includes Taiwan, compare with AMD's 2022 sales in Taiwan alone, given both companies' exposure to the technology market in that geographic area?",
      "original_answer": "Apple reported $74,200 million in net sales in the Greater China region in 2022, which includes China mainland, Hong Kong, and Taiwan. AMD, on the other hand, reported $2,091 million in sales specifically in Taiwan for the same year. This indicates that while Apple has a significantly larger overall presence in the broader Greater China region, AMD's direct sales in Taiwan are much smaller in scale.",
      "llm_answer": "Apple’s FY 2022 Form 10‑K shows that net sales from the Greater China segment (which includes mainland China, Hong Kong and Taiwan) were **$74,200 million**【page_52】.  \nAMD’s FY 2022 Form 10‑K reports that sales to external customers in **Taiwan** were **$2,091 million**【page_78】.  \n\nThus Apple’s Greater China sales were about **$72 billion higher – roughly thirty‑five times the size** of AMD’s Taiwan‑only revenue in the same year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: Apple's $74,200 million in Greater China and AMD's $2,091 million in Taiwan sales for 2022 are correctly reported, with proper sourcing from the respective 10-K filings. (2) The calculation comparing the two—stating Apple's sales were about $72 billion higher and roughly 35 times larger—is mathematically sound: $74,200M / $2,091M ≈ 35.5, which supports the 'roughly thirty-five times' characterization. (3) The reasoning is multi-hop and well-executed: it correctly distinguishes Apple’s broader regional sales (Greater China, including Taiwan) from AMD’s country-specific (Taiwan-only) sales, while still enabling a valid comparison given the shared exposure to the technology market in that geography. (4) All entities—Apple, AMD, fiscal year 2022, geographic regions (Greater China, Taiwan), and financial metric (net sales)—are accurately identified and contextualized. (5) The answer is semantically equivalent to the original, with added clarity in framing the magnitude of difference. No factual, numerical, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 330,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does Duke Energy's exposure to environmental remediation liabilities compare to Southern Company's ability to recover similar costs through regulatory mechanisms, given that Duke Energy's remediation costs are typically expensed as incurred unless recovery is probable, while Southern Company Gas' natural gas utilities specifically include environmental remediation in their approved cost recovery mechanisms?",
      "original_answer": "Duke Energy faces environmental remediation liabilities at multiple sites, with costs typically expensed as incurred unless regulatory recovery is deemed probable. In contrast, Southern Company Gas explicitly includes environmental remediation among the costs eligible for recovery through regulatory riders in its natural gas distribution utilities. This means that while Duke may bear these costs directly unless recovery is approved, Southern Company has a more structured pathway to recover such expenses through approved rate mechanisms, reducing its direct financial exposure to environmental remediation liabilities.",
      "llm_answer": "Duke Energy records environmental‑remediation liabilities as reserves (e.g., $73 million for the parent) and generally expenses remediation costs as incurred, only seeking recovery when a regulatory recovery is deemed probable (DUK 10‑K Remediation Activities, p. 163). In contrast, Southern Company Gas’s natural‑gas utilities have specific regulatory riders that permit recovery of environmental‑remediation expenses as part of their approved cost‑recovery mechanisms (SO 10‑K Natural Gas, p. 22). Thus, Duke Energy faces a more direct, unrecovered cost exposure, whereas Southern Company Gas can offset remediation costs through regulatory rate recoveries.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states Duke Energy's practice of expensing remediation costs as incurred unless recovery is probable, and notes the $73 million reserve for the parent company, which is consistent with Duke's 10-K (p. 163). This quantitative detail is not in the original answer but is factually correct and adds precision. (2) It accurately contrasts this with Southern Company Gas’s regulatory riders that allow recovery of environmental remediation costs, citing SO 10-K (p. 22), which supports the claim of structured cost recovery. (3) The multi-hop reasoning—comparing Duke’s cost-bearing approach with Southern’s recovery mechanism—is sound and correctly synthesizes information across two companies and filings. (4) The conclusion that Duke faces more direct cost exposure while Southern can offset costs via rate recovery matches the semantic meaning of the original answer. The only minor point is that the $73M figure, while accurate, is not in the ground truth and could be seen as over-specific if not fully contextualized across all Duke entities, but this does not detract from correctness. Wording differs but meaning is equivalent. All entities (Duke Energy, Southern Company Gas), mechanisms (regulatory riders, cost recovery), and financial treatments are correctly identified.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 379,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does LOW's use of broker/dealer quotes for Level 2 fair value measurements compare to GM's reliance on valuation models for product warranty reserves, given the role of industry-standard models in both companies' financial reporting?",
      "original_answer": "LOW uses broker/dealer quotes as inputs to Level 2 fair value measurements for financial assets when quoted prices in active markets are not available, relying on third-party pricing models with observable market inputs like issuer spreads and benchmark securities. GM, on the other hand, applies valuation models to estimate product warranty reserves, incorporating significant assumptions such as warranty claims frequency, average cost per claim, and historical claims data. Both companies utilize industry-standard valuation models, but LOW's approach is market-driven with observable inputs (Level 2), while GM's involves more management judgment and forward-looking assumptions. This highlights different applications of valuation models: LOW's fair value measurements are more directly tied to current market data, whereas GM's depend on internal forecasts and historical performance.",
      "llm_answer": "Lowe’s Level 2 fair‑value measurements are derived from industry‑standard pricing models that use observable market inputs—including reported trades and broker‑dealer quotes—as key data points (LOW 10‑K p. 54). In contrast, GM estimates its product‑warranty reserves with valuation models that rely on historical claim experience, frequency and cost assumptions, and actuarial methods rather than market quotes (GM 10‑K p. 56). Both firms therefore depend on industry‑standard models, but Lowe’s approach is driven by external market data while GM’s is driven by internal claim‑based assumptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: LOW uses broker/dealer quotes and observable market inputs (e.g., reported trades) in industry-standard pricing models for Level 2 fair value measurements, as confirmed in the LOW 10-K. GM uses valuation models for warranty reserves based on historical claims, frequency, cost assumptions, and actuarial methods, per GM's 10-K. There are no incorrect numbers, dates, or financial figures—this is a qualitative comparison, so no calculations are needed. (2) Quantitative accuracy is perfect: no numerical inaccuracies, and citations to page numbers (p. 54, p. 56) match the expected sourcing. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies (LOW and GM), two distinct financial reporting areas (fair value measurements vs. warranty reserves), and contrasts their use of models—market-driven vs. assumption-driven. (4) The only minor shortcoming is a slight reduction in detail compared to the original answer: the ground truth elaborates that LOW’s inputs include 'issuer spreads and benchmark securities' and emphasizes that GM’s approach involves 'management judgment and forward-looking assumptions' more explicitly. The LLM answer captures the essence—'external market data' vs. 'internal claim-based assumptions'—but with slightly less depth in characterizing the nature of management judgment. However, this does not detract from factual correctness. Semantic equivalence is maintained. Contextual relevance is excellent, directly addressing the role of industry-standard models in both firms’ reporting and contrasting their inputs. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 501,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How would the implementation of the Basel III Finalization Proposal's Expanded Risk-Based Approach impact both Capital One and Citigroup's regulatory capital requirements, considering the phased-in effective date of July 1, 2025, and the requirement to use the lower of the two calculated risk-based capital ratios?",
      "original_answer": "The Basel III Finalization Proposal introduces a new Expanded Risk-Based Approach that would require both Capital One and Citigroup to calculate their risk-based capital ratios under both this new framework and the existing Basel III standardized approach, using the lower of the two ratios for compliance. For Capital One, this includes a three-year transition period starting July 1, 2025, during which risk-weighted assets under the Expanded Risk-Based Approach would be phased in. Citigroup has indicated that, if the proposal is finalized as written, it would materially increase its required regulatory capital. Both banks must also comply with all capital buffer requirements regardless of which approach yields the lower ratio, further constraining capital flexibility.",
      "llm_answer": "Both firms would have to compute risk‑weighted assets under the new Expanded Risk‑Based Approach and under the existing standardized approach and then use the lower of the two resulting CET1, Tier 1 and total‑capital ratios (Capital One p. 11; Citigroup p. 48). The rule would take effect on July 1 2025 and phase in over three years, so Capital One would add a new RWA calculation that could tighten its capital ratios, while Citigroup explicitly notes that the expanded approach would “materially increase” its required regulatory capital (Citigroup p. 48).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core elements of the ground truth. (1) All factual information is correct: the July 1, 2025 effective date, the three-year phase-in period, and the requirement to use the lower of the two capital ratios (CET1, Tier 1, total capital) are all correctly stated. Citigroup's statement that the rule would 'materially increase' its required regulatory capital is accurately quoted and attributed (p. 48), and Capital One's exposure to potentially tighter capital ratios due to the new RWA calculation is correctly noted (p. 11). (2) Quantitative accuracy is perfect: the date July 1, 2025 is correct, and the three-year transition period aligns with the ground truth. No numerical calculations are required, but all temporal and structural details are precise. (3) Multi-hop reasoning is sound: the answer synthesizes information from both Capital One and Citigroup, correctly identifying that both must run parallel calculations and use the lower ratio. It also captures the differential impact—more explicit for Citigroup, structural for Capital One. (4) The only minor omission is that the ground truth mentions both banks must comply with all capital buffer requirements regardless of the chosen ratio, which adds an extra layer of constraint on capital flexibility. This detail is missing in the LLM answer, slightly reducing completeness. However, the core regulatory mechanism and impact are accurately conveyed. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 450,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does ConocoPhillips' exposure to condensate production through its ownership in Alba Plant LLC compare to Chevron's direct condensate production volumes in 2024, given Chevron reports zero condensate reserves in its 2024 10-K filing?",
      "original_answer": "ConocoPhillips holds a 52.2% interest in Alba Plant LLC, which extracts condensate from the Alba Unit natural gas stream and sells it at market prices, with COP's share reflected in 'Equity in earnings of affiliates.' In contrast, Chevron's 2024 10-K shows no condensate production or reserves across all categories, including both consolidated and affiliated companies. This indicates that while COP has exposure to condensate through its Alba Plant investment, Chevron had no direct condensate production in 2024.",
      "llm_answer": "ConocoPhillips’ exposure to condensate comes from its 52.2 % ownership of Alba Plant LLC, the joint‑venture that processes the Alba Unit’s natural‑gas stream and extracts condensate for sale (the plant’s revenue is reflected in “Equity in earnings of affiliates”)【page_12】. By contrast, Chevron’s 2024 filing reports zero condensate reserves, meaning its direct condensate production in 2024 was effectively nil.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: ConocoPhillips' 52.2% ownership in Alba Plant LLC is accurately reported. (2) The answer correctly identifies that Chevron's 2024 10-K reports zero condensate reserves, leading to the conclusion of effectively nil direct production—this matches the original answer's assertion that Chevron had no condensate production or reserves across consolidated and affiliated entities. (3) The multi-hop reasoning is sound: it connects COP's indirect exposure via equity investment to Chevron's lack of direct production, synthesizing information across two companies and ownership structures. (4) The only minor omission is that the LLM does not explicitly mention that Chevron also has no condensate production in affiliated companies, which the original answer includes for completeness. However, stating 'zero condensate reserves' and concluding 'effectively nil' production reasonably implies no production, making this a minor gap. Wording differences are semantically equivalent. All entities (ConocoPhillips, Chevron, Alba Plant LLC), metrics (ownership percentage, reserves, production), and the year (2024) are correct. The citation of 'Equity in earnings of affiliates' is properly contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 366,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the application of ASU 2020-04 to contract modifications impact both AVGO's revenue recognition practices and ORCL's financial reporting, particularly in relation to reference rate reform?",
      "original_answer": "AVGO evaluates contract modifications to determine whether additional products or services should be accounted for as a separate contract or part of the existing contract, using standalone selling prices adjusted for specific contract circumstances. ORCL adopted ASU 2020-04 related to reference rate reform, which allowed optional expedients for contract modifications affected by changes in reference rates such as LIBOR. According to the evidence, AVGO uses standalone selling prices to allocate consideration in bundled arrangements, and modifications are accounted for prospectively, cumulatively, or a combination depending on the nature of the change. ASU 2020-04 applied to contract modifications made between March 12, 2020, and December 31, 2024, and both AVGO and ORCL reported no material impact on their consolidated financial statements from applying this guidance. ORCL finalized its adoption of ASU 2020-04 in Q1 of fiscal 2024, with no material effect on its financial statements or notes.",
      "llm_answer": "AVGO applied ASU 2020‑04 to its contract‑modification accounting, so each amendment is first tested to see if its price reflects the standalone selling price; when it does not, the added product or service is recognized on a prospective basis (or on a cumulative‑catch‑up basis) rather than restating prior periods, which changes the timing of revenue recognition【page_63】. ORCL’s adoption of the same update—issued to address reference‑rate reform—was disclosed as having no material impact on its consolidated financial statements or related notes for the year ended May 31 2024【page_72】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) Quantitatively, all key facts are correct: both AVGO and ORCL adopted ASU 2020-04, the guidance applied to contract modifications related to reference rate reform (e.g., LIBOR), and both companies reported no material impact on financial statements. The mention of ORCL's fiscal year-end May 31, 2024, aligns with its reporting cycle and matches the timeframe in the original answer (Q1 fiscal 2024). (2) The LLM correctly identifies that AVGO uses standalone selling prices to assess contract modifications and applies prospective or cumulative catch-up accounting—consistent with the ground truth. It also correctly states that ORCL’s adoption had no material impact, as confirmed in its disclosures. (3) The multi-hop reasoning is sound: the model synthesizes how ASU 2020-04 affected both companies’ accounting practices—AVGO’s revenue recognition timing and ORCL’s financial reporting—tying both to reference rate reform. (4) Minor omission: the LLM does not explicitly mention the effective period of ASU 2020-04 (March 12, 2020, to December 31, 2024) or that ORCL finalized adoption in Q1 of fiscal 2024, though the reference to May 31, 2024, implies this. Also, AVGO’s use of standalone selling prices in bundled arrangements is slightly underdeveloped. However, these are minor gaps that do not undermine the core correctness. Wording differs but maintains semantic equivalence. No calculation errors. Strict on completeness, hence 9 instead of 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 425,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How does the dual-class stock structure at META, which negatively impacts the attractiveness of its Class A Common Stock, compare to CMCSA's Class B Common Stock convertibility policy in terms of governance control and shareholder influence?",
      "original_answer": "META's dual-class structure gives disproportionate voting control to Class B shareholders like Mark Zuckerberg, requiring a majority of Class B shares to approve change-of-control transactions until they fall below 35% of combined voting power. In contrast, CMCSA allows Class B Common Stock (with 15 votes per share) to convert share-for-share into Class A Common Stock, maintaining a non-dilutable 33⅓% aggregate voting power for Class B shares. While both structures concentrate governance influence, META's system entrenches control more rigidly through class-vote requirements, whereas CMCSA enables gradual dilution through conversion.",
      "llm_answer": "Meta’s dual‑class structure concentrates voting power in a small group of Class B holders (the founder, CEO and board chair) who control the outcome of all shareholder votes, so Class A shareholders have little ability to influence corporate matters and the Class A stock is viewed as less attractive【page_49†L1-L8】【page_50†L1-L7】.  Comcast’s Class B shares likewise carry super‑voting rights (15 votes per share, about 33 % of total voting power) that are non‑dilutable, but they are convertible share‑for‑share into ordinary Class A stock, allowing holders to potentially reduce that voting power while still retaining significant governance control【page_91†L1-L7】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: Meta's dual-class structure gives disproportionate control to Class B shareholders (e.g., Mark Zuckerberg), limiting Class A influence; CMCSA's Class B shares have 15 votes per share and represent about 33⅓% of total voting power, which is non-dilutable but convertible share-for-share into Class A. (2) Quantitative accuracy is perfect: '15 votes per share' and '33%' (approximation of 33⅓%) are correctly reported; no calculations are required, but the percentages and voting rights match the original. (3) Multi-hop reasoning is sound—LLM correctly contrasts Meta’s entrenched control (via class-vote requirements) with CMCSA’s more flexible structure allowing conversion and potential dilution of voting power. The LLM does not explicitly mention the 'majority of Class B shares required for change-of-control' threshold or the 35% trigger for Meta, which is a minor omission affecting completeness but not the overall correctness. (4) Semantic equivalence is strong: wording differs but meaning aligns closely with the original, and the comparison of governance rigidity vs. gradual dilution is effectively communicated. Contextual relevance is excellent as it directly addresses governance control and shareholder influence for both companies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 379,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How does PEP's use of exchange-traded commodity futures, which are cash-settled daily, compare with COST's disclosure regarding the absence of Level 1 financial assets measured at fair value on a recurring basis, given that Level 1 financial assets typically include exchange-traded commodity futures?",
      "original_answer": "PEP utilizes exchange-traded commodity futures that are cash-settled daily to manage market risk, and these are excluded from the fair value table as of December 25, 2021. These commodity futures fall under Level 1 financial assets, as defined by MDLZ's disclosure, which includes exchange-traded commodity futures valued at quoted market prices. However, COST explicitly states that as of August 28, 2022, it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis, indicating a distinct difference in financial instrument usage between PEP and COST.",
      "llm_answer": "PepsiCo acknowledges that it uses exchange‑traded commodity futures to hedge price risk, but because those contracts are cash‑settled each day they are **not included** in its Level 1 fair‑value table (they are excluded from the table as of December 25 2021)【page_107】. Costco, on the other hand, states that it **holds no Level 1 financial assets measured at fair value on a recurring basis**, which means it does not have exchange‑traded commodity futures in its portfolio【page_51】. Thus, PepsiCo actively employs cash‑settled futures (though they are omitted from the Level 1 hierarchy), whereas Costco reports the absence of any such Level 1 assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that PEP uses exchange-traded commodity futures that are cash-settled daily and excludes them from its fair value table as of December 25, 2021, which matches the original answer. It also accurately notes that COST reports no Level 1 financial assets measured at fair value on a recurring basis as of August 28, 2022 (implied in the LLM answer by referencing Costco's disclosure, though the exact date isn't repeated — a minor omission). (2) All dates and financial concepts are correct: December 25, 2021 for PEP and the exclusion from Level 1 tables due to daily cash settlement are factually sound. The absence of Level 1 assets for COST is correctly reported. (3) The multi-hop reasoning is solid: the model correctly synthesizes that exchange-traded commodity futures are typically Level 1 assets (as confirmed by MDLZ’s disclosure in the ground truth), yet PEP excludes them due to accounting treatment, while COST holds none at all, indicating a real difference in usage. The LLM infers this contrast accurately. (4) The only minor shortcoming is that the LLM does not explicitly mention MDLZ’s role in defining Level 1 assets (which supports the classification), but this does not detract from the core factual accuracy. Wording differs slightly but maintains semantic equivalence. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 403,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How does the value of securities loaned with maturities of 31-90 days at Goldman Sachs compare to the total securities loaned value reported by Morgan Stanley, and what does this suggest about their relative exposure to short-term securities lending risk?",
      "original_answer": "Goldman Sachs reports $1,634 million in securities loaned with maturities of 31-90 days, while Morgan Stanley reports a total of $281 million in securities loaned (U.S. and Non-U.S. combined). This suggests that Goldman Sachs has a significantly higher exposure to short-term securities lending risk compared to Morgan Stanley.",
      "llm_answer": "Goldman Sachs shows $1,634 million of securities loaned that mature in 31‑90 days【page_187】.  Morgan Stanley reports total securities‑loaned liabilities of about $14,988 million【page_198】.  Thus Goldman’s short‑term loaned amount is roughly one‑tenth of Morgan Stanley’s overall securities‑lending exposure, indicating that Morgan Stanley carries a far larger securities‑lending risk while Goldman’s risk is confined to a relatively modest short‑term tranche.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors. It states that Morgan Stanley reports total securities loaned of $14,988 million, which is incorrect. The ground truth is $281 million (U.S. and Non-U.S. combined), making the LLM's figure over 50 times too high. This error completely undermines the comparison. The Goldman Sachs figure of $1,634 million is correct. (2) Quantitative accuracy is severely compromised: the Morgan Stanley number is wrong, and the conclusion that Goldman’s amount is 'one-tenth' of Morgan Stanley’s is false—actually, Goldman’s $1,634 million is nearly six times larger than Morgan Stanley’s $281 million. (3) The multi-hop reasoning is flawed because the model fails to correctly retrieve and synthesize the Morgan Stanley value. Instead of showing Goldman Sachs has significantly higher short-term exposure, the answer incorrectly suggests Morgan Stanley has much larger exposure. (4) Contextual relevance is moderate—the answer addresses the right topic and companies, and attempts a comparative risk assessment, but due to the critical data error, the conclusion is the opposite of the truth. The qualitative reasoning would otherwise be sound if based on correct inputs.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 343,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What percentage of PowerSouth's owned generating capacity comes from its undivided interest in Alabama Power's Plant Miller Units 1 and 2, and how does this compare to Duke Energy's total electricity generation in GWh for 2021?",
      "original_answer": "PowerSouth owns an undivided 8.16% interest in Alabama Power's Plant Miller Units 1 and 2, which contributes to its total generating capacity of over 1,600 MWs. In comparison, Duke Energy generated a combined total of 22,344 GWh of electricity in 2021 across all its operating segments. This comparison highlights the relative scale of PowerSouth’s partial ownership in a specific plant versus Duke Energy’s full system-wide electricity generation.",
      "llm_answer": "PowerSouth’s undivided interest in Alabama Power’s Plant Miller Units 1 and 2 represents **about 8.16 %** of its owned generating capacity【page_17】.  Duke Energy’s electricity generation in 2021 was **approximately 34,713 GWh** (22,344 GWh for Duke Energy, 1,681 GWh for Duke Energy Ohio and 10,688 GWh for Duke Energy Indiana)【page_187】.  Thus PowerSouth’s share is a modest 8.16 % of its capacity, while Duke Energy produced tens of thousands of gigawatt‑hours of power in the same year.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies PowerSouth's 8.16% undivided interest in Plant Miller Units 1 and 2, which matches the ground truth. However, it misrepresents this as 'about 8.16% of its owned generating capacity' when the original answer states that the 8.16% is PowerSouth's ownership stake in the plant units — not that this percentage represents 8.16% of PowerSouth’s total capacity. This is a critical misinterpretation. (2) The Duke Energy generation figure is significantly incorrect: the LLM reports 34,713 GWh by summing 22,344 (Duke Energy), 1,681 (Ohio), and 10,688 (Indiana), but the ground truth specifies that 22,344 GWh is the *combined total* for all Duke Energy operating segments in 2021. The LLM incorrectly treats 22,344 GWh as a component rather than the total, leading to a fabricated sum of ~34,713 GWh, which is factually wrong. (3) The multi-hop reasoning is partially sound in attempting to compare PowerSouth’s partial ownership with Duke Energy’s system-wide generation, but due to the numerical errors and mischaracterization of the 8.16%, the synthesis is flawed. (4) Contextual relevance is high because the answer addresses both parts of the question and attempts comparison. However, correctness is low due to major quantitative inaccuracies and a misunderstanding of the nature of the percentage reported. Thus, correctness score is 4 (partially correct on one fact, major error on the other), quantitative accuracy is 3 (one number right, one severely wrong), qualitative accuracy is 5 (basic reasoning structure is present but flawed), and contextual relevance is 8 (on-topic and attempts full response).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 451,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How does NIKE's exposure to interest rate risk in its $11.6 billion portfolio of fixed-income investments compare to McDonald's sensitivity to market inputs like interest rate yield curves, given both companies rely on pricing models that use observable market data for valuation?",
      "original_answer": "NIKE holds $11.6 billion in short-term investments, including investment-grade fixed-income securities, which are exposed to interest rate risk. These investments are valued using pricing models that incorporate observable market data such as interest rates and yield curves. Similarly, McDonald’s discloses that its derivatives are valued using pricing models that rely on observable market parameters, including interest rate yield curves. While NIKE’s risk stems from changes in interest rates affecting investment returns, McDonald’s exposure is tied to derivative valuations that reflect market fluctuations. Both companies depend on observable inputs for fair value measurements, though the nature and magnitude of risk differ based on the type of financial instrument involved.",
      "llm_answer": "Nike’s interest‑rate risk is confined to its $11.6 billion cash‑equivalents and short‑term investment portfolio, which is made up of investment‑grade fixed‑income securities and has a weighted‑average maturity of only about 65 days, limiting the impact of rate changes【page_50】. McDonald’s, by contrast, is sensitive to market inputs such as interest‑rate yield curves because many of its derivatives and other fair‑value assets are valued with Level‑2 pricing models that rely on observable market data, so changes in those curves can affect earnings and other‑comprehensive‑income directly【page_46】. Thus Nike’s exposure is a modest, short‑duration fixed‑income risk, while McDonald’s exposure is broader and tied to the valuation of derivatives that depend on interest‑rate curves.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all figures are correct: NIKE's $11.6 billion portfolio is accurately cited, and while the weighted-average maturity of 65 days is an additional detail not in the original answer, it does not contradict it and is likely derived from the source (page_50). No calculations were required, and all financial figures match. (2) The entities—NIKE and McDonald’s—are correctly identified, and the financial instruments (fixed-income securities, derivatives) and valuation methods (pricing models using observable market data like interest rate yield curves) are accurately attributed to each company. (3) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly distinguishes NIKE’s exposure via short-term fixed-income investments from McDonald’s derivative-related sensitivity, both tied to observable market inputs but differing in nature and scope. (4) The LLM adds contextual nuance—short duration, Level-2 pricing models, impact on earnings and other comprehensive income—that enhances the comparison without introducing inaccuracies. The only minor gap is that the original emphasizes both companies use observable inputs for fair value measurements, a point slightly underemphasized in the LLM answer, though implied. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth with excellent reasoning and precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 410,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How does the difference in voting rights structure between Netflix's common stock and Alphabet's Class A common stock potentially influence their respective shareholder governance dynamics, given Netflix's uniform one-vote-per-share policy and Alphabet's multi-class structure with differential voting rights?",
      "original_answer": "Netflix's common stock provides each share with one vote, promoting a more egalitarian shareholder governance model. In contrast, Alphabet's multi-class structure, where Class A common stock grants one vote per share while Class B common stock grants 10 votes per share, concentrates voting power among holders of Class B shares. This structural difference means Alphabet's governance is more susceptible to control by a smaller group of insiders or major shareholders, while Netflix maintains a more evenly distributed voting environment.",
      "llm_answer": "Netflix’s charter gives every share of its common stock one vote, so voting power is directly proportional to the amount of stock an investor owns and all shareholders have an essentially equal say in corporate matters【page_60】. Alphabet’s equity is split into three classes: Class A shares also carry one vote, but Class B shares carry ten votes each (and Class C carries none), concentrating control in the hands of insiders who hold Class B stock【page_82】. Thus, Netflix’s uniform one‑vote‑per‑share structure promotes a more democratic, shareholder‑driven governance, whereas Alphabet’s multi‑class system allows a small group of high‑voting shareholders to dominate decision‑making even though Class A holders have the same one‑vote‑per‑share right.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All key facts are correct: Netflix’s one-vote-per-share policy and Alphabet’s multi-class structure with Class A (1 vote), Class B (10 votes), and Class C (no votes) are accurately described. The claim that control is concentrated among insiders holding Class B shares is consistent with the original answer. (2) Quantitative accuracy is perfect: the voting ratios (1:1 for Netflix, 1 vote for Class A, 10 votes for Class B at Alphabet) are correctly stated with no calculation errors. (3) The multi-hop reasoning is sound—comparing governance dynamics across two companies based on their capital structures is well executed. The synthesis correctly infers that Netflix promotes broader shareholder influence while Alphabet enables control by a small group. (4) The only minor shortcoming is stylistic: the LLM mentions 'three classes' of Alphabet stock, which, while technically true, slightly over-specifies by including Class C (non-voting), which is not directly relevant to the comparison of voting rights between Netflix and Alphabet’s Class A. However, this does not detract from the correctness and may even add context. Semantic equivalence is maintained, and the core governance implications are accurately conveyed. Hence, a high score of 9 is warranted.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 373,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How might the IRA's price-setting provisions for Medicare Part D drugs like Imbruvica and XARELTO differently impact AbbVie and Johnson & Johnson's revenue strategies, given their respective exposure to the Medicare program?",
      "original_answer": "The IRA's price-setting provisions for Medicare Part D drugs will likely impact AbbVie and Johnson & Johnson differently due to their distinct product portfolios and revenue strategies. AbbVie has Imbruvica selected for price-setting starting in 2026, which could significantly affect its revenue stream, especially if more high-revenue products are selected in the future. Johnson & Johnson has XARELTO selected under the same program, a major anticoagulant with substantial Medicare utilization. Both companies face uncertainty around the final government-set prices, but J&J has already filed litigation challenging the constitutionality of the IRA’s pricing mechanism, suggesting a more aggressive stance to protect revenue. AbbVie, on the other hand, is more focused on evaluating the broader strategic impact of the IRA, including potential acceleration of revenue erosion prior to patent expirations. The differing responses reflect their respective risk exposure and strategic priorities within the Medicare program.",
      "llm_answer": "The IRA gives CMS the authority to set a ceiling price for selected Medicare Part D drugs, and AbbVie’s Imbruvica was named among the first ten drugs to be price‑set (AbbVie 10‑K p. 19), meaning its Medicare‑related earnings could be directly capped and the company may need to rely more on non‑Medicare sales, new launches or pricing adjustments. Johnson & Johnson’s exposure comes from XARELTO, also on the CMS “Selected Drug” list (J&J 10‑K p. 11), but because XARELTO represents a smaller slice of J&J’s diversified portfolio, the revenue impact is likely to be less material and can be offset by its broader product mix and other Medicare‑covered offerings.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in identifying that both Imbruvica (AbbVie) and XARELTO (Johnson & Johnson) were selected for Medicare Part D price-setting under the IRA, with correct references to the respective 10-K filings. There are no numeric inaccuracies—no specific dollar amounts, percentages, or dates were misstated, and the qualitative descriptions of exposure are reasonable. However, the LLM omits key strategic differences highlighted in the ground truth: (1) J&J’s active litigation challenging the constitutionality of the IRA’s pricing mechanism, which signals a distinct revenue protection strategy, and (2) AbbVie’s concern about accelerated revenue erosion ahead of patent expirations. These omissions reduce completeness and weaken the comparative analysis of revenue strategies, which is central to the question. While the LLM correctly notes J&J’s diversified portfolio as a mitigating factor, it does not fully synthesize the multi-hop insight that corporate responses (litigation vs. strategic evaluation) reflect differing risk management approaches. The reasoning is sound but partial, and the answer remains contextually relevant and well-supported by document evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 337,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How does Citi's governance structure for managing compliance risk specifically address the potential amplification of credit and liquidity risks stemming from transition climate risks as outlined in Morgan Stanley's risk disclosures?",
      "original_answer": "Citi's governance structure includes the Board and Executive Management Team, which oversee enterprise risk management (ERM) and hold management accountable for the effectiveness of internal controls and compliance with legal and regulatory requirements. This includes ensuring that compliance risk is effectively managed across the organization. Transition climate risks, as outlined in Morgan Stanley's disclosures, may amplify credit and liquidity risks by reducing customers' operating income or the value of their assets. These risks also expose firms to reputational, compliance, and litigation risks due to increased legal and regulatory scrutiny. Citi’s Internal Audit, which reports functionally to the Chair of the Citi Audit Committee, provides independent assurance over the effectiveness of governance, risk management, and controls, including those addressing climate-related risks. This structure ensures that compliance risk management processes are aligned with evolving regulatory expectations, such as those related to climate risk, which Morgan Stanley notes are increasingly focused on disclosure and regulation of carbon emissions.",
      "llm_answer": "Citi’s compliance‑risk oversight is built into its second‑line “Independent Compliance Risk Management” (ICRM) function, which reports to the Group Chief Compliance Officer and, through matrix reporting, to the Group Chief Risk Officer and sits on the Risk‑Management Executive Council.  ICRM works with the Group Business Risk and Control Committee and the Board’s Risk‑Management Committee (which also oversees credit, market and liquidity risk) and the Asset‑and‑Liability Committee, so that any climate‑transition‑driven pressures that could magnify credit or liquidity exposures are identified, challenged, monitored and escalated to senior management and the Board for action.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in describing Citi's governance structure for compliance risk, particularly the role of the Independent Compliance Risk Management (ICRM) function, its reporting lines, and integration with key risk committees. It correctly identifies how climate transition risks could amplify credit and liquidity risks and notes the escalation path to senior management and the Board. However, it does not explicitly reference Morgan Stanley's risk disclosures, which is a key multi-hop requirement of the question. The original answer connects Citi’s governance to Morgan Stanley’s stated concerns about transition risks affecting customer income and asset values, increasing regulatory scrutiny, and the need for alignment with evolving climate regulations. While the LLM implies this linkage through context, it fails to directly cite or reflect Morgan Stanley’s specific disclosures as required. There are no numerical inaccuracies (quantitative accuracy is perfect by default, as no numbers are involved), and the structure and reasoning are sound. The omission of explicit reference to Morgan Stanley’s disclosures reduces completeness and weakens the multi-hop synthesis, warranting a score of 7 for correctness and qualitative accuracy. Contextual relevance remains high because the response addresses the core governance mechanisms and risk linkages.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 381,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does QCOM's reliance on Chinese OEMs for 30% of its licensing revenue create different supply chain risks compared to TXN's strategy of expanding internal 300mm wafer fabrication capacity?",
      "original_answer": "QCOM derives a significant portion of its licensing revenues from Chinese OEMs, with 30% of total licensing revenue coming from this group of manufacturers. Delays or disputes in license agreements with these OEMs can directly impact QCOM's revenue and cash flows. In contrast, TXN is expanding internal 300mm wafer fabrication capacity through investments in RFAB2, LFAB1, and SM1 facilities, aiming to achieve greater supply chain control and reduce dependency on external foundries. While QCOM's business model depends heavily on maintaining licensing agreements with external manufacturers, particularly in China, TXN's strategy reduces exposure to external supply chain disruptions by vertically integrating manufacturing. This creates different risk profiles: QCOM faces higher exposure to geopolitical and contractual risks in China, while TXN mitigates manufacturing risks through capital investments in internal capacity.",
      "llm_answer": "Qualcomm’s licensing model ties roughly 30 % of its royalty stream to Chinese OEMs, so its supply‑chain exposure is largely geopolitical – U.S./China trade or national‑security actions, licensing disputes or payment delays by those OEMs can instantly cut off a sizable revenue source (see QCOM risk factors on Chinese OEM concentration and trade‑policy risks, pages 18 & 20). Texas Instruments, by contrast, is building more of its own 300 mm wafer capacity to “lower costs and greater control of our supply chain” (pages 6‑7), so its chief supply‑chain risk is operational – the ability to fund, construct and run large fabs, secure raw‑material inputs and manage capacity‑demand imbalances, rather than exposure to external geopolitical licensing constraints.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 30% figure for QCOM's licensing revenue from Chinese OEMs is correctly stated, and no other numerical data contradicts the original. (2) The answer correctly identifies both companies (QCOM and TXN), their respective strategies, and risk profiles—geopolitical/contractual for QCOM, operational/capacity-related for TXN. (3) Multi-hop reasoning is sound: it synthesizes QCOM’s revenue dependency with external geopolitical risks and contrasts it with TXN’s vertical integration strategy to gain supply chain control, referencing internal fab expansions (RFAB2, LFAB1, SM1 implicitly covered under 'own 300mm wafer capacity'). (4) While the LLM does not explicitly name the specific facilities (RFAB2, etc.), it captures the essence of TXN’s strategy—building internal capacity for cost and control—accurately. The mention of 'pages 6-7' and 'pages 18 & 20' suggests grounding in source material, enhancing credibility. Only minor deduction in qualitative accuracy due to omission of specific fab names, but this does not impair the core comparison. Semantic equivalence is strong, and contextual relevance is excellent as it directly addresses the contrast in supply chain risks arising from differing business models.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 365,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does Southern Company's evaluation of ASU 2020-04 in relation to interest rate derivatives compare with Duke Energy's assessment of the same accounting standard's impact on its LIBOR-indexed financial contracts?",
      "original_answer": "Southern Company continues to evaluate the provisions of ASU 2020-04 and its impact on transitioning to alternative interest rates, particularly in relation to its interest rate derivatives as noted in Note 14, while Duke Energy is assessing the optional expedients provided by the same standard to manage contractual amendments or terminations for LIBOR-indexed financial arrangements, including variable-rate debt and interest rate swaps, which may extend beyond the 2023 LIBOR phase-out. Both companies recognize the uncertainty around the ultimate financial impact, with Duke Energy specifically noting it is not expected to be material.",
      "llm_answer": "Southern Company says it has elected to apply the ASU 2020‑04 amendments to any debt‑modification transactions, has added transition language to its LIBOR‑referenced contracts and expects no material impact, but will keep evaluating the effect of moving to an alternative rate. Duke Energy is similarly reviewing its LIBOR‑indexed variable‑rate debt and interest‑rate swaps, assessing the optional expedients and alternative‑index provisions, and likewise concludes the transition is unlikely to be material, although the final outcome remains uncertain.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in qualitative details and reasoning compared to the ground truth. (1) Correct elements: both companies are assessing ASU 2020-04 in relation to LIBOR transition; both conclude the impact is unlikely to be material; both mention ongoing evaluation and uncertainty. The answer correctly identifies Duke Energy's review of LIBOR-indexed variable-rate debt and interest rate swaps, and references optional expedients. (2) Quantitative accuracy: there are no numeric values, dates, or calculations in the question or ground truth, so this aspect is not applicable—scored as 10 by default since no numbers are misstated. (3) Multi-hop reasoning flaws: the LLM incorrectly states that Southern Company 'has elected to apply' the ASU 2020-04 amendments and 'has added transition language'—this is not supported by the ground truth, which says Southern is still 'continuing to evaluate' the standard and its impact, with no indication of election or implementation actions taken. This misrepresents Southern’s position as more advanced than it is. In contrast, the ground truth emphasizes Southern’s ongoing evaluation without definitive action, while the LLM implies decisions have already been made. (4) The Duke Energy portion is closer to accurate, noting assessment of optional expedients and lack of materiality, aligning with the original answer. However, the synthesis between the two companies is flawed due to the incorrect portrayal of Southern’s stance. The answer is contextually relevant and addresses the comparison asked, but the incorrect attribution of actions to Southern reduces factual reliability. Thus, correctness is reduced to 6 due to significant qualitative inaccuracy in entity actions despite correct framing and context.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 490,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does the exposure of AMZN's foreign currency assets to British Pounds and Euros compare to NKE's reliance on option contracts for managing similar currency risks, given their differing approaches to foreign exchange risk management?",
      "original_answer": "AMZN holds foreign currency assets in British Pounds, Euros, and other currencies, and is exposed to foreign exchange risk due to fluctuations that may materially impact translated values of these assets. NKE actively manages its foreign exchange risk using option contracts, specifically hedging exposures related to product costs, external sales, and other costs denominated in currencies like the British Pound and Euro. While AMZN discloses its exposure to these currencies, it does not specify the use of derivative instruments like options to hedge this risk. In contrast, NKE explicitly states its use of option contracts as part of its foreign currency risk management program to hedge forecasted transactions and balance sheet exposures. This suggests that NKE takes a more proactive and structured approach to mitigating foreign exchange impacts through financial instruments, while AMZN's strategy remains less transparent in terms of derivative usage.",
      "llm_answer": "AMZN’s foreign‑exchange risk stems from the fact that it holds cash equivalents and marketable securities denominated in British Pounds and Euros, so changes in those currencies directly affect the value of its assets (see AMZN page 9). By contrast, NKE does not rely on such foreign‑currency asset holdings; instead it actively hedges its transactional and translational exposures using forward and option contracts, explicitly noting that options are employed to offset anticipated cash‑flow impacts from currency movements (see NKE page 48). Thus, AMZN faces a passive exposure tied to its foreign‑currency asset balances, while NKE uses an active, option‑based hedging program to manage comparable currency risks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that AMZN holds foreign currency assets in British Pounds and Euros, exposing it to foreign exchange risk due to valuation fluctuations—consistent with the original answer. It accurately contrasts this with NKE's use of option contracts to hedge transactional and translational exposures, specifically mentioning forecasted cash flows related to product costs and sales. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification; thus, quantitative accuracy is not applicable but assumed perfect as no numbers were misstated. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (AMZN and NKE), compares their differing FX risk management strategies—passive exposure vs. active hedging—and draws a valid conclusion about NKE’s more structured use of derivatives, particularly options. The only minor shortcoming is that the LLM slightly overstates AMZN's lack of hedging by implying it has no derivative usage at all, whereas the original answer notes only that AMZN does not *specify* use of options—so the absence of disclosure is not equivalent to absence of practice. This nuance is missing but does not materially distort the comparison. (4) The answer is contextually excellent, directly addressing the comparison of AMZN’s exposure to GBP/EUR assets versus NKE’s reliance on options, and clearly differentiating their risk management philosophies. Overall, the response is factually correct, well-reasoned, and semantically equivalent to the ground truth with only a slight deduction for overstating AMZN's lack of hedging activity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 473,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does the voting power distribution between Class A and Class B common stock at META compare to GOOGL's structure, given the dynamic relationship between share class voting rights?",
      "original_answer": "At META, Class A common stockholders hold 66 2/3% of the combined voting power, while Class B common stockholders hold 33 1/3%, with each share of Class B having 15 votes. In contrast, at GOOGL, each share of Class A has one vote and each share of Class B has 10 votes, with no specific percentage provided for their distribution. This indicates that META grants significantly more voting influence to Class B shares relative to Class A compared to GOOGL's structure.",
      "llm_answer": "Meta’s capital structure consists of 2.19 billion Class A shares (one vote each) and 343.8 million Class B shares, which carry ten votes per share, so the relatively few Class B shares hold a disproportionate portion of the company’s voting power【page_1】. Alphabet’s structure is essentially the same – each Class A share gets one vote, each Class B share gets ten votes (and can be converted to Class A), with an additional non‑voting Class C series – meaning both firms concentrate control in a small block of high‑voting Class B shares, creating a dynamic relationship as those shares can be converted to Class A【page_82】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It states that Meta's Class B shares have 10 votes per share, but the ground truth specifies 15 votes per share. It also incorrectly claims there are 2.19 billion Class A shares and 343.8 million Class B shares, which are not supported by the original answer and introduce false quantitative precision. The original answer focuses on voting power distribution (66 2/3% for Class A, 33 1/3% for Class B), which the LLM omits entirely. For GOOGL, the LLM correctly notes that Class A has 1 vote and Class B has 10 votes, but fails to mention that no specific percentage distribution is provided, and incorrectly implies structural equivalence with META, downplaying the key difference in voting weight per share class. (2) Quantitative accuracy is low: vote counts per share are wrong for META (10 vs. actual 15), and fabricated share counts are introduced without basis. No correct calculation of voting power distribution is attempted. (3) Multi-hop reasoning is partially present—the model attempts to compare two companies' share structures—but fails to accurately represent either side of the comparison. The synthesis is flawed due to incorrect inputs. (4) Despite incorrect numbers, the answer is contextually relevant, recognizing the broader theme of control concentration via dual-class shares and conversion dynamics. However, the core factual errors in vote ratios and voting power distribution severely undermine correctness. Semantic equivalence is not achieved due to material factual deviations.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 434,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does Southern Company's (SO) investment in SNG and SNG's need for FERC approval on its pipeline project compare to Duke Energy Ohio's (DUK) experience with FERC approval in terms of regulatory constraints and capital implications?",
      "original_answer": "Southern Company's (SO) investment in SNG was $1,245 million as of December 31, 2024. SNG is developing a $3 billion pipeline project requiring FERC approval, with Southern Company Gas owning 50% of the project. This regulatory dependency could delay the project until 2029 if approvals are not met. Similarly, Duke Energy Ohio (DUK) requires FERC and PUCO approval to pay dividends from specific equity accounts, with a condition to maintain equity at no less than 30% of total capital. Both entities face regulatory constraints from FERC, but while SNG's challenge centers on project execution and timing, DUK's is tied to capital structure and dividend policy.",
      "llm_answer": "Southern Company’s equity‑method investment in Southern Company Gas includes a 50 % share of an approximately $3 billion pipeline (SNG) that cannot be built until all required regulator approvals – notably FERC’s – are obtained, making the large capital outlay (roughly half of the project cost) contingent on that approval (see page 92). In contrast, Duke Energy Ohio’s FERC approval concerns the ability to pay dividends from its equity accounts and imposes a regulatory constraint that its adjusted equity must remain at least 30 % of total capital, limiting capital distributions rather than tying capital to a new project (see page 147).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor omissions. (1) Quantitatively, the $3 billion pipeline project and 50% ownership by Southern Company Gas (implying ~$1.5 billion capital commitment) are correctly stated. However, the original answer specifies Southern Company's (SO) direct investment in SNG as $1,245 million as of December 31, 2024, which is missing in the LLM response—this is a minor omission but not a factual error. The 30% equity threshold for Duke Energy Ohio (DUK) is correctly reported. (2) The LLM correctly identifies FERC’s role for both entities and distinguishes the nature of regulatory constraints: project execution for SNG vs. capital structure/dividend policy for DUK. (3) Multi-hop reasoning is sound—comparing two companies’ regulatory dependencies on FERC across different contexts (project development vs. capital distribution). (4) Semantic equivalence is strong; the LLM captures the essence of regulatory and capital implications without misrepresenting facts. The only shortfall is the absence of the specific $1,245 million investment figure, which slightly reduces completeness but does not impair overall correctness. Contextual relevance is perfect—the response directly addresses regulatory constraints and capital implications as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 372,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does Lowe's share repurchase activity through financial institutions in 2021-2022 compare with Home Depot's use of dividend equivalents in terms of shareholder value distribution mechanisms?",
      "original_answer": "Lowe's authorized $13.0 billion in additional share repurchases in December 2021, bringing total authorization to $28.0 billion since 2020, and executed a $3.0 billion accelerated share repurchase (ASR) with a financial institution, receiving 11.9 million shares. Meanwhile, Home Depot pays dividend equivalents on unvested restricted stock units and performance shares, which accrue and are paid out in the form of additional shares upon vesting or payout. This shows Lowe's prioritized direct share reduction through financial intermediaries, while Home Depot focused on equity-based dividend equivalent compensation aligned with vesting timelines.",
      "llm_answer": "Lowe’s 2021‑22 shareholder‑return strategy relied on an Accelerated Share Repurchase (ASR) with a third‑party financial institution – the company paid $3 billion, received an initial 10.3 million shares and a further 1.6 million shares in January 2022, thereby directly buying back stock and returning cash to all shareholders【page_23】. In contrast, Home Depot distributes value through dividend equivalents attached to its performance‑share, restricted‑stock and restricted‑stock‑unit awards, which accrue on unvested awards and are paid as additional shares when the awards vest or are settled【page_69】. Thus Lowe’s uses a market‑based buy‑back via a financial institution, while Home Depot uses equity‑compensation‑linked dividend equivalents to provide shareholders (primarily award‑recipients) with extra shares rather than a direct repurchase.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Correctly identifies Lowe's $3.0 billion ASR with a financial institution and Home Depot's use of dividend equivalents on unvested equity awards. The share numbers (10.3 million initial + 1.6 million later = 11.9 million total) match the ground truth exactly, though the LLM breaks it down more granularly. (2) Quantitatively, the $3 billion amount and share counts are correct; the only minor omission is that the LLM does not mention Lowe's December 2021 $13.0 billion additional authorization or the $28.0 billion total since 2020, which is part of the original answer but not critical to the direct comparison asked. (3) The reasoning is sound: it correctly contrasts Lowe’s direct market-based buyback via financial intermediaries with Home Depot’s equity-compensation-linked dividend equivalents, highlighting different mechanisms of value distribution. (4) The answer is contextually relevant, directly addressing the comparison of shareholder value distribution mechanisms between the two companies during 2021–2022. The synthesis across entities and mechanisms is accurate and well-articulated. Only a slight deduction in quantitative accuracy due to the missing repurchase authorization context, but the executed ASR details are fully correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 374,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does the adoption of ASU 2022-04 impact the disclosure of supplier finance program obligations for both Caterpillar and Honeywell, particularly in terms of the rollforward requirement effective in 2024?",
      "original_answer": "Caterpillar and Honeywell both adopted ASU 2022-04, which mandates enhanced disclosures for supplier finance programs. The guidance requires annual disclosure of key terms, balance sheet presentation, and a rollforward of obligations, with the rollforward specifically becoming effective on January 1, 2024. Caterpillar included the rollforward in its 2024 disclosures, showing $830 million in obligations at year-end. Honeywell also adopted the rollforward requirement for 2024, aligning with the new standard. Both companies now provide more transparent reporting of their supplier finance obligations, which were $830 million for Caterpillar and would be similarly detailed for Honeywell under the new rules.",
      "llm_answer": "The FASB’s ASU 2022‑04 requires a buyer that uses supplier‑finance programs to disclose the program’s key terms, the balance‑sheet line where the amounts are presented and a roll‑forward of the confirmed obligations, with the roll‑forward element becoming effective on 1 Jan 2024. Caterpillar’s Note 15 now includes a FY 2024 roll‑forward showing a $803 M opening balance, $5.14 B of invoices confirmed, $5.113 B paid and a $830 M closing balance 【page_112】, while Honeywell’s Note 22 provides a similar roll‑forward of $1.112 B opening, $3.098 B confirmed, $3.060 B paid and $1.150 B ending obligations 【page_62】 and its adoption of ASU 2022‑04 (effective 1 Jan 2023, roll‑forward 1 Jan 2024) is disclosed in its accounting‑policy summary 【page_60】. Thus, both companies now give a transparent, period‑by‑period reconciliation of supplier‑finance liabilities for 2024 as required by the new standard.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and provides a detailed, correct response to the multi-hop question about ASU 2022-04's impact on Caterpillar and Honeywell. (1) Quantitatively, the LLM correctly reports Caterpillar’s $830 million ending obligation and Honeywell’s $1.150 billion ending balance, both aligning with the rollforward requirement effective January 1, 2024. The opening and transaction-level figures (e.g., $5.14B confirmed, $5.113B paid for Caterpillar; $3.098B confirmed, $3.060B paid for Honeywell) are specific and consistent with detailed rollforwards, though the ground truth did not include these line items—this additional detail does not contradict but enhances accuracy. However, Caterpillar’s closing balance is stated as $830M in both answers, but the LLM lists an opening of $803M, which is not in the original answer; while plausible and internally consistent ($803M + $5.14B - $5.113B ≈ $830M), this granular reconciliation was not in the ground truth and introduces unverified detail, slightly reducing quantitative accuracy. (2) The entity names (Caterpillar, Honeywell), accounting standard (ASU 2022-04), and effective date (January 1, 2024 for rollforward) are all correct. (3) The reasoning is sound: the LLM correctly synthesizes that both companies adopted the new disclosure requirements, including the 2024 rollforward, and now provide transparent reporting—this matches the multi-hop requirement across companies and time. (4) The answer is semantically equivalent and exceeds the original in detail without introducing errors. The only minor deviation is the inclusion of granular rollforward components not present in the ground truth, but these are plausible and do not contradict known facts. Thus, the answer earns a 9 for correctness due to slightly over-specified numbers not in the original, but remains excellent in all other dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 507,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does the $49,549 million in credit card loans due within 1 year reported by Company C compare to Visa's strategy of driving growth through credit card issuance, given the $20 trillion global opportunity they identify in converting non-card payments to digital credentials?",
      "original_answer": "Company C reports holding $49,549 million in credit card loans due within 1 year, indicating a significant portion of short-term consumer credit exposure. This aligns with Visa's strategic focus on expanding credit card usage to capture a share of the $20 trillion global opportunity in converting non-card payments to digital credentials on their network. Visa's emphasis on growing credit card programs through financial institution partnerships suggests a continued push to increase the volume and velocity of credit card transactions, which would likely feed into larger short-term loan balances across institutions like Company C.",
      "llm_answer": "Company C’s balance sheet shows about **$49.5 billion** of credit‑card loans that are due within one year. By contrast, Visa’s growth strategy is built around expanding credit‑card issuance to tap a **$20 trillion** global opportunity to convert non‑card payments into digital credentials—an addressable market that is orders of magnitude larger than the loan amount reported by Company C.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM correctly reports the $49,549 million (rounded to $49.5 billion) in credit card loans due within 1 year for Company C and accurately references Visa's $20 trillion opportunity in converting non-card payments to digital credentials. These numbers match the ground truth, with acceptable formatting variation ($49.5 billion = $49,549 million). 2) Quantitatively, all figures are correct and properly contextualized. The comparison in scale between Company C’s loan exposure and the global opportunity is valid. 3) However, the LLM answer falls short in fully synthesizing the multi-hop reasoning: while it notes the contrast in scale, it does not explicitly connect how Company C’s short-term credit exposure aligns with Visa’s strategy of growing credit card issuance through institutional partnerships. The original answer emphasizes alignment—Company C’s loans reflect the kind of activity Visa aims to expand—whereas the LLM frames it more as a contrast. This weakens the qualitative reasoning. 4) Despite this, the answer remains contextually relevant and factually accurate on key metrics, earning high marks for quantitative and contextual performance, but loses a point in qualitative accuracy for incomplete synthesis of strategic alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 351,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does the impact of weather conditions on Southern Company's gas distribution revenues compare to the exposure of NextEra Energy's electricity demand, considering their respective risk mitigation strategies?",
      "original_answer": "Southern Company Gas' earnings are affected by customer consumption patterns that are largely a function of weather conditions and natural gas price levels. For example, in 2023, Southern Company Gas experienced a 6.2% decrease in net income compared to 2022, partly due to lower gas volumes sold driven by weather patterns. However, the company utilizes mechanisms like weather normalization and weather derivative instruments to limit exposure to typical weather variations. In contrast, NextEra Energy (NEE) faces more direct and severe operational risks from weather conditions, such as hurricanes, extreme temperatures, and disruptions to power generation from wind and solar facilities. NEE's Florida-based operations are particularly vulnerable to hurricanes, which can cause power outages, infrastructure damage, and increased costs for service restoration. While NEE also seeks cost recovery through regulatory mechanisms, its exposure to unpredictable weather events poses a more immediate threat to both operations and financial performance compared to Southern Company Gas' structured risk management approach.",
      "llm_answer": "Southern Company’s gas‑distribution revenues do rise and fall with weather‑driven heating demand, but the utility cushions that exposure with “weather and revenue‑normalization mechanisms and weather‑derivative instruments” that limit the effect of typical weather swings (see SO 10‑K p. 86 & 200). NextEra Energy’s electricity sales are likewise weather‑sensitive—demand can surge or plunge with temperature extremes and severe storms, and while the company relies on hedging, trading and other risk‑management tools, it cautions that those tools “may not protect against significant losses” from severe weather events (see NEE 10‑K p. 26‑28). Thus Southern Company’s weather risk is more explicitly mitigated, whereas NextEra Energy remains more exposed to weather‑driven demand fluctuations despite its risk‑management programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, while the original answer includes a specific 6.2% decrease in Southern Company Gas' net income in 2023, this figure is not mentioned in the LLM response. However, no incorrect numbers are presented, and the absence of this specific percentage does not introduce inaccuracy—only a minor omission. All other financial and operational claims are consistent with the source. (2) The LLM correctly identifies both companies (Southern Company and NextEra Energy), their respective exposures (gas distribution vs. electricity demand), and relevant risk mitigation strategies (weather normalization, derivatives for SO; hedging and risk management with acknowledged limitations for NEE). (3) The multi-hop reasoning is sound: it compares the structure and effectiveness of weather risk mitigation between the two firms, correctly concluding that Southern Company has more explicit mechanisms to buffer weather impacts, while NextEra remains more exposed despite its tools. This matches the original answer’s core insight. (4) The LLM cites specific pages from the 10-Ks (SO p.86 & 200; NEE p.26–28), enhancing credibility, though these are not required for correctness. The semantic meaning and comparative analysis are equivalent to the ground truth. The only reason for not scoring a 10 is the omission of the specific 6.2% financial impact, which is a factual detail present in the original answer and relevant to quantifying Southern Company’s exposure. However, since the LLM does not make any false claims and captures the key comparative dynamics accurately, the score remains high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 455,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does McDonald's revenue model relying on affiliates compare to General Motors' production strategy for crossovers through nonconsolidated affiliates, particularly in terms of revenue contribution and operational structure?",
      "original_answer": "McDonald's generates revenue from affiliates through royalty payments based on a percentage of sales, along with initial fees, as part of its franchise model. This structure allows McDonald's to maintain a steady income stream tied directly to the performance of affiliate-operated restaurants. In contrast, General Motors produces crossovers through nonconsolidated affiliates involved in development, manufacturing, and marketing, where GM engages in purchasing and selling transactions with these entities. While McDonald's affiliate model centers on brand licensing and royalty income, GM's affiliate relationships focus on vehicle production and distribution. This results in distinct revenue contributions: McDonald's sees recurring revenue from affiliate royalties, whereas GM's revenue from affiliates is transactional and tied to the volume of crossover production and sales.",
      "llm_answer": "McDonald’s revenue model is franchise‑centric: with ≈41 000 franchised restaurants (page 45), the company earns most of its income from rent, royalties and other fees that are a percentage of franchisees’ sales (page 46). In contrast, GM produces crossovers through non‑consolidated joint‑venture affiliates—primarily its China JVs—that generated $27.3 billion of net sales but only $90 million of automotive sales and revenue (page 78) and are reflected in GM’s earnings via equity‑method income of $8.9 billion (page 105), indicating a modest direct revenue contribution and an operational structure based on joint‑venture production rather than a fee‑based franchise model.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numerical figures such as '≈41 000 franchised restaurants', '$27.3 billion of net sales', '$90 million of automotive sales and revenue', and '$8.9 billion' of equity-method income. However, these numbers are not present in the original ground truth answer and cannot be verified against it. Since the ground truth does not include any quantitative data, the introduction of such figures—without confirmation of their accuracy from the source—undermines quantitative accuracy. There is no way to confirm if these numbers are correct based on the provided ground truth, so they represent unsupported claims. (2) The use of page references (e.g., 'page 45', 'page 78', 'page 105') suggests the model is citing specific documents, but the ground truth does not mention or validate these pages or figures, making the quantitative assertions unverifiable and likely hallucinated. This significantly reduces quantitative accuracy. (3) Qualitatively, the LLM correctly distinguishes between McDonald’s franchise/royalty-based model and GM’s joint-venture production model involving nonconsolidated affiliates. It accurately contrasts fee-based income (rent, royalties) with transactional/joint-venture revenue and notes that GM reflects affiliate contributions via equity-method accounting, which aligns with the conceptual distinction in the ground truth. The reasoning correctly identifies the structural and revenue model differences, showing sound multi-hop synthesis across two companies and business models. (4) Contextually, the answer is highly relevant, directly addressing the comparison in terms of revenue contribution and operational structure as asked. While the core conceptual comparison is accurate, the inclusion of unverified numbers reduces overall correctness. The answer would have scored higher if it had avoided unsupported quantitative claims and stuck to the qualitative distinctions present in the ground truth. Thus, the correctness score is moderate due to factual overreach despite strong reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 560,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does the voting power dilution protection for Class B Common Stock at CMCSA compare with the automatic conversion provisions for Class B Common Stock at GOOGL, particularly in light of CMCSA's share-for-share conversion restriction and GOOGL's voluntary and transfer-triggered conversion policy?",
      "original_answer": "At CMCSA, the Class B Common Stock has a non-dilutable 33 1/3% aggregate voting power, which cannot be diluted by additional issuances of any other class of common stock, and is convertible share-for-share into Class A Common Stock, subject to certain restrictions. In contrast, at GOOGL, Class B Common Stock is entitled to 10 votes per share and can be voluntarily converted to Class A Common Stock at any time, with automatic conversion upon sale or transfer. This means CMCSA’s Class B shares maintain structural voting protection unaffected by issuance volumes, while GOOGL’s Class B shares lose enhanced voting rights upon transfer, making CMCSA's Class B shares more resilient to voting dilution.",
      "llm_answer": "CMCSA’s charter locks the Class B holders at a fixed one‑third of the company’s voting power – the 33 ⅓ % aggregate voting share “cannot be diluted by additional issuances” and the shares may only be exchanged for Class A on a one‑for‑one basis subject to specific restrictions【page_91】. In contrast, Alphabet’s Class B shares carry ten votes each but can be converted at the holder’s option at any time and automatically convert to one‑vote Class A shares when they are sold or transferred, which can shift voting power away from the high‑vote class【page_82】. Thus, CMCSA provides a stronger, non‑dilutable voting‑power protection, whereas GOOGL’s voluntary and transfer‑triggered conversion provisions can dilute the concentrated voting power of its Class B stock.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: CMCSA's Class B has a non-dilutable 33 1/3% aggregate voting power, convertible share-for-share into Class A with restrictions; GOOGL's Class B has 10 votes per share, voluntary conversion, and automatic conversion upon sale/transfer. (2) Quantitative elements are precise: '33 1/3%' and '10 votes per share' match the original. No calculations are required, but comparisons are correctly framed. (3) Multi-hop reasoning is sound: the answer synthesizes structural differences in voting protection and conversion policies across two companies (CMCSA vs GOOGL), correctly concluding that CMCSA’s Class B shares offer stronger, structural voting resilience while GOOGL’s are vulnerable to dilution via transfer-triggered conversion. (4) The response addresses all parts of the question: voting power dilution protection, conversion mechanisms, share-for-share restriction at CMCSA, and voluntary/transfer-triggered conversion at GOOGL. Wording differs slightly but meaning is preserved. All entities (CMCSA, GOOGL, Class A/B shares) are correctly identified. No factual errors or omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 338,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does AXP's valuation methodology for Level 3 investment securities expose it to the risks of illiquid market conditions, and how might this impact MS's ability to manage market risk during periods of asset devaluation?",
      "original_answer": "AXP relies on internal credit models and third-party valuations for its Level 3 investment securities, which include debt securities from Community Development Financial Institutions and an embedded derivative in GBT JerseyCo Limited valued using Monte Carlo simulations. These valuation techniques are sensitive to changes in market inputs and assumptions, particularly in illiquid market conditions where observable data is scarce. JPM_10k_2024.pdf confirms that illiquid markets make it extremely difficult to value financial instruments, and valuations may materially change when market conditions shift, leading to potential losses upon disposition. MS_10k_2024.pdf further states that during periods of market volatility and illiquidity, the firm faces challenges in valuing and monetizing financial instruments, which can negatively affect its results of operations and risk management strategies, including hedging inefficiencies and increased counterparty risk.",
      "llm_answer": "AXP’s Level 3 investment securities – mainly debt issued by Community Development Financial Institutions – are valued by using the carrying amount as a “reasonable proxy” for fair value unless its internal credit model indicates a cash‑flow shortfall, a method that relies on unobservable inputs and therefore can become inaccurate when markets are illiquid (AXP 10‑K p.146). Because MS’s market‑risk management depends on reliable pricing and effective hedging, the same illiquid‑market conditions that can misprice AXP’s Level 3 assets also make it harder for MS to value, monetize and hedge its positions, reducing the effectiveness of its risk controls during periods of asset devaluation (MS 10‑K pp.13‑15).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies AXP's use of internal credit models and unobservable inputs for valuing Level 3 securities, specifically mentioning debt from Community Development Financial Institutions, which aligns with the original answer. It also accurately notes the reliance on carrying amount as a proxy unless cash-flow shortfalls are indicated, a detail consistent with AXP’s 10-K. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: it connects AXP’s valuation methodology to the risks in illiquid markets and then links those conditions to MS’s challenges in managing market risk, referencing MS’s 10-K on hedging inefficiencies and valuation difficulties during volatility. The only minor omission is the specific mention of the embedded derivative in GBT JerseyCo Limited valued via Monte Carlo simulations, which is present in the ground truth but missing in the LLM response. This reduces completeness slightly but does not undermine the core correctness. (4) The answer is contextually fully relevant, directly addressing both parts of the question—how AXP’s methodology creates risk in illiquid markets and how that affects MS’s risk management. Wording differs but semantic equivalence is strong. Overall, this is a high-quality, factually correct response with only a small gap in completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 421,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does the valuation approach for Chevron's Level 2 derivatives compare to Exxon's use of discounted cash flow models in valuing upstream assets acquired from Pioneer, particularly in terms of observable market inputs and management judgment?",
      "original_answer": "Chevron classifies its derivatives as Level 2 when valued using third-party broker quotes, industry pricing services, and exchanges, relying on observable market data like interest rates and foreign exchange rates, with minimal adjustments. In contrast, Exxon used discounted cash flow models incorporating management judgment and unobservable inputs—such as projected production volumes, commodity prices based on third-party industry experts, and risk-adjusted discount rates—to determine the fair value of upstream assets acquired from Pioneer. While Chevron's Level 2 derivatives rely on largely consistent and observable inputs, Exxon's valuation required significant assumptions about future market conditions and asset performance, reflecting a higher degree of subjectivity and forward-looking judgment.",
      "llm_answer": "Chevron’s Level 2 derivatives are valued almost entirely from observable market data—third‑party broker quotes, industry pricing services and exchange prices—and the company makes only immaterial adjustments (CVX 10‑K p. 78). In contrast, Exxon’s fair‑value measurement of the upstream assets acquired from Pioneer relies on discounted‑cash‑flow models that use management‑derived forecasts of production, commodity‑price assumptions (averaged from third‑party experts), drilling and operating costs and risk‑adjusted discount rates, requiring substantial judgment (XOM 10‑K p. 71‑72). Thus Chevron’s approach is market‑driven and largely objective, while Exxon’s is model‑driven and heavily dependent on management estimates.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the original answer. (1) All key elements are correct: Chevron's use of observable market inputs (broker quotes, pricing services, exchange prices) with minimal adjustments aligns with the ground truth and is correctly attributed to Level 2 derivatives. Exxon's use of discounted cash flow models with management judgment, unobservable inputs (e.g., production forecasts, commodity price assumptions from third-party experts, risk-adjusted discount rates), and substantial estimation is accurately described. (2) There are no numerical values requiring verification (e.g., dollar amounts, percentages), but the qualitative financial concepts—such as 'immaterial adjustments' and 'substantial judgment'—are consistent with the original and supported by cited 10-K pages (p. 78 for CVX, pp. 71–72 for XOM). (3) The multi-hop reasoning is sound: the model correctly contrasts Chevron’s market-driven, objective approach with Exxon’s model-driven, subjective approach, synthesizing information across two companies, their derivative classifications, and valuation methodologies. (4) The answer fully addresses the question by comparing both companies’ approaches in terms of observable inputs and management judgment. Wording differs slightly but preserves precise technical meaning. No factual errors, omissions, or misattributions. Scores are maximized across all dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 400,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How does Duke Energy's negotiation of PPAs for renewable facilities compare with Southern Power's investment in solar facilities in terms of financial structure and tax credit utilization, given the role of PPAs in financing solar assets?",
      "original_answer": "Duke Energy negotiates PPAs as part of its commercial renewables strategy, which significantly influences the economic performance of its renewable energy VIEs, particularly through siting, PPA negotiation, and ongoing operations. These PPAs are also central to Southern Power's financial structure, where they are accounted for as operating leases with terms up to 25 years for solar facilities. Southern Power utilizes federal tax credits (ITCs and PTCs), with $1.2 billion of unutilized credits at the Southern Company level as of December 31, 2021, largely tied to solar and wind investments. This indicates that while both companies rely on PPAs in the development and operation of solar facilities, Southern Power integrates tax equity partnerships and federal incentives more directly into its investment model, affecting cash flows and net income differently than Duke’s VIE and guarantee-based financing.",
      "llm_answer": "Duke Energy negotiates PPAs for its renewable‑energy VIEs and then backs those contracts with debt guarantees and tax‑equity arrangements that are used to finance the projects (see “Commercial Renewables” – the VIEs are created “to finance the cost of renewable assets eligible for tax credits” and the key decisions include “sit­ing, negotiating PPAs” 【page_204】). Southern Power, by contrast, funds its solar build‑outs by entering long‑term PPAs that are accounted for as operating leases and by partnering with tax‑equity investors who take the bulk of the federal ITC and PTC; the company reports large un‑used ITCs/PTCs that it expects to apply by 2024 (see “Southern Power’s Power Sales Agreements” and “Tax Credits” 【page_96】【page_97】, and the lease‑accounting of solar PPAs 【page_268】). In both firms the PPA provides the stable cash‑flow needed to secure debt and to monetize tax credits, but Duke embeds the PPA within a VIE structure with guarantees, while Southern Power uses the PPA directly as an operating‑lease revenue stream and relies on tax‑equity partners to capture the credits.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Duke Energy uses PPAs within a VIE structure backed by debt guarantees and tax-equity financing, while Southern Power treats PPAs as operating leases and partners with tax-equity investors to utilize ITCs/PTCs. The role of PPAs in enabling stable cash flows for financing and tax credit monetization is correctly explained. (2) Quantitative accuracy is perfect: although the LLM does not explicitly state the $1.2 billion in unutilized credits as of December 31, 2021, it correctly references large unused ITCs/PTCs and notes they are expected to be applied by 2024, which is consistent with the timeline and intent in the original. No incorrect numbers or dates are presented. (3) Multi-hop reasoning is sound—LLM synthesizes information across Duke Energy’s VIE financing model and Southern Power’s lease accounting and tax equity use, correctly contrasting their financial structures. (4) The only minor omission is the lack of specificity around the $1.2 billion figure and the exact date (Dec 31, 2021), which slightly reduces completeness but does not affect the core correctness. Wording differs but semantic equivalence is maintained. Contextual relevance is excellent, directly addressing financial structure and tax credit utilization as requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1526,
        "completion_tokens": 379,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How does the concentration of voting power in NKE's Class A Common Stock, which elects three-quarters of the Board of Directors, compare with HD's treatment of voting rights for restricted stock awards in terms of governance influence?",
      "original_answer": "NKE's Class A Common Stockholders elect three-quarters of the Board of Directors, consolidating governance control within a single class of shares. In contrast, HD grants voting rights to recipients of restricted stock awards at the grant date, allowing them to vote on matters even before the restrictions lapse. This indicates that HD distributes voting influence more broadly across equity compensation recipients, while NKE centralizes it among Class A shareholders. Neither company allows Class B or C common stockholders to vote on most matters, but HD’s approach introduces earlier voting participation through restricted shares.",
      "llm_answer": "Nike’s dual‑class structure concentrates control in the Class A shares – the holders of those shares elect three‑quarters of the Board of Directors, giving them a dominant governance voice【page_27】. By contrast, Home Depot’s restricted‑stock awards (including RSUs and performance shares) confer no voting rights until the awards vest, so recipients have no immediate influence over board elections or other shareholder votes【page_68】.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains a critical factual error in the comparison: it incorrectly states that Home Depot's restricted stock awards confer no voting rights until vesting, directly contradicting the ground truth, which states that HD grants voting rights at the grant date, even before restrictions lapse. This reversal of a key fact undermines the entire governance comparison. The quantitative element (three-quarters of the Board elected by NKE Class A) is correct, hence a moderate quantitative accuracy score. However, the qualitative reasoning is flawed due to the incorrect characterization of HD’s voting policy, leading to an opposite conclusion about governance influence. The answer is contextually relevant—addressing governance influence through voting rights—and structured appropriately, but the core multi-hop synthesis fails because it misrepresents HD’s practice. This major error in entity behavior (HD’s voting rights timing) results in a low correctness and qualitative accuracy score despite correct framing and partial entity identification.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 301,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How does the foreign exchange risk exposure of Netflix's forecasted revenue transactions compare to Disney's VAR model estimates, given both companies' use of financial instruments to hedge against currency fluctuations?",
      "original_answer": "Netflix uses forward contracts to hedge foreign exchange risk on forecasted revenue transactions denominated in non-U.S. dollar currencies, while Disney employs a VAR model that excludes forecasted transactions from its risk estimation. Netflix's foreign currency transactions resulted in a $293 million loss in 2023, indicating volatility in unhedged positions, whereas Disney's VAR estimate for maximum one-day loss decreased to $255 million in 2024 from $284 million in 2023 due to lower interest rate volatility. This suggests that while both companies manage FX risk, Disney's modeled approach excludes certain forecasted exposures that Netflix explicitly hedges.",
      "llm_answer": "Netflix manages the foreign‑exchange risk on its forecasted revenue by entering into forward contracts that are designated as cash‑flow hedges; any gains or losses on those hedges are first recorded in AOCI and later re‑classified into revenue, but the filing does not disclose a quantified exposure amount such as a VAR figure【page_48】【page_49】. Disney also hedges forecasted foreign‑currency revenues with forwards and options, but it quantifies its currency risk with a VAR model that estimates a maximum one‑day loss of roughly $40 million for currency‑sensitive financial instruments in FY 2024 (about $45 million in FY 2023)【page_60】【page_59】. Thus, Disney provides a specific VAR estimate of its foreign‑exchange risk, whereas Netflix’s exposure is described qualitatively and managed through hedges without a disclosed VAR amount.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key quantitative figures. According to the ground truth, Disney's VAR estimate for maximum one-day loss was $255 million in 2024 (down from $284 million in 2023), but the LLM incorrectly states it as $40 million in 2024 and $45 million in 2023—off by more than 80%. This is a major error in core financial data. Additionally, the LLM fails to mention Netflix's $293 million loss in 2023 from foreign currency transactions, which is a critical part of the original answer and directly relevant to assessing unhedged risk. (2) The quantitative accuracy is severely compromised due to the incorrect VAR numbers and omission of Netflix's realized loss. While the LLM correctly identifies the use of forward contracts by both companies, the misrepresented VAR values undermine the comparison. (3) The reasoning is partially sound in structure—comparing Netflix’s qualitative, hedge-based approach to Disney’s quantitative VAR model—but flawed in execution because it synthesizes incorrect data. The multi-hop aspect (comparing risk exposure frameworks across companies) is attempted, but based on false numbers. (4) Contextual relevance is high because the LLM addresses the core question about FX risk management and contrasts Netflix’s lack of disclosed VAR with Disney’s use of it. However, due to major factual errors in numbers and omission of Netflix’s actual loss, the overall correctness score is low. Semantic equivalence fails on key metrics despite some correct conceptual framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 429,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How do the Value at Risk (VAR) calculations for MDLZ and PM differ in terms of the time periods used to estimate expected return distributions under normal market conditions, and what does this imply about their respective risk assessment horizons?",
      "original_answer": "MDLZ uses the prior quarter's interest rate, currency exchange, and commodity price movements to estimate return distributions for VAR calculations at year-end (December 31, 2024 and 2023), and the four prior quarters for average VAR amounts. In contrast, PM primarily uses the preceding quarter for year-end VAR calculations and the four preceding quarters for average, high, and low VAR amounts. This indicates that while both companies rely on recent market data, MDLZ explicitly applies a multi-quarter approach for average VAR, suggesting a slightly more extended risk assessment horizon compared to PM.",
      "llm_answer": "MDLZ’s VAR model builds the expected‑return distribution from market moves observed **over the prior quarter** for the year‑end VAR and from **each of the four preceding quarters** to compute the average VAR (see MDLZ p. 66). PMI’s VAR uses the same logic – it derives the distribution **primarily over the preceding quarter** for the December‑31 VAR and **primarily over each of the four preceding quarters** for the average, high and low VAR (see PMI p. 77). Because both firms rely only on the most recent one‑ to four‑quarter data, their risk assessments are anchored to a short‑term (one‑day loss) horizon rather than a longer‑term outlook.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in terms of time periods used by MDLZ and PM (referred to as PMI) for their VAR calculations: both use the prior quarter for year-end VAR and the four preceding quarters for average VAR metrics. The quantitative details (e.g., 'prior quarter', 'four preceding quarters') match the ground truth exactly, earning a perfect score on quantitative accuracy. Entity accuracy is correct, with proper identification of MDLZ and PM (as PMI), and correct mapping of time periods. However, the implication drawn in the LLM answer—that both companies' risk assessments are anchored to a 'short-term (one-day loss) horizon'—is misleading and not supported by the original answer. The original emphasizes that MDLZ's use of four quarters for average VAR suggests a *slightly more extended risk assessment horizon* compared to PM, which the LLM fails to highlight. Instead, the LLM concludes both have similarly short-term outlooks, missing the nuanced comparative implication. This weakens the qualitative accuracy, particularly in multi-hop reasoning and synthesis. Contextual relevance is high, as all parts of the question are addressed with appropriate focus. Thus, while the facts are correct, the interpretive conclusion is partially misaligned, warranting a correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 364,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How does the $0.6 billion goodwill impairment charge recorded by DIS in fiscal 2024 relate to the auditor's evaluation of significant assumptions, and how does this compare to the auditor's approach in testing significant assumptions at NFLX related to content amortization estimates?",
      "original_answer": "The $0.6 billion goodwill impairment charge recorded by DIS in fiscal 2024 was directly tied to the fair value assessment of the entertainment linear networks reporting unit, which relied on significant assumptions such as future revenues, operating margins, terminal growth rates, and discount rates. The auditor, PricewaterhouseCoopers LLP, evaluated the reasonableness of these assumptions by comparing them to historical performance, external market data, and evidence obtained elsewhere in the audit. Similarly, at NFLX, the auditor (also PricewaterhouseCoopers LLP) tested significant assumptions used in content amortization estimates, including forecasted viewing hour consumption and historical viewing patterns, by comparing them to current trends and prior actual results. Both audits involved sensitivity analyses and the use of professionals with specialized skills to assess the impact of changes in these assumptions on financial outcomes.",
      "llm_answer": "The $0.6 billion goodwill impairment that Disney recorded for fiscal 2024 was the result of management’s quantitative fair‑value test, and the auditor’s work centered on evaluating the significant assumptions in that test – future revenues, operating expenses, margins, terminal growth rates and discount rates – by testing the controls over the valuation model, the completeness and accuracy of the underlying data and the reasonableness of the assumptions with specialized‑skill professionals. Netflix’s auditor took a similar approach but focused on the assumptions behind content amortization, testing management’s historical and forecasted viewing‑hour estimates, verifying the data used in the model, comparing the assumptions to current viewing trends and performing sensitivity analyses. Both audits emphasized testing controls and the reasonableness of key estimates, but Disney’s audit dealt with fair‑value assumptions for goodwill, whereas Netflix’s audit dealt with viewing‑pattern assumptions for content amortization.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $0.6 billion goodwill impairment charge for DIS in fiscal 2024 is correctly stated, with no numerical errors. (2) The entities—DIS, NFLX, PricewaterhouseCoopers LLP (implied as same auditor in both cases)—are correctly identified, and the financial concepts (goodwill impairment, content amortization) are accurately attributed. (3) The multi-hop reasoning is sound: the answer correctly links DIS’s impairment to fair value assumptions (revenues, margins, growth rates, discount rates) and explains how the auditor evaluated them—through controls, data accuracy, and reasonableness checks using specialists—mirroring the ground truth. Similarly, for NFLX, it correctly identifies viewing-hour forecasts and historical patterns as key assumptions, with auditor testing against trends and prior results, including sensitivity analyses. (4) The only minor omission is that the LLM does not explicitly name the reporting unit (entertainment linear networks) for DIS’s impairment, which is included in the original answer and adds specificity. Additionally, while the LLM mentions testing controls—which is accurate and may reflect expanded audit procedures—it slightly shifts emphasis from the original answer’s focus on comparison to historical performance and external market data. However, this does not contradict but rather complements the original. Overall, the semantic meaning, factual content, and synthesis across both companies and audit approaches are correct and complete. Hence, a score of 9 is warranted—excellent accuracy with only minor contextual omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 453,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How does the cost-sharing structure between Gilead and Merck for long-acting HIV injectable products compare to Gilead's other collaboration agreements, such as the one with Arcellx, in terms of financial commitment and milestone-based payments?",
      "original_answer": "Gilead and Merck share global development and commercialization costs for long-acting HIV injectable products at 60% and 40%, respectively, with no material expenses recognized under the agreement through 2024. This contrasts with Gilead's collaboration with Arcellx, where Gilead made a $313 million upfront payment and a $299 million equity investment in 2023, and paid $68 million in development milestones in 2024. Unlike the Merck agreement, which involves shared costs and revenue splits upon approval, the Arcellx collaboration includes significant upfront and milestone-based payments, profit sharing in the U.S., and royalties outside the U.S., indicating a more financially committed and risk-shared structure with Arcellx compared to the cost-sharing model with Merck.",
      "llm_answer": "Gilead’s HIV partnership with Merck is structured as a simple cost‑share – Gilead bears about 60 % of all development and commercialization expenses (the balance 40 % falls to Merck) and the two companies split product revenues 50/50 until each product’s sales exceed set thresholds, after which Gilead’s share rises to 65 % for sales above the thresholds. No material upfront fees or milestone payments are disclosed for the Merck deal. In contrast, the Arcellx collaboration required a large upfront financial commitment – $313 million recorded as a charge and a $299 million equity investment – and includes a profit‑split (50/50 in the U.S.) plus performance‑based development and regulatory milestone payments that can total up to $1.5 billion (Gilead already paid $68 million in 2024).【page_74】【page_74】",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies compared to the ground truth. While it correctly identifies the 60/40 cost-sharing split between Gilead and Merck, it incorrectly states that revenues are split 50/50 with a tiered increase to 65% for Gilead above sales thresholds — this revenue-sharing structure is not mentioned in the original answer and is factually unsupported by the ground truth. The original answer states there are 'no material expenses recognized under the agreement through 2024' and does not mention any revenue split or tiered structure, making this a significant factual error. The upfront and milestone payments for Arcellx are mostly correct: $313M upfront, $299M equity investment, and $68M in milestones paid in 2024. However, the LLM adds that milestone payments 'can total up to $1.5 billion,' which is not present in the original answer and introduces unverified information. (2) Quantitative accuracy is partially correct: the $313M, $299M, and $68M figures are accurate and correctly dated. The 60/40 cost split is correct. However, the fabricated revenue-sharing model and the $1.5B total milestones reduce quantitative accuracy. (3) The multi-hop reasoning is sound in comparing the two collaborations and identifying differences in financial structure — cost-sharing vs. upfront/milestone payments — which shows good qualitative understanding. However, the reasoning is undermined by the inclusion of unverified financial terms not present in the source. (4) Contextual relevance is high as the answer directly addresses the comparison of financial commitments and milestone structures between the two collaborations. The core contrast — Merck involving cost-sharing with no upfront payments vs. Arcellx involving large upfront and milestone payments — is correctly highlighted, justifying a moderate correctness score despite the errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 511,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How do Tesla's multi-year pricing agreements with Panasonic for Gigafactory 2170 and Japan-sourced battery cells compare to GM's battery procurement cost exposure in terms of contractual stability and long-term cost predictability?",
      "original_answer": "Tesla has structured long-term pricing agreements with Panasonic Corporation for both Gigafactory 2170 cells (executed June 9, 2020) and Japan-sourced cells (executed December 29, 2020), providing multi-year cost predictability. In contrast, GM's 2023 10-K filing on page 78 indicates a dependency on battery procurement costs without equivalent visibility into long-term pricing agreements, suggesting greater exposure to market volatility. This creates a differentiated risk profile where Tesla has locked in pricing through 2020+ agreements while GM's battery cost structure appears more variable.",
      "llm_answer": "Tesla’s 10‑K lists a series of multi‑year pricing agreements with Panasonic – a 2020 Pricing Agreement for Gigafactory 2170 cells and 2019/2021 Pricing Agreements for Japan‑sourced cells (exhibits 10.36, 10.35 and 10.37 on page 107) – that lock in battery prices for several years, giving Tesla a stable, predictable cost structure for those supplies. By contrast, GM’s battery cost exposure is tied to its equity stake and capital commitments to Ultium Cells Holdings LLC (e.g., $0.8 billion‑$1.4 billion of committed contributions and related equity earnings shown on pages 80 and 79), which does not lock in a fixed price and therefore provides less contractual stability and long‑term cost predictability.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Tesla's multi-year pricing agreements with Panasonic for Gigafactory 2170 and Japan-sourced cells, noting their role in providing cost predictability. It accurately contrasts this with GM's lack of fixed pricing, instead highlighting GM's capital commitments to Ultium Cells Holdings LLC. However, there are minor inaccuracies in dates: the original answer specifies the Gigafactory agreement was executed June 9, 2020, and the Japan-sourced cell agreement on December 29, 2020, while the LLM cites '2019/2021 Pricing Agreements', which is imprecise and partially incorrect. (2) The dollar amounts mentioned for GM ($0.8 billion–$1.4 billion) are plausible and contextually relevant, though the ground truth does not specify these figures—instead focusing on the qualitative risk of variable costs. These numbers may be factually present in GM’s 10-K but were not part of the original answer, so their inclusion adds detail but isn't required for correctness. (3) The multi-hop reasoning is sound: the model correctly synthesizes Tesla’s contractual stability from its 10-K exhibits and contrasts it with GM’s equity-based exposure, inferring lower cost predictability. This aligns with the original answer’s conclusion about differentiated risk profiles. (4) The answer is contextually excellent, addressing both contractual stability and long-term cost predictability as asked. The core facts—Tesla has long-term fixed pricing, GM does not—are correct. The score is reduced slightly due to date inaccuracies and inclusion of unverified dollar figures not in the ground truth, but the overall qualitative and comparative analysis is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 462,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How does Coca-Cola's use of non-derivative instruments to hedge foreign exchange risk compare to Procter & Gamble's exposure to foreign exchange fluctuations, given that both operate in similar international markets such as the United Kingdom and Germany?",
      "original_answer": "Coca-Cola actively uses non-derivative instruments, such as foreign currency-denominated third-party debt, to hedge foreign exchange risk related to its net investments in foreign subsidiaries, with these instruments designated in hedging relationships to offset currency exposure. In contrast, Procter & Gamble discloses that it is significantly exposed to foreign exchange fluctuations due to its international operations — particularly in the United Kingdom and Germany, which are among its largest markets — and while it employs strategies to manage these risks, it explicitly acknowledges that exchange rate movements have historically negatively impacted its net sales, earnings, and cash flows. Therefore, while Coca-Cola appears to have a more structured hedging approach, Procter & Gamble reports a more direct and material financial sensitivity to FX volatility.",
      "llm_answer": "Coca‑Cola explicitly designates non‑derivative instruments – its foreign‑currency‑denominated senior notes – as net‑investment hedges, so that gains or losses on that debt are recorded in AOCI rather than earnings (see KO page 81). Procter & Gamble, by contrast, reports a material foreign‑exchange exposure that depresses net sales and earnings (≈ $589 million of translation/transaction losses) and relies mainly on forward‑contract hedges of forecasted cash flows, but the exposure remains significant (P&G pages 21‑23).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Coca-Cola uses non-derivative instruments (specifically foreign-currency-denominated senior notes) as net-investment hedges, with gains/losses recorded in AOCI, which matches the original answer's claim about structured hedging via non-derivative instruments. (2) For Procter & Gamble, the LLM correctly states material FX exposure impacting net sales and earnings, and cites a specific figure of approximately $589 million in translation/transaction losses. While the original answer does not include this exact number, the LLM’s inclusion of it (with citation to P&G pages 21–23) suggests it is drawn from actual filing data and adds precision rather than contradicting the ground truth. The mention of forward contracts for cash flow hedges is consistent with P&G’s strategy and does not conflict with the broader point about ongoing significant exposure. (3) The multi-hop reasoning is sound: the model synthesizes information across two companies, compares their hedging strategies (non-derivative hedges vs. derivative reliance), and draws a valid contrast in exposure impact. (4) Minor deduction in quantitative accuracy only because the $589M figure, while plausible and likely correct, is not present in the original answer, introducing a detail that cannot be verified against the ground truth. However, this does not appear to be erroneous—just more detailed. Wording differs but semantic meaning and factual content are equivalent or superior. Contextual relevance is perfect: all parts of the question (comparison, international markets, hedging methods, exposure) are addressed directly.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 463,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How does Amgen's exposure to state-level drug affordability regulations in Maryland, through PDAB laws, compare to Gilead's operational risks in the same state, particularly in relation to their respective biopharma manufacturing and pricing strategies?",
      "original_answer": "Amgen is subject to Maryland’s PDAB laws that grant authority to set upper payment limits on certain drugs for in-state patients, payers, and providers, which affects its pricing strategy and rebate obligations under Medicaid and the 340B Drug Pricing Program. These laws are part of a broader regulatory framework that includes the Inflation Reduction Act’s Medicare price-setting provisions, which began with ENBREL being selected among the first ten drugs for Medicare price negotiation. Meanwhile, Gilead operates a CAR T-cell therapy manufacturing facility in Maryland, exposing it to operational risks such as quality control, production delays, and regulatory compliance. Unlike Amgen, whose primary risk in Maryland is regulatory and pricing-related, Gilead faces logistical and manufacturing risks tied to the complexity of cell therapy production and delivery. Both companies are impacted by Maryland’s healthcare ecosystem, but through different risk vectors—Amgen through pricing regulation and Gilead through manufacturing execution.",
      "llm_answer": "Amgen’s risk in Maryland is product‑specific: the state’s PDAB law gives the Maryland PDAB authority to set upper payment limits on drugs it deems unaffordable, meaning products such as ENBREL could be capped in price (Amgen 10‑K p. 18 & p. 39). Gilead’s exposure in Maryland is broader and indirect—its 10‑K notes only general state‑level pricing and reimbursement pressures that could affect its pricing strategy, with no Maryland‑specific PDAB mechanism or manufacturing footprint, so the risk is limited to pricing policy rather than a state‑mandated price ceiling (Gilead 10‑K p. 37).",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains no explicit numerical data, so quantitative accuracy is not applicable in a traditional sense; however, since there are no incorrect numbers or miscalculations, it scores high on that dimension by default. The main failure lies in qualitative accuracy and completeness. The LLM incorrectly states that Gilead has no Maryland-specific manufacturing footprint, directly contradicting the ground truth, which explicitly notes Gilead operates a CAR T-cell therapy manufacturing facility in Maryland. This is a critical factual error that undermines the core comparison. Additionally, the LLM claims Gilead’s exposure is only to 'general state-level pricing and reimbursement pressures' and lacks a 'Maryland-specific PDAB mechanism or manufacturing footprint,' which is false on the latter point. The original answer correctly distinguishes that Amgen faces pricing and regulatory risks via PDAB and Medicare price negotiation (e.g., ENBREL), while Gilead faces operational/manufacturing risks due to its physical presence and complex production processes. The LLM fails to recognize this key multi-hop contrast: different risk vectors (pricing vs. manufacturing) rooted in different types of exposure (regulatory vs. physical operations). The mention of ENBREL and PDAB is accurate and well-supported, but the misrepresentation of Gilead’s footprint and risk profile severely limits correctness. Contextually, the answer addresses the question’s theme but misses the essential comparative structure, leading to a misleading conclusion. Thus, while wording and some citations appear plausible, the factual foundation for Gilead is incorrect, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 460,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How does AIG's use of separate accounts for policyholder-directed investments compare to MET's utilization of investment management firms in managing ERISA plan assets, particularly in terms of asset diversification strategies and risk mitigation through sub-advisory discretion?",
      "original_answer": "AIG discloses that its separate accounts are legally segregated funds where investment gains and losses accrue directly to policyholders who bear the investment risk, with assets primarily including fixed maturity securities, equity securities, and derivatives. MET utilizes separate accounts backed by similar asset classes (cash, fixed maturities, equities, derivatives, real estate, and private equity) for its ERISA pension and postretirement plans, engaging investment management firms with discretionary authority to manage these assets. Both companies emphasize diversification across asset categories and multiple managers to minimize risk concentration, with MET explicitly stating that its investment policies aim to maximize funded status and minimize volatility, aligning with the long-term nature of benefit obligations. The use of derivatives is restricted to risk mitigation and duration management in both contexts.",
      "llm_answer": "AIG’s “separate accounts” are policy‑holder‑directed funds in which the investment income and gains accrue directly to the owners of the account; each account is legally segregated, has its own investment objective and the policyholder bears the investment risk (AIG 2021 Form 10‑K p. 195). MetLife, by contrast, places the assets of its ERISA‑qualified pension and post‑retirement plans in insurance separate accounts that are run by external investment‑management firms (“Managers”) who have portfolio‑management discretion; the assets are deliberately spread across a range of asset categories and across many managers to minimize concentration risk, using that sub‑advisory discretion as a key risk‑mitigation tool (MetLife 2022 Form 10‑K p. 304‑305).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AIG's separate accounts are properly described as legally segregated, policyholder-directed funds where investment risk is borne by policyholders, with gains accruing directly to them. MET's use of external investment management firms with discretionary authority over ERISA plan assets held in separate accounts is accurately portrayed. The emphasis on diversification across asset classes and managers to mitigate concentration risk is correctly noted for both firms. (2) There are no numeric values, dates, or calculations in the question or answer that require verification—references to AIG 2021 10-K and MetLife 2022 10-K are plausible and contextually appropriate, though not strictly necessary for correctness. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies (AIG and MET), two regulatory/contractual frameworks (insurance separate accounts vs. ERISA plans), and compares their asset diversification and risk mitigation strategies. (4) The only minor omission is that the LLM does not explicitly mention MET’s use of real estate and private equity as asset classes, nor does it reference the restriction on derivatives usage (only for risk mitigation and duration management) that both companies observe. However, the core aspects of diversification, sub-advisory discretion, and risk mitigation are well-covered. Wording differs slightly but maintains semantic equivalence. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 458,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How might the structural differences in voting rights between NKE's Class B Common Stock, which grants no voting rights except on certain defined matters, and HD's restricted stock awards, which grant voting rights from the grant date, impact investor influence on corporate governance decisions such as board composition or takeover defenses?",
      "original_answer": "NKE's Class B Common Stockholders have limited voting rights, only participating on certain defined matters such as exiting the core payments business or major corporate transactions, and do not influence the election of the Board of Directors, which is controlled by Class A Common Stockholders. In contrast, HD's restricted stock recipients are granted voting rights immediately upon grant, allowing them to influence governance matters throughout the vesting period. This structural difference means that NKE's Class B investors have significantly less influence over corporate governance, including board composition and takeover defenses, compared to HD shareholders who hold restricted stock and can exercise voting rights from the outset.",
      "llm_answer": "Nike’s Class B common stock is a non‑voting class that only votes on a narrow set of “defined matters” such as a merger or certain charter amendments (see NKE 10‑K p. 27). Because Class B holders cannot vote on ordinary director elections or most shareholder proposals, their ability to shape board composition or mount a takeover defense is limited and control remains with the voting Class A shareholders. In contrast, Home Depot’s restricted‑stock awards give recipients voting rights as soon as the award is granted (see HD 10‑K p. 67), so employee‑owners can vote on all matters—including director elections and merger votes—providing them a direct channel to influence corporate‑governance decisions and takeover outcomes.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies that NKE's Class B Common Stock has no voting rights except on certain defined matters (e.g., merger, charter amendments), citing the correct page (p.27) from the NKE 10-K, and explains that Class B holders cannot vote on director elections or most proposals, limiting their influence on board composition and takeover defenses—consistent with the original answer. (2) It accurately states that HD’s restricted stock awards grant voting rights immediately upon grant, citing HD 10-K p.67, allowing recipients to influence governance throughout the vesting period. There are no numerical values to verify, so quantitative accuracy is not applicable beyond correct referencing of document pages, which are accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes governance structures across two different companies (NKE and HD), compares their voting rights frameworks, and draws a valid conclusion about differential investor influence. (4) The answer addresses all parts of the question: it contrasts the two companies’ voting structures and explains the implications for corporate governance, including board composition and takeover defenses. Wording differs slightly but meaning is preserved. All entities (NKE, HD, Class B stock, restricted stock awards) are correctly identified and contextualized. No errors in reasoning, facts, or relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 411,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How does the voting structure for Class B common stock at META compare to NFLX's general voting rights framework, considering the specific limitations outlined in the voting rights policies of both companies?",
      "original_answer": "NFLX provides one vote per share to all common stockholders on all matters, while META restricts voting rights for Class B common stockholders to specific defined matters such as amendments to the certificate of incorporation affecting Class B or C stock, decisions to exit the core payments business, or certain consolidation or merger transactions. In these limited cases, Class B stockholders vote together either as a single class or alongside Class A stockholders, but they do not have voting rights on all matters like NFLX's common stockholders.",
      "llm_answer": "Meta’s Class B common stock is essentially non‑voting – holders can only vote on a narrow set of matters (e.g., a decision to exit the core payments business, certain merger or acquisition transactions, and specific charter amendments) and, when they do vote, their votes are counted as a single class (or a separate class for charter changes) and are multiplied by the applicable conversion rate (Meta 10‑K p.90). By contrast, Netflix’s common stock follows a simple “one‑share‑one‑vote” model – every share is entitled to one vote on all shareholder matters with no special limitations (Netflix 10‑K p.59).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly states that NFLX has a one-share-one-vote structure with no special limitations, matching the original answer. For META, it accurately describes the limited voting rights of Class B stockholders, citing specific examples like exiting the core payments business, certain mergers, and charter amendments—consistent with the ground truth. (2) There are no numeric values requiring verification (e.g., percentages, dollar amounts, share counts), so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the model correctly synthesizes voting policies from two different companies (META and NFLX) and contrasts their frameworks. The mention of vote multiplication by conversion rate and voting as a single or separate class adds detail beyond the ground truth but is factually consistent with typical dual-class structures and 10-K disclosures. (4) The only minor deviation is that the original answer specifies Class B votes may be cast alongside Class A in some cases, while the LLM says 'single class' without clarifying if that includes joint voting with Class A. This is a slight nuance but does not materially misrepresent the structure. Overall, the answer is semantically equivalent, contextually precise, and factually correct, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 384,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How does the use of the parametric delta-gamma approximation technique under normal market conditions by PM compare to MDLZ's application of the same method in their VAR model for estimating potential one-day losses in pre-tax earnings?",
      "original_answer": "PM uses the parametric delta-gamma approximation technique under normal market conditions to estimate the risk of underlying positions in its portfolio, observing interest rate and forward currency rate movements primarily over the preceding quarter for determining value at risk (VAR) at year-end. Similarly, MDLZ applies the same technique to estimate the expected return distribution in interest rates, currencies, and commodity prices for calculating VAR, also observing movements over the prior quarter for year-end calculations. Both companies estimate potential one-day losses using a 95% confidence interval and a one-day holding period, with MDLZ specifically reporting the estimated potential one-day loss in pre-tax earnings from currency and commodity instruments as part of its VAR computation.",
      "llm_answer": "Both Philip Morris International (PM) and Mondelēz International (MDLZ) calculate Value‑at‑Risk using a parametric delta‑gamma approximation under normal market conditions, a 95 % confidence interval and a one‑day holding period. PM applies the technique to model the observed inter‑relationships between interest‑rate and currency movements and reports both fair‑value and pre‑tax‑earnings impacts (e.g., $14 million from foreign‑currency and $21 million from commodities at 12/31/23), whereas MDLZ uses the same method to generate expected‑return distributions for rates, currencies and commodities and then estimates the potential one‑day loss in pre‑tax earnings (also $14 million and $21 million respectively). Thus the methodology is identical, but PM’s disclosure links it to both fair‑value and earnings impacts, while MDLZ’s focuses on the earnings‑impact component of its VAR model.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific dollar amounts ($14 million from foreign currency and $21 million from commodities at 12/31/23) and attributes them to both PM and MDLZ, which are not present in the original answer (ground truth). The ground truth does not provide any numerical estimates of potential one-day losses, nor does it state that both companies reported identical figures. This is a significant factual overreach and renders the quantitative claims unsupported. (2) The mention of '12/31/23' as a date is not in the original answer, which only refers to 'year-end' without specifying the year. While the general structure of using a 95% confidence interval and one-day holding period is correctly noted and aligns with the ground truth, the fabricated numbers undermine the quantitative accuracy. (3) The qualitative reasoning is mostly sound: the LLM correctly identifies that both companies use the parametric delta-gamma approximation under normal market conditions, observe movements over the prior quarter, and apply the method to interest rates, currencies, and commodities. It also correctly contrasts PM’s broader disclosure (fair value and pre-tax earnings) with MDLZ’s focus on pre-tax earnings, which is consistent with the original answer’s note that MDLZ specifically reports the pre-tax earnings impact. (4) Contextually, the response is highly relevant and addresses the comparative aspect of the question. However, the inclusion of false precision via invented dollar amounts and a specific date leads to a major deduction in correctness and quantitative accuracy. Without those unsupported numbers, the answer would score 9. Due to these critical quantitative inaccuracies, the overall correctness is reduced to 6, reflecting partial correctness with significant factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 494,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How does the application of the 2.5% Capital Conservation Buffer for Bank of America under the Advanced Approach compare with American Express's reliance on the Stress Capital Buffer under the Standardized Approach for meeting Basel III regulatory requirements?",
      "original_answer": "Bank of America applies a 2.5% Capital Conservation Buffer under the Advanced Approach as part of its CET1 capital regulatory minimum to meet Basel III requirements, while American Express uses the Stress Capital Buffer under the Standardized Approach, which is also a component of its Basel III compliance framework. The two institutions thus rely on different buffer mechanisms depending on their regulatory frameworks, with BAC using the Capital Conservation Buffer and AXP referencing the Stress Capital Buffer as part of their respective capital adequacy strategies.",
      "llm_answer": "Bank of America’s Basel III capital calculation under the Advanced Approach adds a 2.5 % capital‑conservation buffer to its CET1 minimum (BAC 10‑K p. 146). In contrast, American Express does not use a capital‑conservation buffer under the Standardized Approach; instead it must hold a stress‑capital buffer of 5.4 % for 2023 (and 5.8 % in 2022) (AXP 10‑K p. 133). Thus, AXP’s required buffer is larger and of a different type (stress‑capital) than the 2.5 % capital‑conservation buffer that BAC applies.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Bank of America uses the 2.5% Capital Conservation Buffer under the Advanced Approach and that American Express uses the Stress Capital Buffer under the Standardized Approach, which aligns with the ground truth. However, the LLM introduces specific numerical values for American Express’s Stress Capital Buffer (5.4% for 2023 and 5.8% for 2022) that are not present in the original answer and cannot be verified from the provided ground truth. These figures may be factually accurate but go beyond the scope of the original answer, which only states that AXP uses the Stress Capital Buffer without specifying percentages. (2) The quantitative accuracy is reduced because the original answer does not include any specific buffer percentages for American Express, so adding 5.4% and 5.8% introduces unverified data. The 2.5% figure for BAC is correct and matches the ground truth. (3) The multi-hop reasoning is sound—correctly contrasting two different buffer mechanisms used by two institutions under different regulatory approaches (Advanced vs. Standardized). The synthesis across entities (BAC and AXP) and regulatory frameworks is accurate and relevant. (4) The contextual relevance is perfect—the answer directly addresses the comparison asked in the question. The qualitative accuracy is high because the core reasoning and entity identification are correct, though the answer adds unsupported specifics. The correctness score is 7 because while the core factual comparison is accurate and well-reasoned, the inclusion of unverified quantitative details lowers confidence in full factual alignment with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 459,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does LMT's use of a discounted cash flow approach in valuing certain fixed income investments compare with HON's application of the same methodology in testing goodwill and intangible asset impairments, particularly in terms of the significance and sensitivity of the discount rate assumptions used?",
      "original_answer": "LMT applies the discounted cash flow approach to value certain Level 3 fixed income investments, where significant inputs include projected annuity payments and the discount rate applied to those payments. This valuation method introduces sensitivity due to the reliance on unobservable inputs. Similarly, HON uses a discounted cash flow approach to estimate the fair value of goodwill and indefinite-lived intangible assets during impairment testing, incorporating strategic and annual operating plans with terminal value assumptions. HON also acknowledges the sensitivity of these valuations to changes in assumptions, particularly the discount rate, and performs sensitivity analyses to address uncertainty. Both companies rely on the discounted cash flow method with key assumptions around discount rates, making the valuation outcomes at both firms sensitive to changes in these inputs, though applied in different asset contexts—fixed income investments at LMT and intangible assets at HON.",
      "llm_answer": "Lockheed Martin applies a discounted‑cash‑flow model only to a subset of Level 3 fixed‑income assets, noting that “projected annuity payments and the discount rate applied to those payments” are the significant inputs, but the filing does not describe any formal sensitivity testing of that rate. Honeywell, by contrast, uses a discounted‑cash‑flow approach for goodwill and indefinite‑life intangible‑asset impairment testing and explicitly states that “changes to those assumptions could materially impact…we perform sensitivity analyses on key accounting estimates and assumptions,” indicating that the discount‑rate assumption is both material and actively stress‑tested.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the key distinctions and similarities between LMT and HON in their use of discounted cash flow (DCF) methodologies, with precise attention to the role and treatment of discount rate assumptions. (1) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are involved. (2) The LLM correctly identifies that LMT uses DCF for Level 3 fixed income investments with significant inputs being projected annuity payments and discount rates, while HON applies DCF to goodwill and intangible asset impairment testing, incorporating strategic plans and terminal values. The LLM accurately notes that HON explicitly performs sensitivity analyses on discount rate assumptions, whereas LMT’s filings do not describe formal sensitivity testing—this nuance is supported by the ground truth, which states HON performs sensitivity analyses but does not claim LMT does. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies and two different applications of DCF (fixed income vs. intangible assets), highlighting both methodological parallels and differences in transparency around sensitivity testing. (4) The only reason for not scoring a 10 is that the original answer emphasizes that both companies acknowledge sensitivity to discount rate changes, while the LLM slightly underrepresents LMT’s recognition of sensitivity—though it correctly states no formal testing is described. Overall, the LLM answer is factually correct, contextually precise, and semantically aligned with the ground truth, with only minor nuance in emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 461,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA influence the potential impact of share repurchases on voting control, given Alphabet's dual-class share structure where Class B shares convert to Class A with voting dilution?",
      "original_answer": "At CMCSA, holders of Class B common stock maintain a non-dilutable 33 1/3% of the voting power, with each Class B share entitled to 15 votes, whereas voting rights for Class A shares fluctuate based on the number of shares outstanding. This contrasts with Alphabet (GOOGL), where Class B shares convert to Class A shares with a 10:1 voting dilution, and repurchases of Class A and Class C shares totaled $62.0 billion in 2024. Since CMCSA’s Class B shares are convertible share-for-share into Class A stock, but retain a fixed voting percentage, repurchases of Class A shares could increase the relative voting power of Class B holders, unlike Alphabet’s structure where repurchases of Class A and C shares do not create a similar fixed voting skew due to the dilutive conversion mechanism.",
      "llm_answer": "CMCSA’s charter gives Class B holders a fixed one‑third of the total voting power (33 ⅓ % of all votes) and each Class B share carries 15 votes; that aggregate voting power is expressly non‑dilutable (CMCSA Note 11, p. 91). Because the voting power of Class B is locked in, repurchasing Class A (or Class C) shares does not alter the proportion of votes controlled by Class B shareholders, so share buy‑backs have little effect on voting control. In Alphabet, Class B shares have 10 votes each and may be converted into one‑vote Class A shares, so buying back Class A and Class C shares concentrates voting power in the remaining Class B shares, but any conversion of Class B to Class A would dilute that influence (Alphabet Note 11, pp. 82‑84).",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several correct elements but makes a critical error in reasoning that significantly undermines the correctness. (1) Quantitatively, the numbers are accurate: CMCSA Class B has 33 1/3% voting power and 15 votes per share, Alphabet Class B has 10 votes per share, and the reference to Alphabet's $62.0B repurchases in 2024 is missing from the LLM answer but not contradicted. The LLM correctly identifies conversion mechanics at Alphabet. (2) However, the key qualitative error is in the claim that 'repurchasing Class A (or Class C) shares does not alter the proportion of votes controlled by Class B shareholders' — this is incorrect. Because CMCSA’s Class B voting power is a fixed *percentage* (33 1/3%) of total voting power, not a fixed *number* of votes, repurchasing Class A shares reduces total outstanding shares and thus total voting power, which *increases* the relative concentration of voting power held by Class B shares. The LLM incorrectly concludes that buybacks have 'little effect' when in fact they *reinforce* Class B’s fixed share of voting power, effectively increasing their control relative to a shrinking Class A base. (3) The comparison to Alphabet is partially correct: repurchases of Class A and C shares do concentrate voting power among remaining Class B shares, and conversion dilutes that. But the LLM fails to contrast this properly with CMCSA’s structure, where the fixed percentage creates a structural voting skew that is *amplified* by repurchases, not neutralized. (4) The answer is contextually relevant and well-structured, with accurate citations and terminology, but the flawed reasoning on the core mechanism of voting power dynamics in CMCSA reduces the correctness score to 5. The answer misunderstands the implication of a 'non-dilutable percentage' versus a 'non-dilutable vote count'.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 500,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does TGT's beverage sales mix compare to PEP's beverage revenue contribution in the APAC region, given both companies' exposure to this market?",
      "original_answer": "TGT includes beverages as part of its grocery segment, which is a key category within its retail operations. PEP, on the other hand, reports that beverages contribute 23% of its revenue in the APAC region. Additionally, PEP's APAC segment generated $10 million in reported revenue for 2024. This indicates that while both companies operate in the beverages category in APAC, PEP provides a specific quantification of its beverage exposure in the region, whereas TGT does not break down beverage sales separately from its broader grocery offering.",
      "llm_answer": "Target’s “Food & beverage” category generated $23.8 bn of the $106.6 bn total net sales in FY 2024 – roughly **22 %** of its overall revenue (see TGT 10‑K page 49). PepsiCo reports that **23 %** of the APAC division’s net revenue comes from beverages (see PEP 10‑K page 73). Thus, PepsiCo’s APAC beverage contribution is marginally higher than Target’s overall beverage mix, though both are in the low‑20 % range.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that PEP's APAC segment generated $10 million in revenue in 2024, but the LLM does not mention this figure or use it in any way. More critically, the LLM claims that Target's 'Food & beverage' category accounted for $23.8 billion of $106.6 billion in FY2024 sales (~22%), but this data is not present in the ground truth and cannot be verified from the context provided. The ground truth explicitly states that TGT does not break out beverage sales separately from its broader grocery segment, making the LLM's precise quantification of Target's beverage mix factually incorrect. (2) The LLM correctly reports PEP's 23% beverage revenue contribution in APAC, which aligns with the original answer. However, it fails to incorporate the critical detail that PEP's APAC revenue was only $10 million—making the 23% figure apply to a very small base. The comparison to Target’s overall beverage mix is therefore misleading, as Target’s sales are primarily domestic (U.S.) and not comparable in regional scope. (3) The multi-hop reasoning is flawed: the LLM compares Target’s global food & beverage sales (assuming full breakdown) to PEP’s APAC-specific beverage contribution, despite the original answer emphasizing that TGT does not disclose beverage sales separately and that the two companies’ reporting structures and regional exposures differ significantly. The synthesis fails to respect the boundaries of the data provided. (4) While the LLM attempts a relevant comparison and cites correct percentages for PEP, it fabricates quantifiable data for TGT and ignores key contextual limitations in the original answer, leading to a partially correct but ultimately misleading response. Hence, the correctness score is low due to major factual and reasoning errors, despite some accurate elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 512,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How might the Medicare price negotiation under the IRA, which will apply to Otezla starting in 2027, impact Amgen's $5.2 billion intangible asset valuation for Otezla, considering that Bristol-Myers Squibb (BMY) also markets Otezla under a licensing agreement?",
      "original_answer": "The Medicare price negotiation under the IRA, which will apply to Otezla starting January 1, 2027, introduces regulatory and financial risk that could impair Amgen's $5.2 billion intangible asset valuation for Otezla. Since BMY also markets Otezla under a licensing agreement, the negotiated price could affect overall revenue from the drug, further influencing Amgen's ability to recover the carrying value of the asset. Amgen has explicitly stated that future changes in estimates related to IRA price negotiations could unfavorably impact the intangible asset's recoverability.",
      "llm_answer": "Amgen says the $5.2 billion “developed‑product‑technology rights” intangible asset for Otezla is vulnerable to the upcoming Medicare price‑setting under the Inflation‑Reduction Act – which begins in 2027 – because lower Medicare prices could cut the cash‑flow assumptions that support the asset and may force an impairment charge【page_137】.  Since Otezla is also sold by Bristol‑Myers Squibb under a licensing agreement (BMS is listed as a competitor‑marketed product for Otezla in Amgen’s product table)【page_15】, any price reductions would reduce revenues for both companies, heightening the risk that Amgen cannot recover the full $5.2 billion carrying amount.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: the $5.2 billion intangible asset valuation for Otezla, the 2027 start date for Medicare price negotiation under the IRA, and the licensing agreement with Bristol-Myers Squibb (BMY/BMS) are all accurately represented. The dollar amount ($5.2 billion) and year (2027) match exactly. (2) Quantitative elements are precise—no calculations are required beyond correct reporting of values, which are presented accurately (e.g., $5.2 billion, 2027). Format variations like 'billion' vs 'B' are acceptable and do not affect meaning. (3) Multi-hop reasoning is sound: the model correctly links the IRA's price negotiation mechanism to potential impairment of Amgen’s intangible asset, recognizes that reduced prices would affect cash flow assumptions, and incorporates the added complexity that BMS also markets Otezla under license, thereby diluting overall revenue potential and increasing impairment risk. The use of document citations (e.g., page references) supports traceability. (4) The answer fully addresses all parts of the question: impact on valuation, role of IRA/2027 timeline, and BMS's involvement. Wording differs slightly (e.g., 'developed-product-technology rights' vs original phrasing), but the semantic meaning and technical accuracy are preserved. No omissions or inaccuracies noted.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 393,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does AMD's production of FPGAs for hyperscale data centers compare to Altera's FPGA offerings, given Intel's strategic decision to operate Altera as a standalone business?",
      "original_answer": "Altera, now operated as a standalone business by Intel, offers programmable semiconductors primarily FPGAs, targeting embedded, communications, and cloud and enterprise markets. Intel is pursuing monetization opportunities with Altera, including a potential IPO. Meanwhile, AMD produces FPGAs and Adaptive SOCs that are directly incorporated into servers and data center appliances used by hyperscale customers, including for AI workloads such as generative AI models. This positions both companies in competitive yet distinct roles within the FPGA market, with AMD directly serving hyperscale data centers and Intel seeking to unlock value through Altera's standalone structure.",
      "llm_answer": "AMD’s FPGA portfolio—Virtex‑6/7/UltraScale+, Kintex‑7/UltraScale+, Artix‑7/UltraScale+ and Spartan‑6/7— is sold directly to hyperscale cloud providers as part of its data‑center product line 【page_11】 【page_9】. By contrast, Intel’s Altera unit offers programmable semiconductors for a far broader set of markets (embedded, communications, cloud and enterprise) and Intel has elected to run Altera as a standalone business to monetize that wider FPGA portfolio 【page_23】 【page_70】.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and aligns well with the ground truth. It correctly identifies that AMD sells FPGAs (specifically listing product families like Virtex, Kintex, etc.) directly to hyperscale cloud providers as part of its data center offerings, which matches the original answer's assertion that AMD incorporates FPGAs into servers and data center appliances for hyperscalers, including for AI workloads. It also accurately states that Intel operates Altera as a standalone business targeting broader markets (embedded, communications, cloud, enterprise), and that Intel aims to monetize Altera—consistent with the mention of potential IPO in the ground truth. The only minor shortcoming is that the LLM answer does not explicitly mention AMD's Adaptive SOCs or their use in AI/generative AI workloads, which adds contextual depth in the original answer. Additionally, while the LLM cites specific FPGA product lines (which are not in the ground truth), this added detail is accurate and enhances specificity without introducing error. There are no numerical inaccuracies (quantitative accuracy is perfect by default, as no numbers are misstated), and the reasoning correctly synthesizes the strategic positioning of both companies in the FPGA market. The answer is highly relevant and conveys semantically equivalent information, though slightly less comprehensive in scope than the original. Thus, it earns a high score but not perfect due to minor omissions in qualitative depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 416,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA compare to the ownership structure of Class A common stock at GOOGL, given the relative number of shares outstanding and holder concentration?",
      "original_answer": "At CMCSA, the Class B common stock represents 33⅓% of the combined voting power, with all shares beneficially owned by Brian L. Roberts, and only 3 record holders as of December 31, 2021. In contrast, GOOGL’s Class A common stock had 300,754,904 shares outstanding as of January 25, 2022, with a much broader base of non-affiliate ownership contributing to a market value of approximately $1,451.1 billion as of June 30, 2021. Both structures tie voting rights to distinct stock classes, but CMCSA’s Class B shares grant concentrated control to a single individual, while GOOGL’s Class A shares are more widely distributed.",
      "llm_answer": "CMCSA’s Class B stock is extremely concentrated – only three record holders (all owned by Brian L. Roberts) control the entire Class B issue, which carries 15 votes per share and accounts for roughly 33 ⅓ % of the company’s total voting power【page_38】. By contrast, Alphabet’s Class A stock consists of about 300.8 million shares, each with one vote and broadly held in the public market, so voting power is far more dispersed among many shareholders【page_2】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth with only minor omissions. (1) Quantitatively, the LLM correctly states that CMCSA's Class B stock accounts for 33⅓% of voting power and is held by three record holders, all beneficially owned by Brian L. Roberts. The number of GOOGL Class A shares is reported as 'about 300.8 million,' which aligns with the ground truth figure of 300,754,904 (rounded appropriately). The market value of $1,451.1 billion as of June 30, 2021, is omitted, but no incorrect numbers are presented. (2) The LLM mentions '15 votes per share' for CMCSA Class B stock, which is not in the original answer; however, this detail may be contextually accurate based on external knowledge or source material (e.g., page_38 reference), so it does not constitute a factual error but adds unverified detail. (3) Qualitatively, the reasoning correctly contrasts concentrated control at CMCSA with broad public ownership at GOOGL, capturing the multi-hop comparison of ownership structure and voting power distribution. (4) The answer is fully contextually relevant, directly addressing the comparative ownership and voting power question. The only minor shortcoming is the omission of the GOOGL market value figure and the slightly imprecise phrasing around share ownership concentration (ground truth clarifies 'non-affiliate ownership'), but these do not detract significantly from overall correctness. Hence, a score of 9 is warranted.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 410,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the change in Keytruda royalty structure post-2023 impact Bristol-Myers Squibb's revenue dependency on Merck, considering Merck's co-development and financial obligations tied to Keytruda in combination therapies?",
      "original_answer": "The royalty rate Merck pays to Bristol-Myers Squibb (BMS) and Ono for Keytruda drops from 6.5% to 2.5% starting January 1, 2024, which will reduce BMS’s royalty income from Merck. This is significant because Merck co-develops Keytruda-based combination therapies like V940 (mRNA-4157) with Moderna, where Merck bears 50% of development costs and receives 50% of any future profits. Since BMS's revenue from Merck is partly tied to Keytruda's global sales through this licensing agreement and has been a growing component of BMS's income (noted by the 2023 increase in royalties), the reduced royalty rate may diminish the financial upside BMS experiences from Keytruda's continued use in these new combination regimens.",
      "llm_answer": "The 2024 amendment cuts Merck’s royalty on Keytruda from 6.5 % (through 2023) to 2.5 % (2024‑2026), shrinking BMS’s Keytruda royalty income from about $1.19 billion in 2023 to roughly one‑quarter of that amount and thereby reducing the share of BMS’s revenue that comes from Merck’s royalty payments【page_90】. However, BMS remains tied to Merck through joint Keytruda‑based combination programs—such as the V940/Keytruda collaboration where Merck shares development costs and any profits equally and makes continuation and milestone payments—so the royalty cut lowers but does not eliminate BMS’s revenue exposure to Merck【page_90】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the change in royalty rate from 6.5% to 2.5% starting in 2024, aligning with the ground truth. It accurately notes the reduction in BMS's royalty income, estimating the 2023 amount at $1.19 billion and projecting a drop to roughly one-quarter of that, which is consistent with the proportional decrease from 6.5% to 2.5% (a ~62% reduction, though 'one-quarter' implies ~75% reduction—minor overstatement but directionally correct and likely intended as approximate). (2) The dollar figure of $1.19 billion is not explicitly in the ground truth, but such a number could be derived from Keytruda’s global sales and the 6.5% royalty; assuming this is supported by the cited 'page_90', it is acceptable. The calculation logic is sound, though the 'one-quarter' phrasing slightly exaggerates the drop (2.5/6.5 ≈ 38.5%, not 25%), but this is a minor quantitative imprecision rather than a factual error. (3) The LLM correctly synthesizes the multi-hop elements: it links the royalty change to BMS’s revenue dependency on Merck, acknowledges ongoing exposure via combination therapies like V940, and notes Merck’s shared cost/profit structure and milestone payments—key points from the ground truth. (4) The answer is semantically equivalent to the original, with slightly more specific financial estimates and a clear explanation of continued, albeit reduced, revenue exposure. All entities (BMS, Merck, Keytruda, V940, royalty rates, timeframes) are accurate. The reasoning is logical and complete. Minor deduction in quantitative accuracy due to the 'one-quarter' approximation, but overall highly accurate and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 455,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does the adoption of ASU 2022-06, which CAT has listed as applicable to its financial reporting, impact the treatment of contract modifications under U.S. government agreements that BA identified as a material risk in its 2023 disclosures?",
      "original_answer": "ASU 2022-06 extends the sunset date for optional expedients and exceptions related to reference rate reform through December 31, 2024. This allows companies like BA to apply simplified accounting treatments for contract modifications made in response to reference rate changes, such as replacing LIBOR, during that period. BA, which reported that 37% of its 2023 revenues came from U.S. government contracts—where modifications can occur without prior notice—benefits from reduced operational complexity and financial impact when adjusting contracts affected by reference rate reform. CAT, in its 2023 10-K, listed ASU 2022-06 under recently adopted accounting standards, confirming its applicability and alignment with broader corporate practices around reference rate reform.",
      "llm_answer": "Caterpillar notes that its adoption of ASU 2022‑06 (Reference‑Rate Reform) provides optional expedients and extends the sunset date to Dec 31 2024, which “has reduced the operational and financial impacts of contract modifications that replace a reference rate…The adoption…did not have a material impact on the Company’s consolidated financial statements” (CAT 10‑K p. 67). Boeing, however, flags U.S.‑government contract modifications as a material risk that could materially affect its margins, cash‑flows and results of operations (Boeing 10‑K p. 14); the ASU 2022‑06 guidance merely changes the accounting treatment of such modifications for Caterpillar, but does not eliminate the underlying risk Boeing identifies.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all key facts are accurate: the sunset date of December 31, 2024, for ASU 2022-06 is correctly stated, and the reference to CAT’s 10-K (p. 67) noting reduced operational and financial impacts is factually consistent. Boeing’s identification of U.S. government contract modifications as a material risk (10-K p. 14) is also correctly cited. However, the ground truth includes a specific quantitative detail—BA’s 37% of 2023 revenues from U.S. government contracts—which is missing in the LLM answer, representing a minor omission. (2) The reasoning is sound: the LLM correctly distinguishes between the accounting relief provided by ASU 2022-06 (which benefits CAT) and the ongoing business risk Boeing faces from contract modifications, even if accounting treatment is simplified. This reflects proper multi-hop synthesis across CAT’s adoption and BA’s risk disclosure. (3) Entity accuracy is strong: both CAT and BA (Boeing) are correctly identified, along with ASU 2022-06, its purpose (reference rate reform), and the correct years (2023 disclosures). (4) The answer is contextually relevant and directly addresses the question’s core: how ASU 2022-06 affects contract modifications under U.S. government agreements that BA flagged as risky. The only shortcoming is the missing 37% revenue figure, which adds contextual depth in the ground truth but does not undermine the overall correctness. Hence, a score of 8 is warranted—core facts and logic are correct, but with a minor completeness gap.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 434,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does the $4.8 billion transaction with Crown Castle in 2013 compare to Verizon's 2024 $2.8 billion deal with Vertical Bridge REIT in terms of asset treatment and financing obligations, particularly given both companies retained depreciation responsibilities and structured payments as financing obligations?",
      "original_answer": "Both AT&T’s 2013 transaction with Crown Castle and Verizon’s 2024 deal with Vertical Bridge REIT involved transferring exclusive rights to operate wireless towers while retaining depreciation responsibilities on their balance sheets. AT&T received $4.827 billion from Crown Castle, accounted for as a financing obligation with an effective interest rate of ~3.9%, and continues to sublease space on the towers. Similarly, Verizon received $2.8 billion from Vertical Bridge, of which $830 million was recorded as a financing obligation related to the towers Verizon continues to use, with the remainder treated as prepaid rent. Both arrangements reflect a structured financing model where the original owner maintains accounting control and depreciation charges, rather than achieving sale-leaseback treatment.",
      "llm_answer": "AT&T’s 2013 Crown Castle deal treated the entire $4.8 billion cash receipt as a financing liability—interest is accrued on that obligation—while the towers remained on AT&T’s balance sheet and were depreciated like any other PP&E. Verizon’s 2024 Vertical Bridge transaction split the $2.8 billion into a $2.0 billion prepaid‑rent asset and an $830 million financing obligation, yet the towers also stay on Verizon’s books and are depreciated, so both companies retained depreciation responsibility but structured the cash proceeds differently.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth with only minor discrepancies in numerical precision. (1) Quantitatively, the LLM correctly identifies the $4.8 billion (ground truth: $4.827 billion) and $2.8 billion amounts, which are acceptable as rounded figures. The $830 million financing obligation is exactly correct. However, the LLM states that Verizon's $2.8 billion was split into $2.0 billion prepaid rent and $830 million financing obligation, implying a sum of $2.83 billion, which slightly exceeds the total; the ground truth clarifies that only $830 million was a financing obligation and the remainder was prepaid rent—this is semantically close but imprecise in breakdown. (2) The LLM correctly notes that both companies retained depreciation responsibilities and kept towers on their balance sheets, accurately reflecting the accounting treatment under financing obligations rather than sale-leaseback. (3) The multi-hop reasoning is sound: it compares two transactions across different years, companies, and structures, correctly synthesizing asset treatment and financing implications. (4) Entity accuracy is strong: AT&T (not Verizon) did the 2013 Crown Castle deal—this is correctly attributed. The LLM mistakenly refers to 'AT&T’s 2013 Crown Castle deal' but then discusses 'Verizon’s 2024 Vertical Bridge transaction', which is correct. There is no conflation of companies. (5) The answer addresses asset treatment, financing obligations, depreciation, and differences in proceeds structuring, making it contextually complete and relevant. The minor overstatement in the split of Verizon’s proceeds prevents a perfect score, but overall the answer is factually solid and semantically equivalent to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 480,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does PEP's direct operational presence in New Zealand's beverage market compare to KO's financial influence through its 19% stake in CCEP, which bottles and distributes Coca-Cola products in the same region?",
      "original_answer": "PEP operates in New Zealand through its APAC regional structure, selling branded beverages and convenient foods directly and through partners. CCEP, in which KO holds a 19% stake, is responsible for bottling and distributing Coca-Cola products in New Zealand under a bottler's agreement. KO's financial stake allows it to influence CCEP's operations indirectly, while PEP maintains full operational control over its New Zealand beverage activities. This creates two distinct models—direct operation for PEP and equity influence for KO through CCEP—both active in the New Zealand beverage market.",
      "llm_answer": "PepsiCo does not run its own bottling or distribution facilities in New Zealand – its APAC segment simply makes, markets and sells concentrates, syrups and finished‑goods to “authorized and independent bottlers, independent distributors and retailers” in the region【page_6】.  By contrast, Coca‑Cola’s 19 % equity stake gives it a direct financial foothold in the market, because the bottler it backs – Coca‑Cola Europacific Partners (CCEP) – actually bottles and distributes Coca‑Cola beverages in New Zealand【page_7】【page_88】.  Thus PepsiCo’s presence is indirect through third‑party bottlers, while KO’s influence is through a sizable equity investment in the bottler that operates locally.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy regarding PepsiCo's operational model in New Zealand. (1) The quantitative accuracy is perfect: the 19% stake in CCEP is correctly cited, and no other numbers are misstated. (2) However, the qualitative accuracy suffers because the LLM incorrectly claims that PepsiCo does not run its own bottling or distribution facilities and operates only through third-party bottlers. This contradicts the ground truth, which states that PEP operates directly in New Zealand through its APAC regional structure, selling branded beverages directly and through partners. The original answer emphasizes PEP's 'full operational control,' implying a more direct presence than the LLM acknowledges. (3) The reasoning is sound in comparing KO’s equity-based influence via CCEP to a third-party model, but it mischaracterizes PEP’s model as indirect when the ground truth describes it as direct. This breaks the multi-hop synthesis: while CCEP’s role under KO’s 19% stake is accurately described, PEP’s operational presence is misrepresented. (4) Despite this major error, the answer remains contextually relevant and correctly identifies the key contrast between equity influence (KO/CCEP) and operational models. The LLM just flips the characterization of PEP’s model, undermining the core comparison. Hence, correctness is only partial—core facts about KO are right, but PEP’s role is wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 400,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does AIG's use of internal valuation models for mortgage-backed securities compare to SCHW's reliance on broker/dealer quotes for similar asset classes like commercial mortgage-backed securities in determining fair value?",
      "original_answer": "AIG utilizes internal valuation models and third-party asset managers to determine fair values for mortgage-backed securities, subject to management review to ensure model reasonableness. These models incorporate inputs like interest rates, borrower creditworthiness, collateral, and market pricing for comparable loans. In contrast, SCHW primarily relies on broker/dealer quotes and third-party pricing services for similar asset classes such as commercial mortgage-backed securities, using observable market data like trades, spreads, and maturity information to validate pricing. GILD’s evidence further supports that broker/dealer quotes are commonly used alongside valuation models with observable inputs for fair value estimation, indicating a shared industry practice that bridges AIG's internal modeling and SCHW's external pricing reliance.",
      "llm_answer": "AIG values its mortgage‑backed securities—including RMBS and CMBS—primarily with internal (or third‑party) valuation models that incorporate credit‑risk inputs such as CDS spreads, discount‑rate spreads and other assumptions when market quotes are thin (see AIG pp. 112‑113, 115). In contrast, Schwab relies on broker‑dealer quotes and independent pricing services for similar fixed‑income assets—its primary pricing service provides prices for non‑agency CMBS based on observable trades, broker quotes and discounted‑cash‑flow calculations, with little use of internal models (see Schwab pp. 81‑80).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) It correctly identifies that AIG uses internal (or third-party) valuation models for mortgage-backed securities (including RMBS and CMBS), incorporating credit-risk inputs like CDS spreads and discount-rate spreads, especially when market quotes are limited—this matches the ground truth's emphasis on internal models, third-party managers, and model inputs such as interest rates, borrower creditworthiness, and collateral. (2) It accurately contrasts this with SCHW's (Schwab's) reliance on broker/dealer quotes and third-party pricing services for similar assets, noting the use of observable market data such as trades and spreads, and minimal use of internal models—this is consistent with the original answer. (3) The LLM cites specific page numbers (AIG pp. 112–113, 115; Schwab pp. 81–80), which adds precision and supports the claims, though the original answer does not include citations—this is a strength but not required. (4) The only minor shortcoming is that the LLM answer does not mention GILD’s supporting evidence about industry practices that bridge AIG’s and SCHW’s approaches, which was included in the original answer to contextualize the broader industry norm. This omission slightly reduces completeness in multi-hop synthesis but does not affect the core factual accuracy. (5) All entities (AIG, SCHW/Schwab, MBS/CMBS) are correctly identified, and there are no numerical inaccuracies—though no specific numbers (e.g., dollar values) are involved, the qualitative inputs and methodologies are correctly described. (6) The reasoning is sound, clearly contrasting the two firms’ fair value determination methods and grounding them in appropriate data sources. Overall, the answer is factually correct, well-structured, and contextually relevant, warranting a high score with only a slight deduction for missing the GILD contextual link in the multi-hop synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 532,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How does AVGO's valuation methodology for Level 2 securities compare to ADBE's reliance on matrix pricing, given the use of observable market inputs like yield curves and benchmark rates in their fair value determinations?",
      "original_answer": "AVGO categorizes its investments, including equity and short-term money market instruments, as Level 2 securities when they are valued using inputs such as interest rates, yield curves, and broker quotes. These inputs are observable but not quoted prices in active markets, distinguishing them from Level 1 securities. Matrix pricing, which is used for Level 2 securities like corporate bonds and asset-backed securities, relies on observable market data such as yield curves to estimate fair value. ADBE also categorizes its fixed income available-for-sale debt securities as Level 2 and explicitly uses matrix pricing techniques that incorporate benchmark yields, issuer spreads, interest rates, and U.S. Treasury or swap curves to determine fair value. Both companies rely on similar observable inputs, indicating a shared dependence on market-derived data rather than direct quotations for active trading in valuing their Level 2 portfolios.",
      "llm_answer": "AVGO treats securities that do not have quoted market prices as Level 2 assets and values them using observable market inputs—such as benchmark yields, interest‑rate curves, pre‑payment speeds and other market‑derived data—through market‑corroborated or model‑based pricing techniques (AVGO 10‑K pp. 76‑80). Adobe, by contrast, values its fixed‑income securities with a matrix‑pricing approach from independent vendors that also relies on observable inputs like benchmark yields, issuer spreads and U.S. Treasury or swap curves (ADBE 10‑K p. 71). Thus, both firms base their fair‑value estimates on the same types of observable market data, but AVGO describes the process generally as a Level 2 valuation, whereas Adobe explicitly uses matrix pricing within that hierarchy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: both AVGO and ADBE use observable market inputs (e.g., yield curves, benchmark yields, interest rates) to value Level 2 securities; ADBE explicitly uses matrix pricing, while AVGO uses model-based or market-corroborated techniques without naming 'matrix pricing' directly. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a numerical sense—however, the description of valuation methods is factually precise, earning full marks. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (AVGO and ADBE), compares their Level 2 valuation methodologies, and identifies both similarities (use of observable inputs) and differences (explicit use of matrix pricing by ADBE vs. general Level 2 classification by AVGO). (4) The LLM answer conveys the same core conclusion as the original: both firms rely on similar observable market data for fair value determination of Level 2 securities, despite differing in terminology and specificity. The only minor shortcoming is that the LLM slightly underemphasizes that matrix pricing itself is a Level 2 technique, which the original answer clarifies. However, this does not detract significantly from the overall correctness. Wording differs but semantic equivalence is maintained. Contextual relevance is perfect—directly addresses the comparison asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 420,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "What percentage of Coca-Cola's non-U.S. unit case volume is managed by Coca-Cola HBC, and in how many of its operational countries—including the Czech Republic—does it coordinate distribution for Coca-Cola's trademark beverages?",
      "original_answer": "Coca-Cola HBC manages 17% of Coca-Cola's non-U.S. unit case volume and coordinates distribution for Coca-Cola's trademark beverages in 30 countries, including the Czech Republic.",
      "llm_answer": "Coca‑Cola HBC handles roughly 20 % of Coca‑Cola’s non‑U.S. unit‑case volume, and it coordinates distribution for Coca‑Cola trademark beverages in 28 of its operating countries – the Czech Republic being one of them.【CL_10k_2022 p.21】【CL_10k_2022 p.23】",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The percentage of Coca-Cola's non-U.S. unit case volume managed by Coca-Cola HBC is stated as 'roughly 20%' in the LLM answer, while the ground truth is 17%. Similarly, the number of countries where distribution is coordinated is reported as 28, whereas the correct number is 30. These numerical discrepancies are material and affect the factual correctness of the response. (2) Number verification: 17% vs. 20% — incorrect; 30 countries vs. 28 — incorrect. Both key figures are off, despite the inclusion of the Czech Republic, which is correctly mentioned. (3) Multi-hop reasoning: The model correctly identifies that Coca-Cola HBC coordinates distribution in multiple countries including the Czech Republic and provides a country count, showing an understanding of the required synthesis between operational scope and geographic reach. However, the incorrect figures suggest either misreading of the source or faulty recall. (4) While the structure and intent of the answer are relevant and address both parts of the question (percentage and number of countries), the core factual inaccuracies in both numbers reduce the correctness score significantly. The contextual relevance is high because the answer attempts the right synthesis and cites appropriate document locations. Qualitative accuracy is moderate due to correct entity identification and logical framing, but undermined by wrong data.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1127,
        "completion_tokens": 408,
        "total_tokens": 1536
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How do Duke Energy's 50% equity stake in Hardy Storage in West Virginia and NextEra Energy's 31.9% ownership in a 303-mile pipeline under construction in the same region reflect divergent strategic approaches to natural gas infrastructure investment, particularly in light of regulatory and market challenges?",
      "original_answer": "Duke Energy's 50% equity stake in Hardy Storage, an interstate underground natural gas storage facility in West Virginia, indicates a strategic focus on stable, long-term infrastructure assets that support regulated gas operations. This aligns with Duke's broader approach of investing in FERC-regulated infrastructure such as Pine Needle and Hardy Storage to ensure reliable supply and service. In contrast, NextEra Energy's 31.9% ownership in a 303-mile pipeline project in West Virginia and Virginia reflects a more ambitious and risk-exposed strategy aimed at expanding transportation capacity into new markets, despite facing regulatory delays and legal challenges. While both companies are investing in West Virginia's natural gas ecosystem, Duke's approach emphasizes secure, operational assets, whereas NextEra's involvement in a pipeline under construction—subject to permitting and legal hurdles—suggests a higher tolerance for uncertainty in pursuit of future capacity and market access.",
      "llm_answer": "Duke Energy’s 50 % equity interest in Hardy Storage – an underground, FERC‑regulated interstate gas‑storage facility in Hardy and Hampshire counties, West Virginia – fits its strategy of expanding regulated, cost‑recoverable assets that support its gas‑distribution business and provide a stable, rate‑approved revenue stream. By contrast, NextEra Energy’s 31.9 % stake in a 303‑mile interstate pipeline under construction in West Virginia and Virginia is a growth‑oriented, non‑regulated investment whose completion hinges on FERC approvals and the resolution of legal challenges, exposing it to higher regulatory and market risk. Thus Duke leans toward low‑risk, regulated storage infrastructure, while NextEra pursues higher‑risk transmission expansion to capture future market opportunities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Duke Energy's 50% stake in Hardy Storage and NextEra Energy's 31.9% ownership in a 303-mile pipeline project in West Virginia and Virginia are accurately reported. These figures match the original answer exactly, satisfying quantitative accuracy. (2) The answer correctly identifies both companies, the nature of the assets (FERC-regulated storage vs. pipeline under construction), and the associated risks (regulatory delays, legal challenges). (3) The reasoning is sound: it contrasts Duke’s low-risk, regulated infrastructure strategy with NextEra’s higher-risk, growth-oriented approach, which reflects the divergent strategic priorities as described in the ground truth. The synthesis across entities and regulatory contexts is logically coherent. (4) Minor point: the original answer provides slightly more context on Duke’s broader portfolio (e.g., Pine Needle), and emphasizes that NextEra’s pipeline faces 'permitting and legal hurdles'—details that are implied but not explicitly stated in the LLM version. However, the LLM captures the core contrast effectively. Wording differs but semantic meaning is equivalent. No calculation errors. Thus, full marks for quantitative accuracy and contextual relevance, near-perfect qualitative accuracy, and a 9/10 overall for correctness due to slight omission of minor contextual detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 397,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How does the difference in voting rights between Class A and Class B shares at META compare to GOOGL's dual-class structure, and what implications might this have on ownership concentration given META's 2,189,898,148 Class A shares and 343,761,117 Class B shares outstanding as of January 24, 2025, versus GOOGL's 10:1 voting ratio for Class B shares and $62.0 billion in 2024 share repurchases?",
      "original_answer": "META discloses two classes of stock—Class A and Class B—with the latter carrying greater voting rights, though the exact ratio is not quantified in the filing. As of January 24, 2025, META had 2,189,898,148 Class A shares and 343,761,117 Class B shares outstanding, indicating a significant concentration of voting power within Class B. In contrast, GOOGL explicitly states that each Class B share carries 10 votes, creating a defined 1:10 voting disparity. GOOGL also repurchased $62.0 billion in shares during 2024, predominantly from Class A and Class C, which may further consolidate voting control in Class B shares held by insiders. This suggests that while both companies utilize dual-class structures to concentrate voting power, GOOGL's is more explicitly weighted and reinforced through aggressive capital allocation, whereas META’s structure lacks detailed disclosure on voting disparity but similarly reflects a concentrated ownership base through disproportionate Class B shareholding.",
      "llm_answer": "Both Meta and Alphabet use a dual‑class system in which each Class B share carries ten votes and each Class A share carries one vote【page_82】. At Meta, the 343.8 million Class B shares (≈13.5 % of the 2.53 billion total shares outstanding on Jan 24 2025) generate about 61 % of the voting power (10 × 343.8 m ≈ 3.44 bn votes vs. 2.19 bn votes from Class A) — so control is concentrated in a relatively small share class【page_1】. Alphabet’s identical 10‑to‑1 voting ratio, together with $62 billion of Class A and Class C share repurchases in 2024 that reduced the number of non‑voting shares, likewise tightens voting power in the hands of its Class B holders【page_82】.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in asserting that Meta's Class B shares carry 10 votes each, which contradicts the ground truth stating that Meta does not disclose the exact voting ratio. This is a major error in entity and qualitative accuracy. The total shares outstanding (2.53 billion) is approximately correct (2,189,898,148 + 343,761,117 ≈ 2.53 billion), and the Class B share count is correctly rounded. The calculation of voting power (3.44 billion vs 2.19 billion votes) is mathematically sound but based on a false premise, rendering it invalid. GOOGL’s 10:1 voting ratio and $62 billion repurchases are correctly stated. (2) Quantitative accuracy is partially correct: share counts, repurchase amount, and derived totals are accurate or reasonably rounded. However, the 10-vote assumption for Meta is unsupported and incorrect per the original answer, which explicitly notes the lack of disclosed ratio. (3) Multi-hop reasoning is flawed because the model assumes parity between Meta and GOOGL’s voting structures without justification. It fails to recognize that Meta’s structure lacks transparency on voting weight, which is a key distinction in the ground truth. The synthesis of repurchases reducing non-voting shares is logically sound and correctly applied to GOOGL. (4) Contextual relevance is high—the answer addresses both companies, share classes, voting rights, repurchases, and ownership concentration. However, the core factual error about Meta’s voting ratio undermines correctness. The answer presents confident but false equivalence, missing the nuanced distinction that GOOGL’s structure is explicitly defined while Meta’s is not.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 466,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did the enactment of TRAF in Switzerland impact JNJ's effective tax rate in 2020, and how does this compare to MRK's tax benefit from its Swiss tax holiday that began in 2021?",
      "original_answer": "The enactment of TRAF in Switzerland allowed JNJ to adjust the tax basis of certain assets to fair value under transitional provisions, resulting in an incremental Swiss tax deduction and contributing to a 1.9% decrease in JNJ's 2020 effective tax rate compared to 2019. Meanwhile, MRK benefited from a Swiss tax holiday for a newly active legal entity, effective through 2030, which began yielding favorable tax impacts starting in 2021. These provisions in Switzerland contributed to both companies experiencing lower effective tax rates due to localized tax incentives, albeit through different mechanisms and in different fiscal years.",
      "llm_answer": "The TRAF reform gave Johnson & Johnson a net $0.4 billion tax benefit in 2020, which lowered its annual effective tax rate by roughly 2.6 percentage points. Merck’s Swiss tax holiday that started in 2021 helped drive its effective tax rate down to 11.0 % in 2021 from 22.9 % in 2020 – a reduction of about 12 percentage points, indicating a far larger tax advantage than the 2.6‑point benefit J&J received (the filing does not isolate a specific dollar amount for the holiday).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key quantitative claims. The ground truth states that JNJ's effective tax rate decreased by 1.9 percentage points in 2020 due to TRAF, but the LLM claims a 2.6-point reduction, which is incorrect. Additionally, the $0.4 billion tax benefit figure for JNJ is not present in the original answer and cannot be verified against the ground truth, making it a fabrication or misattribution. For MRK, the original answer notes that the tax holiday began yielding favorable impacts starting in 2021 but does not provide specific rate changes or dollar amounts. However, the LLM asserts that MRK’s effective tax rate dropped from 22.9% in 2020 to 11.0% in 2021—a 12-point reduction—attributing this entirely to the Swiss tax holiday. This level of specificity and magnitude is absent from the ground truth and likely overstates the impact, especially since such a dramatic shift would involve multiple factors beyond one tax holiday. (2) Number verification: The 1.9% decrease for JNJ is misrepresented as 2.6%; no dollar amount was provided in the original for JNJ, so $0.4B is unsupported; MRK’s rate change and attribution are not detailed in the original, so the 11.0% and 22.9% figures are unverified and likely incorrect in context. (3) Multi-hop reasoning: The LLM attempts to compare the two companies’ Swiss tax benefits, which aligns with the question’s intent, but does so using inaccurate data. It fails to correctly identify that JNJ’s benefit was realized in 2020 while MRK’s started in 2021, and mischaracterizes the mechanisms—TRAF’s asset revaluation vs. a tax holiday—though it correctly identifies different mechanisms. (4) The contextual relevance is high because the answer addresses both companies, the Swiss tax regimes, and compares their impacts on effective tax rates. However, due to major quantitative errors and unsupported specifics, the correctness and accuracy scores are low. While the direction of impact (lower tax rates) is correct, the magnitude and supporting figures are not, undermining the reliability of the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 570,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How do MCD's foreign currency asset hedging practices compare with NKE's transactional FX risk management strategies using options, particularly regarding notional amounts and objectives?",
      "original_answer": "MCD manages FX exposure by holding diversified foreign currency net asset positions, with its largest exposures denominated in major global currencies (chunk_1). To mitigate associated risks, MCD uses option and forward contracts to hedge forecasted foreign currency transactions, with $9.9 billion in notional amounts of net foreign exchange cash flow hedges as of September 28, 2024 (chunk_2). NKE also uses option contracts as part of its FX risk management, focusing on transactional exposures such as product costs and external sales in non-functional currencies, with hedging strategies aimed at stabilizing U.S. Dollar inventory costs amid FX fluctuations (chunk_3). While both companies use options, MCD's strategy centers on protecting existing foreign currency assets, whereas NKE's approach is more transaction-focused, targeting forecasted cash flows and cost stability.",
      "llm_answer": "McDonald’s (see MCD 10‑K p. 121‑122) hedges the value of its foreign‑currency assets, liabilities, firm commitments and forecasted transactions with option and forward contracts that it designates as cash‑flow hedges.  At September 28 2024 the net notional of those foreign‑exchange cash‑flow hedges was about **$9.9 billion** (down from $8.3 billion in 2023), and the company says the objective is to “reduce earnings and cash‑flow fluctuations associated with changes in foreign‑currency exchange rates.”  \n\nNike (see NKE 10‑K p. 46‑48) also uses forwards and options, but only to offset **transactional FX exposures** such as product‑cost purchases, non‑functional‑currency sales and other costs.  The filing does not disclose a specific notional amount for those option contracts; the stated goal is to “hedg[e] the remaining effect of exchange‑rate fluctuations on probable forecasted future cash flows” rather than to protect a defined asset‑or‑liability balance.  \n\nThus, McDonald’s reports a large, quantified hedge notional focused on stabilising asset‑ and liability‑related earnings, whereas Nike’s approach is a portfolio‑based, un‑quantified use of options aimed at smoothing transactional cash‑flow impacts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: MCD's $9.9 billion notional amount in foreign exchange cash flow hedges as of September 28, 2024, is accurately reported, and the comparison to $8.3 billion in 2023 (though not required for the question) adds context without error. NKE’s use of options for transactional FX risk is correctly described, and the absence of a disclosed notional amount in its filing is properly noted. (2) Quantitative accuracy is perfect: the $9.9 billion figure matches the ground truth exactly, and no incorrect calculations are made. (3) The multi-hop reasoning is sound—LLM correctly synthesizes that MCD hedges both assets and forecasted transactions with a focus on earnings and cash flow stability, while NKE focuses on transactional exposures like product costs and sales in non-functional currencies. The distinction in objectives—MCD protecting net asset positions vs. NKE stabilizing cash flows from transactions—is accurately captured. (4) The only minor shortcoming is that the LLM slightly reframes MCD’s strategy as including liabilities and firm commitments, which are not emphasized in the ground truth; the original answer focuses on MCD’s foreign currency *net asset* positions, not liabilities. However, this does not contradict the core facts and is a minor nuance. Overall, the answer is semantically equivalent, contextually relevant, and factually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1536,
        "completion_tokens": 406,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the exclusive use of RTX's PW800 engine on Gulfstream's G500 support General Dynamics' strategy to position the G500 as a next-generation replacement for the G450 and G550 models?",
      "original_answer": "The G500, developed by General Dynamics, is positioned as a next-generation replacement for the G450 and G550 models with a clean-sheet design that includes a new wing and advanced avionics. RTX's Pratt & Whitney Canada produces the PW800 engine, which exclusively powers the G500 (along with the G400 and G600). This exclusive engine-airframe pairing enhances the G500's performance with improved fuel efficiency, range, and speed, aligning with General Dynamics' investment in new technologies to differentiate the G500 as a modern, high-performance aircraft in the business jet market.",
      "llm_answer": "The PW800 engine – chosen exclusively to power Gulfstream’s G500 – delivers higher thrust, lower fuel burn and reduced emissions, giving the G500 faster cruise speeds, greater range, more cabin volume and improved flight‑control performance 【page_5†L1-L5】【page_5†L1-L4】. Those efficiency and performance gains let General Dynamics market the G500 as a modern, high‑performance successor that replaces the legacy G450 and G550 models 【page_4†L1-L4】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the core information in the ground truth. It correctly identifies the exclusive use of RTX's PW800 engine on the G500 and links it to performance improvements such as fuel efficiency, range, speed, and modern avionics (implied via 'flight-control performance'), which support positioning the G500 as a next-generation replacement for the G450 and G550. The answer captures the strategic intent of General Dynamics to leverage advanced technology for differentiation in the business jet market. All entities (RTX, PW800, G500, G450, G550, General Dynamics) are correct. There are no numerical values in the question or answers requiring quantitative verification, so quantitative accuracy is scored as 10 by default. The only minor omission is that the LLM does not explicitly mention the 'clean-sheet design', 'new wing', or that the PW800 also powers the G400 and G600—details present in the original answer that add context about the broader product family and engineering investment. However, this does not detract significantly from the overall correctness. The reasoning is sound, with proper multi-hop synthesis between engine capabilities and strategic positioning. Semantic equivalence is high, with slightly more emphasis on performance outcomes than design innovation, but the strategic implication is accurately conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 381,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the voting power distribution in META's dual-class structure compare to CMCSA's, particularly regarding the non-dilutable provisions under their respective articles of incorporation and the specific voting percentages allocated to Class A and Class B shareholders?",
      "original_answer": "META's Class B common stock is not publicly traded and as of December 31, 2023, there were only 23 stockholders of record of Class B common stock, suggesting concentrated voting control. In contrast, CMCSA explicitly states that holders of Class A common stock hold 66 2/3% of the combined voting power, while Class B common stockholders (beneficially owned entirely by Brian L. Roberts) hold 33 1/3% of the voting power. CMCSA's Class B common stock has 15 votes per share and its non-dilutable nature is specifically tied to the terms of its articles of incorporation, which preserves the voting power percentage regardless of additional Class A share issuances.",
      "llm_answer": "Meta’s charter gives each Class A share one vote and each Class B share ten votes, so Class B holders control roughly 86 % of the combined voting power and that share is protected by a non‑dilutable provision in Meta’s articles of incorporation (see META 10‑K, p. 56). Comcast, by contrast, provides one vote per Class A share and fifteen votes per Class B share, with Class B representing exactly 33 ⅓ % of the total voting power – a proportion that is expressly non‑dilutable under its articles of incorporation, while Class A holds the remaining 66 ⅔ % (see CMCSA 10‑K, p. 33).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core structural differences between META and CMCSA's dual-class voting systems and correctly identifies the non-dilutable provisions in both companies' articles of incorporation. It accurately states that CMCSA's Class B holds 33 1/3% and Class A holds 66 2/3% of voting power, with Class B having 15 votes per share — all matching the ground truth. However, the LLM introduces a specific quantitative claim about META's Class B controlling 'roughly 86%' of voting power and having a 10:1 vote ratio (Class B vs Class A), which is not present in the original answer or supported by the provided ground truth. The ground truth only states that META's Class B is not publicly traded and that there were 23 stockholders of record as of December 31, 2023 — it does not specify vote ratios or exact voting power percentages. Additionally, the citation to 'META 10-K, p. 56' implies data not reflected in the knowledge graph ground truth, making this an over-assertion. While the qualitative comparison and non-dilution concept are sound and contextually relevant, the inclusion of unsupported numerical specifics reduces quantitative accuracy. The reasoning is logically structured and addresses the multi-hop comparison, but relies on externalized data not in the ground truth, leading to a partial correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 371,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the risk of losing market exclusivity due to patent challenges for BMY's Revlimid in Europe compare to LLY's reliance on data protection for orphan drug designations, given that both companies depend on intellectual property frameworks to extend commercial exclusivity?",
      "original_answer": "BMY faces earlier-than-expected market exclusivity loss for Revlimid in Europe due to patent settlements allowing generic entry in the UK starting January 18, 2022, and in other European countries beginning February 18, 2022. This highlights the vulnerability of market exclusivity when patent rights are challenged or settled. In contrast, LLY leverages regulatory data protection, including orphan drug designations that provide seven years of market exclusivity independent of patent expiration. While BMY's exclusivity is determined largely by patent rights and settlements, LLY benefits from parallel regulatory protections that do not rely solely on patent enforcement, especially in markets where orphan designations apply.",
      "llm_answer": "BMS warns that generic versions of Revlimid are expected to launch in the United Kingdom on January 18 2022 and in other European countries on February 18 2022 as a result of patent‑settlement agreements, creating a near‑term risk that its European market exclusivity will be eroded by patent challenges and “at‑risk” generic launches (BMY 10‑K p. 36). In contrast, Eli Lilly’s strategy leans on the data‑protection granted to orphan‑drug designations, which provides a statutory seven‑year exclusivity period that blocks competitor approvals without depending on patent enforcement (LLY 10‑K p. 8‑9). Thus, BMS faces an immediate, litigation‑driven threat to Revlimid’s exclusivity in Europe, whereas Lilly’s orphan‑drug protection is a defined regulatory exclusivity that is less susceptible to patent challenges but limited in duration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: BMY (BMS) faces generic entry for Revlimid in the UK on January 18, 2022, and in other European countries on February 18, 2022, due to patent settlements—this matches the original answer exactly. The reference to BMY 10-K p. 36 supports the claim. For LLY, the seven-year orphan drug exclusivity based on regulatory data protection (not patents), cited from LLY 10-K pp. 8–9, is also factually correct. (2) Quantitative accuracy is perfect: dates are precise and correctly attributed, and the seven-year exclusivity period is accurate. No calculations were required, but temporal facts are correct. (3) Reasoning is sound: the contrast between BMY’s vulnerability to patent challenges and settlements versus LLY’s reliance on regulatory exclusivity is well-articulated and reflects proper multi-hop synthesis across two companies, two drugs, and two IP strategies. (4) The only minor shortcoming is that the LLM refers to 'BMS' instead of 'BMY' consistently (though BMS is a common alias for Bristol Myers Squibb, and the 10-K reference confirms correct entity identification), and slightly rephrases the broader implication about 'parallel regulatory protections' in the original. However, the core meaning and factual content are semantically equivalent. The answer is fully relevant, directly addressing the comparative risk of IP strategies as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 401,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the sensitivity of MS's asset management revenues to fixed income market fluctuations compare with PYPL's exposure to market risk through its use of pricing models for derivatives and debt securities?",
      "original_answer": "MS's asset management revenues are sensitive to changes in fixed income markets due to their reliance on fee-based client assets, which include fixed income investments valued using pricing models with observable market data like interest rates and credit spreads. MS specifically notes that revenues may not fully correlate with market changes due to factors like client behavior and asset mix. Meanwhile, PYPL also depends on pricing models for valuing its derivatives and available-for-sale debt securities, using observable inputs such as currency rates, interest rate yield curves, and equity prices. However, unlike MS, PYPL has elected the fair value option for foreign currency-denominated debt securities, directly tying gains and losses to market fluctuations. Both firms face market risk through their use of pricing models, but MS's exposure is more indirect through asset management fees, while PYPL's is direct through its investment and derivative valuations.",
      "llm_answer": "MS says that its asset‑management fees are tied to client holdings that include a substantial fixed‑income component, so movements in fixed‑income markets can directly affect those revenues (MS 10‑K p.62). PayPal’s market‑risk exposure, however, is indirect – it arises from valuing its derivatives and debt securities with pricing models that use observable market inputs, so changes in those inputs generate fair‑value gains or losses in other income (PayPal 10‑K p.93).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and correctly identifies the key mechanisms through which MS and PYPL are exposed to market risk via pricing models and asset valuations. It correctly states that MS's asset management revenues are tied to client holdings with a significant fixed-income component, making them sensitive to fixed income market movements (supported by MS 10-K p.62), and that PayPal uses pricing models with observable inputs to value derivatives and debt securities, leading to fair value gains/losses (citing PayPal 10-K p.93). There are no numeric inaccuracies, so quantitative accuracy is perfect. However, the LLM mischaracterizes PYPL's exposure as 'indirect,' when in fact the original answer emphasizes that PYPL has elected the fair value option for foreign currency-denominated debt securities, which creates a *direct* link between market fluctuations and reported gains/losses. This is a significant qualitative oversight that weakens the comparative analysis. Additionally, the LLM omits MS's caveat that revenues may not fully correlate with market changes due to client behavior and asset mix, and fails to note that both firms use observable inputs but differ in how those valuations impact financials—MS via fee sensitivity, PYPL via direct P&L impact. These omissions reduce completeness and reasoning quality, though the overall direction of the comparison is sound. Contextual relevance is high as the response directly addresses the question’s focus on sensitivity and market risk exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 423,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How do Oracle's integration of generative AI in MySQL HeatWave and Qualcomm's investment in IoT applications reflect their respective strategies for on-device AI processing in enterprise and consumer markets?",
      "original_answer": "Oracle integrates generative AI into Oracle MySQL HeatWave, offering it as a managed cloud service that combines transactions, real-time analytics, machine learning, and generative AI capabilities. This enables enterprise customers to deploy AI-driven analytics and applications more efficiently. In contrast, Qualcomm is investing heavily in expanding generative AI into IoT and edge devices, projecting that 46% of smartphones sold in 2027 will be generative AI capable, up from 19% in 2024. Qualcomm’s QCT segment develops integrated circuits for IoT applications, including consumer electronics, industrial devices, and edge networking products, emphasizing on-device processing for immediacy, privacy, and personalization. While Oracle focuses on cloud-native AI integration for enterprise database workloads, Qualcomm is driving AI capabilities into edge devices across multiple industries, particularly IoT, to capitalize on the growing demand for on-device intelligence.",
      "llm_answer": "Oracle is embedding generative‑AI directly into its MySQL HeatWave service so that enterprise customers can run AI‑driven analytics, machine‑learning and generative‑AI workloads inside the same managed database platform—an approach that extends Oracle’s cloud, on‑premise and hybrid infrastructure with on‑device‑like AI capabilities for businesses (Oracle MySQL HeatWave “combines transactions, real‑time analytics, machine learning and generative AI in one managed cloud service” – page 12). Qualcomm, by investing in AI‑enabled Snapdragon SoCs and IoT products such as AI‑focused PCs and consumer‑IoT devices, is putting dedicated AI hardware (the Qualcomm AI Engine and Hexagon NPU) on the device itself to deliver low‑power, real‑time on‑device AI for consumer and edge markets (Qualcomm AI Engine “includes dedicated hardware capable of running complex AI use cases at high‑performance and low‑power on‑device” and “Qualcomm Hexagon NPU … enables leading on‑device AI capabilities with very low power consumption” – pages 7 & 8).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its description of Oracle and Qualcomm's strategies and correctly reflects the core information from the ground truth. It accurately describes Oracle's integration of generative AI into MySQL HeatWave as a managed cloud service combining transactions, analytics, ML, and generative AI, citing the correct source (page 12) and quoting appropriately. It also correctly characterizes Qualcomm's focus on on-device AI via Snapdragon SoCs, the Qualcomm AI Engine, and Hexagon NPU, with accurate citations (pages 7 & 8) and emphasis on low-power, real-time processing for consumer and edge markets. However, the LLM answer omits the specific quantitative projection from the original answer: that Qualcomm projects 46% of smartphones sold in 2027 will be generative AI capable, up from 19% in 2024. This is a key piece of quantitative evidence supporting Qualcomm’s strategy and market outlook, and its absence represents a meaningful but not critical omission. All other entities (Oracle MySQL HeatWave, Qualcomm QCT, IoT applications, on-device processing) and strategic contrasts (cloud-native enterprise AI vs. edge/consumer on-device AI) are correctly identified and logically synthesized. The reasoning is sound, and the answer is highly relevant to the question. The wording differs but maintains semantic equivalence on all points except the missing statistic. Thus, while the answer is strong and factually consistent, the omission of a key multi-hop data point prevents a perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1518,
        "completion_tokens": 419,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How might the compliance costs associated with the EU AI Act, which Adobe anticipates will require costly changes to its AI development practices, affect its competitive positioning against Salesforce, which relies heavily on its AI-powered Agentforce platform for sales and service offerings?",
      "original_answer": "Adobe anticipates that the EU AI Act, which will be implemented in phases through 2030, may require costly changes to its AI development practices, including delays or halts in development, changes to monetization strategies, and increased compliance costs. Meanwhile, Salesforce relies heavily on its AI-powered Agentforce platform across sales, service, and marketing offerings to drive productivity and growth. If Adobe is forced to divert resources to comply with the new regulations, it could slow the pace of its AI innovation, potentially giving Salesforce a competitive edge through its more established and integrated AI capabilities like Agentforce for Sales and Service. The GS_10k_2024 chunk reinforces that evolving AI regulations increase compliance costs and operational risks for companies relying on AI, suggesting both firms face similar pressures, but Salesforce’s deeper integration of AI across its platform may make it better positioned to absorb such regulatory changes.",
      "llm_answer": "Adobe warns that the EU AI Act will raise its compliance, governance and R&D expenses and force costly changes to its AI‑development practices, which could compress margins and slow the rollout of new AI features. Because Salesforce’s growth hinges on Agentforce—a fully integrated, AI‑driven layer that powers its sales and service offerings—Adobe’s added regulatory burden may weaken its ability to compete on price, speed and functionality, giving Salesforce a relative advantage in delivering AI‑enabled solutions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth with strong semantic equivalence. (1) All factual elements are correct: Adobe anticipates increased compliance costs and operational changes due to the EU AI Act, which could slow AI innovation; Salesforce’s reliance on Agentforce for sales and service gives it a competitive edge if Adobe is hindered. There are no numeric values (e.g., dollar amounts, percentages, specific dates like 2030) in either answer, so no discrepancies exist—format flexibility is not needed. (2) Completeness: The LLM addresses all key aspects—Adobe’s expected compliance burden, impact on innovation pace, and the comparative advantage for Salesforce due to deeper AI integration via Agentforce. The only minor omission is the explicit mention of the phased implementation through 2030 and the GS_10k_2024 reference about shared regulatory pressures, which slightly weakens completeness but does not affect the core reasoning. (3) Entity accuracy is perfect: Adobe, Salesforce, Agentforce, and their respective AI strategies are correctly identified and contextualized. (4) Multi-hop reasoning is sound: the model correctly links regulatory pressure on Adobe → increased costs/slower innovation → relative disadvantage vs. Salesforce’s integrated AI platform. The conclusion about Salesforce gaining a competitive edge in AI-enabled solutions is logically supported. (5) Wording differs slightly (e.g., 'compress margins' is an inference not in the original, though reasonable), but meaning remains factually aligned. Overall, this is a strong, accurate response with only minor contextual omissions preventing a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 459,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How does the payout structure of HD's deferred shares, which includes dividend equivalents paid in additional shares, compare with LOW's receipt of additional shares through ASR agreements, in terms of stock-based value distribution to stakeholders?",
      "original_answer": "HD issues additional shares as dividend equivalents to non-employee directors upon the payout of deferred shares following termination of service, based on accrued dividends. This represents a stock-based compensation mechanism tied to director retention and long-term alignment. In contrast, LOW receives additional shares from third-party financial institutions as part of variable notional ASR agreements, which are tied to repurchase efficiency and final notional value calculations. These additional shares in LOW's case are not compensation-related but are part of capital return strategy execution. Both companies issue additional shares, but the context, stakeholders, and triggers differ significantly, reflecting distinct financial strategies.",
      "llm_answer": "Home Depot’s deferred‑share awards give each non‑employee director one share of common stock at the end of service and also pay accrued dividend equivalents as additional shares, directly increasing the directors’ stock holdings【page_68】. Lowe’s accelerated‑share‑repurchase (ASR) agreements, by contrast, are cash‑for‑shares transactions in which the company may receive extra shares (or deliver shares/cash) upon settlement, altering the total share count and thereby affecting the value distribution to all shareholders rather than providing a direct stock award to individuals【page_61】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core distinction between HD's and LOW's mechanisms for issuing additional shares. (1) It correctly identifies that HD issues deferred shares plus dividend equivalents in the form of additional shares to non-employee directors upon termination, which aligns with the ground truth's description of stock-based compensation for directors. (2) It accurately describes LOW's ASR agreements as variable notional arrangements where the company may receive extra shares at settlement based on final calculations, which reflects the capital return strategy context. (3) The LLM correctly contrasts the stakeholders: individual directors (HD) vs. all shareholders (LOW), and the purpose: compensation vs. share count adjustment via capital return. (4) While the LLM does not explicitly use terms like 'non-employee directors', 'accrued dividends', or 'repurchase efficiency' as in the original, it conveys semantically equivalent information. The reasoning is sound and synthesizes multi-hop information correctly across both companies and mechanisms. (5) No numeric values are present, so quantitative accuracy is not applicable but assumed perfect. Minor deduction in qualitative accuracy due to slightly less precise terminology, but overall meaning and factual content match the ground truth. Contextual relevance is excellent—directly addresses the comparison of stock-based value distribution.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 396,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How does AT&T's adoption of ASU 2020-04, which facilitates contract modifications triggered by reference rate reform, compare to Verizon's disclosure of contract modifications in terms of impact on their respective revenue recognition timing and contract performance obligations?",
      "original_answer": "AT&T adopted ASU 2020-04, which provides optional expedients for contract modifications triggered by reference rate reform (e.g., LIBOR transition), and stated that the adoption did not materially impact its financial statements. Meanwhile, Verizon disclosed that contract modifications affect the timing and scope of performance obligations, with $25.7 billion, $18.7 billion, and $7.5 billion expected to be recognized in 2024, 2025, and beyond, respectively. The connection through ASU 2020-04 to contract modifications shows that while AT&T experienced minimal financial impact from reference rate-related modifications, Verizon's broader contract modification landscape significantly influences its future revenue recognition patterns.",
      "llm_answer": "AT&T says that its adoption of ASU 2020‑04 – which gives optional expedients for contract modifications caused by reference‑rate reform – “does not materially impact our financial statements” (page 53), implying that the change does not meaningfully alter the timing of revenue recognition or the measurement of performance obligations. Verizon, by contrast, discloses that contract modifications “affect the timing and scope of contracts… and are reflected in the estimates of unsatisfied performance obligations” (page 67), indicating that its modifications do shift when revenue will be recognized in future periods.",
      "correctness_score": 7,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies AT&T's adoption of ASU 2020-04 and its disclosure that the impact was not material, which aligns with the ground truth. It also correctly notes Verizon's disclosure that contract modifications affect the timing and scope of performance obligations. However, the LLM answer omits all quantitative figures provided in the ground truth—specifically, Verizon's $25.7 billion, $18.7 billion, and $7.5 billion expected to be recognized in 2024, 2025, and beyond—making it significantly less complete in terms of numerical accuracy. (2) The quantitative accuracy is low because the model fails to report any of the key dollar amounts that are central to the comparison in the original answer. These numbers are critical for assessing the magnitude of Verizon’s contract modification impact on revenue recognition, and their absence constitutes a major omission. (3) The qualitative reasoning is sound: the model correctly interprets that AT&T’s adoption of ASU 2020-04 had minimal financial impact, while Verizon’s contract modifications do affect revenue timing and performance obligations. It draws a valid contrast between the two companies’ disclosures, showing appropriate multi-hop synthesis across entities and standards. (4) Contextual relevance is high because the answer directly addresses the question’s focus on revenue recognition timing and performance obligations. The reasoning is logically structured and uses appropriate terminology. However, the lack of specific figures from Verizon’s disclosures limits the depth and precision of the comparison, reducing the overall correctness score despite accurate qualitative analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 460,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How do Union Pacific's and Lockheed Martin's pension plan disclosures reflect differences in their reliance on Level 2 valuation methodologies for municipal bonds, and what does this imply about their adherence to ASC 820 fair value measurement standards?",
      "original_answer": "Union Pacific discloses that its pension plan classifies municipal bonds as Level 2 investments, which are valued using a bid evaluation process with bid data from independent pricing sources. Lockheed Martin's pension plan also discloses the use of Level 2 valuation methodologies for fixed income securities, where indicative quotes from pricing vendors are used if corroborated. UPS's filing explicitly confirms that municipal bonds fall under Level 2, valued via market-corroborated pricing or matrix pricing models using observable inputs like yield curves. The alignment in Level 2 classification for these instruments suggests both companies are applying ASC 820 consistently for fair value measurements, though UNP provides more specificity regarding municipal bonds, while LMT focuses on general fixed income treatment.",
      "llm_answer": "Union Pacific’s pension note (page 57) says that state‑ and local‑municipal bonds are measured using Level 2 inputs, and the fair‑value table (page 58) shows a $1.7 billion “Bonds and debentures” line that includes those municipal securities. Lockheed Martin’s pension disclosure (page 87) does not list municipal bonds at all—its Level 2 amounts are limited to corporate debt and other fixed‑income categories—so it shows little or no reliance on Level 2 for municipal bonds. Both companies are providing the ASC 820 fair‑value hierarchy, but Union Pacific’s explicit Level 2 classification for municipal bonds demonstrates a more direct application of ASC 820, whereas Lockheed Martin’s lack of municipal‑bond exposure simply reflects a different asset mix while still remaining ASC 820‑compliant.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains partial quantitative accuracy—Union Pacific's disclosure of municipal bonds as Level 2 is correctly identified, and the $1.7 billion 'Bonds and debentures' figure may be factually present in the filing (though not explicitly tied to municipal bonds in the ground truth). However, the core qualitative claim that Lockheed Martin does not rely on Level 2 for municipal bonds because it 'does not list municipal bonds at all' is factually incorrect per the ground truth. The ORIGINAL ANSWER confirms that Lockheed Martin *does* use Level 2 methodologies for fixed income securities, including where indicative quotes from pricing vendors are used and corroborated—this encompasses municipal bonds even if not explicitly named. The LLM incorrectly infers lack of municipal bond exposure or Level 2 application based on absence of explicit mention, which contradicts the ground truth that LMT applies Level 2 broadly to fixed income with corroboration. This reflects a failure in multi-hop reasoning: the model misinterprets disclosure specificity as absence of practice. While both companies are ASC 820-compliant per the LLM’s conclusion, the implication that UNP shows 'more direct application' due to explicit mention misrepresents the issue—ASC 820 adherence is not determined by disclosure granularity but by methodology, which both follow. The ground truth emphasizes consistency in ASC 820 application, with UNP being more specific and LMT more general, whereas the LLM frames this as a difference in compliance depth, which is incorrect. Thus, despite some correct elements, the reasoning and factual synthesis are significantly flawed, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 461,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How does KO's reliance on Coca-Cola FEMSA for distribution in Argentina compare to MDLZ's exposure to economic volatility in the same market, given Coca-Cola FEMSA's specific operational footprint and MDLZ's inflation-related financial impacts?",
      "original_answer": "KO relies on Coca-Cola FEMSA for distribution in parts of Argentina, specifically the federal capital of Buenos Aires and surrounding areas, as part of its broader network of equity method investees to whom it sold $14.471 billion in net sales in 2021. Coca-Cola FEMSA operates in Argentina, a market that has been classified as highly inflationary since mid-2018, which directly affects MDLZ’s operations there. MDLZ reported a $13 million remeasurement loss in 2021 due to the volatility of the Argentine peso, with Argentina contributing $401 million (1.4%) to MDLZ’s consolidated net revenues. This highlights how both companies are exposed to Argentina, but through different mechanisms: KO through a distribution dependency and MDLZ through direct financial exposure to currency and inflation risks.",
      "llm_answer": "KO sells its Argentine beverages through its largest bottling partner, Coca‑Cola FEMSA, which only covers the federal capital of Buenos Aires and surrounding areas as part of FEMSA’s broader Mexico‑Cent‑South America footprint【page_7】. In contrast, Mondelēz’s Argentine operations are owned directly and are accounted for as a highly‑inflationary economy, contributing about 1.4 % of net revenue and generating a $13 million remeasurement loss in 2021 (and $9 million in 2020) because of hyper‑inflation【page_89】. Thus KO’s exposure is indirect and geographically limited to a bottler’s territory, while MDLZ bears direct macro‑economic risk that shows up as inflation‑related earnings impacts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor omissions. (1) Quantitative accuracy: All numbers are correct — the $13 million remeasurement loss in 2021, $9 million in 2020 (additional detail not in ground truth but not contradictory), 1.4% of net revenue, and $401 million contribution (implied by 1.4% of MDLZ’s total revenue) align with known data. The $14.471 billion in net sales from KO to equity method investees is omitted, but this does not detract from the Argentina-specific comparison. (2) Completeness: The answer addresses both companies’ exposure — KO’s indirect distribution reliance via Coca-Cola FEMSA in Buenos Aires and surrounding areas, and MDLZ’s direct exposure to inflation and currency volatility. The only minor gap is not explicitly stating that Argentina has been classified as highly inflationary since mid-2018, though it is implied by referencing the remeasurement loss. (3) Entity accuracy: All entities (KO, MDLZ, Coca-Cola FEMSA), financial metrics (remeasurement loss, net revenue contribution), and years (2021, 2020) are correct. (4) Reasoning: The multi-hop synthesis is sound — it correctly links KO’s distribution model through FEMSA to limited geographic exposure, while contrasting with MDLZ’s direct ownership and resulting financial impacts from inflation. The conclusion about indirect vs. direct exposure is logically derived and matches the ground truth. (5) Semantic equivalence: The LLM answer effectively captures the key contrast in exposure mechanisms. The addition of the $9 million 2020 loss is extra context and does not introduce error. Overall, the answer is factually correct, well-reasoned, and contextually appropriate, warranting a 9 due to the slight omission of the $14.471B figure and the start date of the highly inflationary classification, which are secondary but present in the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 516,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does the voting rights structure of META's Class B common stock influence its shareholder equity strategy compared to Alphabet's dual-class stock framework, particularly in light of Alphabet's $62.0 billion share repurchase in 2024 targeting Class A and Class C shares?",
      "original_answer": "META's Class B common stock grants 10 votes per share, compared to 1 vote per share for Class A, giving certain shareholders disproportionate voting power. Similarly, Alphabet follows a dual-class structure where Class B shares also carry 10 votes each, while Class A shares have one vote, and Class C shares have no voting rights. In 2024, Alphabet repurchased $62.0 billion of its Class A and Class C shares, prioritizing repurchases based on economic cost and market conditions. This suggests that both companies maintain strategic flexibility in managing shareholder equity by leveraging their dual-class structures to preserve voting control while repurchasing shares to enhance shareholder value.",
      "llm_answer": "Meta’s Class B shares carry ten votes per share, concentrating voting power with insiders and letting them steer equity actions—such as share‑repurchase timing and dividend policy—without needing broad shareholder approval (Meta 10‑K shows 343 million Class B shares outstanding 【page_1】). Alphabet’s dual‑class system gives voting rights only to Class A (one vote) while Class C has none, and its 2024 $62 billion buy‑back program was directed at both Class A and Class C shares to return capital to all shareholders while preserving control with the voting Class A holders (Alphabet 10‑K notes the 10‑vote Class B, 1‑vote Class A and 0‑vote Class C structure and the $62 bn repurchase of Class A and C shares 【page_82】). Thus, Meta’s high‑vote Class B enables a more centralized equity strategy, whereas Alphabet uses large buybacks across voting and non‑voting shares within its split‑voting framework.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all numbers are accurate: the $62 billion share repurchase by Alphabet in 2024 is correctly cited, and the voting rights (10 votes for Class B, 1 for Class A, 0 for Class C) are accurately represented for both companies. The mention of 343 million Class B shares for Meta, while not in the ground truth, does not contradict it and may be drawn from the cited 10-K, so it does not count as an error. (2) The answer correctly identifies the dual-class structures of both Meta and Alphabet, including the differential voting rights across share classes. (3) The multi-hop reasoning is sound: it connects Meta’s centralized control via high-vote Class B shares to strategic equity decisions, and contrasts this with Alphabet’s use of large repurchases across non-controlling shares (Class A and C) to return value while preserving insider control—this synthesis across companies and strategies is logically coherent. (4) However, there is a minor inaccuracy: the LLM states that Alphabet’s Class A has voting rights and Class C does not, but incorrectly implies that Class B is not the primary control-retention vehicle; in fact, Alphabet’s founders hold Class B shares (10 votes each), which are the cornerstone of control preservation—this nuance is slightly underemphasized. Additionally, the LLM incorrectly states that Alphabet’s Class A has one vote and Class C has none, but fails to mention that Class B (not Class A) is the super-voting class held by insiders—this could mislead readers about the control hierarchy. Despite this, the overall strategic comparison is valid. Hence, the answer earns a high score but not perfect due to this subtle but important misrepresentation in the qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 487,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does the decline in GILD's Veklury sales in 2024, influenced by the availability of alternative treatments, compare to the negative impact AMGN reports from alternative treatments in competitive therapeutic markets?",
      "original_answer": "GILD reported that Veklury sales in 2024 were $1,799 million globally, a decline from $2,184 million in 2023, attributed to reduced demand linked to the availability and uptake of alternative treatments for COVID-19. This reflects a direct impact on revenue due to competitive therapeutic options. Similarly, AMGN notes that in competitive treatment markets such as those for ENBREL, Otezla, Repatha, and Aimovig, payers and PBMs are increasingly using formulary restrictions and cost-containment measures to shift patients toward alternative treatments, which has limited Amgen's product usage and sales. Both companies experience revenue pressure from alternative treatments, though GILD’s impact is more directly tied to pandemic-related dynamics, while AMGN faces systemic payer-driven shifts in competitive markets.",
      "llm_answer": "Gilead’s COVID‑19 antiviral Veklury fell from $2.184 billion in 2023 to $1.799 billion in 2024 – a drop of roughly $385 million (about an 18 % decline) that the company attributes to lower infection rates and the “availability, uptake and effectiveness of vaccines and **alternative treatments** for COVID‑19” (see product‑sales table and risk‑factor discussion)【page_66】【page_19】.  \n\nAmgen, by contrast, flags a **qualitative** hit from alternative therapies: it notes that “the development of new treatment options or standards of care may reduce the use of our products” and lists numerous competing branded, generic and biosimilar products across its portfolio (e.g., ENBREL vs. HUMIRA, Otezla vs. Tremfya, etc.) (see competitive‑product table and risk‑factor narrative)【page_14】【page_15】.  \n\nThus, Gilead’s decline is a concrete, dollar‑amount reduction linked to alternative COVID‑19 therapies, whereas Amgen’s exposure is described more generally as a loss of product use and pricing pressure from competing and alternative treatments, without a specific sales figure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: Veklury sales declined from $2.184 billion in 2023 to $1.799 billion in 2024, a difference of $385 million (~18%), which matches the original data. The formatting variation ($2.184 billion vs $2,184 million) is acceptable and semantically equivalent. (2) The LLM correctly identifies GILD’s revenue decline as directly tied to alternative treatments and lower demand, consistent with the original answer. It also accurately characterizes AMGN’s exposure as qualitative—driven by payer behavior and competition from biosimilars and branded alternatives in markets for ENBREL, Otezla, etc.—without citing a specific dollar impact, which reflects the lack of quantified loss in the source. (3) Multi-hop reasoning is sound: the model synthesizes information across both companies, compares the nature of the impact (quantitative vs. qualitative), and correctly attributes causes. (4) The only minor shortcoming is that the LLM does not explicitly mention Amgen’s reference to formulary restrictions and PBMs, which are part of the mechanism driving the shift to alternatives—this contextual nuance is present in the original answer and slightly strengthens the qualitative analysis. However, the core reasoning and factual content remain intact. Thus, the answer is factually excellent with near-complete synthesis, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 409,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How does AMD's interest payment schedule on its $312 million 7.50% Senior Notes compare with QCOM's interest payment structure on its $14.0 billion aggregate fair value of notes, particularly in terms of payment frequency and fiscal year obligations?",
      "original_answer": "AMD's $312 million 7.50% Senior Notes require semi-annual interest payments on February 15 and August 15 of each year, as stated in the indenture governing the notes. In contrast, QCOM's interest payment structure on its $14.0 billion aggregate fair value of notes includes semi-annual payments for fixed-rate notes and quarterly payments for floating-rate notes. While AMD's interest obligations are tied to a specific fixed schedule with a final maturity in fiscal 2022, QCOM has significant upcoming principal payments starting in fiscal 2023 ($1.4 billion) and continuing through future fiscal years, with no principal due in fiscal 2026.",
      "llm_answer": "AMD’s $312 million 7.50 % senior notes require interest to be paid twice a year – on February 15 and August 15 of each year 【page_66】. Qualcomm’s $14.0 billion of notes have a mixed schedule: floating‑rate notes pay interest quarterly while the fixed‑rate notes pay semi‑annually, and the company also outlines specific principal‑payment obligations by fiscal year (e.g., $1.4 billion due in FY 2023, $914 million in FY 2024, etc.) 【page_79】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: AMD's semi-annual interest payments on February 15 and August 15 are accurately reported, as are QCOM's mixed payment frequencies (semi-annual for fixed-rate, quarterly for floating-rate notes). The dollar amounts and fiscal years for QCOM's principal payments ($1.4 billion in FY 2023, $914 million in FY 2024) match the context. (2) Quantitative accuracy is perfect: all numbers, dates, and percentages are correct and properly formatted. $312 million and $14.0 billion are correctly cited. (3) The multi-hop reasoning is sound—comparing payment frequency and fiscal obligations across two companies' debt instruments is handled clearly and logically. (4) The only minor omission is that the original answer notes no principal is due for QCOM in fiscal 2026, which the LLM answer does not mention. While not critical, this detail was part of the ground truth and adds precision to the comparison. Otherwise, the answer is semantically equivalent, well-structured, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 312,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How might the impending loss of U.S. patent protection for Prolia/XGEVA in February 2025 impact Merck's competitive position, given its reliance on strong patent rights to defend against generic competition and Amgen's own exposure to biosimilar threats in international markets?",
      "original_answer": "The loss of U.S. patent protection for Prolia/XGEVA in February 2025 will likely expose Amgen's product to biosimilar competition, reducing its market exclusivity and potentially decreasing revenue. This dynamic is particularly relevant for Merck, which emphasizes its reliance on strong patent rights to protect its portfolio from generic challenges. Given Merck's acknowledgment of increased global pricing pressure and weakened patent protection in international markets, the erosion of exclusivity for key competitors like Prolia/XGEVA could intensify biosimilar threats across markets, thereby indirectly affecting Merck’s own competitive strategy and market positioning in the therapeutic category.",
      "llm_answer": "The U.S. patents covering the RANKL antibodies in Prolia and XGEVA are set to expire in February 2025 (see the product description and patent table showing a 2/19/2025 U.S. expiry)【page_10†L1-L7】【page_11†L1-L4】, and Merck has repeatedly stressed that its ability to fend off generic competition depends on the strength and duration of its patent portfolio (loss of patent protection “is typically followed promptly by generic or biosimilar substitutes” and “the Company’s policy to actively protect its patent rights” is central to its competitive strategy)【page_33†L1-L9】. Because Amgen’s own patents for the same antibodies also run out internationally (November 2025 in Europe)【page_10†L1-L7】, Amgen will confront biosimilar entrants abroad, amplifying price pressure and market‑share erosion worldwide. Thus, the imminent U.S. patent cliff will likely weaken Merck’s defensive position and, combined with Amgen’s exposure to biosimilars overseas, could accelerate generic competition and compress margins for both companies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the U.S. patent expiration for Prolia/XGEVA is accurately dated to February 2025 (specifically 2/19/2025), and the European expiration in November 2025 is correctly noted. These dates match the multi-hop requirement across geographies and companies. (2) Quantitative accuracy is perfect—dates are precise and correctly cited from the source (page references included), with no calculation errors. (3) The reasoning is sound: the LLM correctly links Amgen’s loss of exclusivity in the U.S. and internationally to increased biosimilar competition, and ties this to Merck’s strategic reliance on strong patent protection. It logically infers that weakened exclusivity for a major competitor (Amgen) could indirectly affect Merck by accelerating market-wide biosimilar entry and price pressure. (4) The answer is contextually relevant and addresses all parts of the question: Merck’s dependence on patents, the impact of Amgen’s patent expiry, and the interconnected global biosimilar threat. The only minor shortcoming is that the original answer emphasizes Merck’s own exposure to weakened international patent environments more explicitly, which the LLM touches on indirectly but could have integrated more clearly. However, the core multi-hop synthesis—linking Amgen’s patent cliff to Merck’s competitive positioning via shared market dynamics—is well executed. Wording differs but semantic equivalence is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 416,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "What portion of Broadcom's VMware Cloud Foundation revenue in fiscal year 2024 was directly tied to enabling AI workloads, and how does this align with Cisco's strategic focus on providing infrastructure for AI training and inference?",
      "original_answer": "In fiscal year 2024, $1,380 million of Broadcom's $2,900 million VMware Cloud Foundation revenue was recognized, and this platform specifically enables advanced AI and machine learning workloads at enterprise scale. This aligns with Cisco's strategic focus on providing network infrastructure to power AI training and inference workloads through high-density routers and switches, improved network management, and high-performance optics, as stated in their 2024 10-K filing.",
      "llm_answer": "Broadcom’s 2024 filing does not break out a separate AI‑specific share of VMware Cloud Foundation revenue – it only notes that VCF “enables advanced AI and machine‑learning workloads at enterprise scale” (AVGO page 8). Cisco, on the other hand, explicitly says its strategy is to provide the high‑density networking infrastructure needed to power AI training and inference workloads (Cisco page 4), so Cisco’s AI‑focused infrastructure emphasis dovetails with Broadcom’s AI‑enabled VCF offering.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct in describing the strategic alignment between Broadcom's VMware Cloud Foundation (VCF) and Cisco's AI infrastructure focus, but it fails to include the key quantitative information from the ground truth. Specifically, the ground truth states that $1,380 million of Broadcom's $2,900 million VMware Cloud Foundation revenue in fiscal year 2024 was tied to enabling AI workloads. The LLM incorrectly claims that 'Broadcom’s 2024 filing does not break out a separate AI-specific share,' which contradicts the ground truth that explicitly provides this figure. This is a major factual omission that undermines the correctness of the answer. (2) Quantitative accuracy is very low because the LLM omits both the $1,380 million and $2,900 million figures entirely, which are central to answering the first part of the question. These numbers are not just context—they are the core of the requested information. (3) The qualitative reasoning is sound in recognizing that VCF enables AI workloads and that Cisco’s strategy involves supporting AI training and inference through networking infrastructure. The LLM correctly cites both companies’ strategic positioning and aligns them appropriately, showing valid multi-hop synthesis between Broadcom’s software platform and Cisco’s hardware infrastructure. However, it fails to confirm that the revenue portion tied to AI is explicitly quantified in the filing, which weakens the reasoning. (4) Contextual relevance is high because the answer addresses both parts of the question—Broadcom’s AI-related revenue and Cisco’s strategic focus—and attempts to draw a meaningful connection. Despite missing key data, the framing and direction of the response are appropriate. Overall, the answer cannot score highly due to the absence of critical financial figures, which are required for full correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 511,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the $1,851 million in assets from NEE's consolidated solar VIEs compare to Southern Power's exposure through PPAs accounted for as operating leases, given both entities operate solar facilities under long-term power sales agreements?",
      "original_answer": "NEE consolidates solar VIEs with approximately $1,851 million in assets at year-end 2021, which sell electricity under long-term PPAs expiring between 2035 and 2052. Southern Power, a subsidiary of SO, operates PPAs related to solar facilities accounted for as operating leases with remaining terms of up to 25 years. While NEE's VIEs directly own the solar assets and bear construction and operational risk, Southern Power's exposure is structured as lessor under operating leases, receiving lease payments tied to energy production. Both entities demonstrate significant long-term commitments to solar generation through contractual arrangements, though NEE holds direct ownership and asset risk while SO participates through lease financing structures.",
      "llm_answer": "NextEra’s consolidated solar VIEs hold about **$1.851 billion** of assets (NEE VIE note, page 97). Southern Power’s exposure from PPAs that are accounted for as operating leases is shown by undiscounted cash‑flow commitments of roughly **$652 million** (Southern Power operating‑lease cash‑flow table, page 270), and that amount does not even include additional contingent‑rent payments from those PPAs. Thus, NEE’s solar‑VIE asset base is roughly three‑times larger than Southern Power’s operating‑lease PPA exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states NEE's consolidated solar VIE assets as $1,851 million (or $1.851 billion), it incorrectly claims Southern Power has $652 million in operating lease exposure from PPAs. The original answer (ground truth) does not provide any dollar amount for Southern Power’s exposure—only qualitative details about lease structure and term length. Thus, the $652 million figure is unsupported and likely fabricated or misattributed. Additionally, the claim that NEE’s asset base is 'three-times larger' is based on this incorrect comparison and therefore invalid. (2) The quantitative accuracy is low because the $652 million number does not appear in the ground truth and cannot be verified from the provided context. There is no mention of undiscounted cash flows or contingent rent in the original answer. (3) The multi-hop reasoning is partially sound in intent—comparing NEE’s direct ownership of solar VIE assets to Southern Power’s lease-based exposure—but fails because it introduces data not present in the source. The model incorrectly assumes quantifiable exposure for Southern Power when only structural differences (ownership vs. lease) were provided. (4) Contextual relevance is high because the answer addresses the core comparison between NEE and Southern Power’s solar exposure models and attempts to quantify and contrast them. However, the introduction of false numerical data undermines correctness. The qualitative accuracy is moderate due to correct identification of entities and structures but flawed synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 443,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the structure of Starbucks' stock-based compensation grants under Stock Appreciation Rights compare to Tesla's use of the 2019 Plan in terms of equity instruments available and vesting timelines?",
      "original_answer": "Starbucks grants Stock Appreciation Rights as part of its equity incentive plans, though it notes that stock options have not been broadly used recently. In contrast, Tesla's 2019 Plan, adopted in June 2019, explicitly includes Stock Appreciation Rights among the equity instruments available for grant, along with stock options, RSUs, and performance shares. Tesla's stock options and RSUs generally vest over four years and are exercisable over a maximum period of 10 years from grant dates. Starbucks records compensation expense based on the fair value of awards at grant date and recognizes it over the service period, with performance-based RSUs tied to metrics like earnings per share and return on invested capital. Tesla also uses vesting schedules and forfeitures estimates but does not specify performance-based conditions in this excerpt.",
      "llm_answer": "Starbucks grants Stock Appreciation Rights (SARs) under its various equity‑incentive plans and accounts for the awards on a “graded vesting expense schedule” that spreads expense over the employee’s service period, without a fixed term disclosed in the filing. Tesla’s 2019 Equity Incentive Plan also authorizes SARs, but it bundles them with a broader menu of equity instruments—including incentive and non‑statutory stock options, RSUs, restricted stock, performance units and shares—and sets a standard four‑year vesting period for both stock options and RSUs (with options exercisable for up to ten years). Thus, while both companies use SARs, Starbucks describes only a service‑based graded vesting, whereas Tesla specifies a four‑year vesting schedule and a wider set of available equity awards.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: both Starbucks and Tesla include Stock Appreciation Rights (SARs) in their equity incentive plans; Tesla’s 2019 Plan authorizes multiple equity instruments including SARs, stock options, RSUs, and performance shares; Tesla specifies a four-year vesting period for stock options and RSUs with a 10-year exercisable window—these numbers and terms match the original answer exactly. (2) Quantitative accuracy is perfect: no incorrect numbers, dates, or timeframes are presented. The four-year vesting and 10-year exercisability for Tesla are correctly cited. (3) The multi-hop reasoning is sound: the model correctly contrasts Starbucks’ use of SARs (with graded vesting over service period, no fixed term disclosed) against Tesla’s broader set of equity instruments and explicit vesting schedules. It accurately infers that Starbucks focuses on service-based vesting without mentioning performance conditions in this context, while Tesla does not specify performance-based conditions in the excerpt. (4) Minor omission: the original answer notes Starbucks has not broadly used stock options recently, and that its performance-based RSUs are tied to metrics like EPS and ROIC—this detail is missing in the LLM response, slightly reducing completeness. However, the core comparison on equity instruments and vesting timelines is fully addressed. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent as it directly answers the comparative structure of compensation grants.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 437,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the difference in voting rights structure between META's Class B common stock and GOOGL's Class A common stock affect the potential influence of large shareholders on corporate governance decisions at each company?",
      "original_answer": "META's Class B common stock has no voting rights except for certain defined matters, such as exiting the core payments business or specific amendments to the certificate of incorporation, limiting the influence of large shareholders on most corporate governance decisions. In contrast, GOOGL's Class A common stock provides one vote per share, allowing shareholders of this class to have a more direct say in company decisions. This structural difference means that at META, significant shareholders holding Class B shares have limited ability to impact governance outside of specific scenarios, while at GOOGL, shareholders with Class A shares can exert more consistent influence on corporate decisions through their voting power.",
      "llm_answer": "META’s Class B common stock is essentially non‑voting – holders can vote only on a narrow set of matters (e.g., a core‑payments exit or certain merger‑type votes) and any votes are multiplied by the applicable conversion rate (Meta 10‑K p. 90). By contrast, Alphabet’s Class A shares carry one vote per share on all shareholder matters, so large Class A owners can directly shape board elections, mergers and other governance decisions (Alphabet 10‑K p. 82).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the same core information as the ground truth. (1) It correctly states that META's Class B shares are non-voting except for a narrow set of matters (e.g., exiting the core payments business), aligning with the original answer. It also accurately describes GOOGL's (Alphabet's) Class A shares as having one vote per share on all matters. (2) There are no numeric values requiring verification (e.g., percentages, dollar amounts, dates), so quantitative accuracy is not applicable beyond correct referencing of 10-K page numbers (p. 90 for Meta, p. 82 for Alphabet), which are plausible and contextually appropriate. (3) The multi-hop reasoning is sound: the model correctly synthesizes voting rights structures across two companies (META and GOOGL) and draws a valid comparison regarding shareholder influence on governance. The only minor shortcoming is that the LLM mentions 'merger-type votes' as a voting right for Meta Class B shareholders, which is not explicitly stated in the ground truth (the original specifies 'exiting the core payments business' and 'amendments to the certificate of incorporation'). This addition, while plausible, slightly extends beyond the provided truth. (4) Despite this small over-specification, the answer remains semantically equivalent in meaning and highly relevant to the question. The conclusion about differential influence of large shareholders is logically supported and correctly contrasts the two structures. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 447,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the use of foreign currency derivatives in risk management activities differ between BAC and JPM, based on their respective derivative asset and liability disclosures?",
      "original_answer": "BAC includes foreign currency derivatives under 'Risk Management Activities' as part of its derivative assets and liabilities, which are presented on a gross basis before netting adjustments as of December 31, 2024, and 2023. JPM specifically states that foreign currency derivatives are used to manage foreign exchange risk associated with non-U.S. dollar-denominated assets, liabilities, and forecasted transactions, and that gains or losses on these instruments are expected to substantially offset this variability. The fair value of these derivatives is reflected in the balance sheets, either in 'Other' or shown separately under 'Risk Management Activities.'",
      "llm_answer": "BAC’s 10‑K shows foreign‑exchange swaps, spot/futures and options recorded as “trading and other risk‑management” contracts with huge gross notional amounts – about $7.7 trillion of assets versus only $110 billion of liabilities (page 105) – leaving a large net‑asset exposure. JPM’s 10‑K, however, places foreign‑currency contracts almost entirely in hedge‑accounting categories (fair‑value, cash‑flow and net‑investment hedges) with gross OTC assets of $112.7 billion and liabilities of $109.1 billion (plus $0.5 billion cleared each side) (pages 211‑212), resulting in a much smaller, roughly balanced hedging position. Thus BAC uses foreign‑currency derivatives mainly for broad risk‑management/trading, while JPM uses them chiefly to offset specific foreign‑exchange exposures through designated hedges.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies and introduces details not present in the original ground truth, undermining factual correctness. While it attempts a multi-hop comparison between BAC and JPM, the specific numbers cited—such as $7.7 trillion in assets for BAC, $110 billion in liabilities, and JPM’s $112.7 billion in OTC assets and $109.1 billion in liabilities—are not found in the ground truth and cannot be verified from the provided information. The original answer does not include any notional amounts, net exposures, or page references, nor does it distinguish between 'trading and other risk-management' versus hedge accounting categories. Thus, these figures appear fabricated or hallucinated, severely impacting quantitative accuracy. The qualitative analysis attempts to draw a reasonable distinction—BAC using derivatives broadly in risk management and JPM using them for specific hedging—but this interpretation goes beyond the original answer, which only states that both use foreign currency derivatives in risk management, with JPM specifying offsetting gains/losses on non-USD items. The LLM adds inferential layers (e.g., 'mainly for broad risk-management/trading' vs 'chiefly to offset specific exposures') that are plausible but not directly supported by the ground truth. Contextually, the response is relevant and addresses the comparative use of derivatives, fulfilling the intent of the question. However, due to major factual inaccuracies and unsupported numerical claims, the overall correctness score is low despite reasonable structure and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 438,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How does Duke Energy's exposure to economic downturns through industrial customers compare to Southern Company's risk from environmental compliance costs affecting similar customer segments, given both companies' regulated rate recovery mechanisms?",
      "original_answer": "Duke Energy notes that industrial customers reducing production during economic downturns can lead to reduced electricity consumption, lowering revenues and cash flows. Southern Company, on the other hand, faces risks that increased environmental compliance costs—estimated to impact capital expenditures through 2028—could be passed through regulated rates, potentially reducing demand from commercial and industrial customers. Both companies rely on rate mechanisms for cost recovery: Duke through periodic adjustment clauses and Southern through ECO Plan, CNP Compliance, and ECCR tariff mechanisms. However, while Duke's risk centers on demand volatility from macroeconomic conditions, Southern's exposure stems from regulatory-driven cost increases that may dampen industrial customer demand despite efforts to recover those costs through rates.",
      "llm_answer": "Duke Energy warns that a sustained economic slowdown can cause its industrial customers to cut electricity and natural‑gas use, which would shrink sales and cash flow even though its electric and gas businesses operate under a cost‑of‑service/rate‑of‑return framework that allows cost recovery (DUK page 27). Southern Company, by contrast, faces the risk that rising environmental‑compliance costs—generally recoverable through regulated retail and wholesale rates—could push rates higher and curb demand from commercial and industrial users, and there is no certainty that all such costs will be fully recovered (SO page 26; SO page 25). Thus Duke’s exposure is primarily a demand‑side shock from an economic downturn, while Southern’s exposure is a cost‑pass‑through shock that could also depress industrial demand, even though both firms rely on regulated rate‑recovery mechanisms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Duke Energy's risk from industrial demand reduction during economic downturns and Southern Company's risk from environmental compliance costs affecting demand are accurately described. Both companies' reliance on regulated rate recovery mechanisms is correctly noted, with Duke using cost-of-service/rate-of-return frameworks and Southern using mechanisms like ECO Plan, CNP Compliance, and ECCR (implied through references to regulated rate recovery). (2) There are no numeric values, dates, or dollar amounts in either answer that require verification—both mention future impacts without specific figures, so quantitative accuracy is intact. (3) The multi-hop reasoning is sound: the model correctly contrasts Duke’s demand-side exposure (economic downturns reducing consumption) with Southern’s cost-pass-through risk (compliance costs increasing rates and potentially reducing demand), synthesizing across both companies and their respective risk disclosures. (4) The LLM adds minor contextual details not in the original (e.g., mention of natural gas, page citations DUK 27/SO 25-26), which are plausible and do not contradict the ground truth. The only reason for not scoring a 10 is that the LLM does not explicitly name Southern’s specific tariff mechanisms (ECO Plan, CNP Compliance, ECCR), though it refers generally to regulated recovery—this is a minor omission in entity specificity, but the semantic meaning and comparative insight remain fully aligned. Overall, the answer is factually correct, well-reasoned, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 456,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How does the voting power distribution tied to CMCSA's Class B common stock, which is fully owned by Brian Roberts, influence the governance structure compared to GOOGL's dual-class stock system where Class A and Class B shares have different voting rights?",
      "original_answer": "CMCSA's Class B common stock, which is fully owned by Brian Roberts, holds 33 1/3% of the combined voting power with each share carrying 15 votes, creating a concentrated control mechanism that is non-dilutable under the company's articles of incorporation. This contrasts with GOOGL's structure, where Class A shares have 1 vote each and Class B shares have 10 votes each, and Class B shares automatically convert to Class A upon sale or transfer. While both companies utilize dual-class structures to preserve founder control, CMCSA's system entrenches Brian Roberts' influence more securely due to the non-dilutable nature and high per-share voting weight of the Class B stock, whereas GOOGL's structure allows for more fluidity in ownership and voting power distribution.",
      "llm_answer": "Comcast’s single‑owner Class B shares carry 15 votes each and, by design, represent roughly one‑third (≈33 %) of the combined voting power, giving Brian Roberts a sizable, non‑dilutable block that can heavily influence board elections and major corporate actions while the public holds the remaining ≈66 % of votes through Class A shares【page_31】. Alphabet’s dual‑class system gives insiders 10 votes per Class B share, the public one‑vote Class A shares, and non‑voting Class C shares, concentrating control among a group of insiders who together hold a majority of voting power【page_82】. Consequently, both firms concentrate voting power, but Comcast’s governance is dominated by a single shareholder’s fixed 33 % block, whereas Alphabet’s control rests on a broader insider class with a higher vote multiplier and a separate non‑voting class for public investors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all numbers are correct: CMCSA's Class B stock carries 15 votes per share and holds approximately 33 1/3% of voting power; GOOGL's Class B shares have 10 votes each, Class A have 1 vote, and there is a non-voting Class C—this aligns with the ground truth. The ≈33% representation is a valid approximation of 33 1/3%. (2) The answer correctly identifies that Brian Roberts fully owns the Class B shares, creating a non-dilutable control block, and contrasts this with Alphabet’s broader insider control and automatic conversion upon transfer (implied by 'insiders' and structure). (3) Multi-hop reasoning is sound: it synthesizes ownership concentration at CMCSA (single individual) vs. GOOGL (group of insiders), and notes structural differences in voting power distribution and transfer rules. (4) Minor omission: the LLM does not explicitly state that GOOGL’s Class B shares convert to Class A upon sale or transfer, which is a key differentiator in fluidity of control. However, the implication of broader insider control and structural contrast is present. Wording differs but semantic meaning is equivalent on key points. Thus, the answer earns a 9 for correctness—very close to perfect, with only a small detail missing on GOOGL’s conversion mechanism.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 379,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did KO's indirect exposure to Taiwan through Swire Beverages' operations compare to PEP's direct growth performance in the Taiwanese beverage market in 2022?",
      "original_answer": "KO had indirect exposure to Taiwan through Swire Beverages, one of its top five bottling partners, which operated in Taiwan and accounted for 17% of KO’s worldwide unit case volume in 2021. Meanwhile, PEP directly reported low-single-digit beverage unit volume growth in Taiwan as part of its APAC division's 34% net revenue increase in 2022. This highlights KO’s reliance on a third-party bottler versus PEP’s direct market performance in the same geography.",
      "llm_answer": "Coca‑Cola’s link to Taiwan is only indirect – its bottling partner Swire Beverages “has bottling and distribution operations … in … Hong Kong, Taiwan and …” (KO 10‑K p. 7) – and the filing does not break out any Taiwan‑specific volume or revenue growth. PepsiCo, by contrast, reports that Taiwan’s market “experienced low‑single‑digit growth” in 2022 (PEP 10‑K p. 48), reflecting a modest but positive direct performance.  Thus KO’s exposure is indirect and unquantified, while PEP recorded low‑single‑digit growth in Taiwan.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies KO's indirect exposure through Swire Beverages and PEP's direct low-single-digit growth in Taiwan in 2022, which aligns with the ground truth. However, it omits the specific quantitative detail that Swire Beverages accounted for 17% of KO’s worldwide unit case volume in 2021—a key metric from the original answer that provides context for the significance of KO’s indirect exposure. This omission affects completeness and quantitative accuracy but does not distort the overall meaning. (2) The numeric information presented (low-single-digit growth for PEP) is accurate and correctly attributed to the 2022 PEP 10-K. The missing 17% figure from KO’s 2021 data is a factual gap, though no incorrect numbers are stated. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across KO’s and PEP’s 10-K filings, distinguishing between indirect vs. direct market exposure and drawing a valid comparison. It correctly infers that KO does not report Taiwan-specific performance, unlike PEP. (4) The answer is contextually excellent—focused, relevant, and clearly addressing the comparison asked. Due to the missing 17% volume contribution from Swire, the correctness and quantitative scores are slightly reduced, but qualitative reasoning and relevance remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 374,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How might the expiration of Trulicity's patent protection impact LLY's revenue trajectory in light of MRK's strategic reliance on strong patent protection to maintain market exclusivity and competitive positioning?",
      "original_answer": "The expiration of Trulicity's patent protection, as noted in LLY's 2024 10-K, is expected to lead to a rapid and severe decline in revenue, as seen in 2024 where Trulicity's U.S. revenue decreased by 32% due to competitive dynamics and supply constraints. This aligns with the broader risk LLY faces as products lose exclusivity, typically resulting in generic competition and steep revenue drops. Similarly, MRK acknowledges that loss of patent protection leads to generic substitutes entering the market, adversely affecting sales and cash flows. Given MRK's emphasis on actively defending patent rights to maintain market exclusivity and profitability, the erosion of Trulicity's patent protection signals a critical vulnerability for LLY, especially if it lacks a robust pipeline or alternative strategies to offset the anticipated revenue losses.",
      "llm_answer": "The loss of Trulicity’s patent (which LLY notes will occur “in the next few years” and has already contributed to a 26 % drop in its 2024 sales – $5.3 bn vs. $7.1 bn in 2023) is likely to trigger generic competition that will further erode that product’s revenue and slow LLY’s overall growth trajectory, especially since Trulicity is one of the six drugs that together generate about three‑quarters of Lilly’s sales 【page_49】. Merck’s filing makes the same point for its own portfolio: it stresses that “loss of patent protection…is followed promptly by generic…substitutes, reducing the Company’s sales” and that strong patent protection is essential to preserve market exclusivity and offset revenue declines 【page_31】【page_33】. Thus, as Merck warns, the expiration of Trulicity’s patents could produce a rapid, material decline in LLY’s top‑line, mirroring the competitive and revenue‑impact risks Merck associates with losing patent exclusivity.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is largely correct in its reasoning and synthesis, accurately drawing a parallel between LLY's Trulicity patent expiration and MRK's reliance on patent protection to maintain market exclusivity. It correctly identifies the risk of generic competition leading to revenue decline, which aligns with both companies' disclosures.\n\n2) Quantitative accuracy has a minor but notable discrepancy: the LLM states a 26% drop in Trulicity sales from $7.1B in 2023 to $5.3B in 2024. However, the ground truth reports a 32% decline in U.S. revenue (not global) due to competitive dynamics and supply constraints. The LLM incorrectly generalizes this as a global sales drop and misstates the percentage. Additionally, the exact dollar figures and geographic scope (U.S. vs. total) are not fully aligned with the original answer, which does not specify global revenue figures. This affects the precision of the quantitative claim.\n\n3) Qualitatively, the reasoning is strong: the LLM correctly performs multi-hop inference by referencing LLY’s dependence on a few key drugs (citing page 49) and linking it to MRK’s explicit warnings about patent expiration leading to generic substitution (citing pages 31 and 33). It effectively uses MRK’s strategic emphasis on patent defense to underscore the vulnerability LLY faces, demonstrating sound cross-company synthesis.\n\n4) Contextual relevance is excellent—the response directly addresses how Trulicity’s patent expiration could impact LLY’s revenue trajectory in light of MRK’s experience and strategic posture. All key elements of the question are addressed with appropriate framing and supporting evidence.\n\nOverall, the answer is factually solid and well-reasoned but loses points for imprecise numerical claims and lack of clarity on the geographic scope of the reported revenue decline.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 498,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How might FedEx's operational reliance on leased retail locations at hotels, such as the 200 stores located at hotels and convention centers, compare with UPS's financial exposure to real estate funds—like the $10.1 billion in pension assets invested in real estate, private debt, and hedge funds—in terms of strategic risk during periods of real estate market volatility?",
      "original_answer": "FedEx maintains a direct operational exposure to hotels through its 200 leased retail locations at hotels and convention centers, positioning it in high-traffic hospitality venues but exposing it to lease renegotiations or relocations if hotel operators change tenants. These leases are typically for five to ten years, and FedEx's ability to maintain these locations depends on the ongoing operation of the hotels themselves. In contrast, UPS holds an indirect financial exposure to real estate through its pension and postretirement plan assets, which include $10.1 billion in investments in real estate funds, private debt, and hedge funds as of December 31, 2024. These funds may include investments in hotels and other commercial properties, meaning UPS’s exposure is tied to the performance of these funds rather than direct occupancy or lease agreements. During real estate market volatility, FedEx could face operational disruptions or increased leasing costs if hotel properties experience financial strain, while UPS could see fluctuations in the value of its pension assets, affecting long-term liability projections and funding obligations. Thus, while both companies are exposed to the real estate sector, the nature of their risk—operational for FedEx and financial for UPS—differs significantly in both timing and impact.",
      "llm_answer": "FedEx’s network includes roughly 200 FedEx Office stores that are located in hotels, convention centers, hospitals and universities, and “substantially all FedEx Office stores are leased, generally for terms of five to ten years” (FedEx 10‑K, p. 44). This creates an operational exposure that could be mitigated by the relatively short lease horizons and the company’s ability to secure alternative sites, but a real‑estate downturn could still affect lease renewal costs or availability. UPS, on the other hand, holds $10.1 billion of pension and post‑retirement plan assets invested in real‑estate, private‑debt and hedge‑fund vehicles, so a decline in real‑estate values would directly erode the funded status of its pension plans and could require higher contributions, representing a larger financial‑risk exposure than FedEx’s operational lease risk (UPS 10‑K, p. 61).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all numbers are correct: the 200 leased retail locations and $10.1 billion in pension assets invested in real estate, private debt, and hedge funds are accurately reported, with correct sourcing to the respective 10-Ks. The date (December 31, 2024) from the ground truth is not mentioned in the LLM answer, but the figure itself is current and correctly attributed. (2) The LLM correctly identifies FedEx’s operational exposure via leases (5–10 year terms) and UPS’s indirect financial exposure through pension investments. It accurately contrasts operational vs. financial risk, noting that FedEx faces potential lease cost or availability issues during real estate volatility, while UPS faces pension funding risks due to asset devaluation. (3) The multi-hop reasoning is sound: it synthesizes FedEx’s lease structure from its 10-K with UPS’s pension asset allocation from its 10-K, and correctly infers differing risk profiles. (4) Minor deduction in qualitative accuracy because the LLM slightly broadens FedEx’s locations to include hospitals and universities, which are not mentioned in the original answer (though present in FedEx’s 10-K); this is factually accurate but introduces detail not relevant to the hotel-specific comparison in the question. Also, the LLM concludes UPS has a 'larger financial-risk exposure'—a subjective comparative not in the original, though reasonable. Overall, the answer is factually correct, contextually relevant, and demonstrates strong reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1609,
        "completion_tokens": 433,
        "total_tokens": 2042
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How does the voting rights structure of GOOGL's Class B Common Stock compare to CMCSA's disclosure around voting rights in its investment in Atairos, particularly in terms of control and influence over strategic decisions?",
      "original_answer": "GOOGL's Class B Common Stock provides its holders with 10 votes per share, significantly enhancing their influence over corporate decisions compared to Class A shares, which carry one vote per share. This structure allows holders of Class B Common Stock to maintain greater control over strategic decisions despite owning fewer shares. In contrast, CMCSA disclosed that it has no voting rights in Atairos, a VIE in which it holds a significant investment, and only retains certain consent rights. As a result, CMCSA lacks the power to direct Atairos’s activities that most significantly impact its economic performance, which limits its control and influence over strategic decisions at Atairos.",
      "llm_answer": "Alphabet’s Class B shares carry ten votes per share, giving their holders a strong voting bloc that can steer corporate and strategic decisions. Comcast’s stake in Atairos, however, is expressly noted as having no voting rights—Comcast only holds economic interests and limited consent rights, so it cannot direct or control Atairos’s strategic actions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) It correctly states that Alphabet's (GOOGL) Class B shares carry ten votes per share, which aligns with the original answer's claim of 10 votes per share, giving holders disproportionate control compared to Class A. This quantitative detail is correct. (2) It accurately contrasts this with Comcast's (CMCSA) investment in Atairos, correctly noting that CMCSA has no voting rights—matching the ground truth. It also correctly identifies that Comcast holds only limited consent rights, which reflects the original answer’s point about lacking power to direct strategic decisions. (3) The multi-hop reasoning is sound: the model synthesizes information across two distinct corporate structures (GOOGL and CMCSA/Atairos) and correctly contrasts voting control versus economic interest without conflation. (4) The only minor omission is that the LLM does not explicitly mention that Atairos is a VIE (variable interest entity) or that CMCSA’s lack of voting rights limits its ability to influence activities that most significantly impact economic performance—details present in the original. However, the core meaning regarding control and influence over strategic decisions is preserved. Wording differs slightly but maintains semantic equivalence. No calculation errors. Entities (GOOGL, CMCSA, Atairos) are correctly identified. Overall, the answer is factually correct, contextually relevant, and well-reasoned with only slight loss in completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 423,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How does the use of commercial paper financing by Duke Energy Ohio compare to PepsiCo's short-term debt strategy, given Duke Energy Ohio's specific disclosures and PepsiCo's broader commercial paper obligations?",
      "original_answer": "Duke Energy Ohio reported $25 million in commercial paper obligations as of December 31, 2023, as part of its overall short-term financing strategy. In comparison, PepsiCo disclosed $2,286 million in commercial paper obligations in 2023, representing a significant portion of its broader short-term debt obligations totaling $6,510 million. This highlights a stark contrast in the scale of commercial paper usage between the two companies, with PepsiCo relying more heavily on this form of short-term financing.",
      "llm_answer": "Duke Energy Ohio’s commercial‑paper financing is modest – only $25 million, which the company classifies as long‑term debt because it is back‑stopped by long‑term credit facilities and carries a weighted‑average maturity of about 23 days (DUK 10‑K p. 165). PepsiCo, by contrast, relies on a far larger short‑term commercial‑paper program of $2.286 billion at a 5.5 % rate (PEP 10‑K p. 100) and uses senior‑note issuances to refinance and repay that commercial paper (PEP 10‑K p. 101).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports Duke Energy Ohio's $25 million in commercial paper obligations as of December 31, 2023, and PepsiCo's $2,286 million (i.e., $2.286 billion) in commercial paper obligations in 2023, matching the ground truth numerically. The formatting variation ($2.286 billion vs $2,286 million) is acceptable and semantically equivalent. (2) The LLM adds contextual details not in the original answer but consistent with likely 10-K disclosures—such as Duke Energy classifying its commercial paper as long-term due to back-stopping facilities and a 23-day weighted-average maturity, and PepsiCo using senior notes for refinancing. These do not contradict the ground truth and enhance accuracy. The 5.5% rate for PepsiCo is an additional detail not present in the original answer; however, since it does not conflict with the ground truth and may be factual, it does not reduce correctness. (3) The multi-hop reasoning is sound: the model correctly identifies and compares commercial paper usage between two companies, synthesizing data across filings. It captures the stark contrast in scale as emphasized in the original answer. (4) The only minor gap is that the LLM does not explicitly mention PepsiCo’s total short-term debt of $6,510 million, which was part of the original answer and provides context for the proportion of commercial paper within overall short-term obligations. This omission slightly reduces completeness in qualitative accuracy but does not undermine the core comparison. Overall, the answer is factually correct, well-reasoned, and highly relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 441,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "Given Duke Energy's expectation of increasing commercial gas customers in the Carolinas, Ohio, and Kentucky, how might Southern Company's reliance on regulated rate recovery for environmental compliance costs be affected if commercial demand declines due to environmental regulations impacting industrial operations in these same regions?",
      "original_answer": "Duke Energy's gas utility operations expect an increase in the number of commercial and industrial customers over time, particularly in North Carolina, South Carolina, Ohio, and Kentucky. Southern Company, on the other hand, relies heavily on regulated rate recovery mechanisms to offset rising environmental compliance costs, which include upgrades to gas distribution infrastructure and compliance with GHG regulations. However, Southern Company also acknowledges that increased costs recovered through regulated rates could lead to reduced demand for natural gas from commercial and industrial customers—many of whom may be directly impacted by environmental requirements such as emission limits or carbon constraints. If these regulations lead to operational changes or reduced production among industrial users, the anticipated growth in commercial gas demand may not materialize, thereby undermining the effectiveness of rate recovery mechanisms and creating financial pressure on Southern Company's gas operations.",
      "llm_answer": "Duke Energy’s filing notes that “the number of residential, commercial and industrial customers … is expected to increase over time” in the Carolinas, Ohio and Kentucky (DUK 10‑K p. 17). Southern Company, however, relies on “retail and wholesale rates … to recover … environmental‑compliance costs” and acknowledges that “there is no assurance … that all such costs will be recovered” (SO 10‑K p. 25; p. 89). If stricter environmental rules curb industrial activity and commercial gas demand in those same markets, the utility’s rate‑base would shrink, making regulators less likely to approve full cost recovery and potentially forcing Southern to absorb more of the compliance expense or seek other financing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) All factual elements are correct: Duke Energy expects growth in commercial and industrial customers in the Carolinas, Ohio, and Kentucky, and Southern Company relies on regulated rate recovery for environmental compliance costs. The LLM correctly cites Duke Energy’s 10-K (p. 17) and Southern Company’s 10-K (pp. 25, 89), supporting its claims with direct quotes. (2) There are no numeric values (e.g., dollar amounts, percentages, customer counts) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the LLM connects Duke’s customer growth outlook with Southern’s rate recovery model, then introduces the risk that environmental regulations could suppress industrial demand, undermining rate-base growth and recovery prospects. This mirrors the original answer’s logic. The only minor shortcoming is that the LLM does not explicitly mention Southern’s gas infrastructure upgrades or GHG compliance costs by name (though 'environmental-compliance costs' is referenced), slightly reducing qualitative completeness. (4) Contextual relevance is perfect—the answer directly addresses the interplay between regional demand trends, regulatory risk, and financial exposure for Southern Company. Wording differs but semantic meaning and analytical depth are equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 403,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "Given that Comcast's Class B shares carry 15 votes each and represent 33 1/3% of the combined voting power, how does the absence of repurchase activity for these shares (only Class A shares were repurchased in 2023) impact Mr. Roberts' ownership control relative to the broader shareholder base?",
      "original_answer": "Comcast's Class B shares, which carry 15 votes per share and represent 33 1/3% of the combined voting power, are not being repurchased, while Class A shares (with fewer votes) are being actively repurchased. This selective repurchase activity reduces the number of outstanding Class A shares, thereby increasing the relative voting influence of the non-repurchased Class B shares. Since Mr. Brian L. Roberts owns all outstanding Class B shares, this dynamic strengthens his control over corporate decisions, even as the broader shareholder base sees its equity diluted through the retirement of Class A shares.",
      "llm_answer": "Mr. Roberts continues to hold the sole Class B share, which carries 15 votes and equals 33 ⅓ % of the company’s total voting power (the Class B stake is “generally non‑dilutable”)【page_33】.  Since the 2023 share‑repurchase program bought only Class A shares and did not touch the single Class B share【page_35】, the total pool of voting shares fell while his 15‑vote block stayed unchanged, leaving his voting percentage intact (and effectively higher relative to the remaining Class A holders), thereby preserving and even strengthening his control over the broader shareholder base.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor factual inaccuracy: it states that Mr. Roberts holds the 'sole Class B share' (singular), while the ground truth implies he owns all outstanding Class B shares, which are multiple, not a single share. This mischaracterization could mislead readers about the structure of ownership, though the core idea—that he controls all Class B shares—is correct. All other key facts are accurate: Class B shares carry 15 votes, represent 33 1/3% of voting power, and only Class A shares were repurchased in 2023. (2) Quantitative accuracy is high: percentages (33 1/3%), vote weight (15 votes), and the year (2023) are correctly cited. No calculations are required, but the logic that retiring Class A shares increases relative voting power of Class B is sound and correctly applied. (3) The multi-hop reasoning is strong: the model connects repurchase activity (Class A only) with reduced total voting pool, unchanged Class B voting power, and resulting increased relative control by Mr. Roberts. It correctly infers the dilutive effect on Class A shareholders and the entrenchment of Roberts’ control. (4) Contextual relevance is perfect—the response directly addresses the impact of repurchase policy on control dynamics. The error in implying a single Class B share is significant enough to prevent a 9–10 correctness score but does not undermine the overall conclusion. Hence, correctness is 8 due to this entity-level inaccuracy, despite strong reasoning and numerical fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 424,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How does the contractual structure of Amgen's performance units, which are subject to specific payout simulations based on stockholder returns, compare to Bristol-Myers Squibb's exposure to financial agreements that include counterparty credit risk mitigation strategies, particularly in terms of payout or risk management predictability?",
      "original_answer": "Amgen's performance units in 2023 were valued at $121 million and are subject to payout simulations that model stockholder returns based on correlations and volatilities of comparator company stocks over the performance period, as dictated by contractual terms. This creates a structured but variable payout mechanism tied to relative performance metrics. In contrast, Bristol-Myers Squibb enters into financial agreements that include counterparty credit risk mitigation strategies such as limiting exposure to individual counterparties, using conventional instruments, and requiring high credit quality standards. These strategies are designed to ensure predictability and minimize financial risk in derivative and other financial instrument transactions. The contractual frameworks differ in that Amgen’s focus is on performance-linked payout predictability, while BMY emphasizes counterparty risk control and financial stability in its agreements.",
      "llm_answer": "Amgen’s performance‑unit awards are equity awards that only vest if the company meets pre‑set stock‑holder‑return goals relative to a comparator group; the company values the awards with a payout‑simulation model that uses the grant‑date stock price, volatility, risk‑free rates and assumed correlations to estimate the fair‑value and the likely payout percentage, so the ultimate number of shares to be issued is uncertain until the performance period ends but is modeled in advance (see Amgen 10‑K p. 126). Bristol‑Myers Squibb’s exposure, by contrast, stems from derivative and other financial agreements that carry counter‑party credit risk, which the company mitigates by limiting exposure to any one counter‑party, transacting only with high‑credit‑quality counterparties and not requiring collateral, making any potential loss predictable and unlikely to be material (see BMS 10‑K p. 97).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and financial terms are correct in context: while the LLM does not explicitly state the $121 million value of Amgen’s performance units mentioned in the original answer, this omission does not appear to be a factual error but rather a focus on the mechanism rather than the specific dollar amount. No incorrect figures are presented. (2) The explanation of Amgen’s payout simulation model—using grant-date stock price, volatility, risk-free rates, and correlations—is factually consistent with the contractual structure described in the ground truth and reflects accurate synthesis from Amgen’s 10-K (p. 126). (3) For Bristol-Myers Squibb, the LLM correctly identifies counterparty credit risk mitigation strategies: limiting exposure per counterparty, requiring high credit quality, and not requiring collateral, which matches the risk control focus in the original answer (BMS 10-K p. 97). (4) The reasoning correctly contrasts Amgen’s performance-linked payout predictability (based on relative shareholder return simulations) with BMY’s focus on financial stability and predictable risk exposure in derivatives, capturing the core conceptual difference in contractual objectives. (5) The answer is semantically equivalent to the original in substance, though slightly less explicit in directly comparing 'payout predictability' vs. 'risk management predictability' using those exact terms. However, the contrast is clearly implied through accurate description. Minor deduction from 10 to 9 in correctness and qualitative accuracy due to the omitted $121M figure and slightly less structured comparison phrasing, but no factual errors exist. Contextual relevance is perfect—directly addresses both companies, mechanisms, and the comparative intent of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 504,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How does MetLife's exposure to derivatives governed by ISDA Master Agreements under the Orderly Liquidation Authority compare to Bank of America's resolution planning risks, given both companies' regulatory obligations under Dodd-Frank?",
      "original_answer": "MetLife manages credit risk in its derivatives transactions through ISDA Master Agreements that allow for close-out netting, which is subject to financial regulations such as the Orderly Liquidation Authority (OLA) under Dodd-Frank. This means that in the event of a counterparty's bankruptcy, MetLife can offset receivables and apply collateral without being subject to the automatic stay. Similarly, Bank of America Corporation is required to submit resolution plans to the FDIC and Federal Reserve that outline a 'single point of entry' strategy under the U.S. Bankruptcy Code or potentially the OLA. If Bank of America were resolved under the OLA, the FDIC could replace the corporation with a bridge holding company, and security holders could face significant losses. Both firms are therefore subject to Dodd-Frank provisions that alter the treatment of their financial obligations and risk profiles during insolvency, with MetLife exposed through its derivative contracts and BAC through its parent company resolution strategy.",
      "llm_answer": "MetLife’s derivative exposure is largely confined to its OTC‑bilateral contracts, which are covered by ISDA Master Agreements that give the firm enforce‑able set‑off and close‑out netting and, under the Orderly Liquidation Authority (Title II of Dodd‑Frank), allow it to offset receivables against payables and apply collateral without an automatic stay【page_261】. By contrast, Bank of America faces broader resolution‑planning risk: it must file a single‑point‑of‑entry plan with the FDIC and Federal Reserve, and if its liquidity deteriorates or the plan is deemed not credible, regulators could invoke the Orderly Liquidation Authority, impose stricter capital, leverage and liquidity requirements, and restrict access to subsidiary funding, creating systemic and liquidity‑impact concerns【page_13】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that MetLife's derivatives exposure is governed by ISDA Master Agreements, which provide enforceable close-out netting and set-off rights under the Orderly Liquidation Authority (OLA), exempting them from automatic stay in bankruptcy—this matches the original answer's core claim. (2) For Bank of America, the LLM accurately states its obligation to file a single-point-of-entry resolution plan with the FDIC and Federal Reserve, and correctly notes that OLA could be invoked if the plan is not credible, leading to regulatory interventions such as capital requirements and funding restrictions. This reflects the systemic risk and resolution strategy outlined in the ground truth. (3) The multi-hop reasoning is sound: the model synthesizes MetLife’s derivative contract-level risk with Bank of America’s firm-wide resolution planning under Dodd-Frank, correctly contrasting the scope (contractual vs. structural) of their respective exposures. (4) While the original answer mentions the possibility of security holder losses and a bridge holding company under OLA for BAC, the LLM omits this specific mechanism but captures the broader regulatory consequences (stricter requirements, funding restrictions), which preserves semantic equivalence. No numbers, dates, or financial figures are incorrect—quantitative accuracy is perfect. Minor deduction in qualitative accuracy due to slightly less detail on the BAC resolution mechanics, but overall reasoning and contextual relevance are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 436,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How does Nike's revenue from the Greater China region, which includes Taiwan, compare to Starbucks' store count in Taiwan specifically, and what might this suggest about their relative market presence in that geographic area?",
      "original_answer": "Nike generated $7,547 million in revenue from the Greater China region in 2022, which includes Taiwan along with mainland China and Hong Kong. In contrast, Starbucks operated 544 stores in Taiwan as of October 2, 2022. Given that Nike's revenue figure represents a broader regional performance across multiple countries while Starbucks' store count is specific to Taiwan, the comparison highlights different dimensions of market presence—Nike's being revenue-based across a larger geographic cluster, and Starbucks' being operationally focused with a localized footprint in Taiwan.",
      "llm_answer": "Nike reported $7.5 billion in revenue from its Greater China segment (which includes Taiwan) for FY 2022【page_88】.  Starbucks, by contrast, operated ≈ 544 licensed stores in Taiwan at the end of fiscal 2022【page_12】.  The multi‑billion‑dollar sales Nike generates across the whole Greater China market far outpaces Starbucks’ modest physical footprint in Taiwan, suggesting Nike has a much larger market presence in the region than Starbucks does in that specific market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports Nike's $7.5 billion revenue from the Greater China region in FY 2022, which aligns with the ground truth of $7,547 million (rounded appropriately). It also accurately states Starbucks operated 544 stores in Taiwan as of the end of fiscal 2022, matching the ground truth. These figures are cited with plausible page references, enhancing credibility. (2) All numeric values are correct and presented in acceptable formats ($7.5 billion = $7,547 million; ≈544 stores = 544 stores). No calculation errors are present. (3) The reasoning correctly identifies that Nike’s revenue covers a broader region (Greater China: mainland China, Hong Kong, and Taiwan), while Starbucks’ store count is specific to Taiwan. The conclusion that Nike has a 'larger market presence' is a reasonable interpretation, though slightly stronger than the more cautious 'different dimensions of market presence' in the original. This is a minor overstatement but not factually incorrect. (4) The answer fully addresses both parts of the question—comparing quantitative metrics and interpreting what they suggest about market presence. It synthesizes information across two companies and geographic scopes correctly. The only minor shortcoming is a slightly less nuanced interpretation of 'market presence' compared to the original’s emphasis on differing metrics (revenue vs. store count) reflecting different aspects of presence rather than a direct size comparison. Overall, the answer is factually sound, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 430,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How does the $5.0 billion upfront payment from American Tower Corporation in March 2015 compare to the $2.8 billion received from Vertical Bridge in December 2024 in terms of Verizon's retained obligations and asset treatment related to the exclusive rights transactions?",
      "original_answer": "The $5.0 billion transaction with American Tower in 2015 and the $2.8 billion transaction with Vertical Bridge in 2024 both involved Verizon transferring exclusive rights to operate wireless towers while retaining ownership and depreciation responsibilities. In both cases, Verizon subleases capacity back from the acquiring entity and continues to include the towers in 'Property, Plant and Equipment - Net' on its balance sheet. However, the Vertical Bridge deal resulted in a $2.0 billion prepaid rent and $830 million financing obligation split based on usage, whereas the American Tower deal did not specify such a breakdown, indicating a potentially different structure in how the financing and lease obligations were allocated between the two transactions.",
      "llm_answer": "The 2015 American Tower deal transferred exclusive rights to about 11,300 towers for a $5 billion cash payment; Verizon simply sub‑leases capacity, keeps the towers on its PP&E balance sheet and depreciates them, and does **not** record a financing liability for the transaction【page_73】. In the 2024 Vertical Bridge deal, the $2.8 billion cash receipt is split on Verizon’s books into $2.0 billion of prepaid rent and an $830 million financing obligation—reflecting Verizon’s retained lease‑related liability for the portion of towers it continues to occupy—while the towers also remain in PP&E and are depreciated【page_73】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $5.0 billion 2015 American Tower transaction and $2.8 billion 2024 Vertical Bridge transaction are correctly cited, along with the $2.0 billion prepaid rent and $830 million financing obligation from the Vertical Bridge deal. The absence of a financing liability in the American Tower deal is accurately noted. (2) Quantitative accuracy is perfect: all dollar amounts and their breakdowns match the original answer. The sum of $2.0B + $830M = $2.83B is approximately $2.8B (minor rounding acceptable). (3) The reasoning correctly synthesizes multi-hop information—both deals involve retained ownership, continued depreciation, inclusion in PP&E, and subleasing—but correctly distinguishes the accounting treatment, particularly the explicit split in the Vertical Bridge deal versus the lack thereof in the American Tower deal. (4) The only minor shortcoming is that the LLM does not explicitly mention that both transactions involved exclusive rights to operate towers, though this is implied by context. Also, the LLM could have clarified that the American Tower deal may have had different structural allocations without specifying them, as noted in the original answer. However, these omissions do not detract significantly from the overall correctness. Wording differs slightly but maintains semantic equivalence. Contextual relevance is excellent, directly addressing the comparison in retained obligations and asset treatment.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 422,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How does JPMorgan's operational risk capital estimation under Basel III, which includes fraud risk as a key component, compare to Citigroup's exposure to fraud-related losses in emerging markets, particularly in scenarios involving asset confiscation or loss of control in Russia?",
      "original_answer": "JPMorgan uses the Advanced Measurement Approach (AMA) under Basel III to estimate operational risk capital, incorporating internal and external losses, scenario analysis, and business environment metrics, with fraud being a key risk category. Meanwhile, Citigroup reports exposure to fraud and political instability in emerging markets, with a specific scenario in Russia involving potential losses of $1.6 billion in CTA (Cumulative Translation Adjustment) and $0.9 billion on intercompany liabilities if control of AO Citibank is lost. These figures highlight how both firms face fraud-related risks but experience them through different financial mechanisms and geographic exposures.",
      "llm_answer": "JPMorgan estimates its operational‑risk capital under Basel III with the Advanced Measurement Approach, using a loss‑distribution model that quantifies fraud risk (along with other operational‑risk losses) at a 99.9 % confidence level (see JPM pages 155‑156). By contrast, Citi does not set a model‑based capital charge for fraud; it simply discloses a concrete emerging‑market exposure, warning that a loss of control or confiscation of its Russian subsidiary would require a $1.6 billion write‑off and a $0.9 billion inter‑company liability (see Citi pages 64‑65). Thus, JPMorgan’s approach is a statistical capital reserve for fraud risk, whereas Citi’s risk is expressed as a specific potential loss amount in a Russia‑related scenario.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: JPMorgan uses the Advanced Measurement Approach (AMA) under Basel III for operational risk capital, which includes fraud risk; Citigroup discloses a specific scenario involving potential losses in Russia. The dollar amounts—$1.6 billion in CTA and $0.9 billion in intercompany liabilities—are exactly matched. (2) Quantitative accuracy is perfect: both figures are correctly reported with no calculation errors. Format variations (e.g., $1.6 billion vs $1.6B) are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model correctly contrasts JPMorgan’s statistical, model-based capital estimation approach with Citigroup’s disclosure of a concrete, scenario-specific loss, highlighting different mechanisms (capital modeling vs. direct exposure). It synthesizes information across two institutions and regulatory/financial frameworks appropriately. (4) Minor deduction in qualitative accuracy due to the claim that 'Citi does not set a model-based capital charge for fraud'—while plausible, this specific assertion isn't in the original answer and goes slightly beyond the provided ground truth, which doesn't comment on Citi's internal capital modeling practices. However, this doesn't materially distort the comparison. Overall, the answer is factually correct, contextually relevant, and effectively communicates the contrast in risk treatment between the two banks.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 413,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How might a prolonged geopolitical conflict involving Taiwan impact Qualcomm's chipset supply chain differently than Intel's operational footprint in the region, given Qualcomm's reliance on Taiwan-based foundry partners and Intel's $6.867 billion in 2023 revenue tied to the region?",
      "original_answer": "A prolonged geopolitical conflict involving Taiwan would impact Qualcomm and Intel through different mechanisms. For Qualcomm, the risk is operational, as the company explicitly states its 'business depends on our ability to receive consistent and reliable chipset supply from our foundry partners, particularly in Taiwan.' A disruption would 'severely limit or prevent us from receiving chipset supply,' directly threatening its product availability. In contrast, Intel's exposure is primarily financial, with $6.867 billion in 2023 revenue tied to Taiwan, but no explicit mention of reliance on Taiwan-based manufacturing in its disclosures. While both face risks from instability in Taiwan, Qualcomm's dependency is on supply continuity, whereas Intel's is on market demand and revenue generation in the region.",
      "llm_answer": "A prolonged conflict would cut off Qualcomm’s core supply chain because the company “depends on … consistent and reliable chipset supply from our foundry partners, particularly in Taiwan” and a “significant or prolonged … conflict … could severely limit or prevent us from receiving chipset supply from Taiwan” (Qualcomm 10‑K p.35). Intel’s exposure is largely financial—$6.867 billion of 2023 revenue was generated in Taiwan (Intel 10‑K p.88)—so a conflict would mainly erode sales from that market, while Intel’s broader manufacturing footprint and diversified operations would keep its overall supply chain less directly disrupted.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, the $6.867 billion in 2023 revenue for Intel is accurately cited, and the source (Intel 10-K p.88) is correctly referenced. Qualcomm's reliance on Taiwan-based foundries is supported by a direct quote from its 10-K (p.35), matching the original answer's factual basis. (2) The answer is complete, addressing both Qualcomm's supply chain vulnerability and Intel's financial exposure, as required by the multi-part question. (3) Entities are accurate: Qualcomm, Intel, correct fiscal year (2023), and proper distinction between supply chain (Qualcomm) and revenue (Intel). (4) The reasoning is sound and reflects multi-hop synthesis: it correctly infers that Qualcomm’s risk is operational due to foundry dependency, while Intel’s is financial due to regional sales, despite having a broader manufacturing footprint. The LLM adds contextual nuance (e.g., 'diversified operations') that aligns with Intel’s disclosed operations without overreaching. Wording differs slightly from the original but maintains semantic equivalence. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 332,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How does RTX's valuation methodology for private equity limited partnerships differ from BA's approach to valuing Level 3 assets measured on a nonrecurring basis, given that both companies report these investments through fair value processes?",
      "original_answer": "RTX values its private equity limited partnerships on a quarterly basis using discounted cash flows, earnings multiples, and market multiples, with valuation adjustments reflecting changes in operating results, financial condition, or prospects of the applicable portfolio company. In contrast, BA applies an income approach based on discounted cash flows for Level 3 assets measured on a nonrecurring basis, such as impaired customer financing assets, which include operating lease equipment and investments in finance leases valued using median collateral values from third-party aircraft publications. While RTX actively adjusts valuations quarterly based on portfolio company performance, BA relies on third-party publications and adjusts values only under specific circumstances, such as unique aircraft attributes or expected net sales prices.",
      "llm_answer": "RTX values its private‑equity limited‑partnership interests on a **quarterly** basis using a blend of **discounted‑cash‑flow models, earnings multiples and market multiples**, with adjustments for any changes in the operating results, financial condition or prospects of the underlying portfolio companies. By contrast, Boeing’s Level 3 assets that are measured only on a **non‑recurring** basis are valued **primarily with an income approach that discounts projected cash flows of the underlying assets** (e.g., for impairment), rather than applying periodic multiple‑based updates. Both are fair‑value measurements, but RTX employs a regular, multi‑method valuation, whereas Boeing uses a one‑time discounted‑cash‑flow income approach for non‑recurring Level 3 assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core differences between RTX's and Boeing's (BA's) valuation methodologies as described in the ground truth. (1) It correctly states that RTX values private equity limited partnerships quarterly using discounted cash flows, earnings multiples, and market multiples, with adjustments based on portfolio company performance—this aligns exactly with the original answer. (2) It accurately describes Boeing’s approach to Level 3 assets measured on a nonrecurring basis as using an income approach based on discounted cash flows, particularly for impaired customer financing assets. (3) The distinction between RTX’s regular, multi-method updates and Boeing’s one-time, nonrecurring DCF approach is clearly and correctly articulated. However, the LLM omits Boeing’s specific reliance on third-party aircraft valuation publications (e.g., median collateral values) and the mention of unique aircraft attributes or expected net sales prices as adjustment triggers—details present in the ground truth that add nuance to BA’s methodology. While this is a minor omission and does not distort the overall accuracy, it slightly reduces completeness in the multi-hop synthesis. (4) All entities (RTX, Boeing/BA, Level 3 assets, private equity limited partnerships) are correctly identified, and there are no numerical or calculation errors (though no explicit numbers are involved). The reasoning is sound and the answer is contextually fully relevant. The semantic meaning is equivalent to the original answer, with only slight loss in granularity regarding Boeing’s data sources.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 441,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How does Netflix's use of forward contracts to manage foreign exchange risk on firm commitments compare to Disney's VAR model estimates in terms of potential one-day loss exposure, given the specific metrics disclosed in their respective financial reports?",
      "original_answer": "Netflix uses forward contracts to hedge foreign exchange risk on firm commitments related to foreign currency-denominated content assets, aiming to reduce cash flow volatility. However, Disney's Value at Risk (VAR) model estimates a maximum potential one-day loss of $255 million (as of September 28, 2024) across its interest rate, foreign exchange, commodities, and equity-sensitive instruments. While Netflix does not disclose a specific VAR metric, Disney's $255 million VAR figure provides a quantified estimate of its exposure, allowing for a comparative view of how each company assesses and manages financial risk in their operations.",
      "llm_answer": "Netflix discloses that it enters into forward contracts to hedge the foreign‑exchange risk on forecasted revenue and on firm‑commitment transactions tied to foreign‑currency‑denominated content assets, but it does not provide a quantified one‑day loss metric—its only FX‑impact numbers are actual remeasurement gains/losses (e.g., a $293 million loss in 2023)【page_48】. In contrast, Disney’s risk‑management section reports a VAR model that, at a 95 % confidence level, estimates a maximum potential one‑day loss of $40 million for its currency‑sensitive financial instruments (and $255 million for the combined portfolio)【page_60】. Thus, Netflix’s approach is described qualitatively without a one‑day loss estimate, whereas Disney quantifies its exposure with a specific VAR figure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the quantitative disclosure from Disney. It states that Disney's VAR model estimates a one-day loss of $40 million for currency-sensitive instruments and $255 million for the combined portfolio. However, the ground truth specifies only the $255 million figure as the maximum potential one-day loss across all risk categories (interest rate, foreign exchange, commodities, and equity-sensitive instruments) — there is no mention of a $40 million currency-only VAR in the original answer. This $40 million figure is unverified and not present in the ground truth, introducing a significant inaccuracy. (2) The Netflix portion is mostly accurate: it correctly notes that Netflix uses forward contracts to hedge foreign exchange risk on firm commitments and forecasted revenue related to foreign currency-denominated content assets, and that it does not disclose a VAR or one-day loss metric. However, the mention of a '$293 million loss in 2023' is not in the original answer and lacks corroboration from the ground truth, making it potentially misleading. (3) The multi-hop reasoning is partially sound — the model correctly identifies that Netflix lacks a quantified one-day loss metric while Disney provides one, allowing for a comparative view of risk disclosure practices. However, the comparison is undermined by the incorrect attribution of Disney's VAR breakdown. (4) Contextual relevance is high because the answer addresses the core contrast in risk management disclosure practices. The qualitative reasoning about Netflix’s qualitative vs. Disney’s quantitative approach aligns with the original, but the inclusion of unsupported specific numbers reduces factual reliability. Thus, the correctness score is limited to 4 due to major quantitative inaccuracies despite structurally sound reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 506,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did the corporate income tax rate reduction in the Philippines enacted in Q1 2021 impact AMD's tax provision compared to Texas Instruments' operational investments in the country, given both companies' exposure to international tax regulations?",
      "original_answer": "The corporate income tax rate reduction in the Philippines enacted in Q1 2021 had a favorable impact on AMD’s effective tax rate by partially offsetting increases from other tax factors, such as GILTI-related foreign tax credit limitations. Meanwhile, Texas Instruments had $370 million in property, plant, and equipment at its two sites in the Philippines as of December 31, 2021, indicating significant operational exposure that would be directly affected by the lower tax rate. AMD’s 2021 effective tax rate increased by 0.1 percentage point to 21.8%, with the Philippines tax reduction noted as a mitigating factor, while TXN’s capital investment in the country suggests a strategic commitment that would benefit from the lower corporate tax rate.",
      "llm_answer": "AMD said that the Philippines’ corporate‑income‑tax cut enacted in the first quarter of 2021 “partially offset” other upward pressures on its tax bill, leaving its 2021 effective tax rate only 0.1 percentage‑point above 2020 (21.8 % vs 21.7 %) and resulting in a $513 million income‑tax provision for the year. In contrast, Texas Instruments’ exposure to the Philippines is reflected in its operating footprint – property, plant and equipment at its two Philippine sites grew to $370 million at 12/31/2021 (up from $333 million in 2020) – rather than a specific tax‑rate benefit. Thus AMD’s tax provision was modestly improved by the rate reduction, while Texas Instruments’ impact is seen as a capital investment in the country.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AMD’s effective tax rate increased by 0.1 percentage point to 21.8% in 2021, with the Philippines tax cut partially offsetting other tax increases (e.g., GILTI-related foreign tax credit limitations). The $513 million income tax provision is consistent with AMD’s reported financials. Texas Instruments’ PPE in the Philippines is correctly stated as $370 million as of December 31, 2021, up from $333 million in 2020, reflecting growth in operational investment. (2) Quantitative accuracy is perfect: all dollar amounts, percentages, and dates match or are reasonably inferred from the ground truth. The $370 million PPE figure is exact; the 21.8% effective tax rate and 0.1 percentage point increase are correct. The $513 million tax provision, while not in the original answer, is plausible and consistent with AMD’s financials—minor addition but not contradictory. (3) Multi-hop reasoning is sound: the model correctly synthesizes that AMD benefited directly from the tax rate reduction (impacting its tax provision), while TXN’s exposure is operational (capital investment), implying future tax benefits under lower rates. The contrast in impact—direct tax effect vs. strategic investment—is logically drawn. (4) The only minor shortcoming is that the original answer explicitly links TXN’s investment to benefiting from the lower tax rate, while the LLM implies it more indirectly. This slightly reduces qualitative accuracy but does not constitute an error. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 449,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How do GM's and McDonald's different approaches to affiliate relationships reflect their respective business models, particularly in terms of vehicle production and franchise operations?",
      "original_answer": "GM engages in transactions with nonconsolidated affiliates for the development, production, and marketing of trucks, crossovers, cars, and automobile parts, which are integral to its automotive manufacturing business model. These affiliates are primarily located in China and produce vehicles under the Baojun, Buick, Cadillac, Chevrolet, and Wuling brands. In contrast, McDonald's relies on affiliates for franchise operations, where revenues are generated through royalties based on a percentage of sales and initial fees. This reflects McDonald's asset-light business model centered on franchising and brand licensing. While GM's affiliate relationships are production-focused and tied to physical goods, McDonald's approach emphasizes service-based revenue through franchisee support and brand management, highlighting the distinct operational structures of the two companies.",
      "llm_answer": "GM’s affiliates are primarily joint‑ventures and variable‑interest entities that actually produce, import and sell vehicles (e.g., its 50 % China JV SGM that manufactures Buick, Chevrolet and Cadillac models [page 76]) and supply key components such as battery cells, as well as financing subsidiaries that securitize auto loans (the VIE structure used by GM Financial for lease‑backed financing and battery‑cell joint ventures [page 79]); these non‑consolidated affiliates are accounted for using the equity method, reflecting a business model built around vehicle production, supply‑chain control and automotive financing. By contrast, McDonald’s affiliates are franchisees, developmental licensees and foreign affiliates that own and operate the restaurants and pay the company rent, royalties and advertising contributions (41,432 franchised restaurants in 2024 [page 45]; franchise‑related revenue streams of rent, royalties and fees [page 46]), and are not consolidated under a VIE scope exception, illustrating a franchise model where the core business is brand licensing and service provision rather than direct production.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) It correctly identifies GM's affiliate relationships as production-focused joint ventures and variable-interest entities (VIEs), particularly in China (e.g., SAIC-GM), producing vehicles under Buick, Chevrolet, and Cadillac—consistent with the original answer’s mention of Baojun, Buick, Cadillac, Chevrolet, and Wuling brands. While Baojun and Wuling are not explicitly named in the LLM response, the core brands and operational model (JV-based production in China) are correct. (2) Quantitatively, the LLM cites '41,432 franchised restaurants in 2024' [page 45], which matches typical McDonald's scale and is plausibly accurate given recent public data (e.g., McDonald's 2023 annual report listed ~40,000+ restaurants); no specific dollar amounts, percentages, or dates are misstated. The reference to GM's 50% JV and VIE structures is consistent with SEC filing disclosures. (3) The reasoning is sound and multi-hop: it contrasts GM’s manufacturing- and financing-oriented affiliate model (including battery JVs and securitization via GM Financial) with McDonald’s franchise-based model generating revenue from royalties, rent, and fees—accurately reflecting the asset-heavy vs. asset-light business model distinction. (4) The LLM adds valuable detail not in the original (e.g., GM Financial’s lease-backed financing, accounting treatment under equity method, VIE scope exception for franchisees), enhancing depth without introducing error. The only minor omission is the lack of mention of 'nonconsolidated affiliates' in the same explicit terms as the original, but the concept is effectively conveyed through 'not consolidated under a VIE scope exception' and 'equity method'. Overall, the answer demonstrates strong semantic equivalence, contextual relevance, and qualitative reasoning, warranting a high score with only a slight deduction for incomplete brand coverage in GM’s affiliate output.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 541,
        "total_tokens": 2054
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "Given Alphabet's significant share repurchase activity of $62.0 billion in Class A and Class C shares in 2024, and the automatic conversion of Class B shares to Class A upon sale or transfer, how might the reduction in outstanding Class A shares impact the relative voting power of remaining Class B shareholders, especially in light of the fact that Class B shares carry 10 votes per share compared to 1 vote for Class A?",
      "original_answer": "Alphabet repurchased $62.0 billion of Class A and Class C shares in 2024, reducing the number of outstanding Class A shares. Since Class B shares convert automatically to Class A shares upon sale or transfer, this limits the ability of Class B holders to retain higher-vote shares if they transact. With fewer Class A shares in circulation due to buybacks, the relative voting concentration among remaining Class B shareholders—who hold 10 votes per share—would increase, potentially consolidating control among long-term holders.",
      "llm_answer": "Alphabet’s $62 billion repurchase of Class A and Class C shares in 2024 shrinks the pool of one‑vote Class A shares outstanding (Note 11, page 82). Because each Class B share still carries ten votes, the total voting base falls while the ten‑vote shares remain unchanged, so the proportion of votes held by the remaining Class B shareholders rises, giving them greater relative voting power. Moreover, any Class B shares that are sold automatically convert to Class A (which are then eligible for repurchase), further concentrating voting power in the still‑held Class B shares (Note 11, page 82).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements are accurately represented: Alphabet's $62.0 billion share repurchase in 2024 of Class A and Class C shares is correctly stated (matching the original answer's amount and year). The automatic conversion of Class B to Class A upon sale/transfer is accurately noted. (2) Quantitative accuracy is perfect: the $62 billion figure is correctly cited with acceptable formatting variation (using ' ' thin space). No calculations are required beyond understanding the impact of reduced share count, which is correctly interpreted. (3) Multi-hop reasoning is sound: the answer correctly synthesizes the effect of reducing low-vote Class A shares via buybacks while high-vote Class B shares remain unchanged, leading to increased relative voting power for remaining Class B holders. It further strengthens the logic by noting that any sale of Class B shares converts them to Class A, making them subject to repurchase and thus further concentrating voting power—this is a nuanced point present in both answers. (4) The LLM cites 'Note 11, page 82' as a source reference, indicating grounding in the document, and uses slightly more detailed financial language without deviating from the original meaning. All entities (Alphabet, Class A/B/C shares, voting rights, 2024 timeframe) are correct. The answer addresses all parts of the question: repurchase impact, conversion rule, and voting power implications. Therefore, all scores are perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 421,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How does the adoption of ASU No. 2020-01 impact the accounting treatment for equity securities by both Colgate-Palmolive and The Coca-Cola Company, particularly in light of the clarification provided by the standard on the interaction between equity securities, equity method investments, and derivative contracts?",
      "original_answer": "ASU No. 2020-01 clarifies the interaction between the accounting for equity securities under Topic 321, equity method investments under Topic 323, and derivative contracts under Topic 815. Colgate-Palmolive adopted this guidance effective January 1, 2021, and concluded that it did not have a material impact on its Consolidated Financial Statements. Similarly, The Coca-Cola Company, which is also subject to the same accounting standard, applies the clarified guidance to its equity securities, including the calculation of net unrealized gains and losses recognized during the year related to equity securities still held at the end of the year (as disclosed in its financial statements). Both companies benefit from the standard’s clarification on when observable transactions should be considered before applying or upon discontinuing the equity method, and how derivatives linked to equity securities should be accounted for without considering whether the underlying securities would be accounted for under the equity method or fair value option.",
      "llm_answer": "Both companies say that the new guidance simply clarified how equity securities should be treated when an equity‑method investment or a derivative contract is also involved, but it did not change their accounting. Colgate‑Palmolive notes that ASU 2020‑01, which clarifies the interaction of Topic 321, 323 and 815, became effective 1 Jan 2021 and “did not have a material impact on the Company’s Consolidated Financial Statements” (page 81). Coca‑Cola likewise continues to measure all non‑consolidated equity investments that are not accounted for under the equity method at fair value (or at cost‑less‑impairment when fair value is not readily determinable) with changes recognized in earnings, consistent with the ASU’s clarification (page 78). Thus, the adoption of ASU 2020‑01 leaves each company’s equity‑security accounting unchanged, while confirming that any forward contracts or purchase options on those securities are accounted for under the derivatives guidance (Topic 815) rather than as part of the equity‑method investment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: Colgate-Palmolive adopted ASU No. 2020-01 effective January 1, 2021, and stated it had no material impact—this matches the original answer and is correctly cited to page 81. Coca-Cola’s application of fair value measurement for non-consolidated equity investments is accurately described and tied to the ASU’s clarification, with reference to page 78. (2) Quantitative accuracy is perfect: the adoption date (January 1, 2021) is correct, and there are no numerical errors. (3) The multi-hop reasoning is sound—information is correctly synthesized across both companies and linked to the standard’s impact on Topics 321, 323, and 815. The answer correctly explains that the standard clarified, but did not change, accounting practices for both firms, particularly regarding derivatives and equity method transitions. (4) The only minor shortcoming is that the LLM does not explicitly mention Coca-Cola’s disclosure of net unrealized gains and losses on equity securities still held at year-end, which is included in the ground truth. However, the core accounting treatment and the lack of material impact are correctly conveyed. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent as all parts of the question are addressed with precise, focused information.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1565,
        "completion_tokens": 387,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How does the difference in the Stress Capital Buffer (SCB) components of the CET1 capital ratio requirements between Goldman Sachs and Citibank reflect their respective approaches to regulatory capital adequacy under the Standardized Capital Rules as of December 2024?",
      "original_answer": "As of December 2024, Goldman Sachs is subject to a Stress Capital Buffer (SCB) of 6.2% under the Standardized Capital Rules, while Citibank’s required CET1 capital ratio under the same rules is 7.0%, which includes the 4.5% minimum CET1 requirement and a fixed 2.5% Capital Conservation Buffer. This indicates that Goldman Sachs faces a higher SCB-driven capital requirement, suggesting a potentially more stringent stress-based capital adequacy assessment compared to Citibank, which does not explicitly include an SCB in its stated CET1 requirement under the Standardized Approach.",
      "llm_answer": "Goldman Sachs’ Standardized‑rules CET1 requirement includes a 6.2 % Stress Capital Buffer (SCB) (plus the 3 % G‑SIB surcharge), driving its total CET1 floor to about 13.7 % as of Dec 2024 【page_208】. Citibank, by contrast, has no SCB component – its required CET1 ratio is only the 4.5 % minimum plus a 2.5 % capital‑conservation buffer (≈7.0 %) and the SCB applies only to the holding company, not the bank subsidiary 【page_35】【page_33】. Thus Goldman Sachs builds a substantially larger stress‑loss cushion into its capital plan, reflecting a more conservative, stress‑focused approach, while Citibank relies on the baseline buffers without an extra SCB, indicating a less aggressive stress‑capital stance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key numbers are correct: Goldman Sachs' 6.2% SCB and Citibank's 4.5% minimum CET1 plus 2.5% Capital Conservation Buffer totaling 7.0% are accurately reported. The mention of the G-SIB surcharge (3%) is factually correct but not part of the original answer; however, it does not contradict it and adds context without distorting the core comparison. (2) Calculations are sound: the 7.0% total for Citibank is correctly derived, and the implication that Goldman Sachs has a higher stress-based requirement is valid. (3) Multi-hop reasoning is strong: the model correctly synthesizes that SCB applies to Goldman Sachs under the Standardized Rules while Citibank’s subsidiary does not include SCB in its requirement, reflecting different regulatory capital approaches. (4) The conclusion about Goldman Sachs adopting a more conservative, stress-focused stance versus Citibank’s reliance on baseline buffers is logically supported and semantically equivalent to the original answer. The only minor point is that the LLM introduces the G-SIB surcharge and total CET1 floor of 13.7%, which, while accurate, shifts focus slightly from the direct SCB component comparison emphasized in the original answer. However, this does not detract from correctness. All entities (Goldman Sachs, Citibank, SCB, CET1, Capital Conservation Buffer), years (Dec 2024), and regulatory frameworks (Standardized Capital Rules) are correctly identified and used.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 419,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How do NextEra Energy's operational infrastructure investments in Indiana compare with Duke Energy Indiana's financing strategy through tax-exempt bonds as of December 31, 2023?",
      "original_answer": "NextEra Energy operates transmission infrastructure in Indiana, including 90 miles of lines and 5 substations operating at 161-345 kilovolts, as part of its broader multi-state network. Meanwhile, Duke Energy Indiana disclosed holding $285 million in tax-exempt bonds as of December 31, 2023, which represents a significant portion of its $435 million total debt portfolio. This contrast highlights different strategic focuses: NextEra's emphasis on physical infrastructure development in Indiana versus Duke Energy Indiana's reliance on tax-advantaged financing instruments to fund its operations.",
      "llm_answer": "NextEra Energy’s Indiana footprint is a physical transmission network – about 90 miles of lines and five substations owned 100 % (NEE page 16). Duke Energy Indiana, on the other hand, finances its Indiana operations through tax‑exempt bonds – $285 million of tax‑exempt bonds classified as long‑term debt and an additional $352 million of tax‑exempt bonds maturing 2027‑2046 (DUK pages 165 & 163).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies NextEra Energy's physical infrastructure in Indiana (90 miles of transmission lines and 5 substations), which matches the ground truth. However, it introduces a significant inaccuracy regarding Duke Energy Indiana's tax-exempt bonds: the ground truth states Duke held $285 million in tax-exempt bonds as of December 31, 2023, representing a portion of its $435 million total debt. The LLM answer, however, claims $285 million classified as long-term debt plus an additional $352 million of tax-exempt bonds maturing 2027–2046, totaling $637 million — a figure not supported by the ground truth and materially overstating the amount. This is a critical quantitative error. (2) The numbers for NextEra are accurate. The Duke Energy bond figures are incorrect — the $352 million additional bonds are not mentioned in the ground truth, and the total debt of $435 million in the original answer implies the $285 million is a subset, not part of a larger $637 million. The LLM likely misread or misattributed data from the source (DUK pages 163 & 165), leading to a major factual deviation. (3) The multi-hop reasoning is partially sound — the model correctly contrasts physical infrastructure investment (NextEra) with financing strategy (Duke) — but the flawed data undermines the comparison. The core strategic contrast is valid, but the evidentiary support for Duke is incorrect. (4) Correctness score is 6 due to accurate entity identification and structural reasoning, but major quantitative inaccuracy in Duke’s bond figures reduces confidence in the conclusion. Quantitative accuracy is 5 because half the numbers (NextEra) are correct, but Duke’s are not. Qualitative accuracy is 7 because the reasoning framework and entity focus are appropriate. Contextual relevance is 9 — the answer directly addresses the question’s comparative intent and structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 514,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How does Apple's reliance on third-party content providers for its App Store revenue model create different business risks compared to Microsoft's strategy of producing its own content, particularly in light of Apple's changes to alternative payment processing and Microsoft's emphasis on brand reputation tied to content decisions?",
      "original_answer": "Apple's App Store revenue model depends heavily on third-party content providers, with developers retaining most of the revenue while Apple keeps a commission. This model is vulnerable to changes in developer incentives and regulatory compliance, such as Apple's recent adjustments to alternative payment processing in the EU under the DMA, which could reduce commission revenue. In contrast, Microsoft produces its own content and highlights the importance of brand reputation tied to its content decisions, noting that backlash could arise from public scrutiny or dissatisfaction with product offerings. While Apple risks losing developer support due to shifting business terms, Microsoft faces brand-related risks from its own content choices, creating fundamentally different exposure points in their respective content strategies.",
      "llm_answer": "Apple’s App Store revenue is tied to third‑party developers and content owners, so the company is exposed to licensing‑availability and commission‑share risk – the Digital Markets Act‑driven changes to alternative payment processing and fee structures can shrink the commission Apple keeps or even cause providers to pull or price‑up their content, directly hurting its earnings. Microsoft, by contrast, produces most of its own content and therefore its chief vulnerability is reputational – brand damage from unpopular or controversial content decisions can erode consumer trust and sales, but it is not subject to the same third‑party licensing or commission‑rate uncertainties that Apple faces.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with strong semantic equivalence. (1) All factual elements are correct: Apple's reliance on third-party developers, commission-based revenue model, risks from DMA-driven changes to alternative payment processing, and potential developer backlash are accurately described. Microsoft's in-house content production and associated reputational risks are also correctly portrayed. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes differences in business models (third-party vs. owned content), links them to distinct risk profiles (commission/availability vs. brand/reputation), and contextualizes recent regulatory changes (DMA in the EU) affecting Apple. The only minor shortcoming is a slight lack of specificity on how exactly Apple’s changes to alternative payment processing could reduce commission revenue (e.g., developers bypassing Apple’s payment system), which is mentioned in the original but implied rather than explicit in the LLM version. (4) Contextual relevance is excellent—the response directly addresses all parts of the complex, multi-faceted question. Overall, the answer is factually correct, well-reasoned, and only slightly less detailed than the ground truth in explaining the mechanism of risk, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 420,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How does the potential liability from tritium leakage at Southern Company's nuclear plants compare to the decommissioning fund shortfalls highlighted in NEE's disclosures, given both companies' exposure to nuclear health risks?",
      "original_answer": "Southern Company's nuclear facilities, which contributed approximately 26% and 28% of total KWHs generated for Alabama Power and Georgia Power respectively in 2021, face health risks including potential leakage of radioactive materials like tritium. These risks expose the company to potential liabilities that could exceed decommissioning trusts or insurance coverage. Similarly, NEE discloses that the cost of decommissioning its nuclear facilities could exceed the amounts available in decommissioning funds, leaving it exposed to additional financial risks. Both companies face comparable challenges in managing nuclear health risks, with Southern Company highlighting potential tritium exposure and NEE emphasizing the risk of decommissioning shortfalls, creating parallel financial exposures despite no direct business relationship.",
      "llm_answer": "Southern Company warns that a nuclear incident – such as a tritium release – could create “potential exposures in excess of insurance coverage” (Southern Co 10‑K operational‑risk discussion, p. 29). By contrast, NEE flags that a decline in the market value of its nuclear decommissioning trust assets could leave it short of the cash needed to retire its plants, forcing additional funding that could materially impair its liquidity and financial condition (NEE 10‑K decommissioning‑fund discussion, pp. 31‑32). Thus, Southern Co’s risk is a possible liability from a release that may exceed insurance, while NEE’s risk is a funding gap in its decommissioning reserves.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth with strong semantic equivalence. (1) There are no numeric values in the LLM answer that contradict the original answer; while the original includes percentages of KWHs generated (26%, 28% in 2021), the LLM omits these but does not misstate any numbers. Since the question does not explicitly ask for generation percentages, their omission does not undermine correctness. (2) Quantitative accuracy is perfect—no incorrect figures, dates, or calculations are presented. (3) The multi-hop reasoning is sound: the LLM correctly identifies Southern Company’s risk as liability from tritium leakage exceeding insurance and NEE’s risk as decommissioning fund shortfalls due to market value declines, synthesizing across both companies’ 10-K disclosures. It accurately contrasts the nature of the risks (incident-driven liability vs. funding shortfall) while aligning both under broader nuclear financial exposure. (4) The answer is contextually relevant and directly addresses the comparison of potential liabilities from tritium leakage versus decommissioning shortfalls. The only minor shortcoming is the lack of explicit mention that both represent parallel financial exposures despite no business relationship—this nuance from the original is omitted but not contradicted. Overall, the response is factually correct, well-reasoned, and focused.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 394,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How does the corporate income tax rate reduction in the Philippines, enacted in Q1 2021, impact both Altria's (MO) effective tax rate and Coca-Cola's (KO) capital investment strategy, given their respective exposures to the Philippine market?",
      "original_answer": "The corporate income tax rate reduction in the Philippines, enacted in Q1 2021, favorably impacted Altria's (MO) effective tax rate in 2021, contributing to a 0.1 percentage point increase to 21.8%. This suggests that Altria benefited from lower tax liabilities on its Philippine-related earnings. Meanwhile, Coca-Cola (KO) maintained a significant capital investment in the Philippines, with property, plant, and equipment in the country representing 10% of its consolidated PPE net as of December 31, 2021 and 2020. The tax cut likely improved the after-tax return on KO's Philippine operations, reinforcing its sustained capital commitment. Therefore, the tax reform positively influenced both companies’ financial positioning in the region, with MO seeing a direct tax benefit and KO maintaining a stable long-term asset base.",
      "llm_answer": "The Philippines corporate‑income‑tax cut that took effect in the first quarter of 2021 helped Altria’s tax picture by partially offsetting other tax‑related cost increases, so its 2021 effective tax rate rose only 0.1 percentage point to 21.8% (MO p. 94). Because Coca‑Cola’s balance sheet shows that roughly 10 % of its consolidated property, plant and equipment is located in the Philippines (KO p. 124), the lower tax rate improves the after‑tax return on new projects there and supports the company’s Asia‑Pacific capital‑expenditure strategy, encouraging continued or expanded investment in the market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the Q1 2021 enactment of the corporate income tax rate reduction in the Philippines and its impact on Altria's effective tax rate, accurately stating that it rose by only 0.1 percentage point to 21.8%—this matches the ground truth. The figure for Coca-Cola’s Philippine PPE (10% of consolidated PPE) is also correct and consistent across 2020 and 2021. (2) All numeric values—0.1 percentage point, 21.8%, and 10%—are factually accurate and align with the original answer. No calculation errors are present. (3) The multi-hop reasoning is sound: the model correctly links the tax reduction to Altria’s lower tax burden (despite the slight rate increase being due to offsetting factors) and infers that the improved after-tax returns support Coca-Cola’s capital investment strategy in the region. While the original answer explicitly states KO 'maintained' its investment level, the LLM interprets this as potentially encouraging 'continued or expanded investment,' which is a reasonable inference though slightly more speculative. (4) The answer is contextually fully relevant, addressing both companies and both aspects of the question (tax impact on MO, investment strategy for KO). The only minor deviation is the interpretation of KO’s strategy as possibly expanding, whereas the ground truth emphasizes stability; however, this does not undermine factual correctness. Overall, the answer is semantically equivalent and highly accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 411,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How might Samsung's dual role as a supplier to NVIDIA for semiconductor wafer production and as a competitor to Qualcomm in the integrated circuit market impact Qualcomm's $12.8 billion in multi-year capacity purchase commitments, particularly if Samsung prioritizes its own product lines over external manufacturing demand?",
      "original_answer": "Samsung plays a critical role in NVIDIA's supply chain, producing semiconductor wafers for the company (Hop 1). At the same time, Samsung develops and produces its own integrated circuit products, directly competing with Qualcomm in this space (Hop 2). Qualcomm has $12.8 billion in multi-year capacity purchase commitments tied to its integrated circuit product manufacturing (Hop 3). If Samsung prioritizes its own competitive product lines over external manufacturing obligations, including those to Qualcomm, it could lead to capacity constraints or increased costs for Qualcomm. This would put pressure on Qualcomm’s ability to meet its manufacturing needs under existing commitments, potentially requiring renegotiation of terms or impacting margins if alternative suppliers must be sourced at higher costs.",
      "llm_answer": "Samsung is listed as a key wafer‑fab supplier for NVIDIA (NVDA 10‑K p.9) and also as a large customer that designs its own integrated‑circuit products and competes directly with Qualcomm (QCOM 10‑K p.19, p.21). Because Qualcomm’s $12.8 billion of multi‑year capacity purchase commitments depend on external foundry capacity (QCOM 10‑K p.82), a shift by Samsung to favor its own product lines could tighten wafer supply for Qualcomm, trigger incremental fees or loss of advance payments, and reduce demand for Qualcomm’s chips—thereby jeopardizing its ability to meet those commitments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Samsung is a supplier to NVIDIA and a competitor to Qualcomm in integrated circuits; Qualcomm has $12.8 billion in multi-year capacity purchase commitments. The dollar amount is correctly stated and matches the ground truth. (2) Quantitative accuracy is perfect: $12.8 billion is accurately reported with no calculation errors. (3) Multi-hop reasoning is sound: the answer correctly links Samsung’s role as both a foundry supplier (to NVIDIA) and a competitor to Qualcomm, then connects this dual role to potential supply constraints for Qualcomm’s capacity commitments. It logically infers that if Samsung prioritizes its own products, it could restrict foundry capacity, leading to financial and operational risks for Qualcomm. (4) The only minor shortcoming is that the LLM does not explicitly state that Samsung could prioritize its own product lines *over external manufacturing demand*—though this is implied by 'favor its own product lines.' Also, while the original answer discusses renegotiation or margin pressure from higher-cost alternatives, the LLM mentions 'incremental fees or loss of advance payments' and reduced demand, which are plausible but slightly different risk pathways. Still, the core reasoning and factual synthesis are correct. Wording differs but semantic meaning is equivalent. Citations to 10-K pages add precision and support credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 406,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What is the impact of Lockheed Martin's commercial customer receivables on United Launch Alliance's financial position, given Boeing's equity stake in ULA and its reported income from the joint venture?",
      "original_answer": "Lockheed Martin reported $665 million in receivables from commercial customers as of December 31, 2024, which includes entities like ULA. ULA is a key commercial customer for Lockheed Martin through its Space segment, where Lockheed holds a 50% ownership interest. Boeing also holds the other 50% and reported $125 million in equity income from ULA in 2024. This suggests that ULA’s financial performance is significant to both companies, and Lockheed’s exposure to ULA through receivables and ownership could influence its contract asset management and overall liquidity. Therefore, any financial strain on ULA could affect both Lockheed’s $665 million commercial receivables and Boeing’s equity income.",
      "llm_answer": "Lockheed Martin’s 2024 balance sheet shows roughly **$665 million of net receivables from commercial customers** (in addition to $1.7 billion from the U.S. Government)【page_76】. Boeing, which holds the other 50 % of United Launch Alliance, reported **$125 million of equity‑method income from ULA in 2024**【page_42】. Thus, Lockheed’s commercial receivable pool is a far larger source of cash that can support its half‑interest in ULA, while Boeing’s share of the joint‑venture earnings is modest in comparison.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the $665 million in commercial customer receivables from Lockheed Martin and $125 million in equity income from Boeing related to ULA in 2024, which matches the ground truth numerically and contextually. These figures are accurately attributed to the correct companies and time period, satisfying quantitative accuracy. (2) However, the LLM misinterprets the relationship between the receivables and ULA. The original answer clarifies that ULA is a commercial customer of Lockheed Martin within its Space segment, but the LLM incorrectly implies that the entire $665 million in commercial receivables is directly supporting Lockheed’s interest in ULA. This is a significant qualitative error: the $665 million is not solely or necessarily primarily from ULA—it is a broader category that includes ULA among other commercial customers. (3) The multi-hop reasoning is flawed: while the model identifies both Lockheed’s receivables and Boeing’s equity income, it fails to correctly synthesize the impact of ULA’s financial position on both parties. Instead, it draws an unsupported conclusion that Lockheed’s receivables 'support' its interest in ULA, which reverses the causal relationship—the strength of ULA’s financial performance affects the collectability of receivables, not the other way around. The original answer emphasizes potential risk to Lockheed’s receivables if ULA faces financial strain; the LLM misses this risk-based impact entirely. (4) Despite this, the answer remains contextually relevant by addressing the key entities (Lockheed, Boeing, ULA), correct financial figures, and the joint venture structure. The numerical precision earns high marks, but the flawed reasoning and misrepresentation of the receivables’ role reduce the overall correctness score to 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 494,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did the invalidation of the '190 Patent in the CAR T litigation affect Gilead's amortization expense following its acquisition of Kite?",
      "original_answer": "The invalidation of the '190 Patent in August 2021 removed the risk of ongoing 27.6% running royalties on Kite’s Yescarta sales, which had been previously awarded to Juno and SKI. This resolution likely reduced Gilead’s contingent liabilities and improved the valuation of the acquired intangible assets. As a result, Gilead’s amortization expense for finite-lived intangible assets, which included Yescarta-related rights from Kite, was $1.7 billion in 2021, up from $1.2 billion in 2020, reflecting the clearer path to monetization of these assets post-litigation.",
      "llm_answer": "The court’s invalidation of the “190 Patent” forced Gilead to write down the value of the finite‑life intangible asset that represents axicabtagene ciloleucel (the Kite CAR‑T product) by about $800 million.  That impairment lowered the carrying amount of the asset and therefore reduced the amortization expense on the asset in the years after the Kite acquisition【page_83】, which is reflected in the aggregate amortization expense for finite‑life intangibles (e.g., $1.2 billion in 2020 and $1.7 billion in 2021)【page_82】.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual and logical errors that contradict the ground truth. (1) It claims the patent invalidation led to an $800 million write-down and asset impairment, which directly contradicts the original answer stating the resolution improved asset valuation and supported higher amortization due to reduced royalty risk. The original answer indicates no impairment but rather a clearer path to monetization, increasing amortization from $1.2B to $1.7B. (2) The LLM incorrectly frames the $800M impairment as reducing amortization, but the actual amortization expense increased, not decreased, post-invalidation. The numbers cited for amortization ($1.2B in 2020, $1.7B in 2021) are quantitatively accurate and match the ground truth, earning partial credit. (3) The reasoning is flawed: invalidation removed royalty liability, which should increase the value of intangible assets (not impair them), thus supporting higher amortization. The LLM reverses the cause-effect relationship. (4) Entity accuracy (Gilead, Kite, Yescarta/axicabtagene ciloleucel, 2020–2021 timeline) is correct, and the answer is contextually relevant to the question, but the core financial logic and direction of impact are incorrect. Due to major factual and reasoning errors despite some correct numbers, the correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 370,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does Apple's revenue from Greater China in 2022 compare to Intel's revenue from Taiwan in 2021, given that Greater China includes Taiwan as one of its key markets?",
      "original_answer": "Apple reported $74,200 million in net sales from Greater China in 2022, which includes Taiwan. Intel reported $13,461 million in net revenue from Taiwan in 2021. This indicates that Apple's revenue from the broader Greater China region was significantly higher than Intel's revenue specifically from Taiwan during those periods.",
      "llm_answer": "Apple’s 2022 10‑K shows net sales of **$74.2 billion** in the Greater China segment (which includes Taiwan)【page_52】. Intel’s 2021 10‑K reports net revenue from **Taiwan of $13.5 billion**【page_87】. Thus Apple’s Greater China revenue was about **$60.7 billion (≈5.5 times) larger** than Intel’s Taiwan revenue.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: Apple's $74.2 billion (i.e., $74,200 million) in Greater China for 2022 and Intel's $13.5 billion (rounded from $13,461 million) in Taiwan for 2021 are correctly reported, with acceptable rounding. The difference of approximately $60.7 billion and the 5.5x comparison are mathematically sound: (74.2 - 13.5 = 60.7) and (74.2 / 13.5 ≈ 5.5). (2) The answer is complete, addressing both companies, correct years, correct geographies, and the comparative aspect of the question. (3) Entity accuracy is perfect: Apple and Intel are correctly identified, with accurate fiscal years (2022 vs 2021), and the metrics (net sales/revenue by region) are correct. (4) The multi-hop reasoning is strong: the model correctly synthesizes data from two different companies, two different years, and two different geographic segments, while acknowledging that Greater China includes Taiwan—directly addressing the nuance in the question. (5) The semantic meaning fully aligns with the original answer, with slightly more precise quantitative analysis (including the 5.5x comparison), enhancing clarity without introducing error. All sources are appropriately cited to 10-K pages, adding credibility. No factual, numerical, or logical errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 375,
        "total_tokens": 1540
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How do UPS's derivative valuation practices involving yield curves and Boeing's approach to fixed income investments compare in terms of reliance on observable market data like credit spreads and interest rates?",
      "original_answer": "UPS relies on pricing models that use observable market data such as yield curves and foreign currency exchange rates for valuing derivatives, which are classified as Level 2. Similarly, Boeing's fixed income investments, including interest rate swaps, are valued using pricing models that incorporate verifiable observable market data like interest rates, yield curves at commonly quoted intervals, and credit spreads, also categorizing them as Level 2 when observable inputs are available. Both companies emphasize the use of market-observable inputs for Level 2 classifications, though UPS focuses on derivatives tied to foreign exchange and Boeing on fixed income instruments.",
      "llm_answer": "UPS values its over‑the‑counter currency and interest‑rate derivatives with pricing models that depend on market‑observable inputs such as yield curves (and FX rates), classifying those derivatives as Level 2. Boeing’s fixed‑income securities and swaps are valued using observable market data that include benchmark yields, swap curves and credit (base) spreads, also Level 2. Thus, both firms rely on observable market inputs, but UPS’s practice centers on yield‑curve information for derivative pricing, while Boeing’s approach incorporates both yield‑curve data and credit‑spread information for its fixed‑income valuations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: UPS uses observable market data like yield curves and FX rates for derivative valuation, classifying them as Level 2; Boeing uses benchmark yields, swap curves, and credit spreads for fixed income and swaps, also Level 2. These inputs match the original answer’s mention of yield curves, interest rates, and credit spreads. (2) There are no numerical values requiring calculation, so quantitative accuracy is perfect—no figures were misstated. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (UPS and Boeing), their respective instruments (derivatives vs. fixed income), and valuation methodologies, highlighting both commonalities (use of observable inputs, Level 2 classification) and distinctions (UPS focused on yield curves and FX, Boeing also incorporating credit spreads). (4) The only minor shortcoming is a slight underemphasis on Boeing’s use of 'commonly quoted intervals' for yield curves, a detail present in the original but not in the LLM response—however, this does not affect the core accuracy. Wording differs slightly but maintains semantic equivalence. Contextual relevance is excellent as it directly addresses the comparison in reliance on observable data. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 408,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does the use of discounted cash flow models for impairment testing by META compare to DIS's application of these models in valuing Level 2 derivatives, particularly in terms of the inputs and assumptions each company relies on?",
      "original_answer": "META uses discounted cash flow (DCF) models with Level 3 inputs to estimate the fair value of impaired operating lease ROU assets and leasehold improvements, incorporating assumptions such as expected downtime, projected sublease income, and discount rates reflecting risk levels. In contrast, DIS applies internal DCF models to value Level 2 derivatives using observable inputs like interest rates, yield curves, and foreign currency exchange rates. While both companies utilize DCF models, META relies on less observable (Level 3) assumptions, whereas DIS uses more market-based (Level 2) data, reflecting different applications and risk profiles in their respective financial reporting.",
      "llm_answer": "META applies discounted‑cash‑flow (DCF) models only to test impairment of lease‑right‑of‑use assets and lease‑hold improvements, using Level 3 (unobservable) inputs such as the expected downtime before subleasing, projected sublease cash flows over the remaining lease term and a risk‑adjusted discount rate. DIS, by contrast, values its Level 2 derivatives with internal DCF models that rely on observable market inputs—interest‑rate curves, yield curves and foreign‑exchange rates (with only a modest credit‑risk adjustment). Thus META’s DCF relies on management‑estimated cash‑flow assumptions, while DIS’s DCF is driven by market‑observable data.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that META uses DCF models with Level 3 (unobservable) inputs for impairment testing of lease-related assets, citing specific assumptions like expected downtime, projected sublease cash flows, and risk-adjusted discount rates. DIS is accurately described as using internal DCF models for Level 2 derivatives with observable market inputs such as interest-rate curves, yield curves, and foreign exchange rates, with only a minor credit-risk adjustment. (2) There are no numeric values requiring calculation in this question, but all qualitative financial inputs and classifications (Level 2 vs Level 3) are correctly reported. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (META and DIS), two distinct applications of DCF models (impairment testing vs derivative valuation), and contrasts their input observability (management estimates vs market data). (4) The answer is fully contextually relevant, directly addressing the comparison requested in terms of inputs, assumptions, and model application. Wording differs slightly from the original but conveys the same meaning with high precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 352,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does the IQOS device supply constraint mentioned in PM's 2022 filing impact PM USA's ability to commercialize heated tobacco products in the U.S., considering the FDA authorization dependency and PM USA's role as a guarantor under Altria's financial structure?",
      "original_answer": "The IQOS device supply constraint due to the global semiconductor shortage, as reported in PM's 2022 filing, limited IQOS user growth in the second half of 2021 and contributed to the delay in resuming U.S. supply following the ITC import ban. PM USA, as the exclusive commercialization partner for PMI's heated tobacco products in the U.S., depends on FDA authorization for IQOS devices, including IQOS 3, which is under review. The cessation of IQOS device sales in the U.S. after November 29, 2021, due to the ITC cease-and-desist order, further disrupted PM USA’s product portfolio. Given PM USA's role as a guarantor of Altria's debt obligations, any prolonged inability to market IQOS devices could strain PM USA's financial position, particularly if it affects cash flows or dividend distributions to Altria, thereby increasing the risk of insolvency considerations under fraudulent conveyance laws.",
      "llm_answer": "The filing says that a global semiconductor shortage has left IQOS device supply “tight” (page 28) and, after an ITC import‑ban, the product is not available for U.S. sale (page 36); therefore PM USA cannot commercialize its heated‑tobacco system until the supply bottleneck eases and the FDA’s pending MRTP authorization for the IQOS 3 device is granted (page 36). Because PM USA also acts as the guarantor of Altria’s senior debt (page 51), its cash is tied up meeting those guarantee obligations, which further limits the resources it can devote to overcoming the device‑supply constraint and scaling U.S. commercialization.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the global semiconductor shortage as a cause of IQOS device supply constraints and references the ITC import ban halting U.S. sales, which aligns with the ground truth. It accurately notes PM USA's dependency on FDA authorization for IQOS 3 and its role as guarantor of Altria’s debt. However, it omits key details present in the original answer, such as the specific impact on user growth in the second half of 2021, the November 29, 2021, cessation date of sales, and the connection between disrupted commercialization and potential insolvency risks under fraudulent conveyance laws. (2) There are no numeric values, dates, or calculations in the LLM answer that contradict the ground truth; where dates or numbers are implied (e.g., timing of ITC ban), they are consistent. The absence of specific dates like 'November 29, 2021' is a completeness issue but not a quantitative error. (3) The multi-hop reasoning is partially sound: it links supply constraints, regulatory dependency, and financial structure, but fails to fully synthesize the causal chain from supply issues to commercial disruption to financial risk exposure via guarantee obligations. The answer mentions cash being tied up due to guarantees but does not explain how a failure to generate revenue from IQOS could impair PM USA’s financial health or affect dividend flows to Altria, which is central to the original answer’s logic. (4) The contextual relevance is high because all points discussed are directly related to the question. The qualitative accuracy is lower due to missing key causal and temporal details that weaken the completeness of the synthesis. Overall, the answer is factually consistent but lacks depth in connecting the financial guarantee role to the broader risk implications under prolonged commercial inactivity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 503,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does the impact of biosimilar competition on BMY's revenue outlook compare to ABBV's exposure given that Humira alone accounted for 27% of ABBV's 2023 net revenues and faces direct biosimilar pressure globally?",
      "original_answer": "BMY faces significant risk from biosimilar competition, which threatens to rapidly erode revenues for products losing market exclusivity, especially as seen with Eliquis and Revlimid. Meanwhile, ABBV's Humira, which accounted for 27% of its 2023 net revenues, is under direct global biosimilar pressure. While both companies are exposed to biosimilar threats, ABBV has a concentrated risk tied to a single product, whereas BMY faces broader portfolio risk across multiple products.",
      "llm_answer": "BMY warns that loss of exclusivity and the entry of lower‑priced generics or biosimilars could erode sales of its biologics (see BMY risk‑factor discussion of “competition … lower‑priced generic products” and the need to replace revenue lost when products lose market exclusivity, pages 27‑28). By contrast, AbbVie’s Humira – which alone generated roughly 27 % of its 2023 net revenue – is already under direct global biosimilar pressure (AbbVie page 81; competition discussion page 8). Thus, the biosimilar threat is far more concentrated and material for AbbVie than for BMY, whose revenue is more diversified and not dependent on a single blockbuster product.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 27% figure for Humira's contribution to AbbVie's 2023 net revenue is correctly cited, matching the original answer. No other numerical values are present, and all references to pages and disclosures are consistent with source-based reasoning. (2) The answer correctly identifies both companies (BMY and ABBV), the relevant product (Humira), the correct year (2023), and the appropriate risk context (biosimilar competition). (3) The multi-hop reasoning is sound: it contrasts BMY’s broad exposure across multiple products (e.g., Eliquis, Revlimid implied via 'biologics') with ABBV’s concentrated risk on Humira, which is the core insight in the ground truth. The LLM emphasizes that ABBV’s threat is more concentrated and material due to reliance on a single blockbuster, which is semantically equivalent to the original answer’s point about 'concentrated risk tied to a single product' vs. BMY’s 'broader portfolio risk'. (4) Minor deduction in qualitative accuracy because the original answer explicitly names Eliquis and Revlimid as examples, while the LLM only refers to 'biologics' more generally—this is a slight omission of specificity but does not impair the correctness of the comparison. Otherwise, the reasoning, structure, and factual content are excellent and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 387,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How does the treatment of dividend equivalents on RSU awards differ between PM and PEP in terms of payout structure and vesting triggers, given PM's inclusion of dividend equivalents during vesting and PEP's cash payout upon vesting?",
      "original_answer": "PM includes dividend equivalents on RSU awards that accrue during the vesting period and are paid out as part of the RSU settlement, typically after three years or upon specific events like death, disability, or reaching age 58. PEP also accrues dividend equivalents on RSUs, but these are paid out in cash (without interest) only when the RSU vests and becomes payable. Unlike PM, which may vest RSUs upon age or disability, PEP ties payout strictly to the end of the service period or performance-based vesting for PSUs, with no mention of age-based triggers. This reflects a structural difference in how each company manages equity compensation benefits.",
      "llm_answer": "PM’s RSU awards “earn dividend equivalents” that are treated as participating securities and are included in earnings‑per‑share calculations throughout the three‑year vesting period, with the RSUs generally vesting on the third anniversary of the grant date (subject to employment conditions)【page_110】. By contrast, PepsiCo’s RSUs (and PSUs) “accrue dividend equivalents that pay out in cash (without interest) if and when the applicable RSU … vests and becomes payable”【page_92】, so the dividend equivalents are not reflected in EPS during vesting but are paid only at the moment the award vests.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that PM includes dividend equivalents during the vesting period, which are treated as participating securities and factored into EPS calculations, and that RSUs generally vest on the third anniversary of the grant date—consistent with the three-year vesting mentioned in the original answer. It also accurately states that PEP accrues dividend equivalents but pays them in cash only upon vesting, without interest, and not during the vesting period. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but timeframes like 'three-year vesting' and 'third anniversary' are correctly cited. (3) The multi-hop reasoning is sound: the model correctly contrasts PM’s inclusion of dividend equivalents in EPS and payout at settlement with PEP’s cash payout only upon vesting, and implicitly captures structural differences in vesting triggers—though it does not explicitly mention PM’s age 58 or disability triggers, which are present in the ground truth. This is a minor omission affecting completeness but not core accuracy. (4) The answer is semantically equivalent in key aspects: payout structure (accrual vs. cash at vesting), vesting timing, and financial treatment (EPS inclusion). The only gap is the lack of explicit mention of PM’s non-service-based vesting triggers (age, death, disability), which slightly reduces qualitative accuracy. Overall, the response is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 429,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How does GE's $1,410 million investment in illiquid real estate funds through its run-off insurance operations compare to BA's broader real estate investment strategy, particularly in terms of liquidity risk and fund structure?",
      "original_answer": "BA invests in a diversified portfolio of global real estate, including office, retail, apartment, and industrial properties, primarily through limited partnerships or fund structures that allow for varied market exposure. These investments are part of a broader asset allocation strategy that includes private equity, hedge funds, and real assets. In contrast, GE holds $1,410 million in illiquid real estate funds through its run-off insurance operations, which are measured at net asset value and generally not eligible for redemption without the general partner's approval. Both use fund structures that limit liquidity, but GE's exposure is more concentrated and less flexible, as distributions depend on the liquidation of underlying assets at the discretion of the fund's general partner, whereas BA's approach is more diversified and integrated within a broader investment framework.",
      "llm_answer": "GE’s run‑off insurance portfolio carries a concentrated $1.41 billion holding in limited‑partnership stakes in private‑equity, infrastructure and real‑estate funds that are measured at NAV, are not redeemable and can only be sold with the general‑partner’s approval, making the exposure highly illiquid【page_51】. Boeing’s pension program, by contrast, allocates about 7 % of its assets to real‑estate and real‑asset funds held through LPs or other fund structures, spreads the exposure across multiple contractual maturities (under‑5‑year, 5‑10‑year and over‑10‑year tranches) and actively manages liquidity risk as part of its broader pension‑risk framework【page_99】【page_100】【page_101】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all figures are correct: GE's $1.41 billion (equivalent to $1,410 million) investment is accurately reported, and Boeing's ~7% allocation to real estate and real-asset funds is consistent with the source. The use of 'billion' vs. 'million' is a valid format variation. (2) The answer correctly identifies both companies' use of limited partnerships (LPs) and fund structures that limit liquidity, and notes GE's lack of redemption rights without general partner approval—matching the ground truth's emphasis on illiquidity and NAV measurement. (3) It adds value by specifying Boeing's maturity tranches (under 5-year, 5–10-year, over 10-year), which enhances the liquidity risk discussion and reflects deeper contextual understanding from the source pages. (4) The multi-hop reasoning is sound: it contrasts GE’s concentrated, inflexible exposure in run-off insurance with Boeing’s diversified, actively managed pension strategy, capturing the core of the comparison. (5) Minor point: the LLM mentions GE’s investment includes private equity and infrastructure funds, which slightly broadens beyond 'illiquid real estate funds' in the question, but this is consistent with the broader context of GE’s fund holdings. Overall, the answer is factually correct, well-synthesized, and contextually precise—justifying a 9/10 due to slight expansion beyond real estate, but not enough to undermine accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 409,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How does BAC's exposure to equity market risk, as managed through derivative instruments, compare to MET's use of equity market derivatives in terms of notional value and sensitivity to a 10% decrease in equity prices?",
      "original_answer": "BAC discloses exposure to equity market risk through trading positions involving equity-linked instruments such as options, futures, and swaps. MET reports a notional value of $23,595 million for its equity market derivatives, with a sensitivity of $522 million to a 10% decrease in equity prices. While BAC does not specify exact notional amounts for its equity derivatives, it emphasizes the use of similar hedging tools. MET's quantified exposure highlights a direct sensitivity to equity market movements, which contrasts with BAC's broader market risk management approach that includes equity risk as one of several components.",
      "llm_answer": "Bank of America does not disclose a specific notional amount for its equity‑market derivatives; instead it reports the equity‑risk component of its market‑risk VaR as only $9 million at year‑end (about $18 million on an average basis)【page_77】. MetLife, by contrast, holds roughly $23.6 billion of equity‑market derivative notional and estimates a $522 million loss if equity prices fall 10 %【page_129】. Thus MetLife’s equity‑market exposure is orders of magnitude larger in notional terms and is quantified with a sizable sensitivity, whereas Bank of America’s exposure is modest and presented only through a small VaR figure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that BAC does not disclose a specific notional value for its equity-market derivatives and instead references its market-risk VaR, which aligns with the ground truth. It accurately reports MET's notional value as $23.6 billion (equivalent to $23,595 million) and sensitivity of $522 million to a 10% decrease in equity prices. These figures match the original answer exactly in substance, with acceptable formatting variation ($23.6 billion = $23,595 million). (2) Quantitative accuracy is perfect: all numbers are correct, including the $522 million sensitivity and the implied equivalence of $23.6 billion to $23,595 million. The mention of BAC’s VaR ($9 million year-end, $18 million average) adds detail not in the original answer but is consistent with typical disclosures and does not contradict the ground truth; it enhances precision without introducing error. (3) The multi-hop reasoning is sound: the model correctly contrasts BAC’s qualitative, VaR-based risk presentation with MET’s explicit notional and sensitivity disclosures, capturing the core comparative insight. It synthesizes information across two companies and risk-reporting methodologies appropriately. (4) The only reason for not scoring a 10 is that the original answer emphasizes BAC’s use of hedging tools (options, futures, swaps) similar to MET, which the LLM omits—though this is a minor omission in context. Overall, the LLM answer is factually correct, well-reasoned, and directly responsive to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 425,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How does Microsoft's operational footprint in Greater China compare to AMD's revenue concentration in Taiwan, and what does this suggest about their respective regional market strategies in 2022?",
      "original_answer": "Microsoft operates a regional center in Singapore that supports operations in Greater China, indicating a centralized approach to managing its activities across the region, which includes China mainland, Hong Kong, and Taiwan. AMD, on the other hand, reported $2,091 million in sales to Taiwan in 2022, highlighting a significant direct revenue contribution from the region. While Microsoft's presence in Greater China is part of a broader Asia-Pacific operational structure, AMD's financial data shows a more concentrated revenue exposure to Taiwan specifically, suggesting differing regional market strategies: Microsoft leans on regional hubs to support broad market access, while AMD has a pronounced financial dependency on Taiwan as a key market.",
      "llm_answer": "Microsoft’s 2022 filing shows that its Greater‑China activities are handled by a regional operations center in Singapore (“the center in Singapore supports … Greater China”)【page_16】, indicating a hub‑based, indirect footprint rather than a large dedicated presence in China. By contrast, AMD’s 2022 segment data reveal that sales to Taiwan were $2.1 billion of $16.4 billion total external‑customer revenue (about 13 % of its revenue)【page_78】, showing a strong concentration in that single market. Thus, Microsoft pursues a broader, multi‑regional support model for Greater China, while AMD’s strategy in 2022 relied heavily on a focused, high‑concentration market in Taiwan.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Microsoft's operational model through a regional center in Singapore supporting Greater China, and accurately reports AMD's $2.1 billion in sales to Taiwan in 2022, which aligns with the ground truth value of $2,091 million (rounded appropriately). The percentage calculation (13%) is accurate: $2.1B / $16.4B ≈ 12.8%, which rounds to 13%. All entities (Microsoft, AMD, Greater China, Taiwan, 2022) are correctly identified and contextualized. (2) Quantitative accuracy is perfect: dollar amounts, percentage, and revenue figures match or are correctly rounded versions of the original data. The LLM uses $2.1 billion instead of $2,091 million, which is an acceptable and standard rounding. (3) The multi-hop reasoning is sound—comparing Microsoft’s operational footprint strategy with AMD’s revenue concentration requires synthesizing information across two different companies and types of disclosures (operational structure vs. geographic revenue breakdown). The conclusion that Microsoft uses a hub-based, indirect model while AMD has a high-revenue concentration in Taiwan is logically derived and consistent with the ground truth. (4) The only minor shortcoming is that the LLM does not explicitly mention that Microsoft's approach covers China mainland, Hong Kong, and Taiwan as part of Greater China, nor does it contrast the broader Asia-Pacific structure as directly as the original answer. However, this does not detract significantly from the overall correctness. Hence, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 456,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How does the dual-class stock structure at META, which affects the voting rights of Class A common stockholders, compare to NFLX's approach to shareholder voting rights in terms of investor influence over corporate governance decisions?",
      "original_answer": "META's dual-class common stock structure gives disproportionate voting power to Class B stockholders, such as Mark Zuckerberg, limiting the influence of Class A common stockholders on key corporate decisions, including board composition and change-of-control transactions. This contrasts with NFLX's one-share-one-vote policy, where each share of common stock entitles the holder to one vote on all matters, ensuring equal voting influence for all shareholders. The difference in voting rights structures reflects divergent approaches to corporate governance, with META prioritizing founder control and NFLX emphasizing broad shareholder participation.",
      "llm_answer": "Meta’s dual‑class system gives its Class B shares ten votes each while Class A shares have only one vote, concentrating control with Mark Zuckerberg and other insiders and effectively limiting Class A shareholders’ ability to affect corporate‑governance votes【page_49】. In contrast, Netflix grants every holder of its common stock one vote per share, so all investors have equal voting power on shareholder matters【page_61】. Thus Meta’s structure restricts ordinary investors’ influence, whereas Netflix’s single‑class model provides broader, more democratic shareholder voting rights.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. (1) It correctly identifies META's dual-class structure with Class B shares having ten votes versus one for Class A, which concentrates control with insiders like Mark Zuckerberg—this matches the original answer’s claim about disproportionate voting power. The citation of page_49 supports this. (2) It accurately states that Netflix follows a one-vote-per-share model, citing page_61, which is consistent with the ground truth’s description of NFLX's equal voting rights. (3) The reasoning correctly contrasts the two companies’ governance models: Meta limiting influence for ordinary shareholders vs Netflix enabling broader participation. This reflects sound multi-hop synthesis across two companies and their governance structures. (4) The only minor shortcoming is that the LLM does not explicitly mention 'board composition' or 'change-of-control transactions' as specific governance areas affected, which the original answer includes for completeness. However, the phrase 'corporate-governance votes' broadly covers these. All entities (Meta, Netflix, share classes) are correct. Number accuracy is perfect: 'ten votes' and 'one vote' are correctly stated. Wording differs slightly but maintains semantic equivalence. Thus, high scores across all dimensions with a 9 on correctness due to slight incompleteness in specificity of governance impact.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 394,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How does the expiration of patent rights for JNJ's pharmaceutical products impact their market exclusivity, and how does this compare to LLY's reliance on regulatory exclusivity extensions for maintaining competitive advantage in the U.S. market?",
      "original_answer": "JNJ notes that patent expirations are typically followed by the introduction of competing generic products, which can result in significant revenue and market share losses. Additionally, JNJ highlights that increasingly aggressive challenges to its patents may lead to a loss of market exclusivity sooner than expected. In contrast, LLY relies on regulatory exclusivity extensions—such as those granted for orphan drug designations or pediatric exclusivity—to maintain market exclusivity beyond patent terms. According to BMY’s 10-K, regulatory exclusivity can provide a market exclusivity period that expires beyond the patent term, offering a strategic buffer against generic competition. Thus, while JNJ faces declining sales due to patent erosion and legal challenges, LLY strategically leverages regulatory exclusivity to prolong its market protection.",
      "llm_answer": "Johnson & Johnson’s market exclusivity is tied chiefly to its patents; when a product’s patents run out the legal barrier to generic entry disappears and the company normally experiences a rapid, steep decline in sales (JNJ page_6; JNJ page_4). Eli Lilly, however, leans on regulatory exclusivity—data‑protection periods, orphan‑drug and pediatric extensions—to extend protection beyond the patent term and preserve a competitive advantage in the U.S. market (LLY page_10; LLY page_13).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that JNJ's market exclusivity primarily relies on patents, and upon expiration, generic competition leads to steep sales declines—consistent with the original answer's emphasis on significant revenue and market share losses. It also notes the risk of early loss due to patent challenges, aligning with JNJ’s concern about aggressive challenges. For LLY, the answer accurately states reliance on regulatory exclusivity mechanisms like orphan-drug and pediatric extensions to extend protection beyond patent terms, which matches the ground truth. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across JNJ and LLY filings to contrast their strategies—patent dependence vs. regulatory exclusivity leverage—and supports each with appropriate citations. The only minor omission is not explicitly referencing BMY’s 10-K as a source for the general principle that regulatory exclusivity can extend beyond patent terms, which slightly weakens the cross-company synthesis. However, the core insight about LLY’s strategy remains correct. (4) The answer is highly contextually relevant, directly addressing both parts of the question and providing a clear, concise comparison. Wording differs but meaning is preserved. Thus, correctness is 9 due to high accuracy with a minor gap in sourcing breadth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 433,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How does AMD's reduction in interest expense from convertible debt conversions compare with Nuance's outstanding convertible senior notes liability post-acquisition by Microsoft, and what does this imply about their respective capital structure strategies?",
      "original_answer": "AMD reduced its interest expense from $47 million in 2020 to $34 million in 2021 due to conversions of its 2.125% Convertible Senior Notes due 2026, indicating a proactive approach to reducing debt. Meanwhile, Nuance, which had issued $986 million in convertible senior notes in 2015 and 2017, had redeemed $985 million of those notes by June 30, 2022, leaving only $1 million outstanding. Microsoft, having acquired Nuance, now holds this remaining liability as part of its Intelligent Cloud segment. This suggests that AMD focused on reducing debt through voluntary conversions, while Nuance’s strategy under Microsoft involved largely redeeming its convertible notes, reflecting differing capital structure management approaches between the two companies.",
      "llm_answer": "AMD’s interest expense fell from $47 million to $34 million – a $13 million reduction – after holders converted its 2.125 % convertible senior notes due 2026, lowering the company’s debt balance and interest cost【page_48】.  By contrast, Microsoft’s acquisition of Nuance left only about $1 million of Nuance’s convertible senior notes still on the books after it redeemed roughly $985 million of the $986 million issued in 2015‑2017【page_78】.  The comparison shows AMD is using conversions to actively cut interest‑bearing debt, while Microsoft has essentially eliminated the legacy convertible liability, reflecting a strategy of simplifying and de‑leveraging the acquired firm’s capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AMD's interest expense decreased from $47 million to $34 million (a $13 million reduction), consistent with the conversion of its 2.125% Convertible Senior Notes due 2026. Nuance issued $986 million in convertible notes, with $985 million redeemed by mid-2022, leaving $1 million outstanding post-acquisition by Microsoft. These figures match the original answer exactly. (2) Calculations are accurate: the $13 million difference is correctly derived, and the redemption amount ($985M out of $986M) is properly represented. Number formats are consistent and acceptable. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across AMD’s debt conversions and Nuance’s note redemptions under Microsoft, comparing their capital structure strategies. It identifies that AMD used voluntary conversions to reduce interest-bearing debt, while Microsoft, post-acquisition, largely eliminated Nuance’s convertible liability, simplifying the capital structure. (4) The only minor shortcoming is that the LLM does not explicitly name the Intelligent Cloud segment as the holder of the remaining liability, though this detail is peripheral to the core comparison. Wording differs slightly but maintains semantic equivalence. The conclusion about differing capital structure strategies is logically supported and matches the original answer’s implication. Thus, the answer is factually complete and well-reasoned, warranting a high score with only a slight deduction in qualitative accuracy for the omitted segment detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 446,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How does the $5.0 billion upfront payment from American Tower in 2015 for exclusive rights to 11,300 Verizon towers compare to the $4.827 billion transaction Crown Castle executed in 2013 for similar exclusive rights to AT&T's towers, considering both companies retained ownership and depreciation responsibilities?",
      "original_answer": "The $5.0 billion upfront payment from American Tower in 2015 for exclusive rights to 11,300 Verizon towers is slightly higher than the $4.827 billion Crown Castle paid in 2013 for 9,048 AT&T towers and the purchase of 627 towers. Both Verizon and AT&T retained ownership of the towers and continued to include them in Property, Plant and Equipment - Net on their balance sheets, depreciating them accordingly. In both cases, the companies subleased capacity back from the acquiring entity (American Tower or Crown Castle) for extended terms, with Verizon leasing back for a minimum of 10 years and AT&T subleasing for an estimated original term of 20 years.",
      "llm_answer": "The American Tower deal brought an upfront cash payment of $5.0 billion for the exclusive lease‑and‑operate rights to roughly 11,300 Verizon towers (Verizon 10‑K, page 73). Crown Castle’s 2013 transaction was for $4.827 billion (including the purchase of 627 AT&T towers) for exclusive rights to about 9,048 AT&T towers (AT&T 10‑K, page 90). In both cases the tower owners retained legal title, kept the towers on their property‑plant‑and‑equipment balances and continued to depreciate them, while the cash proceeds were recorded as financing obligations rather than a sale‑lease‑back.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the $5.0 billion American Tower payment for 11,300 Verizon towers in 2015 and the $4.827 billion Crown Castle transaction for 9,048 AT&T towers plus 627 purchased towers in 2013 are accurately reported. (2) Quantitative accuracy is perfect—dollar amounts, tower counts, and years match the original answer exactly. The comparison correctly implies that $5.0B > $4.827B, aligning with the ground truth's 'slightly higher' assessment. (3) The qualitative reasoning is sound: the LLM correctly identifies that both Verizon and AT&T retained ownership, kept the towers on their PP&E, and continued depreciation. It also correctly notes the financing obligation treatment, which is consistent with accounting treatment in such transactions. (4) The only minor omission is that the LLM does not explicitly mention the leaseback terms (Verizon for minimum 10 years, AT&T for ~20 years), which are part of the original answer and relevant to the comparison. However, this does not undermine the core factual accuracy. The LLM adds value by correctly citing 10-K page references and clarifying the accounting treatment (financing obligations vs sale-leaseback), which is contextually relevant and accurate. Overall, the answer is factually correct, well-reasoned, and highly relevant, missing only a small detail on leaseback duration.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 399,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How does Southern Power's use of tax equity partnerships for wind facilities, which are connected to long-term PPAs with up to 25-year terms, compare with Duke Energy's approach to structuring PPAs for its renewable VIEs, particularly in terms of monetizing federal tax credits like PTCs?",
      "original_answer": "Southern Power utilizes tax equity partnerships for its wind facilities, allowing a tax partner to capture most of the federal tax benefits, including PTCs tied to the first 10 years of energy production. These partnerships are consolidated using the HLBV method, and the associated PPAs have remaining terms of up to 25 years. The PPAs are critical in monetizing these tax credits through long-term revenue streams. Similarly, Duke Energy structures PPAs as part of its renewable VIEs, where it is the primary beneficiary and makes key decisions including PPA negotiations. These PPAs are also essential in monetizing tax credits, but Duke does so under a model involving third-party tax equity investors to finance eligible assets. Both companies rely on PPAs for revenue predictability, but Southern Power explicitly ties its PPA terms and tax equity structures to the PTC window, while Duke’s focus is on broader VIE financing and guarantees.",
      "llm_answer": "Southern Power places its wind projects in tax‑equity partnerships that hand the bulk of the federal production‑tax‑credit (PTC) benefits to the tax partner, while the projects are sold under long‑term PPAs (some as long as 25 years) that lock in a stable revenue stream for Southern Power 【page_97】 【page_268】. Duke Energy, by contrast, houses its renewable assets in VIEs that are financed with guarantees and tax‑equity investors; the PPAs are embedded in those VIEs to fund debt service and O&M, and the PTCs are monetized through the VIE’s tax‑equity structure rather than through a separate, long‑term PPA 【page_204】 【page_201】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Southern Power uses tax equity partnerships where the tax partner captures most PTC benefits, and that these are linked to long-term PPAs with up to 25-year terms—matching the original answer. Duke Energy’s use of VIEs with tax equity investors and embedded PPAs for financing and monetizing PTCs is also accurately described. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the 'up to 25 years' PPA term is correctly referenced, consistent with the ground truth. Format and references to page numbers do not affect factual accuracy. (3) The multi-hop reasoning is sound: the model synthesizes information across Southern Power’s tax equity + PPA structure and Duke’s VIE + tax equity model, correctly contrasting their approaches—Southern Power ties PPA duration directly to PTC monetization, while Duke embeds PPAs within VIEs primarily for debt and O&M funding, with PTCs monetized through the VIE structure. (4) The only minor shortcoming is that the LLM does not explicitly mention Southern Power’s use of the HLBV method for consolidation, which is a small but relevant detail in the original answer. However, this does not undermine the core comparison about PPA and tax credit monetization strategies. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth with only a slight omission in technical accounting treatment.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 421,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How do the differences in voting rights structures between CMCSA's Class B common stock and GOOGL's dual-class stock system affect their respective corporate governance models, particularly in terms of shareholder influence on major corporate decisions?",
      "original_answer": "CMCSA's Class B common stock has no voting rights, limiting shareholder influence on major decisions unless specific conditions are met, such as exiting the core payments business or undergoing a merger. In contrast, GOOGL's dual-class structure allows Class B stockholders to have 10 votes per share, significantly concentrating voting power in the hands of a few, while Class A stockholders have 1 vote per share and Class C stockholders have no voting rights. This creates a governance model at GOOGL where a small group of insiders can dominate decision-making, whereas CMCSA maintains a more uniform governance structure among its voting shareholders. The differential voting rights at GOOGL can lead to more decisive strategic direction but less democratic shareholder oversight compared to CMCSA.",
      "llm_answer": "Comcast’s filing shows that its capital structure includes a separate “Class B common stock” (see the balance‑sheet note that lists Class B shares distinct from Class A – e.g., page 67), which carries voting rights that differ from the ordinary Class A shares.  By contrast, Alphabet’s 10‑K spells out a dual‑class system in which each Class A share gets one vote, each Class B share gets ten votes, and Class C shares have no voting rights at all (page 82).  Because Comcast’s Class B shares retain voting power, holders of that class can influence board elections and major corporate actions, whereas Alphabet’s structure concentrates decisive voting power in the insider‑held 10‑vote Class B stock and leaves the publicly‑traded Class C shareholders without a vote on key decisions, resulting in a more founder‑centric governance model.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains a critical factual error regarding CMCSA's Class B common stock: it incorrectly states that CMCSA's Class B shares 'retain voting power,' when in fact the ground truth specifies that CMCSA's Class B common stock has *no voting rights*. This mischaracterization fundamentally undermines the comparison between CMCSA and GOOGL's governance models. The LLM also incorrectly implies that CMCSA Class B shareholders can influence board elections and major actions, which contradicts the ground truth that their voting rights are absent except under specific conditions (e.g., exiting core payments or merger). In contrast, the description of GOOGL's dual-class structure is accurate: Class A (1 vote), Class B (10 votes), Class C (no votes), with correct implications for concentrated insider control. Quantitatively, no numerical values are misstated (e.g., vote ratios for GOOGL are correct), so quantitative accuracy is high. However, the qualitative reasoning is flawed due to the incorrect premise about CMCSA, leading to an invalid comparison. The answer is contextually relevant and addresses the question's focus on governance and shareholder influence, but the core factual inaccuracy on CMCSA's voting rights severely limits its correctness. This is a multi-hop failure: the model must correctly extract and contrast two companies' voting structures, but one side of the comparison is wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 391,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How might the difference in voting rights structures between GOOGL (with 1 vote per Class A share and 10 votes per Class B share) and NFLX (1 vote per common share) affect control dynamics, especially considering GOOGL's $62.2 billion in share repurchases during 2023?",
      "original_answer": "GOOGL's dual-class share structure, where Class B shares carry 10 votes per share compared to Class A's 1 vote, allows certain major shareholders to maintain outsized voting control despite owning a smaller economic stake. In 2023, GOOGL repurchased $62.2 billion of its Class A and Class C shares, which likely further consolidated voting power among remaining Class B shareholders. In contrast, NFLX maintains a one-share-one-vote structure, distributing control more evenly across all shareholders. This structural difference means GOOGL’s leadership has greater insulation from shareholder influence compared to NFLX, even as both companies manage capital through stock repurchases and equity grants.",
      "llm_answer": "Alphabet’s charter creates a dual‑class system in which each Class A share carries one vote and each Class B share carries ten votes 【page_81†L1-L4】. In 2023 the company bought back $62.2 billion of Class A and non‑voting Class C shares 【page_81†L5-L9】, shrinking the pool of low‑vote stock and leaving the relatively few Class B shares (held by founders and insiders) with an even larger share of total voting power. Netflix, by contrast, has a single‑class structure where every common share gets one vote 【page_61†L1-L4】, so any repurchase would reduce voting influence proportionally across all owners, making control more directly tied to economic ownership.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: GOOGL's dual-class structure (1 vote for Class A, 10 votes for Class B), the $62.2 billion share repurchase in 2023, and the repurchase of Class A and Class C shares (with Class C being non-voting) are all accurately stated. The contrast with NFLX's one-share-one-vote structure is correctly described. (2) Quantitative accuracy is perfect: the $62.2 billion figure is correctly cited and attributed to 2023, matching the original answer. (3) Multi-hop reasoning is sound: the LLM correctly infers that repurchasing low-vote or non-voting shares (Class A and C) reduces the total voting pool, thereby increasing the relative voting power concentration among Class B holders (founders/insiders), which is a nuanced but critical point. (4) The answer fully addresses the question’s focus on control dynamics and structural differences, explaining how capital allocation (repurchases) interacts with governance design. Wording differs slightly but meaning is preserved, and citations (e.g., page references) add precision without altering correctness. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 343,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What is the financial significance of BMY's retained royalty rights related to Byetta*, given its divestiture of the diabetes business and the trademark's current ownership by LLY?",
      "original_answer": "BMY retains royalty rights related to Byetta*, a product originally associated with Amylin, even after divesting its diabetes business. According to BMY's 2022 10-K, pretax income from such royalties was approximately $1.9 billion in 2021, and a decline in these royalty streams could adversely affect BMY's future financial performance. Although Eli Lilly (LLY) now holds the trademark for Byetta*, BMY still has financial exposure through its retained royalty rights, indicating a continued revenue relationship between BMY and LLY despite the divestiture.",
      "llm_answer": "BMS kept royalty rights on the Byetta® brand when it sold its diabetes business to Eli Lilly, so it still receives a stream of royalty payments even though the trademark is now owned by LLY.  Those retained royalties were a material source of earnings – they generated roughly $1.9 billion of pretax royalty income in 2021 and appear as $410 million of cash‑flow‑derived royalties (versus $461 million in 2020) on BMS’s statement of cash flows【page_48】【page_141】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, it correctly states that BMY (BMS) received approximately $1.9 billion in pretax royalty income in 2021 from Byetta-related royalties, matching the original answer. It adds additional detail from the cash flow statement—$410 million in cash-flow-derived royalties in 2021 versus $461 million in 2020—which is consistent with the 10-K and provides deeper context, though this specific cash flow figure is not in the ground truth. This does not detract from accuracy but enhances completeness. (2) The entities are correct: BMS (BMY), LLY (Eli Lilly), Byetta®, and the timeline (2021 income) are all accurately referenced. (3) The reasoning correctly synthesizes the multi-hop logic: despite divesting the diabetes business and LLY owning the trademark, BMS retained royalty rights, which continue to generate significant revenue—this is the core financial significance. (4) The answer is semantically equivalent to the ground truth, with slightly more granular financial breakdown. The only minor limitation is that it doesn't explicitly state that a decline in these royalties could affect future performance, a forward-looking risk mentioned in the original. However, the materiality and financial significance are clearly conveyed. Thus, the answer is excellent but not fully exhaustive of all qualitative nuances in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 394,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How does the difference in capital buffer structures between Schwab and JPMorgan Chase affect their respective minimum total risk-based capital ratio requirements, considering Schwab's requirement includes both a 2.5% stress capital buffer and 2.5% capital conservation buffer while JPMorgan Chase applies only a 2.5% capital conservation buffer?",
      "original_answer": "Schwab's minimum total risk-based capital ratio requirement is 10.5%, which incorporates both a 2.5% stress capital buffer and a 2.5% capital conservation buffer above the base regulatory minimum. In contrast, JPMorgan Chase's minimum total risk-based capital ratio is also 10.5%, but this only includes a 2.5% capital conservation buffer without an additional stress capital buffer component. This reflects different regulatory treatments where Schwab is subject to both buffers while JPMorgan Chase only applies the capital conservation buffer.",
      "llm_answer": "Schwab’s minimum total risk‑based capital ratio is 10.5% – the 8% regulatory floor plus a 2.5% capital‑conservation buffer (the 2.5% stress buffer applies only to CET1 and does not raise the total‑capital ratio)【page_122】. JPMorgan Chase Bank’s minimum total risk‑based capital ratio is also 10.5%, reflecting the same 8% floor plus the single 2.5% capital‑conservation buffer required for the bank【page_291】. Thus, even though Schwab carries both a stress and a conservation buffer, the total‑risk‑based capital requirement ends up the same as JPMorgan Chase’s.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: both Schwab and JPMorgan Chase have a 10.5% minimum total risk-based capital ratio, derived from an 8% regulatory base plus a 2.5% capital conservation buffer. The LLM correctly notes that the 2.5% stress capital buffer for Schwab applies only to CET1 (Common Equity Tier 1), not the total risk-based capital ratio, which explains why the total requirement remains 10.5% despite Schwab having an additional buffer. This nuance is not present in the original answer but is factually correct and adds precision. (2) The calculations are sound: 8% + 2.5% = 10.5% for both institutions. (3) Entity accuracy is correct—Schwab and JPMorgan Chase are properly identified, and the regulatory components (capital conservation buffer, stress capital buffer) are accurately attributed. (4) The reasoning is strong and reflects proper multi-hop synthesis: the model correctly infers that although Schwab is subject to both buffers, only the capital conservation buffer impacts the total risk-based capital ratio, hence the equivalence with JPMorgan Chase. The only minor gap is that the original answer emphasizes the 'different regulatory treatments' more explicitly, but the LLM implies this through accurate explanation. Overall, the answer is semantically equivalent and slightly more technically precise than the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 396,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How does the transition from LIBOR to alternative reference rates impact both LMT's credit facility and GE's floating-rate debt and preferred stock, considering the accounting relief provided under ASU 2020-04?",
      "original_answer": "The transition from LIBOR to alternative rates impacts LMT’s credit facility and derivatives through fallback provisions like SOFR, with LMT expecting minimal financial impact due to ASU 2020-04's accounting relief that limits the effect of contract modifications. Similarly, GE’s floating-rate debt and preferred stock will transition to SOFR plus a spread adjustment under New York law, with any financial impact also being accounted for under ASU 2020-04. Both companies rely on the same accounting standard to ease the financial reporting burden during the LIBOR transition, despite differing in the types of financial instruments affected.",
      "llm_answer": "LMT’s revolving credit facility already contains fallback language that will automatically replace LIBOR with an alternative rate (such as SOFR) when LIBOR is no longer published, and because the change is treated under ASU 2020‑04 as a non‑modification, the company does not expect any material effect on its results, position or cash flows. Similarly, GE’s floating‑rate debt and preferred‑stock are governed by New York‑law fallback provisions that will deem them to switch to the “recommended benchmark replacement” (SOFR + a spread), and the accounting relief in ASU 2020‑04 limits any modification‑related gain/loss or hedge‑accounting impact, also leaving the transition without a material financial impact.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: LMT’s credit facility uses fallback provisions (e.g., SOFR) with no material impact due to ASU 2020-04’s accounting relief; GE’s floating-rate debt and preferred stock transition under New York law to SOFR plus a spread adjustment, also with minimal financial impact under the same standard. (2) There are no numeric values requiring calculation in this question, but references to accounting standards (ASU 2020-04) and rate benchmarks (SOFR) are precise and consistent with the original. (3) Multi-hop reasoning is sound: the answer correctly synthesizes information across two companies (LMT and GE), different financial instruments (credit facility, derivatives, debt, preferred stock), and a shared accounting standard, showing how each is affected by the LIBOR transition. (4) The wording differs slightly but preserves full meaning—e.g., 'non-modification' treatment under ASU 2020-04 aligns with 'limits the effect of contract modifications' in the original. No omissions or inaccuracies; response fully addresses all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 331,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "What is the significance of CMCSA's issuance of 9,444,375 shares of Class B common stock in 2023, and how does this structure compare to GOOGL's dual-class system where Class B shares automatically convert to Class A shares upon sale or transfer?",
      "original_answer": "CMCSA issued 9,444,375 shares of Class B common stock in 2023, indicating a strategic move to maintain control while potentially raising capital without diluting voting power significantly. This mirrors GOOGL's dual-class structure, where Class B shares carry 10 votes per share and convert to single-vote Class A shares upon sale or transfer, preserving founder control. However, unlike GOOGL, which actively repurchased $62.2 billion of Class A and Class C shares in 2023, CMCSA's equity strategy appears more focused on maintaining a stable capital structure with no mention of a similar buyback program for Class B shares.",
      "llm_answer": "Comcast’s 2023 balance sheet shows that it issued 9,444,375 Class B common shares – a small slice of total equity but a high‑voting class (each share carries ten votes) that is typically used for insider or employee‑plan holdings and therefore concentrates voting power in a limited group 【page_69】. Alphabet’s dual‑class structure also has a 10‑vote Class B share, but those shares are required to convert to one‑vote Class A shares whenever they are sold or transferred, so the super‑voting rights stay with the original insiders and cannot be passed to the broader market 【page_81】.  Thus, while both companies employ a high‑voting Class B, Comcast’s shares remain convertible only at the holder’s option, whereas Google’s automatically lose their extra votes on any transfer.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the number of shares issued by CMCSA — 9,444,375 — is correctly stated, and the year 2023 is accurate. No dollar amounts or calculations are misstated. (2) The qualitative analysis correctly identifies that CMCSA's Class B shares carry 10 votes per share and are used to concentrate voting power, similar to GOOGL’s structure. It accurately contrasts the conversion rules: CMCSA’s Class B shares are convertible at the holder’s option, while GOOGL’s Class B shares automatically convert to Class A upon sale or transfer, thus preserving insider control. (3) The multi-hop reasoning is sound — the model correctly synthesizes information across CMCSA and GOOGL, comparing their dual-class structures and control mechanisms. (4) The only minor omission is that the original answer notes GOOGL repurchased $62.2 billion in shares in 2023, a detail absent in the LLM response. While this adds context about capital allocation differences, it is not central to the core comparison about share structure and voting control. The LLM answer captures the essential significance and structural comparison accurately, warranting a high score. Wording differs but semantic meaning is equivalent. All entities (CMCSA, GOOGL, Class B shares, 2023) are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 371,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How do the vesting-related financial commitments in MDLZ's multiemployer pension plans compare with WMT's equity compensation vesting schedules in terms of duration and cost recognition patterns?",
      "original_answer": "MDLZ has long-term financial obligations tied to multiemployer pension plans, with vesting periods governed by union agreements that result in multi-year liabilities such as a $526 million withdrawal liability paid over 19 years. These costs are recognized through ongoing contributions and interest accruals (e.g., $11 million in 2021). In contrast, WMT structures its employee incentives through equity compensation with defined vesting periods—such as restricted stock units that vest 25% annually over four years—with fair value discounted for expected dividends (e.g., 3.8% in fiscal 2022) and expensed ratably over the vesting term. While MDLZ's obligations are shaped by collective bargaining and multiemployer fund rules, WMT's vesting schedules are internally designed to align with shareholder interests and are accounted for as equity or expense over shorter, fixed timeframes.",
      "llm_answer": "MDLZ’s multi‑employer pension obligations are funded by modest annual cash contributions – $5 million in 2020, $4 million in 2021 and $5 million in 2019 – that are recorded as expense when paid, even though the plans have vesting periods defined by the collective‑bargaining agreements (the exact duration is not disclosed). Walmart’s equity‑based awards, however, vest over a multi‑year horizon (RSUs now vest 25 % each year over four years, previously 3‑ and 5‑year cliffs) and the fair‑value of the awards is expensed ratably over that vesting period, producing a much larger, amortized share‑based‑compensation cost. (MDLZ 10‑K p. 120‑122; WMT 10‑K p. 66‑67)",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general contrast between MDLZ's multiemployer pension obligations and WMT's equity compensation vesting schedules, but contains significant quantitative inaccuracies that undermine factual correctness. (1) Quantitative Accuracy: The LLM states MDLZ's annual contributions as $5M in 2020, $4M in 2021, and $5M in 2019, which contradicts the ground truth that highlights a $526 million withdrawal liability paid over 19 years and $11 million in interest accruals in 2021. These figures are not minor discrepancies—they reflect fundamentally different scales and cost recognition patterns. The LLM’s portrayal of contributions as small, expensed when paid, omits the long-term, accrual-based nature of the liability. (2) Completeness: While the answer addresses duration (e.g., 25% annual vesting over four years for WMT) and cost recognition (ratable expensing), it fails to mention MDLZ’s $526M withdrawal liability and its 19-year payment structure, a key multi-hop fact. The vesting duration for MDLZ plans is noted as undisclosed, but the ground truth implies multi-year obligations through the 19-year payout, which the LLM overlooks. (3) Entity Accuracy: Correctly identifies MDLZ and WMT, fiscal years, and instruments (multiemployer plans, RSUs), and accurately describes WMT’s vesting schedule and expensing method. (4) Reasoning: The qualitative comparison between collective bargaining-driven obligations (MDLZ) and internally designed equity plans (WMT) is sound and contextually appropriate, showing decent multi-hop synthesis. However, the financial magnitude and accounting treatment for MDLZ are misrepresented. (5) Semantic Equivalence: The core idea—that MDLZ faces long-term union-driven pension costs while WMT uses structured equity vesting with ratable expensing—is partially aligned, but the omission of the $526M liability and misrepresentation of contribution amounts severely weakens factual equivalence. The LLM answer downplays the scale and accrual-based nature of MDLZ’s commitments, making the comparison misleading despite correct framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 560,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How does the combined capital buffer requirement above the minimum risk-based capital ratios for BAC under the Advanced Approach compare to MS's requirement, considering both institutions' application of the 2.5% Capital Conservation Buffer and the zero Countercyclical Capital Buffer?",
      "original_answer": "Both BAC and MS apply the 2.5% Capital Conservation Buffer and face a zero Countercyclical Capital Buffer under the Advanced Approach. For BAC, this buffer combines with a 2.5% G-SIB surcharge, resulting in a total buffer requirement of 5.0% above the minimum risk-based capital ratio. Similarly, MS also computes its capital buffer as the sum of the 2.5% Capital Conservation Buffer and the 2.5% G-SIB surcharge, leading to an identical total buffer requirement of 5.0% above the minimum risk-based capital ratio. Thus, both institutions have the same total capital buffer requirement above minimums under the Advanced Approach.",
      "llm_answer": "Both Bank of America and Morgan Stanley have a 5.5 % capital‑buffer requirement above the regulatory minimum under the Advanced Approach. Each firm’s buffer is the sum of the 2.5 % capital‑conservation buffer, the 3.0 % G‑SIB surcharge and a zero counter‑cyclical buffer, yielding an identical 5.5 % total (BAC – 5.5 %【page_134】; MS – 5.5 %【page_54】).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claim. It states that both BAC and MS have a 5.5% capital buffer requirement, composed of a 2.5% Capital Conservation Buffer and a 3.0% G-SIB surcharge. However, the ground truth specifies a 2.5% G-SIB surcharge for both institutions, not 3.0%. This results in a correct total buffer of 5.0% (2.5% + 2.5%), not 5.5%. The LLM incorrectly inflates the G-SIB surcharge and thus the total buffer. (2) Calculation verification: Ground truth = 2.5% (CCB) + 2.5% (G-SIB) + 0% (CCyB) = 5.0% for both. LLM claims: 2.5% + 3.0% + 0% = 5.5%, which is incorrect. The cited pages (134 for BAC, 54 for MS) may contain errors or were misread. (3) Multi-hop reasoning: The model correctly identifies that both firms apply the same CCB and face zero CCyB, and it attempts to sum components across institutions. However, it fails in synthesizing the correct G-SIB surcharge values, undermining the comparison. The conclusion that both have identical requirements is coincidentally correct in structure but based on wrong inputs. (4) Scores justified: Correctness is low (3) due to major factual and calculation errors. Quantitative accuracy is poor (3) because key percentages and totals are wrong. Qualitative accuracy is moderate (4) as reasoning structure is sound but based on incorrect data. Contextual relevance is high (8) because the answer addresses the right institutions, buffers, and framework.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 405,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How does the sensitivity of AVGO's $56.3 billion fixed rate senior notes to interest rate changes compare to ORCL's effective interest rate management through swaps, considering the role of interest rate swaps in converting fixed-rate debt to floating-rate as demonstrated by CSCO's $0.5 billion swap?",
      "original_answer": "AVGO's $56.3 billion in fixed rate senior notes is highly sensitive to interest rate changes, with a 50 basis point shift affecting fair value by $1.7 billion. In contrast, ORCL uses interest rate swaps to stabilize its borrowing costs, achieving an effective interest rate of 4.74% for fiscal 2024 and 2023 on its floating-rate debt after converting it to fixed-rate debt with a 3.07% base rate. CSCO's use of a $0.5 billion interest rate swap illustrates how such instruments convert fixed-rate debt into floating-rate debt to offset fair value fluctuations, aligning with AVGO's and ORCL's broader strategies to manage interest rate exposure through financial hedging instruments.",
      "llm_answer": "AVGO’s $56.3 billion of fixed‑rate senior notes are quite rate‑sensitive – a 50‑basis‑point shift in market rates would change their fair value by roughly $1.7 billion (about $3.4 billion per 100 bps). Oracle, by contrast, uses interest‑rate swap contracts to lock in or convert the cost of its debt, so the effective interest expense on its borrowings is largely insulated from such moves. The Cisco example shows that a modest $0.5 billion swap can hedge the fair‑value impact of a fixed‑rate issue, a technique Oracle employs to manage its own interest‑rate exposure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies AVGO's $56.3 billion fixed-rate senior notes and the $1.7 billion fair value impact from a 50 bps shift, which matches the ground truth. It also accurately notes ORCL's use of interest rate swaps to manage exposure, and references CSCO's $0.5 billion swap as a hedging example. However, the LLM omits specific figures from the ground truth about ORCL's effective interest rate of 4.74% and base rate of 3.07%, which are key quantitative details in the original answer. (2) The calculation implied by 'about $3.4 billion per 100 bps' is a linear extrapolation from the 50 bps/$1.7B figure and is mathematically sound, though not explicitly stated in the original. All other numbers (AVGO's $56.3B, $1.7B, 50 bps; CSCO's $0.5B) are correct. ORCL's specific rates are missing, reducing quantitative completeness. (3) The multi-hop reasoning is strong: the model connects AVGO's rate sensitivity, ORCL's use of swaps for stability, and CSCO's swap as an illustrative example of fair value hedging. It correctly infers that swaps are used to manage interest rate exposure across firms, though it reverses the direction in CSCO's case (CSCO converts fixed to floating, while ORCL converts floating to fixed), but does not misrepresent the overall hedging purpose. (4) The answer is contextually excellent—directly addresses the comparison of AVGO's sensitivity vs ORCL's swap strategy, using CSCO as a supporting example. The omission of ORCL's exact rates prevents a top score, but core facts and synthesis are accurate and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 432,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How does the voting power distribution tied to Class B common stock at META compare to GOOGL's repurchase strategy across its multiple stock classes, given the interplay between voting rights and share structure?",
      "original_answer": "META's Class B common stock, which represents 33 1/3% of the combined voting power and has 15 votes per share, is non-dilutable and held entirely by a single individual, creating concentrated voting control. In contrast, GOOGL has a structure where Class B common stock has 10 votes per share and can be converted to Class A (1 vote per share), with no mention of non-dilutable voting power. Additionally, GOOGL actively repurchased $62.0 billion worth of shares in 2024 across both Class A and Class C shares, which have differing voting rights, suggesting a strategy that considers both capital allocation and governance dynamics.",
      "llm_answer": "Meta’s dual‑class structure gives its 343.8 million Class B shares (≈13.5 % of the 2.19 billion total shares outstanding on Jan 24 2025) ten votes each, so a relatively small share count controls a majority of the voting power (Meta 10‑K, p. 1). In contrast, Alphabet’s share‑repurchase program focuses on buying back its low‑voting Class A (one vote per share) and non‑voting Class C shares—repurchasing 73 million Class A and 306 million Class C shares in 2024—while leaving the high‑voting Class B shares untouched, thereby preserving the existing voting control (Alphabet 10‑K, Note 11, p. 82).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in quantitative details. The ground truth states that META's Class B stock has 15 votes per share, but the LLM claims 10 votes per share—this is a significant error. Additionally, the ground truth does not mention any specific number of Class B shares (e.g., 343.8 million) or total shares outstanding (2.19 billion), nor a date like Jan 24, 2025—these figures appear fabricated or misattributed. The claim that Class B shares represent '≈13.5%' of total shares is unsupported in the original answer and introduces false precision. (2) For GOOGL, the original answer states $62.0 billion in repurchases in 2024 across Class A and C shares, but the LLM instead cites 73 million Class A and 306 million Class C shares repurchased—without providing dollar values or confirming the $62.0 billion total. These share counts are not present in the ground truth and cannot be verified, making them potentially incorrect. The LLM correctly notes that repurchases focused on low/no-voting shares, preserving control, which aligns with the original's implication. (3) The multi-hop reasoning is partially sound: the model correctly contrasts META’s concentrated voting control with GOOGL’s repurchase strategy favoring non-controlling shares. It infers correctly that not repurchasing high-vote Class B shares preserves voting power. However, it misses the key point that META’s Class B is explicitly 'non-dilutable' and held by a single individual—critical context for governance. Also, the original mentions GOOGL’s Class B shares are convertible, which the LLM omits. (4) Despite incorrect numbers and missing key qualitative distinctions, the LLM captures the strategic contrast in governance-aware capital allocation, so contextual relevance is high. Correctness is penalized heavily due to invented figures and vote count error, but reasoning and intent are directionally accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 528,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How does Qualcomm's projected growth in generative AI-capable smartphone shipments by 2027 influence its strategic focus on AI and connectivity technologies, as compared to Salesforce's investment in generative and agentic AI across its CRM products?",
      "original_answer": "Qualcomm projects that 46% of smartphones sold in 2027 will be generative AI-capable, up from 19% in 2024, which directly informs its strategic focus on developing on-device AI and advanced connectivity technologies like 5G and 5G Advanced to support edge computing and AI workloads. Meanwhile, Salesforce is investing in generative and agentic AI across its CRM products, including the introduction of Agentforce, a new platform layer enabling autonomous AI agents for sales, service, marketing, and commerce. While Qualcomm's strategy centers on enabling AI at the device level through hardware innovation, Salesforce is embedding AI into its cloud-based CRM platform to enhance customer engagement and productivity. The convergence lies in their shared emphasis on AI capabilities—Qualcomm enabling them at the edge, Salesforce deploying them in enterprise workflows—though neither company has stated a direct business relationship or dependency.",
      "llm_answer": "Qualcomm’s outlook that 46 % of smartphones will be generative‑AI capable by 2027 – up from 19 % in 2024 – is driving it to double‑down on on‑device AI engines, low‑power NPUs and advanced 5G/5G‑Advanced connectivity to enable immersive, AI‑rich experiences on those handsets (Qualcomm, page 7). By contrast, Salesforce is directing its investment toward embedding generative and agentic AI (via its new Agentforce layer) across its CRM suite to automate decisions and personalize customer interactions, reflecting a software‑centric AI strategy rather than a hardware‑connectivity focus (Salesforce, page 41).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Qualcomm's projection that 46% of smartphones will be generative AI-capable by 2027, up from 19% in 2024, matching the ground truth exactly. It accurately reflects Qualcomm’s strategic focus on on-device AI, NPUs, and 5G/5G-Advanced connectivity. For Salesforce, it correctly references the investment in generative and agentic AI via the Agentforce platform and its application across CRM functions. The contrast between Qualcomm’s hardware/device-level AI and Salesforce’s software/cloud-centric approach is well articulated. (2) All numeric values—46%, 19%, 2027, 2024—are factually correct and properly contextualized. No calculations are required, but the comparison over time is accurately presented. (3) The multi-hop reasoning is sound: the model synthesizes information across two distinct companies (Qualcomm and Salesforce), correctly attributes strategic directions to each based on their respective domains (hardware vs. software), and draws a valid implicit contrast without overstating connections. The only minor omission is that the original answer explicitly notes the lack of a direct business relationship or dependency between the two firms, which the LLM answer does not mention—though this is a secondary detail. (4) The LLM answer is contextually fully relevant, directly addressing how each company's AI strategy is shaped by market projections or internal priorities. The qualitative reasoning is strong, with precise use of terms like 'on-device AI', 'low-power NPUs', 'Agentforce', and 'CRM suite'. The absence of the 'no direct relationship' note prevents a perfect 10, but all core facts and synthesis are correct. Thus, correctness is 9/10, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 486,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How does Adobe's focus on enhancing user experience through AI-driven digital media tools align with Qualcomm's projections for generative AI-capable edge devices in 2027, particularly in relation to on-device AI processing and user interface improvements?",
      "original_answer": "Adobe emphasizes that the intuitiveness and visual appeal of user interfaces are key competitive factors in its Digital Media segment, particularly as it integrates AI capabilities for digital media generation and editing. Qualcomm projects that 46% of smartphones sold in 2027 will be generative AI-capable, up from 19% in 2024, and highlights that on-device AI processing enhances user experiences with immediacy, privacy, and personalization. Qualcomm’s advancements in edge AI processing and user interface technologies are positioned to support Adobe’s strategic direction by enabling more powerful, responsive, and secure AI-driven tools directly on devices, aligning with Adobe’s need to deliver best-in-class user experiences across platforms.",
      "llm_answer": "Adobe is building generative‑AI features such as Firefly, Sensei and generative‑fill tools directly into Creative Cloud and Experience Cloud to make its interfaces more intuitive, visually appealing and personalized (see Adobe pages 8‑10). Qualcomm expects that by 2027 roughly 46 % of smartphones and at least 50 % of PCs will be generative‑AI capable, driven by its on‑device AI Engine and Hexagon NPU that deliver high‑performance, low‑power inference (see Qualcomm pages 7‑9). Because Adobe’s AI‑driven media tools rely on fast, on‑device processing, the growth of Qualcomm‑enabled edge devices will let those tools run locally, delivering richer, more responsive UI experiences with lower latency and better privacy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: Qualcomm's projection of 46% of smartphones being generative AI-capable by 2027 matches the original answer; the 19% baseline from 2024 is omitted but not contradicted. The LLM adds a specific projection for PCs (at least 50%), which is not in the ground truth but does not conflict with it and may reflect additional data from the source. (2) Entity accuracy is strong: Adobe’s Firefly, Sensei, and generative-fill tools are correctly attributed to Creative Cloud and Experience Cloud. Qualcomm’s AI Engine and Hexagon NPU are accurately cited as enablers of on-device AI. (3) Reasoning is sound: the LLM correctly synthesizes that Adobe’s AI-driven UX improvements depend on responsive, private, low-latency processing, which Qualcomm’s edge AI advancements enable via local inference. (4) The answer addresses all parts of the question—Adobe’s AI-driven UX focus, Qualcomm’s 2027 projections, on-device processing benefits, and UI improvements—with strong multi-hop logic linking Adobe’s software strategy to Qualcomm’s hardware roadmap. The only minor omission is the explicit mention of 'privacy, personalization, and immediacy' as user experience enhancements directly tied to on-device processing in the original, though these are partially covered under 'better privacy' and 'more responsive UI'. Wording differs but semantic meaning is equivalent. No factual errors; minor augmentation with PC projection does not detract. Thus, correctness is excellent but not perfect due to slight expansion beyond ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 447,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How does the treatment of dividend equivalents on RSU awards differ between Lockheed Martin's and Honeywell's compensation plans, based on the specific vesting terms and payment structures disclosed?",
      "original_answer": "Lockheed Martin discloses that dividend equivalents on vested stock units for non-employee directors may be paid on the first business day of April following the one-year anniversary of the grant, indicating a delayed payment structure tied to director tenure and stock ownership guidelines. In contrast, Honeywell does not specify a delayed payment schedule for dividend equivalents on RSUs, focusing instead on vesting periods ranging from three to six years with payment in common stock upon vesting. Additionally, Lockheed Martin’s Deferred Management Incentive Compensation Plan (DMICP) credits dividend equivalents as stock units at dividend payment times, while Honeywell’s RSU awards are more focused on performance-based vesting tied to company goals.",
      "llm_answer": "Lockheed Martin’s RSU awards for directors accrue dividend equivalents that are paid **separately** – directors who meet the stock‑ownership guidelines may elect to receive the award (and any dividend equivalents) on the first business day of April following the one‑year anniversary of the grant, rather than at the normal termination‑of‑service payoff. Honeywell’s RSUs, by contrast, simply “earn dividend equivalents” that are settled **with the RSU award itself** when the units vest, which occurs over a three‑ to six‑year vesting schedule and is paid in Honeywell common stock.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the key differences in dividend equivalent treatment between Lockheed Martin and Honeywell. (1) It correctly states that Lockheed Martin allows non-employee directors to receive dividend equivalents separately, with a specific payment date (first business day of April following the one-year anniversary), tied to stock ownership guidelines—this aligns with the ground truth. The mention of an election to receive payment earlier than termination-of-service is a nuanced but consistent detail. (2) For Honeywell, the LLM correctly notes that dividend equivalents are earned and settled with the RSU upon vesting, which occurs over 3–6 years in common stock—this matches the original answer. (3) The multi-hop reasoning is sound: the model synthesizes information across two companies, comparing both timing and structure of dividend equivalent payments. (4) The only minor omission is that the LLM does not explicitly mention Lockheed Martin’s DMICP crediting dividend equivalents as stock units at dividend payment times, nor Honeywell’s performance-based vesting focus. While the core structural difference (separate vs. concurrent payment) is correctly highlighted, this missing context slightly reduces qualitative completeness. However, the answer remains semantically equivalent in key aspects and fully addresses the comparative treatment as required. No numeric or entity errors are present—company names, vesting periods, and payment terms are all correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 414,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How does the reliance of Texas Instruments (TXN) on subcontractors for 40% of its assembly and test services compare with NVIDIA's (NVDA) exposure to third-party manufacturers, given the shared dependency on external production capacity and the risks highlighted by AMD's experience with third-party suppliers?",
      "original_answer": "Texas Instruments relies on subcontractors for 40% of its assembly and test services, supplementing internal capacity to meet customer demand. This external dependency aligns with NVIDIA’s reliance on third-party manufacturers for semiconductor fabrication, assembly, and testing, which exposes them to risks such as limited control over delivery schedules, quality assurance, and potential prioritization of other customers. AMD's experience highlights the vulnerability in this model, as their dependence on third-party manufacturers—including GF and ATMP joint ventures—can lead to supply disruptions, capacity constraints, and financial penalties if purchase targets are not met. Therefore, both TXN and NVDA face similar exposure to third-party production risks, though NVDA's exposure is amplified by the complexity of its products and global supply chain dependencies.",
      "llm_answer": "Texas Instruments says it sources roughly 40 % of its assembly‑and‑test work from subcontractors (TXN 10‑K p. 9), while NVIDIA’s filing notes a broad reliance on third‑party manufacturers and warns that “the inability of our suppliers to deliver on their supply commitments to us” could disrupt its production (NVDA 10‑K p. 26). AMD’s experience shows that such dependence on external foundries and ATMP providers can create capacity constraints, price volatility and loss of control over quality and delivery (AMD 10‑K pp. 22‑23), risks that are inherent to both TI’s subcontractor‑heavy model and NVIDIA’s supplier‑dependent supply chain.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Texas Instruments relies on subcontractors for 40% of its assembly and test services, matching the ground truth exactly. It also accurately reflects NVIDIA's reliance on third-party manufacturers and cites the relevant risk from its 10-K about supplier delivery failures. AMD's experience with external foundries and ATMP providers is correctly summarized, including risks like capacity constraints, quality control, and delivery issues. All key facts are present and factually aligned with the original answer. (2) Quantitatively, the 40% figure is correct and properly attributed to TXN’s 10-K. No other numerical values require verification, and there are no calculation errors. Format and sourcing (e.g., page numbers) are consistent with expectations. (3) The multi-hop reasoning is sound: the model synthesizes information across TXN, NVDA, and AMD filings to draw a valid comparison between their third-party dependencies. It correctly infers shared risks without overstating equivalence—acknowledging that both companies face similar structural vulnerabilities. The only minor gap is that the LLM does not explicitly note that NVDA’s exposure is 'amplified' by product complexity and global supply chain depth, a nuance present in the ground truth. This omission slightly weakens the comparative analysis but does not invalidate the core conclusion. (4) Contextual relevance is high—the response directly addresses the comparative reliance, shared risks, and AMD’s cautionary example. Wording differs but semantic meaning is equivalent. Overall, this is a highly accurate, well-supported answer with only a slight reduction in qualitative accuracy due to the missing amplification nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 477,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What is the total estimated cost of Duke Energy Florida's 10 new solar facilities, and how does this investment relate to Southern Power's use of PPAs as operating leases with terms up to 25 years for similar renewable energy projects?",
      "original_answer": "Duke Energy Florida's 10 new solar facilities have an estimated total cost of $1 billion over the next three years. These facilities are part of a voluntary solar program approved by the FPSC in January 2021. Southern Power, a subsidiary of Southern Company, utilizes Power Purchase Agreements (PPAs) related to solar and wind facilities, which are accounted for as operating leases with remaining terms of up to 25 years. This indicates that both Duke Energy Florida and Southern Power are investing in long-term renewable energy infrastructure, with Duke making direct investments included in base rates and Southern Power leveraging PPAs as a financial mechanism to support similar projects.",
      "llm_answer": "Duke Energy Florida’s Clean Energy Connection program calls for ten new solar generating facilities with an estimated total cost of **about $1 billion**【page_153】.  Southern Power funds comparable solar and wind projects through power‑purchase agreements that it records as **operating leases with terms that can run up to 25 years**【page_268】, providing a long‑term lease‑payment structure that mirrors the financing of Duke Energy Florida’s solar investment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total estimated cost of Duke Energy Florida's 10 new solar facilities as about $1 billion, matching the ground truth. It also accurately states that Southern Power uses PPAs accounted for as operating leases with terms up to 25 years. All key facts are present and correct. (2) Quantitatively, the $1 billion figure is accurate and properly attributed, and the 25-year term is correctly reported. No calculations are required, but the numbers are precise and match the ground truth exactly. Format variation ('about $1 billion' vs. '$1 billion') is acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model connects Duke Energy Florida’s direct investment in solar infrastructure with Southern Power’s use of PPAs as a financial mechanism for similar projects. While the LLM does not explicitly contrast the two models (direct investment vs. off-balance-sheet financing via leases), it implies a parallel by stating that Southern Power’s lease structure 'mirrors the financing' of Duke’s investment—this is a slight oversimplification but not factually incorrect. The core synthesis across entities and mechanisms is logically valid. (4) The answer is highly relevant, directly addressing both parts of the question. The only minor shortcoming is the lack of explicit mention of the FPSC approval in January 2021 and the voluntary nature of the program, which are contextual details present in the ground truth but not critical to the core answer. Overall, the response is factually accurate, well-supported, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 443,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How does the difference in voting rights structure between Netflix's common stock and Alphabet's Class C capital stock influence the strategic allocation of Alphabet's $62.0 billion share repurchase in 2024 between Class A and Class C shares?",
      "original_answer": "Netflix's common stock provides one vote per share, establishing a straightforward voting rights framework. In contrast, Alphabet's Class C capital stock carries no voting rights except as required by law, while Class A shares have one vote per share and Class B shares have 10 votes per share. Given this differentiated voting structure and Alphabet's 2024 repurchase of $62.0 billion in Class A and Class C shares, the lack of voting rights in Class C likely influences the company's repurchase strategy by prioritizing liquidity and cost efficiency over governance influence, allowing Alphabet to retire shares without diluting control held by voting-class shareholders.",
      "llm_answer": "Netflix’s common stock gives each share one vote (NFLX 10‑K p. 60). Alphabet’s Class C capital stock has no voting rights, whereas Class A shares have one vote each (Alphabet 10‑K p. 82). Because Class C shares do not affect voting control, Alphabet can allocate a larger portion of its $62 billion 2024 buy‑back to the non‑voting Class C shares (≈$50 bn) while preserving voting power by repurchasing a smaller amount of Class A shares (≈$12 bn), a strategic flexibility that does not arise for Netflix’s uniformly voting common shares.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the voting structures of Netflix and Alphabet, citing one vote per share for Netflix common stock and no voting rights for Alphabet Class C shares, which aligns with the ground truth. It also correctly contrasts this with Class A shares having one vote and implicitly acknowledges the control-preserving logic in share repurchases. However, the LLM introduces specific numerical allocations—$50 billion to Class C and $12 billion to Class A—that are not present in the original answer or supported by the question. The ground truth does not specify any split of the $62.0 billion repurchase between share classes, only that the lack of voting rights in Class C allows strategic flexibility in repurchasing without diluting control. These fabricated figures significantly undermine factual accuracy. (2) Quantitative accuracy is low because the $50B and $12B figures are not in the original data and sum to $62B only approximately (off by $0B in sum but entirely speculative in split). There is no source in the provided context for such a precise allocation, making this a serious error. (3) The multi-hop reasoning is otherwise sound: the model correctly links Netflix’s uniform voting structure to the absence of governance-based repurchase strategy, and contrasts it with Alphabet’s differentiated voting rights to infer strategic flexibility. This demonstrates good qualitative understanding of corporate governance implications. (4) Contextual relevance is high because the answer directly addresses the influence of voting structure on repurchase strategy. Despite the invented numbers, the core logic about preserving voting power by buying non-voting shares is valid and responsive. The correctness score is moderate because while the conceptual reasoning is strong, the inclusion of unsupported quantitative claims undermines trust and factual correctness, which is critical in financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 526,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How does the activation of voting rights for preferred stockholders in BAC due to dividend arrears compare to the limited voting rights of Class C common stockholders at V, particularly in the context of corporate governance during financial stress?",
      "original_answer": "At BAC, if dividends on certain preferred stock series are in arrears for three or more semi-annual or six or more quarterly periods, holders gain voting rights to elect two additional directors, which terminate once dividends are paid for at least two semi-annual or four quarterly periods following the arrearage. This mechanism serves as a governance safeguard for preferred stockholders during financial distress. In contrast, V’s Class C common stockholders have no general voting rights except in specific defined matters, such as exiting the core payments business or certain corporate restructurings, and they do not participate in amendments solely affecting preferred stock. Unlike BAC’s contingent voting rights tied to dividend performance, V’s Class C stockholders’ voting power is structurally limited and not directly linked to financial performance metrics like dividend arrears.",
      "llm_answer": "Bank of America’s preferred stock includes a stress‑triggered voting provision: if dividends on a series are in arrears for three + semi‑annual (or six + quarterly) periods, the holders of that series (and any equally‑ranked series) gain the right to vote as a single class and elect two additional directors, a right that lapses once dividends are caught up (BAC 10‑K p. 142). Visa’s Class C common shares, however, have no general voting power and may only vote on a narrow set of defined actions—such as a merger, an exit from the core payments business, or certain charter amendments—regardless of the company’s financial condition (Visa 10‑K p. 90). Thus, BAC gives preferred investors a direct governance lever when the firm is under financial stress, whereas Visa’s Class C holders remain largely disenfranchised except for specific corporate events.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: BAC's preferred stockholders gain voting rights to elect two additional directors if dividends are in arrears for three or more semi-annual (or six or more quarterly) periods, and these rights terminate after two consecutive semi-annual (or four quarterly) periods of dividend payments—this is correctly summarized. The LLM accurately notes that the rights lapse once dividends are caught up, which matches the termination condition in the original answer. (2) Quantitative elements—'three or more semi-annual' and 'six or more quarterly'—are precisely stated, with no calculation errors. (3) Entity accuracy is strong: BAC and V (Visa) are correctly identified, and the references to their respective 10-K filings (p.142 and p.90) support the claims, though page numbers were not in the ground truth but do not detract from accuracy. (4) The reasoning correctly contrasts BAC’s performance-contingent voting mechanism with Visa’s structurally limited, event-based voting rights for Class C common stockholders. The LLM captures the core distinction: BAC ties voting rights to financial stress (dividend arrears), while Visa’s Class C voting rights are fixed and not performance-sensitive. (5) The only minor omission is that the original answer specifies Class C voting rights do not extend to amendments solely affecting preferred stock—a nuance absent in the LLM response. However, this does not undermine the overall correctness. Semantic equivalence is maintained, and the answer is contextually excellent, directly addressing corporate governance implications during financial stress.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 460,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How does Disney's licensing revenue from Star Wars-branded merchandise influence its ability to fund content development for Disney+ in European markets where it competes with CMCSA's Sky Glass and XClass TV platforms?",
      "original_answer": "Disney earns licensing royalties from third-party products featuring Star Wars characters, which contributes to funding content development for its DTC services, including Disney+ in European markets. Disney+ includes Star Wars programming as a core content tile, which is critical to attracting subscribers in competitive regions like Europe. CMCSA competes in this market with its own video services and DTC-aligned platforms like Sky Glass and XClass TV, which integrate with its European broadband offerings. Therefore, licensing revenue from Star Wars enhances Disney's content investment capacity, directly supporting its competitive positioning against CMCSA’s integrated hardware and content strategy in Europe.",
      "llm_answer": "Disney’s licensing business generates royalty cash from Star Wars‑branded merchandise – a key revenue stream that “earns royalties … based on a fixed percentage of the wholesale or retail selling price” of those products (DIS 10‑K, Licensing section, p. 22).  That cash flow can be redeployed to finance new Disney+ original series and localized content for European markets, giving Disney the financial firepower to expand its DTC library as it competes with Comcast’s Sky Glass smart‑TV service and XClass TV platform (CMCSA 10‑K, Network & Technology and Competition sections, pp. 17‑18).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Disney earns licensing royalties from Star Wars merchandise, which funds content development for Disney+, particularly in competitive European markets. The mention of Comcast (CMCSA) competing via Sky Glass and XClass TV is accurate and contextually appropriate. (2) There are no numeric values (e.g., dollar amounts, percentages, years) in the ground truth, and the LLM correctly avoids fabricating any, instead citing the royalty mechanism as a percentage of wholesale/retail price without specifying a number—consistent with the source. Thus, quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the model connects Disney’s licensing revenue → funding for Disney+ content → strategic importance in Europe → competition with CMCSA’s integrated platforms. It references appropriate sections of both companies’ 10-Ks, demonstrating proper synthesis. (4) The only minor shortcoming is that the LLM does not explicitly state that Star Wars programming is a 'core content tile' for subscriber acquisition in Europe—a nuance present in the original—but this is implied through the emphasis on funding original and localized content. Wording differs slightly but meaning is semantically equivalent. Contextual relevance is excellent, directly addressing all parts of the multi-faceted question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 391,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How does the sensitivity of AXP's net interest income to a 200 basis point increase in interest rates relate to MS's use of interest rate caps in securitization transactions, considering the role of repricing risk in both firms' financial strategies?",
      "original_answer": "AXP estimates that a 200 basis point increase in interest rates would negatively impact its net interest income, based on its repricing risk assumptions which include the effect of interest rate caps or floors. This sensitivity is linked to the repricing dynamics of interest-rate sensitive assets and liabilities, where certain deposits reprice at lower magnitudes than benchmark rate movements. On the other hand, MS enters into interest rate caps as part of its securitization transactions, which are designed to manage interest rate exposure. These caps are subject to similar repricing risk dynamics, suggesting that both firms are managing interest rate volatility through derivative instruments, though in different business contexts—AXP through its core interest income and MS through structured finance activities involving SPEs.",
      "llm_answer": "American Express says a parallel 200‑basis‑point rise would cut its annual net‑interest income by roughly **$560 million**, reflecting the firm’s repricing risk – its assets and liabilities tend to reprice together, only limited by any caps or floors in place. Morgan Stanley, aware of the same repricing exposure in the assets it securitizes, **uses interest‑rate caps (and swaps) in those transactions** to cap the effect of rising rates on the cash‑flows it retains, thereby hedging the rate‑sensitivity that drives AXP’s earnings impact. Both companies manage repricing risk, but AXP experiences it directly in net‑interest income, while MS mitigates it through caps in its securitization structures.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces a specific dollar amount—$560 million—that is not present in the original (ground truth) answer. There is no mention in the ground truth of any numerical estimate of the impact on AXP's net interest income, only a qualitative description of the sensitivity and its relation to repricing risk and interest rate caps/floors. This introduces a potentially misleading level of precision not supported by the source. However, the mention of AXP’s sensitivity to a 200 bps increase and its link to repricing risk is accurate and aligns with the original. (2) The quantitative inaccuracy stems solely from the unsupported $560 million figure; no other numbers are present or required. The ground truth does not provide any dollar impact, so this number cannot be verified and appears to be hallucinated. Other numerical references (200 basis points) are correct and consistent. (3) The multi-hop reasoning is sound: the LLM correctly identifies that both AXP and MS use interest rate caps in the context of managing repricing risk, albeit in different business contexts—AXP in net interest income and MS in securitization transactions. The synthesis between the two firms’ strategies is logically coherent and captures the conceptual link emphasized in the original answer. (4) The contextual relevance is high, as the response directly addresses the relationship between AXP’s interest rate sensitivity and MS’s use of caps, with accurate framing of repricing risk. The qualitative reasoning is strong, but the hallucinated figure reduces quantitative accuracy significantly. Correctness score is 7 because the core conceptual and relational understanding is correct, but the addition of an unsupported specific financial impact undermines full factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 488,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How does the impact of a weaker U.S. dollar on MDLZ's consolidated earnings compare to the favorable currency effects experienced by Coca-Cola's Europe, Middle East and Africa segment, given both companies explicitly call out exchange rate fluctuations involving the euro and British pound?",
      "original_answer": "MDLZ states that a weaker U.S. dollar benefits its consolidated earnings and net assets, as many subsidiaries operate in non-dollar functional currencies. KO specifically notes that a weaker U.S. dollar compared to the euro and British pound had a favorable impact on its Europe, Middle East and Africa segment. Both companies explicitly identify these two currencies as key drivers of their respective foreign exchange impacts, showing a direct parallel in how they are affected by similar currency dynamics.",
      "llm_answer": "MDLZ said that a weaker U.S. dollar versus the euro and British pound gave a **favourable boost to its Europe, Middle East and Africa (and Global Ventures) segment**, but the overall foreign‑currency effect was still **an 11 % unfavourable impact on consolidated operating income**, contributing to a 12 % drop in operating profit (MDLZ 10‑K p. 51).  \n\nCoca‑Cola likewise noted that a weaker dollar versus the euro and pound **provided a favourable effect for its Europe, Middle East and Africa segment**, which **partially offset a 5 % decline in consolidated net operating revenues caused by a stronger dollar versus other currencies** (Coca‑Cola 10‑K p. 49).  \n\nThus, while both firms cite the same currency pair, MDLZ’s net result was still a sizable negative hit to earnings, whereas Coca‑Cola’s currency gain merely mitigated a smaller overall revenue decline.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness, despite correctly identifying the relevant currencies (euro and British pound) and regions (Europe, Middle East and Africa). (1) The claim that MDLZ experienced an '11% unfavourable impact on consolidated operating income' and a '12% drop in operating profit' due to foreign currency is not supported by the ground truth and introduces specific numbers not present in the original answer. The original answer only states that a weaker U.S. dollar benefits MDLZ’s earnings and net assets, without citing any negative net impact. (2) Similarly, the assertion that Coca-Cola had a '5% decline in consolidated net operating revenues' due to a stronger dollar is not in the original answer, which only notes a favorable effect from the weaker dollar without quantifying an overall decline. (3) The LLM incorrectly implies that MDLZ had a net negative outcome from currency movements, contradicting the ground truth that a weaker dollar is beneficial. (4) While both companies do cite the euro and pound as key currencies, the LLM fabricates comparative quantitative impacts and misrepresents MDLZ’s overall exposure. (5) The reasoning is partially sound in drawing a parallel between the two companies’ exposure to the same currencies, but the conclusion that MDLZ had a 'sizable negative hit' versus Coca-Cola’s 'mitigated' decline is factually incorrect. The original answer emphasizes a direct parallel in favorable impacts, not divergent outcomes. Quantitative accuracy is low due to unsupported percentages. Qualitative accuracy is moderate because entities and regions are correct, but synthesis is flawed. Contextual relevance is high as the response addresses the core comparison question using the right companies and currencies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 491,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How does the voting power concentration in MA's dual-class share structure compare to V's, given the relationship between their respective Class A and Class B shares and the 15-vote weighting per Class B share?",
      "original_answer": "MA's dual-class structure includes 907 Class A shares and 7 Class B shares outstanding, with Class B shares carrying 15 votes each, resulting in a voting power concentration of approximately 10.4% for Class B shares. V has 125 Class B shares outstanding as of September 30, 2024, against 1,733 Class A shares, and if following the same 15-vote weighting per Class B share from the intermediary evidence, Class B would hold approximately 68.5% of the voting power despite representing just 6.7% of total shares. This indicates significantly more concentrated control at V compared to MA.",
      "llm_answer": "Mastercard’s capital structure includes about 907 Class A shares (1 vote each) and only 7 Class B shares, each worth 15 votes, giving the Class B stock roughly 105 votes out of a total of ≈1,012 votes – about 10 % of the voting power (see page 68). Visa, by contrast, has roughly 1,733 Class A shares and 125 Class B shares (15 votes each), so the Class B shares supply about 1,875 votes of a total ≈3,608 votes – roughly 52 % of the voting power (see page 58). Thus, voting power is far more concentrated in Visa’s Class B shares than in Mastercard’s.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the share counts for MA (907 Class A, 7 Class B) and V (1,733 Class A, 125 Class B), and correctly applies the 15-vote weighting to Class B shares. However, the voting power percentage for Visa's Class B shares is miscalculated. The LLM states ~52%, but the correct figure is approximately 68.5% (1,875 / (1,733 + 125*15) = 1,875 / 3,608 ≈ 51.97% — wait, this actually matches the LLM’s calculation). Rechecking the ground truth: total votes = 1,733 (Class A) + (125 × 15) = 1,733 + 1,875 = 3,608. Class B share of votes = 1,875 / 3,608 ≈ 51.97%, so the LLM's ~52% is quantitatively correct. But the original answer claims 68.5%, which appears to be an error in the ground truth or a different calculation basis. Given that the LLM’s math is correct based on provided numbers, this suggests the ground truth may be flawed. However, per evaluation guidelines, we must score against the provided ground truth. Since the LLM reports 52% vs. ground truth’s 68.5%, this is a significant discrepancy. But upon deeper inspection, 68.5% does not align with the numbers given (125 Class B, 1,733 Class A, 15x votes). There is no indication in the question or original answer that additional shares or voting rights exist. Therefore, the LLM’s calculation is mathematically accurate, while the original answer’s 68.5% appears incorrect. This creates a conflict: the LLM is factually correct, but diverges from the stated ground truth. Given the instructions to evaluate against the original answer as ground truth, even if it contains errors, the LLM must be penalized for quantitative inaccuracy despite correct arithmetic. (2) All other numbers are accurate: MA’s total votes = 907×1 + 7×15 = 907 + 105 = 1,012; Class B share = 105/1,012 ≈ 10.4%, which the LLM rounds to 'about 10%', acceptable. (3) Multi-hop reasoning is sound: the model compares voting power concentration across two companies using dual-class structures and synthesizes data correctly. (4) Contextual relevance is perfect — directly addresses the comparison asked. Final scores reflect tension between actual correctness and alignment with provided ground truth: quantitative accuracy reduced due to divergence from stated percentage, though LLM’s math is superior. Correctness score is 7 because core data and logic are correct, but conclusion differs from ground truth due to disputed percentage.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 640,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How do the financial risks associated with nuclear power plants at NEE compare to those at Southern Company, particularly in terms of potential exposure from decommissioning costs exceeding available reserves?",
      "original_answer": "NEE and FPL face potential financial risks from decommissioning costs of their nuclear facilities possibly exceeding the available decommissioning funds. Similarly, Southern Company's subsidiaries Alabama Power and Georgia Power also face exposure if decommissioning costs exceed available reserves or insurance coverage. In both cases, the companies acknowledge that the financial impact could be material if the costs surpass the accumulated funds, which are subject to uncertainties in estimation and long-term planning.",
      "llm_answer": "Both companies flag the same core risk – that the cost to shut down and dismantle their nuclear plants could outstrip the money they have set aside. NextEra notes that a decline in the market value of its nuclear‑decommissioning fund could force additional funding and materially hurt liquidity and its financial condition (NEE 10‑K pp. 31‑32). Southern Company likewise warns that decommissioning costs or damages could exceed the amounts in its decommissioning trusts or insurance coverage, creating a potential shortfall in capital reserves (Southern Co. 10‑K pp. 29, 10‑11).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the core financial risk for both NEE (and its subsidiary FPL, though not explicitly named) and Southern Company: that decommissioning costs could exceed available reserves, potentially leading to material financial impacts. The answer cites specific risks related to market value declines in decommissioning funds for NEE and potential shortfalls due to cost overruns or insufficient insurance for Southern Company. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not compromised—no calculations or figures to verify. (3) The multi-hop reasoning is sound: the LLM synthesizes risk disclosures from both companies' 10-Ks, correctly attributing similar but independently assessed risks to each entity. It references specific page numbers (e.g., NEE 10-K pp. 31–32; Southern Co. 10-K pp. 29, 10–11), indicating proper sourcing. (4) The only minor omission is that the LLM does not explicitly name FPL (a subsidiary of NEE) or Alabama Power and Georgia Power (subsidiaries of Southern Company) as the entities holding the nuclear assets, which the original answer includes. However, this does not detract significantly from the overall correctness, as the parent company disclosures encompass these risks. Wording differs but semantic meaning is equivalent. Thus, the answer is factually correct, contextually relevant, and well-reasoned, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 412,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How does the $9.9 billion valuation of UPS's pension plan investments in real estate funds compare to the valuation approaches used by General Dynamics for its Level 3 assets, given that both companies rely on valuation models through real estate or private equity fund investments?",
      "original_answer": "UPS valued its $9.9 billion in pension plan investments in real estate funds using net asset value (NAV) as a practical expedient, based on audited and unaudited financial reports from fund managers, with adjustments for investment activity between reporting dates. These real estate funds rely on valuation models, as stated in the second chunk, which notes that real estate funds use NAV based on such models and periodic appraisals. General Dynamics, on the other hand, disclosed that its Level 3 assets include direct private equity investments that are measured using unobservable inputs—essentially internal or fund-level valuation models. Thus, while both companies depend on valuation models for real estate or private equity fund investments, UPS relies on NAV with manager reporting and adjustments, whereas GD directly uses unobservable inputs for its Level 3 private equity holdings.",
      "llm_answer": "UPS values the $9.9 billion of its pension‑plan real‑estate fund holdings at net‑asset value (NAV), using the fund managers’ audited and unaudited reports and activity‑adjustments as a practical expedient for fair value (see page 58). General Dynamics, however, classifies its private‑equity and real‑estate holdings as Level 3 assets and values them with Level 3 valuation models that rely on unobservable inputs—such as discounted‑cash‑flow and internal NAV calculations based on appraisal and model assumptions—rather than quoted market prices (see pages 87‑88).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $9.9 billion valuation for UPS's pension plan real estate fund investments is correctly stated. No other numerical values are in dispute. (2) The LLM correctly identifies that UPS uses net asset value (NAV) as a practical expedient, based on fund managers’ audited and unaudited reports with adjustments for activity between reporting dates—matching the original answer. It also accurately notes that General Dynamics classifies its private equity and real estate holdings as Level 3 assets, which rely on unobservable inputs such as discounted cash flow and internal NAV models. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (UPS and General Dynamics), two types of investments (real estate funds vs. private equity), and two valuation approaches (NAV as practical expedient vs. Level 3 models with unobservable inputs). (4) The only minor shortcoming is that the LLM answer slightly generalizes GD’s approach by including 'real-estate holdings' as Level 3 assets, while the original answer specifically emphasizes GD’s 'direct private equity investments' as Level 3. However, this does not materially misrepresent the facts, as private equity and real estate fund investments often fall under similar Level 3 categorizations using unobservable inputs. Wording differs slightly but maintains semantic equivalence. All key points—reliance on models, lack of quoted prices, and distinction in methodology—are preserved. Thus, the answer earns a 9/10 for correctness due to excellent factual accuracy, strong reasoning, and high relevance, with only a minor imprecision in asset specificity for GD.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 474,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "Given PepsiCo's 30% beverage revenue exposure in the Africa and Middle East region and Target's vendor arrangements where they only pay for merchandise after guest sale, what potential impact could a supply disruption in this region have on Target's inventory turnover and cash flow timing for beverage SKUs?",
      "original_answer": "A supply disruption in the Africa and Middle East region, which accounts for 30% of PepsiCo's beverage revenue, could delay product availability at Target. Since Target only pays vendors after merchandise is sold to guests, this delay could reduce inventory turnover for beverage SKUs during the disruption period. This would temporarily lower cash flow generation from beverage sales, as Target recognizes revenue only upon guest purchase and does not pay vendors until then.",
      "llm_answer": "A supply disruption in the AMESA region—where PepsiCo derives roughly 30 % of its beverage revenue【page_73】—would likely limit the availability of PepsiCo beverage SKUs at Target, slowing the turnover of those items. Because Target’s vendor contracts defer payment until the merchandise is actually sold and the goods are not recorded as inventory【page_49】, the shortage would both reduce inventory turnover and push any cash outflows to a later date (or lower cash outflows overall) while also curtailing cash inflows from the missed sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 30% beverage revenue exposure in the Africa and Middle East (AMESA) region is correctly cited, and no other numerical values require verification. (2) The reasoning correctly synthesizes two key facts: PepsiCo’s regional revenue concentration and Target’s vendor payment model (pay-on-sale). It logically concludes that a supply disruption would reduce inventory turnover and delay cash flows. (3) The multi-hop logic is sound—connecting PepsiCo’s supply risk to Target’s inventory and cash flow dynamics via their vendor arrangement. (4) The only minor deviation is the claim that goods 'are not recorded as inventory'—this overreaches slightly; while Target may not pay until sale, consignment or drop-ship arrangements vary, and the original answer does not assert this inventory accounting treatment. This does not materially affect the core conclusion on cash flow timing but introduces a small inaccuracy. Otherwise, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 309,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How have LLY and AMGN responded differently to payer-driven pricing pressures on their high-cost biologics, particularly in light of access restrictions affecting Repatha and insulin products?",
      "original_answer": "LLY faces increasing public and private payer scrutiny on pricing, especially for insulin, with proposed legislation enabling government price negotiation and restrictive reimbursement policies like the Alzheimer’s Monoclonal Antibody NCD, which could materially affect revenue. In contrast, AMGN has responded to payer restrictions on Repatha—such as formulary exclusions, step therapy requirements, and copay accumulator programs—by reducing both net and list prices, discontinuing higher-priced NDCs in 2019, and directly partnering with payers to align on health outcomes. While LLY emphasizes regulatory and legislative uncertainty, AMGN has taken active pricing and partnership strategies to mitigate payer-imposed access barriers.",
      "llm_answer": "Lilly’s 2022 filing simply flags the payer‑driven risk that new U.S. legislation could force government‑negotiated pricing for its insulin products, noting the potential impact but not describing any immediate price‑cut actions (LLY 10‑K p. 29). Amgen, on the other hand, details active steps to blunt payer restrictions on its high‑cost PCSK9 inhibitor Repatha – it lowered the net price, offered larger discounts and rebates to PBMs and Medicare Part D plans, introduced new lower‑list‑price NDCs and eliminated the higher‑price option (Amgen 10‑K p. 41).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that LLY acknowledges payer-driven pricing risks, particularly from proposed U.S. legislation on insulin pricing, without taking immediate price-cutting actions, citing its 2022 10-K. This matches the original answer's emphasis on regulatory and legislative uncertainty. (2) For AMGN, the LLM accurately details concrete actions: lowering net price, increasing discounts and rebates, introducing lower-list-price NDCs, and eliminating higher-priced options—consistent with the ground truth's mention of price reductions and discontinuation of higher-priced NDCs in 2019. The reference to Amgen’s 10-K p. 41 supports this. (3) The multi-hop reasoning is sound: it contrasts LLY’s passive risk disclosure with AMGN’s active mitigation strategies in response to payer restrictions on high-cost biologics (insulin vs. Repatha), correctly synthesizing information across two companies and their respective drugs. (4) Minor omission: the LLM does not explicitly mention AMGN’s direct partnerships with payers to align on health outcomes, a qualitative nuance present in the original answer. However, the described pricing and rebate strategies imply such alignment. All entities (LLY, AMGN, Repatha, insulin, 2022 filing), metrics (net/list price, rebates, NDCs), and context (payer restrictions, legislative risk) are correct. No numeric inaccuracies; dates and page references are consistent. Wording differs slightly but maintains semantic equivalence. Thus, the answer is factually excellent with only a slight gap in completeness regarding AMGN’s payer partnerships.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 453,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How do BAC and SCHW's approaches to meeting capital buffer requirements compare under the current regulatory framework where the Countercyclical Capital Buffer remains at zero?",
      "original_answer": "BAC applies a Stress Capital Buffer of 2.5% under the Standardized approach as of December 31, 2023, while SCHW's subsidiary CSB maintains a Capital Conservation Buffer of 2.5%. Both institutions benefit from the Federal Reserve's current setting of the Countercyclical Capital Buffer at zero, which reduces their overall capital requirements. However, BAC's capital strategy incorporates a G-SIB surcharge of 2.5% alongside its buffer requirements, whereas SCHW structures its capital to meet minimum ratios of 7.0%, 8.5%, and 10.5% for Common Equity Tier 1, Tier 1, and Total Risk-Based Capital respectively, inclusive of buffers.",
      "llm_answer": "Both Bank of America and Charles Schwab are operating with a zero Counter‑cyclical Capital Buffer, but each satisfies the remaining buffer requirements through other components. Bank of America adds a 2.5 % capital‑conservation (or stress) buffer and a 2.5 % G‑SIB surcharge to the 4.5 % CET1 minimum, posting CET1 ratios of roughly 12 %–13 % versus a 9.5 % regulatory floor (BAC 10‑K p.146). Charles Schwab meets its buffers with a 2.5 % stress‑capital buffer at the holding‑company level and a 2.5 % capital‑conservation buffer at its banking subsidiary, resulting in CET1 ratios of 24.5 % (CSC) and 37.9 % (CSB) well above the 7 % minimum (Schwab 10‑K p.122‑123).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that impact the correctness score, despite capturing the general context and structure of the question. (1) Quantitative Accuracy: The LLM incorrectly states that BAC applies a '2.5% capital-conservation (or stress) buffer'—the ground truth specifies a 'Stress Capital Buffer of 2.5%' under the Standardized approach, which is distinct from the Capital Conservation Buffer. Additionally, the LLM claims BAC has a '4.5% CET1 minimum' and combines it with buffers and G-SIB surcharge to reach a '9.5% regulatory floor', but this synthesis is not supported by the original answer, which does not specify BAC’s total minimum or derived regulatory floor. The LLM also fabricates CET1 ratios of '12%–13%' for BAC, which are not in the ground truth. For SCHW, the LLM states '2.5% stress-capital buffer at the holding-company level'—but the original answer only mentions CSB (the subsidiary) maintaining a 'Capital Conservation Buffer of 2.5%', with no mention of a stress-capital buffer at the holding level. The reported CET1 ratios of 24.5% (CSC) and 37.9% (CSB) are not in the ground truth and appear to be fabricated. (2) Completeness: The LLM addresses the zero countercyclical buffer and attempts to compare both firms’ capital strategies, which is good, but introduces unverified details and omits key points from the original—specifically, SCHW’s stated minimum ratios of 7.0%, 8.5%, and 10.5% for CET1, Tier 1, and Total Risk-Based Capital, inclusive of buffers. (3) Entity Accuracy: The companies (BAC, SCHW, CSB) and regulatory concepts (G-SIB surcharge, buffers) are correctly identified. The date (December 31, 2023) is missing from the LLM answer but implied contextually. (4) Reasoning: The multi-hop reasoning is partially sound—linking zero countercyclical buffer to reduced requirements and differentiating BAC’s G-SIB surcharge from SCHW’s structure—but the synthesis is undermined by incorrect numerical claims and misattribution of buffer types. (5) Semantic Equivalence: While the overall intent and direction of comparison match, the inclusion of fabricated metrics and mischaracterization of buffer types reduces factual equivalence. The answer is contextually relevant and structured well, but numerical inaccuracies significantly reduce correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 616,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How does Southern Company's investment in solar facilities, which are connected to power purchase agreements (PPAs), compare with Duke Energy's reliance on PPAs in terms of renewable energy facility financing strategies and tax credit utilization timelines?",
      "original_answer": "Southern Company has approximately $1.2 billion of unutilized federal ITCs and PTCs as of December 31, 2021, which are expected to be fully utilized by 2024, and uses tax equity partnerships for solar and wind projects where the tax partner captures most of the federal tax benefits. These solar facilities are connected to PPAs that are accounted for as operating leases with remaining terms of up to 25 years. In contrast, Duke Energy negotiates PPAs as part of its commercial renewables strategy and enters into tax equity arrangements to finance renewable assets eligible for tax credits. Duke's PPAs significantly impact the economic performance of its renewable facilities, and Duke is the primary beneficiary of these VIEs due to its control over siting, PPA negotiation, and operations. The connection between Southern Company's solar investments and PPAs, and Duke's PPA-driven renewable financing, reveals differing approaches to leveraging long-term contracts and tax incentives in renewable energy development.",
      "llm_answer": "Southern Company’s solar projects are largely funded through long‑term PPAs that are treated as operating leases (up to 25‑year terms) and are paired with tax‑equity partnerships that capture the Investment Tax Credit; the company disclosed roughly $1.2 billion of un‑used ITCs/PTCs that it expects to exhaust by 2024 (see pages 96 & 97, 268). By contrast, Duke Energy finances its renewable assets through non‑consolidated VIEs and tax‑equity arrangements that include guarantees for debt service, but its filing does not specify a tax‑credit utilization schedule, indicating a more project‑by‑project, VIE‑driven approach rather than a PPA‑centric one (see pages 203 & 204).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: Southern Company's $1.2 billion in unutilized ITCs/PTCs as of December 31, 2021, and expected utilization by 2024 are accurately reported. The 25-year PPA lease terms are also correctly stated. (2) The LLM correctly identifies Southern Company’s use of tax equity partnerships where tax benefits are captured by the partner, and that its solar facilities are financed via PPAs structured as operating leases. It also correctly notes Duke Energy’s use of VIEs and tax equity arrangements, and that Duke acts as primary beneficiary due to control over siting, PPA negotiation, and operations—though this last point is implied via 'VIE-driven approach' rather than explicitly stated. (3) The multi-hop reasoning is sound: the model synthesizes financing mechanisms (PPAs, tax equity), accounting treatment (operating leases, VIEs), and tax credit utilization timelines across both companies. The only minor gap is that the LLM states Duke’s filing 'does not specify a tax-credit utilization schedule,' which is accurate but slightly understates the ground truth point that Duke’s PPAs 'significantly impact economic performance'—a qualitative insight not fully reflected. However, the core contrast—Southern’s PPA-and-tax-equity model vs. Duke’s VIE-and-tax-equity model—is correctly drawn. (4) Wording differs but semantic meaning is equivalent. Number formats are acceptable ($1.2 billion). No factual errors. One point deducted from qualitative accuracy for slight underrepresentation of Duke’s PPA economic impact, but overall reasoning and contextual relevance are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 461,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How might the automatic conversion of Class B shares to Class A shares upon transfer at Google, combined with Comcast's non-dilutable Class B voting structure, influence investor sentiment toward Meta's dual-class governance model that grants disproportionate voting control to its founder?",
      "original_answer": "Google's Class B shares automatically convert to Class A shares upon transfer, reducing long-term concentration of voting power. In contrast, Comcast's Class B shares retain 33 1/3% of voting power and are non-dilutable, preserving control. Meta's governance risks highlight concerns that its dual-class structure could make Class A stock less attractive to investors. When considering these three elements together, the contrast in how voting power is preserved or diluted across these companies may shape investor perceptions of governance fairness and control concentration, particularly in Meta's case where founder control remains strong despite lower ownership percentages.",
      "llm_answer": "Alphabet’s charter lets any Class B share be converted at the holder’s option and forces an automatic conversion to Class A whenever the share is sold or transferred, so voting power erodes over time (Alphabet 10‑K p. 81). Comcast, by contrast, protects a 33 % voting block for its Class B shares that cannot be diluted by new issuances (Comcast 10‑K p. 91), illustrating that a fixed, non‑dilutable voting stake can be accepted but also signals permanent concentration of control. Because Meta’s dual‑class structure gives its founder ten votes per Class B share and does not provide an automatic conversion mechanism—concentrating voting power and making the Class A stock potentially less attractive (Meta 10‑K p. 49)—investors may view Meta’s governance as more entrenched and therefore view its stock less favorably compared with the safeguards seen at Google and the protected but transparent voting arrangement at Comcast.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Google's Class B shares convert automatically upon transfer (citing Alphabet 10-K p.81), reducing long-term voting concentration; Comcast's Class B shares retain 33 1/3% voting power and are non-dilutable (citing Comcast 10-K p.91); Meta’s dual-class structure gives founders 10 votes per share with no automatic conversion (citing Meta 10-K p.49), preserving founder control. The percentage '33%' in the LLM answer is a correct approximation of '33 1/3%'—a minor rounding acceptable under semantic equivalence. (2) Quantitative accuracy is perfect: no calculations required, but percentages and voting rights are correctly reported. (3) Multi-hop reasoning is sound: the answer synthesizes governance mechanisms across three companies (Google/Alphabet, Comcast, Meta), contrasts their treatment of voting power dilution, and draws a logical conclusion about investor sentiment toward Meta’s more entrenched structure. (4) Contextual relevance is high: the response directly addresses how Google’s erosion of voting power and Comcast’s protected but transparent block influence perceptions of Meta’s model. Wording differs slightly but meaning is preserved and enhanced with specific citation details. No factual errors, omissions, or misinterpretations.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 379,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "Given CVS's launch of Cordavis to co-produce biosimilars with pharmaceutical manufacturers, and UnitedHealth's (UNH) $12.5 billion in rebates receivable from those same manufacturers, how might the increased market availability of lower-cost biosimilars impact UNH's rebate structure and revenue recognition timing, considering rebates are based on product utilization and contract terms?",
      "original_answer": "CVS launched Cordavis to work directly with pharmaceutical manufacturers to commercialize and/or co-produce high-quality biosimilar products, aiming to increase market access and reduce costs. This initiative could increase the utilization of biosimilars, which are typically less expensive than branded biologics. UnitedHealth (UNH) has $12.5 billion in rebates receivable from pharmaceutical manufacturers as of December 31, 2024, which are accrued monthly based on utilization, historical data, and contract terms. Since rebates are influenced by the volume and type of products used, a shift toward greater biosimilar adoption could reduce the rebate amounts negotiated by manufacturers, especially if biosimilars are priced lower and displace branded drugs. Additionally, changes in utilization patterns may affect the timing and predictability of rebate collections for UNH, as lower-cost biosimilars may alter the dynamics of rebate accruals and payment cycles outlined in manufacturer contracts.",
      "llm_answer": "CVS’s Cordavis subsidiary is intended to “provide broader access to biosimilars in the U.S. … lead to lower costs and higher savings for our clients” (CVS 10‑K p. 12). UnitedHealth’s 10‑K notes that it “accrues rebates as they are earned … on a monthly basis … based on the terms of the applicable contracts, historical data and current estimates” and that it “generally receives rebates two to five months after billing” (UNH 10‑K p. 50). Consequently, as more low‑cost biosimilars enter the market, UnitedHealth’s rebate calculations are likely to shift – per‑prescription rebate rates may fall because of lower list‑prices, but higher biosimilar utilization could increase volume‑based rebates and prompt renegotiation of contract terms. The monthly accrual model means that any acceleration in biosimilar use would cause the related rebate reductions to cost of products sold to be recognized sooner (still with the 2‑5‑month receipt lag), while the total rebate dollar amount could decline if overall drug spend drops.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: CVS's Cordavis aims to expand biosimilar access and lower costs (citing CVS 10-K p.12), and UNH accrues rebates monthly with a 2–5 month collection lag (citing UNH 10-K p.50). The $12.5 billion rebate receivable from the ground truth is not explicitly mentioned in the LLM answer, but the omission does not distort the reasoning, as the focus is on the structural impact rather than the specific dollar figure. (2) Quantitative accuracy is strong: no incorrect numbers are presented, and the timing of rebate accruals and collections (monthly accrual, 2–5 month lag) matches the source. (3) Multi-hop reasoning is sound: the model correctly links CVS’s biosimilar expansion to potential shifts in drug utilization, which affects UNH’s rebate structure through lower per-unit rebates (due to lower list prices) but possibly higher volume-based rebates. It also correctly infers that faster adoption would accelerate recognition of rebate impacts in financial statements, even with the payment lag. (4) The answer captures the core dynamics—impact on rebate rates, volume, contract renegotiation, and timing of revenue recognition—mirroring the ground truth’s logic. The only minor shortcoming is the lack of explicit mention of the $12.5 billion receivable, which slightly reduces completeness but does not impair the overall correctness. Wording differences are semantically equivalent and acceptable.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1567,
        "completion_tokens": 414,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How might the SEC's Regulation Best Interest, which requires broker-dealers to act in the best interest of retail consumers, influence Goldman Sachs' compliance costs and competitive positioning against Morgan Stanley, given their differing approaches to consumer protection regulations and retail client expansion?",
      "original_answer": "Goldman Sachs faces increased compliance costs due to consumer protection regulations like Regulation Best Interest, which applies to its consumer-oriented activities, including transaction banking and retail client services. The MET_10k_2024.pdf evidence shows that Regulation Best Interest imposes conduct standards on broker-dealers when recommending securities, including variable insurance products, and that state-level extensions could allow private litigation, increasing legal exposure. Meanwhile, Morgan Stanley's 2024 10-K acknowledges intense competition in the U.S. and globally, particularly from firms offering similar products and services to retail and institutional clients, and notes that some competitors may operate under less stringent regulatory regimes. This suggests that while both firms are subject to Regulation Best Interest, Morgan Stanley may have a more established retail client infrastructure, giving it a competitive edge in adapting to the regulation with lower incremental costs compared to Goldman Sachs, which is expanding in this space and facing higher compliance investments.",
      "llm_answer": "Goldman Sachs warns that the SEC’s Regulation Best Interest adds “additional legal requirements…such as Regulation Best Interest” and could make it “more costly to provide and distribute our products and services” and increase litigation risk (GS 10‑K p. 20, 61). Morgan Stanley, by contrast, emphasizes its wealth‑management push into retail investors and the competitive pressure to win retail clients (MS 10‑K p. 23‑25). Thus, the extra compliance and litigation costs tied to RBI are likely to raise Goldman Sachs’s operating expenses and put it at a relative cost disadvantage versus Morgan Stanley’s retail‑client expansion strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Regulation Best Interest increases compliance costs and litigation risk for Goldman Sachs, citing specific page references (p. 20, 61) from the GS 10-K, which matches the original answer's emphasis on legal exposure and higher compliance costs. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no errors in numbers, dates, or calculations. (3) The multi-hop reasoning is sound: it connects Goldman Sachs’ regulatory cost burden under RBI with Morgan Stanley’s retail expansion strategy, correctly inferring a relative cost disadvantage. The original answer notes Morgan Stanley’s more established retail infrastructure leading to lower incremental compliance costs, which the LLM captures semantically by highlighting MS’s focus on retail clients and competitive positioning. (4) The only minor gap is that the LLM does not explicitly mention state-level extensions enabling private litigation (a nuance in the original), nor does it directly state that some competitors may operate under less stringent regimes as per Morgan Stanley’s 10-K. However, the core synthesis—Goldman facing higher relative costs due to RBI while Morgan Stanley is more entrenched in retail—is correct. Wording differs slightly but meaning is preserved. Thus, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning with only a slight omission of a supporting detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 432,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How does the voting power distribution tied to CMCSA's Class A and Class B common stock structure compare with GOOGL's approach to Class B common stock in terms of concentrated control, given that CMCSA's Class B stock carries 15 votes per share and GOOGL's Class B stock carries 10 votes per share?",
      "original_answer": "CMCSA's Class A and Class B common stock structure allocates 66 2/3% of the combined voting power to Class A shares held broadly, while the Class B shares, which carry 15 votes per share and are entirely owned by Brian L. Roberts, control the remaining 33 1/3% of voting power. In contrast, GOOGL's Class B common stock carries 10 votes per share, and although the company also maintains a dual-class structure, the voting power distribution is not explicitly quantified in the evidence provided. However, GOOGL's Class B shares can be converted to Class A shares upon sale or transfer, which could potentially dilute concentrated control over time—unlike CMCSA’s Class B shares, which are non-dilutable.",
      "llm_answer": "CMCSA’s capital structure gives its single Class B holder, Brian L. Roberts, a disproportionate voting block – each Class B share carries 15 votes and together the Class B shares represent about one‑third (33 ⅓ %) of the company’s total voting power, while Class A shares hold the remaining two‑thirds【page_31†L13-L20】. Alphabet’s (GOOGL) structure also concentrates voting power in a small group of insiders: each Class B share is entitled to 10 votes per share【page_82†L5-L7】, providing outsized influence relative to its one‑vote Class A shares, though the filing does not spell out the exact percentage held. Thus, both companies use dual‑class stock to concentrate control, but CMCSA’s Class B shares carry a higher vote‑per‑share weight (15 vs. 10) and are explicitly held by a single individual.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: CMCSA's Class B shares carry 15 votes per share and hold 33 1/3% of voting power, with Class A holding 66 2/3% (implied by 'two-thirds'), and GOOGL's Class B shares carry 10 votes per share—both match the original answer. (2) The answer correctly notes that the exact voting power distribution for GOOGL is not provided in the evidence, which is consistent with the ground truth. (3) The multi-hop reasoning is sound: it compares both companies' dual-class structures, highlights the higher vote-per-share in CMCSA (15 vs. 10), identifies concentrated control in both, and correctly names Brian L. Roberts as the sole holder of CMCSA’s Class B shares. (4) One minor omission: the LLM does not mention that GOOGL’s Class B shares can be converted to Class A upon sale or transfer, which introduces a potential dilution mechanism absent in CMCSA’s non-dilutable structure. This limits completeness slightly, but the core comparison on concentrated control and vote weight is accurate and well-reasoned. Wording differences are semantically equivalent and acceptable.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 332,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How does the increase in illicit trade prevalence in Turkey, which negatively impacted PM's cigarette volume growth, compare to PG's exposure to Turkey's foreign exchange volatility, and what does this reveal about the dual operational risks each company faces in the same market?",
      "original_answer": "PM reported that Turkey's cigarette market grew by 8.2%, primarily due to the easing of pandemic restrictions and increased tourism, but this growth was partially offset by a higher estimated prevalence of illicit trade. This illicit trade directly impacts PM's market dynamics by reducing legitimate sales volume and potentially eroding brand loyalty. Meanwhile, PG disclosed that Turkey is one of several countries where it faces significant foreign exchange exposure, with currency fluctuations having historically impacted its net sales, costs, and earnings. Given Turkey's economic instability, PG's exposure includes both transaction and translation risks that affect margins and cash flows. Together, these facts highlight that while PM is grappling with illicit trade undermining its cigarette sales in Turkey, PG is simultaneously facing financial risks from the country's volatile currency, illustrating how different types of market-specific risks—operational and financial—can concurrently challenge multinational corporations in the same geopolitical environment.",
      "llm_answer": "PM notes that Turkey’s market grew 8.2 % in 2022 but that “the higher estimated prevalence of illicit trade” partially offset that growth and weighed on its cigarette‑volume performance (PM page 56). In contrast, P&G flags Turkey as one of the countries where “significant exchange‑rate fluctuations” have created translation and transaction‑currency exposure that hurt net sales, costs and earnings (PG page 23). Together, the two disclosures show that the same market poses a product‑level risk for PMI (illicit trade cutting legal sales) and a macro‑financial risk for P&G (currency volatility eroding profitability), underscoring the dual operational challenges firms can face in Turkey.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 8.2% market growth in Turkey and attributes it to PM's reporting, aligning with the ground truth. It accurately notes that illicit trade partially offset this growth and negatively impacted PM's cigarette volume. For PG, it correctly states that Turkey presents significant foreign exchange exposure due to exchange-rate fluctuations, affecting net sales, costs, and earnings—consistent with the original answer. All key facts are present and factually accurate. (2) Quantitatively, the 8.2% figure is correct and properly attributed. No calculations are required, but the comparison between the two companies’ exposures is logically sound. Number formats and references (e.g., page numbers) are appropriately included and do not affect accuracy. (3) The multi-hop reasoning is strong: the model synthesizes information from two different companies (PM and PG), identifies distinct risk types (illicit trade vs. currency volatility), and draws a valid conclusion about dual operational challenges in the same market. The only minor shortcoming is the use of 'PMI' in parentheses when the question and original answer refer to 'PM'—though PMI (Philip Morris International) is contextually correct, it introduces a slight inconsistency in entity naming. (4) The answer is highly relevant, directly addressing the comparison of risks and what they reveal about dual operational challenges. The semantic meaning fully matches the ground truth, with only negligible variation in terminology. Thus, the answer earns a 9/10 for correctness due to excellent factual accuracy, completeness, and reasoning, with near-perfect qualitative execution.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 462,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How does JPMorgan's approach to identifying and managing transition risk compare to Bank of America's exposure to reputational risk in the context of their climate-related commitments, particularly given JPM's Firmwide Climate Risk Framework and BAC's $1.5 trillion sustainable finance goal?",
      "original_answer": "JPMorgan addresses transition risk through its Firmwide Climate Risk Framework, which includes setting policies, developing metrics and stress testing mechanisms, and establishing a climate risk data strategy to assess financial impacts. This structured approach is designed to integrate climate risk considerations across its business lines. In contrast, Bank of America identifies reputational risk as a potential consequence of failing to meet its climate-related commitments, such as its $1.5 trillion sustainable finance goal, which includes $1 trillion dedicated to supporting the transition to a low-carbon economy. While both institutions recognize climate risk broadly, JPMorgan emphasizes proactive identification and scenario-based analysis of transition risks, whereas BAC focuses on reputational risk mitigation tied to its public climate goals and stakeholder expectations.",
      "llm_answer": "JPMorgan tackles transition risk through a dedicated Climate Risk Management function that establishes a Firmwide Climate Risk Framework, sets policies, metrics and stress‑testing scenarios, and integrates oversight of the risk into its board‑level committees and three‑lines‑of‑defense structure【page_148】. Bank of America, by contrast, faces reputational risk tied to its $1.5 trillion sustainable‑finance goal – if it falls short of that commitment, negative public perception could damage the firm – and it mitigates this exposure with formal reputational‑risk monitoring, governance oversight and communication processes【page_83】【page_82】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all figures are correct: JPMorgan's Firmwide Climate Risk Framework and Bank of America's $1.5 trillion sustainable finance goal (including the $1 trillion low-carbon component, though not explicitly broken down in the LLM answer) are accurately referenced. The dollar amount ($1.5 trillion) matches the original answer. (2) The LLM correctly identifies JPMorgan’s structured approach to transition risk via policies, metrics, stress testing, and governance integration, including board-level oversight and the three-lines-of-defense model—details not in the ground truth but consistent with and enriching the original. (3) For Bank of America, the LLM accurately links reputational risk to the $1.5 trillion goal and describes mitigation through monitoring, governance, and communication, which is semantically equivalent to the original’s focus on stakeholder expectations and public commitments. (4) The multi-hop reasoning is sound: the model contrasts JPMorgan’s proactive, framework-driven transition risk management with BAC’s reputational risk exposure tied to goal achievement, correctly synthesizing across both firms’ climate strategies. The only minor shortcoming is that the LLM does not explicitly mention the $1 trillion subset of BAC’s goal dedicated to the low-carbon transition, which is included in the original answer—this is a small omission but does not undermine the core accuracy. Wording differs but meaning is preserved. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 450,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How does the timing of Microsoft's revenue recognition for hardware sales, which combines hardware and software as a single performance obligation, align with Cisco's average loan receivable terms for financing hardware purchases, and what is Cisco's total credit loss allowance for these financing arrangements as of July 29, 2023?",
      "original_answer": "Microsoft recognizes revenue for hardware sales at the point in time when ownership is transferred to resellers or end customers, treating the hardware and software as a single performance obligation. Cisco offers loan receivables with average terms of one to three years to finance hardware purchases. As of July 29, 2023, Cisco's total credit loss allowance for financing arrangements, including loan and lease receivables, was $72 million.",
      "llm_answer": "Microsoft records revenue for hardware + software bundles at the point in time ownership is transferred to the reseller or end‑customer (i.e., a point‑in‑time recognition). Cisco’s financing of hardware is provided through loan receivables that carry average terms of 1 to 3 years, extending well beyond the moment of sale. As of July 29 2023, Cisco’s total credit‑loss allowance for these financing receivables (loan + lease) was $72 million.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: Microsoft recognizes revenue for hardware-software bundles at the point in time when ownership transfers, which aligns with the original answer. Cisco's loan receivables have average terms of 1 to 3 years, correctly reported. The credit loss allowance as of July 29, 2023, is accurately stated as $72 million. (2) Quantitative elements—date (July 29, 2023) and dollar amount ($72 million)—are correct, with acceptable formatting (e.g., $72 million vs $72M). No calculations were required. (3) Multi-hop reasoning is sound: the answer correctly synthesizes Microsoft's revenue recognition timing with Cisco's financing terms and credit loss allowance, drawing from two distinct company disclosures. (4) The response is contextually precise, directly addressing all three components of the question without extraneous information. Wording differences (e.g., 'point in time' vs 'point-in-time recognition') do not affect factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 301,
        "total_tokens": 1569
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How might potential delays in FAA certification of Gulfstream's G700 aircraft impact FedEx's compliance costs under ICAO's 2028 production cutoff for non-compliant aircraft, given FedEx's reliance on fuel-efficient fleets to manage CORSIA obligations?",
      "original_answer": "Delays in FAA certification of Gulfstream's G700 aircraft could limit FedEx’s ability to acquire newer, more fuel-efficient aircraft before the 2028 cutoff date for non-compliant models, potentially increasing FedEx’s CORSIA compliance costs. FedEx noted in its 2023 10-K that its CORSIA-related expenses depend on factors including the fuel efficiency of its fleet and the availability of qualifying sustainable aviation fuels. Gulfstream’s 2023 inventory ramp-up for the G700 was explicitly tied to FAA certification timing, meaning a delay could slow the introduction of next-generation aircraft into FedEx’s fleet. This would prolong the use of older, less-efficient aircraft, increasing the company’s carbon offset or allowance purchase obligations under CORSIA and ETS, especially as free allowances are phased out by 2026.",
      "llm_answer": "A delay in FAA certification of the G700 would keep FedEx from adding the aircraft’s advanced fuel‑efficiency to its fleet, forcing it to rely longer on older, less‑efficient jets that may fall short of the ICAO 2017 emissions standards applied to any aircraft delivered after the Jan 1 2028 production cutoff. Because FedEx’s CORSIA‑cost model hinges on fleet fuel‑efficiency, the continued use of non‑compliant aircraft would raise the amount of carbon offsets, sustainable‑fuel purchases or emissions allowances it must acquire, increasing its compliance expenses【page 71】【page 18】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the 2028 ICAO production cutoff, the link between FAA certification delays and G700 availability, FedEx's reliance on fuel efficiency for CORSIA compliance, and the implication of increased offset/allowance costs. The mention of 'Jan 1 2028' is a minor but acceptable precision not contradicted by the original. (2) Quantitative accuracy is perfect: no incorrect numbers, dates (2028 cutoff, implied 2023 context), or financial figures. The answer correctly references regulatory thresholds without introducing false metrics. (3) Multi-hop reasoning is sound: it connects FAA certification → G700 delivery → fleet modernization → fuel efficiency → CORSIA compliance costs, synthesizing implications across regulatory (ICAO, CORSIA), corporate (FedEx), and manufacturing (Gulfstream) domains. The original also notes free allowances phase out by 2026, which the LLM omits, slightly weakening the completeness of the compliance cost explanation—hence not a perfect 10. (4) The answer is contextually excellent, directly addressing the question’s core concern about certification delays impacting compliance costs, and cites relevant pages (71, 18), indicating proper grounding. Only the omission of the 2026 free allowance phaseout—a secondary but relevant detail—prevents full qualitative and correctness scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 390,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How does the voting power distribution tied to Class A and Class B common stock at CMCSA compare to the voting rights structure of Class A and Class B common stock at GOOGL, particularly in terms of the per-share voting ratio?",
      "original_answer": "At CMCSA, Class A common stockholders hold 66 2/3% of the combined voting power, with each share of Class A common stock receiving a variable number of votes depending on the outstanding shares, while each share of Class B common stock has 15 votes and collectively holds 33 1/3% of the voting power. In contrast, at GOOGL, each share of Class A common stock has 1 vote, and each share of Class B common stock has 10 votes, though the specific ownership percentages of each class are not disclosed. This indicates that CMCSA's structure grants significantly more voting weight to Class B shares compared to GOOGL's 10:1 ratio.",
      "llm_answer": "Comcast’s capital structure gives each Class B share 15 votes while a Class A share carries one vote, so Class A holders own roughly two‑thirds (≈66 %) of the total voting power and Class B about one‑third (≈33 %) (CMCSA p. 33). Alphabet’s structure provides one vote per Class A share and ten votes per Class B share, creating a 10‑to‑1 voting weight for Class B relative to Class A (GOOGL p. 81). Thus, Comcast’s Class B shares have a higher per‑share voting ratio (15:1) than Alphabet’s (10:1).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all numbers are correct: CMCSA Class B shares have 15 votes per share, Class A has 1 vote per share (implied by context), with voting power distributed at approximately 66 2/3% to Class A and 33 1/3% to Class B. GOOGL’s structure correctly states 1 vote for Class A and 10 votes for Class B, with a 10:1 ratio. These match the ground truth exactly. (2) The comparison of per-share voting ratios (15:1 vs 10:1) is accurate and correctly concludes that CMCSA’s Class B shares have greater per-share voting weight. (3) The reasoning is sound: it synthesizes voting rights across two companies (CMCSA and GOOGL), compares their dual-class structures, and draws a valid conclusion about relative voting power. (4) Minor omission: the original answer notes that CMCSA Class A voting power is variable depending on outstanding shares, which the LLM simplifies to 'one vote' per Class A share. While functionally accurate in outcome (Class A collectively holds ~66.7%), this slightly oversimplifies the mechanism—Class A votes are not fixed per share but allocated to achieve the 66 2/3% total. This nuance is missing but does not invalidate the overall correctness. Wording differences (e.g., '≈66%' vs '66 2/3%') are semantically equivalent. All entities (CMCSA, GOOGL, Class A/B stock) are correctly identified. The answer fully addresses the question about per-share voting ratios and comparative structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 415,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA compare to GOOGL's dual-class structure, particularly in terms of the relative influence of holders of Class B shares?",
      "original_answer": "At CMCSA, holders of Class B common stock (owned entirely by Brian L. Roberts) have 15 votes per share and represent 33 1/3% of the combined voting power, while Class A common stockholders hold 66 2/3% of the voting power. In contrast, at GOOGL, Class B common stockholders have 10 votes per share, and upon conversion, these shares convert to Class A common stock, which has only one vote per share. This means that while both companies use a dual-class structure to concentrate voting power among certain shareholders, CMCSA’s Class B shares carry more per-share voting weight (15 votes vs. 10 votes) and are non-dilutable, giving the holder a fixed minority voting control compared to GOOGL’s structure, which allows for more fluidity through conversion.",
      "llm_answer": "Comcast’s single Class B share carries 15 votes per share and, because it is the only Class B share outstanding, it represents about one‑third (33.3 %) of the combined voting power of the company’s common stock【page_33】. Alphabet’s dual‑class system gives each Class B share ten votes versus one vote for Class A (and none for Class C), concentrating voting control in the hands of insiders, but the Class B shares account for a smaller proportion of total voting power than Comcast’s 33 % (the exact percentage isn’t disclosed)【page_81】. Both structures grant disproportionate influence to Class B holders, though Comcast’s lone Class B share translates into a larger slice of overall voting power.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that CMCSA's Class B stock has 15 votes per share and represents 33 1/3% of voting power, matching the ground truth. It accurately states that GOOGL's Class B shares have 10 votes per share versus 1 for Class A, which is correct. However, the LLM notes that 'the exact percentage [of GOOGL Class B voting power] isn’t disclosed,' whereas the ground truth does not require this percentage for comparison — instead, the key point is the structural difference in conversion and dilution. The LLM omits the critical detail that GOOGL’s Class B shares can convert to Class A, which affects long-term voting control fluidity, a key differentiator emphasized in the original answer. (2) All numeric values — 15 votes, 10 votes, 33.3% — are accurate and correctly attributed. There are no calculation errors. Format variations (e.g., '33.3%' vs '33 1/3%') are acceptable and semantically equivalent. (3) The multi-hop reasoning is mostly sound: the model compares voting rights across two companies and correctly synthesizes that both use dual-class structures to concentrate power. However, it fails to fully address the structural implications of convertibility in GOOGL’s case versus the non-dilutable, fixed control in CMCSA’s structure, which is central to the original answer’s comparative insight. (4) The answer is contextually relevant and well-supported with citations. While it captures the core quantitative comparison and relative influence, the omission of the conversion mechanism in GOOGL reduces the depth of qualitative analysis, preventing a top score. Overall, the answer is factually strong but slightly incomplete on structural nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 462,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How does the FDA approval timeline for BMY's Zeposia in ulcerative colitis compare with the regulatory milestone achieved by MRK for Welireg in von Hippel-Lindau disease, and what were the respective impacts on each company's 2021 oncology and immunology portfolios?",
      "original_answer": "BMY received FDA approval for Zeposia in May 2021 for the treatment of moderately to severely active ulcerative colitis (UC), based on the Phase III True North trial, which demonstrated its efficacy and led to expanded market access in immunology. In contrast, MRK received FDA approval for Welireg (belzutifan) in August 2021 for the treatment of von Hippel-Lindau (VHL) disease, marking a key oncology milestone. The approval of Zeposia contributed to BMY's immunology pipeline growth, while Welireg's approval led to a $50 million milestone payment to former Peloton shareholders and positioned MRK more strongly in the oncology space with a novel HIF-2α inhibitor.",
      "llm_answer": "Zeposia was cleared by the FDA for ulcerative colitis in May 2021 (see the May 2021 FDA‑approval entry for Zeposia on page 93), whereas Merck’s Welireg (belzutifan) received its first FDA approval in August 2021 (the August 2021 U.S. approval is noted on page 52 and reinforced by the August‑2021 milestone description on page 101). The Zeposia approval added a new immunology product to BMS’s 2021 portfolio, while Welireg’s approval expanded Merck’s 2021 oncology portfolio with a first‑in‑class therapy for von Hippel‑Lindau disease.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Zeposia received FDA approval in May 2021 for ulcerative colitis, and Welireg (belzutifan) was approved in August 2021 for von Hippel-Lindau disease—both dates and indications match the original answer. (2) Quantitative accuracy is perfect: no numerical errors; dates are correctly cited (May 2021 vs. August 2021), and no incorrect figures are introduced. (3) The reasoning is sound: the LLM correctly identifies that Zeposia expanded BMS’s (BMY) immunology portfolio, while Welireg marked a first-in-class oncology approval for Merck (MRK), reinforcing its oncology positioning. (4) The only minor omission is that the original answer includes the $50 million milestone payment to former Peloton shareholders and notes the True North trial as the basis for approval—details not included in the LLM response. While this adds context, it does not undermine the core correctness. The LLM uses 'BMS' instead of 'BMY', but this is a commonly accepted synonym (Bristol-Myers Squibb). Semantic equivalence is maintained, and the multi-hop synthesis—comparing timelines and portfolio impacts across two companies and therapeutic areas—is logically executed. Thus, the answer is factually complete and contextually appropriate, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 373,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does the vesting period structure for restricted stock at EMR compare to the vesting requirements in the multiemployer pension plans that UPS contributes to, given the differences in funding risk and benefit delivery mechanisms?",
      "original_answer": "EMR applies cliff vesting periods ranging from three to ten years for restricted stock awards, with compensation expense recognized ratably over these periods. In contrast, UPS contributes to multiemployer pension plans where vesting periods are defined by collective bargaining agreements and are tied to retirement, death, or termination benefits. These plans are subject to shared funding risks, where assets contributed by one employer may be used to fund benefits for employees of other employers, and UPS may face additional liabilities such as withdrawal liability or surcharge contributions if plans enter critical status. This highlights a fundamental difference in both the structure and risk exposure of vesting mechanisms between EMR’s equity-based compensation and UPS’s pension obligations.",
      "llm_answer": "EMR’s equity awards vest on a fixed, company‑determined schedule – restricted‑stock awards “cliff‑vest at the end of service periods ranging from three to ten years” and RSUs “cliff‑vest after a three‑year period” (EMR 10‑K p. 72). UPS’s multi‑employer pension plans, however, vest according to the collective‑bargaining agreements that set eligibility and service‑based vesting rules, and the employer’s contributions are subject to plan‑wide funding risk because assets are pooled across participating employers and benefits are delivered as defined‑benefit payments from the plan trust (UPS 10‑K p. 106‑110).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all details are correct: EMR's cliff vesting periods of 3 to 10 years for restricted stock and 3 years for RSUs match the original answer’s range (3–10 years), and the citation to EMR’s 10-K p.72 supports this. UPS’s vesting via collective bargaining agreements and plan-wide funding risks are correctly described, with accurate reference to UPS 10-K pp.106–110. (2) The answer addresses all parts of the multi-hop question: it compares EMR’s equity-based vesting structure with UPS’s pension plan vesting, highlights differences in funding risk (pooled assets, shared liability), and touches on benefit delivery mechanisms (defined-benefit payments from trust). (3) Multi-hop reasoning is sound—correctly synthesizing data from two companies’ 10-Ks and contrasting equity compensation vs. multiemployer pension structures. (4) Minor deduction in qualitative accuracy because the LLM does not explicitly mention UPS’s potential withdrawal liability or surcharge contributions in critical status (a key risk in the original answer), but otherwise captures the core contrast in risk exposure. Wording differs slightly but maintains semantic equivalence. Contextual relevance is perfect—directly responsive and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 366,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does NFLX's exposure to data privacy risks under the Communications Act compare to CMCSA's regulatory obligations under the same Act, particularly in terms of potential financial penalties and operational constraints related to handling personal information?",
      "original_answer": "NFLX faces potential financial penalties and reputational damage due to unauthorized data breaches involving member personal information, including billing data, which could result in material costs and regulatory fines without insurance coverage. CMCSA, being subject to the Communications Act, must comply with privacy and data protection restrictions that govern the collection, use, and disclosure of personal information, which could lead to legal consequences if violated. Both companies are exposed to regulatory scrutiny and potential penalties under the Communications Act, though NFLX lacks insurance to mitigate such risks, whereas CMCSA’s obligations are framed within a broader regulatory compliance framework that includes audits and potential changes in law.",
      "llm_answer": "NFLX notes that the Communications Act (along with GDPR, CPRA and other privacy statutes) makes it vulnerable to investigations, claims and possible fines if it mishandles member data, but its filing does not detail specific penalty amounts and frames the risk mainly as reputational and legal exposure. In contrast, CMCSA’s 10‑K spells out concrete privacy duties imposed by the Communications Act—such as protecting customer‑proprietary network information, complying with FCC rules on E911, number‑portability and data‑retention—and warns that failure can trigger administrative enforcement, civil or criminal fines and other remedial actions, creating clear operational constraints on its handling of personal information.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that NFLX faces legal and reputational risks under the Communications Act and other privacy laws due to potential mishandling of member data, particularly noting the absence of specific penalty amounts in its filing—consistent with the original answer's emphasis on material costs and lack of insurance coverage. CMCSA’s obligations are accurately described as concrete regulatory duties under the Communications Act, including FCC rules on E911, number portability, and data retention, with clear consequences for noncompliance such as administrative enforcement and civil/criminal fines. (2) There are no numeric values or calculations in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is sound: the model correctly contrasts NFLX’s general risk exposure with CMCSA’s specific, operationally binding obligations under the same Act, synthesizing information across both companies’ regulatory postures. (4) The LLM captures the core distinction: NFLX’s exposure is framed around potential penalties and reputational harm without mitigation via insurance, while CMCSA operates under a structured compliance regime with enforceable constraints. The only minor shortcoming is that the LLM does not explicitly mention CMCSA’s potential exposure to audits or changes in law as part of its broader compliance framework, a nuance present in the original answer. However, this omission does not undermine the overall correctness. Semantic equivalence is maintained, and the response is fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 462,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does the commercialization of Platform 5 nicotine pouches in Sweden by PM compare to CCEP's role as a bottler for KO in the same market, particularly in terms of their respective market entry strategies and product dependencies?",
      "original_answer": "Coca-Cola Europacific Partners (CCEP) serves as a key bottler for The Coca-Cola Company (KO) in Sweden, handling the distribution of Coca-Cola trademark beverages under contractual agreements that require CCEP to purchase concentrates from KO. In 2021, KO's five largest bottlers, including CCEP, represented 41% of KO’s total worldwide unit case volume. Meanwhile, Philip Morris International (PM) launched its Platform 5 nicotine pouch product in Sweden in January 2022 under the Shiro brand, following the acquisition of AG Snus. This launch represents a direct market entry strategy by PM, contrasting with CCEP’s role as a contracted third-party distributor for KO, where product supply is dependent on KO’s concentrate pricing and availability. Both companies operate in Sweden, but PM’s strategy involves direct product innovation and brand acquisition, while CCEP relies on KO for product inputs and brand authorization.",
      "llm_answer": "PM entered Sweden by directly launching its reformulated Platform 5 nicotine‑pouch (the Shiro brand) in January 2022, using a market‑specific rollout that emphasizes retail trials, digital engagement and e‑commerce and that relies on PM’s own pharmaceutical‑grade nicotine, flavors and pouch technology (PM 10‑K pp. 45‑46). In contrast, CCEP’s role in Sweden is that of an independent Coca‑Cola bottler that distributes finished beverages under a bottling agreement, purchasing Coca‑Cola concentrates and syrups from the Company and therefore depends on Coca‑Cola’s brand and concentrate supply rather than creating a new product category (KO 10‑K pp. 7 and 6‑8).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: PM launched Platform 5 (Shiro brand) in Sweden in January 2022, following the acquisition of AG Snus (implied by 'reformulated' and context), and CCEP operates as a bottler for KO under contractual agreements. The dependency on KO for concentrates and PM’s direct innovation strategy are correctly contrasted. (2) Quantitative accuracy is perfect: the date January 2022 is correct; no percentages or financial figures are misstated. The LLM does not include the 41% figure from the original answer (KO’s five largest bottlers representing 41% of unit case volume), which is a minor omission but not critical to the core comparison asked. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across PM and KO’s 10-Ks, distinguishing between PM’s direct market entry via product launch and brand acquisition versus CCEP’s third-party distribution role dependent on KO’s inputs. (4) Semantic equivalence is strong—wording differs but meaning matches. The LLM adds contextual detail (e.g., retail trials, digital engagement, e-commerce, pharmaceutical-grade nicotine) not in the original but supported by typical 10-K disclosures and consistent with the strategic contrast. These enhancements do not introduce inaccuracies. The only reason for not scoring 10 is the omission of the 41% statistic, which provides context on CCEP’s importance but is not central to the comparison of market entry strategies and product dependencies. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 446,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does the 8% decline in UNH's Medicare Part D enrollment from 2023 to 2024 interact with the IRA's manufacturer discount requirements and reinsurance shifts to assess CVS's financial exposure under its Medicare Advantage contracts?",
      "original_answer": "The 8% decline in UNH's Medicare Part D enrollment from 3,315,000 in 2023 to 3,050,000 in 2024 suggests a reduction in the number of Part D beneficiaries served by UNH, which may reflect broader market adjustments under the IRA's redesign of Medicare Part D. The IRA introduced significant changes, including capping beneficiary out-of-pocket costs and reducing Federal reinsurance in the catastrophic phase starting January 1, 2025, which shifts more financial responsibility to Part D plans and manufacturers through required manufacturer discounts. For CVS, this creates a dual exposure: first, as a provider of Medicare Advantage plans, it must manage the financial risk associated with the reduced reinsurance and increased member cost-sharing volatility; second, the IRA's rebate mechanism, which Amgen began accruing for in 2022, introduces further pricing pressures that may impact the pharmacy benefit manager's (PBM) drug acquisition costs and rebate negotiations. Thus, the enrollment decline at UNH, combined with the IRA's structural changes and Amgen's experience with manufacturer discounts, collectively signal a complex risk environment for CVS under its Medicare contracts.",
      "llm_answer": "UnitedHealth’s 2024 filing shows its stand‑alone Medicare Part D membership fell from 3,315 thousand in 2023 to 3,050 thousand in 2024 – a ≈ 8 % decline 【page_31†L31-L35】.  The Inflation‑Reduction Act, however, now forces manufacturers to provide additional discounts on Part D drugs and, beginning 1 Jan 2025, reduces federal catastrophic reinsurance, shifting those costs to the Part D sponsor (including Medicare‑Advantage plans) 【page_17†L1-L5】.  For CVS, the smaller enrollee base modestly dampens the total discount‑related outlay, but the per‑member cost pressure from the IRA‑mandated discounts and the loss of reinsurance – combined with CVS’s disclosed exposure to Medicare‑Advantage funding cuts and contract‑rate volatility 【page_42†L1-L8】【page_38†L1-L4】 – means its financial exposure under its Medicare‑Advantage contracts remains elevated despite the enrollment drop.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: UNH's Medicare Part D enrollment declined from 3,315,000 (3,315 thousand) in 2023 to 3,050,000 (3,050 thousand) in 2024, which is an 8% decline—correctly calculated and reported. The date of January 1, 2025, for the IRA reinsurance changes is accurate. (2) The LLM correctly identifies the IRA’s manufacturer discount requirements and the shift in catastrophic reinsurance responsibility to Part D sponsors, including Medicare Advantage plans. It accurately links this to CVS’s financial exposure. (3) The reasoning is sound: while the enrollment decline slightly reduces total exposure, per-member cost pressures increase due to IRA mandates, and the LLM supports this with references to CVS’s own disclosures about Medicare Advantage funding cuts and rate volatility (citing pages 42 and 38), which adds contextual depth not explicitly in the original answer but consistent with the multi-hop logic. (4) The only minor gap is that the LLM does not mention Amgen’s rebate accrual experience, which the original answer uses as a supporting example of manufacturer discount impacts. However, this omission does not undermine the core financial exposure analysis for CVS. The LLM instead focuses on CVS’s direct exposure, which remains contextually appropriate. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with only a slight reduction in breadth of supporting evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1540,
        "completion_tokens": 423,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How does Southern Company's use of cost recovery mechanisms for environmental remediation at its natural gas utilities compare to Duke Energy's financial exposure from environmental remediation liabilities, given the differences in their regulatory and liability frameworks?",
      "original_answer": "Southern Company utilizes cost recovery mechanisms approved by state regulatory agencies to recover environmental remediation costs at its natural gas distribution utilities, allowing it to pass on prudently-incurred expenses—including those related to infrastructure replacement and environmental cleanup—to customers through regulated rates. In contrast, Duke Energy faces environmental remediation liabilities at various current and former sites, with $X million (hypothetical placeholder based on typical reporting) in reserves for probable and estimable costs, but without guaranteed regulatory recovery, meaning these costs are often expensed directly as operational expenses unless recovery is deemed probable. While Southern Company benefits from structured cost recovery riders, Duke Energy must manage uncertain future costs without assured cost pass-through, leading to greater financial exposure.",
      "llm_answer": "Southern Company’s natural‑gas utilities can pass remediation costs through state‑PSC‑approved cost‑recovery riders that are added to customer rates, so environmental‑remediation expenses are largely recoverable (see Note 2 on Southern Company Gas, p. 22). Duke Energy, on the other hand, carries $73 million of remediation reserves and expenses the costs as incurred, with any recovery uncertain and subject to joint‑and‑several liability, strict‑liability and insurance arrangements, exposing it to direct financial risk (see remediation‑reserve table, p. 163).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Southern Company uses state regulatory-approved cost recovery mechanisms (riders) to pass environmental remediation costs to customers, citing a specific note and page for support. This matches the original answer's emphasis on structured, recoverable cost treatment. (2) For Duke Energy, the LLM provides a specific dollar amount—$73 million—for remediation reserves, which is a concrete figure not present in the hypothetical placeholder ($X million) in the ground truth. Assuming this number is drawn from actual filing data (e.g., Duke’s 10-K), its inclusion improves precision over the placeholder. The explanation that Duke expenses costs as incurred and faces uncertain recovery due to joint-and-several liability and strict liability frameworks adds important legal and financial context absent in the original but factually consistent. (3) The multi-hop reasoning is sound: the model contrasts Southern’s regulated, recoverable cost structure with Duke’s direct financial exposure, correctly synthesizing differences in regulatory frameworks and financial treatment. (4) Minor deduction in quantitative accuracy only because the ground truth uses a placeholder ($X million), making full verification of $73M impossible from the provided data—but since the LLM cites a source (p. 163), it suggests fidelity to real document evidence. Overall, the answer is semantically equivalent, contextually rich, and factually robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 420,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "What is the combined total of securities remaining available for future issuance under equity compensation plans approved by security holders for Caterpillar and Johnson & Johnson, and how does this compare to 3M's total available securities under similar plans?",
      "original_answer": "The combined total of securities remaining available for future issuance under equity compensation plans approved by security holders for Caterpillar (40,873,176) and Johnson & Johnson (111,042,139) is 151,915,315. This is significantly higher than 3M's total of 39,563,000 available securities under the same category.",
      "llm_answer": "Caterpillar reports 40,873,176 securities still available under its shareholder‑approved equity plans and Johnson & Johnson reports 111,042,139 such securities, for a combined total of 151,915,315 shares.  By contrast, 3M’s equity‑compensation plans approved by security holders have only 39,563 shares remaining available (3M page 116).  Thus the Caterpillar‑J&J total is roughly 152 million shares, dwarfing 3M’s roughly 40 thousand‑share pool.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Caterpillar's available securities (40,873,176) and Johnson & Johnson's (111,042,139), and accurately calculates their combined total (151,915,315). However, it incorrectly reports 3M's available securities as 39,563 instead of 39,563,000 — this is a critical error that changes the magnitude by a factor of 1,000. The original answer correctly states 3M's figure as 39,563,000, making the Caterpillar-J&J total significantly higher. The LLM's version erroneously implies 3M has only 39,563 shares, which drastically distorts the comparison. (2) Numeric values for Caterpillar and J&J are correct; the sum is accurate. 3M’s number is off by three orders of magnitude, and the characterization of 3M’s pool as '40 thousand' instead of '40 million' is factually wrong. (3) The multi-hop reasoning — combining two companies’ totals and comparing to a third — is logically sound and properly structured. The synthesis across entities is appropriate, but the faulty input for 3M undermines the conclusion. (4) Contextual relevance is high — the answer addresses all parts of the question and follows the correct structure. However, the quantitative inaccuracy in 3M’s figure severely impacts the correctness score, as it leads to a misleading comparison despite otherwise strong reasoning and structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 374,
        "total_tokens": 1594
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How do Merck's Januvia and Janumet U.S. market exclusivity expiration timelines (May 2026) and IRA-imposed pricing constraints compare to Pfizer's regulatory exclusivity strategy, and what does this indicate about their respective post-2025 revenue protection mechanisms?",
      "original_answer": "Merck’s Januvia and Janumet are set to lose U.S. market exclusivity in May 2026 due to patent settlements and court rulings, with Janumet XR following in July 2026. Despite this, the IRA mandates government price-setting for Januvia starting in 2026 and for Janumet/Janumet XR in 2027, adding pricing pressure. In contrast, Pfizer relies on both patent rights and concurrent regulatory exclusivity periods upon drug approval to protect revenue beyond patent terms. This indicates that Merck is managing near-term exclusivity erosion through price adjustments and rebate reductions, while Pfizer’s strategy emphasizes regulatory exclusivity as a parallel shield alongside patents, suggesting divergent approaches to post-2025 revenue sustainability.",
      "llm_answer": "Merck’s flagship diabetes drugs will keep U.S. market exclusivity only until May 2026 for Januvia (and July 2026 for Janumet XR) and, under the Inflation‑Reduction Act, a government‑set price will be imposed on Januvia on Jan 1 2026 and on Janumet on Jan 1 2027, sharply limiting any revenue shield after 2025【page_58】. By contrast, Pfizer relies on statutory regulatory exclusivity (5 years of data exclusivity for chemical drugs, 12 years for biologics plus orphan‑drug and pediatric extensions) that runs concurrently with its patents, many of which do not expire until the 2030s‑2040s (e.g., Comirnaty and Paxlovid through 2041)【page_13】【page_14】, indicating a far longer post‑2025 revenue‑protection horizon.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Merck's exclusivity expiration for Januvia in May 2026 and Janumet XR in July 2026, aligning with the ground truth. However, it incorrectly states that the IRA-imposed price for Januvia begins on January 1, 2026, whereas the ground truth specifies 2026 without a month/day—more critically, the original answer indicates Januvia is subject to pricing in 2026 and Janumet/Janumet XR in 2027, while the LLM answer assigns Janumet (not XR) to 2027, creating ambiguity and potential misalignment. (2) The LLM’s claim about Pfizer’s regulatory exclusivity (5 years for chemical drugs, 12 for biologics) is accurate and contextually relevant, and examples like Comirnaty and Paxlovid with patents into the 2040s are plausible and support the broader point. However, these specific patent expiration dates (e.g., 2041) are not in the ground truth and may be speculative or over-specified, though they do not contradict it. (3) The multi-hop reasoning is strong: the model contrasts Merck’s near-term exclusivity loss and pricing pressure under the IRA with Pfizer’s reliance on regulatory exclusivity as a parallel protection mechanism, correctly inferring divergent post-2025 revenue strategies. The synthesis across companies, timelines, and policy impacts is logically sound. (4) The answer is contextually excellent—directly addressing all parts of the question with relevant detail. The correctness score is 8 due to minor but notable inaccuracies in IRA implementation timing and drug-specific attribution (Janumet vs Janumet XR), which affect quantitative precision. Qualitative and contextual accuracy remain high due to strong reasoning and strategic comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 467,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How does the credit event risk associated with MS's investments in CLNs, which embed credit protection sold to issuers, compare to BAC's use of credit derivatives to mitigate commercial credit exposure, particularly in terms of how each firm manages counterparty risk through derivative instruments?",
      "original_answer": "Morgan Stanley (MS) invests in CLNs and CDOs, which are hybrid instruments containing embedded derivatives in which credit protection has been sold to the issuer of the note. If there is a credit event of a reference entity underlying the instrument, the principal balance of the note may not be repaid in full to the firm, indicating a direct exposure to counterparty risk. This contrasts with Bank of America (BAC), which actively purchases credit protection to cover both funded and unfunded portions of certain credit exposures as part of its commercial credit risk management strategy. BAC also uses credit derivatives to hedge risk, with changes in fair value recorded in other income. Both firms utilize credit derivatives, but MS assumes risk by investing in instruments where it has sold protection, while BAC mitigates risk by purchasing protection.",
      "llm_answer": "MS’s CLN investments expose the firm to a “credit‑event” loss of principal if the reference entity defaults – the credit protection is sold to the issuer, so the firm bears the residual credit‑event risk. To curb the counter‑party risk of those CDS‑type contracts, MS posts collateral, uses bilateral downgrade‑payment agreements and net‑ting arrangements and enforces aggregate market‑risk limits on its credit‑derivative book. Bank of America, by contrast, employs credit derivatives (both bought and sold protection) to hedge the credit risk of its funded and unfunded commercial loan commitments; the contracts are carried at fair value and are managed through active monitoring of loan‑exposure limits rather than explicit collateral or downgrade clauses. Thus MS leans on collateral and downgrade safeguards for CLN credit‑event risk, while BAC relies on derivative hedges and exposure‑monitoring to mitigate commercial credit risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Morgan Stanley (MS) invests in CLNs where it effectively sells credit protection, exposing it to credit-event risk if the reference entity defaults—this matches the original answer’s assertion of MS bearing direct counterparty risk. It contrasts this with Bank of America (BAC), which uses credit derivatives to purchase protection and hedge commercial credit exposure, accurately reflecting BAC’s risk-mitigation strategy. (2) There are no numeric values in the question or answers requiring verification; thus, quantitative accuracy is 10 as no numbers are misstated. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both firms use credit derivatives but in opposing directions—MS as a protection seller (risk taker), BAC as a protection buyer (risk mitigator). The LLM adds slightly more operational detail (e.g., collateral posting, netting, downgrade clauses for MS; fair value accounting and exposure monitoring for BAC) that are consistent with typical risk management practices and plausibly inferred from the context, though not explicitly detailed in the ground truth. These additions do not contradict but enrich the response. (4) The only minor gap is that the original answer explicitly notes BAC records changes in fair value in 'other income,' a detail omitted in the LLM response. However, the mention of fair value accounting is sufficient for semantic equivalence. All entities (MS, BAC, CLNs, credit derivatives) are correct, and the comparison logic is robust. Thus, the answer earns a 9 for correctness and qualitative accuracy due to this slight omission, but full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 480,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How does the indemnification structure established by 3M in connection with Solventum's spin-off compare to RTX's indemnification arrangements for its financial guarantees, particularly regarding the transfer of liability and the recognition of potential losses?",
      "original_answer": "3M transferred certain liabilities to Solventum as part of the spin-off, including those related to the Bair Hugger and Federal False Claims Act/Qui Tam Litigation, with Solventum assuming indemnification and defense obligations. 3M records liabilities for legal proceedings when probable and estimable, and discloses possible losses when not accrued. Similarly, RTX is subject to indemnification for certain liabilities under its financial guarantees, which could affect its financial exposure. Both companies recognize indemnification rights or obligations as part of their liability management, but 3M explicitly transferred liability to a spun-off entity, whereas RTX retains exposure subject to third-party indemnification terms. This distinction affects how each company accounts for contingent liabilities and insurance receivables under ASC 450 and ASC 610-30.",
      "llm_answer": "3M’s spin‑off agreement shifts the health‑care and PFAS liabilities to the new Solventum entity, and Solventum expressly indemnifies and defends 3M for those pre‑spin‑off matters (e.g., the Bair Hugger and False Claims Act claims) so that the risks are removed from 3M’s balance sheet【page_84】. RTX, by contrast, keeps its guarantee exposures on its own books; a portion of the third‑party guarantees is covered by indemnification from the counterparties, but RTX still records a liability and accrues for any probable, estimable loss (e.g., a $1 million liability for third‑party guarantees) rather than transferring the risk to another entity【page_102】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that 3M transferred liabilities (e.g., Bair Hugger and False Claims Act litigation) to Solventum, with Solventum assuming indemnification and defense obligations, effectively removing these risks from 3M’s balance sheet. This matches the original answer’s claim about liability transfer in the spin-off. (2) For RTX, the LLM correctly states that RTX retains guarantee exposures on its books, records liabilities for probable and estimable losses (citing a $1 million liability), and relies on third-party indemnifications without transferring risk—this is consistent with the ground truth. The $1 million figure is correctly attributed to RTX’s third-party guarantees per the source (page 102), and no other numbers are misstated. (3) The multi-hop reasoning is sound: the model contrasts 3M’s risk transfer via spin-off with RTX’s retention of liability despite indemnification rights, capturing the key distinction in accounting treatment and financial exposure. (4) The answer omits explicit mention of ASC 450 and ASC 610-30, which the original answer includes as part of the accounting framework for contingent liabilities and de-recognition. This is a minor gap in completeness but does not undermine the core factual or conceptual accuracy. Wording differs but semantic meaning is equivalent. Quantitative accuracy is perfect—$1 million is correctly cited and formatted. Contextual relevance is full, addressing both companies, the nature of indemnifications, liability transfer, and recognition of losses.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 441,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does the geographic revenue distribution of AMD in Taiwan compare to the potential supply chain risk NVIDIA faces through its foundry partners operating in the same region, given the geopolitical tensions mentioned in both companies' filings?",
      "original_answer": "AMD reported $1,841 million in sales to external customers from Taiwan in 2023, highlighting the region's significance in its revenue distribution. Meanwhile, NVIDIA explicitly states that its foundry partners—critical to its chipset supply—are primarily located in Taiwan, and a significant or prolonged geopolitical conflict involving China and Taiwan could severely limit or prevent NVIDIA from receiving chipset supply. This indicates that while Taiwan is a notable market for AMD's sales, it represents a core supply chain vulnerability for NVIDIA due to its dependency on foundry partners operating in the region.",
      "llm_answer": "AMD’s 2023 10‑K shows sales of $1.841 billion to customers in Taiwan – about 8 % of its total $22.68 billion revenue (AMD 10‑K 2023 p. 71). In NVIDIA’s filing, the company warns that its key foundry partners are concentrated in Taiwan and that “a significant or prolonged military or other geopolitical conflict involving China and Taiwan could severely limit or prevent us from receiving chipset supply from Taiwan,” creating a material supply‑chain risk (NVDA 10‑K 2023 p. 35).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the revenue figure for AMD in Taiwan is accurately reported as $1.841 billion (equivalent to $1,841 million), and the total revenue of $22.68 billion is correctly cited, allowing for the implied ~8% calculation, which is accurate. (2) The LLM correctly identifies that NVIDIA’s supply chain risk stems from its reliance on foundry partners in Taiwan and quotes the relevant risk disclosure from its 2023 10-K (page 35), matching the original answer’s key point about geopolitical risk disrupting chipset supply. (3) The multi-hop reasoning is sound: the model synthesizes AMD’s revenue exposure (market demand side) with NVIDIA’s supply-side vulnerability through foundry concentration in Taiwan, directly addressing the comparative aspect of the question. (4) All entities—AMD, NVIDIA, Taiwan, 2023 filings—are correctly identified, and the semantic content fully aligns with the ground truth. Minor additions (e.g., percentage of revenue, page numbers) enhance clarity without introducing error. No factual, numerical, or reasoning flaws are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 324,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does NEER's 15-year weighted average contract term for repowered wind facilities influence long-term revenue predictability, and how might this structural advantage compare to Southern Power's reliance on power sales agreements where specific contract terms are not disclosed?",
      "original_answer": "NEER benefits from a 15-year weighted average remaining contract term on its power sales agreements tied to repowered wind facilities, which enhances revenue predictability by locking in long-term pricing and output commitments. In contrast, Southern Power discloses its reliance on power sales agreements but does not specify contract durations, limiting visibility into its own revenue stability. This difference suggests NEER may have a more transparent and structured approach to securing long-term cash flows from renewable assets, which could influence investor confidence and financial planning strategies.",
      "llm_answer": "NEER’s portfolio shows a weighted‑average remaining contract term of roughly 15 years for its repowered wind assets (including the life of the associated production tax credits) 【page_13】, which locks in capacity and energy payments for a decade‑plus horizon and therefore makes its future cash flows far more predictable and insulated from short‑term market swings. By contrast, Southern Power’s revenue is driven by power‑sales agreements that are described only as “long‑term PPAs” without any disclosed term lengths 【page_81】【page_80】, so the durability of its cash‑flow stream is less transparent and more vulnerable to variability than NEER’s clearly defined, multi‑year contracts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 15-year weighted average remaining contract term for NEER's repowered wind facilities is correctly stated and matches the original answer. The format '15 years' is consistent and no calculations are required. (2) The LLM correctly identifies that Southern Power relies on long-term PPAs but does not disclose specific contract terms, which is factually correct and supported by the cited pages. (3) The multi-hop reasoning is sound: it synthesizes information about NEER’s disclosed contract duration and links it to revenue predictability, then contrasts it with Southern Power’s lack of transparency. The only minor shortcoming is that the LLM mentions the 15-year term includes 'the life of the associated production tax credits,' which adds a detail not present in the ground truth and could imply causation (i.e., that PTC duration defines the contract term), potentially conflating two related but distinct concepts. However, this does not materially distort the conclusion. (4) The answer is contextually relevant, directly addressing both parts of the question—NEER’s structural advantage and the comparative transparency with Southern Power. Overall, the semantic meaning and factual content are nearly identical to the original answer, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 382,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does RTX's revenue recognition practices under FAR guidelines for U.S. government fixed-price contracts compare to Honeywell's exposure to contract termination risks under the same regulatory framework?",
      "original_answer": "RTX recognizes revenue in excess of billings under U.S. government fixed-price contracts due to performance-based or progress payments that typically cover only 80-90% of costs incurred, creating contract assets. These practices are governed by the FAR, which outlines allowable costs and payment structures. Honeywell, also subject to the FAR, faces unique risks such as the U.S. government's right to terminate contracts for convenience, which could impact its contract assets or liabilities similarly structured. Both companies are bound by the same FAR-regulated payment and cost frameworks, but Honeywell's risk profile includes potential contract termination that could disrupt revenue already recognized under FAR-compliant accounting practices.",
      "llm_answer": "RTX follows FAR‑mandated accounting for its U.S. government fixed‑price work by treating the contracts as long‑term performance obligations, recognizing revenue over time on a percentage‑of‑completion basis and recording any excess of billings as contract assets (RTX p.79). Honeywell, by contrast, highlights that FAR gives the government the right to terminate contracts for convenience, exposing Honeywell to termination risk, possible loss of revenue and even suspension from future government awards (Honeywell p.35).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: RTX recognizes revenue under FAR using percentage-of-completion accounting, resulting in contract assets when revenue exceeds billings, which matches the original answer's description of progress payments covering 80-90% of costs. The citation of RTX p.79 supports this. Honeywell’s exposure to termination for convenience under FAR is correctly identified, including potential revenue loss and suspension from future awards (Honeywell p.35), which directly corresponds to the original answer’s emphasis on termination risk. (2) There are no numeric values requiring verification (e.g., percentages or dollar amounts), but the qualitative financial mechanisms described—such as revenue recognition timing and contract assets—are consistent with the ground truth. No calculation errors. (3) Multi-hop reasoning is sound: the model correctly synthesizes RTX’s revenue recognition practices and Honeywell’s termination risks under the same FAR framework, comparing two different aspects (accounting treatment vs. risk exposure) as required by the question. (4) The only minor shortcoming is that the LLM does not explicitly connect how termination risk could affect already-recognized revenue or contract assets—mentioned in the original answer—but this is implied in 'possible loss of revenue.' Otherwise, the answer is semantically equivalent, contextually precise, and entity-accurate with proper sourcing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 415,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does the absence of voting rights associated with Alphabet's Class C Capital Stock compare to Comcast's relinquishment of voting rights in Hulu, particularly in terms of governance control and financial outcomes?",
      "original_answer": "Alphabet's Class C Capital Stock has no voting rights except as required by law, which allows the company to maintain control through higher-vote Class A and Class B shares while repurchasing non-voting shares to optimize capital structure. In 2024, Alphabet had $44.7 billion remaining available for Class A and Class C share repurchases. In contrast, Comcast relinquished substantially all voting rights in Hulu in 2019, giving Disney full operational control, and exercised a put option in 2023 to sell its interest for a minimum equity value of $9.2 billion. This resulted in a $8.6 billion payment from Disney (net of $557 million for prior capital calls) and a recorded investment value of $883 million as of December 31, 2024. Both companies strategically managed voting rights to influence governance and financial returns, albeit through different mechanisms and outcomes.",
      "llm_answer": "Alphabet’s Class C capital stock carries no voting rights, but governance of Alphabet remains concentrated in its 10‑vote Class B shares and the certificate of incorporation guarantees that dividend and liquidation rights are identical across all classes, so the lack of voting does not affect the company’s financial outcomes【page_82】【page_84】. In contrast, Comcast voluntarily gave up its board seats and virtually all voting rights in Hulu, ceding operational control to Disney, yet retained a 33 % equity interest with put/call options that generated an $8.6‑$9.2 billion cash payment (and future tax benefits), showing a financial gain despite the loss of governance control【page_85】.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core contrast between Alphabet's structural governance design and Comcast's strategic relinquishment of control for financial gain. It accurately notes that Alphabet’s Class C shares have no voting rights and that governance is concentrated in Class B shares, while Comcast gave up voting rights and board seats in Hulu, transferring operational control to Disney. The financial outcome for Comcast is correctly framed around the $8.6–$9.2 billion range. However, there are minor quantitative inaccuracies: the ground truth specifies a minimum equity value of $9.2 billion and a net payment of $8.6 billion (after $557 million for prior capital calls), but the LLM presents $8.6–$9.2 billion as a range rather than a precise outcome with a defined minimum and actual net payment. Additionally, the LLM omits key details such as the $44.7 billion share repurchase authorization remaining for Alphabet in 2024 and the $883 million recorded investment value for Comcast as of December 31, 2024. (2) The numbers related to Comcast’s transaction are partially correct but lack precision—while $8.6 billion net payment is accurate, the presentation as a range ($8.6–$9.2 billion) misrepresents the structure: $9.2 billion was the minimum equity value, and $8.6 billion was the actual net cash received. The absence of the $44.7 billion repurchase capacity and the $883 million carrying value reduces quantitative completeness. (3) The multi-hop reasoning is strong: the model correctly synthesizes governance mechanisms (voting rights vs. equity retention) across two companies and links them to financial and control outcomes. It identifies that Alphabet retains control via share structure while optimizing capital, whereas Comcast traded control for financial returns. This reflects sound cross-document reasoning. (4) The contextual relevance is excellent—the response directly addresses governance control and financial outcomes as required. The qualitative accuracy is high due to correct entity identification (Alphabet, Comcast, Hulu, Disney), accurate characterization of voting rights structures, and logical comparison. The correctness score is 8 due to missing key financial figures and slight misrepresentation of the payment range, but the core reasoning and factual framework are solid.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 626,
        "total_tokens": 2036
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "Given LLY's ongoing challenges scaling production of incretin products while relying on third-party manufacturers, and TMO's $26.92 billion in remaining performance obligations—many tied to contract manufacturing over 3-5 year durations—how might shared vulnerabilities in quality assurance and supply chain execution affect both companies' ability to fulfill long-term commitments?",
      "original_answer": "LLY is experiencing intermittent supply delays for incretin products like Mounjaro and Zepbound, with tight supply expected to persist until additional manufacturing capacity becomes operational 'in the next several years.' These production constraints are tied to reliance on third-party manufacturers, which face quality assurance risks that could lead to regulatory actions, product recalls, or delays in approvals. Meanwhile, TMO has $26.92 billion in remaining performance obligations, with a significant portion linked to contract manufacturing agreements that typically span 3-5 years. If third-party manufacturers fail to maintain quality standards or encounter capacity limitations—as AMD also highlights in its 10-K—both companies could face fulfillment risks: LLY may struggle to meet patient demand amid supply volatility, while TMO could face delays or defaults on long-term manufacturing contracts, impacting revenue recognition and customer relationships.",
      "llm_answer": "Both Eli Lilly and Thermo Fisher rely heavily on external manufacturers, so any lapse in quality‑assurance, yield or delivery timing can ripple through their long‑term plans. Lilly’s “intermittent delays” in meeting strong demand for its incretin medicines and its limited control over third‑party capacity, yields and quality (LLY 10‑K p. 45 & p. 24) mean that supply shortages could delay product launches and erode customer relationships, while Thermo Fisher’s $26.92 billion of remaining performance obligations—most of which are tied to three‑to‑five‑year contract‑manufacturing commitments (TMO 10‑K p. 49)—could be jeopardized if those contract manufacturers experience similar quality or capacity problems, leading to missed revenue milestones, penalties and strained client contracts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: LLY's intermittent supply delays for incretin products (Mounjaro/Zepbound), reliance on third-party manufacturers with associated quality and capacity risks, and TMO's $26.92 billion in remaining performance obligations tied to 3-5 year contract manufacturing agreements are all accurately represented. The dollar amount ($26.92 billion) is exact and correctly attributed. (2) Quantitative accuracy is perfect—no calculations were required, and the single numeric value matches the original. (3) Multi-hop reasoning is sound: the model correctly synthesizes risks across LLY and TMO by identifying shared vulnerabilities in third-party manufacturing, including quality assurance, yield, and delivery timing, and logically connects these to potential impacts on customer relationships, revenue recognition, and contract fulfillment. The reference to AMD as an additional example (from the ground truth) is omitted but not required for correctness. (4) Semantic equivalence is strong—while the LLM uses slightly different phrasing (e.g., 'erode customer relationships' vs. 'impact customer relationships'), the meaning and factual content are consistent. One minor point: the ground truth emphasizes regulatory actions or recalls as potential outcomes of QA failures, which the LLM does not explicitly mention, slightly reducing qualitative completeness. However, this does not undermine the core accuracy. Overall, the response is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 434,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "What was the total cumulative impairment charge recognized by NextEra Energy Resources on its investment in XPLR as of December 31, 2024, and how does this compare to the carrying value of the investment before the 2024 impairment?",
      "original_answer": "As of December 31, 2024, NextEra Energy Resources had recognized a cumulative impairment charge of $2.0 billion on its investment in XPLR, combining the $1.2 billion impairment from September 30, 2023, and the $0.8 billion impairment from December 31, 2024. The carrying value of the investment before the 2024 impairment was approximately $2.6 billion, which was then written down to $1.8 billion after the 2024 impairment.",
      "llm_answer": "The 2024 filing shows that NextEra Energy Resources recorded a $0.8 billion impairment on XPLR in 2024 and had already taken a $1.2 billion impairment on the same investment in 2023, for a total cumulative impairment of roughly **$2.0 billion** as of December 31 2024【page_92】.  Before the 2024 write‑down, the XPLR equity‑method investment carried a balance of about **$2.6 billion**, so the cumulative impairments are about $0.6 billion less than that pre‑2024 carrying amount, leaving a post‑impairment value of roughly $1.8 billion【page_92】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the $0.8 billion 2024 impairment and $1.2 billion 2023 impairment sum to the correct cumulative total of $2.0 billion. The pre-2024 carrying value of $2.6 billion and post-impairment value of $1.8 billion are correctly stated. The calculation of the write-down ($2.6B - $0.8B = $1.8B) is implied and accurate. (2) The answer is complete, addressing both parts of the question: the total cumulative impairment as of December 31, 2024, and the comparison to the carrying value before the 2024 impairment. (3) Entities are correctly identified: NextEra Energy Resources, XPLR, and the relevant time periods (2023 and 2024) are accurate. (4) The reasoning is sound and demonstrates proper multi-hop synthesis by combining impairments across two years and relating the 2024 impairment to the carrying value before that charge. The semantic meaning is equivalent to the original answer, with only minor rephrasing. All criteria are met with high precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 305,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How does the adoption of ASU 2022-04 by GE impact its transparency around supplier finance obligations compared to MMM's disclosures under the same standard, particularly in terms of confirmed invoice balances and presentation in financial statements?",
      "original_answer": "GE adopted ASU 2022-04 on January 1, 2023, which requires retrospective disclosures for supplier finance programs, with the annual roll-forward information applicable prospectively starting January 1, 2024. This means GE began disclosing key terms, balance sheet presentation, and confirmed amounts outstanding from its supplier finance programs in 2024. Similarly, MMM discloses that as of December 31, 2024 and 2023, its outstanding balances of confirmed invoices under supplier finance programs were approximately $0.3 billion each, and these amounts are included within accounts payable on MMM's consolidated balance sheet. Both companies now provide clearer visibility into their supplier finance obligations under the new standard, with MMM specifically quantifying its confirmed invoice balances and their classification in accounts payable, aligning with the enhanced disclosure requirements introduced by ASU 2022-04.",
      "llm_answer": "GE says it adopted ASU 2022‑04 on 1 Jan 2023 and that the change “did not have a material impact on the Company’s consolidated financial statements” (see GE 10‑K p. 47) and its supply‑chain‑finance discussion (p. 46) does not break out a specific confirmed‑invoice balance – the obligations are simply treated as trade payables. In contrast, 3M’s Note 16, required by the same ASU, quantifies the program – reporting about $0.3 billion of confirmed invoices outstanding at year‑end 2024 and 2023 and stating that these amounts are included in accounts payable on the balance sheet (see MMM 10‑K p. 77), thereby providing a far more transparent disclosure of the size and presentation of its supplier‑finance obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: ASU 2022-04 adoption by GE on January 1, 2023, and MMM's confirmed invoice balances of $0.3 billion at year-end 2023 and 2024 are accurately reported. The format variation ($0.3 billion) is acceptable and matches the original. (2) The LLM correctly identifies that GE did not break out a specific confirmed invoice balance and treats obligations as trade payables, while MMM explicitly quantifies its balances in Note 16 and includes them in accounts payable—this matches the ground truth's emphasis on MMM’s more transparent disclosure. (3) The multi-hop reasoning is sound: the answer compares GE’s and MMM’s disclosures under the same standard, correctly noting differences in transparency despite both being subject to ASU 2022-04. It synthesizes information across both companies’ 10-Ks and correctly interprets the implications of the standard. (4) The only minor shortcoming is that the LLM does not explicitly mention that GE will begin providing roll-forward disclosures prospectively from January 1, 2024, which is part of the original answer. However, this omission does not undermine the core comparison about current transparency levels. Overall, the answer is factually correct, contextually relevant, and conveys the same key insight: MMM provides more transparent, quantified disclosures than GE under ASU 2022-04.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 401,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How does Altria's equity-method accounting for its Cronos investment expose it to financial risks tied to Cronos's compliance with FDA regulations, and how does this compare to Walmart's exposure through its pharmacy operations under the same regulatory framework?",
      "original_answer": "Altria's investment in Cronos is accounted for under the equity method, meaning its financial statements reflect Altria's share of Cronos's earnings or losses. Since Cronos operates in the cannabis-derived product space, it is subject to FDA regulations in the U.S., and any failure to comply could result in fines, penalties, or reputational harm, directly impacting Cronos's financial performance and, by extension, Altria's earnings. Walmart also faces exposure through its pharmacy operations, which must comply with FDA regulations governing the dispensing and sale of pharmaceuticals. Walmart notes that noncompliance could lead to significant sanctions and operational disruptions, mirroring the regulatory risk profile faced by Cronos. Both companies are thus financially exposed to the same regulatory framework, though through different business models and investment structures.",
      "llm_answer": "Altria’s 75 % equity‑method stake in Cronos means it records Cronos’s share of earnings and adjusts the carrying value of the investment each quarter (MO 10‑K p. 61). Because Cronos’s business is subject to U.S. FDA (and other) regulations, any FDA‑related enforcement, civil or criminal action could depress Cronos’s earnings or force an impairment charge, which would flow directly into Altria’s net income and equity (MO 10‑K p. 16).  \n\nWalmart’s exposure is operational: its U.S. pharmacy and health‑services units must comply with FDA (and DEA) licensing, labeling, dispensing and controlled‑substance rules, and non‑compliance could trigger fines, product recalls, loss of licenses or other sanctions that would hurt Walmart’s pharmacy margins and overall results (WMT 10‑K p. 25‑26).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 75% equity-method stake is correctly stated (per Altria's 10-K), and all referenced page numbers (MO 10-K p.61, p.16; WMT 10-K p.25-26) are consistent with actual disclosures. No monetary values or dates were misstated. (2) The answer correctly identifies that Altria’s financial exposure arises through equity-method accounting, where Cronos’s regulatory noncompliance could reduce earnings or trigger impairment, directly affecting Altria’s net income and equity—this matches the original answer’s logic. (3) For Walmart, the answer accurately describes operational exposure via pharmacy compliance with FDA and DEA regulations, including risks like fines, recalls, and license loss, which is semantically equivalent to the ground truth. (4) The multi-hop reasoning is sound: it synthesizes Altria’s investment accounting method with Cronos’s regulatory environment, and contrasts it with Walmart’s operational compliance risks under the same FDA framework. The only minor shortcoming is that the LLM answer does not explicitly state that both companies face exposure under the 'same regulatory framework' (FDA), though this is implied through parallel discussion. This slight omission in synthesis phrasing prevents a perfect 10, but overall the response is factually correct, well-sourced, and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 391,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How does LLY's reliance on Cardinal Health for U.S. distribution impact CVS's consolidated financial exposure to Red Oak Sourcing, given Cardinal's dual role in the joint venture?",
      "original_answer": "LLY depends on Cardinal Health for 15-20% of its U.S. revenue through distribution, which makes Cardinal a critical link in LLY's supply chain. Cardinal also co-owns Red Oak Sourcing with CVS, a generic pharmaceutical sourcing entity that CVS consolidates due to its primary beneficiary status. As part of the Red Oak arrangement, Cardinal makes quarterly payments to CVS (e.g., $183 million annually as of 2021), which reduce CVS's inventory costs. Therefore, any disruption in Cardinal's ability to distribute LLY products could affect Cardinal’s financial health, which in turn could impact its ability to meet its financial commitments to Red Oak—and consequently, CVS’s consolidated financial position.",
      "llm_answer": "Lilly reports that Cardinal Health accounts for roughly 15‑20 percent of its U.S. wholesale distribution (LLY 10‑K p. 7). CVS co‑owns Red Oak Sourcing with Cardinal and, as the primary beneficiary, consolidates the venture in its statements, but the quarterly payments Cardinal makes to the joint venture are described as immaterial (CVS 10‑K p. 138). Therefore, Lilly’s reliance on Cardinal for distribution does not materially enlarge CVS’s consolidated financial exposure to Red Oak beyond CVS’s 50 percent ownership stake.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "(1) The LLM answer contains partially correct facts but reaches a conclusion that contradicts the ground truth. It correctly identifies that LLY relies on Cardinal Health for 15-20% of its U.S. distribution (matching the original answer) and that CVS co-owns Red Oak Sourcing with Cardinal and consolidates it. However, the LLM claims that Cardinal's quarterly payments to Red Oak are 'immaterial' based on the CVS 10-K, which directly contradicts the ground truth stating these payments were $183 million annually as of 2021—a significant amount. This mischaracterization leads to an incorrect conclusion about financial exposure. (2) Quantitatively, the 15-20% figure is accurate and matches the ground truth. However, the LLM fails to report the $183 million annual payment from Cardinal to Red Oak, which is a key financial figure in assessing CVS's exposure. The omission or dismissal of this number as immaterial undermines the quantitative completeness. (3) The multi-hop reasoning is flawed: while the model identifies the relationships (LLY → Cardinal distribution; CVS-Cardinal → Red Oak JV), it fails to synthesize the causal chain: disruption to Cardinal’s role in LLY distribution → potential impact on Cardinal’s financial health → risk to its ability to make $183M/year payments to Red Oak → negative effect on CVS’s consolidated financials. Instead, the LLM dismisses the linkage due to 'immateriality,' breaking the logical chain present in the ground truth. (4) Contextually, the answer addresses the entities and structure of the relationships, so it is relevant, but the critical error in qualitative reasoning and omission of a major financial commitment results in a substantially incorrect overall assessment. The conclusion that there is no material increase in CVS's exposure is not supported by the evidence in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 499,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How does Oracle's use of its $6.0 billion commercial paper program for short-term financing compare to Cisco's debt structure, particularly in light of Cisco's $13.5 billion senior fixed-rate note issuance and the pari passu ranking of those notes with commercial paper obligations?",
      "original_answer": "Oracle utilizes a $6.0 billion commercial paper program for short-term financing, with $401 million in outstanding notes as of May 31, 2024, which mature through August 2024. These notes are unsecured and issued under a private placement exemption. In contrast, Cisco issued $13.5 billion in senior fixed-rate notes in February 2024, which are redeemable at any time with a makewhole premium and are ranked at par with Cisco’s own commercial paper obligations. This indicates that while both companies use commercial paper as part of their short-term financing strategies, Cisco has a significantly larger long-term debt component through its senior notes, which are hedged via interest rate swaps to manage interest rate exposure.",
      "llm_answer": "Oracle relies on a relatively modest $6 billion commercial‑paper program to fund short‑term needs, issuing unsecured CP notes that totaled $401 million at May 31 2024 and using the proceeds for general corporate purposes【page_90】. Its senior notes are expressly “pari‑passu with all existing and future notes issued pursuant to our commercial paper program”【page_89】.  \n\nCisco, by contrast, maintains a much larger CP facility of up to $15 billion (with $10.9 billion outstanding as of July 27 2024) that also funds general corporate purposes【page_88】, and it complemented this with a $13.5 billion senior fixed‑rate note issuance in February 2024. Those senior notes “rank at par with the commercial paper notes” issued under its short‑term program, giving Cisco’s senior debt the same seniority as its CP obligations【page_89】.  \n\nThus, while both companies give their senior notes equal seniority to CP, Cisco’s debt structure is larger and includes a substantial senior‑note issuance alongside a far bigger CP program than Oracle’s.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly impact correctness, particularly in quantitative details. (1) It incorrectly states that Cisco has a $15 billion commercial paper (CP) facility with $10.9 billion outstanding as of July 27, 2024—this is not supported by the ground truth, which does not mention the size of Cisco’s CP program or any outstanding balance; the original answer only discusses Cisco’s $13.5 billion senior note issuance. This is a major error. (2) The LLM claims Oracle’s senior notes are pari passu with its CP program, but the ground truth does not state this for Oracle—only that Oracle issues unsecured commercial paper under a private placement; the pari passu language applies to Cisco, not Oracle. This misattribution undermines the comparison. (3) The ground truth states that Cisco’s senior notes are redeemable with a makewhole premium and hedged via interest rate swaps—information missing from the LLM answer, reducing completeness. (4) While the LLM correctly identifies Oracle’s $6.0 billion CP program and $401 million outstanding as of May 31, 2024, and correctly notes Cisco’s $13.5 billion February 2024 issuance and pari passu ranking with CP, the erroneous addition of Cisco’s CP size and Oracle’s pari passu status introduces significant inaccuracies. (5) The reasoning structure is sound—comparing short-term and long-term debt structures and seniority—and the answer is contextually relevant, synthesizing across entities. However, the incorrect numerical claims and misattribution of financial terms reduce quantitative and qualitative accuracy. Semantic equivalence fails on key points due to fabricated data.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 457,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How does Duke Energy's reliance on wind energy in its Commercial Renewables segment compare with Southern Company's strategic commitment to the Skookumchuck wind project, given the 136 MW nameplate capacity and 20-year PPA term associated with Skookumchuck?",
      "original_answer": "Duke Energy's Commercial Renewables segment relies on wind as one of several generation sources, alongside solar, fuel cells, and batteries, but does not disclose specific capacity figures for wind. In contrast, Southern Company's Skookumchuck wind project has a defined 136 MW nameplate capacity and is supported by a 20-year PPA, indicating a concrete long-term commitment to wind energy in a specific geographic location (Lewis and Thurston Counties, WA). While both companies are engaged in wind energy, Southern's detailed disclosure around capacity and contract duration provides clearer evidence of a targeted wind strategy compared to Duke's broader renewable portfolio approach.",
      "llm_answer": "Duke Energy’s Commercial Renewables segment leans on wind as a core resource, operating 23 wind facilities that together form a sizable share of its 3,554 MW renewable portfolio across 22 states【page_21】. In contrast, Southern Company’s wind strategy is anchored on a single, dedicated project—Skookumchuck—a 136 MW wind farm secured by a 20‑year power‑purchase agreement, reflecting a focused, long‑term commitment to that specific asset【page_330】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) QUANTITATIVE INACCURACY: The LLM claims Duke Energy operates 23 wind facilities and has a 3,554 MW renewable portfolio, but the ground truth states that Duke does not disclose specific wind capacity—making these figures fabricated or misattributed. There is no support in the original answer for any numerical breakdown of Duke's wind assets. (2) COMPLETENESS: While the answer addresses both companies and the Skookumchuck project, it fails to accurately contrast Duke’s lack of disclosed wind-specific data with Southern’s concrete commitments. Instead, it falsely presents Duke’s wind operations as quantifiable and substantial. (3) ENTITY & REASONING ERROR: The core multi-hop reasoning is flawed—Duke’s approach is described as having a 'sizable share' of wind in its portfolio, which contradicts the ground truth that Duke treats wind as one of several sources without specificity. This misrepresents the nature of the comparison. (4) SEMANTIC NON-EQUIVALENCE: The LLM implies Duke has a significant, measurable wind footprint, while the original answer emphasizes the absence of such disclosures, making the strategic contrast opposite in meaning. The Skookumchuck details (136 MW, 20-year PPA) are correctly stated, but the synthesis fails due to incorrect portrayal of Duke. Thus, despite correct mention of Southern Company's project terms and contextual relevance to the question’s structure, the answer is factually incorrect on key points, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 431,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How does the capital buffer requirement structure under the Advanced Approach for MS compare with SCHW's requirements, given the role of the Countercyclical Capital Buffer which is currently set at zero by the Federal Reserve?",
      "original_answer": "Morgan Stanley's (MS) capital buffer requirement under the Advanced Approach includes a fixed 2.5% Capital Conservation Buffer, a G-SIB capital surcharge, and the Countercyclical Capital Buffer (CCyB), which is currently set at zero by the Federal Reserve. Schwab (SCHW) is also subject to the same CCyB, which was zero as of December 31, 2023, and must maintain a 2.5% Capital Conservation Buffer. Therefore, both firms have identical Capital Conservation Buffer percentages and are influenced by the same CCyB policy, though SCHW is not subject to the G-SIB surcharge that applies to systemically important institutions like MS.",
      "llm_answer": "Under the Advanced Approach, Morgan Stanley’s buffer is built from a 2.5 % capital‑conservation buffer + a 3.0 % G‑SIB surcharge + a 0 % counter‑cyclical buffer, giving a total requirement of 5.5 % of CET1 above the regulatory minimum. Charles Schwab, which is not a G‑SIB, only carries a 2.5 % capital‑conservation (or stress) buffer and a 0 % counter‑cyclical buffer, so its total buffer is 2.5 % above the minimum. Both firms have the CCyB set at zero, but MS’s Advanced‑Approach buffer is larger because it includes the G‑SIB surcharge.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: both MS and SCHW have a 2.5% Capital Conservation Buffer and are subject to a 0% Countercyclical Capital Buffer (CCyB), with the CCyB set at zero by the Federal Reserve. MS, as a G-SIB, faces an additional G-SIB surcharge (stated as 3.0%, which is plausible and consistent with public expectations, though the exact surcharge level is not specified in the ground truth). SCHW is correctly identified as not being subject to the G-SIB surcharge. (2) Quantitative accuracy is excellent: the 2.5% buffer for SCHW and the 5.5% total for MS (2.5% + 3.0%) are mathematically correct and clearly explained. While the ground truth does not specify the exact G-SIB surcharge percentage, the LLM’s inclusion of 3.0% is reasonable and within expected ranges for MS; this does not constitute a factual error given the context. (3) Multi-hop reasoning is sound: the model correctly synthesizes that both firms share the same CCyB and Conservation Buffer, but differ due to G-SIB status. (4) The only minor limitation is that the LLM adds a specific G-SIB surcharge value (3.0%) not present in the ground truth, which could be seen as overprecision, but it does not contradict known facts and supports correct comparative analysis. Overall, the answer is factually solid, contextually relevant, and semantically equivalent to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 398,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does Disney's use of discounted cash flow models for valuing Level 2 derivatives compare to Meta's application of the same models in assessing impairment losses on operating lease assets, given Disney's $383 million impairment charge in fiscal 2024?",
      "original_answer": "Disney utilizes internal discounted cash flow models with observable inputs like interest rates and foreign exchange rates to value its Level 2 derivatives, ensuring fair value estimates remain accurate and counterparty risk is mitigated. Meanwhile, Meta applies discounted cash flow models with Level 3 inputs—such as projected sublease income and downtime assumptions—to estimate the fair value of impaired operating lease assets, which led to a $383 million impairment charge in 2024. While both companies use discounted cash flow techniques, Disney applies them in a Level 2 fair value context for derivatives, whereas Meta uses them in a Level 3 context for non-recurring asset impairments.",
      "llm_answer": "Disney values its Level 2 derivatives with internal discounted‑cash‑flow (DCF) models that rely on observable market inputs such as interest‑rate curves, yields and foreign‑exchange rates (DIS p. 119). Meta, by contrast, uses DCF models to estimate the fair value of operating‑lease right‑of‑use assets and leasehold improvements for impairment testing, but those models depend on Level 3, unobservable assumptions – e.g., expected downtime, projected sublease cash flows and risk‑adjusted discount rates – and produced a $383 million impairment charge for FY 2024 (META p. 98). Thus Disney’s DCF valuations are based on observable inputs for derivative fair‑value measurement, whereas Meta’s DCF valuations are based on unobservable, management‑driven inputs for impairment assessment.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $383 million impairment charge in fiscal 2024 is accurately reported and correctly attributed to Meta, not Disney—this is a key detail that the LLM correctly interprets (the original question's phrasing could mislead one to assign the charge to Disney, but the ground truth and LLM clarify it belongs to Meta). (2) The LLM correctly identifies that Disney uses discounted cash flow (DCF) models with Level 2 inputs (observable: interest rates, FX rates) for valuing derivatives, citing appropriate context (DIS p.119). (3) It accurately states that Meta uses DCF models with Level 3 inputs (unobservable: sublease income, downtime, risk-adjusted discount rates) for impairment testing of operating lease assets, resulting in the $383M charge (META p.98). (4) The multi-hop reasoning—comparing two companies' use of DCF models across different accounting contexts (derivatives vs. lease impairments) and different fair value hierarchy levels (Level 2 vs. Level 3)—is sound and well-articulated. (5) The semantic content is equivalent to the ground truth, with enhanced clarity in specifying 'risk-adjusted discount rates' and 'right-of-use assets', which are consistent with GAAP and the filings. No factual, numerical, or conceptual errors are present. All entities, years, and financial concepts are accurate and correctly synthesized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 396,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does the 8.2% increase in Turkey's total tobacco market volume, partly offset by higher illicit trade prevalence, impact PM's market share dynamics, and how does this compare to MO's exposure to illicit trade risks in the broader context of their respective tobacco businesses?",
      "original_answer": "PM's shipments in Turkey increased to 55.7 billion units in 2021 from 47.5 billion in 2020, contributing to a rise in its market share from 41.3% to 44.8%. This growth was partly offset by a higher estimated prevalence of illicit trade in Turkey, which negatively impacts legitimate sales and tax revenues. Similarly, MO highlights that illicit trade in tobacco products, including counterfeit goods and untaxed sales, adversely affects its business by reducing lawful sales and potentially triggering regulatory actions. While PM directly benefits from increased volume in Turkey despite illicit trade, MO emphasizes the broader systemic risks illicit trade poses to the tobacco industry, including brand dilution and loss of tax revenues that could lead to stricter regulations.",
      "llm_answer": "The 8.2 % rise in Turkey’s total tobacco market (PM 10‑K p. 56) helped PMI lift its shipment volume in Turkey by 17.2 % (PM 10‑K p. 57), which in turn raised its Middle‑East & Africa regional market‑share by roughly 1.1 percentage point despite the offset from a higher illicit‑trade prevalence. Altria, by contrast, flags illicit trade only as a systemic risk to its business (MO 10‑K pp. 40‑42), noting that counterfeit and untaxed sales can erode volume, tax revenues and trigger stricter regulation, but it does not cite a comparable market‑size boost or offset as PMI experiences in Turkey.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in numbers and misattributes data. While the 8.2% increase in Turkey's total tobacco market is mentioned in the PM 10-K (p.56), the LLM claims PMI's shipment volume increased by 17.2%, which is a miscalculation: the actual shipment rise was from 47.5B to 55.7B units, a 17.3% increase (not 17.2%), though this is a minor rounding issue. However, the LLM incorrectly states that this raised PM's 'Middle-East & Africa regional market-share by roughly 1.1 percentage point'—the ground truth specifies PM's *Turkey* market share rose from 41.3% to 44.8% (a 3.5-point increase), not a 1.1-point rise at the regional level. This is a significant factual error. (2) The LLM fails to report the actual market share figures (41.3% to 44.8%) and instead invents a regional metric not present in the original answer. The illicit trade impact is correctly framed as an offsetting factor for PM, and MO’s characterization of illicit trade as a systemic risk (pp.40–42) is accurately cited. (3) The multi-hop reasoning is partially sound: the model connects Turkey's market growth to PM's volume increase and acknowledges illicit trade as a counterforce, and contrasts PM's exposure with MO’s broader risk discussion. However, it fails to correctly synthesize the market share dynamics at the country level and introduces an unsupported regional aggregation. (4) The contextual relevance is high—both companies and the illicit trade theme are correctly addressed. Qualitative accuracy is moderate due to correct use of document references and conceptual framing, but quantitative accuracy is low due to incorrect percentages and invented metrics. Correctness score reflects partial factual correctness with significant errors in key metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 485,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does the redesign of the Medicare Part D program under the Inflation Reduction Act affect both CVS's financial exposure to Medicare Part D liabilities and AbbVie's pricing strategy for drugs like Imbruvica under Medicare Part D?",
      "original_answer": "The redesign of the Medicare Part D program under the Inflation Reduction Act shifts more claim liability to insurers like CVS, which could negatively impact their profitability due to increased financial risk and administrative complexity. At the same time, AbbVie is subject to government-set pricing for certain drugs, such as Imbruvica, starting in 2026, which will cap reimbursement rates at a statutory ceiling likely below current average prices, significantly affecting revenue projections. These changes create a dual pressure where CVS faces higher liability and AbbVie faces downward pricing pressure, both under the same regulatory framework.",
      "llm_answer": "The Inflation Reduction Act’s overhaul of Medicare Part D moves much of the drug‑claim risk from the government to the health‑plan sponsors, so CVS now bears a larger share of the liability for Part D costs【page_57】.  At the same time, the IRA gives CMS authority to set price caps and require manufacturer discounts on single‑source drugs, meaning AbbVie must price Imbruvica under a government‑set ceiling and provide the mandated 10%‑20% discount for Medicare Part D beneficiaries, compressing its reimbursement【page_19】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core elements of the ground truth. (1) It correctly identifies that the Inflation Reduction Act (IRA) shifts financial risk in Medicare Part D from the government to plan sponsors like CVS, increasing their liability—this aligns with the original answer’s point about CVS facing higher financial exposure and administrative burden. (2) It accurately states that the IRA grants CMS authority to set price caps and mandates manufacturer discounts (10%-20%) for single-source drugs like Imbruvica, which directly affects AbbVie’s pricing strategy and reimbursement—this matches the ground truth’s assertion about government-set pricing starting in 2026 and downward pressure on revenue. While the LLM does not explicitly mention the 2026 start date for price controls, this is a minor omission that does not undermine the overall correctness. (3) The multi-hop reasoning is sound: it connects regulatory changes to financial impacts on both CVS (as insurer) and AbbVie (as drug manufacturer), synthesizing cross-entity implications under the same policy framework. (4) The 10%-20% discount range is consistent with IRA provisions, though the original answer emphasizes a 'statutory ceiling' rather than the discount range; both are factually valid aspects of the same mechanism. Number formats and terminology are appropriate. The answer is fully contextually relevant, directly addressing both parts of the question. A score of 9 is justified due to the omission of the 2026 effective date for price setting, but the core financial and strategic impacts are correctly conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 442,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does Boeing's use of third-party aircraft value publications for valuing impaired customer financing assets compare to RTX's quarterly valuation methodology for private equity limited partnerships, particularly in terms of reliance on unobservable inputs?",
      "original_answer": "Boeing derives the fair value of impaired customer financing assets, including operating lease equipment, by calculating a median collateral value from a consistent group of third-party aircraft value publications, which are based on market trades and other market factors. Management reviews these publications quarterly and may adjust values based on specific aircraft attributes. In contrast, RTX values private equity limited partnerships quarterly using discounted cash flows, earnings multiples, and market multiples, with valuation adjustments reflecting changes in operating results or financial condition of the portfolio companies. Both approaches rely on unobservable inputs typical of Level 3 assets, but Boeing leans more on consistent third-party market data while RTX applies more forward-looking financial modeling.",
      "llm_answer": "Boeing values its impaired customer‑financing assets by taking a median collateral value from a set of third‑party aircraft‑value publications and then adjusting for aircraft condition – a market‑approach that is classified as Level 3 and therefore relies on significant unobservable inputs. RTX, by contrast, values its private‑equity limited‑partnership interests each quarter using discounted‑cash‑flow, earnings‑multiple and market‑multiple models, also a Level 3 measurement that depends on internal, unobservable assumptions. Thus both companies depend on unobservable inputs, but Boeing leans on external aircraft‑price publications while RTX relies on its own quarterly DCF and multiple‑based models.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core comparison between Boeing and RTX's valuation methodologies. (1) All factual elements are correct: Boeing uses a median from third-party aircraft value publications, adjusts for aircraft-specific attributes, and classifies this as Level 3 due to unobservable inputs. RTX uses discounted cash flows, earnings multiples, and market multiples for quarterly valuations of private equity limited partnerships—also Level 3. These points align with the ground truth. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in the question or original answer, so quantitative accuracy is not compromised; the LLM correctly avoids introducing any false numbers. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two different companies, asset types (impaired customer financing vs. private equity), and valuation approaches, then compares their reliance on unobservable inputs. It accurately notes that both use Level 3 inputs but differ in source—Boeing relying more on external market data, RTX on internal modeling. (4) The only minor shortcoming is that the LLM omits Boeing’s quarterly review process and RTX’s use of valuation adjustments based on portfolio company performance, which are present in the original. However, these are secondary details that do not undermine the central comparison. Wording differs slightly but maintains semantic equivalence. Thus, the answer is excellent but not perfect, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 430,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does the voting power disparity between Class A and Class B common stock at META and GOOGL affect the concentration of corporate control, particularly given META's outstanding share structure and GOOGL's recent share repurchase activity?",
      "original_answer": "At META, Class A common stock has full voting rights while Class B common stock has no voting rights except in limited circumstances, which concentrates control among Class A shareholders. As of January 24, 2025, META had 2,189,898,148 shares of Class A common stock and 343,761,117 shares of Class B common stock outstanding, indicating a significant majority of voting power is held by Class A shareholders. In contrast, at GOOGL, Class B common stockholders have 10 votes per share compared to 1 vote per share for Class A, giving disproportionate voting control to Class B holders. GOOGL repurchased $62.0 billion of Class A and Class C shares in 2024, which could further consolidate voting power among remaining Class B shareholders by reducing the overall number of voting shares in circulation.",
      "llm_answer": "Meta’s dual‑class structure gives its 10‑vote Class B shares outsized influence: the 343 million Class B shares (10 votes each) represent only ~14 % of the 2.53 billion total shares outstanding (2.19 billion Class A + 0.34 billion Class B) but supply a majority of the voting power【page_1】. Alphabet’s charter is similar—each Class B share carries ten votes while Class A carries one and Class C carries none【page_82】—and the company’s recent repurchase program has retired large amounts of low‑voting Class A and non‑voting Class C shares (≈$62 billion in 2024)【page_82】, thereby increasing the proportion of votes controlled by the relatively few high‑voting Class B shares and concentrating corporate control in the hands of insiders.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual errors in the quantitative details, particularly regarding META's share structure. It incorrectly states that META's Class B shares have 10 votes each and Class A have 1 vote, when in fact the ground truth specifies that at META, Class A has full voting rights and Class B has *no* voting rights except in limited circumstances. This is a critical error that inverts the actual voting structure. The LLM also miscalculates the total shares outstanding: 2.19B Class A + 0.34B Class B = 2.53B total, which is correct, but then claims Class B represents ~14% of shares — while technically accurate — incorrectly implies they hold majority voting power, which contradicts the ground truth (Class B has no voting power). This undermines the entire reasoning about control concentration at META. For GOOGL, the answer is mostly correct: Class B has 10 votes, Class A has 1, Class C has none, and the $62B repurchase of Class A and C shares in 2024 is accurately cited. The logic that retiring low/no-vote shares increases Class B's relative control is sound and correctly synthesized. However, due to the fundamental misrepresentation of META's voting structure — a core part of the multi-hop comparison — the overall correctness is severely compromised. The contextual relevance is high as it addresses both companies and the impact of share structure and repurchases on control. Qualitative reasoning is partially sound for GOOGL but flawed for META. Quantitative accuracy is low due to the misattribution of voting rights and misleading interpretation of share percentages.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 439,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does PEP's 19% convenient foods unit volume growth in APAC, including low-single-digit growth in Taiwan, compare with PG's market position across Greater China, where Taiwan is explicitly included in its regional structure?",
      "original_answer": "PEP reported 19% convenient foods unit volume growth in APAC in 2022, with Taiwan contributing low-single-digit growth as part of that performance. In contrast, PG holds a leadership or significant market share position in many of its product segments across Greater China, a region that explicitly includes Taiwan according to Apple's segment reporting. This suggests PG maintains a strong competitive presence in the broader regional market, while PEP's exposure in Taiwan appears more modest but still positive.",
      "llm_answer": "PepsiCo’s APAC “convenient‑foods” business posted a 19 % unit‑volume increase for FY 2022, with Taiwan contributing only low‑single‑digit growth (PEP 2022 MD&A, APAC section, p. 48). Procter & Gamble, by contrast, does not give a growth rate for the same region but describes its Greater China segment – which explicitly includes Taiwan – as a market‑leader or holder of a “significant (often number‑one or number‑two) market‑share position” (PG 2022 MD&A, overview and market‑share discussion, pp. 18‑19; segment definition, p. 40). Thus, PepsiCo is reporting a strong volume‑growth metric, whereas P&G emphasizes its dominant market‑share standing in the broader Greater China market that includes Taiwan.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies PEP's 19% convenient foods unit volume growth in APAC for 2022 and notes Taiwan's low-single-digit contribution, matching the ground truth. It accurately contrasts this with PG's market position in Greater China, which includes Taiwan, and correctly states that PG emphasizes leadership or significant market share (often #1 or #2) in that region. All key facts are present and factually aligned with the original answer. (2) Quantitative accuracy is perfect: the 19% growth and low-single-digit characterization for Taiwan are correctly reported. The fiscal year (2022) is accurate, and no calculations are required beyond correct interpretation of growth metrics. (3) The multi-hop reasoning is sound: the model synthesizes PEP’s growth performance in APAC (with Taiwan as a subset) and compares it to PG’s market share leadership in Greater China (which explicitly includes Taiwan), drawing a logical contrast between growth momentum (PEP) and established position (PG). The only minor shortcoming is that the LLM attributes the segment definition to 'Apple’s segment reporting' in the ground truth, but this appears to be an error in the original answer (likely meant to be PG’s reporting), not the LLM. The LLM correctly cites PG’s 2022 MD&A for the segment definition. (4) The answer is contextually excellent, directly addressing the comparison between PEP’s growth and PG’s market position in a region that includes Taiwan. Wording differs slightly but maintains semantic equivalence. A score of 9 is given because while all facts are correct, the original answer includes a subtle inference about PEP’s 'modest but positive' exposure in Taiwan, which the LLM implies but does not explicitly characterize—this is a minor completeness gap, not an error.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 492,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How do the updated PCA Framework thresholds under Basel III affect capital requirements differently for banks like BAC and COF, particularly in terms of CET1 capital ratios and classification as well-capitalized institutions?",
      "original_answer": "Under Basel III, the PCA Framework thresholds were updated to require higher capital ratios for banks to be classified as well-capitalized. For COF, as a Category III institution, it must maintain a minimum CET1 capital ratio of 4.5%, Tier 1 capital ratio of 6.0%, and total capital ratio of 8.0%. However, to be considered well-capitalized under PCA, COF must meet higher thresholds: a CET1 capital ratio of 6.5% or more, Tier 1 capital ratio of 8% or more, and total risk-based capital ratio of 10% or more. Similarly, BAC is subject to these same PCA thresholds, with its CET1 capital regulatory minimum set at 4.5% under Basel III, but to be well-capitalized under PCA, it must maintain a CET1 ratio of 6.5% or more, reflecting the updated PCA requirements. This means both banks must hold significantly more capital to avoid PCA restrictions, impacting their capital planning and dividend capacity.",
      "llm_answer": "The Basel‑III PCA update raises the CET1 floor for a “well‑capitalized’’ depository institution to 6.5% (and to 4.5% for “adequately capitalized’’)【page_11】. Bank of America reports a CET1 ratio of 13.5% under the standardized approach (16.8% under the advanced approach) and is listed as well‑capitalized in its capital‑ratio table【page_146】, while Capital One’s CET1 ratio is 12.9% (13.1% for its bank subsidiary) and also exceeds the 6.5% threshold, so it is likewise classified as well‑capitalized【page_193】. The practical difference is that BAC’s regulatory minimum CET1 (9.5%/7.0% because of the G‑SIB surcharge and buffers) is higher than COF’s (4.5%), yet both banks comfortably meet the new, higher PCA standards.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the updated PCA threshold for CET1 capital ratio (6.5%) for a bank to be classified as well-capitalized under Basel III, which aligns with the ground truth. It also correctly states that both BAC and COF exceed this threshold, supporting their classification as well-capitalized. However, there are significant factual inaccuracies in the quantitative details: the LLM claims BAC’s regulatory minimum CET1 is 9.5%/7.0% due to G-SIB surcharge and buffers, which contradicts the ground truth stating BAC’s Basel III CET1 minimum is 4.5%. While G-SIBs do face higher requirements, the 9.5% figure is not supported by the provided ground truth and introduces unverified specifics. Similarly, the LLM reports BAC’s CET1 as 13.5% and COF’s as 12.9%, which may be accurate based on filings but are not present in the ground truth and thus cannot be verified as correct for this evaluation. The ground truth focuses on regulatory thresholds, not actual reported ratios. The answer also omits key multi-hop elements: it fails to mention COF’s Category III classification and the required Tier 1 (8%) and total capital (10%) ratios for well-capitalized status, which are central to the original answer. While the core idea—that Basel III raised PCA thresholds and both banks meet them—is correct, the inclusion of unverified numbers, misrepresentation of regulatory minima, and omission of critical capital ratio requirements for full PCA classification reduce factual accuracy. The reasoning is partially sound but lacks synthesis of all required regulatory thresholds across both banks. Contextual relevance is high as it addresses the impact on capital requirements and classification.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 464,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How does the sensitivity of NFLX's content amortization to viewing pattern assumptions compare to T's sensitivity analyses around pension discount rates and goodwill impairment assumptions?",
      "original_answer": "NFLX's auditor performed sensitivity analyses on content amortization assumptions, particularly focusing on historical and forecasted viewing hour consumption, which directly affects the timing of content amortization recognition. T's auditor, on the other hand, conducted sensitivity analyses on two key areas: pension discount rates tied to corporate bond credit quality and timing of benefit payments, and goodwill impairment assumptions such as terminal growth rates, EBITDA margins, and weighted average cost of capital (WACC). While both companies undergo sensitivity testing, NFLX's focus is on consumption-based amortization estimates, whereas T's analyses center on long-term financial obligations and asset valuations.",
      "llm_answer": "Netflix’s content amortization is highly sensitive to the assumptions about historical and forecasted viewing patterns – the auditors even ran sensitivity analyses to see how changes in those viewing‑hour estimates would shift the timing and amount of amortization. AT&T’s sensitivity work, by contrast, centers on the discount‑rate assumptions used to measure its defined‑benefit pension and post‑retirement obligations and on the key inputs (terminal growth rates, long‑term EBITDA margins, weighted‑average cost of capital) in its goodwill‑impairment tests, where changes can materially affect liability and goodwill valuations. Thus, Netflix’s risk hinges on consumer‑usage forecasts, while AT&T’s hinges on financial‑valuation assumptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: NFLX's sensitivity analyses focus on viewing patterns affecting content amortization timing, while T (AT&T) has sensitivity analyses on pension discount rates and goodwill impairment assumptions (terminal growth rates, EBITDA margins, WACC). The entities (Netflix, AT&T), financial concepts (content amortization, pension obligations, goodwill impairment), and key assumptions are correctly identified. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies undergo auditor-led sensitivity analyses, but the nature differs—NFLX's is consumption-driven (viewing hours), while T's is finance-driven (discount rates, valuation inputs). The comparison is logically structured and mirrors the original. (4) Minor wording differences exist (e.g., 'corporate bond credit quality' and 'timing of benefit payments' from the original are slightly condensed in the LLM answer), but these do not affect factual accuracy. The LLM uses 'AT&T' instead of 'T', which is semantically equivalent and widely accepted. Overall, the answer is factually complete, contextually relevant, and correctly contrasts the two companies’ sensitivities. A score of 9 is given because the LLM slightly simplifies T's pension assumptions without fully mentioning bond credit quality and payment timing, though the essence remains intact.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 435,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How does Adobe's localized field office presence in Taiwan compare to Apple's broader Greater China segment strategy, particularly given Apple's $74.2 billion in net sales attributed to that region which includes Taiwan?",
      "original_answer": "Adobe maintains a localized field office in Taiwan as part of its global operations, allowing it to directly engage with customers in that market. Apple, on the other hand, reports its financial performance for the broader Greater China segment, which includes Taiwan along with mainland China and Hong Kong, and generated $74.2 billion in net sales in 2022. While Adobe's approach focuses on direct local engagement through physical offices, Apple manages the region as a consolidated market with a unified strategy, reflecting its larger scale and different operational model.",
      "llm_answer": "Adobe lists Taiwan as one of its many local field‑office locations, giving it a dedicated on‑the‑ground presence there (page 15). Apple, however, does not highlight a separate Taiwan office; it groups Taiwan with mainland China and Hong Kong under its “Greater China” segment (page 40), which generated $74.2 billion in net sales in 2022 (page 52). Thus Adobe’s strategy is a localized office in Taiwan, while Apple’s strategy treats Taiwan as part of a much larger regional market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All key facts are correct: Adobe has a localized field office in Taiwan, while Apple includes Taiwan in its Greater China segment, which reported $74.2 billion in net sales in 2022. The numbers match exactly, and the years and entities (Adobe, Apple, Taiwan, Greater China) are correctly identified. (2) Quantitative accuracy is perfect: $74.2 billion is correctly cited with the proper year (2022), and no calculations were required beyond accurate reporting. (3) The multi-hop reasoning is sound—comparing Adobe’s localized operational presence to Apple’s consolidated regional reporting strategy—though the LLM slightly omits the nuance that Apple’s approach reflects its larger scale and different operational model, which is present in the original. This minor omission reduces qualitative accuracy slightly but does not affect factual correctness. (4) The answer is highly relevant, directly addressing the comparison between the two companies’ regional strategies. Wording differs but semantic meaning is equivalent. Minor point: page references (e.g., page 15, 40, 52) are not part of the ground truth and appear to be hallucinated or extraneous, but they don’t detract from factual accuracy. Overall, this is a strong, correct response with only slight room for added contextual depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 380,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How does Lockheed Martin's exposure to LIBOR-based financing instruments compare to 3M's preparedness for reference rate reform, given the provisions of ASU 2020-04 that both companies reference in their filings?",
      "original_answer": "Lockheed Martin (LMT) has credit facilities and derivative instruments referencing LIBOR-based rates and has adhered to the ISDA 2020 IBOR Fallbacks Protocol, expecting minimal financial impact from the transition to alternative rates by December 31, 2022. 3M (MMM) also reviewed its relevant arrangements and concluded that ASU 2020-04 would not have a material impact on its financial statements, indicating a similar low expectation of disruption. Both companies rely on ASU 2020-04 to ease the accounting burden of transitioning from LIBOR to alternative rates like SOFR, showing parallel preparedness despite differing financial structures.",
      "llm_answer": "Lockheed Martin notes that its credit facility and certain derivative contracts still reference LIBOR, but those agreements contain fallback language and the company has adopted the ISDA 2020 IBOR Fallback Protocol, so it does not expect a material impact from the transition (LMT page 85). 3M, by contrast, says it has reviewed all relevant contracts, will apply the optional expedients of ASU 2020‑04 (and ASU 2021‑01) when they are modified, and likewise expects no material effect—indicating a proactive, “ready‑for‑reform” stance (3M pages 68‑68).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that Lockheed Martin has LIBOR-based credit facilities and derivatives, has adopted the ISDA 2020 IBOR Fallbacks Protocol, and expects no material impact by the end of 2022 (implied by context, though not explicitly stated as December 31, 2022). The mention of LMT page 85 adds sourcing precision not in the original but does not contradict it. For 3M, the answer accurately states that the company reviewed contracts, will apply ASU 2020-04 (and ASU 2021-01, a minor addition), and expects no material effect—correctly characterizing this as a 'proactive, ready-for-reform' stance, which is semantically equivalent to the original's 'low expectation of disruption.' The reference to 3M pages 68-68 appears to be a typo but does not affect factual accuracy. Quantitatively, no numbers are misstated; dates and standards (ASU 2020-04, ISDA Protocol) are correct. The multi-hop reasoning—comparing two companies' preparedness for LIBOR transition under ASU 2020-04—is sound and well-synthesized. The only minor shortcoming is slightly less explicit emphasis on the parallel nature of both companies' low-impact expectations despite structural differences, but the conclusion of similar preparedness is implied. Thus, the answer is highly accurate with negligible omissions, warranting a 9/10 on correctness and qualitative accuracy, full marks on quantitative and contextual dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 408,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "What is the voting power distribution between Class A and Class B common stock at CMCSA, and how does the structure of Class B common stock's 15 votes per share impact overall shareholder control?",
      "original_answer": "At CMCSA, holders of Class A common stock have 66⅔% of the combined voting power, while the Class B common stock, which has 15 votes per share, represents 33⅓% of the combined voting power. This structure gives disproportionate voting control to the holder(s) of Class B common stock, despite their minority ownership on a share count basis.",
      "llm_answer": "Comcast’s capital structure gives Class A shareholders about two‑thirds of the voting power (≈ 66 ⅔ %) and Class B shareholders the remaining one‑third (≈ 33 ⅓ %). Each Class B share carries 15 votes, so the 9.44 million Class B shares owned by Mr. Brian L. Roberts confer roughly a third of all votes, making the Class B voting bloc non‑dilutable and giving its holder disproportionate control over corporate decisions despite the far larger number of Class A shares【page_31】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key figures are correct: the 66⅔% and 33⅓% voting power splits between Class A and Class B shares are accurately reported, and the 15 votes per Class B share are correctly stated. While the ground truth does not mention the number of Class B shares (9.44 million) or Mr. Brian L. Roberts, this additional detail is contextually valid and does not contradict the original answer—it enhances it with specific ownership context supported by the source (page_31). (2) Calculations are not required beyond the proportional split, which is correctly interpreted. (3) The multi-hop reasoning is sound: the model correctly infers that despite fewer shares, Class B holds significant voting power due to the 15:1 vote ratio, leading to disproportionate control—this matches the core logic of the ground truth. (4) The answer fully addresses both parts of the question: the voting power distribution and the impact on shareholder control. The only minor deviation is the inclusion of an extra detail (Mr. Roberts’ ownership) not in the original, but this does not reduce accuracy and may reflect deeper contextual understanding. Wording differs slightly but maintains semantic equivalence. Thus, the answer is factually correct, complete, and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy due to the introduction of unrequested granular detail, though not inaccurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 414,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How do the different uses of sensitivity analyses by CMCSA and NFLX reflect their distinct financial risk exposures, particularly given that both are audited by the same firm?",
      "original_answer": "CMCSA uses sensitivity analyses to assess its exposure to interest rate risk, which is critical given its reliance on derivative instruments like interest rate swaps that decreased consolidated interest expense by $56 million in 2023. In contrast, NFLX applies sensitivity analyses in the context of content amortization, a judgment-heavy process where changes in estimated viewing patterns can significantly affect the timing of amortization expenses. Both companies rely on the same auditor, who has served NFLX since 2012 and also reviews CMCSA’s market risk disclosures, suggesting a consistent audit approach despite the differing applications and financial impacts of sensitivity analyses at each firm.",
      "llm_answer": "CMCSA uses sensitivity analyses to gauge how changes in market interest rates would affect the fair value of its debt and interest‑rate swap positions, underscoring its exposure to interest‑rate‑related cost and cash‑flow volatility【page_60】. Netflix, by contrast, performs sensitivity analyses on the assumptions underlying its content‑amortization model—particularly viewing‑pattern forecasts—to see how those changes would alter amortization expense, reflecting its risk that content valuation and revenue recognition may shift with consumer behavior【page_40】. Thus, even though the same audit firm reviews both companies, the analyses target the distinct risk drivers of each business: market‑rate risk for Comcast versus content‑valuation risk for Netflix.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: CMCSA's use of sensitivity analysis for interest rate risk and NFLX's for content amortization are accurately described. The mention of interest-rate swaps and viewing-pattern forecasts aligns with the distinct risk exposures. (2) Quantitative accuracy is perfect—while the LLM answer does not include the specific $56 million reduction in interest expense mentioned in the ground truth, this omission does not distort the meaning or correctness of the response; it simply lacks one quantitative detail. No incorrect numbers or dates are presented. (3) Multi-hop reasoning is sound: the model correctly identifies that both companies use sensitivity analyses differently based on their business models and that they share the same auditor, implying consistent audit standards despite different applications. The synthesis across entities (CMCSA, NFLX, auditor) and risk types is logical and well-executed. (4) Semantic equivalence is strong—wording differs but meaning matches. The LLM emphasizes market-rate risk vs. content-valuation risk, which accurately reflects the original. The only minor gap is the absence of the auditor’s tenure (serving NFLX since 2012) and explicit mention of the auditor reviewing CMCSA’s market risk disclosures, which slightly reduces completeness but does not impair overall correctness. Hence, a score of 9 is warranted, with full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 424,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How does the expiration timeline of Enbrel's key U.S. formulation patent in 2037 impact Pfizer's competitive positioning compared to AbbVie's regulatory exclusivity strategy for its biologics?",
      "original_answer": "Pfizer's Enbrel, marketed outside the U.S. and Canada, benefits from a U.S. formulation patent that expires in 2037, offering extended protection for its composition and preparation methods. This long runway could help Pfizer maintain market presence for Enbrel in key international markets by deterring biosimilar competition. In contrast, AbbVie relies on a broader regulatory exclusivity strategy, including 12-year exclusivity for biologics under the BPCIA and potential pediatric exclusivity extensions, which may allow it to manage competitive threats through both patent and regulatory mechanisms. While Pfizer’s formulation patent provides a specific technical barrier, AbbVie’s layered approach combines patent protection with statutory exclusivity to maximize market control post-approval.",
      "llm_answer": "Pfizer’s Enbrel enjoys a U.S. formulation patent that does not expire until 10 / 19 / 2037【page_11】—well beyond the typical 12‑year BPCIA exclusivity period granted to biologics (which can be extended only by a 180‑day pediatric add‑on) that AbbVie relies on for its biologic portfolio【page_10】. Because Enbrel’s patent protection runs many years after the standard regulatory exclusivity window, Pfizer can keep biosimilar competitors at bay longer, giving it a stronger competitive position than AbbVie, whose biologics become vulnerable to biosimilar entry once the 12‑year exclusivity expires.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies the 2037 expiration of Enbrel's U.S. formulation patent and accurately contrasts it with the 12-year BPCIA exclusivity period applicable to biologics, which is central to the question. The date '10/19/2037' is more specific than the ground truth's '2037', but this level of precision is acceptable and does not contradict the original. However, the LLM incorrectly implies that AbbVie relies solely on regulatory exclusivity (BPCIA + pediatric extension), when the ground truth clarifies that AbbVie uses a *combination* of patent protection and regulatory exclusivity—a key distinction. The LLM also overstates Pfizer’s competitive advantage by concluding it has a 'stronger competitive position' than AbbVie, which is a subjective interpretation not supported in the original answer; the ground truth presents a nuanced comparison without making a hierarchical judgment. 2) Quantitatively, all dates and timeframes are accurate: '2037' for Enbrel’s patent and '12-year exclusivity' under BPCIA are correct. The mention of a '180-day pediatric add-on' aligns with the law (though not explicitly stated in the original answer, it is factually accurate and adds context). 3) The multi-hop reasoning is partially sound: the model correctly links Enbrel’s patent timeline to competitive positioning and contrasts it with AbbVie’s regulatory strategy. However, it fails to fully synthesize the layered nature of AbbVie’s approach (patents + regulatory exclusivity), reducing it to only regulatory reliance, which misrepresents the original comparison. 4) Contextual relevance is high—the answer addresses the core issue of competitive positioning based on IP and regulatory strategies. The inclusion of BPCIA and pediatric exclusivity shows good contextual understanding. However, the lack of mention of international market dynamics (e.g., Pfizer marketing Enbrel outside U.S./Canada) slightly reduces completeness. Overall, the answer is factually strong but oversimplifies the strategic comparison, warranting a 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 553,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How would a potential shift from 0.5-percentage-point to 0.1-percentage-point increments in the G-SIB surcharge proposal impact JPMorgan Chase's capital requirements under a resolution scenario where the Parent Company enters bankruptcy, given the loss-absorbing structure of its eligible long-term debt?",
      "original_answer": "The proposed shift from 0.5-percentage-point to 0.1-percentage-point increments in the G-SIB surcharge under the Federal Reserve's proposal would likely allow for more granular calibration of capital requirements for systemically important institutions like JPMorgan Chase. For JPM, this could mean a more tailored capital burden, which would interact with its 'single point of entry' resolution strategy where losses would first be imposed on equity holders and then on unsecured creditors, including holders of eligible long-term debt. If this surcharge adjustment is adopted, JPM may experience either a marginal increase or decrease in required capital depending on its G-SIB score, which would influence how much loss-absorbing capacity it must maintain under its current regulatory framework.",
      "llm_answer": "A shift to 0.1‑percentage‑point increments would trim the Method 2 G‑SIB surcharge, lowering the extra capital JPMorgan must hold (page 60). In a resolution where the Parent Company files for bankruptcy, that reduction simply shrinks the regulatory capital buffer that must be kept before the loss‑absorbing eligible long‑term debt is called on; the hierarchy of loss absorption—eligible LTD holders bearing losses first—remains unchanged (page 15).",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partially correct information but introduces significant inaccuracies and omissions that affect factual correctness and reasoning. (1) Quantitatively, the claim that shifting to 0.1-percentage-point increments would 'trim' the G-SIB surcharge and reduce capital requirements is not supported by the original answer, which states the change allows for more granular calibration—potentially increasing or decreasing capital depending on JPMorgan's G-SIB score. The LLM incorrectly assumes a directional reduction ('trim'), which is not guaranteed and contradicts the neutral, conditional nature of the original. (2) The original emphasizes that the impact could be a marginal increase or decrease—this balanced assessment is missing in the LLM response, which asserts a definitive lowering of capital. (3) Regarding entity and structural accuracy, the LLM correctly identifies JPMorgan, the G-SIB surcharge, eligible long-term debt (LTD), and the resolution context. It also correctly notes that the loss-absorption hierarchy remains unchanged, which aligns with the 'single point of entry' strategy mentioned in the original. (4) However, the LLM misrepresents the regulatory mechanism: it references 'Method 2' and specific page numbers (60, 15), which are not present or verifiable in the ground truth and suggest overconfidence in unverified document references. (5) Multi-hop reasoning is partially sound—linking capital requirements to resolution and loss absorption—but fails in the critical synthesis that the surcharge adjustment enables finer calibration, not necessarily a reduction. The conclusion that the capital buffer 'shrinks' is speculative and not universally valid. (6) While the LLM captures the relevance of capital buffers and loss-absorbing debt in resolution, its definitive tone and incorrect directional claim on capital reduction undermine factual accuracy. Semantic equivalence is partially achieved but compromised by key factual misstatements.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 535,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does LMT's use of a discounted cash flow approach in valuing Level 3 fixed income investments compare to HON's application of the same method in testing goodwill and indefinite-lived intangible assets, particularly in terms of the sensitivity to projected cash flows and discount rates?",
      "original_answer": "LMT applies the discounted cash flow approach to certain Level 3 fixed income investments, relying on projected annuity payments and a discount rate applied to those payments. This valuation method is used when observable market inputs are unavailable, and it introduces sensitivity to changes in these projected cash flows and discount assumptions. Similarly, HON utilizes a discounted cash flow approach for testing goodwill and indefinite-lived intangible assets, incorporating strategic and annual operating plans adjusted for terminal value assumptions. HON also performs sensitivity analyses on key estimates, including expected growth rates, sales volumes, and discount rates, to assess the impact of changes in assumptions. Both companies depend on forward-looking financial projections and discounting techniques, making their valuations highly sensitive to shifts in economic conditions and internal performance expectations.",
      "llm_answer": "Lockheed Martin values those Level 3 fixed‑income securities that lack observable inputs with a discounted‑cash‑flow model that hinges on “projected annuity payments and the discount rate applied to those payments” (see LMT 10‑K p. 88). Honeywell also uses a discounted‑cash‑flow model for goodwill and indefinite‑life intangibles, but it explicitly “performs sensitivity analyses on key estimates and assumptions” – including the projected cash‑flows and discount rate – and warns that changes to those assumptions could materially affect fair value and any impairment charge (see HON 10‑K p. 47).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the original answer. (1) All factual elements are correct: LMT uses a discounted cash flow (DCF) approach for Level 3 fixed income investments based on projected annuity payments and discount rates, and HON uses DCF for goodwill and indefinite-lived intangible assets with sensitivity analyses on key assumptions. The citations to page numbers (LMT 10-K p. 88, HON 10-K p. 47) align with the expected sources and support the claims. (2) There are no numeric values in the question or answers that require verification—both responses rely on qualitative descriptions of valuation methods, so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (LMT and HON), two distinct applications of DCF (Level 3 investments vs. goodwill/intangibles), and compares their sensitivity to cash flows and discount rates. It correctly identifies that both firms use forward-looking projections and discounting, and that HON explicitly performs sensitivity analyses. (4) The only minor shortcoming is that the LLM answer does not explicitly mention HON’s use of 'strategic and annual operating plans' or 'terminal value assumptions,' which are part of the full picture in the ground truth. However, this omission does not distort the overall meaning or accuracy. The emphasis on sensitivity analysis in HON’s case is well captured, and the comparison remains valid and insightful. Wording differs slightly but maintains semantic equivalence. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 469,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does AT&T's use of discount rates tied to corporate bond credit quality in pension obligations compare to Netflix's reliance on forecasted viewing patterns in content amortization, given both are subject to auditor evaluation of significant assumptions?",
      "original_answer": "AT&T's pension obligations are sensitive to discount rates derived from corporate bonds' credit quality, which directly affects the measurement of $67,854 million in goodwill and postretirement liabilities. Netflix, on the other hand, relies on forecasted viewing patterns to amortize content assets, a process that is similarly judgmental and subject to auditor scrutiny. Both companies' financial statements depend heavily on significant assumptions—discount rates for AT&T and viewing forecasts for Netflix—that are evaluated by auditors using sensitivity analyses and comparisons to historical data. This highlights a parallel in how both firms manage subjectivity in long-term financial reporting, despite differing industries and asset types.",
      "llm_answer": "AT&T measures its pension and post‑retirement obligations with discount rates that are built from a yield curve of **high‑quality corporate bonds**, so the audit focuses on the **credit quality of those bonds and how their cash‑flow timing matches expected benefit payments** (AT&T pg 43‑44). Netflix, by contrast, amortizes its content on the basis of **historical and forecasted viewing‑hour patterns**, and the audit tests management’s assumptions about future viewing and the completeness of the underlying data (Netflix pg 40). Both are “significant assumptions” that require auditor scrutiny, but AT&T’s is a market‑rate/credit‑quality judgment, whereas Netflix’s is a consumer‑behavior/forecasting judgment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth, with only minor omissions affecting completeness. (1) Quantitatively, no specific dollar amounts or percentages are misstated—the LLM does not include the $67,854 million figure from the original answer, but this is the only numeric omission. Since the question does not explicitly ask for financial figures and the LLM correctly describes the nature of the assumptions without introducing any incorrect numbers, quantitative accuracy remains high. (2) The LLM correctly identifies both companies (AT&T and Netflix), the relevant accounting practices (discount rates based on corporate bond credit quality for AT&T; forecasted viewing patterns for Netflix), and the role of auditors in evaluating significant assumptions. It also accurately cites page numbers (e.g., AT&T pg 43-44, Netflix pg 40), suggesting fidelity to source documents. (3) The multi-hop reasoning is sound: the model compares two different companies’ use of judgmental assumptions in financial reporting, synthesizes across industries, and contrasts types of auditor scrutiny—market-rate/credit-quality vs. consumer-behavior/forecasting—mirroring the conceptual parallel in the ground truth. (4) The only shortcoming is the omission of the specific goodwill and postretirement liability amount ($67,854 million), which was present in the original answer and adds concrete financial magnitude to AT&T’s exposure. While this detail enhances completeness, its absence does not undermine the correctness of the conceptual comparison. Wording differs but maintains semantic equivalence. Contextual relevance is perfect—the response directly addresses the comparison requested and the role of auditor evaluation. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 513,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does the adoption timeline of ASU No. 2023-07 differ between MO and PM, and what specific changes did each company implement in their segment reporting as a result?",
      "original_answer": "MO adopted ASU No. 2023-07 in 2024 and began including expanded footnote disclosures in Note 17, with interim disclosure requirements set to appear in Q1 2025. PM adopted the ASU retrospectively for the year ended December 31, 2024, and updated its segment reporting by incorporating the former Swedish Match segment into its four existing geographical segments starting in January 2024.",
      "llm_answer": "Altria (MO) only adopted ASU 2023‑07 when it prepared its 2024 Form 10‑K – i.e., for the year ended December 31 2024 (see page 62).  The company responded by adding expanded foot‑note disclosures of incremental segment information (including disaggregated expense data) in Note 17 and will begin providing the new interim segment disclosures in its Q1 2025 condensed statements (page 63).  \n\nPhilip Morris International (PM) incorporated the same update earlier, revising its segment presentation in January 2024; it folded the former Swedish Match segment into its four existing geographic segments and restated prior‑year amounts to conform with the new structure (page 86).  This re‑classification was the primary change to its segment reporting resulting from the ASU 2023‑07 adoption.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: MO adopted ASU 2023-07 for the year ended December 31, 2024, with expanded disclosures in Note 17 and interim disclosures starting Q1 2025. PM adopted the standard retrospectively effective January 2024, integrating the Swedish Match segment into its four geographic segments and restating prior periods. (2) Quantitative accuracy is perfect: dates (2024 adoption, Q1 2025 interim disclosures, January 2024 reorganization) are correct and match the ground truth. (3) Multi-hop reasoning is sound—information is synthesized correctly across two companies and their respective reporting changes. (4) The only minor shortcoming is that the LLM does not explicitly state PM's adoption was 'retrospective for the year ended December 31, 2024'—though it implies this by mentioning restatement of prior periods and January 2024 implementation. This omission is minor given the overall precision. Wording differs but semantic equivalence is maintained. All parts of the question are addressed: adoption timelines and segment reporting changes for both MO and PM.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 331,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does the inclusion of Pomalyst in the Inflation Reduction Act's (IRA) drug price negotiation program impact BMY's revenue outlook compared to PFE's exposure under the same IRA provisions, given both companies' reliance on Medicare Part D sales and regulatory exclusivity timelines?",
      "original_answer": "BMY faces potential revenue erosion for Pomalyst starting in 2027 due to its selection by HHS for government-set pricing under the IRA, which could accelerate prior to the expiry of its intellectual property protections. Similarly, PFE anticipates a net unfavorable revenue impact of approximately $1 billion in 2025 due to IRA-driven Medicare Part D redesign changes and faces additional IRA pricing pressures on products like Ibrance and Xtandi, which were selected for price negotiation effective 2027. Both companies are exposed to the IRA’s long-term financial implications, but BMY’s risk is specifically tied to Pomalyst’s regulatory exclusivity and market dynamics, while PFE’s exposure spans a broader portfolio affected by Part D redesign and inflation rebates.",
      "llm_answer": "BMY’s 2024 filing says HHS has selected Pomalyst for IRA price‑negotiation beginning in 2027 (page 43) and that the company already expects generic erosion for Pomalyst outside the U.S. in 2025 (page 42), so the negotiation is likely to accelerate revenue erosion before its exclusivity expires and weigh on BMY’s outlook. Pfizer, by contrast, already has several high‑revenue drugs (e.g., Eliquis, Ibrance, Xtandi) in the IRA’s Medicare Part D price‑setting program and projects roughly a $1 billion year‑over‑year revenue hit in 2025 (pages 17‑18), reflecting a broader but more immediate exposure despite similar reliance on Medicare Part D sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key numbers and dates are correct: Pomalyst selected for IRA price negotiation in 2027 (BMY 2024 filing, p.43), PFE's projected $1 billion revenue impact in 2025 (p.17-18), and generic erosion of Pomalyst outside the U.S. in 2025. These match or are consistent with the original answer’s timeline and financial impact. (2) The answer correctly identifies entities: BMY (Bristol Myers Squibb) and PFE (Pfizer), drugs Pomalyst, Ibrance, Xtandi, and Eliquis, and relevant programs (IRA, Medicare Part D). (3) Multi-hop reasoning is sound: it synthesizes BMY’s exposure via Pomalyst’s early pricing pressure before IP expiry with PFE’s broader, more immediate exposure due to Part D redesign and multiple drugs in negotiation. (4) The only minor shortcoming is that the LLM answer does not explicitly mention that PFE’s IRA pricing pressures on Ibrance and Xtandi are also effective in 2027, which would strengthen the parallel with BMY’s 2027 timeline. Additionally, the original answer notes PFE’s exposure to inflation rebates, which the LLM omits. These are small omissions that do not undermine the core accuracy. Wording differs but semantic meaning is equivalent. The answer is contextually excellent, directly addressing the comparative revenue outlook under IRA, Part D reliance, and exclusivity timelines.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 389,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How does the exposure of MDLZ's Argentine operations, which contributed $401 million in 2021 net revenues, compare to KO's reliance on Arca Continental in Argentina, given that Arca Continental is one of KO's top bottlers and operates in northern Argentina?",
      "original_answer": "MDLZ's Argentine operations contributed $401 million in net revenues in 2021 and were subject to significant currency risk due to Argentina's highly inflationary status, resulting in a $13 million remeasurement loss in that year. Meanwhile, KO relies on Arca Continental, one of its top five bottlers, which operates in northern Argentina and contributes to KO's global unit case volume. Arca Continental is a key distribution partner in the region, and KO's bottler agreements require Arca to source concentrates exclusively from KO, making KO's exposure in Argentina indirect but strategically significant through this contractual relationship.",
      "llm_answer": "MDL Z’s Argentine business generated about $401 million in 2021, roughly 1.4 % of its consolidated net revenues.  Coca‑Cola’s exposure to Argentina is indirect – it is supplied by Arca Continental, one of the company’s five largest bottlers (which together account for about 41 % of worldwide case volume) and whose territory includes northern Argentina, but the filing does not break out a specific revenue amount for that Argentine segment.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core of the multi-hop comparison between MDLZ and KO's exposure to Argentina. (1) Quantitatively, it correctly states MDLZ's $401 million in 2021 net revenues from Argentina and notes it as ~1.4% of consolidated revenue (which aligns with MDLZ's ~$28.5B total revenue in 2021). It accurately identifies Arca Continental as one of KO's top five bottlers and notes that these five account for ~41% of global case volume, consistent with KO's filings. However, it omits the $13 million remeasurement loss due to currency risk in Argentina for MDLZ, a key financial impact mentioned in the ground truth. (2) The answer correctly notes that KO’s exposure is indirect and that Arca operates in northern Argentina, but it fails to mention the exclusive sourcing agreement between KO and Arca, which is a critical element of the strategic relationship. (3) The reasoning is sound in comparing direct vs. indirect exposure and synthesizing data from both companies’ operations, but the omission of the remeasurement loss and contractual details weakens the completeness of the multi-hop analysis. (4) Despite these omissions, the answer remains contextually relevant, factually accurate on the numbers provided, and conveys the essential contrast between MDLZ’s direct operations and KO’s indirect reliance via a bottler. Minor deductions for missing key qualitative and quantitative details from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 400,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How does BMY's engagement with the FDA's Fast Track Designation process inform the strategic value of LLY's acquisition of Prevail's PR006 gene therapy, given PR006's regulatory status and the CVR payment timeline tied to its approval?",
      "original_answer": "BMY's engagement with the FDA's Fast Track Designation process highlights the importance of expedited regulatory pathways in accelerating drug approvals and improving patient access to critical therapies. LLY acquired Prevail in 2021, including PR006, which was granted Fast Track Designation by the FDA for treating frontotemporal dementia with GRN mutations. The acquisition included a CVR entitling Prevail shareholders to up to an additional $4.00 per share (approximately $160 million total) upon the first regulatory approval of a Prevail product in specified countries by December 31, 2024. Given the Fast Track status of PR006, the likelihood of expedited approval may directly influence the timing and value of the CVR payout, thereby enhancing the strategic value of the acquisition if PR006 achieves regulatory approval within the stipulated timeline.",
      "llm_answer": "BMY points out that the FDA’s Fast‑Track designation is a key tool that can “facilitate the development of certain drugs or expedite certain applications” and that “improvements in the efficiency of this process can have significant impact on bringing new therapies to patients more quickly”【page_18】. Lilly’s purchase of Prevail includes PR006 – a gene‑therapy candidate that “was granted Fast Track designation from the U.S. Food and Drug Administration”【page_70】 – and the deal’s CVR pays an extra $4 per share only if a product receives its first regulatory approval in a major market by Dec 31 2024 (with a monthly decay thereafter)【page_70】. Thus, the Fast‑Track status that BMY values for accelerating approvals directly underpins the strategic upside of Lilly’s acquisition, because it improves the odds that PR006 will be approved within the CVR window and unlock the contingent payment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PR006 received Fast Track Designation from the FDA, the CVR pays $4.00 per share (totaling ~$160 million), and the deadline for approval to trigger the CVR is December 31, 2024, with a monthly decay thereafter. The LLM correctly cites page 70 for PR006’s Fast Track status and the CVR terms, and page 18 for BMY’s view on Fast Track. (2) Quantitative accuracy is perfect: $4.00 per share and Dec 31, 2024 deadline match the original; the mention of 'monthly decay' adds precision not in the ground truth but is consistent with typical CVR structures and does not contradict it. (3) Multi-hop reasoning is sound: the answer correctly links BMY’s emphasis on Fast Track efficiency to the strategic value of LLY’s acquisition by highlighting how expedited development increases the likelihood of meeting the CVR deadline. (4) The only minor shortcoming is that the LLM does not explicitly name the indication (frontotemporal dementia with GRN mutations) or specify that the $160 million total is implied from $4.00 per share, though this is not critical to the core logic. Overall, the answer captures the strategic linkage between regulatory strategy and financial incentives accurately and concisely.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 363,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How does V's increase in Class A common stock shares from 1,594 in 2023 to 1,733 in 2024 compare with MA's Class B-to-A conversion mechanism, especially considering MA's disclosure that only 7 shares of Class B common stock were outstanding in 2024, to assess the differing dynamics of shareholder structure evolution in both companies?",
      "original_answer": "V reported an increase in Class A common stock shares from 1,594 in 2023 to 1,733 in 2024, indicating an expansion in its Class A shareholder base. Meanwhile, MA disclosed that only 7 shares of Class B common stock were outstanding in 2024, showing minimal remaining shares eligible for conversion into Class A. This contrast highlights different dynamics in shareholder structure evolution: V is seeing organic growth or issuance in its Class A shares, while MA's structure is shaped by its conversion rules, which require Class B holders (typically principal or affiliate customers) to convert and then divest Class A shares, limiting long-term Class B retention.",
      "llm_answer": "Visa’s Class A common stock rose from 1,594 shares at September 30 2023 to 1,733 shares at September 30 2024 – an increase of 139 shares (about an 8.7 % rise)【page_58】.  Mastercard’s charter allows its Class B shares to be converted one‑for‑one into Class A shares, but only seven Class B shares were outstanding in 2024, so any conversion could add at most seven shares to Class A【page_92】【page_93】.  Thus, Visa’s shareholder base is expanding noticeably through new Class A issuances, whereas Mastercard’s conversion mechanism has a negligible effect on its Class A count because of the tiny number of Class B shares.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: Visa's Class A shares increased from 1,594 to 1,733 (a difference of 139 shares), and Mastercard had only 7 Class B shares outstanding in 2024. The 8.7% increase calculation is accurate (139 / 1,594 ≈ 0.087). These match the original data. (2) The entity identification is correct—V refers to Visa, MA to Mastercard—and the years (2023 to 2024) are properly referenced with appropriate fiscal dates (September 30). (3) The reasoning correctly synthesizes the multi-hop elements: it contrasts Visa’s organic growth in Class A shares with Mastercard’s minimal conversion potential due to the near-exhaustion of Class B shares. It accurately describes the one-for-one conversion mechanism and its limited impact. (4) The answer captures the core insight from the ground truth about differing shareholder structure dynamics—Visa’s expansion via issuance vs. Mastercard’s structurally constrained conversion process. The only minor shortcoming is that it omits the detail about Mastercard requiring divestiture after conversion (a nuance in the original answer), which slightly weakens the qualitative depth. However, the omission does not distort the overall meaning. Wording differs but maintains semantic equivalence. All in all, this is a factually correct, well-reasoned, and contextually appropriate response.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 394,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How might Saudi Arabia's data localization requirements, which Adobe identifies as a risk to its international operations, affect NVIDIA's ability to deploy its H100 and L40S chips in the country under U.S. export control regulations?",
      "original_answer": "Saudi Arabia's implementation of data localization requirements mandates that data be stored and processed within the country, which Adobe notes could adversely impact its international business operations. NVIDIA, which relies on Saudi Arabia as a market for its high-performance chips like the H100 and L40S, faces U.S. export licensing restrictions on these products to Saudi Arabia under updated Country Group D4 rules. Since these chips require U.S. government approval for export and NVIDIA has not received such licenses for restricted products, the combination of Saudi regulatory requirements and U.S. export controls could significantly limit NVIDIA's ability to serve Saudi customers with these advanced AI chips, potentially reducing its market access and revenue opportunities in the region.",
      "llm_answer": "Adobe warns that Saudi Arabia is among the jurisdictions that are adopting data‑localisation rules that require personal and other data to be collected, stored and processed inside the country (ADBE 10‑K p. 23). NVIDIA’s 10‑K notes that the U.S. government now requires an export licence for H100 and L40S GPUs shipped to “Country Group D5” – which explicitly includes Saudi Arabia – and that such licences can be delayed, denied or come with onerous conditions (NVDA 10‑K p. 27‑28). Consequently, the Saudi data‑localisation mandate could compound the U.S. licensing hurdle, making it harder for NVIDIA to obtain approval and to deploy H100/L40S chips in Saudi Arabia without meeting both export‑control and local‑data‑residency requirements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. (1) It correctly identifies Adobe's warning about Saudi data localization requirements (citing ADBE 10-K p.23) and NVIDIA's disclosure of U.S. export licensing requirements for H100 and L40S GPUs to Country Group D5, which includes Saudi Arabia (citing NVDA 10-K pp.27–28). These citations confirm the use of correct entities and sources. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes Adobe’s observation about Saudi regulatory policy with NVIDIA’s export control constraints under U.S. rules, concluding that the combination of local data residency mandates and export licensing hurdles could impede deployment of H100/L40S chips. This reflects accurate causal logic. (4) The only minor shortcoming is that the LLM answer does not explicitly state that NVIDIA has not received licenses (a point in the original), nor does it mention the potential impact on market access and revenue—though the implication of 'making it harder' is close. This slight omission prevents a perfect 10 on qualitative accuracy. Otherwise, the answer is contextually precise, directly addressing how data localization interacts with U.S. export controls to affect NVIDIA’s operations in Saudi Arabia.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 400,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How do FedEx's and GE's disclosures regarding the discontinuation of LIBOR reflect differing applications of the accounting relief provided by ASU 2020-04, as extended by ASU 2022-06?",
      "original_answer": "FedEx notes that there has been 'no material effect' from reference rate reform on its financial condition as of May 31, 2024, but continues to monitor contracts for potential application of ASU 2022-06, which extended the optional expedients in ASU 2020-04 through December 31, 2024. In contrast, GE explicitly states that the overall impact of LIBOR reform under ASU 2020-04 on its financial statements is 'immaterial.' This suggests that while both companies applied the same accounting framework (ASU 2020-04, extended by ASU 2022-06), FedEx maintained a more cautious stance with ongoing monitoring, whereas GE concluded the transition had no significant financial impact.",
      "llm_answer": "FedEx’s filing notes that the optional expedients in ASU 2020‑04 (and its extension ASU 2022‑06) are available for contracts that reference LIBOR, but as of May 31 2024 the company has seen “no material effect to our financial condition, results of operations, or cash flows” and is simply monitoring its agreements for any needed application (FedEx 10‑K p. 93). GE, by contrast, says it evaluated the LIBOR discontinuation under ASU 2020‑04 (the same relief) and concluded that the overall impact on its financial statements is “immaterial” (GE 10‑K p. 17). Thus FedEx emphasizes a forward‑looking, monitoring approach with no material effect yet, while GE reports having applied the relief and determined the effect to be immaterial.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original answer. (1) All key facts are correct: FedEx as of May 31, 2024, reports 'no material effect' on financial condition and is monitoring contracts for potential application of ASU 2020-04 and ASU 2022-06; GE explicitly states the impact under ASU 2020-04 is 'immaterial.' (2) Quantitative accuracy is perfect: correct dates (May 31, 2024), correct references to ASUs (2020-04 and 2022-06), and correct characterization of both companies' disclosures with proper citations (FedEx 10-K p.93, GE 10-K p.17). (3) Multi-hop reasoning is sound: the model correctly synthesizes information from two different companies' filings, compares their differing applications of the same accounting relief, and draws a valid contrast—FedEx maintains a forward-looking monitoring stance, while GE has concluded its assessment with an immaterial determination. (4) The answer fully addresses the question about differing applications of ASU 2020-04 and ASU 2022-06, with precise entity identification and contextual nuance. Wording differs slightly but meaning is preserved. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 336,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How might geopolitical tensions involving Taiwan impact both Apple's and NVIDIA's supply chain operations, considering their reliance on manufacturing locations and foundry partners in the region?",
      "original_answer": "Apple's business is significantly impacted by geopolitical tensions involving Taiwan, as it relies heavily on outsourcing partners located in Taiwan for manufacturing critical components. A significant or prolonged conflict involving Taiwan could severely limit Apple's ability to manufacture and deliver products, creating delays and inefficiencies in its supply chain. Similarly, NVIDIA depends on foundry partners in Taiwan for chipset supply, and any disruption due to geopolitical tensions could severely limit or prevent NVIDIA from receiving this supply, which would have a material adverse impact on its business. Both companies face heightened risks due to their reliance on operations in a region with ongoing geopolitical instability.",
      "llm_answer": "Apple’s 10‑K notes that a large share of its hardware is assembled in Taiwan and that “manufacturing or logistics in these locations … can be disrupted … by geopolitical tensions, or conflict” (p. 9‑11). If Taiwan‑China tensions rise, Apple could face delayed shipments, higher component costs or even loss of supply from those Taiwanese factories. NVIDIA likewise warns that “geopolitical tensions, such as those involving Taiwan and China … where we have suppliers, contract manufacturers, and assembly partners … could have a material adverse impact” on its ability to obtain wafers from its Taiwanese foundry partners, creating capacity constraints, price spikes and potential revenue loss (p. 17‑18).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that both Apple and NVIDIA rely on manufacturing and foundry partners in Taiwan, and that geopolitical tensions involving Taiwan and China pose significant risks to their supply chains. The answer accurately reflects the content of the original answer, noting potential disruptions such as delayed shipments, supply loss, capacity constraints, and material adverse impacts. (2) There are no numeric values, dates, or financial figures in the question or ground truth, so quantitative accuracy is not applicable—no errors here. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from both Apple’s and NVIDIA’s 10-K filings, linking their shared dependency on Taiwanese operations to the broader geopolitical risk. It cites specific page numbers (p. 9–11 for Apple, p. 17–18 for NVIDIA), which adds credibility and suggests accurate sourcing. (4) The only minor shortcoming is that the LLM slightly overemphasizes assembly in Taiwan for Apple—while Apple does rely on partners in Taiwan, much of its final assembly occurs in China (e.g., via Foxconn). However, the core point about reliance on Taiwanese manufacturing for components and logistics remains valid. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning with only negligible imprecision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 395,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "What percentage of Broadcom's $24,156 million developed technology intangible asset from the VMware acquisition is specifically tied to VMware Cloud Foundation, and how does this compare to Oracle's net value of developed technology as a percentage of its total intangible assets?",
      "original_answer": "Of Broadcom's $24,156 million developed technology intangible asset from the VMware acquisition, a 'significant portion' is tied to VMware Cloud Foundation (VCF), though the exact percentage is not disclosed. Oracle's net value of developed technology was $1,276 million as of May 31, 2024, which represents approximately 18.4% of Oracle's total intangible assets of $6,890 million. While Broadcom emphasizes that a significant portion of its developed technology relates to VCF, Oracle's developed technology is a much smaller share of its overall intangible asset base, indicating differing strategic valuations of technology assets post-acquisition.",
      "llm_answer": "Broadcom’s VMware‑Cloud‑Foundation‑related intangible assets total $4,730 million, which is about 19.6 % of the $24,156 million developed‑technology intangible asset recorded from the VMware acquisition (see $24,156 million on page 68 and $4,730 million on page 69). Oracle’s net developed‑technology intangible asset of $1,276 million represents roughly 18.5 % of its total net intangible assets of $6,890 million (see $1,276 million and $6,890 million on page 86).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in asserting that $4,730 million of Broadcom's developed technology intangible asset is specifically tied to VMware Cloud Foundation (VCF). The ground truth explicitly states that while a 'significant portion' is tied to VCF, the exact percentage or dollar amount is not disclosed. The LLM fabricates a precise figure ($4,730 million) and calculates 19.6%, which is not supported by the source data. (2) The numbers for Oracle are correct: $1,276 million developed technology and $6,890 million total intangible assets, resulting in ~18.5% (correctly rounded from 18.4%). However, the LLM incorrectly implies that Broadcom's VCF-specific value is known and quantifiable, which contradicts the original answer. (3) The multi-hop reasoning fails because the model invents data for the first hop (Broadcom/VCF allocation) instead of acknowledging the lack of disclosure. It correctly performs the percentage calculation for Oracle but applies false precision to Broadcom. (4) Scores reflect major factual inaccuracy in quantitative and qualitative dimensions—fabricating undisclosed figures severely undermines correctness. Contextual relevance is high because the structure and intent align with the question, but factual integrity is compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 363,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA compare to the relative stockholder ownership structure at GOOGL, particularly in terms of non-affiliate market value and class-based control mechanisms?",
      "original_answer": "At CMCSA, holders of Class B common stock, of which there are only 3 record holders, maintain 33⅓% of the combined voting power of the company’s common stock, with each share carrying 15 votes. This concentrated voting power is designed to preserve control, as the Class B shares are non-dilutable under the company's articles of incorporation. In contrast, GOOGL disclosed that as of June 30, 2021, the aggregate market value of shares held by non-affiliates was approximately $1,451.1 billion, with 300,754,904 shares of Class A common stock outstanding. While GOOGL’s structure also includes differentiated voting rights, the non-affiliate ownership suggests a more dispersed market-based control mechanism compared to CMCSA’s concentrated Class B structure.",
      "llm_answer": "Comcast’s three Class B shares, each carrying 15 votes, account for roughly 33 ⅓ % of the company’s total voting power, leaving the remaining 66 ⅓ % to the much larger pool of Class A shares (CMCSA Item 5, p. 38). Alphabet, by contrast, reports that non‑affiliates own about $1.451 trillion of market value and its equity is divided among 300.8 M Class A shares, 44.6 M Class B shares (which have super‑voting rights) and 315.6 M Class C shares, concentrating voting control with insiders while the bulk of market value rests with non‑affiliates (GOOGL Item 5, p. 2).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the 33⅓% voting power held by CMCSA's Class B shares with 15 votes per share and the three record holders, aligning with the ground truth. However, it incorrectly states that the remaining 66⅓% of voting power goes to Class A shares—this should be 66⅔%, not 66⅓%, indicating a clear arithmetic error. Additionally, while the ground truth only provides non-affiliate market value and Class A shares outstanding for GOOGL as of June 30, 2021, the LLM adds unsourced figures for Class B (44.6M) and Class C (315.6M) shares, which are not present in the original answer and may be factually inaccurate or from a different time period. The $1.451 trillion figure matches the ground truth’s $1,451.1 billion, so that is quantitatively acceptable.\n\n2) Quantitative accuracy is compromised by the incorrect percentage (66⅓% vs correct 66⅔%) and the inclusion of additional share counts for GOOGL classes not mentioned in the ground truth. While the non-affiliate market value is correctly converted ($1.451 trillion ≈ $1,451.1 billion), the added detail about Class B and C shares introduces potential inaccuracies without citation to the same timeframe or source, reducing confidence in full numerical fidelity.\n\n3) The reasoning correctly contrasts CMCSA’s concentrated control via Class B shares with GOOGL’s structure where voting control is insider-concentrated but market value is dispersed among non-affiliates. The multi-hop synthesis—comparing control mechanisms and ownership dispersion across two companies—is logically sound and captures the essence of the question. However, the unsupported addition of GOOGL share class counts weakens the qualitative rigor.\n\n4) The answer remains highly contextually relevant, addressing both companies, their voting structures, and the contrast in control vs. ownership distribution. Despite overextending with unverified numbers, the core comparison is valid and responsive. The correctness score is 7 due to accurate key facts but significant quantitative additions and one calculation error.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 556,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How does the difference in issued Class A and Class B common stock shares between CMCSA and META reflect on their respective equity structure concentration as disclosed in their 2024 filings?",
      "original_answer": "CMCSA disclosed that it issued 4,651,093,045 Class A common shares and 9,444,375 Class B common shares as of December 31, 2024, indicating a significantly higher proportion of Class A shares in its equity structure. META, on the other hand, reported 2,189,898,148 Class A common shares and 343,761,117 Class B common shares outstanding as of January 24, 2025, showing a much higher relative weighting of Class B shares. The evidence from Alphabet's filing clarifies that Class B shares carry 10 votes per share versus 1 vote for Class A, and that Class B shares automatically convert to Class A upon sale or transfer. This suggests META's equity structure maintains stronger voting rights concentration among fewer shareholders compared to CMCSA, where ownership appears more diffused due to the dominance of standard voting Class A shares.",
      "llm_answer": "Comcast’s 2024 filing shows it had roughly 4.65 billion Class A shares issued (and about 3.78 billion outstanding) but only 9.4 million Class B shares issued and outstanding — the equity is overwhelmingly concentrated in the Class A series (see CMCSA page 67). Meta’s 2024 filing reports about 2.19 billion Class A shares and 344 million Class B shares outstanding, so Class B makes up a sizable share of total equity, indicating a far less skewed equity structure than Comcast’s (see META page 1).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the approximate number of Class A and Class B shares for both CMCSA and META, with acceptable rounding (e.g., 4.65 billion vs. 4,651,093,045; 344 million vs. 343,761,117). However, it introduces an irrelevant detail—Comcast’s 3.78 billion shares outstanding—which is not in the original answer and distracts from the issued share focus of the question. The original answer emphasizes issued shares, while the LLM shifts slightly to outstanding, which, while related, is not equivalent. (2) The numbers are quantitatively accurate within reasonable rounding, but the LLM omits the critical voting rights information (10 votes for Class B vs. 1 for Class A) and the automatic conversion upon transfer, which are central to the original answer’s conclusion about voting concentration. This omission weakens the qualitative analysis. (3) The reasoning correctly contrasts the relative proportions of Class A and Class B shares between the two companies, noting that CMCSA’s equity is dominated by Class A shares while META has a more balanced structure. However, it fails to synthesize the key implication—voting control concentration—due to missing the voting rights data, which was provided in the original answer via Alphabet’s filing context. This breaks the multi-hop logic chain. (4) The answer is contextually relevant and addresses the core comparison, but lacks the depth of equity structure analysis (voting rights, control) that the original answer provides. Hence, correctness is reduced due to missing key qualitative details despite numerical accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 442,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How does the exposure of CVS's Oak Street Health business to Medicare reimbursement risks compare to AbbVie's exposure under the IRA's price-setting provisions, given the IRA's impact on the Medicare program?",
      "original_answer": "CVS's Oak Street Health business derives a significant portion of its revenue from Medicare or Medicare Advantage plans and is exposed to risks such as reductions in reimbursement rates and changes in Medicare program rules. The IRA introduces new financial pressures on Medicare-participating drug manufacturers like AbbVie by enabling government price-setting for certain Part B and Part D drugs starting in 2026 and 2028, respectively. AbbVie specifically faces exposure as Imbruvica has already been selected for price-setting under the IRA, with government-dictated prices set to take effect in 2026. This regulatory shift under the IRA compounds the existing Medicare-related risks faced by CVS's Oak Street Health, as both are tied to the same evolving Medicare framework, albeit through different mechanisms—direct reimbursement risk for CVS and mandated pricing for AbbVie.",
      "llm_answer": "CVS’s Oak Street Health business is highly dependent on Medicare and Medicare‑Advantage payments, so any reductions in Medicare reimbursement rates or rule changes to the Medicare program could directly cut its revenue (see CVS 10‑K p. 47). By contrast, AbbVie’s risk stems from the IRA’s new price‑setting authority, which allows the government to cap or set prices for single‑source drugs and biologics reimbursed under Medicare Part B and Part D, potentially lowering drug prices, eroding revenues and exposing the company to penalties for non‑compliance (see AbbVie 10‑K p. 19). Thus, CVS faces payer‑side reimbursement cuts, while AbbVie faces product‑side statutory price caps under the IRA.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information in the ground truth with strong semantic equivalence. (1) All factual elements are correct: CVS's Oak Street Health is exposed to Medicare reimbursement risks due to its reliance on Medicare/Medicare Advantage payments, and AbbVie faces IRA-driven price-setting risks for drugs under Medicare Part B and Part D. The LLM correctly identifies the mechanism of risk—payer-side reimbursement cuts for CVS and product-side price caps for AbbVie. (2) There are no numeric values, dates, or percentages in the LLM answer that conflict with the ground truth; while the ground truth mentions specific years (2026, 2028) and Imbruvica being selected, the LLM omits these details but does not misstate anything. This is a minor completeness gap but does not affect factual correctness. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across CVS and AbbVie, linking both companies’ exposures to the IRA’s impact on Medicare, albeit through different pathways. (4) The answer is contextually precise, directly addressing the comparative exposure question. The only reason for not scoring a 10 is the omission of the specific example of Imbruvica and the exact timeline (2026/2028), which are present in the ground truth and add granularity. However, the absence does not distort meaning or reduce overall accuracy significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 390,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How does Microsoft's inclusion of operating systems in its product revenue influence AMD's dependency on Microsoft's operating system support for its x86-based microprocessor and graphics products?",
      "original_answer": "Microsoft's product revenue includes operating systems, which are critical components for PC functionality. AMD relies on Microsoft to design and develop its operating systems to support AMD's x86-based microprocessors and graphics products. If Microsoft does not continue to support AMD's innovations through its operating systems, independent software vendors may avoid optimizing applications for AMD products, and customers may be less inclined to purchase PCs with AMD components, materially affecting AMD's business.",
      "llm_answer": "Microsoft’s 2022 filing shows that operating‑system licenses are classified as “product revenue” – a core revenue stream for the company (see MSFT 10‑K p. 62).  AMD explicitly warns that its ability to sell and innovate with its x86‑based microprocessors and graphics products “depends partially on Microsoft designing and developing its operating systems to run on or support” those products, and that loss of Microsoft’s OS support would materially hurt AMD’s business (see AMD 10‑K p. 28).  Thus, because Microsoft treats OS as a key product line, AMD’s success is tightly linked to Microsoft’s continued OS development and support.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. (1) It correctly identifies that Microsoft classifies operating system licenses as product revenue, citing the correct context from Microsoft's 10-K (p. 62), and accurately reflects AMD's dependency on Microsoft OS support, citing AMD’s 10-K (p. 28). These citations support the key claims and match the original answer’s intent. (2) There are no numerical values, dates, or calculations in the question or answers that require verification—both responses are qualitative and consistent. (3) The multi-hop reasoning is sound: it connects Microsoft's classification of OS as product revenue to the importance of OS development, then links that to AMD’s reliance on Microsoft for support, explaining the business impact. The logic chain is complete and well-supported. (4) The LLM answer conveys the same core message as the original: AMD’s business success depends on Microsoft continuing to support its hardware through OS development. The only minor shortcoming is that the LLM answer does not explicitly mention the downstream effects on independent software vendors or customer purchasing behavior, which are included in the original answer and help explain *why* lack of support would hurt AMD. While implied in 'materially hurt AMD’s business,' the explicit causal chain is slightly less detailed. Overall, the answer is highly accurate, well-sourced, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 402,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How does Cisco's network infrastructure for AI training and inference workloads compare to Broadcom's support for enterprise-scale AI and machine learning workloads through VMware Cloud Foundation, particularly in terms of enabling multicloud architectures and Kubernetes integration?",
      "original_answer": "Cisco provides high-density routers, switches, and high-performance optics to scale network infrastructure for AI training and inference workloads, aiming to simplify data center operations across multicloud environments. VMware Cloud Foundation (VCF), produced by Broadcom, enables enterprise-scale AI and machine learning workloads by offering native Kubernetes support, allowing both virtual machines and containerized workloads to run on a single platform. VCF also provides license portability, enabling customers to move environments between on-premises and cloud endpoints, aligning with Cisco's vision of policy and operational consistency across multicloud architectures. Broadcom values VCF through developed technology using the multi-period excess earnings method, reflecting its strategic role in supporting AI workloads.",
      "llm_answer": "Cisco’s AI‑training and inference offering relies on its high‑density routing and switching hardware (e.g., Cisco 8000‑series routers, Nexus 9000 data‑center switches) together with high‑performance optics and software‑based automation (Cisco DNA) to scale network capacity and deliver “multicloud architectures that bring policy and operational consistency, regardless of where applications or data reside”【page_4】. Broadcom, by contrast, delivers AI/ML capability through VMware Cloud Foundation, a software‑defined private‑cloud platform that integrates compute, networking, storage and management, embeds native Kubernetes for both VMs and containers, and provides license‑portability so AI/ML workloads can run at enterprise scale across on‑premise data centers and public‑cloud endpoints【page_8】【page_9】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: Cisco's role in providing high-density routers (e.g., 8000-series), switches (Nexus 9000), optics, and software automation (Cisco DNA) for AI/ML network infrastructure is accurately described, as is Broadcom's delivery of AI/ML capabilities via VMware Cloud Foundation (VCF). The description of VCF’s native Kubernetes support, integration of compute/storage/networking, and license portability across on-premises and cloud environments matches the original answer. (2) There are no numeric values, dates, or financial figures in either answer that require verification—thus, quantitative accuracy is unaffected and scores perfectly. (3) Multi-hop reasoning is sound: the model correctly synthesizes Cisco’s hardware-centric network infrastructure approach with Broadcom’s software-defined VCF platform, and draws a valid comparison in how both support multicloud architectures and Kubernetes, albeit through different layers (networking vs. cloud foundation). (4) The only minor omission is that the LLM answer does not mention Broadcom’s valuation of VCF using the multi-period excess earnings method, which appears in the ground truth and speaks to the strategic financial valuation of VCF in supporting AI workloads. This is a secondary detail but contributes to completeness. Despite this, the core of the question—comparing Cisco and Broadcom/VCF in enabling multicloud and Kubernetes for AI workloads—is thoroughly and correctly addressed. Wording differs but semantic equivalence is strong. Contextual relevance is excellent as all content directly addresses the comparative, multi-faceted question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 467,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How does PayPal's use of pricing models for derivatives compare to Morgan Stanley's Level 3 valuation techniques, particularly in terms of reliance on unobservable inputs for fair value measurement?",
      "original_answer": "PayPal primarily uses Level 2 inputs for its derivatives, incorporating observable data such as currency rates, interest rate yield curves, option volatility, and equity prices in its pricing models, and did not have any Level 3 assets or liabilities as of December 31, 2024. In contrast, Morgan Stanley utilizes Level 3 classifications when unobservable inputs are significant, particularly for non-exchange-traded investments and certain secured financings where market liquidity is limited or unavailable. This indicates that Morgan Stanley has a greater reliance on internally derived assumptions for fair value measurement compared to PayPal, which avoids Level 3 classifications entirely.",
      "llm_answer": "PayPal says that most of its derivatives are valued with pricing models that use contract terms together with observable market data (e.g., currency rates, yield curves, option volatilities) and it has no recurring fair‑value items that require significant unobservable inputs – its derivative valuations are classified as Level 2 【page_93】. Morgan Stanley, by contrast, reports sizable Level 3 fair‑value positions (e.g., mortgage‑backed securities, CDOs, certain OTC and equity‑linked contracts) whose valuations depend on significant unobservable assumptions such as credit‑correlation, illiquid spread inputs or other model‑derived estimates, requiring a higher degree of judgment 【page_96】【page_97】【page_98】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly states that PayPal uses Level 2 inputs for its derivatives, relying on observable market data such as currency rates, yield curves, and option volatilities, and explicitly notes the absence of recurring fair-value items requiring significant unobservable inputs—aligning with the original answer's claim that PayPal had no Level 3 assets or liabilities as of December 31, 2024. (2) For Morgan Stanley, the LLM accurately highlights the use of Level 3 classifications with significant unobservable inputs, citing specific examples like mortgage-backed securities, CDOs, and OTC contracts, and mentions inputs such as credit correlation and illiquid spread estimates, which reflects the original answer’s emphasis on internally derived assumptions due to limited market liquidity. (3) The multi-hop reasoning is sound: the model correctly contrasts PayPal’s avoidance of Level 3 with Morgan Stanley’s reliance on it, synthesizing information across both companies’ valuation techniques. (4) All entities (PayPal, Morgan Stanley), financial concepts (Level 2 vs Level 3, unobservable inputs), and contexts (fair value measurement of derivatives) are accurately identified and compared. Minor wording differences (e.g., 'no recurring fair-value items' vs 'did not have any Level 3 assets') do not affect factual equivalence. No numerical inaccuracies; no dates or figures are incorrect. The answer fully addresses the comparative aspect of the question regarding reliance on unobservable inputs.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 435,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "Given that META's Class B common stockholders have limited voting rights on specific corporate actions, and CMCSA's Class A common stock is the primary voting share class, how might the ownership structure of 343,761,117 outstanding Class B shares at META affect the potential for shareholder-driven governance changes compared to CMCSA's 3,778,302,017 outstanding Class A shares?",
      "original_answer": "META's Class B common stockholders, of which there are 343,761,117 outstanding shares, possess limited voting rights, only applicable in specific corporate actions such as exiting the core payments business or certain mergers. This restricts their ability to influence broader governance decisions, which are largely controlled by Class A shareholders. In contrast, CMCSA's 3,778,302,017 outstanding Class A shares carry full voting rights, enabling more direct shareholder influence over corporate governance. As a result, shareholder activism or governance overhauls would face a higher threshold for success at META due to the constrained voting power of its Class B holders, compared to the more broadly distributed and influential Class A shareholder base at CMCSA.",
      "llm_answer": "Meta’s 343,761,117 outstanding Class B shares (page 1) carry only limited voting rights on a narrow set of corporate actions, so even a sizable holder of those shares cannot readily influence broader governance matters. By contrast, Comcast’s 3,778,302,017 outstanding Class A shares (page 67) constitute the primary voting class, giving its shareholders a far larger and unrestricted voting base to drive shareholder‑led governance changes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: META has 343,761,117 Class B shares with limited voting rights, and CMCSA has 3,778,302,017 Class A shares as the primary voting class. The numbers match exactly and are correctly attributed. (2) Quantitative accuracy is perfect—both share counts are correct, and no calculations were required beyond accurate reporting. (3) The reasoning correctly synthesizes the multi-hop concept: limited voting rights at META restrict shareholder-driven governance changes, while CMCSA’s broad voting share base enables greater influence. The LLM correctly infers that despite the large number of META Class B shares, their restricted voting power limits governance impact. (4) The only minor shortcoming is that the LLM does not explicitly name the specific corporate actions (e.g., exiting core payments business or certain mergers) where Class B votes apply, which is included in the ground truth and adds nuance. However, the phrase 'narrow set of corporate actions' captures this idea generally. Overall, the answer is factually sound, contextually relevant, and semantically equivalent to the original, with only slight room for added specificity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 352,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "What percentage of KO's non-U.S. unit case volume is attributable to sparkling soft drinks in territories where CCEP operates, and how does this compare to PM's operational presence in Portugal, one of CCEP's key markets?",
      "original_answer": "KO's non-U.S. unit case volume is 71% attributable to sparkling soft drinks in territories where CCEP operates, including Portugal. Meanwhile, PM has a manufacturing facility in Portugal, which is among its largest facilities producing over 30 billion units (cigarettes and heated tobacco units combined). This highlights KO's significant reliance on CCEP for sparkling beverage distribution in key international markets, while PM maintains a direct production footprint in one of those same strategic locations.",
      "llm_answer": "Coca‑Cola’s non‑U.S. unit‑case volume is 71 % sparkling soft drinks – a share that applies to all of its overseas markets, including the territories where its bottling partner CCEP operates【page_7】.  In contrast, PepsiCo’s footprint in one of CCEP’s key markets, Portugal, is a physical manufacturing site – one of the company’s largest plants worldwide【page_19】.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 71% figure for KO's non-U.S. unit case volume attributable to sparkling soft drinks in CCEP-operated territories, which matches the ground truth. However, it generalizes this share as applying to 'all of its overseas markets' rather than specifically emphasizing that the 71% is tied to CCEP-operated territories, slightly misrepresenting the scope. (2) The quantitative accuracy is high—the percentage (71%) is correct, and there are no calculation errors. The reference to Portugal and a manufacturing facility aligns with the ground truth. (3) The multi-hop reasoning is partially sound: it connects KO’s reliance on CCEP with PM’s (actually PepsiCo’s) presence in Portugal. However, there is a critical entity error: the LLM refers to 'PM' as having a facility in Portugal, but 'PM' refers to Philip Morris, while the correct company in the context is PepsiCo. This undermines the qualitative accuracy, as the comparison is between KO and PepsiCo, not Philip Morris. The original answer correctly contrasts KO with PM (Philip Morris), noting PM's tobacco production in Portugal. The LLM incorrectly substitutes PM for PepsiCo, which is a significant factual and entity-level error. (4) Despite this major entity confusion, the answer retains contextual relevance by discussing manufacturing presence in Portugal and distribution reliance on bottlers. The correctness score is reduced to 7 due to the entity mix-up, though core numbers and structure are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 417,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "Given Cisco's reduced credit loss allowance for loan receivables from $103 million in 2022 to $53 million in 2023, how might this change impact their ability to finance technical support services, which are explicitly included in their loan receivables portfolio?",
      "original_answer": "Cisco's credit loss allowance for loan receivables decreased by 48.5% from $103 million in 2022 to $53 million in 2023. Since Cisco explicitly states that loan receivables include financing arrangements for technical support services, this reduction in credit loss allowance suggests improved credit quality or lower risk in these financing arrangements. A smaller allowance could indicate Cisco is more confident in the creditworthiness of customers receiving technical support financing, potentially enabling Cisco to expand financing options for technical support services with reduced financial risk. This could lead to more competitive financing terms for customers seeking technical support services.",
      "llm_answer": "Cisco’s allowance for credit losses on loan receivables dropped from $103 million in 2022 to $53 million in 2023 (Note 9, “Allowance for credit loss roll‑forward,” page 84). Since loan receivables expressly cover financing for hardware, software and **technical‑support services** (Note 9 (a), page 82), the lower allowance indicates Cisco expects fewer defaults and frees roughly $50 million of net receivable capacity, which can be redeployed to fund or expand its technical‑support financing programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the reduction in Cisco's credit loss allowance from $103 million in 2022 to $53 million in 2023, matching the ground truth. The implied $50 million difference is accurate (103 - 53 = 50), though the percentage decrease (48.5%) is not explicitly mentioned, which is a minor omission. (2) All numeric values and years are correct, and the calculation of the $50 million freed capacity is logically derived and factually sound. Format variations (e.g., $50 million) are acceptable. (3) The multi-hop reasoning is strong: the model correctly links the reduced allowance to improved credit expectations, identifies that technical support services are part of loan receivables (citing Note 9(a)), and infers that freed capacity could be redeployed to expand financing—aligning with the ground truth’s conclusion about expanded financing options. The only slight gap is not explicitly stating that the reduced allowance reflects higher confidence in customer creditworthiness, though 'fewer defaults' implies this. (4) The answer is highly relevant, directly addressing how the allowance change impacts financing for technical support services. The inclusion of footnote references adds precision. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with only minor depth differences in explanatory nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 390,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How does AT&T's Series B Preferred Stock structure, which grants limited voting rights only on specific merger-related matters, compare to Netflix's universal voting rights for common stockholders in terms of corporate governance influence?",
      "original_answer": "AT&T's Series B Preferred Stockholders have no voting rights except on specific merger-related matters where they can vote as a single class with each holder casting votes equal to the number of shares held. This contrasts with Netflix, where each share of common stock provides one vote on all matters to be voted upon by stockholders, giving common stockholders broader governance influence. AT&T's structure limits Series B Preferred Stockholders' influence to defined corporate actions, whereas Netflix's model ensures universal voting participation for common stockholders.",
      "llm_answer": "AT&T’s Series B preferred shares are essentially non‑voting except for a narrow set of merger‑ or consolidation‑related actions, where holders may vote only on those specific transactions (see AT&T 10‑K p. 90). In contrast, Netflix’s common stock grants each share one vote on every shareholder matter, giving all stockholders universal voting power over the company’s governance (see Netflix 10‑K p. 61). Thus, AT&T’s preferred investors have a much more limited corporate‑governance role than Netflix’s broadly empowered common shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: AT&T’s Series B Preferred Stock has limited voting rights only on specific merger-related matters, while Netflix’s common stock provides one vote per share on all matters. There are no numerical values requiring calculation, but the qualitative financial terms (e.g., non-voting, universal voting power) are correctly interpreted. (2) The answer cites specific page numbers from the 10-Ks (p. 90 for AT&T, p. 61 for Netflix), which aligns with the expected sourcing and adds precision, though these were not in the original ground truth—this is a strength, not an error. (3) The multi-hop reasoning is sound: the model correctly synthesizes governance structures across two different companies and contrasts their implications for corporate influence. (4) Minor deduction in qualitative accuracy due to slightly stronger phrasing ('essentially non-voting') compared to the more precise 'no voting rights except...', but this does not distort meaning. Overall, the answer is complete, contextually relevant, and conveys the same core comparison as the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 331,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How does PayPal's risk of technological disruption from emerging payment methods like BNPL and cryptocurrency compare with Visa's strategic positioning as both partner and competitor to these alternative payment providers?",
      "original_answer": "PayPal faces significant risk from rapid technological changes, particularly in payment methods like BNPL and cryptocurrency, which could render its current offerings obsolete if not adopted timely. Visa, on the other hand, strategically partners with these alternative payment providers while also competing with them, leveraging its global network and security advantages to maintain relevance. This dual role allows Visa to adapt to the evolving payments landscape, whereas PayPal must invest heavily to keep pace or risk losing market share to these emerging platforms.",
      "llm_answer": "PayPal treats BN Pay‑Later and crypto as a technology‑risk that could erode its business – its 2022 10‑K warns that “if we cannot keep pace with rapid technological developments…our revenues could decline” and calls out specific regulatory and custodial exposures for its BNPL offering (CFPB order) and cryptocurrency products (custody‑theft risk and evolving regulation)【page_18】【page_19】【page_20】. In contrast, Visa describes the same alternative‑payment players as “alternative payments providers…BNPL solutions and cryptocurrency platforms” that can be “both a partner and a competitor” and leans on its global brand, network‑of‑networks and value‑added services to stay competitively positioned【page_16】. Thus PayPal is on the defensive, fearing disruption, while Visa adopts a dual‑partner/competitor stance to capture opportunities from those emerging methods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) It correctly identifies PayPal's exposure to technological disruption from BNPL and cryptocurrency, citing specific risks mentioned in its 10-K (regulatory issues with CFPB, custody-theft risk, evolving regulation), which matches the qualitative risk assessment in the ground truth. It also accurately characterizes Visa's dual role as both partner and competitor to alternative payment providers, referencing its strategic advantages (global brand, network-of-networks), which is semantically equivalent to the original answer. (2) There are no numeric values, dates, or financial figures in the question or ground truth that require verification; the LLM does not introduce any incorrect numbers and correctly references page numbers from the filings as evidence, which supports authenticity. (3) The multi-hop reasoning is sound: the model synthesizes information from both PayPal’s and Visa’s 10-K filings, compares their strategic postures, and draws a valid contrast—PayPal as reactive/defensive vs. Visa as adaptive/strategic. The use of direct quotes (e.g., 'if we cannot keep pace...') enhances fidelity. (4) Minor deduction in qualitative accuracy due to slightly more emphasis on regulatory/custodial risks than the original answer, but this is supported by the source and adds depth rather than misrepresenting. Overall, the answer is factually correct, contextually complete, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 420,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How does the voting power per share of Netflix's common stock compare to the voting rights associated with Alphabet's Class A Common Stock, given both companies' disclosed equity structures?",
      "original_answer": "Netflix's common stock grants one vote per share, as stated in its 2023 10-K filing. Similarly, Alphabet's Class A Common Stock also provides one vote per share, as outlined in its 2023 10-K filing. This indicates that both companies offer equivalent voting power per share for their respective common stockholders, despite Alphabet having multiple stock classes with differing voting rights, such as Class B shares with 10 votes per share.",
      "llm_answer": "Netflix’s 2023 proxy statement notes that each share of its common stock carries **one vote per share** 【page_61】. Alphabet’s 2023 Form 10‑K similarly states that each share of its **Class A common stock is entitled to one vote per share** (while its Class B shares have ten votes) 【page_81】. Thus, the voting power per share of Netflix’s common stock is the same as the voting rights attached to Alphabet’s Class A shares—both provide one vote per share.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the key fact that both Netflix and Alphabet Class A shares provide one vote per share is accurately stated, with no numerical or date errors. The mention of Alphabet's Class B shares having ten votes per share is also factually correct and consistent with the 2023 10-K. (2) The answer is complete, addressing both companies' voting structures and making the correct comparison. (3) Entity accuracy is perfect: Netflix, Alphabet, Class A and Class B shares, and the 2023 filing year are all correctly identified. (4) The reasoning is sound and demonstrates proper multi-hop synthesis by retrieving and comparing equity structures from two different companies' filings. The conclusion that voting power per share is equivalent for Netflix common stock and Alphabet Class A stock is logically and factually supported. Minor wording differences (e.g., 'proxy statement' vs '10-K' for Netflix) do not affect factual accuracy, as both documents disclose the same voting rights. Semantic equivalence is maintained throughout.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 316,
        "total_tokens": 1550
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How does the use of the parametric delta-gamma approximation technique by PM under normal market conditions compare with MDLZ's application of the same method, particularly in terms of their respective VAR estimates and risk exposure assumptions?",
      "original_answer": "Both PM and MDLZ utilize the parametric delta-gamma approximation technique in their VAR models under normal market conditions, with a 95% confidence interval and a one-day holding period. PM observed interest rate and forward currency rate movements primarily over the preceding quarter to determine interrelationships and calculate risk for their portfolio. MDLZ similarly observed interest rate, currency exchange, and commodity price movements over the prior quarter for VAR calculations at year-end. However, MDLZ specifically notes that the values of currency and commodity options do not change on a one-to-one basis with the underlying assets and were valued accordingly, while PM focuses on interrelationships between movements in interest rates and currencies. Both companies use VAR to estimate maximum potential one-day losses, but MDLZ provides specific disclosure of their VAR amounts at year-end, while PM focuses on the methodology and assumptions without disclosing a specific VAR figure.",
      "llm_answer": "Both companies compute VaR with a parametric delta‑gamma approximation assuming normal market conditions, a 95 % confidence level and a one‑day holding period (PM page 81; MDLZ page 64). PM’s VaR for interest‑rate‑sensitive instruments is roughly $300‑$500 million (average $332 m) and its foreign‑currency fair‑value VaR about $70‑$80 million, whereas MDLZ’s interest‑rate VaR is only $119‑$234 million (average $144 m) and its foreign‑currency (pre‑tax earnings) VaR $14‑$18 million, reflecting a smaller exposure that also includes commodity‑price risk. Thus, while the methodological assumptions are the same, MDLZ’s estimated potential losses are considerably lower and are reported both as fair‑value and earnings‑impact, whereas PM reports only fair‑value impacts.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that PM does not disclose a specific VAR figure, but the LLM claims PM's interest-rate VaR is $300–$500 million and foreign-currency VaR is $70–$80 million—these numbers are entirely fabricated and not present in the original answer. Similarly, the LLM attributes specific VAR ranges to MDLZ (e.g., $119–$234 million for interest rates, $14–$18 million for currency), but the original answer only states that MDLZ discloses VAR amounts at year-end without specifying these exact figures. (2) There are no verifiable calculations in the ground truth to support the LLM's numerical ranges; thus, all quantitative claims are incorrect. The format variations are acceptable in principle, but the numbers themselves are false. (3) The multi-hop reasoning is partially sound in that the LLM correctly identifies that both companies use the parametric delta-gamma method, a 95% confidence level, and a one-day holding period. It also correctly notes differences in disclosure practices—MDLZ reports specific VAR amounts while PM focuses on methodology. However, the LLM incorrectly infers that PM reports any VaR figures at all, contradicting the ground truth. Additionally, the claim that MDLZ reports VaR in both fair-value and earnings-impact terms is not supported in the original answer. (4) The contextual relevance is moderate because the structure and intent of the comparison align with the question, and some qualitative aspects (methodology, confidence level, holding period) are correct. However, the inclusion of completely inaccurate numerical data severely undermines the answer’s correctness, warranting a low score overall.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 471,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How does Capital One's exposure to the Market Risk Rule, which adjusts capital ratios based on trading book risks, compare with JPMorgan Chase's regulatory capital requirements under Basel III, particularly in relation to their respective trading asset thresholds and VaR methodologies?",
      "original_answer": "Capital One (COF) is subject to the Market Risk Rule due to its trading assets and liabilities exceeding $1 billion or 10% of total assets, requiring adjustments to its risk-based capital ratios. This rule supplements the Basel III Capital Rules, which are also central to JPMorgan Chase's (JPM) regulatory capital framework. JPM calculates Regulatory VaR under Basel III with a 99% confidence level and a ten-business-day holding period, applying it to 'covered' positions. In contrast, COF’s capital adequacy is evaluated under Basel III standardized and proposed Expanded Risk-Based Approaches, with the latter phasing in by 2028. These differences highlight how both firms manage market risk capital requirements, with JPM using a more granular internal VaR model while COF must comply with both current and evolving Basel III standards.",
      "llm_answer": "Capital One is subject to the “Market Risk Rule” because its trading‑book assets and liabilities exceed the rule’s trigger—either 10 % of total assets or $1 billion—so the firm must adjust its risk‑based capital ratios to reflect trading‑book risk. JPMorgan Chase, by contrast, meets Basel III capital requirements that incorporate a VaR framework: a historical‑simulation model using the prior 12 months of data, with a 1‑day, ≈95 % confidence “Risk‑Management VaR” and a 10‑day, ≈99 % confidence “Regulatory VaR” that feeds directly into its market‑risk capital charge. Thus, Capital One’s exposure is triggered by a size‑based trading‑asset threshold and leads to ratio adjustments, while JPMorgan’s capital is driven by detailed VaR calculations rather than a specific asset‑size threshold.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Capital One is subject to the Market Risk Rule due to exceeding $1 billion or 10% of total assets in trading assets/liabilities, and that this affects its risk-based capital ratios—this aligns with the ground truth. It also correctly states that JPMorgan Chase uses a VaR framework under Basel III. However, there is a significant quantitative inaccuracy: the LLM claims JPM uses a '1-day, ≈95% confidence' Risk-Management VaR, which is not supported by the original answer. The ground truth specifies only the 'Regulatory VaR' with a 99% confidence level and 10-business-day holding period for covered positions; it does not mention a 1-day or ≈95% VaR. This misrepresents JPM’s regulatory methodology. (2) The dollar amount ($1 billion) and percentage threshold (10%) are correct. The description of Capital One’s exposure being size-based is accurate. But the VaR confidence level and holding period for JPM are partially incorrect—while the 10-day and 99% Regulatory VaR is correct, the addition of a 1-day ≈95% VaR is extraneous and not in the ground truth, potentially confusing risk-management vs. regulatory VaR without clarification. (3) The multi-hop reasoning is generally sound: the model correctly contrasts Capital One’s threshold-based trigger with JPMorgan’s model-based VaR approach. It synthesizes the idea that COF complies with size-triggered rules while JPM applies internal VaR models under Basel III. However, it misses the detail that COF is transitioning under the proposed Expanded Risk-Based Approaches phasing in by 2028, which is a key differentiator in their long-term capital treatment. This omission reduces completeness. (4) The contextual relevance is high—the answer directly addresses the comparison of market risk exposure and capital requirements. Qualitative accuracy is good due to correct entity identification (COF, JPM), proper framing of regulatory frameworks, and logical comparison. Quantitative accuracy is reduced due to the unsupported ≈95% and 1-day VaR claim. Correctness score is 7 because core facts are right but key technical details about VaR are inaccurate or added without basis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 587,
        "total_tokens": 2030
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How does Cisco's credit loss allowance for loan receivables tied to technical support services compare to Salesforce's reliance on third-party technical support providers, given both companies' exposure to service delivery risks?",
      "original_answer": "Cisco reported a $53 million credit loss allowance for loan receivables as of July 29, 2023, which includes financing arrangements specifically related to technical support services provided to customers. This indicates a financial risk exposure tied directly to service delivery outcomes. Meanwhile, Salesforce acknowledges its reliance on third parties to deliver technical support services to customers, stating that dissatisfaction with third-party service quality could harm its business and revenue recognition. While Cisco directly finances its technical support services and bears credit risk, Salesforce's risk manifests through potential third-party service failures affecting customer satisfaction and retention.",
      "llm_answer": "Cisco reports an allowance for credit losses of **$50 million on its loan receivables** – which include financing tied to the sale of hardware, software and “technical support and advanced services” (see Cisco 10‑K, Note 9, “Allowance for credit loss” $50 m for loan receivables, page 82/84).  \n\nSalesforce, by contrast, does not quantify a credit‑loss reserve for its service‑delivery exposure; instead it **discloses a qualitative reliance on third‑party providers** to deliver professional and technical support for its applications and warns that failures by those providers could hurt its business (Salesforce 10‑K, “Any failure in the delivery of high‑quality professional and technical support services…”, page 19).  \n\nThus, Cisco translates its support‑related risk into a $50 million allowance, whereas Salesforce’s risk is described only in narrative terms, without a specific credit‑loss amount.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Cisco's credit loss allowance and its connection to technical support financing, and accurately characterizes Salesforce's reliance on third-party providers and associated risks. However, the dollar amount reported for Cisco is $50 million, while the ground truth specifies $53 million as of July 29, 2023. This $3 million discrepancy affects quantitative accuracy. The date is not mentioned in the LLM answer, which is a minor omission but relevant for full precision. (2) The number $50 million is incorrect per the ground truth ($53 million); all other qualitative details (e.g., no quantified reserve for Salesforce, risk through third-party service quality) are factually aligned. Format variation ($50 million vs $53 million) is not acceptable here because it's a material difference in financial reporting context. (3) The multi-hop reasoning is sound: the model correctly synthesizes Cisco’s financial risk via credit allowances tied to service financing and contrasts it with Salesforce’s operational risk via third-party dependencies. The comparison logic — one company quantifies risk in financial reserves, the other discloses it qualitatively — is accurate and insightful. (4) Scores reflect high correctness due to strong qualitative and contextual alignment, with a moderate deduction in quantitative accuracy due to the incorrect dollar figure. Contextual relevance is perfect as all aspects of the question are addressed directly and appropriately.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 416,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How does the governance risk associated with META's dual-class structure, particularly its impact on investor confidence in Class A common stock, contrast with CMCSA's equity structure that includes Class B common stock but lacks a conversion mechanism tied to governance restrictions?",
      "original_answer": "CMCSA's equity structure includes 9,444,375 issued and outstanding shares of Class B common stock as of 2023, but unlike META, there is no indication that CMCSA ties governance rights or stock conversion to special investor restrictions. In contrast, META's dual-class structure grants Class B stockholders, including Mr. Zuckerberg, disproportionate control over corporate decisions, such as requiring a majority of Class B stock approval for any change in control until those shares represent less than 35% of combined voting power. META also notes that its status as a 'controlled company' could make its Class A common stock less attractive to some investors due to reduced corporate governance protections. This implies that while both companies have Class B shares, META's structural governance risks tied to its dual-class system are more pronounced and explicitly linked to investor sentiment toward Class A shares, unlike CMCSA where the Class B shares do not appear to carry similar governance-linked conversion or control features.",
      "llm_answer": "Meta’s dual‑class design gives its ten‑vote Class B shares – held mainly by Mark Zuckerberg and other insiders – a controlling stake, so that holders of the one‑vote Class A shares “will limit or preclude your ability to influence corporate matters” and the company’s “controlled‑company” status “could make our Class A common stock less attractive to some investors” (Meta 10‑K pp. 48‑49). By contrast, Comcast’s equity includes a non‑voting Class B that can be converted one‑for‑one into voting Class A shares, but the conversion is limited to eligible customers and requires the new Class A shares to be sold, and there is no governance‑control provision attached to the conversion (Comcast 10‑K p. 99). Thus Meta’s structure creates a governance‑risk premium that can depress confidence in Class A stock, whereas Comcast’s structure does not concentrate voting power and therefore carries far less governance‑related investor‑confidence risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core governance differences between META and CMCSA, citing relevant risks in META's dual-class structure and referencing investor confidence impacts on Class A shares. It accurately quotes language from META's 10-K about limited influence and reduced attractiveness of Class A stock, aligning with the ground truth. However, it introduces a significant factual inaccuracy regarding CMCSA (Comcast): the claim that CMCSA's Class B shares are 'non-voting' and can be converted one-for-one into Class A shares 'limited to eligible customers' is not supported by the ground truth. The original answer states only that CMCSA has 9,444,375 Class B shares outstanding with no mention of voting rights, conversion mechanisms, or customer eligibility—details the LLM fabricates or misrepresents. This undermines the qualitative accuracy, especially in multi-hop reasoning, as the contrast hinges on an incorrect characterization of CMCSA’s structure. While the overall direction of the comparison (META has stronger governance risks) is correct, the flawed description of CMCSA’s equity structure reduces factual reliability. Quantitative accuracy is high because no incorrect numbers are introduced (though the LLM omits the specific share count of 9,444,375 for CMCSA’s Class B shares mentioned in the ground truth). Contextual relevance is strong as the response directly addresses governance risk, investor confidence, and structural contrasts. The reasoning would be sound if based on accurate data, but the invented conversion mechanism and voting status for CMCSA’s shares constitute a major deviation from the source truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 451,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How does AIG's valuation of RMBS using discounted cash flow models compare to MS's use of discounted cash flow in fair value estimation, particularly in terms of reliance on unobservable inputs?",
      "original_answer": "AIG values its RMBS portfolio using discounted cash flow models that rely heavily on unobservable inputs such as constant prepayment rate (ranging from 4.10% to 9.26%) and loss severity (ranging from 40.81% to 76.72%). Similarly, MS identifies discounted cash flow as a key valuation technique in estimating fair value for financial instruments and goodwill impairment testing, particularly for Level 3 assets which rely on significant unobservable inputs. MS notes that Level 3 assets represented 0.9% of total assets as of December 31, 2024, indicating a smaller but still material reliance on unobservable assumptions in their fair value measurements.",
      "llm_answer": "AIG values its RMBS as Level‑3 assets with a discounted‑cash‑flow model that relies on several security‑specific unobservable inputs – a constant pre‑payment rate, loss‑severity, constant default rate and the yield used in the model (AIG 10‑K p. 120‑119). Morgan Stanley also uses discounted‑cash‑flow techniques for fair‑value measurement of intangible assets and goodwill, but its unobservable inputs are mainly management’s projected cash‑flows and a cost‑of‑equity derived from the CAPM, and Level‑3 assets represent only a small share of its total assets (MS 10‑K p. 42). Thus, both firms depend on unobservable inputs, but AIG’s RMBS valuation is more granular and driven by security‑specific assumptions, whereas MS’s DCF is applied at the reporting‑unit level with broader macro‑level assumptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that AIG uses discounted cash flow (DCF) models for RMBS valuation relying on unobservable inputs such as constant prepayment rate and loss severity, consistent with the original answer. While the LLM adds 'constant default rate' and 'yield' not explicitly mentioned in the ground truth, these are plausible unobservable inputs in DCF models for RMBS and do not contradict the source. (2) For Morgan Stanley (MS), the LLM correctly states that DCF is used for fair value estimation of intangible assets and goodwill, particularly involving Level 3 assets, and notes their small proportion—though the exact percentage (0.9%) is omitted, the qualitative description 'small share' is consistent. The reference to management’s projected cash flows and cost of equity via CAPM is reasonable context not contradicted by the ground truth. (3) The multi-hop reasoning is sound: the LLM compares AIG’s security-specific, granular use of unobservables in RMBS valuation to MS’s broader, reporting-unit-level DCF applications, correctly highlighting differences in scope and granularity. (4) All entities (AIG, MS, RMBS, Level 3 assets) and valuation techniques are accurately identified. The only minor gap is the absence of the specific 0.9% figure for MS’s Level 3 assets, which slightly affects quantitative precision but not overall correctness. Wording differs but semantic meaning and factual content are equivalent. Thus, the answer earns a 9 for correctness, with high marks across all dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 435,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How does the change in Cisco's allowance for credit losses on loan receivables tied to hardware financing compare to Microsoft's revenue recognition approach for hardware that is similarly interdependent with software, and what does this reveal about their respective financial exposures to integrated hardware-software offerings?",
      "original_answer": "Cisco's allowance for credit losses on loan receivables tied to hardware financing decreased from $103 million in fiscal year 2022 to $53 million in fiscal year 2023, indicating a reduction in expected defaults on financing extended for hardware sales. These loan receivables are explicitly tied to the sale of Cisco's hardware and third-party products. Meanwhile, Microsoft recognizes hardware revenue at the point of sale only when it is transferred to resellers or end customers, especially in cases where the hardware is highly interdependent with the operating system and cannot function without it, similar to Cisco's financing structure for integrated offerings. This reveals that while Cisco manages credit risk exposure through allowances on multi-year financing arrangements, Microsoft's financial exposure is more closely tied to point-of-sale recognition, with less direct credit risk but greater dependency on the performance of integrated software-hardware systems post-sale.",
      "llm_answer": "Cisco’s allowance for credit losses on loan receivables that finance its hardware fell $3 million, from $53 million at July 29 2023 to $50 million at July 27 2024 (see Cisco 10‑K p. 84/82). Microsoft, by contrast, treats hardware that cannot operate without its software as a single performance obligation and records the full revenue at the point of transfer to the customer (see Microsoft 10‑K p. 62). Thus, Cisco’s financial exposure is tied to credit risk on the financing of integrated hardware‑software sales, whereas Microsoft’s exposure is mainly about the timing and allocation of revenue for bundled offerings, with far less direct credit‑loss risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, Cisco's allowance for credit losses decreased from $103 million in fiscal year 2022 to $53 million in fiscal year 2023—a $50 million reduction. However, the LLM incorrectly states a decrease from $53 million in 2023 to $50 million in 2024, which misrepresents both the time period and the magnitude of change. This is a critical error in financial context, especially since the question focuses on comparing changes over a specific period (2022 to 2023). (2) The calculation of the change is also wrong: the LLM reports a $3 million decrease, but the correct decrease is $50 million. Additionally, the fiscal years cited (2023 to 2024) do not align with the original answer’s 2022 to 2023 comparison, indicating a mismatch in timeframes. (3) On qualitative reasoning, the LLM correctly identifies that Cisco’s exposure stems from credit risk in financing arrangements and that Microsoft recognizes hardware revenue at point of sale when interdependent with software. It also correctly notes Microsoft bundles hardware and software as a single performance obligation. However, it fails to mention that Cisco’s financing is tied to both its own and third-party hardware, and it misses the broader implication that Cisco’s model creates ongoing credit risk exposure, while Microsoft’s model shifts risk to post-sale performance rather than default risk. (4) Contextual relevance is strong—the answer addresses the core contrast in financial exposure models and cites appropriate concepts from revenue recognition and credit loss allowances. Despite correct conceptual framing, the severe quantitative inaccuracies and incorrect time periods undermine the factual reliability, leading to a correctness score of 4. The answer is partially right in logic but fundamentally flawed in data.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 516,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How does AIG's $75 million loss from embedded derivatives in 2024 compare to MS's credit risk exposure through CDOs that contain similar hybrid instruments with embedded derivatives, given both firms' involvement in structured credit products?",
      "original_answer": "AIG reported a $75 million loss from embedded derivatives in 2024, indicating significant credit-related losses from these structured instruments. MS disclosed involvement in CDOs and CLNs that are classified as hybrid instruments containing embedded derivatives, where credit protection has been sold to the issuer. If a credit event occurs on the underlying reference entity, the principal balance of the note may not be repaid in full to the Firm. This parallels AIG’s exposure, as both firms face direct credit risk tied to the performance of reference entities in structured products, with MS’s CDOs posing similar potential for principal loss under credit events as seen in AIG’s realized loss.",
      "llm_answer": "AIG reported a $75 million loss from embedded‑derivative positions in 2024 (see the “Embedded derivatives” line in its derivative‑income table)【page_144】.  Morgan Stanley’s credit‑risk exposure tied to CDOs that contain similar hybrid instruments is reflected in the “Debt and equity interests” line for CDOs in its non‑consolidated VIE table – about $62 million for 2024【page_128】.  Thus, AIG’s loss is roughly $13 million larger than the credit‑risk exposure Morgan Stanley carries on its CDO holdings.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual and reasoning errors that undermine its correctness. (1) Quantitatively, while AIG's $75 million loss in 2024 is correctly stated, the claim that Morgan Stanley has a $62 million credit-risk exposure from CDOs is not supported by the ground truth. The original answer does not provide any specific dollar amount for MS's exposure—only a qualitative description of its involvement in CDOs and CLNs with embedded derivatives. Thus, the $62 million figure appears to be fabricated or misattributed, and the $13 million difference calculation is therefore invalid. (2) The LLM incorrectly equates 'Debt and equity interests' in non-consolidated VIEs with 'credit risk exposure through CDOs containing hybrid instruments,' which is a misinterpretation of both the financial structure and the data source. The ground truth emphasizes risk due to sold credit protection and potential principal loss upon credit events, not a direct balance-sheet exposure amount. (3) Qualitatively, the reasoning fails to capture the multi-hop synthesis required: it does not recognize that AIG’s $75M is a realized loss, while MS’s exposure is potential/unrealized, making a direct numerical comparison invalid. The original answer draws a conceptual parallel in risk type (credit risk from embedded derivatives in structured products), not a quantitative one. (4) Contextually, the answer addresses both firms and structured credit products, so it remains relevant, but the incorrect use of numbers and misrepresentation of risk metrics severely reduce accuracy. The LLM invents a precise comparison that is neither present nor inferable from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 456,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How does the duration of Disney's foreign exchange cash flow hedges for forecasted transactions compare to Google's hedge maturity periods, given both companies' use of option contracts to manage foreign currency exposure?",
      "original_answer": "Disney hedges its forecasted foreign currency transactions for periods generally not to exceed four years, while Google's foreign currency cash flow hedges have maturities of 24 months or less. Both companies use option contracts as part of their cash flow hedging strategies, with Disney reporting $9.9 billion in net foreign exchange cash flow hedges as of September 28, 2024, and Google holding $731 million in net accumulated gains on foreign currency cash flow hedges as of December 31, 2024.",
      "llm_answer": "Disney’s 10‑K states that its foreign‑exchange cash‑flow hedges for forecasted transactions are short‑term – the contracts “have maturities of 24 months or less” (and the company notes it does not hedge forecasted foreign‑currency items beyond four years)【page_70】.  Google’s 10‑K, by contrast, shows a much longer maturity distribution for its foreign‑exchange hedges: $6.3 bn due in ≤1 year, $37.2 bn due in 1‑5 years, $10.9 bn due in 5‑10 years and $12.9 bn due after 10 years【page_68】.  Thus Disney’s hedges are confined to a two‑year (or at most four‑year) horizon, while Google’s hedges span from short‑term to multi‑year, including contracts that extend well beyond ten years.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. It incorrectly states that Disney's hedges have maturities of 24 months or less, while the ground truth specifies that Disney generally hedges for periods not exceeding four years—this is a significant misrepresentation of the duration. Additionally, the LLM falsely claims Google has long-dated hedges extending beyond 10 years (e.g., $12.9B after 10 years), which contradicts the ground truth stating Google’s hedges have maturities of 24 months or less. These errors completely reverse the correct comparison: in reality, Disney has a longer hedge horizon (up to 4 years) than Google (≤2 years), but the LLM claims the opposite. (2) The dollar amounts cited for Google ($6.3B, $37.2B, etc.) are not only absent from the ground truth but also grossly inconsistent—Google’s actual net accumulated gains are $731 million, not tens of billions. The LLM fabricates numbers and misattributes them to Google’s hedge maturities. (3) The multi-hop reasoning is fundamentally flawed: instead of correctly synthesizing that Disney hedges up to 4 years and Google only up to 2 years, the model inverts the relationship and introduces non-existent long-term hedges for Google. The use of option contracts is correctly mentioned for both, but this does not compensate for the core errors. (4) The contextual relevance is moderate because the answer addresses the right topic (hedge durations, use of options), but the factual foundation is so incorrect that the conclusion is misleading. Quantitative accuracy is very low due to fabricated figures and incorrect timeframes. Qualitative accuracy is poor due to flawed reasoning and entity misattribution. Correctness score is low because the answer gets the central comparison backwards and invents data.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 491,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How does the expected impact of the Global Minimum Tax on QCOM's fiscal year 2025 tax liabilities compare to INTC's exposure under the Pillar Two Model Rules, given the differing geographic distribution of their operations?",
      "original_answer": "QCOM expects minimal impact from the Global Minimum Tax starting in fiscal year 2025, as it does not operate materially in jurisdictions with tax rates below the 15% Pillar Two minimum. In contrast, INTC, which has a significant portion of its income taxed in non-US jurisdictions, is still evaluating the impacts of Pillar Two, particularly as several jurisdictions like the EU plan to adopt components starting in 2024. Both companies monitor Pillar Two developments closely, but INTC faces more immediate uncertainty due to its broader international tax footprint and ongoing legislative adoptions in key markets.",
      "llm_answer": "Qualcomm notes that the OECD’s 15 % global‑minimum‑tax (Pillar Two) will begin to apply to it in fiscal 2025, but because “substantially all of our income is taxed in the U.S.” it does **not expect a material impact on its consolidated tax expense**【page_43】. Intel similarly says the Pillar Two rules could ultimately apply to its worldwide operations, yet “we do not have material operations in jurisdictions with tax rates lower than the Pillar Two minimum, [so] these rules are not expected to materially increase our global tax costs”【page_75】. Thus both firms anticipate only a minimal effect, with Intel’s exposure limited by its global footprint that lacks low‑tax sites, while Qualcomm’s impact is limited by its primarily U.S.‑taxed earnings.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its use of numbers, percentages, and fiscal years, correctly citing that both companies expect minimal impact from the 15% Global Minimum Tax starting in fiscal year 2025. It accurately reflects Qualcomm’s (QCOM) position that substantially all of its income is taxed in the U.S., leading to no material impact, and references Intel (INTC) stating it does not have material operations in low-tax jurisdictions, hence no material increase in tax costs. These points align with the ground truth and are supported by correct page citations.\n\nHowever, the qualitative accuracy is slightly lower because the LLM answer downplays the key distinction in uncertainty between the two firms. The original answer emphasizes that INTC is still evaluating the impacts due to ongoing legislative adoptions in key markets like the EU starting in 2024, indicating greater exposure and uncertainty. The LLM answer, while noting Intel’s global applicability, concludes both face minimal effects without adequately conveying that INTC faces more immediate complexity and unresolved exposure due to its broader international footprint and external regulatory timelines. This nuance is critical to the comparative aspect of the question.\n\nThe reasoning is mostly sound and the entities (QCOM, INTC, Pillar Two, 15% rate, FY2025) are correctly identified. The synthesis across both companies is appropriate, but the comparison lacks depth on INTC’s ongoing evaluation and jurisdictional risks, which weakens the multi-hop reasoning component. Contextually, the answer is highly relevant and well-structured, but the omission of INTC’s heightened uncertainty reduces completeness in the comparative analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 468,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How does the difference in voting power ratios between Alphabet's Class B to Class A conversion structure and Comcast's non-dilutable Class B voting rights affect the degree of founder control in corporate governance decisions?",
      "original_answer": "Alphabet maintains a 10:1 voting power ratio between Class B and Class A shares, with Class B shares converting automatically to Class A upon sale or transfer, which allows for dynamic founder control that can diminish with share transfers. In contrast, Comcast's Class B shares hold 33⅓% of voting power that is non-dilutable and convertible share-for-share into Class A, preserving a fixed level of control for Class B holders regardless of share issuance. This means Alphabet's structure allows for more fluid founder influence depending on shareholding behavior, while Comcast's design guarantees a minimum level of voting control that cannot be diluted, offering stronger long-term governance insulation for its Class B shareholders.",
      "llm_answer": "Alphabet’s dual‑class system gives each Class B share ten votes versus one vote for Class A, and the founders retain a majority of the combined voting power as long as the Class B shares represent roughly 9 % of all shares; conversion of Class B to Class A can erode that power over time but still lets the founders dominate most governance votes. Comcast, by contrast, fixes its Class B shares at 15 votes each but caps their aggregate influence at a non‑dilutable 33 ⅓ % of total voting power, giving its controlling shareholders a substantial but minority block that cannot be diluted. Thus Alphabet’s founders can wield near‑total control, whereas Comcast’s owners are limited to a protected one‑third voting bloc.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer captures the general contrast between Alphabet's and Comcast's dual-class structures but contains key factual inaccuracies. It correctly identifies Alphabet's 10:1 voting ratio and the conversion of Class B to Class A upon transfer, but incorrectly states that Comcast's Class B shares have '15 votes each'—the ground truth does not specify a per-share vote count for Comcast, only that Class B holds a non-dilutable 33⅓% of total voting power. This is a critical quantitative error. Additionally, the claim that Alphabet founders need only 'roughly 9%' of shares to maintain majority control is speculative and not supported in the original answer. 2) The original answer emphasizes Comcast's share-for-share convertibility and fixed 33⅓% voting power as non-dilutable, which the LLM partially captures but misrepresents by implying a 15-vote-per-share structure, which is not confirmed in the ground truth. The 33⅓% figure is correctly cited, but the mechanism (aggregate cap vs. per-share voting) is misrepresented. 3) The reasoning correctly contrasts dynamic vs. fixed control and recognizes that Alphabet’s control can erode over time while Comcast’s is insulated, showing sound multi-hop synthesis of governance implications. However, the flawed numeric foundation weakens the conclusion. 4) Despite inaccuracies, the answer remains contextually relevant, addressing founder control, voting structures, and long-term governance effects. The core conceptual comparison is valid, but factual precision—especially on voting mechanics—is lacking, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 438,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How does the indemnification agreement between PM USA and PMI affect Altria's (MO) financial exposure to tobacco-related litigation liabilities compared to PM's retained obligations through RBH deconsolidation?",
      "original_answer": "Under the Distribution Agreement, PMI indemnifies Altria and PM USA for liabilities related to tobacco products manufactured by PMI or contract manufactured by PM USA, while PM USA indemnifies PMI for liabilities related to its own manufactured products, excluding those made for PMI. Altria has not recorded a liability for this indemnification as its fair value is considered insignificant. Meanwhile, PM retains obligations tied to the deconsolidation of RBH, which involved reclassifications from accumulated other comprehensive losses. This structure limits Altria's direct financial exposure to PMI-related litigation, while PM faces ongoing impacts from RBH-related reclassifications.",
      "llm_answer": "The distribution agreement makes PMI the indemnitor for any tobacco‑product claims that arise from cigarettes PMI makes (or that PM USA contract‑manufactures for PMI), so Altria carries essentially no liability on its books – the fair‑value of the indemnity is recorded as “insignificant” (MO 10‑K p. 108). By contrast, PMI still bears the bulk of the Canadian litigation risk tied to its former subsidiary RBH; even after RBH was de‑consolidated, PMI recorded a $194 million pre‑tax charge for the Blais judgment and remains subject to a stay of the RBH lawsuits that could involve billions of dollars (PM 10‑K pp. 113‑114). Thus Altria’s exposure is effectively insulated by the indemnity, while PMI retains substantial, albeit de‑consolidated, litigation obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains a significant factual error in the quantitative domain: it attributes a $194 million pre-tax charge and ongoing Canadian litigation risk (Blais judgment, RBH lawsuits) to PMI, but in the ground truth, these liabilities are tied to the deconsolidation of RBH by PM (Philip Morris), not PMI. This misassignment of entity responsibility undermines the core multi-hop comparison. The original answer clarifies that PM retains obligations from RBH deconsolidation, involving reclassifications from accumulated other comprehensive losses—this is misrepresented in the LLM answer by shifting RBH liabilities to PMI. Additionally, the LLM incorrectly states that PMI 'bears the bulk of the Canadian litigation risk' and references PM 10-K pages, implying PM (not PMI) is the filer, further confusing entity roles. While the indemnification structure between PMI and PM USA is correctly described, and Altria's lack of recorded liability due to 'insignificant' fair value is accurate (with correct citation to MO 10-K p.108), the conflation of PM and PMI in the RBH litigation context leads to a flawed comparison. The reasoning is partially sound in structure but based on incorrect entity-attribution, breaking the multi-hop logic. The answer is contextually relevant and captures the intent of comparing Altria's insulated exposure to ongoing liabilities, but the misassignment of RBH liabilities to PMI instead of PM results in major factual inaccuracy. Number format ($194 million) is acceptable, but the value and its attribution are not supported by the ground truth, which does not mention a $194 million charge or Blais judgment at all. Thus, quantitative accuracy is low, qualitative accuracy is moderate due to correct indemnity framework, and contextual relevance is high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 485,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How does the decline in Cisco's allowance for credit losses on loan receivables from $103 million in 2022 to $53 million in 2023 impact the financing of technical support services, and how does this compare to Adobe's approach in funding its technical support offerings?",
      "original_answer": "Cisco's allowance for credit losses on loan receivables decreased significantly from $103 million in 2022 to $53 million in 2023, indicating a reduced financial risk in their financing arrangements tied to hardware, software, and services—including technical support. This decline may suggest either improved credit quality of borrowers or a strategic reduction in financing extended for such services. Cisco offers financing, including loans and leases, for the sale of its products and services, which explicitly include technical support and advanced services. In contrast, Adobe funds its technical support through subscription entitlements and annual fee-based maintenance programs, providing customers with technical support, product help, and upgrades over 1- to 3-year terms. Unlike Cisco, Adobe does not rely on loan receivables but integrates support funding directly into its subscription and maintenance models.",
      "llm_answer": "Cisco’s loan‑loss allowance for financing receivables fell from $103 million in FY 2022 to $53 million in FY 2023 (Note 9), which lowers the reserve for potential defaults on the loans that fund the sale of its hardware, software and “technical support and advanced services” 【page_84】. This reduction frees up net financing capacity for those support services, whereas Adobe funds its technical‑support through subscription entitlements and annual maintenance fees embedded in product pricing rather than through customer loans, so it does not rely on a credit‑loss allowance for support financing 【page_17】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the decline in Cisco's allowance for credit losses from $103 million in 2022 to $53 million in 2023 is accurately reported, with proper fiscal year labeling (FY 2022/FY 2023). No calculations were required beyond the stated decline, which is correctly implied. (2) The LLM correctly identifies that Cisco uses financing (loans) to support the sale of technical support services and that the reduction in allowance frees up financing capacity, which is a sound interpretation of the impact. It also correctly contrasts this with Adobe’s model, noting that Adobe funds technical support through subscription entitlements and maintenance fees embedded in pricing, not through loans or receivables. (3) The multi-hop reasoning—linking Cisco’s credit loss allowance to its financing of services, then contrasting with Adobe’s subscription-based funding—is logically sound and synthesizes information across entities and models. (4) Minor deduction in qualitative accuracy due to slightly less detail than the original (e.g., not specifying 1- to 3-year terms for Adobe’s programs), but the core meaning and comparison remain semantically equivalent. Contextual relevance is perfect, as all parts of the question are addressed with precise, on-topic information.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 380,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How does the involvement of Citibank, N.A. as administrative agent in Caterpillar's 2022 5-Year Credit Facility compare with its role in Boeing's similarly named 2019 Five-Year Credit Agreement, particularly in terms of the amendment timelines and the syndication structure?",
      "original_answer": "Citibank, N.A. served as the administrative agent in both Caterpillar's 2022 5-Year Credit Facility and Boeing's 2019 Five-Year Credit Agreement. In Caterpillar's case, Amendment No. 1 to the 5-Year Facility was dated August 31, 2023, indicating a modification within one year of the original agreement. For Boeing, Amendment No. 1 to its Five-Year Credit Agreement occurred on August 25, 2022, nearly three years after the initial agreement on October 30, 2019. Additionally, Boeing's syndication structure included JPMorgan Chase Bank, N.A. as syndication agent and joint lead arranger alongside Citibank, N.A., while Caterpillar's syndication involved Citibank, N.A. and MUFG Bank, Ltd. in agent roles without a comparable dual lead arranger structure.",
      "llm_answer": "Both companies name Citibank, N.A. as the administrative agent, but the surrounding terms differ. Boeing’s 2019 Five‑Year Credit Agreement lists JPMorgan Chase Bank, N.A. as the syndication agent and was formally amended on August 25 2022 (Amendment No. 1) 【page_126†L1-L4】【page_126†L5-L7】. In the Caterpillar 2022 5‑Year Credit Facility the filing only identifies Citibank, N.A. as the agent and provides no disclosed syndication agent or amendment date in the excerpts shown (Citibank appears as agent on Caterpillar’s credit‑agreement exhibits) 【page_128†L1-L4】, indicating a simpler agent structure and no publicly noted amendment timeline.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies Citibank, N.A. as the administrative agent for both Caterpillar's 2022 5-Year Credit Facility and Boeing's 2019 Five-Year Credit Agreement, and correctly notes JPMorgan Chase Bank, N.A.'s role as syndication agent in Boeing's agreement. It also accurately reports the August 25, 2022 date for Boeing's Amendment No. 1. However, it incorrectly claims that Caterpillar's filing provides 'no disclosed syndication agent or amendment date,' which contradicts the ground truth: Caterpillar's Amendment No. 1 was dated August 31, 2023, and MUFG Bank, Ltd. was involved in agent roles. The absence of this information in 'the excerpts shown' does not justify stating it is not disclosed in the filing overall—this reflects a failure in multi-hop synthesis or data retrieval. The claim of a 'simpler agent structure' is unsupported because the LLM fails to acknowledge MUFG Bank, Ltd.'s role. Additionally, the answer omits the key comparative point that Caterpillar amended its facility within one year, while Boeing did so after nearly three years—a central element of the original question about amendment timelines. While the Boeing facts are correct, the Caterpillar-side omissions and incorrect assertions significantly undermine the accuracy. Quantitative accuracy is partially correct (Boeing amendment date is right), but missing Caterpillar's 2023 amendment date reduces precision. Qualitative accuracy suffers due to flawed reasoning in assuming absence of evidence equals evidence of absence. Contextual relevance is high as the response addresses the core comparison framework.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 440,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How might a prolonged geopolitical conflict involving Taiwan impact both NVIDIA's and Qualcomm's supply chain reliability, given their shared dependency on foundry partners in the region?",
      "original_answer": "A prolonged geopolitical conflict involving Taiwan could severely disrupt both NVIDIA's and Qualcomm's supply chains, as both companies rely heavily on foundry partners located in Taiwan for critical semiconductor manufacturing. NVIDIA has explicitly stated that challenges in estimating demand could be exacerbated by geopolitical tensions involving Taiwan and China, which are significant to their revenue and supply continuity. Similarly, Qualcomm depends on consistent chipset supply from foundry partners in Taiwan, and a conflict could severely limit or prevent them from receiving these components, directly impacting their ability to manufacture and deliver products. Both companies face the risk of supply constraints, production delays, and potential revenue loss due to the geographic concentration of their manufacturing dependencies in a geopolitically sensitive region.",
      "llm_answer": "Both NVIDIA and Qualcomm note that a prolonged conflict over Taiwan would jeopardize the chip supply they receive from Taiwanese foundries – the region that houses the majority of their key wafer‑fabrication partners. A disruption there could sharply curtail or halt the flow of critical components, forcing production delays, inventory shortages and higher costs, and would therefore pose a material‑risk to the reliability of each company’s supply chain.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. It correctly identifies that both NVIDIA and Qualcomm rely on Taiwanese foundries for semiconductor manufacturing and that a prolonged geopolitical conflict would pose a significant risk to their supply chain reliability. The answer captures the core consequences: disruption to chip supply, production delays, inventory shortages, and increased costs. All entities (NVIDIA, Qualcomm, Taiwanese foundries) are correctly identified, and the reasoning accurately reflects the shared dependency and associated risks. While the original answer includes slightly more detail—such as NVIDIA's explicit mention of demand estimation challenges and Qualcomm's dependency on consistent chipset supply—the LLM response still conveys the essential multi-hop synthesis: (1) both companies depend on Taiwan-based foundries, (2) geopolitical conflict threatens those foundries, (3) this threatens supply chain reliability. There are no numerical inaccuracies (quantitative accuracy is 10), and the context fully addresses the question. The qualitative score is 9 because the LLM omits specific references to revenue impact and demand estimation noted in the original, but these are secondary details. Contextual relevance is perfect as the response directly and appropriately addresses the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 379,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How does Boeing's indemnification risk exposure from U.S. government contracts compare with 3M's indemnification liabilities transferred to Solventum following the spin-off, particularly in relation to their respective legal proceedings and liability assumptions?",
      "original_answer": "Boeing discloses indemnification risks tied to U.S. government contracts where pension cost allocations under CAS may affect contract profitability. Meanwhile, 3M transferred indemnification obligations related to historical legal proceedings—such as the Bair Hugger and Federal False Claims Act litigation—to Solventum as part of the April 1, 2024 spin-off. Both companies face potential liabilities from legal proceedings, but Boeing's exposure is tied to contract cost allocations and uninsurable risks from defense and aerospace products, whereas 3M's transferred liabilities are now the responsibility of Solventum, which must indemnify and defend claims previously held by 3M.",
      "llm_answer": "Boeing says that for certain U.S. government contracts it “may receive indemnification from the U.S. government,” but its insurance may not cover all claims and it remains exposed for products not shielded by the SAFETY Act or for work outside the United States 【page_20】. By contrast, 3M’s spin‑off agreement transferred a defined set of liabilities—including Bair‑Hugger, Federal False Claims Act and PFAS matters—to Solventum, which will “indemnify and defend the Company in these actions” 【page_84】【page_85】. Thus Boeing’s indemnification is conditional and limited to government contracts, whereas 3M has actively shifted specific legal exposures to Solventum, securing indemnification for those matters.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and synthesis. (1) It accurately captures Boeing's conditional indemnification exposure from U.S. government contracts, noting that indemnification is not guaranteed and depends on specific conditions such as SAFETY Act coverage and geographic scope. It also correctly states that Boeing may receive indemnification but remains exposed for certain claims. (2) Regarding 3M, the LLM correctly identifies that liabilities related to Bair Hugger, Federal False Claims Act, and PFAS matters were transferred to Solventum in the spin-off, with Solventum assuming responsibility to indemnify and defend 3M in these actions. The date of the spin-off (April 1, 2024) is missing, which is a minor omission, but the core transfer of liability is accurately conveyed. (3) The multi-hop reasoning is sound: the model correctly contrasts Boeing’s ongoing, conditional exposure tied to government contracts with 3M’s active transfer of specific legal liabilities to Solventum. However, the LLM slightly misrepresents Boeing’s risk by emphasizing potential indemnification it may receive, whereas the ground truth focuses on Boeing’s risk from pension cost allocations under CAS affecting contract profitability—an important nuance about cost accounting and contract performance rather than indemnification receipt. This shifts the emphasis away from the core financial risk mechanism in Boeing’s case. (4) All entities (Boeing, 3M, Solventum), legal proceedings, and indemnification frameworks are correctly identified. No numerical inaccuracies exist—there are no figures to verify, so quantitative accuracy is满分. Contextual relevance is high as all parts of the question are addressed. The qualitative accuracy is slightly reduced due to the emphasis misalignment on Boeing’s risk. Overall, the answer is factually strong but misses a key nuance in Boeing’s exposure mechanism.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 527,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How does the voting power structure of CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, influence the governance risks associated with META's Class A common stock, particularly in light of META's controlled company status and dual-class structure?",
      "original_answer": "CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, holds 33⅓% of the combined voting power, with each share carrying 15 votes. This concentrated voting power allows the holder significant influence over corporate decisions. Similarly, META's governance structure gives its Class B common stockholders, including Mark Zuckerberg, outsized voting control, with the dual-class structure requiring a majority of Class B votes for any change in control until they fall below 35% of voting power. This setup increases governance risks for Class A shareholders, as it limits their influence and could deter investors, mirroring the concerns raised in META's 10-K about its 'controlled company' status making Class A shares less attractive.",
      "llm_answer": "Comcast’s Class B shares – all 9.44 million of them owned by Brian L. Roberts – carry 15 votes each and represent roughly one‑third of the company’s total voting power (CMCSA page 33). That same concentration of voting power exists at Meta, where Mark Zuckerberg’s Class B shares (10 votes per share) give him majority control of the combined voting power (Meta page 49) and the company’s “controlled‑company” status exempts it from many Nasdaq governance safeguards (Meta page 50). Because both firms concentrate voting authority in a single insider, Meta’s Class A shareholders face heightened governance risk – their ability to influence corporate matters is limited in the same way it is at Comcast, making the dual‑class, controlled‑company structure a key source of governance concern.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the LLM correctly states that CMCSA's Class B shares carry 15 votes each and represent roughly one-third (33⅓%) of total voting power, consistent with the original answer. It accurately notes that Mark Zuckerberg holds majority control via Class B shares with 10 votes per share, and correctly references Meta’s controlled-company status. While the exact percentage of voting power concentration (e.g., 60%+ for Zuckerberg) isn't specified, the characterization of 'majority control' is factually sound. (2) The mention of '9.44 million' shares owned by Roberts is an additional detail not in the ground truth but does not contradict it and may reflect actual data from the cited page (CMCSA p.33); since the original answer doesn’t specify share count, this is not an error. (3) The reasoning correctly draws a parallel between CMCSA and META’s dual-class structures, highlighting concentrated voting power and its implications for governance risk, particularly for Class A shareholders. It properly identifies that controlled-company status leads to exemptions from Nasdaq governance rules, which increases governance risks—mirroring the concern in the original answer about Class A shares being less attractive. (4) The multi-hop synthesis across CMCSA and META is logically sound and contextually appropriate. The only minor shortcoming is that the LLM does not explicitly mention the 35% threshold for change in control referenced in the original answer, which slightly reduces completeness. However, the core facts, comparisons, and implications are correct and well-reasoned. Wording differs but semantic meaning matches. Thus, the answer earns a 9/10 for correctness—excellent but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 484,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How does Coca-Cola's reliance on Arca Continental for beverage distribution in northern Argentina intersect with Procter & Gamble's foreign exchange risk exposure in the same country?",
      "original_answer": "Coca-Cola relies on Arca Continental for beverage distribution in northern Argentina, which accounts for a portion of its 17% worldwide unit case volume through bottling partners. Arca Continental's operations in northern Argentina expose Coca-Cola indirectly to macroeconomic risks in the country. Meanwhile, Procter & Gamble directly cites Argentina as one of the countries with significant exchange rate fluctuations that have historically impacted its financials, noting foreign exchange volatility in Argentina has significantly affected its net sales, costs, and earnings. This creates a shared exposure point where both companies face risks tied to Argentina’s economic environment, with Coca-Cola exposed through its supply chain dependency and P&G through direct market operations.",
      "llm_answer": "Coca‑Cola’s system depends on its independent bottler Arca Continental to bottle and distribute its beverages in northern Argentina (KO 10‑K, p. 7). Procter & Gamble flags Argentina as a country with significant exchange‑rate fluctuations, creating both translation and transaction foreign‑exchange risk (PG 10‑K, p. 23). Thus, the Argentine peso volatility that PG must manage also directly influences Coca‑Cola’s sales through Arca Continental, linking the two companies’ exposure to the same currency risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the core intersection between Coca-Cola's reliance on Arca Continental in northern Argentina and Procter & Gamble's foreign exchange risk exposure in the country. (1) There are no numeric values in the original or LLM answer that conflict—both correctly avoid citing specific percentages or financial figures beyond what is in the filings, and no calculations are required. (2) The LLM correctly identifies both companies (Coca-Cola/KO and Procter & Gamble/PG), the bottler Arca Continental, and the geographic focus (northern Argentina), with proper reference to 10-K disclosures. (3) The multi-hop reasoning is sound: it connects Coca-Cola’s indirect exposure via its bottling partner to P&G’s direct FX risk due to Argentine peso volatility. The LLM correctly infers that both companies face currency risk in Argentina, albeit through different channels—supply chain dependency vs. direct operations. (4) The only minor shortcoming is that the LLM omits the detail from the ground truth that Coca-Cola’s global unit case volume through bottlers is 17%, which adds context about the scale of its partnership model. While not critical to the main point, this contextual nuance strengthens the original answer. Otherwise, the LLM answer is semantically equivalent, well-supported, and highly relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 374,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How might the expiration of Alimta's patent protection impact Eli Lilly's oncology revenue stream compared to Amgen's exposure to patent-related risks for its biologics, given the differing regulatory frameworks governing small molecule drugs and biologics?",
      "original_answer": "The expiration of Alimta's patent protection is expected to result in a rapid and severe decline in Eli Lilly's revenue from the product due to the entry of generic competitors in the U.S. and other jurisdictions. This is typical for small molecule drugs like Alimta, where loss of exclusivity often leads to immediate and significant revenue erosion. In contrast, Amgen, which relies heavily on patent protection for its biologics, faces a different regulatory landscape where biosimilars may not enter the market as quickly due to manufacturing complexities and regulatory uncertainties, such as the FDA's stance on 'umbrella exclusivity'. However, Amgen still faces increasing biosimilar competition in the U.S., Europe, and elsewhere, which has had and could increasingly have a material adverse effect on its product sales. Thus, while both companies are exposed to patent-related risks, the speed and severity of revenue impact differ due to the nature of their product portfolios and the regulatory frameworks governing them.",
      "llm_answer": "Eli Lilly notes that Alimta’s patent expiration will likely bring swift generic entry and a rapid, severe decline in its oncology sales because small‑molecule drugs lose exclusivity quickly under the Hatch‑Waxman framework (LLY p.25‑p.46). Amgen’s biologics, however, are protected by the BPCIA’s 12‑year data‑exclusivity and a more complex biosimilar approval pathway, so while the company still faces patent‑challenge and possible early biosimilar competition, the regulatory regime generally delays revenue loss compared with the immediate impact on a small‑molecule like Alimta (AMGN p.44‑p.46).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Alimta's patent expiration will lead to rapid generic entry and a severe decline in Eli Lilly's oncology revenue, consistent with the Hatch-Waxman framework for small molecule drugs. It contrasts this with Amgen's biologics, which benefit from the BPCIA's 12-year data exclusivity and a more complex biosimilar approval process, delaying revenue loss. These key points match the original answer's core message. (2) There are no specific numerical values (e.g., dollar amounts, exact years beyond the 12-year exclusivity) in the ground truth that are contradicted; the 12-year data exclusivity under BPCIA is factually correct. No calculations are required, and all referenced regulatory frameworks (Hatch-Waxman, BPCIA) are accurately named and applied. (3) The multi-hop reasoning is sound: the model correctly synthesizes differences in regulatory frameworks (small molecule vs. biologic) and links them to differing revenue risk profiles for Eli Lilly and Amgen. It appropriately cites page references (LLY p.25–46, AMGN p.44–46), suggesting grounding in source material. (4) The only reason for not scoring a 10 is minor: the original answer mentions Amgen's exposure to 'umbrella exclusivity' and broader global biosimilar competition having a 'material adverse effect,' which adds slightly more context about ongoing risks despite regulatory delays. The LLM answer captures the essence but omits this nuance. Otherwise, the response is factually correct, well-reasoned, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 440,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How does the impact of the OECD's Pillar Two Model Rules on Intel's non-US tax benefits compare to Microsoft's exposure under the global minimum tax, given the differences in their international tax strategies?",
      "original_answer": "Intel's tax benefits have increased due to a higher proportion of income taxed in non-US jurisdictions, and the company is actively evaluating the impact of Pillar Two Model Rules, which may begin in 2024 in several jurisdictions where Intel operates. In contrast, Microsoft acknowledges the global minimum tax as part of its broader regulatory exposure but does not expect a material increase in tax costs due to limited operations in jurisdictions below the 15% minimum rate. This suggests that while both companies are subject to Pillar Two, their exposure differs based on geographic tax strategy and operational footprint.",
      "llm_answer": "Intel notes that because it has no material operations in jurisdictions with rates below the 15 % Pillar‑Two floor, the OECD’s Pillar‑Two Model Rules are not expected to materially raise its global tax cost and its non‑U.S. tax benefits – driven by R&D credits and a higher share of income taxed abroad – should remain largely intact (Intel 10‑K p. 44). Microsoft, however, flags that the OECD‑driven global minimum‑tax proposals could increase its tax burden, acknowledging exposure to additional tax liabilities from recent domestic and international tax reforms and the global‑minimum‑tax guidance (Microsoft 10‑K p. 30).",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct elements but reverses the core conclusion about Intel and Microsoft's exposure under Pillar Two, which undermines factual accuracy. Quantitatively, the 15% Pillar Two floor is correctly stated, and the references to the 10-K pages (p. 44 for Intel, p. 30 for Microsoft) are accurate, suggesting proper sourcing. However, the qualitative reasoning is flawed: the original answer states that Intel has a higher proportion of income taxed in non-US jurisdictions and is evaluating the impact of Pillar Two, implying potential exposure, while the LLM incorrectly claims Intel has 'no material operations' in jurisdictions below 15% and thus no material tax increase—this contradicts the ground truth, which does not make such a definitive claim. Conversely, the LLM says Microsoft expects increased tax burden, but the original answer states Microsoft does *not* expect a material increase due to limited operations in low-rate jurisdictions—the LLM directly inverts this. This reversal of positions between the two companies represents a critical error in multi-hop reasoning and synthesis. While the answer addresses the question's scope and uses appropriate context (R&D credits, international footprint), the misattribution of exposure levels invalidates the comparison. Semantic equivalence fails on the key analytical point. Thus, despite correct percentages and document citations, the core comparative insight is incorrect, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 411,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How does KO's 2024 transfer of $523 million in surplus international pension assets to general assets affect its exposure to limited partnerships compared to PEP's continued use of limited partnerships in its pension investment strategy?",
      "original_answer": "KO's transfer of $523 million in surplus international pension assets to general assets in 2024 reduced its exposure to limited partnerships, as these assets were previously part of its pension plan investments, which include vehicles like limited partnerships (as seen in NEE's pension strategy). Meanwhile, PEP continues to maintain exposure to limited partnerships through its pension investments, as explicitly stated in its 2024 10-K, where it holds investments in limited partnerships and private credit funds valued based on net asset value. This indicates a strategic divergence: KO reduced its pension-linked alternative investments, while PEP maintains them as part of its diversified pension fund strategy.",
      "llm_answer": "KO’s 2024 transfer of $523 million of surplus international pension assets out of the pension trusts and into the Company’s general assets removes those assets – which included limited‑partnership holdings – from the pension plan, thereby lowering KO’s exposure to limited‑partnership investments 【page_43】. In contrast, PepsiCo’s 10‑K states that its pension‑plan investment strategy continues to include allocations to limited‑partnership vehicles, so PEP’s exposure to limited partnerships remains unchanged 【PEP_10k_2024.pdf page_98】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the $523 million transfer by KO in 2024 is accurately stated, and the reference to PEP's continued use of limited partnerships is supported. Number format ($523 million) matches, and no calculations were required. (2) The answer addresses both parts of the multi-hop question: KO’s reduced exposure due to asset transfer and PEP’s ongoing exposure. It correctly identifies that the transferred assets included limited partnership holdings, which explains the reduction in exposure. (3) Entity accuracy is strong: KO and PEP are correctly identified, along with the relevant years (2024) and financial instruments (limited partnerships). The citation of PEP’s 10-K on page 98 adds verifiability. (4) Reasoning is sound: the LLM correctly infers that moving pension assets (which included limited partnerships) into general assets reduces pension-linked exposure to such vehicles, contrasting this with PEP’s maintained strategy. The only minor shortcoming is a slightly less explicit mention of the 'strategic divergence' framing present in the original answer, and less detail on how NEE’s strategy was used as contextual support in the knowledge graph (though not strictly necessary). However, the core multi-hop synthesis—linking KO’s action to reduced exposure and contrasting it with PEP’s ongoing approach—is logically and factually sound. Semantic equivalence is high, with no factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 416,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How does the $17.3 billion increase in PFE's income from continuing operations in 2021 compared to 2020 relate to the role of patent rights in determining market exclusivity periods, especially when considering LLY's reliance on 12-year U.S. biologic data protection to safeguard revenue post-patent expiration?",
      "original_answer": "The $17.3 billion increase in PFE's income from continuing operations in 2021 compared to 2020 was partly due to factors like lower asset impairment charges and higher net gains on equity securities. However, PFE acknowledges that patent expirations could materially affect revenues, as patent rights are a key determinant of market exclusivity in the pharmaceutical industry. According to evidence, market exclusivity for pharmaceuticals is largely determined by patent rights and regulatory data protection. In the U.S., biologics benefit from a 12-year data protection period under the BPCIA, which LLY explicitly references as a critical mechanism to retain market exclusivity and protect revenues even after compound patents expire. This implies that while PFE's short-term financial performance saw a significant boost, the long-term sustainability of such gains for patented products will depend on both patent strength and complementary regulatory exclusivity mechanisms like those LLY relies on for its biologics.",
      "llm_answer": "Pfizer’s $17.3 billion jump in income from continuing operations in 2021 versus 2020 was driven mainly by higher revenues (including its COVID‑19 products) together with net benefit credits, lower impairment charges and other favorable items (see page 36). That gain highlights how essential patent‑based market exclusivity is to pharma earnings—once a patent expires, firms must lean on regulatory exclusivities such as data‑protection periods; Eli Lilly, for example, counts on the 12‑year U.S. biologic data‑protection regime to keep revenue flowing after its patents run out (see page 9). Thus, Pfizer’s income surge reflects the financial value of strong IP protection, while Lilly’s strategy shows how data‑protection can sustain sales once patent terms end.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $17.3 billion increase in PFE's income from continuing operations in 2021 vs. 2020, which matches the ground truth. It accurately attributes the increase to factors like lower impairment charges and favorable items, and references Pfizer's reliance on IP protection, aligning with the original answer. The mention of COVID-19 products as a revenue driver is consistent with PFE’s 2021 financial performance, even if not in the original answer—this is a reasonable inference and does not contradict ground truth. (2) All numeric values are correct: $17.3 billion is accurately cited, and no calculations are required beyond that. The years (2020–2021) and entities (PFE, LLY) are correct. (3) The multi-hop reasoning is sound: the model connects PFE’s financial performance to the broader theme of market exclusivity, then correctly links LLY’s reliance on the 12-year U.S. biologic data protection period as a post-patent revenue safeguard. This synthesis across PFE’s financials and LLY’s regulatory strategy is logically coherent and factually supported. (4) The LLM slightly simplifies the causal explanation of PFE’s income increase by emphasizing revenue from COVID-19 products more than the original answer does, but this is contextually accurate and well-documented in PFE’s filings. It omits explicit mention of 'net gains on equity securities' and 'asset impairment charges' as detailed in the ground truth, but does reference 'lower impairment charges' and 'favorable items,' which captures the essence. Overall, the answer is semantically equivalent, factually correct, and contextually appropriate, warranting a high score with only minor room for added nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 469,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How does the revenue-sharing arrangement between ESPN and Hulu, as reflected in Disney's 2024 financials, relate to the $8.6 billion payment Comcast received in late 2023 following the partial exit of its Hulu stake?",
      "original_answer": "Disney's ESPN receives fees from Hulu for the right to air its networks, as noted in the elimination section of Disney's 2024 financials. This relationship is central to Hulu's content costs and revenue model. In late 2023, Comcast exercised a put option, requiring Disney to buy its 33% stake in Hulu for $8.6 billion, which included a $9.2 billion minimum equity value less $557 million for prior capital calls. This payment reflects the financial value derived from Comcast’s stake in Hulu, which is partially driven by revenue streams like those from ESPN content licensing fees. Thus, the revenue-sharing mechanism between ESPN and Hulu underpins part of the valuation that led to the $8.6 billion payment to Comcast.",
      "llm_answer": "Disney’s 2024 filing shows that Hulu pays ESPN fees for the right to carry ESPN’s linear networks on Hulu Live, which is recorded as revenue in the Sports segment and eliminated in the consolidated results (see Disney 10‑K, “Eliminations” bullet, p. 38). In contrast, the $8.6 billion Comcast received in November 2023 was a one‑time cash payment for the sale of its 33 % Hulu equity stake—not a recurring fee—and therefore is unrelated to the ongoing ESPN‑Hulu revenue‑sharing arrangement (see Comcast 10‑K, “Hulu and Collateralized Obligation,” p. 85).",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct in its quantitative details and entity identification but fails in multi-hop reasoning and overall synthesis, leading to a significant factual misrepresentation. (1) Quantitatively, the numbers are mostly accurate: the $8.6 billion payment from Disney to Comcast in November 2023 for the 33% Hulu stake is correctly cited, and the reference to ESPN receiving fees from Hulu for linear networks on Hulu Live aligns with the ground truth. The mention of elimination in consolidation (p.38 of Disney 10-K) and Comcast’s disclosure (p.85) adds document-level support. (2) However, the core error lies in stating that the $8.6 billion payment is 'unrelated' to the ESPN-Hulu revenue-sharing arrangement. This contradicts the ground truth, which correctly explains that the value of Hulu—and thus the $8.6 billion price—was partially driven by revenue streams such as ESPN content licensing fees. The LLM incorrectly frames the two elements as unrelated, when in fact the ongoing revenue-sharing contributes to Hulu’s profitability and valuation, which directly impacts the equity stake value. (3) The multi-hop reasoning fails: while the model identifies both components (ESPN fees and Comcast exit), it does not synthesize them correctly. The relationship is not direct causation but one of financial contribution—ESPN’s content drives Hulu Live’s value, which contributes to Hulu’s overall equity value, which in turn determines the put option payout. (4) Thus, while numbers and entities are accurate (hence a moderate quantitative score), the qualitative reasoning is flawed, and the conclusion is misleading. The answer is contextually relevant but misses the key linkage the question asks for, warranting a correctness score of 4.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 477,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How do KO's and MDLZ's respective uses of financial assumptions differ in terms of the instruments they apply them to and the time periods over which the associated costs are recognized?",
      "original_answer": "KO uses the Black-Scholes-Merton option-pricing model to estimate the fair value of stock option awards, which are expensed on a straight-line basis over a typical four-year vesting period. This approach incorporates weighted-average assumptions such as volatility and expected term. In contrast, MDLZ applies weighted-average assumptions to determine net periodic postretirement healthcare costs, which are measured annually and reflect actuarial estimates for long-term obligations. The key differences are that KO applies these assumptions to equity-based compensation instruments with a fixed four-year expense recognition period, while MDLZ applies them to postretirement benefit liabilities that are recalculated annually based on updated actuarial estimates.",
      "llm_answer": "KO applies its financial assumptions to two different equity‑based instruments.  For stock‑option awards it uses Black‑Scholes inputs (dividend yield, expected volatility, risk‑free rate and a 6‑year expected term) and expenses the fair value on a straight‑line basis over the typical four‑year vesting period【page_95】.  For performance‑share units it uses a Monte‑Carlo valuation model and recognizes expense proportionally over the performance period (generally three years) and then on a straight‑line basis for the remainder of that period【page_96】 (the company also expects to recognize its remaining unvested compensation cost over a weighted‑average 1.7‑year period【page_94】).\n\nMDLZ also uses Black‑Scholes assumptions (risk‑free rate, 5‑year expected life, volatility and dividend yield) for its stock‑option awards【page_108】, but the unamortized compensation expense for its deferred‑stock‑unit and performance‑share‑unit awards is spread over a weighted‑average 1.7‑year period【page_108】【page_109】.  Thus, KO’s assumptions are tied to options and performance‑share units with costs amortized over the vesting or performance periods, whereas MDLZ’s assumptions are applied to options and DSU/PSU awards with the associated costs recognized over a shorter, 1.7‑year weighted‑average period.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several correct details but fundamentally misrepresents the core distinction in financial assumption usage between KO and MDLZ as described in the ground truth. (1) The original answer emphasizes that KO applies assumptions to equity-based compensation (stock options via Black-Scholes) with a four-year straight-line expense period, while MDLZ applies weighted-average assumptions to postretirement healthcare costs—actuarial liabilities recalculated annually. However, the LLM incorrectly states that MDLZ applies its assumptions to stock options, DSUs, and PSUs, which contradicts the ground truth: MDLZ’s use of assumptions for postretirement benefits is entirely absent in the LLM response. (2) Quantitatively, the LLM accurately reports KO’s four-year vesting and MDLZ’s 1.7-year weighted-average recognition period, and correctly identifies models like Black-Scholes and Monte-Carlo for KO. However, the 6-year expected term for KO and 5-year for MDLZ are not in the original answer and distract from the actual contrast. These numbers may be factually present in filings but misalign the focus. (3) The multi-hop reasoning fails because the LLM does not synthesize the correct contrast: KO (equity awards, fixed vesting) vs. MDLZ (postretirement liabilities, annual recalculation). Instead, it compares both on equity compensation, which is incorrect per the ground truth. (4) While the LLM provides detailed, relevant-sounding information with proper citation, it misses the key conceptual difference—MDLZ’s use of assumptions for long-term actuarial obligations—rendering the core answer factually flawed. Wording and structure are strong, but factual correctness on the central point is lacking, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1525,
        "completion_tokens": 476,
        "total_tokens": 2001
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How might the expiration timeline of specific patent protections for Enbrel impact Pfizer's international revenue from the drug, given AbbVie's broader strategy around patent term restoration and regulatory exclusivity?",
      "original_answer": "The expiration timeline for Enbrel's U.S. patents begins in 2028 (fusion protein composition) and extends to 2037 for formulation methods, which could delay biosimilar competition internationally. However, AbbVie's strategy of seeking patent term restoration and leveraging regulatory exclusivity under the Hatch-Waxman Act—where patent extensions can add up to five years—may further extend protection in key markets. Pfizer, which markets Enbrel outside the U.S. and Canada, could see prolonged exclusivity in certain regions, potentially extending beyond 2028, thereby preserving revenue streams if biosimilar challenges are delayed or unsuccessful.",
      "llm_answer": "Pfizer’s Enbrel patents – a composition patent that expires 11/22/2028, a DNA‑encoding patent that expires 4/24/2029 and a formulation patent that expires 10/19/2037 – mean that after those dates the drug will be vulnerable to generic competition, which could erode the portion of Pfizer’s revenue that comes from international markets. AbbVie’s broader practice of using Hatch‑Waxman patent‑term restoration and other regulatory exclusivities to extend protection for its own biologics suggests Pfizer would have to rely on similar extensions (capped at five years) to blunt the impact, but the statutory limits imply that overseas sales of Enbrel are likely to decline once the listed patents lapse.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes specific patent expiration dates (11/22/2028, 4/24/2029, 10/19/2037), which are more precise than the ground truth's general year-based ranges (2028, 2029, 2037). However, the ground truth does not specify exact dates, so it is unclear if these dates are factually correct. The inclusion of such precision introduces risk of inaccuracy without explicit support in the original answer. The core timeline (protection beginning to expire around 2028 and extending to 2037) is consistent and correct. (2) The quantitative accuracy is partially compromised by the introduction of exact dates not present in the ground truth; while not necessarily incorrect, they imply a level of specificity not confirmed by the source. The mention of a 'DNA-encoding patent' expiring in 2029 is not mentioned in the original answer, representing an addition not supported by the ground truth, which only references 'fusion protein composition' (2028) and 'formulation methods' (2037). This introduces a potential factual overreach. (3) The reasoning is sound: the LLM correctly identifies that patent expirations will expose Enbrel to biosimilar/generic competition, potentially eroding Pfizer's international revenue. It accurately references AbbVie’s strategy of using Hatch-Waxman patent-term restoration (capped at five years) and implies Pfizer might rely on similar mechanisms. This reflects correct multi-hop synthesis between patent expirations, regulatory strategy, and revenue impact. However, the original answer emphasizes that AbbVie’s actions may *delay* biosimilar competition internationally, thereby *preserving* Pfizer’s revenue—whereas the LLM leans toward an inevitable decline, missing the nuance that extensions could *successfully* blunt the impact. (4) The answer is contextually relevant and addresses all key components: patent expiration, impact on Pfizer’s international revenue, AbbVie’s strategy, and regulatory exclusivity. While the core facts about expiration windows and Hatch-Waxman are correct, the addition of unsupported patent types and dates reduces quantitative accuracy. The qualitative reasoning is strong but slightly underrepresents the possibility of successful extension strategies preserving revenue. Thus, correctness is high but not fully aligned with ground truth precision and emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 628,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How does MET's stress testing approach, which factors in early policyholder withdrawal scenarios, influence its reliance on global funding sources like commercial paper compared to COF's liquidity framework that emphasizes diversified funding sources and liquidity reserves?",
      "original_answer": "MET's stress testing includes scenarios of early policyholder withdrawal, which directly impacts its reliance on global funding sources like commercial paper to meet liquidity needs under stress conditions. MET adjusts asset mix and maturities based on rolling 12-month forecasts and relies on alternatives such as commercial paper and credit facilities when anticipated liquidity is exceeded. Similarly, COF's Liquidity Framework emphasizes diversified funding sources and maintains a liquidity reserve of cash, high-quality unencumbered securities, and committed credit lines to withstand systemic and idiosyncratic liquidity events. Both companies use stress testing to inform their funding strategies, but MET's exposure to policyholder behavior introduces a unique risk factor that directly affects its funding source selection, aligning with AIG's defined liquidity stress scenarios that impact funding sources.",
      "llm_answer": "MET’s stress‑testing explicitly models early contract‑holder and policy‑holder withdrawals and therefore keeps global funding sources—including commercial paper and other credit facilities—readily available as a back‑stop for any unexpected cash‑outflow (MetLife 10‑K p. 123). In contrast, Capital One’s liquidity framework relies on a diversified funding base (deposit‑gathering, committed credit lines, secured/unsecured debt issuance) and a sizable reserve of cash, cash equivalents and high‑quality securities, which lessens its dependence on any single source such as commercial paper (COF 10‑K p. 96).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the original answer. (1) All factual elements are correct: MET's stress testing includes early policyholder withdrawals, leading to reliance on global funding sources like commercial paper and credit facilities as a backstop. COF’s framework emphasizes diversified funding and a liquidity reserve, reducing dependence on any single source. These points align with the ground truth. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) The multi-hop reasoning is sound: the model correctly synthesizes MET’s exposure to policyholder behavior affecting funding choices and contrasts it with COF’s diversified, reserve-based approach. It also implicitly links MET’s strategy to broader industry practices (e.g., AIG-like stress scenarios), though this specific reference is omitted—however, this is a minor contextual detail, not a factual error. (4) Semantic equivalence is strong: wording differs but meaning matches. The LLM uses 'contract-holder' and 'policy-holder' (plural), which is consistent with MET’s disclosures. Citations to 10-K pages (p.123, p.96) add precision, though not required. The only minor gap is the lack of explicit mention that both firms use stress testing to inform funding strategies—a point emphasized in the original—but this is implied in the LLM’s explanation. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 421,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How does the adoption of ASU 2022-04 impact the comparability of supplier finance obligation disclosures between CAT and GE, particularly regarding the roll-forward requirements that GE began applying in 2024?",
      "original_answer": "GE adopted ASU 2022-04 on January 1, 2023, and began applying the annual roll-forward disclosure requirement prospectively starting January 1, 2024 (GE_10k_2024.pdf:page_47). This aligns with CL's explanation that ASU 2022-04 mandates disclosures including key terms, balance sheet presentation, and a roll-forward of confirmed obligations (CL_10k_2024.pdf:page_57). CAT, in its 2024 10-K (CAT_10k_2024.pdf:page_111), provides a roll-forward of its supplier finance obligations, showing $830 million outstanding at year-end 2024. The adoption of ASU 2022-04 enhances comparability between CAT and GE by standardizing how supplier finance obligations are disclosed, particularly with the new roll-forward requirement that GE implemented in 2024.",
      "llm_answer": "Both companies now present their supplier‑finance obligations in a roll‑forward format (beginning‑of‑period balance, invoices confirmed, invoices paid, ending‑of‑period balance). GE adopted ASU 2022‑04 on 1 Jan 2023, but the roll‑forward disclosure is required only prospectively from 1 Jan 2024 (GE 10‑K p.47; roll‑forward shown on p.111), whereas Caterpillar’s 2024 filing already includes the same roll‑forward table (CAT 10‑K p.112). Consequently, the 2024 numbers are directly comparable, but GE’s earlier years lack the roll‑forward detail, limiting comparability across prior periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all dates and implementation timelines are correct: GE adopted ASU 2022-04 on January 1, 2023, and began applying the roll-forward requirement prospectively from January 1, 2024 (cited to GE 10-K p.47), which matches the original answer. The mention of CAT’s 2024 filing including the roll-forward (CAT 10-K p.112) is consistent with the ground truth (CAT_10k_2024.pdf:page_111), with only a minor page number discrepancy that does not affect factual accuracy. The $830 million year-end 2024 balance for CAT is not explicitly repeated in the LLM answer, but the focus is on the format and comparability, so this omission does not undermine correctness. (2) The reasoning is sound: the LLM correctly identifies that the adoption of ASU 2022-04 standardizes disclosures via the roll-forward requirement, enhancing comparability in 2024. It also accurately notes that GE applies the roll-forward prospectively, meaning prior periods lack this detail—this is a key nuance supported by the source and adds value beyond the original answer. (3) Entity accuracy is strong: both CAT and GE are correctly identified, along with ASU 2022-04, the roll-forward requirement, and correct fiscal years (2023 adoption, 2024 application). (4) The LLM synthesizes multi-hop information across both companies’ filings and correctly infers the impact on comparability: enhanced in 2024, limited for prior periods. The only minor shortcoming is the lack of explicit mention of CL’s explanation about ASU 2022-04 requirements (from CL_10k_2024.pdf), which slightly reduces completeness but does not affect the core conclusion. Overall, the answer is factually correct, well-reasoned, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 482,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How does the valuation methodology for MDLZ's Level 1 financial assets, which include exchange-traded commodity futures, differ from PEP's treatment of exchange-traded commodity futures, particularly in terms of fair value determination and daily settlement practices?",
      "original_answer": "MDLZ determines the fair value of its Level 1 financial assets, including exchange-traded commodity futures, based on quoted market prices on commodity exchanges. In contrast, PEP notes that exchange-traded commodity futures are cash-settled on a daily basis and therefore not included in their fair value hierarchy tables. While MDLZ relies directly on observable exchange prices for valuation, PEP's daily cash settlement approach for these instruments results in their exclusion from balance sheet reporting, highlighting distinct operational and accounting treatments despite both companies engaging with the same class of financial instruments.",
      "llm_answer": "Mondelez International classifies exchange‑traded commodity futures as **Level 1** assets, meaning their fair value is taken directly from the quoted market price on the commodity exchange 【page_96】. PepsiCo, however, does not record those futures in its fair‑value tables; it notes that “exchange‑traded commodity futures are **cash‑settled on a daily basis** and, therefore, not included in the table” 【page_106】. Thus, MDLZ determines fair value by the observable exchange price, while PEP treats the contracts as daily‑settled cash flows and excludes them from the fair‑value hierarchy measurement.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original answer. (1) It correctly identifies that MDLZ classifies exchange-traded commodity futures as Level 1 assets valued using quoted market prices, and that PEP excludes these from its fair value hierarchy due to daily cash settlement. (2) There are no numerical values requiring calculation, but the qualitative financial concepts—fair value determination, Level 1 classification, daily cash settlement, and exclusion from fair value tables—are all correctly represented. (3) The multi-hop reasoning is sound: the model synthesizes information from two different companies (MDLZ and PEP), compares their accounting treatments, and correctly infers the distinction in reporting based on settlement practices. (4) The answer is fully contextually relevant, directly addressing the differences in valuation methodology and fair value determination practices. Minor wording differences (e.g., 'cash-settled on a daily basis' vs. 'daily cash settlement') do not affect meaning and are acceptable under semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 311,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How does the voting rights structure between Class A and Class B common stock at CMCSA compare with META's dual-class share structure?",
      "original_answer": "At CMCSA, Class A common stockholders hold 66 2/3% of the combined voting power, while Class B common stockholders collectively hold 33 1/3%, with each share of Class B having 15 votes. In contrast, META also maintains a dual-class share structure, with Class B common stock possessing superior voting rights, although the exact vote ratio per share is not disclosed in the evidence. META had 343,761,117 shares of Class B common stock outstanding as of January 24, 2025.",
      "llm_answer": "CMCSA’s capital structure is a dual‑class system in which each Class A share carries one vote and each Class B share carries 15 votes, giving Class B about one‑third of the total voting power (Class A 66 % and Class B 33 %)【page_31】. Meta also uses a dual‑class structure, issuing separate Class A and Class B shares (2.19 billion Class A and 344 million Class B outstanding)【page_1】, but the excerpt provided does not specify the vote‑per‑share weighting for those classes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all numbers are correct: CMCSA's Class A and Class B voting power split (66% and 33%, respectively) matches the ground truth (66 2/3% and 33 1/3% — minor rounding in LLM is acceptable), and the 15 votes per Class B share is correctly stated. For META, the 344 million Class B shares outstanding is consistent with the ground truth value of 343,761,117 (rounded appropriately). The LLM also correctly notes that META's vote-per-share ratio is not disclosed. (2) The LLM mentions 2.19 billion Class A shares for META, which is not in the ground truth; however, this detail does not contradict the original answer and may be accurate based on external data — since the ground truth does not provide Class A share count, this addition is not penalized as it doesn't affect correctness. (3) The reasoning is sound: the LLM correctly compares the dual-class structures of both companies, highlights the voting power distribution at CMCSA, and acknowledges the lack of voting weight details for META. (4) The only minor shortcoming is the slight simplification of CMCSA’s voting power split (rounding 66 2/3% to 66% and 33 1/3% to 33%), which is common and semantically acceptable but slightly less precise. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 385,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How do AIG's and MetLife's exposures to CLOs differ in terms of their credit loss evaluation methodologies and unrealized loss recognition, given that both hold these instruments within structured products portfolios?",
      "original_answer": "AIG evaluates credit losses on CLOs by estimating future cash flows based on delinquency rates, default expectations, loss severity timing, and structural features like credit enhancement, with unrealized losses split between credit-related impairments and non-credit fair value changes recorded in OCI. MetLife, while also holding CLOs as part of structured products within AFS fixed maturity securities, limits its involvement to passive investment in trusts without substantial equity and does not appear to disclose the same level of detailed cash flow modeling for credit loss evaluation, instead focusing on maximum exposure to loss being limited to carrying amounts. AIG explicitly accounts for credit impairments under CECL with reversibility features, whereas MetLife emphasizes its passive investor status and lack of active management involvement in CLO structures.",
      "llm_answer": "**AIG** evaluates credit loss on its CLO holdings under the CECL model, estimating the present value of expected cash‑flows using historical performance, delinquency, default, loss‑severity, pre‑payment and the security’s credit‑enhancement structure (see AIG 10‑K p. 129).  When a fair‑value decline is driven by credit factors an allowance for credit losses is recorded in net realized gains/losses; any non‑credit‑related shortfall is reported as “unrealized appreciation (depreciation)” in OCI (AIG 10‑K p. 128).  \n\n**MetLife** also uses an allowance‑for‑credit‑losses approach for CLOs that incorporates the same cash‑flow inputs and structural considerations (MetLife 10‑K p. 130), but it tracks the allowance separately for structured securities and records both the change in the allowance and the unrealized fair‑value change directly in earnings (net investment income), as shown by the “unrealized net gains (losses) recognized in earnings” line (MetLife 10‑K p. 225).  \n\nThus, while both insurers model CLO credit loss similarly, AIG’s non‑credit unrealized losses flow through OCI, whereas MetLife’s unrealized losses are recognized in earnings.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant qualitative inaccuracies in reasoning and entity-specific methodology that deviate from the ground truth. (1) Quantitatively, there are no numeric errors because the answer does not include specific numbers (e.g., dollar amounts, percentages), so the quantitative accuracy is high by default. (2) However, the core error lies in the claim that MetLife uses 'the same cash-flow inputs and structural considerations' and an allowance-for-credit-losses approach similar to AIG—this contradicts the original answer, which states that MetLife does *not* disclose detailed cash flow modeling like AIG and instead emphasizes its passive investor status with exposure limited to carrying amounts. The original answer highlights that AIG explicitly applies CECL with reversibility, while MetLife’s disclosures focus on structural insulation and lack of active management, not detailed modeling. (3) The LLM incorrectly asserts that MetLife records both allowance changes and unrealized fair value changes in earnings, citing a line item on p.225. This misrepresents MetLife’s approach: the ground truth does not support that MetLife recognizes *all* unrealized losses in earnings—rather, it emphasizes its limited exposure and passive role, without detailing a CECL-style modeling framework. AIG’s distinction between credit (P&L) and non-credit (OCI) components is accurately described. (4) The conclusion that both insurers 'model CLO credit loss similarly' is therefore incorrect and undermines the multi-hop synthesis. While the answer correctly identifies both hold CLOs in structured portfolios and contrasts OCI vs. earnings treatment of non-credit losses, it fabricates methodological similarities that the ground truth denies. Hence, correctness and qualitative accuracy are moderate due to major reasoning flaws despite correct contextual framing and no numerical errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1526,
        "completion_tokens": 519,
        "total_tokens": 2045
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How does the Inflation Reduction Act's redesign of Medicare Part D affect CVS's ability to forecast medical cost trends and BMY's rebate accruals for the same program?",
      "original_answer": "The Inflation Reduction Act (IRA) redesigns Medicare Part D by reducing federal reinsurance in the catastrophic phase and shifting more costs to manufacturers like BMY starting in 2025, which increases their rebate obligations. This directly impacts BMY’s gross-to-net U.S. rebate accruals for Medicare Part D, as they must account for these new liabilities in their financial reporting. For CVS, the IRA’s changes to Medicare Part D contribute to the uncertainty in forecasting health care and benefit costs, especially as new cost-sharing obligations for manufacturers may alter utilization patterns and overall program dynamics. These shifts make it more challenging for CVS to predict medical cost trends and manage profitability in their Medicare-insured products.",
      "llm_answer": "The Inflation Reduction Act’s redesign of Medicare Part D—capping beneficiary out‑of‑pocket costs and shifting a larger share of drug spending to manufacturers and Part D plans—adds a new layer of uncertainty to CVS’s cost‑trend modeling, making its health‑care benefit pricing and medical‑cost forecasts more difficult (CVS 10‑K p. 40). For Bristol‑Myers Squibb, the same redesign creates new rebate‑and‑inflation‑penalty obligations under Medicare Part D, so its GTN U.S. rebate accruals now depend on significant assumptions and judgments about legal interpretations, payer mix and contract terms (BMY 10‑K pp. 125‑126).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the Inflation Reduction Act's redesign of Medicare Part D is correctly described in terms of shifting costs to manufacturers (BMY) and increasing uncertainty for CVS in forecasting medical cost trends. The 2025 effective date is implied by context in both the original and LLM answer, and no incorrect dates are stated. (2) There are no explicit numbers (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; the LLM correctly avoids inventing figures. (3) Multi-hop reasoning is sound: the LLM correctly links the IRA’s structural changes to BMY’s increased rebate accruals (via gross-to-net or GTN) and to CVS’s forecasting challenges, citing appropriate sections of each company’s 10-K (p. 40 for CVS, pp. 125–126 for BMY), which demonstrates proper synthesis across documents. (4) Semantic equivalence is strong: while the LLM uses slightly different phrasing (e.g., 'capping beneficiary out-of-pocket costs' and 'shifting spending to manufacturers and Part D plans'), this is consistent with the IRA provisions and adds contextual detail not in the original but still accurate. The only minor gap is that the original explicitly mentions reduced federal reinsurance in the catastrophic phase, a key mechanism driving the change, which the LLM omits. However, the core causal chain—IRA changes → greater manufacturer liability → higher rebate accruals for BMY and forecasting uncertainty for CVS—is fully preserved. Thus, the answer is factually correct, well-reasoned, and contextually appropriate, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 483,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How does JPMorgan Chase's exposure to Stress Capital Buffer requirements influence its capital distribution constraints compared to Charles Schwab's obligations under the Capital Conservation Buffer, given the composition of their respective regulatory buffer requirements?",
      "original_answer": "JPMorgan Chase is subject to a Stress Capital Buffer (SCB) as part of its regulatory capital requirements, which could increase based on stress loss estimates from the Federal Reserve’s Comprehensive Capital Analysis and Review. This buffer, along with the GSIB surcharge and countercyclical buffer (CCyB), contributes to JPMorgan’s total capital buffer requirement. On the other hand, Charles Schwab’s banking subsidiary, Charles Schwab Bank (CSB), is required to maintain a Capital Conservation Buffer (CCB) of 2.5%, which imposes restrictions on capital distributions if not met. According to regulatory definitions, the CCB is a fixed component of capital buffer requirements, whereas JPMorgan’s SCB is dynamic and tied to stress testing outcomes. Therefore, JPMorgan faces a more variable and forward-looking capital constraint tied to macroeconomic stress scenarios, while Schwab faces a static buffer requirement that acts as a floor to avoid distribution limitations.",
      "llm_answer": "JPMorgan Chase must hold a Stress Capital Buffer of 5.4 % of CET1, which together with a 3.0 % G‑SIB surcharge creates an 8.4 % total capital‑buffer requirement that must be kept above the regulatory minimum before any dividends, share repurchases or discretionary bonuses can be paid, thereby tightening its distribution capacity (see JPMorgan 10‑K p. 134; p. 22). Charles Schwab, by contrast, is subject only to a 2.5 % stress‑capital buffer and a separate 2.5 % capital‑conservation buffer (total 5 % of CET1), and limits on capital distributions arise only if either buffer falls below its minimum, giving Schwab comparatively more leeway to distribute capital (see Schwab 10‑K p. 122).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. It incorrectly states that JPMorgan Chase has a Stress Capital Buffer (SCB) of 5.4% and a 3.0% G-SIB surcharge, combining into an 8.4% total buffer. The original answer does not specify exact percentages for JPMorgan’s SCB, G-SIB surcharge, or CCyB, emphasizing instead the dynamic nature of the SCB. More critically, the LLM misrepresents Charles Schwab’s requirements by claiming it has both a 2.5% stress-capital buffer and a separate 2.5% capital-conservation buffer (totaling 5%), which contradicts the ground truth: Schwab is only subject to the standard 2.5% Capital Conservation Buffer (CCB), not a stress-capital buffer. This is a major error in regulatory understanding. (2) The calculations (e.g., 5.4% + 3.0% = 8.4%) are mathematically correct but based on fabricated or misattributed numbers. The claim that Schwab has a '2.5% stress-capital buffer' is unsupported and incorrect—no such buffer is mentioned in the ground truth for Schwab. (3) The multi-hop reasoning is partially sound in structure—comparing JPMorgan’s dynamic SCB with Schwab’s static CCB—but fails in execution due to incorrect entity-specific buffer compositions. The model conflates SCB and CCB frameworks and misattributes regulatory requirements. (4) While the answer attempts to address the comparative regulatory constraints and capital distribution implications (hence decent contextual relevance), the core factual inaccuracies—especially the invented percentages and misapplication of stress-capital buffers to Schwab—severely undermine correctness. The qualitative reasoning is plausible but built on false premises, leading to a low correctness and quantitative accuracy score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 485,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How do General Dynamics and Raytheon Technologies differ in their financial exposure to state and local income taxes on U.S. government contracts regulated by the FAR, especially considering GD's exclusion of these taxes from its tax provision and RTX's FAR-governed cost allowability and pricing mechanisms?",
      "original_answer": "General Dynamics excludes state and local income taxes allocable to U.S. government contracts from its tax provision, instead recognizing them in operating costs and expenses. This treatment is governed by the Federal Acquisition Regulation (FAR), which dictates how costs are allocated and allowed on government contracts. Raytheon Technologies, also subject to the FAR, structures its pricing under these contracts based on allowable costs, including mechanisms like performance-based payments and progress payments that influence revenue recognition patterns. The difference in financial exposure stems from GD directly expensing these taxes while RTX incorporates them into broader cost considerations under FAR-regulated pricing frameworks.",
      "llm_answer": "General Dynamics does not include the state‑ and local‑income taxes that are allocable to its U.S. government contracts in its income‑tax provision; they are recorded as operating costs and therefore are borne directly by the company (GD 10‑K p.66). Raytheon Technologies, however, treats those same taxes as allowable costs under the FAR, allocates them to its RIS and RMD contracts and recovers them through contract pricing, so the taxes are effectively reimbursed (RTX 10‑K p.78‑79). Consequently, GD’s exposure is a direct expense, while RTX can offset the taxes against government reimbursements, reducing its net tax exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that General Dynamics excludes state and local income taxes on U.S. government contracts from its tax provision and instead records them as operating costs (citing GD 10-K p.66), while Raytheon Technologies treats these taxes as allowable costs under the FAR and recovers them through contract pricing (citing RTX 10-K pp.78–79). This matches the original answer’s core distinction: GD bears the cost directly, whereas RTX incorporates it into cost-reimbursable pricing mechanisms. (2) There are no numerical values requiring verification (e.g., dollar amounts, percentages, dates), so quantitative accuracy is not compromised—no errors in this dimension. (3) The multi-hop reasoning is sound: the model synthesizes information across two companies, their respective tax treatments, regulatory framework (FAR), and financial impact (expense vs. reimbursement). The conclusion about differing financial exposure—direct expense for GD vs. offset via reimbursement for RTX—is logically derived and factually supported. (4) The only minor shortcoming is that the LLM answer does not explicitly mention RTX’s use of performance-based or progress payments, which the original answer includes as part of its FAR-governed pricing mechanisms. However, this detail is contextual rather than central to the core comparison on tax treatment and exposure. Overall, the LLM captures the essential contrast accurately and with strong evidentiary support, warranting a high correctness score of 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 432,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How does the voting power distribution in META's dual-class structure, including the dividend initiation on Class B shares, compare with GOOGL's structure where Class B shares automatically convert to Class A upon transfer?",
      "original_answer": "META’s Class B common stock is entitled to a non-dilutable 33 1/3% aggregate voting power, with each share receiving 15 votes, and it now receives the same $0.50 per share quarterly dividend as Class A stock following META’s initiation of dividends in 2024. Class B shares can convert share-for-share into Class A common stock, subject to restrictions. In contrast, GOOGL’s Class B shares are entitled to 10 votes per share and automatically convert to Class A shares upon sale or transfer, ensuring a more fluid transition between voting tiers. Both companies maintain dual-class systems to preserve founder control, but the structural mechanics and dividend treatment differ significantly.",
      "llm_answer": "Meta’s capital structure gives Class A shares one vote per share and Class B shares ten votes per share, and for the first time both classes will receive the same cash dividend of $0.50 per share (equivalent to $2.00 annually) 【META 10‑K p.56】【META 10‑K p.57】. Google (Alphabet) also issues one‑vote Class A and ten‑vote Class B shares, but every Class B share automatically converts to Class A on any sale or transfer, preserving voting control with insiders, while its Class C shares have no voting rights 【GOOGL 10‑K p.81】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in vote counts and voting power distribution. According to the ground truth, META's Class B shares have 15 votes per share, not 10 as stated in the LLM answer. Additionally, the ground truth specifies that Class B holds a non-dilutable 33 1/3% aggregate voting power, a key structural detail entirely missing from the LLM response. The dividend amount of $0.50 per share is correctly reported, as is the 2024 initiation (implied by context), but the LLM does not mention that this dividend policy is new and applies equally to both classes only after 2024. (2) For GOOGL, the LLM correctly states that Class B shares have 10 votes and automatically convert to Class A upon transfer, which aligns with the ground truth. However, the mention of Class C shares with no voting rights, while factually true, was not part of the original comparison and slightly distracts from the core dual-class focus. (3) The multi-hop reasoning is partially sound—comparing dividend treatment and conversion mechanics across META and GOOGL—but fails to capture the full structural distinction in voting power concentration (e.g., META’s fixed 33 1/3% control via Class B). The synthesis is surface-level and misses deeper implications of the differing vote allocations. (4) The contextual relevance is high because the answer addresses both companies’ dual-class structures, dividends, and transfer rules. However, due to incorrect vote counts (10 vs. 15 for META Class B) and omission of the non-dilutable voting block, the quantitative and overall correctness scores are reduced significantly. Minor formatting of dollar amounts is acceptable, but vote counts are critical and incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 476,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How does the use of a 95% confidence interval in the VaR model under normal market conditions impact the one-day loss estimation methodology for both Philip Morris's derivative instruments and Mondelez's currency and commodity exposures, given their shared reliance on the parametric delta-gamma approximation technique?",
      "original_answer": "Both Philip Morris (PM) and Mondelez (MDLZ) rely on the parametric delta-gamma approximation technique within their Value at Risk (VaR) models, which operate under the assumption of normal market conditions and a 95% confidence interval. This methodology estimates the potential one-day loss by observing interest rate and currency movements—PM excludes anticipated transactions and hedges in its calculation, while MDLZ includes currency and commodity instruments, explicitly noting the non-linear response of options in the computation. The shared modeling assumption limits both firms' risk assessments to typical market behavior, potentially underestimating losses during periods of market stress.",
      "llm_answer": "Both companies base their one‑day loss estimates on a VaR model that assumes normal market conditions, a one‑day holding period and a **95 % confidence interval**, meaning the loss figure represents an amount that would be exceeded only 5 % of the time. Under this framework the **parametric delta‑gamma approximation** translates the observed volatility and inter‑relationships of rates, currencies and commodities into a statistical loss distribution: for Philip Morris it yields the potential one‑day loss in the **fair value of its interest‑rate‑sensitive and foreign‑currency derivative instruments** (PM 10‑K p. 77), while for Mondelez it produces the potential one‑day loss in **pre‑tax earnings from its currency‑exchange and commodity‑price exposures** (MDLZ 10‑K p. 66). Thus, the 95 % confidence level provides a common, tail‑risk‑focused metric that both firms use to quantify daily market‑risk loss via the same delta‑gamma methodology.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: both Philip Morris (PM) and Mondelez (MDLZ) use a 95% confidence interval in their VaR models under normal market conditions with a one-day holding period, and both employ the parametric delta-gamma approximation technique. The 95% confidence level correctly implies the loss would be exceeded only 5% of the time—this matches the ground truth quantitatively and conceptually. (2) The entities (PM and MDLZ), metrics (VaR, delta-gamma approximation), and financial exposures (interest rate and currency for PM; currency and commodities for MDLZ) are accurately identified. The LLM correctly distinguishes PM’s focus on fair value of derivatives from MDLZ’s focus on pre-tax earnings impact, citing appropriate pages from the 10-Ks. (3) Multi-hop reasoning is sound: the model synthesizes shared methodology (VaR with 95% CI and delta-gamma) across two firms while differentiating their respective risk exposures and calculation scopes. (4) Minor omission: the ground truth notes that PM excludes anticipated transactions and hedges, and MDLZ accounts for non-linear option behavior—these nuances are not mentioned in the LLM answer, slightly reducing completeness. However, this does not undermine the core correctness. Wording differs but meaning is semantically equivalent. No calculation errors. Thus, high scores across all dimensions with a 9 for correctness due to partial omission of methodological nuances.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 416,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How do the embedded derivatives within CDOs referenced by Morgan Stanley compare in risk exposure to Bank of America's structured liabilities that also contain embedded derivatives, particularly in the context of credit events impacting their market-making activities?",
      "original_answer": "Morgan Stanley's involvement with CDOs includes hybrid instruments containing embedded derivatives where credit protection has been sold to the issuer of the note, exposing the firm to risk in the event of a credit event on the reference entity, which could result in the principal balance of the note not being repaid in full. Similarly, Bank of America's structured liabilities also contain embedded derivatives that are part of their market-making activities, and these derivatives are typically offset by gains or losses on hedging instruments. Both firms face credit risk tied to these derivatives, though the specific impact on Morgan Stanley is tied to the performance of the CDOs' underlying reference entities, while Bank of America's exposure is more broadly tied to the performance of their structured liabilities and the effectiveness of their hedging strategies.",
      "llm_answer": "Morgan Stanley’s CDO exposure comes from CLNs and CDOs that embed credit‑protection swaps – the firm sells protection and therefore faces a direct loss of principal if a reference entity experiences a credit event, a risk that is shown by its net derivative liabilities with credit‑contingent features of about $22 bn and credit‑protection notional of roughly $4 bn. Bank of America’s structured liabilities are recorded under the fair‑value option and contain embedded interest‑rate and credit derivatives whose risk is reflected in fair‑value gains or losses on market‑making (e.g., a $550 m gain in 2024 versus a $1.2 bn loss in 2023) rather than a direct principal‑loss trigger, so its market‑making risk is managed through valuation adjustments rather than a specific credit‑event exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides a reasonable qualitative comparison between Morgan Stanley's and Bank of America's exposures to embedded derivatives, correctly identifying that Morgan Stanley faces direct credit-event risk through selling protection in CDOs (e.g., CLNs), while Bank of America's structured liabilities are managed through fair-value accounting and hedging, with market-making impacts reflected in valuation gains/losses. This aligns with the ground truth's core point about differing risk mechanisms. However, the quantitative accuracy is poor: the LLM introduces specific figures—$22 billion in net derivative liabilities with credit-contingent features, $4 billion in credit-protection notional, and a $550M gain in 2024 versus $1.2B loss in 2023—that are not present in the original answer or supported by the knowledge graph. These numbers appear fabricated or hallucinated, as the ground truth contains no such data. This severely undermines factual reliability. While the reasoning framework is sound—correctly distinguishing between principal-loss triggers and fair-value volatility—the introduction of unsupported metrics breaks semantic equivalence. The entities (Morgan Stanley, Bank of America, CDOs, structured liabilities, embedded derivatives) and contexts (market-making, credit events, hedging) are accurately identified and appropriately contrasted. The answer is contextually relevant and addresses both firms and the comparative risk exposure question, but the inclusion of false quantitative details reduces overall correctness despite strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 434,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How does the global minimum tax under the OECD's Pillar Two model rules impact Salesforce's effective tax rate compared to Microsoft's projected tax liability, given the uncertainty around implementation timelines and jurisdictional adoption?",
      "original_answer": "Salesforce notes that global tax developments, including the OECD's Pillar Two model rules introducing a 15% global minimum tax, may have a material impact on its business, cash flows, or financial results. Microsoft, which currently operates with an effective tax rate of 19% (down to 18% in fiscal 2024), expects Pillar Two to apply to its operations starting in fiscal 2025 but does not currently estimate a material impact to its consolidated financial statements. However, uncertainty remains as to the final Pillar Two model rules and their adoption across jurisdictions, which could affect both companies differently depending on their global footprint and tax planning strategies.",
      "llm_answer": "Salesforce warns that the OECD‑Pillar Two global minimum tax could lift its effective tax rate – it cites the rule as a “potentially material” tax development but does not quantify the effect and stresses the uncertainty around when and where the rules will be adopted (CRM 10‑K p. 29). By contrast, Microsoft reports an effective tax rate of about 18 % for FY 2024 and says Pillar Two is not expected to materially increase its projected tax liability because it has little exposure to jurisdictions with rates below the 15 % floor, although it also notes that the final model rules and implementation timeline remain uncertain (MSFT 10‑K p. 47 & 75).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and percentages are correct: Microsoft's effective tax rate of 18% for fiscal 2024 is accurately reported, and the reference to Salesforce not quantifying the impact but labeling it 'potentially material' matches the original. There are no calculation errors. (2) The answer correctly identifies both companies (Salesforce and Microsoft), references the correct fiscal year (FY2024), and accurately describes the expected timing of Pillar Two applicability (Microsoft from fiscal 2025, though not explicitly stated in the LLM answer, the implication of future but limited impact is consistent). (3) The multi-hop reasoning is sound: it contrasts Salesforce’s caution about material impact due to uncertainty with Microsoft’s expectation of no material impact due to low exposure to low-tax jurisdictions—this synthesis across two companies’ filings is correctly executed. (4) The LLM cites specific page numbers from the 10-Ks (p.29 for CRM, pp.47 & 75 for MSFT), which adds precision and supports credibility, even though the original answer does not include them. The only minor shortcoming is that the original mentions Microsoft expects Pillar Two to apply starting in fiscal 2025, which the LLM omits slightly by focusing on lack of material impact without explicitly stating the expected start date—hence a 9 instead of 10 on qualitative accuracy. Otherwise, the semantic meaning, context, and factual content are equivalent and highly relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 430,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How does Boeing's Five-Year Credit Agreement, which involves JPMorgan Chase Bank, N.A. as syndication agent, compare with Honeywell's credit agreement with JPMorgan Chase Bank, N.A. in terms of syndication structure and key banking partners?",
      "original_answer": "Boeing's Five-Year Credit Agreement, dated October 30, 2019, includes JPMorgan Chase Bank, N.A. as syndication agent alongside Citibank, N.A. as administrative agent, with both also serving as joint lead arrangers and joint book managers. Honeywell's Amended and Restated Five-Year Credit Agreement, dated March 20, 2023, also features JPMorgan Chase Bank, N.A., along with Wells Fargo Bank, National Association, as syndication agents, with Bank of America, N.A. serving as administrative and swing line agent. Both agreements involve JPMorgan Chase Bank, N.A. in a syndication role, but differ in the lead arranger structure and partner institutions involved.",
      "llm_answer": "Boeing’s five‑year credit agreement names JPMorgan Chase Bank, N.A. as the sole syndication agent, with Citibank N.A. acting as administrative agent and, together with JPMorgan, serving as joint lead arrangers and book‑managers【page_125】. Honeywell’s comparable facility uses a multi‑agent syndication structure – JPMorgan Chase Bank, N.A. and Wells Fargo Bank, N.A. are both syndication agents – while Bank of America, N.A. is the administrative (and swing‑line) agent and Citibank does not appear【page_125】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key entities and roles in both Boeing's and Honeywell's credit agreements. It accurately states that JPMorgan Chase Bank, N.A. is the syndication agent for Boeing, with Citibank N.A. as administrative agent and both as joint lead arrangers and book managers. For Honeywell, it correctly identifies JPMorgan and Wells Fargo as co-syndication agents and Bank of America as administrative and swing line agent, while noting Citibank's absence. The only minor inaccuracy is describing JPMorgan as the 'sole syndication agent' for Boeing — while technically true, the original answer notes that Citibank is also a joint lead arranger and book manager, which the LLM mentions but could have more clearly distinguished from the syndication agent role. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable — but all referenced roles and institutions match the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two different credit agreements, compares syndication structures, and identifies overlapping and distinct banking partners. (4) The answer is contextually relevant, directly addressing the comparison of syndication structures and key banking partners. The slight deduction in qualitative accuracy is due to the subtle conflation of syndication agent role with joint lead arranger roles, but overall the answer is factually strong and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 429,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How does the absence of the Countercyclical Capital Buffer requirement impact the total capital buffer requirements for both Bank of America and Morgan Stanley under the Advanced Approaches framework, given their respective G-SIB surcharges of 2.5% and inclusion of the 2.5% Capital Conservation Buffer?",
      "original_answer": "For Bank of America, the absence of the Countercyclical Capital Buffer (CCyB) means its total Common Equity Tier 1 (CET1) capital buffer requirement under the Advanced Approaches framework is the sum of its G-SIB surcharge of 2.5% and the 2.5% Capital Conservation Buffer, totaling 5.0%. Similarly, Morgan Stanley’s CET1 capital buffer requirement under the same framework is also the sum of its G-SIB surcharge (which is not quantified in the provided data but assumed to be included), the 2.5% Capital Conservation Buffer, and the zero CCyB. Therefore, the absence of CCyB directly reduces the total CET1 buffer requirement for both banks by the amount the CCyB would have otherwise contributed.",
      "llm_answer": "Because the counter‑cyclical capital buffer (CCyB) is set to 0 % for both firms, the only buffers that count under the Advanced Approaches are the 2.5 % capital‑conservation buffer (CCB) plus each firm’s G‑SIB surcharge.  \n\n* **Bank of America** – the filing states the CET1 minimum includes a 2.5 % G‑SIB surcharge and a 2.5 % CCB, with the CCyB “zero for both periods”【page_146】. Thus the total buffer = 2.5 % + 2.5 % = 5.0 %.  \n\n* **Morgan Stanley** – the capital‑buffer table shows a 2.5 % CCB, a 3.0 % G‑SIB surcharge and a CCyB of 0 %, giving a “capital buffer requirement” of 5.5 %【page_134】.  \n\nSo, without a CCyB, Bank of America’s Advanced‑Approach buffer is 5.0 % of risk‑weighted assets, while Morgan Stanley’s is 5.5 %.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: Bank of America's 2.5% G-SIB surcharge + 2.5% Capital Conservation Buffer = 5.0%, and Morgan Stanley's 3.0% G-SIB surcharge (from filing) + 2.5% CCB + 0% CCyB = 5.5%. These match the cited data and calculations. (2) The LLM correctly identifies that the absence of the CCyB (i.e., 0%) reduces total buffer requirements, which is consistent with the original answer’s reasoning. (3) The only discrepancy is that the original answer assumes Morgan Stanley’s G-SIB surcharge is 'not quantified' but included, while the LLM correctly pulls the actual 3.0% figure from the filing (page 134), making the LLM answer more precise than the ground truth. This reflects superior data usage, not an error. (4) Multi-hop reasoning is sound: the model synthesizes buffer components across two banks, applies the absence of CCyB correctly, and computes totals under the Advanced Approaches framework. (5) All entities (Bank of America, Morgan Stanley, G-SIB, CCB, CCyB) are correctly identified and contextualized. The answer is semantically equivalent to and factually more complete than the original. Minor deduction in qualitative accuracy only because the original answer’s ambiguity about Morgan Stanley’s G-SIB surcharge was interpreted conservatively, but the LLM improved upon it with specific data.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 389,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "What was NVIDIA's effective tax rate in fiscal year 2022, and how does it compare to Apple's operating income margin in the Greater China region during the same period?",
      "original_answer": "NVIDIA's effective tax rate in fiscal year 2022 was 1.9%, significantly lower than the U.S. federal statutory rate of 21%, due in part to income earned in jurisdictions like Hong Kong that have lower tax rates. Meanwhile, Apple reported $31,153 million in operating income from $74,200 million in net sales in the Greater China region during fiscal year 2022, resulting in an operating income margin of approximately 42%. These metrics reflect different financial impacts from operating in the region, with NVIDIA benefiting from lower tax rates and Apple demonstrating strong profitability from its sales in the same market.",
      "llm_answer": "NVIDIA’s 2022 Form 10‑K states that its annual effective tax rate was **1.9 %** for the fiscal year ended January 30 2022【page_52】.  \n\nApple’s 2022 Form 10‑K shows that the Greater China segment recorded net sales of **$74.2 billion** and operating income of **$31.2 billion**, giving an **operating‑income margin of roughly 42 %** (31.2 ÷ 74.2)【page_52】.  \n\nThus, NVIDIA’s effective tax rate (1.9 %) is far lower than Apple’s operating‑income margin in Greater China (≈ 42 %).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: NVIDIA's effective tax rate is correctly stated as 1.9%, Apple's Greater China net sales as $74.2 billion (equivalent to $74,200 million), and operating income as $31.2 billion (rounded from $31,153 million — a negligible and acceptable rounding difference). The calculated operating income margin of approximately 42% (31.2 ÷ 74.2 ≈ 0.4205) is correct. (2) The answer addresses both parts of the multi-hop question: NVIDIA’s tax rate and Apple’s operating margin in Greater China, both for fiscal year 2022. (3) Entities are accurately identified: NVIDIA and Apple, correct fiscal year (ended January 30, 2022, aligns with FY2022), and correct financial metrics (effective tax rate, operating income margin). (4) The reasoning is sound: the LLM correctly synthesizes data from two different 10-K filings, computes the margin, and draws a valid comparison between the two figures, noting that 1.9% is far lower than 42%. Wording differs slightly from the original answer but maintains full semantic equivalence and adds citation markers without altering meaning. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 346,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How do BA's and UPS's uses of pricing models for valuing Level 2 assets differ based on the observable inputs they emphasize in their 2024 filings?",
      "original_answer": "BA values its fixed income investments categorized as Level 2 using pricing models that incorporate inputs such as benchmark yields, swap curves, and inter-dealer broker rates. These models are primarily income-based and rely on structured cash flow analysis and rating agency data. In contrast, UPS applies pricing models to value its Level 2 derivatives—mainly over-the-counter instruments—using market observable inputs like yield curves, foreign currency exchange rates, and investment forward prices. While both companies rely on observable market data for Level 2 classifications, BA emphasizes credit and yield-related inputs for fixed income instruments, whereas UPS focuses on currency and interest rate dynamics for its derivative positions.",
      "llm_answer": "Boeing’s 2024 filing says its Level 2 fair‑value estimates are generated with pricing models that pull in a wide array of observable market data – reported trades, broker quotes, benchmark yields and base spreads, swap curves, cash‑flow analyses, rating‑agency spreads and comparable market prices (including cost, operating results and discounted‑cash‑flow inputs for NAV‑based private‑equity, real‑estate and hedge‑fund investments)【page_102】. United Parcel Service, on the other hand, notes that its Level 2 assets—primarily over‑the‑counter foreign‑currency and interest‑rate derivatives—are valued using models that rely chiefly on market‑observable yield curves, foreign‑exchange rates and forward‑price information【page_136】【page_137】. Thus Boeing emphasizes a broader set of observable inputs across many asset classes, while UPS focuses on macro‑level rate and FX inputs for its Level 2 valuations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: Boeing (BA) uses pricing models with observable inputs such as benchmark yields, swap curves, broker quotes, and rating-agency spreads for fixed income and other Level 2 assets, which matches the original answer’s emphasis on credit and yield-related inputs. UPS uses models based on yield curves, foreign exchange rates, and forward prices for its OTC derivatives—consistent with the ground truth. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; all referenced data types are correctly attributed. (3) The multi-hop reasoning is sound: the model correctly identifies both companies, their respective asset types (fixed income vs. derivatives), and the differing emphasis in observable inputs. The synthesis across two filings is accurate. (4) Minor deduction in qualitative accuracy due to the LLM’s phrasing that BA emphasizes a 'broader set of observable inputs across many asset classes,' which slightly overgeneralizes compared to the original answer’s more precise focus on fixed income instruments and structured cash flow analysis. However, this does not distort the core contrast: BA emphasizes credit/yield inputs for fixed income, while UPS focuses on FX and interest rate dynamics for derivatives. Semantic equivalence is maintained. Contextual relevance is perfect—directly addresses the question about differences in pricing model inputs for Level 2 assets in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 429,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How does the voting power disparity between Class A and Class B common stock at GOOGL compare to the uniform voting rights structure at NFLX, particularly in light of GOOGL's $62.2 billion share repurchase program in 2023?",
      "original_answer": "GOOGL's Class A common stockholders have 1 vote per share, while Class B common stockholders have 10 votes per share, creating a significant disparity in voting power. This contrasts sharply with NFLX, where each share of common stock carries exactly one vote, ensuring equal voting rights across all shareholders. Additionally, GOOGL's 2023 share repurchase program, which retired $62.2 billion worth of shares, primarily targeted Class A and Class C shares, potentially influencing the overall voting balance by reducing the number of shares that convert from Class B to Class A upon transfer, thereby preserving the voting control of existing Class B holders.",
      "llm_answer": "Alphabet’s (GOOGL) capital structure is dual‑class: each Class A share carries one vote, but each Class B share carries ten votes 【page_81†L1-L4】. Visa (NFLX) has a single‑class structure in which every share receives one vote 【page_61†L1-L3】. Even after Alphabet repurchased $62.2 billion of its Class A and Class C shares in 2023 【page_81†L7-L9】, the ten‑to‑one voting gap between Class B and Class A remains, whereas Netflix’s voting power is uniformly distributed among all shareholders.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the 1:10 voting ratio between GOOGL's Class A and Class B shares and accurately states that NFLX has uniform voting rights with one vote per share. The $62.2 billion share repurchase figure for 2023 is correctly cited, and the focus on Class A and Class C repurchases aligns with the ground truth. Quantitative accuracy is perfect—numbers, amounts, and dates are correct. However, the LLM incorrectly refers to 'Visa (NFLX)' instead of 'Netflix (NFLX)', which is a critical entity error that undermines credibility. This misidentification suggests a failure in entity recognition, likely confusing NFLX with V (Visa). While the core structural comparison is sound, the answer omits the key qualitative point that the repurchase of Class A and C shares (non-super-voting) indirectly preserves Class B control by reducing potential dilution of voting power upon transfer, which involves multi-hop reasoning from repurchases to ownership structure to voting dynamics. The answer captures the surface-level contrast but misses deeper synthesis present in the original answer. Contextual relevance is high as it addresses voting structures and repurchases directly, but the entity mistake and incomplete reasoning limit its accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 352,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How does ACN's classification of U.S. government debt securities as Level 2 assets affect comparability with AVGO's investment disclosures, given that such securities are typically categorized as Level 1 based on active market pricing?",
      "original_answer": "ACN classified its U.S. government debt securities as Level 2 assets totaling $9,765 million, which contrasts with AVGO's disclosures where Level 1 securities are described as being valued based on quoted prices in active markets. This is notable because the UPS evidence indicates that U.S. government debt securities are generally categorized as Level 1 due to quoted prices in active markets. AVGO’s disclosures explicitly differentiate Level 1 and Level 2 securities based on valuation methodology, suggesting that ACN’s choice to classify these assets as Level 2 could reduce transparency and comparability in investment valuation practices between the two firms.",
      "llm_answer": "**Answer:**  \nAccenture (ACN) treats its U.S. government‑debt holdings as Level 2 assets—valued using observable inputs such as yield curves rather than quoted market prices (see the fair‑value hierarchy table where U.S. treasuries are listed under Level 2 with the accompanying note (c) 【page_78】). Because Broadcom (AVGO) reports U.S. government securities as Level 1 (valued at quoted prices in active markets), the two companies use different valuation hierarchies; this makes a direct comparison of their investment portfolios and fair‑value disclosures less straightforward, as ACN’s figures incorporate more model‑based inputs while AVGO’s rely on observable market prices.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that ACN classifies U.S. government debt securities as Level 2 assets and contrasts this with AVGO's classification of similar securities as Level 1, which aligns with the ground truth. While the exact dollar amount ($9,765 million) is omitted in the LLM response, this is the only quantitative detail missing; however, the focus of the question is on classification impact rather than the specific value, so this omission does not undermine the core correctness. (2) All other factual elements are accurate: ACN uses observable inputs like yield curves (not quoted prices), placing these in Level 2; AVGO uses quoted prices in active markets (Level 1); and U.S. government securities are typically Level 1 per market standards (as noted in UPS evidence in the original answer). The LLM correctly references a specific document section (page_78, note c), supporting its claim. (3) Multi-hop reasoning is sound: the model synthesizes information across ACN and AVGO disclosures, understands the fair value hierarchy implications, and draws a valid conclusion about reduced comparability due to differing valuation methodologies. It correctly infers that model-based inputs (Level 2) vs. observable prices (Level 1) affect transparency and comparability. (4) The answer is semantically equivalent to the ground truth in intent and substance, with slightly less emphasis on the 'transparency' aspect but still clearly conveying reduced comparability. The omission of the $9,765 million figure prevents a perfect score, but all other aspects—entity accuracy (ACN, AVGO), reasoning, and contextual relevance—are fully correct and well-articulated.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 462,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How does Colgate-Palmolive's adoption timeline for ASU 2022-04, which mandates detailed disclosures on supplier finance obligations, compare to Target's implementation of similar disclosures, particularly regarding the confirmed amount outstanding at year-end?",
      "original_answer": "Colgate-Palmolive adopted ASU 2022-04 beginning January 1, 2023, with the roll-forward information disclosure effective January 1, 2024. Target discloses its confirmed obligations outstanding under supplier finance programs within Accounts Payable on its Consolidated Statements of Financial Position, with early payment options available to vendors up to 120 days from the invoice date. While Colgate-Palmolive references Note 15 for program details, Target explicitly outlines the structure of its arrangements and vendor discretion in electing early payments, though exact confirmed amounts are not quantified in the provided excerpt.",
      "llm_answer": "Colgate‑Palmolive said it adopted the supplier‑finance disclosure requirements of ASU 2022‑04 on January 1 2023 (with the roll‑forward detail required beginning January 1 2024)【page_84】【page_57】. Target’s filing now includes the same disclosure, showing a confirmed vendor‑obligation balance of $3.398 billion at the February 3 2024 year‑end (and $3.666 billion at February 1 2025)【page_54】. Thus, Colgate‑Palmolive’s adoption was effective earlier (2023), while Target’s current disclosures reveal a year‑end outstanding amount of roughly $3.4 billion.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in asserting that Target disclosed a confirmed vendor-obligation balance of $3.398 billion at year-end. The original answer (ground truth) explicitly states that 'exact confirmed amounts are not quantified in the provided excerpt' for Target. This is a major quantitative error. Additionally, the LLM claims Target reported a balance at February 1, 2025, which is a future date relative to the filing context and not supported by the ground truth. (2) The adoption timeline for Colgate-Palmolive is correctly stated: January 1, 2023, for initial adoption and January 1, 2024, for roll-forward disclosures. However, the attribution of specific dollar amounts to Target’s year-end obligations is incorrect and unsupported. The format variation ($3.4 billion vs $3.398 billion) would be acceptable if the number were accurate, but it is not. (3) The multi-hop reasoning is partially sound—comparing adoption timelines and disclosure practices between two companies is appropriate. However, the synthesis fails because it fabricates precise numerical disclosures for Target that do not exist in the ground truth. The model incorrectly assumes that because Target provides structural details about its program, it must also quantify the obligation, which the original answer confirms it does not. (4) The contextual relevance is high because the response addresses the right companies, standard (ASU 2022-04), and disclosure types. Qualitative accuracy is moderate due to correct identification of Colgate’s timeline and general awareness of Target’s disclosure framework, but undermined by incorrect inference. Quantitative accuracy is low due to the invention of specific dollar figures. Correctness score is 4 due to partial correctness on adoption timing but major error in asserting unreported financial figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 513,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How does BlackRock's exposure to operational risks through third-party technology partners like Microsoft compare to Mastercard's approach in managing similar reputational risks stemming from their own operational resilience strategies?",
      "original_answer": "BlackRock discloses that its reliance on key technology partners like Microsoft for hosting Aladdin on Azure introduces operational and execution risks, including infrastructure reliability, software security, and regulatory oversight, which could lead to reputational harm or legal liability if not managed properly. Operational risk is explicitly defined in the COF evidence as having the potential to result in reputational impact due to internal process failures, system issues, or external events. Mastercard identifies 'Reputational Impact' as a named risk factor in its 10-K and structures its risk management framework around it, listing 'Operational Resilience' as a core component of its reputational risk mitigation strategy. This suggests that while both firms recognize the reputational consequences of operational failures, BlackRock's risk is heightened by its dependency on external cloud providers, whereas Mastercard integrates operational resilience directly into its brand protection framework.",
      "llm_answer": "BlackRock warns that its reliance on Microsoft Azure for the Aladdin platform and other cloud‑based systems creates “operational and execution risks” – including infrastructure reliability, security and regulatory‑oversight issues – that could trigger reputational harm if a cloud outage occurs (see page 28). In contrast, Mastercard embeds operational resilience in a formal risk‑management framework, with a Chief Operational Risk Officer and an Executive Vice President of External Affairs overseeing dedicated operational‑risk and reputation‑risk policies, stakeholder engagement and controls to proactively contain any reputational impact from operational disruptions (see page 26).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: BlackRock's reliance on Microsoft Azure for Aladdin is accurately described, including the associated operational and execution risks (infrastructure reliability, security, regulatory oversight) and potential reputational harm. Mastercard's integration of operational resilience into its formal risk management framework is correctly portrayed, including leadership roles (Chief Operational Risk Officer, Executive Vice President of External Affairs) and the focus on reputation-risk policies and stakeholder engagement. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in a traditional sense—however, the absence of any incorrect numbers or fabricated details supports a score of 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (BlackRock and Mastercard), contrasting their approaches—external dependency vs. internal resilience—while linking both to reputational risk. The LLM adds specific structural details (executive roles) not in the original answer but consistent with plausible 10-K disclosures and contextually appropriate, which enhances rather than detracts from accuracy. (4) Semantic equivalence is strong: the core insight—that both firms recognize reputational risks from operational failures but differ in strategy (external reliance vs. internal control)—is preserved and clearly communicated. The only minor limitation is that the LLM does not explicitly mention the 'COF evidence' or define operational risk as having reputational impact per that source, slightly reducing qualitative completeness. However, the omission does not impair the correctness of the comparison. Overall, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 519,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How significant was Cardinal Health as a customer for BMY in 2021, and what role does Cardinal play in CVS's generic pharmaceutical sourcing strategy through Red Oak Sourcing, LLC?",
      "original_answer": "Cardinal Health represented 20% of BMY's revenue in 2021, making it a significant customer relationship. CVS partners with Cardinal through Red Oak Sourcing, LLC, where both companies hold 50% ownership and jointly negotiate generic pharmaceutical supply contracts. This strategic arrangement enables CVS and Cardinal to leverage combined sourcing capabilities, though it does not involve inventory ownership by Red Oak. The shared sourcing venture highlights Cardinal's dual role as both a key BMY customer and a strategic partner in CVS's supply chain infrastructure.",
      "llm_answer": "In 2021, Cardinal Health purchased about 20 % of Bristol‑Myers Squibb’s global gross product sales, making it the third‑largest wholesaler and a very significant BMS customer. At CVS, Cardinal is a 50 % owner of Red Oak Sourcing, LLC, partnering with CVS to provide sourcing and supply‑chain expertise and jointly negotiate generic‑drug supply contracts for both companies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) Quantitatively, the 20% figure for Cardinal Health's share of BMY's (Bristol-Myers Squibb's) revenue in 2021 is correct, and the 50% ownership in Red Oak Sourcing, LLC is accurately stated. (2) The entity names are correct—Cardinal Health, Bristol-Myers Squibb (referred to as BMS, which is acceptable), CVS, and Red Oak Sourcing, LLC. The year 2021 is correctly referenced. (3) The multi-hop reasoning is sound: the answer connects Cardinal’s role as a major BMS customer with its strategic partnership in CVS’s generic sourcing via Red Oak. (4) Minor deduction in qualitative accuracy due to the use of 'BMS' instead of 'BMY' (though BMS is a common and correct abbreviation for Bristol-Myers Squibb, the original question used 'BMY', which may refer to the same company but could cause ambiguity if strict ticker alignment is required). Additionally, the LLM omits the detail that Red Oak does not own inventory, which is a minor contextual point but not central to the core question. Otherwise, the answer captures the significance of the customer relationship and the strategic sourcing role accurately. Wording differences do not affect semantic equivalence, and the answer remains factually aligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 368,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How does the voting power of Class B common stockholders at META compare to that of NFLX common stockholders, given that META Class B shares are restricted to specific voting scenarios and each share carries a multiplier based on the conversion rate?",
      "original_answer": "META's Class B common stockholders have restricted voting rights, only applicable in specific scenarios such as exiting the core payments business, a merger, or certain amendments to the certificate of incorporation. In these cases, each Class B share's voting power is multiplied by the applicable conversion rate in effect on the record date. In contrast, NFLX common stockholders receive one vote per share on all matters requiring stockholder approval. This means that while META Class B shareholders have conditional voting rights with variable influence based on the conversion rate, NFLX shareholders have consistent, unconditional voting power proportional to their shareholding.",
      "llm_answer": "META’s Class B common shares do not vote on most matters; they can only cast votes in limited situations (e.g., a merger or certain charter amendments) and, when they do, each share’s vote is multiplied by the applicable conversion rate, so a single share may count for more than one vote 【page_90】. By contrast, every Netflix common share carries a universal right to one vote on all shareholder matters 【page_61】. Thus META’s Class B holders have far more restricted voting power overall (though with a vote‑multiplier when voting is allowed), whereas Netflix shareholders have a consistent one‑vote‑per‑share right.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the same core information as the ground truth. (1) It correctly states that META Class B shares have limited voting rights, applicable only in specific scenarios like mergers or charter amendments, and that each share's vote is multiplied by the conversion rate when voting occurs. It accurately contrasts this with NFLX common stockholders, who have one vote per share on all matters. (2) There are no numeric values requiring calculation (e.g., conversion rate multipliers are not quantified in either answer), so quantitative accuracy is fully preserved. (3) The multi-hop reasoning—comparing voting structures across two companies with different governance models—is sound and well-synthesized. The only minor shortcoming is that the LLM omits one specific example mentioned in the ground truth (exiting the core payments business), which slightly reduces completeness. (4) Despite this omission, the answer remains semantically equivalent in meaning and highly relevant to the question, with clear, accurate comparison and proper contextualization of voting rights. Hence, correctness is rated 9/10, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 341,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How does the automatic conversion of Class B shares upon transfer at GOOGL contrast with META's structural protections that require Class B approval for change-of-control transactions, and what role does Mastercard's mandatory post-conversion Class A stock transfer mechanism play in evaluating dual-class governance frameworks?",
      "original_answer": "META requires that any change-of-control transaction must be approved by a majority of its outstanding Class B common stock voting as a separate class until those shares represent less than 35% of combined voting power. In contrast, GOOGL's Class B shares automatically convert to Class A shares upon sale or transfer, effectively limiting concentrated voting control over time. Mastercard's framework mandates that converted Class B shares become Class A shares that must be sold or transferred, creating a structural mechanism that prevents long-term retention of higher-vote shares. This contrast reveals different approaches to dual-class governance: META entrenches control through voting rights preservation, while GOOGL and Mastercard implement mechanisms that eventually dilute concentrated voting power through mandatory conversion and divestiture.",
      "llm_answer": "Google’s Class B shares “may be converted at any time at the option of the stockholder and automatically convert upon sale or transfer to Class A common stock” (Alphabet 10‑K p. 81). In contrast, Meta’s charter preserves voting control by requiring that any transaction that would change control “requires the approval of a majority of our outstanding Class B common‑stock voting as a separate class” while Class B still exceeds 35 % of combined voting power (Meta 10‑K p. 50). Mastercard adds another layer of protection: its Class B shares are “convertible on a one‑for‑one basis… and Class B stockholders are required to subsequently sell or otherwise transfer any shares of Class A common stock received pursuant to such a conversion” (Mastercard 10‑K p. 99), a mandatory post‑conversion disposal rule that limits the ability of converted shares to accumulate voting power and therefore is a key factor in assessing the strength of dual‑class governance frameworks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: GOOGL's Class B shares automatically convert to Class A upon transfer; META requires majority Class B approval for change-of-control transactions while Class B holds more than 35% of voting power; Mastercard mandates post-conversion sale or transfer of Class A shares received from Class B conversion. (2) Quantitative accuracy is perfect: the 35% threshold is correctly cited, and no numerical errors exist. Format and citation placement (e.g., page numbers from 10-Ks) are consistent with source material. (3) Multi-hop reasoning is sound: the answer successfully contrasts GOOGL’s automatic conversion, META’s voting control entrenchment, and Mastercard’s mandatory divestiture mechanism, synthesizing across three companies to evaluate dual-class governance frameworks. (4) The only minor shortcoming is that the LLM does not explicitly state the broader interpretive conclusion present in the original answer—namely, that META entrenches control while GOOGL and Mastercard dilute concentrated voting power over time—though this is strongly implied by the described mechanisms. Wording differs but semantic meaning and factual content are equivalent. Contextual relevance is excellent, directly addressing all parts of the complex, multi-entity question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 377,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How do MRK's pediatric market exclusivity opportunities compare with AMGN's regulatory exclusivity risks given recent changes to data protection periods for biologics?",
      "original_answer": "MRK benefits from six-month pediatric market exclusivity extensions that can apply to products like its high-risk adult COVID-19 treatment, potentially extending protection beyond patent expiration. In contrast, AMGN faces regulatory exclusivity risks as the FDA considers changes to biologic data exclusivity, including whether umbrella exclusivity applies, which could reduce the effective protection period for products like EPOGEN. These differences reflect MRK's proactive IP strategy versus AMGN's exposure to policy shifts in biologic exclusivity frameworks.",
      "llm_answer": "Merck can earn an additional six‑month pediatric market‑exclusivity extension in the United States (under the FDAMA provision) and a comparable six‑month pediatric SPC in the EU, which can be layered on top of its existing patent and data‑exclusivity periods (MRK 10‑K pp. 16‑18). Amgen, however, flags regulatory exclusivity risk: recent policy changes – the removal of a 10‑year data‑exclusivity requirement in the USMCA and the FDA’s possible limitation of “umbrella” or the 12‑year BPCIA data‑exclusivity for biologics – could shorten or erode its 12‑year biologic exclusivity and expose its products to earlier biosimilar competition (Amgen 10‑K pp. 44‑46).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and time periods are correct: the six-month pediatric exclusivity for MRK and the 12-year biologic data exclusivity for AMGN are accurately cited, with proper context from regulatory frameworks (FDAMA, BPCIA, USMCA). These match the original answer’s references to pediatric extensions and risks to 12-year exclusivity. (2) The answer is complete, addressing both MRK’s opportunities (U.S. and EU pediatric exclusivity) and AMGN’s risks (policy changes in USMCA and FDA interpretation of umbrella exclusivity), which reflects the multi-hop requirement to compare two firms’ regulatory environments. (3) Entity accuracy is strong: MRK and AMGN are correctly identified, and product references (implied for MRK’s adult treatments and AMGN’s biosimilars exposure) are contextually appropriate, though EPOGEN is not explicitly named—this is a minor omission but does not detract from factual correctness. (4) Reasoning is sound: the LLM correctly synthesizes how pediatric exclusivity extends protection beyond patents (MRK) versus how policy shifts could erode biologic exclusivity (AMGN), capturing the strategic contrast in IP approaches. The mention of 10-K page numbers adds sourcing credibility. The only reason for not scoring a 10 is the slight lack of specificity around AMGN’s EPOGEN, which was named in the ground truth as an example; however, the broader risk to biologics is accurately conveyed. Overall, the answer is factually correct, well-reasoned, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 435,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How do MA's and V's dual-class stock structures differ in terms of voting power distribution and control concentration mechanisms, particularly regarding the balance between Class A and Class B shares?",
      "original_answer": "MA's dual-class structure grants Class B common stock 15 votes per share, with all outstanding shares held by Mr. Brian L. Roberts, representing 33⅓% of the combined voting power, while Class A common stockholders collectively hold 66⅔% of the voting power. In contrast, V's structure ties Class B common stock transferability and convertibility to the resolution of U.S. covered litigation, with conversion rates for Class B shares into Class A shares subject to adjustments based on follow-on offerings or litigation outcomes. Additionally, V's Class C common stock has no transfer restrictions, and its exchange program allows for partial release of restrictions on Class B shares, further differentiating its control mechanisms from MA's more static voting power allocation.",
      "llm_answer": "Mastercard’s 10‑K shows a dual‑class system with a publicly listed Class A common stock and a non‑public Class B common stock (listed under Section 12(g) on page 1); the Class B shares carry 15 votes per share, giving their holder roughly one‑third of the combined voting power and concentrating control in a single shareholder. In contrast, Visa’s 10‑K states that only Class A shares vote on all matters, while its Class B and Class C shares have no voting rights except on limited matters and are subject to transfer restrictions and conversion‑rate adjustments that limit their influence (see Visa’s voting‑rights description on page 90).",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that MA (Mastercard) has a dual-class structure where Class B shares have 15 votes per share and are held by a single shareholder (Brian L. Roberts), giving that shareholder approximately one-third of voting power, which aligns with the ground truth (33⅓%). However, the LLM does not explicitly state that Class A collectively holds 66⅔% of voting power, though it implies it by saying Class B has one-third. This omission affects completeness. Regarding V (Visa), the LLM incorrectly states that Class B and Class C shares have no voting rights except on limited matters — the ground truth does not mention this lack of voting rights; instead, it emphasizes transferability, convertibility, and conversion-rate adjustments tied to litigation and follow-on offerings. The LLM also fails to mention Visa’s Class C having no transfer restrictions and the exchange program for partial release of Class B restrictions, which are key differentiating mechanisms. (2) Quantitatively, the 15 votes per share and one-third voting power for MA are correct. However, the LLM does not quantify the exact 33⅓% or 66⅔%, using approximations ('roughly one-third'), which is acceptable but less precise. No numerical errors in stated values, but missing specificity. (3) The multi-hop reasoning is partially sound — the model identifies both companies’ structures and attempts a comparison, but it introduces unverified claims about Visa’s voting rights (i.e., no voting power for Class B/C) not present in the ground truth, and omits critical control mechanisms like litigation-linked conversion rates and exchange programs. This reflects flawed synthesis. (4) Correctness is scored 5 due to partial factual alignment on MA but significant inaccuracies and omissions on V. Quantitative accuracy is 6 because core numbers are present but lack precision. Qualitative accuracy is 5 due to incorrect characterization of Visa’s voting rights and missing key differentiators. Contextual relevance is 8 because the response addresses the question’s intent and structure, even if factually flawed in parts.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 570,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How does RTX's financial exposure to FAR-regulated U.S. government fixed-price contracts compare to LMT's risk profile under similar contracts, particularly in terms of revenue recognized in excess of billings and potential liabilities from government audits?",
      "original_answer": "RTX reports that under U.S. government fixed-price contracts, they typically receive performance-based or progress payments, which often result in revenue recognized in excess of billings, presented as Contract assets on their Consolidated Balance Sheet. This indicates a financial exposure tied to delayed cash receipt despite early revenue recognition. The FAR regulates these payment structures and cost-allowability, directly shaping RTX's financial reporting and risk. Similarly, LMT, which is also heavily dependent on U.S. government contracts, faces potential liabilities from government audits and investigations, including the risk of debarment or suspension from future contracts, which could have a material adverse effect given their 'dependence on contracts with the U.S. Government.' While RTX's exposure is primarily balance sheet-related (e.g., contract assets), LMT's risk is more compliance and enforcement-oriented, with potential financial penalties or operational restrictions stemming from FAR-regulated audits. Both companies are therefore financially and operationally impacted by the FAR’s regulatory framework, but through different risk mechanisms.",
      "llm_answer": "Raytheon Technologies states that its U.S.‑government fixed‑price contracts, which are governed by the FAR, “generally result in revenue recognized in excess of billings which we present as Contract assets” and that the FAR (together with CAS) “subjects us to audits and other government reviews” that could generate loss provisions (RTX 10‑K p. 79). Lockheed Martin reports a materially larger exposure – contract assets of about $9.5 billion at year‑end (revenue recognized ahead of billings) – and likewise notes that its FAR‑regulated contracts are subject to audit scrutiny and potential adjustments, although its mix of cost‑plus work and internal controls helps moderate the risk (LMT 10‑K p. 108‑109).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains a significant factual error in quantitative accuracy: it claims LMT has 'contract assets of about $9.5 billion at year-end' related to revenue recognized in excess of billings. This specific figure is not present in the ground truth and cannot be verified from the provided knowledge graph; the original answer makes no mention of any dollar amount for LMT's contract assets, nor does it compare absolute levels of contract assets between RTX and LMT. This introduces a false quantitative comparison. Additionally, the LLM implies LMT has a 'materially larger exposure' than RTX based on this number, which is not supported by the original answer—while both companies have contract assets and audit risks, the ground truth emphasizes different risk *types* (RTX: balance sheet exposure; LMT: compliance/enforcement risk), not a quantitative comparison of exposure size. On qualitative accuracy, the LLM correctly identifies that both companies operate under FAR-regulated fixed-price contracts, recognize revenue in excess of billings (presented as contract assets), and are subject to government audits. It also appropriately cites regulatory scrutiny and potential loss provisions, aligning with the original answer’s themes. Contextual relevance is high—the response addresses the core aspects of financial exposure under FAR contracts, multi-hop elements (comparing two companies’ risk profiles), and draws on appropriate risk factors from each company’s 10-K. However, the unsupported $9.5B figure and the resulting misleading comparison undermine the correctness score, preventing it from being higher than a 6 despite otherwise sound reasoning and structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 458,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How does the voting power distribution between Class A and Class B common stock at META compare to GOOGL's structure, given the specific voting rights tied to each share class?",
      "original_answer": "At META, Class B common stockholders hold 33 1/3% of the combined voting power, with each Class B share carrying 15 votes, while Class A shares (publicly traded) hold the remaining 66 2/3% of voting power. In contrast, at GOOGL, Class B shares carry 10 votes per share and Class A shares carry 1 vote per share, though the equity note does not specify the exact percentage split between the two classes. This indicates that both companies use dual-class structures to concentrate voting control, but META's structure gives significantly more per-share voting power to Class B shares compared to GOOGL.",
      "llm_answer": "Meta’s charter gives each Class A share one vote and each Class B share ten votes, concentrating most of the voting power in the relatively few Class B holders. Alphabet’s (Google’s) structure is the same—Class A shares have one vote per share and Class B shares have ten votes per share—so the voting‑power distribution between the two companies is essentially identical.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual errors in both quantitative and qualitative aspects. (1) Quantitatively, it incorrectly states that Meta's Class B shares have 10 votes per share; the ground truth is 15 votes per share. It also falsely claims that Meta's Class A shares have 1 vote each, which would imply a simple 10:1 ratio, but the actual voting power distribution is 66 2/3% for Class A and 33 1/3% for Class B—this cannot be derived from a 10:1 vote ratio and contradicts the stated distribution. The answer fails to mention these exact percentage splits, which are critical to the comparison. (2) For GOOGL, while the LLM correctly identifies that Class A shares have 1 vote and Class B have 10 votes per share, it incorrectly asserts that the voting power distribution is 'essentially identical' to Meta’s, when in fact the knowledge graph notes that GOOGL's exact percentage split is unspecified, making such a conclusion unsupported. (3) Qualitatively, the reasoning is flawed: the model fails to recognize that Meta’s structure gives *significantly more* per-share voting power to Class B (15x) than GOOGL (10x), and thus incorrectly concludes the structures are the same. This misrepresents the core multi-hop comparison the question demands. (4) Contextually, the answer addresses the right companies and the concept of dual-class structures, so relevance is moderate. However, due to major errors in numbers, missing key data (percentages), and incorrect synthesis, the overall correctness is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 416,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "Given BMY's reliance on regulatory data protection for key products like Opdivo, how does the expiration of such protections create a precedent for increased Paragraph IV ANDA challenges that could directly impact JNJ's litigation exposure for drugs like Stelara facing similar patent cliffs in the coming years?",
      "original_answer": "BMY's 2022 10-K highlights that when market exclusivity expires, there are often 'substantial and rapid declines' in sales of the original product, and that ANDAs with Paragraph IV certifications are frequently filed after four years of a five-year regulatory data protection period. AbbVie's filing demonstrates how such Paragraph IV challenges directly lead to increased patent litigation exposure, with companies filing Abbreviated New Drug Applications seeking to market generic forms of branded drugs before patent expiration. JNJ's 2022 10-K specifically cites patent litigation as a material risk, noting the company faces litigation related to its major products and that adverse judgments could significantly impact financial performance. Stelara, which generated over $8 billion in 2022, is a prime target for such challenges once exclusivity periods lapse, mirroring the pathway seen in BMY's and AbbVie's experiences.",
      "llm_answer": "The filing shows that when Opdivo’s five‑year regulatory data‑protection expires, the FDA is no longer barred from approving a generic, so competitors can file a Paragraph IV aNDA certification and force the innovator into patent‑infringement litigation (JNJ 10‑K, “Paragraph IV certification” and “regulatory data protection” discussion). That same mechanism will apply to J&J’s Stelara once its data‑protection and patents run out, creating a predictable surge of Paragraph IV ANDA challenges and expanding J&J’s litigation exposure (JNJ 10‑K risk factors on patent expirations and Stelara listed as a key product).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth, with only minor omissions in contextual detail. (1) All entities are correct: BMY (Bristol Myers Squibb), JNJ (Johnson & Johnson), Opdivo, Stelara, Paragraph IV ANDA challenges, and regulatory data protection are accurately referenced. The 2022 10-K context is implied through discussion of current risk factors, though not explicitly cited by year. (2) Quantitative accuracy is perfect: while no specific dollar amounts or dates are mentioned in the LLM response, it does not misstate any numbers. The ground truth notes Stelara generated over $8 billion in 2022—this figure is omitted in the LLM answer, but its absence does not introduce inaccuracy, only slight incompleteness. There are no calculation errors. (3) Multi-hop reasoning is sound: the LLM correctly links BMY’s experience with Opdivo’s data protection expiry to the general mechanism of Paragraph IV filings, then applies that precedent to JNJ’s Stelara, recognizing the parallel regulatory and litigation risks. It correctly identifies that expiration of data protection enables Paragraph IV ANDAs, which lead to patent litigation—mirroring the causal chain in the original answer. (4) The answer is highly contextually relevant, directly addressing how BMY’s precedent informs JNJ’s litigation exposure. The only minor shortcoming is the lack of explicit mention of AbbVie as a demonstrated example of litigation surge post-exclusivity, which appears in the ground truth and strengthens the argument; however, this does not detract significantly from the overall correctness. Wording differences (e.g., 'a surge of Paragraph IV ANDA challenges') are semantically equivalent to the original. Thus, the answer earns a 9/10 for correctness due to high factual and logical fidelity, with near-complete synthesis across entities and mechanisms.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 510,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How does the structure of META's dual-class stock system, which requires Class B approval for change-of-control transactions until their voting power drops below 35%, compare with GOOGL's dual-class voting framework where Class B shares carry 10 votes each but automatically convert to Class A upon transfer?",
      "original_answer": "META's dual-class structure requires a separate Class B majority vote for any change-of-control transaction until Class B shares fall below 35% of total voting power, providing concentrated control to its primary stockholder. In contrast, GOOGL allows Class B shares to carry 10 votes each but mandates automatic conversion to Class A voting rights upon sale or transfer, limiting long-term entrenchment while still preserving enhanced voting power during ownership retention. Both structures concentrate control, but META's framework offers more enduring governance insulation due to its non-automatic nature and threshold-based trigger.",
      "llm_answer": "Meta’s charter ties change‑of‑control approval to its super‑voting Class B stock: any transaction that would shift control must be approved by a majority of the Class B votes until the Class B shares represent less than 35 % of the total voting power (Meta 10‑K p. 50). Alphabet’s framework also gives Class B shares ten votes each, but those shares automatically convert to one‑vote Class A shares on any transfer, so the extra voting power stays with the original holder and is lost when the shares are sold (Alphabet 10‑K p. 81).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: META requires Class B majority approval for change-of-control until Class B voting power drops below 35%, and GOOGL's Class B shares carry 10 votes but convert to Class A upon transfer. These match the original answer exactly. (2) Quantitative accuracy is perfect: the 35% threshold and 10-to-1 vote ratio are correctly stated, and no calculations are required. (3) Multi-hop reasoning is sound—information from both META and GOOGL is correctly synthesized and contrasted. The LLM cites specific 10-K page numbers (p.50 and p.81), indicating proper sourcing. (4) The only minor shortcoming is that the LLM does not explicitly state the comparative implication about 'enduring governance insulation' or 'limiting long-term entrenchment' as in the original answer, which slightly weakens the qualitative depth. However, the factual basis for that conclusion is fully present. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent—directly addresses the structural comparison asked in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 324,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "UPS chose not to apply the practical expedients under ASU 2020-04 for its transition to SOFR in 2023 - how does this approach contrast with how MMM likely managed its hedging relationships affected by reference rate reform, given the optional relief available through December 31, 2024?",
      "original_answer": "UPS explicitly stated it did not elect to apply the practical expedients provided under ASU 2020-04 when transitioning its affected debt instruments to SOFR in 2023. In contrast, MMM's detailed disclosures of hedging relationships suggest it may have utilized the optional relief under the same standard, particularly since ASU 2022-06 extended the sunset date to December 31, 2024, allowing companies to apply the expedients to contracts modified through that date. MMM's reporting includes extensive hedging activity data, such as $152 million reclassified from accumulated other comprehensive income into income in 2023 for foreign currency contracts, which implies active management of hedging relationships—potentially benefiting from the optional relief provided by ASU 2020-04 as extended.",
      "llm_answer": "UPS disclosed that it “did not elect to apply the practical expedients provided under Topic 848 to these transitions” when it moved its debt and contracts to SOFR in 2023 【page_74】. In contrast, 3M’s (MMM’s) interest‑rate swaps were amended to reference SOFR and remain designated as hedges, showing the company continued its hedging relationships under the optional relief that ASU 2020‑04 (and its extension through Dec 31 2024) makes available 【page_77】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly states that UPS did not apply the practical expedients under Topic 848 (which is the codification that includes ASU 2020-04) for its SOFR transition in 2023, citing page 74, matching the original answer. (2) For MMM, it accurately notes that 3M amended its interest-rate swaps to reference SOFR and maintained hedge designations, implying use of the optional relief under ASU 2020-04, extended through December 31, 2024, which is consistent with the ground truth's reasoning. (3) While the original answer includes a specific quantitative detail—$152 million reclassified from AOCI into income in 2023 for foreign currency contracts—the LLM answer omits this figure. This is a minor omission affecting completeness but not the core correctness of the contrast being drawn. (4) The reasoning is sound: the LLM correctly synthesizes multi-hop information by comparing UPS’s explicit non-election with MMM’s continued hedge designations, inferring likely use of relief. (5) All entities (UPS, MMM/3M), years (2023), standards (ASU 2020-04), and deadlines (Dec 31, 2024) are accurate. (6) Semantic equivalence is strong; the LLM conveys the same conclusion using slightly different phrasing. The only reason for not giving a 10 is the missing $152M detail, which adds contextual support in the original but is not central to the main contrast. Quantitative accuracy is perfect as no incorrect numbers are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 411,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How does the daily cash-settlement of exchange-traded commodity futures impact MDLZ's valuation methodology for Level 1 financial assets, given PEP's similar exposure to these instruments?",
      "original_answer": "MDLZ values its Level 1 financial assets, which include exchange-traded commodity futures, based on quoted market prices from commodity exchanges. These instruments are marked-to-market daily, as noted in PEP's disclosure that exchange-traded commodity futures are cash-settled on a daily basis and therefore not included in the balance sheet table as of year-end. This daily cash-settlement mechanism directly supports MDLZ's use of quoted market prices for fair value measurement, as both companies are exposed to the same class of instruments that are subject to daily valuation adjustments through cash settlement.",
      "llm_answer": "Mondelez treats exchange‑traded commodity futures as Level 1 assets because they settle in cash each day, so their fair value can be taken directly from the quoted market price on the exchange; the daily cash‑settlement makes the price observable and the contracts are therefore excluded from the “OTC‑derivative” tables that list Level 2 items. PepsiCo also holds commodity futures, but its filing only describes those contracts as marked‑to‑market commodity derivatives that affect earnings (cost of sales or SG&A) and does not reference a Level 1 classification tied to daily settlement. Thus, the daily cash‑settlement drives Mondelez’s Level 1 valuation methodology, while PepsiCo’s similar exposure is reflected mainly through earnings‑impact accounting rather than a distinct Level 1 fair‑value hierarchy.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and contains no incorrect numbers or misstatements of financial data, earning a high quantitative accuracy score. It correctly identifies that MDLZ classifies exchange-traded commodity futures as Level 1 assets due to daily cash settlement and observable market prices, and notes their exclusion from OTC derivative tables (consistent with PEP's disclosure logic). However, the qualitative accuracy is slightly lower because the LLM introduces a distinction not present in the ground truth: it claims PEP does not reference Level 1 classification or daily settlement in the same way, implying a difference in accounting treatment. In reality, the original answer emphasizes that *both* MDLZ and PEP are exposed to the same class of instruments and that PEP’s disclosure about daily cash settlement supports MDLZ’s valuation methodology—implying shared practice, not divergence. The LLM incorrectly frames PEP's similar exposure as being accounted for only through earnings impact, which downplays the multi-hop synthesis that PEP’s disclosure *validates* MDLZ’s Level 1 classification via shared instrument characteristics. This misrepresents the reasoning link between the two companies. Contextual relevance is high because the answer addresses the impact of daily settlement on valuation methodology and references both companies appropriately, though with a slight misinterpretation of the intercompany inference. Semantic equivalence is mostly preserved but with a notable deviation in the comparative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 429,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How does the voting power distribution tied to CMCSA's Class A and Class B common stock structure compare to GOOGL's approach, given that GOOGL also maintains a multi-tier voting rights system with Class B common stock?",
      "original_answer": "CMCSA's Class A common stockholders hold 66 2/3% of the combined voting power, while the Class B common stockholders (beneficially owned entirely by Brian L. Roberts) hold 33 1/3% of the voting power, with each Class B share carrying 15 votes. In contrast, GOOGL's Class B common stockholders have 10 votes per share, while Class A common stockholders have 1 vote per share, and Class C capital stock has no voting rights. This indicates that CMCSA concentrates more voting power in Class B shares relative to GOOGL, where Class B shares have a lower per-share vote weight but still serve to maintain control for certain key stakeholders.",
      "llm_answer": "Comcast’s dual‑class system gives each Class B share 15 votes, but the 9.4 million Class B shares owned by Brian L. Roberts represent only about 33 % of the company’s total voting power, leaving roughly 66 % with the publicly‑traded Class A shares【page_31】. Google’s structure also uses two voting classes, but each Class B share carries ten votes versus one vote for Class A, which concentrates the majority of voting power (about two‑thirds) in the hands of the Class B holders【page_82】. Thus, while both firms employ multi‑tier voting, Comcast’s Class B is a smaller slice of overall voting power (33 %) despite a higher per‑share vote, whereas Google’s Class B dominates voting control (≈ 66 %).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: CMCSA's Class A has ~66% voting power, Class B (owned by Brian L. Roberts) has ~33%, with each Class B share carrying 15 votes; GOOGL's Class B shares have 10 votes per share vs. 1 for Class A, and Class C has no voting rights. The LLM correctly states that Class B in GOOGL holds about two-thirds of voting power, which matches the typical understanding of Google's structure. (2) Calculations and proportions are accurate: 33% and 66% splits are correctly attributed, and per-share vote weights (15 vs. 10) are exact. (3) Reasoning is sound: the LLM correctly synthesizes that while CMCSA gives higher per-share voting power to Class B (15x), that class holds a minority (33%) of total voting power, whereas in GOOGL, Class B’s 10x voting power results in majority control (~66%), indicating a more concentrated control in GOOGL despite lower per-share vote weight. (4) The only minor shortcoming is that the LLM does not explicitly mention GOOGL's Class C having no voting rights, which is in the original answer, but this detail is implied by the focus on Class A and B voting dynamics. Overall, the answer captures the core comparative insight accurately and clearly, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 365,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How does BAC's market-making gains related to embedded derivatives compare to MS's involvement in CLNs structured as hybrid instruments with embedded derivatives, given the shared exposure to credit event risks in structured notes?",
      "original_answer": "BAC reports that its net gains (losses) in market-making activities relate to embedded derivatives in structured liabilities and are typically offset by gains (losses) on derivatives and securities used to hedge these liabilities. MS, on the other hand, structures CLNs as hybrid instruments containing embedded derivatives, where the Firm sells credit protection and faces risk of principal loss upon a credit event in the reference entity. Both firms demonstrate exposure to credit-linked derivatives, but BAC actively hedges these exposures while MS retains risk through structured note design.",
      "llm_answer": "Bank of America reports that its market‑making and similar activities produced a net $4.2 billion gain in 2024 (the $4,228 million of other income offset by a $44 million loss), and the note explains that these gains arise from the embedded derivatives in structured liabilities and are typically offset by opposite‑direction gains on the hedging derivatives【page_164】. Morgan Stanley, on the other hand, only discloses that it invests in credit‑linked notes (CLNs) and CDOs—hybrid instruments that contain embedded derivatives and expose the firm to the risk that a credit event could curtail or eliminate principal repayment—without providing a comparable quantified gain figure【page_109】. Thus, BAC’s market‑making gains are explicitly measured and positive, whereas MS’s CLN involvement is described mainly as a credit‑event exposure rather than a reported gain.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numerical figures—$4.2 billion gain in 2024, $4,228 million of other income, and $44 million loss—that are not present in the original ground truth answer and cannot be verified from the provided context. The ground truth does not quantify BAC’s gains or provide any dollar amounts, so these numbers are hallucinated, severely impacting quantitative accuracy. (2) The mention of '2024' and detailed income breakdowns (e.g., $4,228 million) is unsupported by the original answer, which makes no reference to specific fiscal years or monetary values. This constitutes a major factual deviation. (3) On qualitative aspects, the LLM correctly identifies that BAC’s gains from embedded derivatives in structured liabilities are typically offset by hedging instruments, and that MS structures CLNs as hybrid instruments with embedded derivatives where it faces principal loss upon credit events. The contrast in risk management approach—BAC hedging vs. MS retaining risk—is partially aligned with the ground truth, though the LLM frames MS’s involvement as investment rather than structuring/selling, slightly misrepresenting the original. (4) Contextually, the response addresses the core comparison: BAC’s market-making gains with embedded derivatives versus MS’s CLN exposure, and both firms’ exposure to credit event risks. However, the introduction of unverified quantitative data undermines correctness. While the multi-hop synthesis between firms and instruments is attempted, the inclusion of fabricated metrics reduces the correctness score to 5—partially correct but significantly flawed in factual precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 454,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How does the implementation of the OECD's Pillar Two Model Rules, which Salesforce (CRM) identifies as a global tax development, potentially affect Intel's (INTC) effective tax rate given Intel's exposure to non-US jurisdictions and ongoing evaluation of Pillar Two impacts?",
      "original_answer": "Salesforce (CRM) identifies the OECD's Pillar Two Model Rules, which introduce a global minimum tax of 15%, as a material global tax development that could impact multinational businesses. Intel (INTC), which reports that a higher proportion of its income is taxed in non-US jurisdictions, is actively evaluating the impact of Pillar Two, particularly as several non-US jurisdictions, including EU Member States, have enacted or plan to enact legislation aligning with the rules starting in 2024. Since Intel's effective tax rate has been influenced by its geographic income distribution and non-US tax regimes, the implementation of Pillar Two could constrain its ability to benefit from lower tax jurisdictions, thereby increasing its effective tax rate or reducing future tax benefits.",
      "llm_answer": "Salesforce flags the OECD Pillar‑Two model rules as a material global‑tax development (CRM 10‑K p. 29). Intel’s effective tax rate is heavily influenced by the share of income taxed in non‑U.S. jurisdictions, and the company says it is still evaluating how the 15 % global minimum tax will apply in those jurisdictions (Intel 10‑K p. 44). Consequently, if any of Intel’s foreign earnings are currently taxed below the Pillar‑Two floor, the new rules could push its effective tax rate higher, but Intel notes it has no material operations in low‑tax jurisdictions, so any impact is expected to be modest.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all numbers and percentages are accurate: the 15% global minimum tax rate is correctly cited, and there are no calculation errors. (2) The LLM correctly identifies Salesforce (CRM) as flagging Pillar Two as a material tax development and Intel (INTC) as evaluating its impact, citing appropriate page numbers from the 10-Ks. (3) The reasoning is sound: it correctly links Intel's exposure to non-U.S. tax jurisdictions with the potential for Pillar Two to increase its effective tax rate if foreign earnings are taxed below 15%. (4) However, the LLM adds a claim not present in the original answer — that Intel 'has no material operations in low-tax jurisdictions' and therefore expects a 'modest' impact. This specific assertion is not in the ground truth and may understate the potential effect, as the original answer emphasizes ongoing evaluation and the risk of increased tax rates due to constrained benefits from lower-tax jurisdictions. While this addition does not contradict core facts, it introduces a nuance (minimal expected impact) not supported in the source, slightly reducing qualitative accuracy. Otherwise, the answer is contextually relevant, complete, and correctly synthesizes multi-hop information across CRM and INTC disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 373,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How does RTX's revenue recognition timing under FAR-regulated U.S. government fixed-price contracts compare to BA's exposure to termination risk in their U.S. government contracts, and what implications does this have for cash flow predictability?",
      "original_answer": "RTX recognizes revenue in excess of billings on U.S. government fixed-price contracts due to retained customer payments until contract completion, typically receiving performance-based payments (PBPs) or progress payments covering 80-90% of costs incurred. This creates contract assets on their balance sheet. In contrast, BA faces risks of contract termination at the convenience of the U.S. government, which could limit payments to work completed and allowable termination costs, or even result in liability for re-procurement costs if terminated for default. The FAR regulations that govern both companies' U.S. government contracts allow for interim payments but expose contractors to different financial risks—RTX to cash flow timing mismatches, and BA to potential revenue reversals or liabilities—making BA's cash flow more unpredictable despite similar regulatory frameworks.",
      "llm_answer": "RTX recognizes revenue on its FAR‑regulated U.S. government fixed‑price contracts using a percentage‑of‑completion approach, so revenue is recorded as work progresses and often exceeds billings, creating contract‑asset balances (RTX p. 79; also see RTX p. 78). Boeing’s contracts, by contrast, carry a termination‑for‑convenience and default risk that can cut off or reduce cash receipts, limiting payments to work already accepted and sometimes requiring the company to absorb unrecovered costs (BA p. 7). Thus, RTX’s over‑time revenue recognition yields a more predictable, performance‑driven cash‑flow pattern, whereas Boeing’s exposure to contract termination adds greater uncertainty to its cash‑flow timing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, no specific numbers (percentages, dollar amounts, dates) are misstated; the mention of 80–90% of costs covered by PBPs or progress payments is implied in both the LLM and original answers, though the LLM does not explicitly cite that range but still correctly describes interim payments exceeding billings. The absence of explicit percentage figures does not constitute an error since the LLM accurately describes the revenue-billing mismatch. (2) The LLM correctly identifies RTX’s percentage-of-completion method leading to revenue in excess of billings and the creation of contract assets, which matches the ground truth. It also accurately notes Boeing’s exposure to termination-for-convenience and default risks, including potential absorption of unrecovered costs. (3) The multi-hop reasoning is sound: it contrasts RTX’s cash flow timing risk (predictable but lags) with Boeing’s termination-driven uncertainty, correctly inferring implications for cash flow predictability. (4) The only minor shortcoming is that the LLM slightly underemphasizes the FAR’s role in governing both companies’ payment structures and does not explicitly mention that RTX receives 80–90% of costs via interim payments, though this nuance is contextually implied. Overall, the answer conveys semantic equivalence with strong factual and logical accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 395,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "How does the $119 million in floating rate notes with put provisions due in 2025 disclosed by MMM compare to GE's $315 million investment in fixed and floating rate notes containing similar 2025 put options, considering both companies' exposure to near-term debt obligations?",
      "original_answer": "MMM discloses $119 million in floating rate notes with put provisions due in 2025, which are classified as current portion of long-term debt. GE holds $315 million in fixed and floating rate notes that also contain put options exercisable in 2025, despite contractual maturities occurring after 2025. Both companies are exposed to near-term liquidity risks tied to these put options, though GE’s exposure is more than 2.5 times larger than MMM’s. This indicates a significant potential cash outflow in 2025 for both companies depending on whether the put options are exercised.",
      "llm_answer": "MMM’s 2025 debt exposure is limited to the $119 million of floating‑rate notes that carry put provisions and are classified as the current portion of long‑term debt【page_69】. By contrast, GE reports $315 million of fixed‑ and floating‑rate notes that contain put options exercisable in 2025, although those securities do not actually mature until after 2025【page_55】. Thus, GE’s put‑option exposure is roughly three times larger than MMM’s, but GE’s notes are not due in 2025, whereas MMM’s $119 million is a scheduled near‑term repayment.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies all key facts: MMM's $119 million floating rate notes with put provisions due in 2025 classified as current debt, and GE's $315 million investment in fixed and floating rate notes with 2025 put options despite later maturities. All numbers, dates, and classifications match the ground truth. (2) Quantitative accuracy is perfect: $119M and $315M are correctly reported, and the comparison 'roughly three times larger' is a reasonable approximation of 315/119 ≈ 2.65 (ground truth says 'more than 2.5 times', so LLM's 'three times' is slightly rounded but acceptable). (3) The reasoning is mostly sound and synthesizes information across both companies correctly. However, the LLM introduces a subtle but important mischaracterization: it states that 'GE’s notes are not due in 2025, whereas MMM’s $119 million is a scheduled near-term repayment', which implies MMM’s obligation is contractual while GE’s is optional. This downplays the fact that both companies face similar liquidity risks from put options—GE’s exposure is not less real or urgent because the puts are exercisable, not contractual. The ground truth emphasizes that both face significant near-term liquidity risks, but the LLM under-synthesizes this shared risk, instead contrasting them. (4) Scores reflect high factual accuracy and relevance, with a minor deduction in qualitative accuracy due to incomplete risk synthesis. Correctness score is 8 because core facts and numbers are correct, but the comparative risk assessment is slightly misleading.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 429,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "How does the valuation methodology for exchange-traded commodity futures used by PEP compare to MDLZ's treatment of Level 1 financial assets, given both companies' reliance on daily market pricing for fair value determination?",
      "original_answer": "PEP excludes exchange-traded commodity futures from its fair value table because they are cash-settled daily, while MDLZ explicitly includes exchange-traded commodity futures as Level 1 financial assets, valued based on quoted market prices on commodity exchanges. Both companies rely on daily market pricing for fair value determination, but PEP focuses on the daily cash settlement mechanism as the reason for exclusion, whereas MDLZ emphasizes quoted market prices as the basis for Level 1 classification.",
      "llm_answer": "PEP notes that its exchange‑traded commodity futures are cash‑settled on a daily basis and therefore are not listed in the fair‑value hierarchy tables (PEP p. 107). MDLZ, by contrast, classifies exchange‑traded commodity futures as Level 1 financial assets and values them directly from quoted market prices on the exchanges (MDLZ p. 95). Thus, both companies rely on daily market pricing for fair‑value measurement, but MDLZ explicitly reports the contracts as Level 1 assets, whereas PEP simply acknowledges the daily cash‑settlement and excludes the contracts from its disclosed hierarchy.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original answer. (1) It correctly states that PEP excludes exchange-traded commodity futures from its fair value hierarchy tables due to daily cash settlement, citing the correct rationale and implying the mechanism without needing to explicitly name the 'exclusion reason' as in the ground truth. (2) It accurately notes that MDLZ includes such futures as Level 1 financial assets valued using quoted market prices, which aligns with the ground truth's emphasis on exchange pricing. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (PEP and MDLZ), compares their differing reporting treatments, and identifies the common reliance on daily market pricing despite different disclosure approaches. (4) All entities (PEP, MDLZ, exchange-traded commodity futures, Level 1 financial assets) are correctly identified and contextualized. The answer includes document page references (p. 107, p. 95), enhancing credibility. There are no numerical inaccuracies, as the question does not involve specific numbers, percentages, or calculations. The wording differs slightly but preserves full meaning—e.g., 'acknowledges the daily cash-settlement and excludes' conveys the same idea as PEP's focus on settlement mechanism for exclusion. All aspects of the question are addressed: valuation methodology, comparison of treatments, and the role of daily market pricing. Thus, all scores are perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 414,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does Apple's revenue from the Greater China region, which includes Taiwan, compare to Intel's revenue specifically from Taiwan operations in 2022?",
      "original_answer": "Apple generated $74,200 million in net sales from the Greater China region in 2022, which includes Taiwan among other markets. In contrast, Intel reported $13,461 million in net revenue specifically from Taiwan operations during the same period. This indicates that Apple's revenue exposure through the Greater China segment, which encompasses Taiwan, is significantly higher than Intel's direct revenue from Taiwan.",
      "llm_answer": "Apple’s Greater China segment (which includes Taiwan) generated $74.2 billion of net sales in fiscal 2022【page_25】. Intel’s disclosed net revenue from Taiwan was $13.5 billion (the most recent figure in the filing)【page_87】. Thus Apple’s revenue from the region is roughly $60 billion higher—about five‑to‑six times the amount Intel earned in Taiwan.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the numbers are correctly reported with acceptable rounding: Apple's $74.2 billion matches $74,200 million, and Intel's $13.5 billion is a reasonable rounding of $13,461 million. The comparison stating Apple's revenue is 'roughly $60 billion higher' is accurate (difference is ~$60.7 billion), and the 'five-to-six times' multiplier is reasonable (74.2 / 13.5 ≈ 5.5). (2) The answer is complete, addressing both companies' revenues, the correct year (2022/fiscal 2022), and the geographic scope (Greater China including Taiwan vs. Taiwan-specific). (3) Entities are correct: Apple, Intel, Greater China region, Taiwan operations, net sales/revenue, and fiscal year 2022. (4) The multi-hop reasoning is sound—correctly synthesizing data from two different companies and geographic reporting segments to make a valid comparison. The only minor deduction is for rounding Intel's revenue from $13,461M to $13.5B without explicit mention of rounding, though this is common and acceptable in financial communication. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 338,
        "total_tokens": 1531
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does the combined net property, plant, and equipment investment in the Americas by MMM compare to GD's revenue contribution from South America over the same geographic footprint, given that the Americas segment includes South America as part of its geographic definition?",
      "original_answer": "MMM reported $5,864 million in net property, plant, and equipment for the Americas in 2021, which includes South America. GD, in the same year, generated $234 million in revenue specifically from South America. This indicates that while GD's revenue from South America is relatively small, MMM has a significantly larger asset base tied to the broader Americas region, which encompasses South America.",
      "llm_answer": "3M’s 2021 net property, plant and equipment (PP&E) was $106 million (see page 133). General Dynamics reported $234 million of revenue from South America in 2021 (see page 80). Thus, GD’s South‑America revenue exceeds 3M’s net PP&E investment in the Americas by about $128 million – more than twice the amount.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors. It states that 3M's (MMM) net property, plant, and equipment (PP&E) for the Americas in 2021 was $106 million, which is incorrect. The ground truth is $5,864 million. This is a significant underreporting by over $5.7 billion. GD's South America revenue of $234 million is correctly stated. (2) The calculation comparing GD's $234 million to 3M's $106 million is mathematically correct (difference of ~$128 million), but it is based on a false premise because the 3M PP&E figure is wrong. The conclusion that GD's revenue exceeds 3M's PP&E is therefore invalid. In reality, MMM's PP&E in the Americas ($5,864M) is vastly larger than GD's South American revenue ($234M). (3) The multi-hop reasoning fails because the model did not correctly extract or synthesize the key financial figure for MMM’s PP&E. It also mischaracterizes the comparison, drawing an incorrect conclusion due to the erroneous input. The geographic scope (Americas including South America) is acknowledged, but the synthesis is flawed due to the incorrect data. (4) The contextual relevance is moderate because the answer attempts to compare the two companies on the right metrics and geography, but the severe quantitative inaccuracy undermines the entire response. The qualitative reasoning is poor due to reliance on an incorrect number, leading to a false conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 389,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does the use of sensitivity analyses by NFLX's auditor in evaluating content amortization assumptions compare to CMCSA's application of sensitivity analyses in managing interest rate risk exposure?",
      "original_answer": "NFLX's auditor performed sensitivity analyses to evaluate how changes in assumptions about viewing patterns could affect content amortization timing, which directly impacts financial reporting accuracy. In contrast, CMCSA uses sensitivity analyses as part of its interest rate risk management strategy to assess the potential impact of interest rate fluctuations on its debt portfolio, with derivative instruments reducing interest expense by $56 million in 2023. While both companies apply sensitivity analyses, NFLX uses it for accounting policy judgment, whereas CMCSA applies it for financial risk management.",
      "llm_answer": "Netflix’s auditor tests the content‑amortization model by running sensitivity analyses that vary key assumptions (e.g., historical and forecasted viewing‑hour consumption) to see how the recorded amortization would change【page_40】. Comcast, on the other hand, uses sensitivity analyses as a risk‑management tool to model how shifts in interest rates would affect the fair value of its debt and interest‑expense exposure【page_60】. Thus, Netflix’s sensitivity work supports audit validation of amortization estimates, while Comcast’s sensitivity work supports ongoing management of interest‑rate risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: NFLX's auditor uses sensitivity analyses on viewing patterns to assess content amortization (p.40), and CMCSA uses sensitivity analyses to evaluate interest rate risk impact on debt and interest expense (p.60). (2) There are no numeric inaccuracies; while the LLM does not mention the $56 million reduction in interest expense from derivatives in 2023, this is a minor omission that does not affect the core comparison. The absence of this figure prevents a perfect 10 on correctness but does not undermine the overall accuracy. (3) Multi-hop reasoning is sound: the model correctly distinguishes between NFLX’s use of sensitivity analysis for audit validation of accounting estimates versus CMCSA’s use for financial risk management. (4) Semantic equivalence is strong—'audit validation of amortization estimates' matches 'accounting policy judgment,' and 'ongoing management of interest-rate risk' aligns with 'financial risk management.' The answer is contextually precise, directly addressing the comparative application of sensitivity analyses. Minor deduction from 10 due to omission of CMCSA's $56M derivative impact, which was present in the original answer and adds quantitative depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 362,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does PEP's use of exchange-traded commodity futures to manage risk compare with COST's disclosure regarding the absence of Level 1 financial liabilities, given that both companies report under the same fair value hierarchy framework?",
      "original_answer": "PEP actively uses exchange-traded commodity futures, which are cash-settled daily and excluded from the balance sheet as of December 25, 2021, to manage market risk, particularly in relation to deferred compensation liabilities. These instruments fall under Level 1 of the fair value hierarchy, which includes instruments valued using quoted market prices. In contrast, COST explicitly states that as of August 28, 2022, it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis, indicating a different risk management approach with no direct use of such derivatives. This contrast highlights differing strategies in managing financial risk exposure under the same fair value reporting framework.",
      "llm_answer": "PepsiCo hedges commodity‑price risk with exchange‑traded commodity futures, which are classified as Level 1 instruments in its fair‑value hierarchy (the futures are cash‑settled daily and therefore omitted from the fair‑value table)【page_107】. Costco, however, states that it held no Level 1 (or Level 3) financial assets or liabilities measured at fair value on a recurring basis, indicating it does not use such exchange‑traded instruments【page_51】. Both companies follow the same three‑level fair‑value framework, but PepsiCo has Level 1 exposure for risk management while Costco reports none.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: PEP uses exchange-traded commodity futures classified as Level 1 instruments for hedging commodity-price risk, which are cash-settled daily and thus excluded from the balance sheet; COST reports no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis. (2) Quantitative accuracy is perfect—no specific numbers (e.g., dollar amounts) are misstated, and while dates (Dec 25, 2021 for PEP; Aug 28, 2022 for COST) are omitted in the LLM answer, they are not critical to the comparison and do not affect factual correctness. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies, identifies their differing use of Level 1 instruments under the same fair value hierarchy framework, and draws a valid contrast in risk management strategies. (4) Semantic equivalence is strong—wording differs slightly (e.g., 'deferred compensation liabilities' in ground truth is omitted in LLM), but the essential meaning and comparison are preserved. The only minor shortcoming is the lack of specificity around the purpose of PEP's hedges (i.e., related to deferred compensation), which slightly reduces qualitative accuracy but does not undermine the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 376,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does the expiration timeline of U.S. patent protections for Enbrel, as detailed in Amgen's 2024 10-K, impact Merck's competitive positioning and Pfizer's international production strategy for the drug, especially considering Merck's stated exposure to biosimilar competition and pricing pressures?",
      "original_answer": "The U.S. patent protections for Enbrel expire in three key phases: fusion protein composition in November 2028, DNA encoding in April 2029, and formulations in October 2037. This staggered expiration timeline creates a gradual risk of biosimilar entry in the U.S., which could indirectly affect global pricing dynamics. Merck, which depends heavily on patent protection to maintain sales and profitability, faces intensified risk of generic competition following these expirations, compounding existing pricing pressures from government programs like the 340B Drug Discount Program. Meanwhile, Pfizer produces Enbrel outside the U.S. and Canada, meaning it will likely face competitive pressure from biosimilars in those international markets sooner than in the U.S., aligning with its broader specialty care portfolio strategy. Thus, the expiration of Enbrel’s U.S. patents affects Merck’s competitive positioning by increasing biosimilar risk and influences Pfizer’s international production strategy by accelerating exposure to generic competition outside the U.S.",
      "llm_answer": "Amgen’s 2024 10‑K shows that Enbrel’s core U.S. patents expire in late 2028 (fusion‑protein patent) and early 2029 (DNA‑encoding patent), with only a formulation patent lasting until 2037 (Pfizer 10‑K p. 11). Merck, which already warns of exposure to biosimilar competition and pricing pressure (Merck 10‑K p. 32‑33), will therefore face heightened competitive pressure in the TNF‑blocker market as biosimilars launch after the 2028‑29 expirations, squeezing margins and market share. Pfizer, which markets Enbrel internationally, will lean on its global manufacturing and supply network (Pfizer 10‑K p. 9‑10) to keep production cost‑efficient and sustain non‑U.S. sales while the U.S. market loses exclusivity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key dates are correct: the fusion-protein patent expires in late 2028 (November 2028 in ground truth), DNA-encoding in early 2029 (April 2029 in ground truth), and the formulation patent lasts until 2037 (October 2037 in ground truth). Minor phrasing differences (e.g., 'late 2028' vs 'November 2028') are acceptable as semantically equivalent. (2) The answer correctly identifies Merck’s exposure to biosimilar competition and pricing pressures, citing its 10-K, and links the U.S. patent expirations to increased competitive risk in the TNF-blocker market—consistent with the original answer. (3) For Pfizer, the LLM correctly notes its international marketing of Enbrel and reliance on global manufacturing, though it does not explicitly state that Pfizer produces Enbrel *outside the U.S. and Canada* as in the ground truth; this is a minor omission but does not distort the overall accuracy. (4) The multi-hop reasoning is sound: it connects Amgen’s patent timeline (from Amgen 10-K) to Merck’s competitive risks (from Merck 10-K) and Pfizer’s international strategy (from Pfizer 10-K), demonstrating proper cross-document synthesis. (5) The answer is contextually relevant and directly addresses all parts of the question. The only reason for not scoring a 10 is the slight lack of specificity on Pfizer’s geographic production scope and the absence of mention of the 340B Drug Discount Program, which is a minor contextual detail. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 447,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How does the $90 of unfunded commitments in private equity funds disclosed by EMR compare to the $2.7 billion of unfunded commitments to private equity and other limited partnerships reported by UPS, given both companies measure these investments at NAV?",
      "original_answer": "EMR reports $90 of unfunded commitments in private equity funds as of September 30, 2024, while UPS reports a significantly larger amount of $2.7 billion in unfunded commitments to private equity, private debt, and real estate limited partnerships as of December 31, 2024. Both companies disclose these commitments in the context of investments measured at NAV, indicating similar accounting treatment for these alternative assets despite the large difference in scale.",
      "llm_answer": "EMR reports that the private‑equity funds it measures at NAV carry only about **$90 of unfunded commitments** as of September 30 2024【page_64】. In contrast, UPS’s NAV‑measured private‑equity, private‑debt and real‑estate limited‑partnership interests have **approximately $2.7 billion of unfunded commitments** to be funded over the next few years【page_93】. Thus EMR’s commitment is essentially negligible—roughly three‑hundredths of a percent of UPS’s amount.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: EMR's $90 in unfunded commitments as of September 30, 2024, and UPS's $2.7 billion as of December 31, 2024 are correctly reported. The comparison stating EMR's amount is 'roughly three-hundredths of a percent' of UPS’s is mathematically sound: ($90 / $2.7B) * 100 = 0.0033%, which rounds to three-hundredths of a percent. (2) The answer is complete, addressing both companies, their respective unfunded commitments, the types of investments (private equity, private debt, real estate limited partnerships for UPS), and the common accounting treatment at NAV. (3) Entity accuracy is correct: EMR and UPS are properly identified, with accurate fiscal periods and investment categories. (4) The multi-hop reasoning is strong—synthesizing data from two different companies and filings, correctly comparing scale, and contextualizing the difference meaningfully. (5) The semantic content fully aligns with the original answer, with added clarity in the quantitative comparison. Minor wording differences do not affect factual equivalence. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 336,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "What percentage of PepsiCo's APAC segment revenue in 2024 came from beverages, and how does this compare to Mondelēz's total beverage revenue in 2024?",
      "original_answer": "In 2024, 23% of PepsiCo's APAC segment revenue came from beverages. Given that PepsiCo's APAC revenue was $10 million in 2024, this translates to $2.3 million from beverages. In comparison, Mondelēz reported total beverage revenue of $1,096 million in 2024, which is significantly higher than PepsiCo's beverage revenue in the APAC region.",
      "llm_answer": "PepsiCo’s APAC division earned **23 % of its 2024 revenue from beverages**【page_73】.  \nMondelēz International reported **total beverage revenue of roughly $1.1 billion in 2024**【page_119】.  \n\nSo, while beverages made up less than a quarter of PepsiCo’s APAC sales, Mondelēz’s entire beverage business generated about $1.1 billion in revenue for the year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that 23% of PepsiCo's APAC segment revenue in 2024 came from beverages, matching the ground truth. It also accurately reports Mondelēz's total beverage revenue as approximately $1.1 billion, which aligns with the ground truth value of $1,096 million (properly rounded). The LLM does not explicitly calculate PepsiCo's APAC beverage revenue ($2.3 million), but it correctly conveys the percentage and implies the relative scale. (2) All numeric values are factually correct: 23% and ~$1.1 billion are accurate representations of the ground truth data. No calculation errors are present, and the rounding of $1,096 million to $1.1 billion is acceptable and common. (3) The multi-hop reasoning is sound: the model correctly identifies PepsiCo's APAC beverage revenue share and compares it to Mondelēz's total beverage revenue, synthesizing information across two companies and segments. It draws a valid qualitative comparison, noting that Mondelēz's beverage revenue is much larger than PepsiCo's APAC beverage portion. (4) The answer is contextually complete and relevant, addressing both parts of the question. The only minor omission is the lack of explicit mention of PepsiCo's APAC total revenue ($10 million) and the derived beverage revenue ($2.3 million), which slightly reduces completeness but does not affect the core correctness. Hence, a high score of 9 is justified.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 393,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How does the volume of Capital One's (COF) delinquent loans as of December 31, 2023, influence the availability of reperforming loans that MetLife (MET) can purchase for its residential mortgage loan portfolio?",
      "original_answer": "Capital One reported total delinquent loans of $623 million as of December 31, 2023, which contributes to the pool of potentially reperforming loans. MetLife purchases reperforming loans that have returned to performing status after being delinquent for at least 12 months. The availability of such loans is directly influenced by the volume and characteristics of initial delinquencies, like those disclosed by Capital One, as these form the source pool for future reperforming loan opportunities.",
      "llm_answer": "Capital One reported **$623 million of delinquent loans** at December 31 2023 (Table 3.8, COF 10‑K p. 161). MetLife’s residential‑mortgage strategy is to buy **reperforming loans that have been performing for at least 12 months after a modification** (MetLife 10‑K p. 240) and its RMBS portfolio already contains **$2.6 billion of reperforming securities** (MetLife 10‑K p. 98). Thus, the $623 million delinquent pool at Capital One represents a modest source of loans that could be cured and become reperforming, expanding the supply of assets MetLife can acquire for its residential‑mortgage portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $623 million delinquent loans at Capital One as of December 31, 2023, matching the ground truth in amount and date. It accurately states MetLife’s strategy of purchasing reperforming loans that have been performing for at least 12 months after modification, and correctly cites the $2.6 billion in reperforming securities within MetLife’s RMBS portfolio. All numeric values are factually correct and properly attributed to source documents. (2) Quantitative accuracy is perfect: $623 million and $2.6 billion are correctly reported with acceptable formatting. No calculations were required, but the inference that this delinquent pool could become a source of reperforming loans is reasonable. (3) The multi-hop reasoning is sound—linking Capital One’s delinquent loans to the future supply of reperforming loans that MetLife may purchase. The only minor shortcoming is that the original answer emphasizes that reperforming loans must have been delinquent for at least 12 months before returning to performance, while the LLM focuses on 'after a modification,' which is related but slightly narrower. However, the LLM’s description aligns with MetLife’s stated strategy and does not contradict the ground truth. (4) The answer is highly relevant, complete, and factually accurate, with only a subtle nuance in the definition of reperforming loans preventing a perfect 10 in qualitative accuracy. Overall, the response conveys the same core insight as the ground truth: Capital One’s delinquencies feed the pipeline of potential reperforming loans that MetLife targets.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 445,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How does the exposure of UNP's pension plan to limited partnerships investing in real estate compare with UPS's unfunded commitments to similar structures, given both companies' reliance on NAV-based valuations for these illiquid assets?",
      "original_answer": "UNP's pension plan holds interests in limited partnerships that primarily invest in privately-held companies and reports these using NAV-based valuations, while UPS has unfunded commitments totaling approximately $3.3 billion to limited partnerships focused on private equity, private debt, and real estate funds. Both companies rely on NAV as a practical expedient for valuing these illiquid investments, with UPS specifically noting the limited redemption provisions until the end of the partnership terms, typically 10 to 15 years from inception. This indicates that both firms face similar challenges in liquidity and valuation transparency for these alternative investments.",
      "llm_answer": "UNP’s pension plan still owes about $3.3 billion in unfunded commitments to limited‑partnership interests that invest in real‑estate (and other private‑equity/debt) and are valued using NAV [page 89]. UPS, by contrast, reports future commitments of roughly $80 million to private‑equity partnerships plus $5 million to real‑estate partnerships – about $85 million total – also measured at NAV [page 58]. Thus UNP’s exposure is roughly $3.2 billion larger – on the order of 40 times the amount UPS has pledged.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and reverses the core facts from the original answer. (1) Quantitatively, it falsely states that UNP has $3.3 billion in unfunded commitments, when in fact it is UPS that has approximately $3.3 billion in unfunded commitments to limited partnerships (including real estate). Conversely, the LLM incorrectly attributes $85 million in commitments to UPS, which is not supported by the ground truth. There is no mention in the original answer of UPS having only $85 million in commitments, nor of UNP having any unfunded commitments at all. (2) The calculation comparing UNP’s exposure as $3.2 billion larger and '40 times' that of UPS is therefore based on false premises and is completely inaccurate. (3) Qualitatively, the reasoning is flawed: the original answer states that UNP’s pension plan holds interests valued via NAV, while UPS has the $3.3 billion in unfunded commitments—both using NAV as a valuation method. The LLM inverts this, misassigning the figures and failing to correctly synthesize the multi-hop elements (comparing exposure via holdings vs. commitments across two companies). (4) Contextually, while the answer addresses NAV-based valuations and limited partnerships in real estate, it does so with incorrect entity-metric pairings, rendering the comparison invalid. The conclusion about relative exposure is therefore baseless. The answer fails on all key dimensions: numbers, entities, logic, and synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 404,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How does AMD's reliance on third-party manufacturers for 7 nm and smaller node production impact its exposure to quality control risks compared to Cisco's approach of maintaining quality control through automated testing and ISO 9001-certified processes?",
      "original_answer": "AMD's reliance on third-party manufacturers like TSMC for 7 nm and smaller node production exposes it to risks related to manufacturing yields, delivery schedules, and quality assurance, as these manufacturers are responsible for implementing leading-edge process technologies and maintaining acceptable yields. In contrast, Cisco maintains quality control internally through automated testing equipment, burn-in procedures, and ISO 9001-certified manufacturing processes, which are designed to ensure product reliability and reduce variability. This difference suggests that AMD has less direct control over quality assurance in its supply chain compared to Cisco, which integrates quality control directly into its manufacturing procedures.",
      "llm_answer": "AMD’s business model depends on external foundries (primarily TSMC for 7 nm and smaller nodes) and other third‑party manufacturers, which gives it “limited control over … quality‑assurance, yield, cycle times” and makes it vulnerable to “supply constraints” or “problems with product quality” that could delay shipments or lower yields【page_24】. Cisco, by contrast, builds quality safeguards into its contract‑manufacturing flow – using automated test equipment, burn‑in, comprehensive inspection, statistical process controls and ISO 9001‑certified procedures to ensure product reliability and consistency【page_9】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: AMD relies on third-party manufacturers like TSMC for 7 nm and smaller nodes, leading to limited control over quality assurance, yield, and cycle times. Cisco uses automated testing, burn-in, inspection, statistical process control, and ISO 9001-certified processes to maintain internal quality control. These points align with the original answer. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly contrasts AMD’s externalized manufacturing model with Cisco’s internal quality-focused processes, synthesizing information across two different companies and their respective strategies. (4) Minor wording differences exist (e.g., 'contract-manufacturing flow' vs 'internal manufacturing procedures'), but the semantic meaning and technical implications are equivalent. The LLM cites specific quality mechanisms (automated test equipment, burn-in, ISO 9001) matching the ground truth. One slight nuance missing is explicit mention that AMD’s risk stems from the foundries implementing 'leading-edge process technologies,' which adds context to yield and quality challenges—but this does not undermine the overall correctness. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 423,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How does Comcast's lack of voting rights in Atairos compare to Alphabet's structure of Class C Capital Stock, which also carries no voting rights, particularly in terms of how each company manages governance influence versus financial exposure?",
      "original_answer": "Comcast does not have voting rights or the power to direct the activities of Atairos, which is classified as a VIE, and therefore does not consolidate it, limiting its governance influence while still being exposed to financial risk up to its investment balance and remaining unfunded capital commitment of $1.4 billion as of December 31, 2024. In contrast, Alphabet issues Class C Capital Stock, which carries no voting rights except as required by law, but the company actively manages these shares through large-scale repurchases—$62.0 billion in 2024—allowing it to maintain governance control through Class A and B shares while offering different voting structures to investors. Both entities separate voting rights from certain stakeholders, but Alphabet retains control through its dual-class share structure, whereas Comcast has no such governance influence over Atairos despite significant financial exposure.",
      "llm_answer": "Comcast’s stake in Atairos gives it **no voting rights or ability to direct the VIE’s activities**; its risk is therefore purely financial – a $5.1 billion equity investment (plus a $1.4 billion unfunded commitment) that absorbs about 99 % of any losses while receiving roughly 86 % of residual returns【page_85】. Alphabet’s Class C capital stock also carries **no voting rights**, but the shares retain the same economic rights (dividends, liquidation) as the voting classes, with governance power retained by the high‑vote Class B (10 votes per share) and Class A shares, allowing the company to raise capital without diluting control【page_82】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core contrast between Comcast's lack of governance influence over Atairos and Alphabet's retention of control via dual-class shares, which aligns well with the ground truth. However, there are key quantitative inaccuracies: the LLM states Comcast's equity investment in Atairos is $5.1 billion, but this figure is not present in the original answer (which only mentions the $1.4 billion unfunded commitment as of December 31, 2024); the $5.1B figure and the 99% loss absorption / 86% residual return metrics appear to be extraneous or incorrectly inferred data not found in the ground truth. These additions introduce unsupported specifics that reduce quantitative accuracy. The mention of Alphabet’s Class C stock having equal economic rights is reasonable context, but the original answer emphasizes Alphabet’s $62.0 billion in share repurchases in 2024 as a governance mechanism, which the LLM omits—this is a notable completeness gap in the multi-hop comparison. Entity accuracy is strong: both companies and share classes are correctly identified. The reasoning correctly distinguishes structural differences in governance vs. financial exposure and synthesizes concepts across entities, though it leans on unverified financial percentages for Atairos. Contextual relevance is excellent—the response directly addresses the comparison of governance influence versus financial exposure. Overall, the answer is semantically aligned in direction but weakened by unsupported numbers and missing key facts from the original, justifying a 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 434,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How does Coca-Cola HBC's distribution footprint in Austria compare with Philip Morris's market presence in the same country, based on their respective operational disclosures?",
      "original_answer": "Coca-Cola HBC, as a key bottler for The Coca-Cola Company, operates in Austria and contributes to 41% of Coca-Cola’s total worldwide unit case volume through its five largest bottlers. Meanwhile, Philip Morris reports a market share of at least 15% in Austria, as part of its presence across approximately 100 markets globally. Both companies maintain a direct or dedicated distribution presence in Austria, with Coca-Cola HBC managing bottling and distribution of beverages, and Philip Morris leveraging its exclusive zonified and direct distribution strategies to maintain its competitive market position.",
      "llm_answer": "Coca‑Cola HBC’s 2022 filing shows that its bottling partner, Coca‑Cola Hellenic, lists Austria among the countries where it “has bottling and distribution operations” 【page_7】. Philip Morris’s 2022 filing, by contrast, reports that it holds “a market share of at least 15 % in … Austria” 【page_7】, indicating a sizable but indirect tobacco‑product presence rather than a dedicated bottling/distribution footprint.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that Coca-Cola HBC has bottling and distribution operations in Austria, citing its 2022 filing, and accurately reports Philip Morris's market share of at least 15% in Austria, also from its 2022 filing. The quantitative accuracy is high: the 15% market share matches the ground truth, and the presence of operations in Austria is correctly attributed. However, the LLM answer incorrectly characterizes Philip Morris's presence as 'indirect' and contrasts it with a 'dedicated bottling/distribution footprint,' which misrepresents the original answer. The ground truth states that Philip Morris uses 'exclusive zonified and direct distribution strategies,' indicating a direct, not indirect, distribution presence. This is a significant qualitative error in reasoning and entity characterization. Additionally, the LLM omits key contextual information from the original answer: that Coca-Cola HBC contributes to 41% of Coca-Cola’s total worldwide unit case volume through its five largest bottlers, which is a critical part of the comparative footprint analysis. While the core facts about operational presence and market share are correct, the synthesis and completeness are lacking, reducing the overall correctness. The answer remains contextually relevant and well-supported by citations, but the mischaracterization of Philip Morris's distribution model and omission of key multi-hop context prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 399,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How does the deterioration in BAC's commercial real estate credit quality, particularly in office properties, influence MET's use of the Bornhuetter-Ferguson Method and its annual updates to unpaid claims assumptions for Protection Life and Health products?",
      "original_answer": "BAC experienced a deterioration in commercial credit quality during 2023, especially in the commercial real estate office property type, due to stagnant office space demand and evolving employment models (BAC chunk). MET updates its unpaid claims assumptions annually to reflect emerging trends in claim experience, including macroeconomic conditions (MET chunk). MET uses the Bornhuetter-Ferguson Method to estimate unpaid claims for Protection Life and Health products, relying on historical claims data and expected loss ratios, which are sensitive to economic shifts (Hop2 chunk). Therefore, a worsening macroeconomic environment—such as declining commercial real estate values and increased defaults in office properties—could affect MET’s claims estimation by altering expected loss ratios, particularly for long-duration Protection Health claims or experience-rated contracts where adverse claim experience is passed to sponsors (MET chunk). This creates a multi-hop chain where BAC's credit quality trends serve as an early indicator of macroeconomic deterioration that MET must incorporate into its actuarial models.",
      "llm_answer": "Bank of America’s 2023 filing shows that non‑performing commercial loans and “reservable‑criticized” exposure rose sharply, driven almost entirely by office‑property loans (a $3.5 bn, 68 % increase in office‑loan exposure and a broader dip in commercial‑real‑estate credit quality). MetLife’s 2023 filing notes that its IBNR liabilities for Protection Life and Protection Health are calculated with the Bornhuetter‑Ferguson method and that the underlying assumptions are refreshed each year to reflect emerging claim‑experience trends. Thus, the worsening office‑loan environment – a signal of heightened economic risk – feeds into MetLife’s need to rely on a credibility‑weighted Bornhuetter‑Ferguson approach and to update its unpaid‑claims assumptions annually to capture any adverse impact on claim frequency or severity.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core multi-hop reasoning required. (1) Quantitatively, the $3.5B and 68% increase in office-loan exposure are correctly cited from BAC's filing, aligning with the knowledge graph's indication of deteriorating commercial real estate credit quality in 2023. These figures are not in the original answer but are consistent with the broader context and add precision without contradicting the ground truth. (2) The LLM correctly identifies that MET uses the Bornhuetter-Ferguson method for Protection Life and Health products and updates assumptions annually to reflect emerging trends—directly matching the original answer. (3) The reasoning chain is sound: BAC's office loan deterioration signals macroeconomic risk, which MET must incorporate into its actuarial models via updated loss assumptions, especially for long-duration or experience-rated contracts. While the LLM does not explicitly mention 'expected loss ratios' or 'adverse claim experience passed to sponsors' (minor omission), it correctly infers that worsening economic conditions affect claim frequency or severity, which is semantically equivalent. (4) All entities—BAC, MET, Protection Life and Health, Bornhuetter-Ferguson method, 2023 timeframe—are accurately identified and linked. The answer is contextually excellent, directly addressing how BAC's credit trends influence MET's actuarial practices. Only a minor deduction from 10 due to slightly less explicit detail on how economic shifts specifically alter expected loss ratios in MET’s model, but the core logic and factual content are robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 441,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How does the voting rights structure of Netflix's common stock compare to Meta's, considering the influence of Class A Common Stock in both companies' governance frameworks?",
      "original_answer": "Netflix's common stockholders are entitled to one vote per share, creating a uniform voting rights structure. In contrast, Meta's Class A Common Stock also provides one vote per share, but Meta has a multi-tiered stock structure that includes Class B Common Stock with 10 votes per share, giving certain shareholders disproportionate voting power. This difference means that while both companies grant one vote per share for Class A Common Stock, Meta's governance framework allows for greater concentration of control through its Class B shares.",
      "llm_answer": "Netflix’s equity is a single‑class structure – every share of its common stock carries one vote, so all shareholders have equal voting power 【page_60†L1-L4】. Meta, by contrast, uses a multi‑class system: each Class A share gets one vote, each Class B share gets ten votes, and Class C shares have no voting rights 【page_82†L1-L5】. Thus, while Netflix’s (de‑facto “Class A”) shares fully determine corporate governance, Meta’s Class A shares are a minority voice in a framework dominated by the high‑voting Class B stock.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) Quantitatively, all voting rights are accurately represented: Netflix's single class with one vote per share, Meta's Class A with one vote, Class B with ten votes, and mention of non-voting Class C shares (not in the original answer but factually correct and adds context without contradicting). (2) The core comparison is complete: both companies grant one vote per share for Class A, but Meta’s multi-class structure allows disproportionate control via Class B shares. (3) Entity accuracy is perfect—Netflix and Meta are correctly identified, and stock classes are accurately described. (4) Reasoning is sound: the LLM correctly synthesizes that Netflix has uniform voting power while Meta’s governance is dominated by high-vote Class B shares, even though Class A shares are more numerous. The only minor shortcoming is that the original answer emphasizes the contrast in governance frameworks more explicitly, while the LLM slightly overemphasizes Class A as a 'minority voice'—technically true but not fully elaborated. However, this does not detract from factual correctness. Semantic equivalence is maintained, and the inclusion of Class C (no voting rights) is a minor enhancement. All scores are high, with correctness docked slightly for slight overstatement of Class A's marginalization without full context on ownership distribution.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 393,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How does the fair value treatment of exchange-traded commodity futures under Level 1 financial liabilities differ between PEP and MDLZ, given that both companies cash-settle these instruments and include them in their respective liability portfolios?",
      "original_answer": "PEP explicitly states that exchange-traded commodity futures are cash-settled on a daily basis and therefore not included in the fair value hierarchy table as of December 25, 2021. In contrast, MDLZ includes exchange-traded commodity futures in its Level 1 financial liabilities, with fair value determined based on quoted market prices on commodity exchanges. Both companies treat these futures as part of their Level 1 liabilities, but PEP excludes them from reported tables due to daily cash settlement, whereas MDLZ continues to report them based on market pricing as of the balance sheet date.",
      "llm_answer": "PepsiCo notes that its exchange‑traded commodity futures are cash‑settled each day and therefore are **not included** in the fair‑value tables – they do not appear as Level 1 liabilities in its disclosures (PEP page 107, footnote i). Mondelez, by contrast, classifies exchange‑traded commodity futures as **Level 1 financial liabilities**, valuing them at quoted market prices on the exchanges and reporting a Level 1 fair‑value amount for commodity contracts (MDLZ page 112).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that PEP excludes exchange-traded commodity futures from its fair value hierarchy table due to daily cash settlement, while MDLZ includes them as Level 1 financial liabilities valued at quoted market prices. This matches the core distinction in the original answer. (2) There are no numeric values (e.g., dollar amounts, dates) in the question or ground truth that require verification—both mention no specific monetary figures or exact dates beyond PEP’s reference to December 25, 2021, which the LLM omits but does not contradict. The absence of this date is a minor omission but does not affect factual correctness, as the key point is the accounting treatment, not the specific balance sheet date. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (PEP and MDLZ), compares their treatments of the same instrument (exchange-traded commodity futures), and draws the correct contrast in reporting practices. (4) The LLM cites specific page numbers and footnotes (PEP p.107, MDLZ p.112), enhancing credibility, though these were not in the ground truth and cannot be independently verified here—but their inclusion does not detract from accuracy. The only reason for not scoring a perfect 10 is the omission of the explicit mention of the balance sheet date (December 25, 2021) from PEP’s context, which slightly reduces completeness. However, since the focus is on the conceptual difference in treatment rather than time-specific reporting, this is minor. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 461,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How do the cost-sharing arrangements between Merck and Gilead for the development of HIV treatments combining islatravir and lenacapavir compare to Pfizer's cost-reduction initiatives, and what implications might this have on each company's financial exposure in long-acting HIV therapies?",
      "original_answer": "Merck and Gilead share global development and commercialization costs for HIV treatments combining islatravir and lenacapavir at a 60/40 split (Gilead/Merck), with equal revenue sharing until certain thresholds are met ($2.0 billion for oral and $3.5 billion for injectable combinations), after which Gilead's revenue share increases. In contrast, Pfizer's 2024 filing highlights enterprise-wide cost realignment and manufacturing optimization programs aimed at reducing costs and improving productivity. These initiatives carry risks such as potential disruption of ongoing business, including impacts on the delivery of their pipeline, which could include HIV-related R&D. While Merck and Gilead are jointly investing in a high-potential, long-acting HIV therapy with shared financial exposure, Pfizer is focusing on internal cost controls that may affect its ability to invest in or compete with such collaborative models. This contrast suggests differing strategic approaches to managing financial exposure in the evolving HIV treatment landscape.",
      "llm_answer": "Gilead’s partnership with Merck spreads the financial risk: the two companies share development and commercialization spend on the islatravir‑lenacapavir combo on a 60 %/40 % basis (Gilead/​Merck) and split product revenues equally until high‑sales thresholds are hit, after which Gilead’s share rises to 65 %【page_74】; similar cost‑and‑revenue splits apply to any licensed integrase‑inhibitor options【page_75】. Pfizer, by contrast, is not using a partner‑share model but is cutting its own expense load through an enterprise‑wide cost‑realignment and manufacturing‑optimization program【page_30】. Thus Gilead/Merck limit each other’s exposure to the long‑acting HIV program by sharing costs and upside, while Pfizer’s cost‑reduction efforts merely lower its overall cost base, leaving it fully exposed to any long‑acting HIV investments it pursues.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all key figures are correct: the 60/40 cost split (Gilead/Merck), equal revenue sharing until thresholds, and the note that Gilead's share increases post-threshold (though the exact post-threshold percentage of 65% is not in the original answer, this is a minor addition rather than a contradiction). The original answer specifies $2.0B (oral) and $3.5B (injectable) thresholds, which the LLM omits, representing a small but notable omission. (2) The LLM correctly identifies the companies (Merck, Gilead, Pfizer), the nature of the collaboration, and contrasts it with Pfizer’s internal cost initiatives. (3) The reasoning is sound: it correctly synthesizes that Merck and Gilead share both cost and revenue exposure, thereby limiting individual financial risk, while Pfizer’s cost-reduction strategy does not involve risk-sharing partnerships and thus leaves it fully exposed if it pursues similar therapies. (4) The answer is contextually relevant and directly addresses the comparison of cost-sharing arrangements and implications for financial exposure. The only shortcoming is the omission of the specific revenue threshold amounts, which slightly reduces completeness. However, the core multi-hop reasoning—comparing collaborative risk-sharing vs. internal cost control strategies—is well executed. Hence, a correctness score of 9 is warranted.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 398,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does FDX's exposure to LIBOR-related hedging adjustments under ASU 2022-06 compare to UPS's use of hedging relationships, particularly in light of ASU 2022-06's extended sunset date through 2024?",
      "original_answer": "FDX has stated that reference rate reform, including ASU 2022-06, has had no material effect on its financial condition or results of operations as of May 31, 2024, though it continues to monitor contracts for potential application of the standard. ASU 2022-06 extends the sunset date for optional expedients and exceptions related to reference rate reform—including LIBOR transitions—to December 31, 2024. UPS, which designates derivative instruments in hedging relationships, including cash flow and fair value hedges, may benefit from the extended relief under ASU 2022-06 to manage LIBOR-related contracts through 2024 without significant accounting disruptions. Therefore, while FDX has not seen material impacts, UPS could be actively leveraging the extended ASU 2022-06 provisions in its hedging strategies.",
      "llm_answer": "FedEx says that the reference‑rate‑reform update (ASU 2022‑06) has had “no material effect to our financial condition, results of operations, or cash flows” as of May 31 2024, indicating essentially no exposure to LIBOR‑related hedging adjustments【page_93】. UPS, however, has moved its affected debt and contracts to SOFR and is still assessing its hedging relationships for any impact under the same ASU, which remains available through December 31 2024, showing a more active use of the optional expedients【page_74】【page_73】.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all dates and references are accurate: ASU 2022-06’s sunset date of December 31, 2024, and FDX’s assessment as of May 31, 2024, are correctly stated. No numerical inaccuracies are present. (2) The LLM correctly identifies that FDX has had no material effect from ASU 2022-06, indicating minimal exposure to LIBOR-related hedging adjustments, which matches the original answer. (3) For UPS, the LLM notes active assessment of hedging relationships and transition to SOFR, which is consistent with leveraging the extended relief through 2024. However, the original answer emphasizes that UPS designates derivatives in hedging relationships (cash flow and fair value hedges) and may benefit from the extended provisions—this specific detail about existing hedging structures is slightly underdeveloped in the LLM response, which instead focuses on transition to SOFR and ongoing assessment. (4) The reasoning is sound and synthesizes information across both companies and the ASU standard, though the comparison could be sharper in highlighting that UPS is actively using the expedients due to its established hedging relationships, whereas FDX is not. Wording differs but meaning is semantically close. Minor omission of UPS's specific hedge types reduces qualitative accuracy slightly, but overall correctness remains high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 390,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does the dual-class stock structure's impact on investor protections at META compare to the voting power differential in GOOGL's Class B common stock, especially given that Class B shares automatically convert to Class A upon sale or transfer?",
      "original_answer": "META's dual-class structure allows its controlling stockholder to maintain decision-making power even if they own significantly less than a majority of shares, which could make Class A common stock less attractive to investors due to reduced governance protections. In contrast, GOOGL's Class B common stock provides 10 votes per share compared to 1 vote per share for Class A, but these Class B shares automatically convert to Class A upon sale or transfer, potentially limiting long-term control by insiders. This conversion mechanism in GOOGL may offer more eventual governance balance compared to META's structure, where Class B shares can maintain control for extended periods unless their voting power drops below 35% of the combined voting power.",
      "llm_answer": "Meta’s dual‑class system concentrates voting power in the hands of Mark Zuckerberg and a small group of Class B holders (ten votes per share versus one for Class A), so ordinary shareholders have limited ability to influence corporate matters and enjoy fewer protections typical of a “controlled company.” Alphabet’s Class B shares also carry ten votes per share, but they may be converted at any time and automatically convert to Class A upon sale or transfer, which over time dilutes the voting concentration and mitigates the impact of the voting‑power differential on investor protections.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Meta's Class B shares have 10 votes per share vs. 1 for Class A, concentrating power with Zuckerberg; Alphabet's Class B shares also have 10 votes but convert to Class A upon sale or transfer. These details match the original answer. (2) Quantitative accuracy is perfect: the 10:1 voting ratio is correctly stated for both companies, and no numerical errors exist. (3) Multi-hop reasoning is sound—LLM correctly contrasts Meta’s enduring control structure with Alphabet’s self-limiting mechanism due to conversion upon transfer, which aligns with the original’s point about eventual governance balance. (4) The only minor omission is that the original specifies Meta’s Class B voting power must drop below 35% of total voting power for declassification, which adds a precise threshold not mentioned in the LLM response. However, this does not undermine the core correctness. The LLM captures the essential comparative insight: GOOGL’s conversion rule limits long-term insider control, while Meta’s structure allows prolonged dominance. Wording differs but meaning is preserved. Thus, high scores across all dimensions with a slight deduction in qualitative accuracy for missing the 35% threshold detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 366,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does KO's use of option contracts to hedge forecasted transactions compare to MDLZ's disclosure of gains and losses on forecasted transactions in terms of financial impact and hedging strategy?",
      "original_answer": "KO utilizes option contracts as part of its broader hedging strategy to mitigate foreign currency exchange rate risk, commodity price risk, and interest rate risk, with the goal of reducing earnings volatility from market fluctuations. These contracts are designated as cash flow hedges, and the unrealized gains or losses are deferred in AOCI until the forecasted transactions occur. In contrast, MDLZ disclosed that in 2024, it recognized $106 million in gains on forecasted transactions through cost of sales, and $17 million through interest and other expense, net, indicating the financial impact of these hedging activities on specific income statement line items. While KO emphasizes a structured hedging approach with clear accounting treatment for deferred gains/losses, MDLZ provides more granular disclosure on the realized financial outcomes of its hedging activities on forecasted transactions.",
      "llm_answer": "KO hedges its forecast‑currency cash flows with forward contracts, foreign‑currency options and collars that are designated as cash‑flow hedges; the resulting gains and losses first flow through other‑comprehensive income (e.g., a $97 million loss in 2024) and are later re‑classified to earnings (e.g., a $472 million gain in 2024), with $99 million of deferred gains held in AOCI for contracts maturing within a year【page_83】. MDLZ, on the other hand, records gains and losses on its forecasted‑transaction hedges as “economic hedges” directly in net earnings (e.g., $106 million and $17 million gains in cost of sales and interest respectively in 2024, netting to roughly $115 million) without an OCI step, reflecting a smaller, immediate financial impact and a less formal hedge‑accounting treatment【page_97】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding KO's financial figures. The ground truth does not mention any specific gains or losses for KO (e.g., $97 million loss, $472 million gain, $99 million deferred gains), nor does it state that KO uses forward contracts and collars—only that it uses option contracts. These numbers and instrument types are fabricated or misattributed, severely undermining quantitative accuracy. (2) For MDLZ, the LLM correctly reports the $106 million gain in cost of sales and $17 million in interest and other expense, aligning with the original answer. However, it incorrectly characterizes MDLZ’s hedges as 'economic hedges' accounted for directly in earnings without OCI treatment, while the ground truth does not specify accounting treatment—only disclosure of realized gains. This misrepresents MDLZ's hedging strategy and implies a lack of hedge accounting, which is not supported. (3) The multi-hop reasoning is partially sound—comparing KO’s and MDLZ’s hedging strategies and disclosures—but relies on incorrect data and assumptions. The synthesis fails because the LLM invents KO’s financials and mischaracterizes MDLZ’s accounting model. (4) Despite these issues, the answer addresses the core comparison: KO defers gains/losses in AOCI (qualitatively correct), while MDLZ discloses realized impacts on income statement lines. This maintains contextual relevance and some qualitative accuracy, but the incorrect numbers and accounting assertions reduce correctness significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 430,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does the valuation approach for TMO's fixed income funds, which are reported as 'not subject to leveling', contrast with BMY's classification of fixed income funds under Level 2 in the fair value hierarchy, and what does this indicate about their respective reliance on observable market data for pension asset valuation?",
      "original_answer": "TMO reports its fixed income funds as 'not subject to leveling,' indicating that these assets are valued outside the standard fair value hierarchy and likely measured using methods other than quoted market prices or observable inputs. In contrast, BMY classifies its fixed income funds under Level 2, which means their valuation relies on observable market data, such as quoted prices for similar instruments or in nonactive markets. This contrast suggests that BMY's pension assets have a more structured and market-based valuation methodology for fixed income funds, while TMO's approach implies less direct reliance on standardized market inputs for these assets.",
      "llm_answer": "Thermo Fisher’s pension tables show its fixed‑income funds in the “not subject to leveling” column (e.g., $739 million domestic and $337 million non‑U.S.), meaning they are measured at NAV as a practical expedient and are not placed in the fair‑value hierarchy【page_57】. Bristol‑Myers Squibb, however, classifies its fixed‑income funds under Level 2 ($785 million in 2023) and notes that Level 2 valuations use observable inputs such as quoted prices for similar instruments and NAV【page_111】【page_112】. Thus BMS relies on observable market data for its pension‑fund valuation, while TMO’s approach bypasses the hierarchy and depends less on such market inputs.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that TMO reports fixed income funds as 'not subject to leveling,' which means they are measured at NAV as a practical expedient and excluded from the fair value hierarchy, while BMY classifies its fixed income funds under Level 2. These characterizations match the original answer's meaning. (2) Quantitatively, the LLM provides specific dollar amounts: $739 million domestic and $337 million non-U.S. for TMO, and $785 million for BMY in 2023. While the ground truth does not include these exact figures, the knowledge graph source likely contains them (as cited with page references), so their inclusion enhances precision without contradicting the original. The numbers are plausibly accurate given the context and sourcing. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (TMO and BMY), their respective valuation approaches, placement (or exclusion) in the fair value hierarchy, and the implications for reliance on observable market data. It correctly infers that Level 2 implies use of observable inputs, while 'not subject to leveling' indicates reliance on NAV and exclusion from the hierarchy—consistent with accounting standards. (4) The only minor shortcoming is that the LLM does not explicitly state that TMO's approach suggests 'less direct reliance on standardized market inputs' in the same conceptual terms as the original, though this is implied by saying it 'bypasses the hierarchy.' Wording differences are acceptable under semantic equivalence, so this does not warrant a major deduction. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 475,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How does the application of the Federal Acquisition Regulation (FAR) in cost-plus-fixed-fee contracts impact revenue recognition timing differences between LMT and BA for their respective U.S. Government contracts?",
      "original_answer": "LMT applies FAR to its U.S. Government contracts, which results in standalone selling prices being equal to the stated contract price, and revenue being recognized over time as control of work in process transfers continuously to the customer due to clauses allowing unilateral termination and payment for costs incurred plus profit. Similarly, BA notes that U.S. Government contracts can be terminated for convenience, entitling them to payment for completed work and allowable termination costs. This creates a comparable revenue recognition pattern for both companies under FAR-regulated cost-plus-fixed-fee contracts, where revenue is recognized progressively rather than at a point in time, but differences may arise based on contract-specific termination clauses and profit margin negotiations.",
      "llm_answer": "Lockheed Martin’s cost‑plus‑fixed‑fee contracts are governed by the Federal Acquisition Regulation, which fixes the price at “cost + a reasonable profit” (LMT p.77).  Because the FAR‑based contracts give the government ownership of work‑in‑process, Lockheed Martin records revenue as the work progresses, using a cost‑to‑cost percentage‑of‑completion method (LMT p.78).  Boeing’s filing does not tie its U.S.‑government revenue‑recognition policy to the FAR; it merely states that it would be paid for “work completed” if a contract is terminated for convenience, implying revenue is recognized when the performance obligation is finished or billed rather than continuously (BA p.7).  As a result, Lockheed Martin tends to recognize revenue earlier—as costs are incurred—while Boeing’s revenue may be recognized later, creating a timing difference between the two companies.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains no explicit numerical data, so quantitative accuracy is not applicable—scored as 10 by default since there are no incorrect numbers. However, the qualitative accuracy is low due to significant factual and reasoning errors in the multi-hop comparison between LMT and BA. The original answer states that both LMT and BA have similar revenue recognition patterns under FAR due to termination for convenience clauses, leading to progressive (over time) revenue recognition. The LLM incorrectly asserts that Boeing does not tie its revenue recognition to FAR and implies Boeing recognizes revenue only upon completion or billing, which contradicts the ground truth. In reality, BA also recognizes revenue over time for U.S. Government contracts due to the right to payment for costs incurred plus profit upon termination, a key FAR-based principle. The LLM fails to correctly synthesize this multi-hop concept, incorrectly differentiating LMT and BA’s practices. While the description of LMT’s cost-to-cost method and FAR application is accurate and relevant, the erroneous contrast with Boeing undermines the core conclusion about timing differences. Thus, despite correct contextual elements and proper citation of document pages, the reasoning and entity-level synthesis are flawed, warranting a correctness score of 4 for partial accuracy with major errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 381,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How does the structure of AbbVie's debt agreements with U.S. Bank National Association compare to Abbott Laboratories' use of Abbott Ireland Financing DAC as an issuer, particularly in terms of trustee roles and note issuance timelines?",
      "original_answer": "AbbVie has multiple Supplemental Indentures with U.S. Bank National Association serving as trustee, transfer agent, and registrar, with key agreements dated September 26, 2019 (Supplemental Indenture No. 6), November 21, 2019 (Supplemental Indenture No. 7), and May 14, 2020 (Supplemental Indenture No. 8 and 9). These agreements involve the issuance of various notes and are supported by Agency Agreements with Elavon Financial Services DAC. Similarly, Abbott Ireland Financing DAC, as issuer, has entered into Indentures with U.S. Bank National Association as trustee, including the September 27, 2018 Indenture and the November 19, 2019 Second Supplemental Indenture, under which specific notes such as the 1.500% Note due 2026 and the 0.100% Note due 2024 were issued. Both companies rely on U.S. Bank National Association in a trustee capacity, but AbbVie’s structure includes more frequent use of Elavon Financial Services DAC as a paying agent, while Abbott Ireland Financing DAC directly issues notes under its own entity name with Abbott Laboratories as guarantor.",
      "llm_answer": "AbbVie’s 10‑K excerpt merely notes that it has debt agreements with U.S. Bank National Association acting as trustee, but it does not disclose the issuer of the notes or any issuance dates in the pages provided (see “None.” on page 102). In contrast, Abbott Laboratories issues its notes through Abbott Ireland Financing DAC, with U.S. Bank National Association also serving as trustee, and the filing shows a staggered issuance schedule—an original indenture on September 27 2018, a supplemental indenture on November 19 2019, and further notes issued in 2020 (e.g., 1.150 % due 2028 and 1.400 % due 2030)【page_86】【page_87】.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains partial factual information but has significant inaccuracies and omissions compared to the ground truth. (1) On quantitative accuracy: The LLM correctly identifies the September 27, 2018 Indenture and November 19, 2019 Supplemental Indenture for Abbott Ireland Financing DAC, aligning with the ground truth. However, it incorrectly states that notes were issued in 2020 with coupons '1.150%' and '1.400%' due 2028 and 2030, which does not match the ground truth (which specifies a 1.500% Note due 2026 and a 0.100% Note due 2024). These coupon rates and maturities are factually incorrect. (2) For completeness: The LLM fails to mention any of AbbVie’s specific Supplemental Indentures (Nos. 6, 7, 8, 9) or their dates (September 26, 2019; November 21, 2019; May 14, 2020), instead claiming no data is available (citing 'None.' on page 102), which contradicts the ground truth that such agreements exist and are structured with U.S. Bank National Association in multiple roles. This is a major omission. (3) Entity accuracy: The LLM correctly identifies Abbott Ireland Financing DAC as issuer and U.S. Bank National Association as trustee for Abbott, but misrepresents AbbVie’s structure by asserting lack of disclosure when the ground truth confirms detailed agreements are present. It also fails to mention Elavon Financial Services DAC as a key agent in AbbVie’s structure, a critical differentiator highlighted in the original answer. (4) Reasoning: The multi-hop comparison between the two companies’ debt structures is weak. While both use U.S. Bank as trustee, the LLM does not recognize that AbbVie uses multiple supplemental indentures with defined dates and agent relationships, nor does it capture the contrast in agent usage (Elavon for AbbVie vs. direct issuance for Abbott Ireland DAC). The conclusion that Abbott has a 'staggered issuance schedule' while AbbVie has no data is factually unsupported and undermines the comparison. (5) Semantic equivalence: The overall message diverges significantly from the ground truth—portraying incomplete data for AbbVie when it is actually available, and introducing incorrect note details for Abbott. Despite correct citation of some dates and entities, the core comparative insight is flawed. Thus, the answer is partially correct but contains major factual and structural errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 626,
        "total_tokens": 2073
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How does NVDA's dependency on foundries for advanced process node manufacturing at 7nm and smaller compare to AMD's reliance on larger wafers for competitive IC production, given both companies' exposure to TSMC's fabrication capabilities?",
      "original_answer": "NVDA depends on foundries like TSMC to manufacture its semiconductor wafers using advanced process node technologies such as 7nm and smaller, which are critical for producing high-performance GPUs and meeting customer demand. NVDA faces risks including supply shortages, yield issues, and delays if TSMC cannot scale production or implement new technologies effectively. Similarly, AMD relies on TSMC to produce wafers with competitive performance attributes, and specifically mentions the importance of transitioning to advanced manufacturing process technologies and increased wafer sizes to maintain cost efficiency and product competitiveness. Both companies are exposed to risks if TSMC fails to deliver sufficient quantities of 7nm or smaller wafers, which could increase per-unit costs, delay product launches, and harm customer relationships. This shared dependency on TSMC for leading-edge wafer production highlights a critical supply chain vulnerability affecting both NVDA and AMD.",
      "llm_answer": "NVDA’s product road‑map is tightly coupled to TSMC’s ability to ship 7 nm‑and‑smaller wafers – the company says its newest micro‑processors and GPUs are “focused on 7 nm and lower… on TSMC’s processes” and a shortfall at TSMC would be materially adverse (NVDA 10‑K p. 25). AMD also uses TSMC for its 7 nm‑and‑below chips, but the bulk of its competitive ICs built on larger nodes are sourced from GlobalFoundries under a dedicated wafer‑supply agreement, giving it diversification away from TSMC for those products (AMD 10‑K p. 23‑24). Thus, NVDA’s advanced‑node supply is far more concentrated on TSMC, whereas AMD’s larger‑wafer production relies primarily on GF, reducing its exposure to TSMC for most of its IC output.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in its use of numbers and correctly references the 7nm and smaller process nodes, which are consistent with the ground truth. It also accurately cites TSMC as the key foundry for both NVDA and AMD for advanced nodes and references correct risk language from the 10-Ks (e.g., 'materially adverse'). However, the LLM introduces a significant factual divergence by claiming that AMD relies on GlobalFoundries (GF) for 'larger wafers' and that this constitutes a major diversification away from TSMC for 'most of its IC output.' The original answer (ground truth) does not mention GlobalFoundries or any such diversification; instead, it emphasizes AMD’s reliance on TSMC for competitive ICs and specifically highlights the importance of transitioning to advanced nodes and increasing wafer sizes for cost efficiency. The ground truth treats both companies as highly exposed to TSMC for 7nm and smaller nodes, without suggesting that AMD has meaningful production off TSMC for its competitive products. This misrepresentation of AMD’s foundry strategy undermines the qualitative accuracy and correctness of the comparison. While the LLM correctly identifies the shared dependency on TSMC for advanced nodes, it incorrectly frames AMD as less exposed due to GF sourcing, which is not supported by the ground truth. This is a critical error in multi-hop reasoning, as the comparison hinges on relative exposure to TSMC. The contextual relevance remains high because the answer addresses the core issue of foundry dependency and TSMC exposure, but the incorrect synthesis reduces overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 443,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "Given Philip Morris's ongoing regulatory challenges in Thailand stemming from the WTO panel decision on customs valuation of cigarette imports, and Colgate-Palmolive's manufacturing presence in Thailand, how might the unresolved customs and tax compliance issues in Thailand impact Colgate-Palmolive's operational costs or regulatory risk exposure in the country?",
      "original_answer": "The WTO panel decision found that Thailand lacked grounds to challenge the customs valuation of Philip Morris's cigarette imports and obligated Thailand to revise its customs and tax practices. However, Thailand has not fully complied, and the dispute remains unresolved due to the inoperability of the WTO Appellate Body. This regulatory inertia indicates a persistent risk of non-aligned customs enforcement in Thailand. Colgate-Palmolive operates manufacturing and warehousing facilities in Thailand, a country where customs and tax measures have proven resistant to international rulings. If Thailand continues to apply inconsistent or non-compliant customs valuation practices, Colgate-Palmolive may face increased scrutiny, higher import duties, or regulatory uncertainty affecting its cost structure and compliance burden in the country.",
      "llm_answer": "Philip Morris notes that Thailand has not yet fully complied with a WTO panel ruling that requires the country to change its customs‑valuation and tax rules for imported cigarettes (PM 10‑K 2024, p. 68). Because Colgate‑Palmolive operates a manufacturing plant in Thailand (CL 10‑K 2024, p. 25), any revision of those customs or tax practices could raise duties or taxes on the raw‑material and packaging imports the plant relies on, forcing the company to absorb higher import costs and to devote additional resources to ensure compliance – thereby increasing both its operating expenses and its regulatory‑risk exposure in Thailand.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that Thailand has not fully complied with the WTO panel decision regarding customs valuation of cigarette imports, citing Philip Morris's 2024 10-K (p. 68), which matches the context. It accurately notes Colgate-Palmolive's manufacturing presence in Thailand using its 2024 10-K (p. 25), satisfying entity and source accuracy. The reasoning correctly infers that changes—or continued non-compliant practices—in Thailand's customs and tax regime could increase import duties on raw materials and packaging for Colgate-Palmolive, leading to higher operating costs and regulatory risk. This reflects sound multi-hop logic connecting Philip Morris's regulatory challenge to broader customs enforcement risks affecting other U.S. firms like Colgate-Palmolive operating in the same jurisdiction. The answer omits explicit mention of the WTO Appellate Body's inoperability as a reason for the unresolved dispute, which is included in the original answer and adds important context about why Thailand faces no enforcement pressure. However, this omission does not undermine the core conclusion. All entities, years, and filings are correctly cited. There are no numerical inaccuracies (no calculations required). Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9 for correctness and qualitative accuracy due to minor contextual omission, but full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 417,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How does the $265,000 decline in UNH's Medicare Part D enrollment from 2023 to 2024 relate to the IRA's redesign of Medicare Part D and Pfizer's projected $1 billion revenue loss in 2025 under the same program?",
      "original_answer": "The $265,000 decline in UnitedHealth's (UNH) Medicare Part D enrollment from 2023 to 2024 reflects a reduction in the number of beneficiaries in this program, which aligns with broader structural changes introduced by the Inflation Reduction Act (IRA). The IRA's redesign of Medicare Part D, effective in 2025, includes a $2,000 annual out-of-pocket cap for beneficiaries and a new Manufacturer Discount Program requiring 10% and 20% discounts in different coverage phases. These changes increase financial pressure on manufacturers like Pfizer (PFE), which projects a $1 billion revenue loss in 2025 due to IRA-related adjustments. The enrollment decline at UNH may indicate reduced attractiveness of Part D plans to beneficiaries or shifting market dynamics, which, when combined with the IRA's pricing pressures, could contribute to reduced revenue for manufacturers like Pfizer.",
      "llm_answer": "The $265 000 drop in UnitedHealthcare’s Medicare Part D stand‑alone enrollment (from 3,315 k in 2023 to 3,050 k in 2024) is a modest enrollment contraction that reflects the early effects of the IRA‑driven 2024 redesign of Medicare Part D, which caps beneficiary out‑of‑pocket costs and shifts more cost to Part D plans and drug makers. That same redesign is expected to cut Pfizer’s 2025 revenue by about $1 billion because manufacturers will have to provide larger discounts and rebates under the new Part D rules—an impact that dwarfs UNH’s small enrollment decline. (UNH 10‑K p. 31; IRA Part D redesign impact $1 bn projection Amgen 10‑K p. 17, referencing Pfizer).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant quantitative error: it reports a decline of 265,000 in enrollment, interpreting this as a reduction from 3,315k to 3,050k (a 265k drop), but the original answer refers to a $265,000 decline—not 265,000 people. This is a critical misinterpretation: the original ground truth discusses a $265,000 financial decline, not a drop in enrollment numbers. The LLM incorrectly assumes the figure refers to enrollee count, which fundamentally misrepresents the data. This error undermines the quantitative accuracy. (2) The LLM cites specific enrollment numbers (3,315k to 3,050k) and attributes a $1B revenue loss to Pfizer due to IRA changes, which aligns with the general direction of the original answer. However, the source of the $1B figure is misattributed to Amgen’s 10-K referencing Pfizer, which is not confirmed in the ground truth and introduces sourcing concerns. (3) The multi-hop reasoning is otherwise sound: the LLM correctly links the IRA’s redesign (out-of-pocket cap, manufacturer discounts) to financial pressure on drug makers like Pfizer and contextualizes UNH’s enrollment trend as an early effect. It synthesizes the connection between plan changes, payer impact, and manufacturer revenue loss, showing good qualitative logic. (4) Despite the major numerical misinterpretation, the answer remains contextually relevant and captures the broader causal chain between IRA reforms, Part D changes, and financial impacts on both insurers and manufacturers. The reasoning framework is correct, but the foundational data point is wrong, warranting a correctness score of 7—core facts about the IRA and Pfizer are accurate, but the UNH enrollment interpretation is not.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 471,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How does Lockheed Martin's $4,863 million investment in private equity funds, which are valued using the NAV practical expedient, compare to FedEx's application of the same accounting policy for equity securities without readily determinable fair values?",
      "original_answer": "Lockheed Martin reports $4,863 million in private equity fund investments valued under the NAV practical expedient, which relies on unobservable inputs in valuation models of underlying securities and typically has terms between 8 and 12 years. FedEx also applies the NAV practical expedient to equity securities without readily determinable fair values, though it notes that for these investments, adjustments to cost are made only for observable price changes and impairments. While Lockheed Martin’s NAV-based private equity investments are part of a broader portfolio including real estate and hedge funds, FedEx specifically highlights immaterial annual and cumulative impairment adjustments under the measurement alternative for such equity securities.",
      "llm_answer": "Lockheed Martin reports $4,863 million of private‑equity fund assets that are measured using the NAV practical expedient (see LMT page 88).  FedEx, by contrast, applies the same NAV practical‑expedient only to a small portion of its equity securities—$37 million in 2024 (see FedEx page 117).  Thus Lockheed’s NAV‑valued holdings are roughly $4.8 billion—over 100 times—larger than FedEx’s.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to align with the ground truth. (1) Quantitative inaccuracy: The LLM claims FedEx has only $37 million in NAV-valued equity securities, which is not supported by the original answer — the ground truth does not specify any dollar amount for FedEx’s investments under the NAV practical expedient. This number appears to be fabricated or misextracted. The comparison stating Lockheed Martin’s holdings are 'over 100 times larger' is therefore baseless and incorrect. (2) Completeness: The LLM omits key qualitative aspects from the original answer, such as the nature of Lockheed Martin’s investments (private equity funds with 8–12 year terms, part of a broader portfolio), and FedEx’s specific accounting treatment — namely that adjustments are made only for observable price changes and impairments, and that impairments are immaterial both annually and cumulatively. (3) Entity and reasoning accuracy: While both companies are correctly identified and the reference to the NAV practical expedient is accurate, the LLM incorrectly frames the comparison as one of size, introducing unsupported numerical data for FedEx. This undermines the multi-hop reasoning, which should focus on differences in application and disclosure, not unsupported quantitative comparisons. (4) Semantic equivalence: The LLM answer diverges significantly in meaning — it reduces a nuanced accounting policy comparison to a misleading size comparison. The contextual relevance is moderate because it addresses the NAV expedient and names the correct companies, but the introduction of false data severely compromises correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 453,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How does the voting power dilution mechanism in CMCSA's Class B to Class A common stock conversion compare with GOOGL's dual-class structure, particularly in light of GOOGL's $62.0 billion share repurchase in 2024 targeting Class A and Class C shares?",
      "original_answer": "GOOGL's 2024 share repurchase of $62.0 billion focused on Class A and Class C shares, which could indirectly impact ownership concentration by reducing the number of shares outstanding, while maintaining the dual-class voting structure where Class B shares retain 10 votes per share. In contrast, CMCSA's Class B common stock is convertible share-for-share into Class A common stock and holds 33⅓% of the total voting power, which is non-dilutable under their articles of incorporation. This means CMCSA's Class B stock maintains a fixed voting influence regardless of conversions or new issuances, whereas GOOGL's repurchase strategy may influence the economic value of shares without altering the 10:1 voting rights disparity between Class B and Class A shares.",
      "llm_answer": "CMCSA’s Class B shares carry 15 votes each and are convertible, share‑for‑share, into Class A shares that have only one vote; each conversion therefore removes a high‑vote share and reduces the voting power of the remaining Class B holders (the 33.3 % aggregate voting power is protected only against new issuances, not against conversion)【page_91】. In Alphabet’s dual‑class system, Class B shares have ten votes while Class A and Class C have one and zero votes, respectively, and the 2024 $62 billion repurchase of Class A and Class C shares shrank the pool of low‑vote stock, concentrating voting power in the high‑vote Class B class rather than diluting it【page_82】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative and factual errors: The claim that CMCSA’s Class B shares carry '15 votes each' is incorrect — the ground truth states that CMCSA’s Class B stock holds 33⅓% of total voting power collectively, not per share, and there is no indication of 15 votes per share. This misrepresents the voting mechanism. Additionally, the LLM incorrectly implies that the 33.3% voting power protection applies only against new issuances and not conversions, contradicting the ground truth that CMCSA’s Class B voting power is 'non-dilutable under their articles of incorporation,' which includes protection regardless of conversions. (2) The description of GOOGL’s structure is mostly accurate: Class B shares do have 10 votes, Class A have 1, and Class C have 0, and the $62.0 billion 2024 repurchase of Class A and C shares is correctly cited. The interpretation that this concentrates voting power in Class B is logically sound and aligns with the ground truth. (3) Reasoning: The LLM attempts multi-hop synthesis by comparing dilution mechanisms and repurchase effects, but the flawed understanding of CMCSA’s voting structure undermines the comparison. The conclusion about GOOGL concentrating voting power is valid, but the contrast with CMCSA is based on incorrect premises. (4) Contextual relevance is high — the answer addresses both companies, their dual-class structures, conversion mechanics, and the impact of repurchases. However, due to core factual errors in voting rights and dilution protection, the correctness score is low despite relevant structure and partial accuracy on GOOGL.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 457,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How does the revenue exposure of CVS through its 50% ownership in Red Oak Sourcing, LLC—which negotiates generic pharmaceutical supply contracts with Cardinal Health, Inc., compare to LLY's reliance on Cardinal Health as a top-three distributor accounting for 15–20% of its consolidated revenue?",
      "original_answer": "CVS has a 50% ownership stake in Red Oak Sourcing, LLC, which serves as a joint venture with Cardinal Health, Inc. to negotiate generic pharmaceutical supply contracts for both companies, though Red Oak does not hold inventory. Meanwhile, LLY relies on Cardinal Health, Inc. as one of only three U.S. wholesale distributors each accounting for 15–20% of LLY’s consolidated revenue, alongside McKesson and AmerisourceBergen. This means Cardinal plays a dual role—both as a strategic sourcing partner to CVS via Red Oak and as a critical distribution channel for LLY’s pharmaceutical products in the U.S. market.",
      "llm_answer": "CVS’s 50 % stake in Red Oak Sourcing, LLC is a joint‑venture that merely negotiates generic‑drug contracts for CVS and Cardinal and holds no inventory, so the revenue exposure to CVS is limited and not material to its overall results (see CVS 10‑K p. 18). In contrast, Eli Lilly relies heavily on Cardinal Health as one of its three largest U.S. distributors, with Cardinal accounting for about 15 %–20 % of Lilly’s consolidated revenue (see LLY 10‑K p. 7).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: CVS has a 50% stake in Red Oak Sourcing, LLC, which negotiates generic drug contracts with Cardinal Health but holds no inventory. LLY (Eli Lilly) relies on Cardinal Health as one of its top three U.S. distributors, accounting for 15–20% of consolidated revenue. These figures match the original answer exactly, with acceptable formatting variations (e.g., '15 %–20 %' vs '15–20%'). (2) Quantitative accuracy is perfect—percentages and ownership stakes are correctly reported. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (CVS and LLY), their respective relationships with Cardinal Health, and the nature of those relationships (sourcing JV vs. distribution channel). (4) The only minor shortcoming is a slight omission of the explicit dual-role framing—i.e., that Cardinal plays a 'dual role' as both a sourcing partner to CVS and distributor for LLY—though this is implied in the contrast drawn. The addition of 10-K page references (p.18, p.7) enhances credibility and shows grounding in source material. Wording differs slightly but maintains semantic equivalence. Overall, the answer is factually complete, contextually relevant, and logically structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 367,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 171,
      "question": "What is the difference in voting rights per share between Class B common stock disclosed by UPS and the common stock voting rights at Honeywell as of 2024?",
      "original_answer": "UPS's Class B common stock has 10 votes per share, while Honeywell's common stock has 1 vote per share, resulting in a 9-vote difference per share in favor of UPS's Class B shares.",
      "llm_answer": "UPS’s Class B common stock is entitled to ten votes per share【page_82】, whereas Honeywell’s common stock carries one vote per share【page_96】. Thus, UPS’s Class B shares have nine more votes per share than Honeywell’s common shares.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual information is accurate: UPS Class B common stock has 10 votes per share, Honeywell common stock has 1 vote per share, and the difference is correctly calculated as 9 votes per share. (2) Quantitative accuracy is perfect—numbers match exactly, and the subtraction (10 - 1 = 9) is correct. (3) Multi-hop reasoning is sound: the model correctly synthesizes voting rights from two different companies (UPS and Honeywell) as required by the question, identifying the correct share classes and their respective voting rights. (4) The answer is contextually relevant, directly addressing the comparative voting rights difference in 2024 as specified. Minor wording differences (e.g., 'nine more votes' vs '9-vote difference') do not affect meaning and are semantically equivalent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1105,
        "completion_tokens": 254,
        "total_tokens": 1359
      },
      "error": null
    },
    {
      "question_id": 171,
      "question": "How does the maturity of AMGN's 3.625% 2024 Notes, which triggered the termination of $1.4 billion in associated interest rate swap contracts, compare with ABBV's use of interest rate swap contracts as cash flow hedges in 2024?",
      "original_answer": "AMGN's 3.625% 2024 Notes matured in 2024, which led to the termination of $1.4 billion in interest rate swap contracts that were hedging this fixed-rate debt. In contrast, ABBV did not have any active interest rate swap contracts designated as cash flow hedges in 2024, as the amount reported for that year was $0, compared to $6 million in 2022. This indicates a difference in hedging strategy between the two companies with respect to interest rate exposure on debt instruments.",
      "llm_answer": "Amgen’s 3.625 % senior notes were due in 2024, so when they matured the company terminated the related $1.4 billion of interest‑rate swap contracts that had been hedging those notes (AMGN 10‑K p. 148‑149). By contrast, AbbVie’s interest‑rate swap contracts were still being used as cash‑flow hedges in 2024 – they remained on the balance sheet and generated no material gain or loss, indicating the swaps were not terminated by a note maturity (AbbVie 10‑K p. 82).",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct but contains a critical factual error in the qualitative analysis that undermines the overall correctness. (1) Quantitatively, the numbers and dates are accurate: AMGN's 3.625% notes maturing in 2024 and the $1.4 billion in terminated swaps are correctly reported. However, the claim about ABBV is incorrect—while the LLM states that AbbVie's interest rate swaps were still being used as cash flow hedges in 2024, the ground truth explicitly states that ABBV had $0 in active interest rate swap contracts designated as cash flow hedges in 2024. This contradicts the LLM's assertion and represents a major factual error. (2) The quantitative accuracy is high because the numbers cited (3.625%, 2024, $1.4 billion) match the ground truth, and no calculations are required. (3) The multi-hop reasoning fails because the comparison between AMGN and ABBV is based on incorrect information about ABBV’s hedging activity. The model incorrectly infers continued use of swaps from the absence of material gain/loss, which does not imply active hedges—this misinterprets the accounting disclosure. (4) Contextual relevance is fair because the answer addresses the right companies, time frame, and financial instruments, but the erroneous conclusion about ABBV’s 2024 hedge activity significantly reduces its accuracy. The core contrast in hedging strategies is misrepresented, which is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 395,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 171,
      "question": "How did the adoption of ASU 2022-02 impact Capital One's reporting of financial difficulty modifications compared to JPMorgan's prior TDR disclosures, particularly in terms of modification types and their financial effects?",
      "original_answer": "The adoption of ASU 2022-02 eliminated the TDR framework and introduced FDMs, changing how Capital One reports loan modifications. Capital One noted that the types of modifications offered—such as interest rate reductions, term extensions, and principal reductions—remained the same, but they are now categorized and reported differently under FDMs. For JPMorgan, prior to the change, TDRs included similar modifications but were assessed under concession criteria. After the adoption, JPMorgan reported $136 million in FDMs for 2023, primarily involving term extensions and interest rate reductions that extended loan lives by 20 years and reduced the weighted-average rate from 7.21% to 4.44%. This shift reflects a more standardized reporting approach under ASU 2022-02, removing the previous TDR distinctions while maintaining the same types of borrower support.",
      "llm_answer": "The adoption of ASU 2022‑02 forced Capital One to drop the “concession” test and to report every qualifying change as a Financial‑Difficulty Modification (FDM).  Capital One now breaks out the dollar amount of each modification type (interest‑rate cuts, term extensions, principal reductions, etc.) and quantifies the aggregate impact – $136 million of FDMs in 2023 lengthened the weighted‑average loan life by about 20 years and cut the average contractual rate from 7.21 % to 4.44 % – whereas JPMorgan’s pre‑ASU TDR disclosures presented concessions as percentages of loans and showed financial effects such as a drop in weighted‑average interest rate from 4.75 % to 3.35 %, term extensions from 22 to 38 years, modest charge‑offs, principal deferrals/forgiveness and re‑default balances.  In short, Capital One’s new reporting shifts from percentage‑based concession metrics to dollar‑level FDM totals and highlights timing/cash‑flow impacts, while JPMorgan’s older TDR disclosures focused on concession rates and specific loss‑related effects.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. While it correctly identifies the shift from TDRs to FDMs due to ASU 2022-02 and notes that both Capital One and JPMorgan report similar modification types (interest rate reductions, term extensions, etc.), it misattributes key financial figures. The $136 million in FDMs, 20-year extension of loan life, and rate reduction from 7.21% to 4.44% are attributed to JPMorgan in the ground truth for 2023, but the LLM incorrectly assigns these numbers to Capital One. Additionally, the LLM fabricates data about JPMorgan’s prior TDR disclosures—such as a rate drop from 4.75% to 3.35%, term extensions from 22 to 38 years, and mentions of charge-offs and re-default balances—which are not present in the original answer and cannot be verified. The qualitative reasoning about the change in reporting (from concession-based TDRs to FDMs without the concession test) is sound and contextually relevant, showing understanding of the accounting change. However, the incorrect attribution of financial effects between the two banks and the inclusion of unsupported specifics severely undermine factual correctness. The answer also incorrectly implies that Capital One reported $136 million in FDMs, while the original answer states this figure for JPMorgan. Thus, despite correct conceptual framing, the answer fails on core quantitative accuracy and entity-specific details, resulting in a partial score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 409,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How does the alignment of interest rate swap maturities with debt exposure differ between GD's hedging strategy and UPS's economic hedge approach, and what does this reveal about their respective risk management priorities?",
      "original_answer": "GD's hedging strategy involves interest rate swap contracts with a dollar-weighted two-year average maturity that generally matches the duration of the activities at risk, indicating a focus on closely aligning hedge instruments with underlying exposure timelines. In contrast, UPS uses interest rate swaps as economic hedges for portions of its outstanding debt but does not specify a maturity alignment, instead emphasizing the use of offsetting positions to terminate existing swaps and eliminate market valuation effects. This reveals that GD prioritizes duration-matching to manage interest rate risk over time, while UPS focuses on dynamic risk mitigation through offsetting transactions, reflecting different approaches to managing financial exposure.",
      "llm_answer": "GD’s swaps are “duration‑matched” – the company notes that the dollar‑weighted average maturity of its interest‑rate swap contracts is set to line up with the maturity of the underlying debt, so the hedge mirrors the specific borrowing exposure (GD 10‑K p. 82). UPS, by contrast, uses an “economic hedge” in which the notional of its interest‑rate swaps is chosen to offset the company’s net interest‑expense rather than to match each debt instrument’s term (UPS 10‑K p. 136; see the cash‑flow‑hedge reclassifications for interest‑rate contracts on p. 137). Thus GD prioritizes precise matching of hedge to individual debt to eliminate interest‑rate risk on those borrowings, while UPS prioritizes smoothing overall earnings and cash‑flow volatility by hedging the aggregate cost of capital.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies GD's duration-matching strategy, citing the dollar-weighted average maturity alignment with underlying debt, consistent with the original answer's 'dollar-weighted two-year average maturity that generally matches the duration of the activities at risk.' While the LLM does not explicitly mention 'two-year,' this detail is minor and does not affect the core correctness, as 'duration-matched' captures the essence. (2) For UPS, the LLM accurately characterizes the use of interest rate swaps as economic hedges focused on offsetting net interest expense rather than maturity matching, which aligns with the original answer's point about UPS not specifying maturity alignment and instead using offsetting positions. The reference to 'eliminate market valuation effects' in the ground truth is implicitly captured in the LLM’s emphasis on smoothing earnings and cash-flow volatility. (3) The multi-hop reasoning is sound: the model correctly synthesizes contrasting strategies from two companies’ 10-K disclosures and infers their differing risk management priorities—GD focusing on precise risk elimination via matching, UPS on aggregate financial stability. (4) All entities (GD, UPS, interest rate swaps, debt exposure) and financial concepts (duration matching, economic hedge, notional alignment) are correctly identified and contrasted. The only minor gap is the absence of explicit mention of 'offsetting positions to terminate existing swaps' from UPS’s approach, but the broader intent—managing overall cost of capital and volatility—is accurately conveyed. Wording differs but semantic meaning is equivalent. Quantitative accuracy is perfect—no numerical errors. Contextual relevance is excellent, directly addressing all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 499,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How might Alphabet's share repurchase activity in 2023, which focused on Class A and Class C shares, impact the relative voting power of its undiluted Class B shares, and how does this compare to the non-dilutable 33 1/3% voting power structure of Class B shares at Comcast?",
      "original_answer": "Alphabet's 2023 share repurchase of $62.2 billion in Class A and Class C shares likely increased the relative voting power of its undiluted Class B shares, which are held by insiders and carry 10 votes per share. This mirrors the structure at Comcast, where Class B shares, held entirely by Brian L. Roberts, maintain a non-dilutable 33 1/3% of combined voting power despite having 15 votes per share. Both companies use dual-class structures to protect long-term strategic control, but Alphabet's repurchase activity may have amplified the concentration of voting power further by reducing the number of publicly traded shares.",
      "llm_answer": "Alphabet’s 2023 repurchase program removed 78 million Class A shares (one vote each) and 450 million Class C shares (no votes) – a total of 528 million shares – which shrinks the pool of voting shares and therefore raises the proportion of total votes held by its undiluted Class B shares (each with ten votes). By contrast, Comcast’s charter fixes its single Class B share at a non‑dilutable one‑third of the voting power (33 ⅓ %), so its voting influence remains constant regardless of any Class A repurchases. (Alphabet: p. 81; Comcast: p. 33)",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the mechanism by which Alphabet's share repurchases increase the relative voting power of Class B shares—by reducing the total pool of voting shares (Class A) and non-voting shares (Class C), thereby increasing the proportion of votes held by Class B. It also correctly contrasts this with Comcast's fixed 33 1/3% non-dilutable voting power for Class B shares. However, there are significant quantitative inaccuracies: the ground truth states Alphabet repurchased $62.2 billion in shares in 2023, but the LLM claims 78 million Class A and 450 million Class C shares were repurchased—specific figures not present in the original answer and unsupported by the knowledge graph. There is no verification that these exact share counts are accurate, and the dollar amount ($62.2B) is omitted entirely, which is a key factual element. The LLM introduces precise share counts without sourcing them from the provided truth, risking fabrication. While the reasoning about voting power concentration is sound and the comparison to Comcast is conceptually accurate, the inclusion of unsourced quantitative details reduces factual reliability. The answer is contextually relevant and addresses all parts of the question, but the numerical claims cannot be verified and diverge from the ground truth, which only specifies the dollar amount of repurchases, not share counts.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 385,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How does the structure of Robert Iger's Rule 10b5-1 trading plan at DIS, including the number of shares and termination date, compare to Peggy Alford's plan at META, given both are governed by the same regulatory framework?",
      "original_answer": "Robert Iger's trading plan at DIS involves the potential sale of up to 372,412 shares of Disney common stock, with a termination date of December 17, 2024. Peggy Alford's plan at META provides for the sale of up to $1.2 million worth of META Class A common stock, with a termination date of November 15, 2025. Both plans were adopted under Rule 10b5-1(c), which provides an affirmative defense for insider trading activities conducted under a prearranged plan. The comparison shows that while Iger's plan focuses on a fixed number of shares tied to expiring options, Alford’s plan is value-based and has a longer duration.",
      "llm_answer": "Robert Iger’s Disney Rule 10b5‑1 plan authorizes the sale of up to **372,412 shares** of Disney common stock and is slated to **terminate on December 17 2024** (subject to early termination)【page_61】. Peggy Alford’s Meta Rule 10b5‑1 plan, by contrast, permits the sale of **up to $1.2 million worth of Class A shares** (no specific share count disclosed) and will **terminate on November 15 2025** (subject to early termination)【page_124】. Both plans are structured under the same Rule 10b5‑1 affirmative‑defense framework, but Iger’s is share‑quantity‑based with an earlier end date, while Alford’s is dollar‑value‑based with a later end date.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitative accuracy: The number of shares (372,412) for Robert Iger at DIS and the dollar amount ($1.2 million) for Peggy Alford at META are correctly reported. Termination dates (December 17, 2024, for Iger; November 15, 2025, for Alford) are accurate. The format variations (e.g., $1.2 million vs $1.2M) are acceptable and semantically equivalent. (2) Completeness: The answer addresses all parts of the question—structure (share-based vs value-based), number of shares, termination dates, and the fact that both plans operate under Rule 10b5-1. (3) Entity accuracy: Companies (DIS/Disney and META/Meta), individuals (Iger and Alford), and regulatory framework (Rule 10b5-1) are correctly identified. (4) Reasoning: The multi-hop comparison is sound—correctly contrasting Iger’s fixed-share plan tied to option expirations (implied from context) with Alford’s value-based, longer-duration plan. The synthesis across two executives, firms, and plan structures is accurate and logically presented. (5) Semantic equivalence: Though phrased more concisely, the LLM conveys all key information from the original answer, including the regulatory basis, structural differences, and timing. No factual omissions or distortions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 363,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How does the vesting timeline for equity awards at CL compare with PM's RSU vesting schedule, and what does this imply about the timing of compensation expense recognition for each company?",
      "original_answer": "CL issues stock options that generally vest ratably over three years, with a contractual term of eight years post-2019. In contrast, PM grants RSU awards that typically vest on the third anniversary of the grant date. For CL, this means compensation expense is recognized evenly over the three-year vesting period. For PM, the fair value of RSU awards is amortized to expense over the restriction period, which is typically three years after the award date, or earlier upon death, disability, or reaching age 58. As of December 31, 2023, PM had $160 million of total unrecognized compensation costs related to non-vested RSUs, expected to be recognized over a weighted-average period of approximately seventeen months. This indicates that while both companies align on a three-year vesting horizon, PM's structure allows for more accelerated expense recognition based on specific triggering events.",
      "llm_answer": "Colgate‑Palmolive’s equity awards are time‑vested restricted‑stock units that “generally vest at the end of the restriction period, which is generally three years from the date of grant, or ratably over the restriction period” (​page 98​), and the company says the $60 million of unrecognized compensation expense for those unvested RSUs “will be recognized over a weighted‑average period of 1.6 years” (​page 98​). Philip Morris International’s RSUs “generally vest on the third anniversary of the grant date” (​page 110​), and the $160 million of unrecognized RSU compensation “is expected to be recognized over a weighted‑average period of approximately seventeen months” (​page 110​). Thus, both firms use a three‑year vesting horizon, but CL spreads expense ratably (≈1.6 years) while PMI’s expense is recognized slightly faster (≈17 months) after the grant.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly impact correctness. First, it incorrectly states that Colgate-Palmolive (CL) issues restricted stock units (RSUs), while the ground truth specifies that CL issues stock options that vest ratably over three years. This is a critical error in entity and instrument type. Second, the LLM claims CL has $60 million in unrecognized compensation expense to be recognized over 1.6 years, but this figure does not appear in the original answer and contradicts the ground truth, which does not provide CL's unrecognized cost or weighted-average period. The $60M and 1.6-year figures are fabricated or misattributed. In contrast, the information about Philip Morris International (PM) is mostly accurate: PM’s RSUs vest on the third anniversary, and the $160 million of unrecognized compensation expense to be recognized over approximately seventeen months matches the original answer. The conclusion that both companies have a three-year vesting horizon is correct, but the claim that CL spreads expense ratably (≈1.6 years) while PM’s is slightly faster (≈17 months) is flawed because the 1.6-year figure for CL is unsupported. Additionally, the original answer notes PM allows accelerated expense recognition upon death, disability, or age 58—key qualitative information entirely missing in the LLM response. While the LLM correctly identifies the three-year vesting framework and compares expense recognition timing, it fails on key multi-hop elements: misidentifying CL’s equity instrument, inventing financial figures, and omitting PM’s early vesting triggers. These errors undermine the reasoning and factual basis. Contextual relevance is high as the structure and intent align with the question, but quantitative and qualitative accuracy are compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 492,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How do regulatory restrictions on product differentiation, such as flavor bans and standardized packaging, impact the ability of both PM and MO to maintain brand equity and pricing power in key international and U.S. markets?",
      "original_answer": "Regulatory restrictions on product differentiation, such as flavor bans and standardized packaging, significantly impair both PM and MO's ability to maintain brand equity and pricing power. PM faces specific risks from the EU's ban on characterizing flavors in cigarettes and roll-your-own tobacco, menthol bans in Turkey and Brazil, and potential future restrictions on slim cigarettes and flavor capsules. These limitations reduce PM’s ability to differentiate products, especially in international markets where they estimate illicit trade accounts for 8% of EU cigarette consumption, further eroding legitimate brand value and pricing control. Similarly, MO faces flavor bans in six U.S. states and the District of Columbia, including California’s broad restriction on menthol, mint, and wintergreen, which is currently delayed due to a referendum. These bans, along with proposed nicotine caps in Massachusetts, constrain MO’s ability to market differentiated products and maintain premium pricing. Both companies are also restricted in advertising and branding through global FCTC guidelines and domestic regulations like the State Settlement Agreements, which prohibit youth-targeted marketing and outdoor advertising, further limiting brand equity development and pricing flexibility.",
      "llm_answer": "Both companies say that regulatory rules that strip away flavor options and force “plain” or standardized packs blunt the tools they use to set premium brands apart, which weakens brand equity and squeezes pricing power. Philip Morris notes that EU‑wide flavor bans (including menthol) and plain‑packaging laws in markets such as Australia, France, Saudi Arabia and Turkey limit branding and could drive down‑trading and pressure premium prices (PM p.41‑42, p.16). Altria likewise points out that U.S. and international bans on characterizing flavors, packaging restrictions and advertising limits curtail brand communication, push consumers toward lower‑priced or illicit alternatives and erode the ability to command premium pricing (MO p.40‑42).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically aligned with the ground truth, with strong contextual relevance and no numerical errors. (1) Quantitative Accuracy: There are no explicit numbers (percentages, dollar amounts, dates) in either the original or LLM answer that conflict; the LLM does not introduce any incorrect figures and avoids making claims about specific values like the 8% EU illicit trade figure, which is acceptable as omission rather than inaccuracy. (2) Completeness: The LLM captures the core impact of flavor bans and standardized packaging on brand equity and pricing power for both PM and MO. However, it omits some specific details present in the original: PM’s market-specific restrictions in Turkey, Brazil, and potential rules on slim cigarettes and flavor capsules; MO’s state-level bans in six U.S. states plus D.C., and the proposed nicotine cap in Massachusetts. It also omits mention of FCTC guidelines and State Settlement Agreements that restrict advertising. (3) Entity Accuracy: All named entities (PM, MO, EU, Australia, France, Saudi Arabia, Turkey, California) are correct and appropriately attributed. References to document page numbers (e.g., PM p.41-42) suggest source fidelity, though not required for truthfulness. (4) Reasoning: The multi-hop synthesis is sound—linking regulatory restrictions to weakened differentiation, then to brand equity and pricing power—for both companies across international and U.S. markets. The logic chain is preserved even if some supporting evidence is condensed. (5) Semantic Equivalence: The LLM conveys the same central thesis: regulatory constraints on flavors and packaging reduce branding tools, weaken premium positioning, and increase risks of downtrading and illicit competition. Wording differs but meaning aligns. The score is reduced slightly (from 9–10 to 8) due to moderate omissions of specific regulatory examples and mechanisms that add depth to the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1529,
        "completion_tokens": 529,
        "total_tokens": 2058
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How does AIG's exposure to structured securities containing RMBS, as measured by their accounting treatment for credit losses and yield adjustments, compare to BAC's valuation risks associated with RMBS holdings under fluctuating prepayment speeds and default rates?",
      "original_answer": "AIG accounts for structured securities, including RMBS, by recalculating effective yields based on actual payments and updated prepayment expectations, adjusting amortized cost accordingly with a corresponding impact on net investment income. For non-high credit quality structured securities, AIG bases yields on expected cash flows that factor in credit losses and prepayments, and recognizes changes in expected cash flows through an allowance for credit losses. Meanwhile, BAC notes that a significant increase in default rates or loss severities would materially lower the fair value of RMBS long positions, while changes in prepayment speeds would have differential impacts depending on instrument seniority. This shows that while AIG focuses on yield and credit loss adjustments tied to expected cash flows, BAC emphasizes sensitivity to default and prepayment volatility in RMBS valuation.",
      "llm_answer": "AIG’s RMBS exposure is reflected on its balance sheet by a modest allowance for credit losses – $35 million on a $20.9 billion RMBS portfolio – and by “prospective” yield adjustments that are updated as expected cash‑flows (including credit losses and pre‑payment expectations) change (AIG 10‑K p. 169). In contrast, Bank of America’s RMBS holdings are valued under Level 3 fair‑value models where the key sources of valuation risk are unobservable inputs such as pre‑payment speed (modeled anywhere from 1 % to 42 % CPR) and default rates (up to 3 % CDR), making the fair‑value of its RMBS far more sensitive to shifts in those assumptions (BAC 10‑K p. 159‑161).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly captures AIG's accounting treatment for RMBS, emphasizing prospective yield adjustments based on expected cash flows, including credit losses and prepayment expectations, and references the allowance for credit losses. It also accurately describes BAC's use of Level 3 fair-value models where prepayment speeds (CPR) and default rates (CDR) are key unobservable inputs affecting valuation. (2) Quantitatively, the LLM provides specific figures: a $35 million allowance on a $20.9 billion RMBS portfolio for AIG, and for BAC, prepayment speeds modeled from 1% to 42% CPR and default rates up to 3% CDR. These numbers are plausible and consistent with typical 10-K disclosures (e.g., BAC’s 2022 10-K does report CPR ranges and CDR assumptions in its Level 3 sensitivity), though the exact pages cited (p.159–161, p.169) cannot be independently verified here but are contextually reasonable. No calculation errors are present. (3) The multi-hop reasoning is sound: the model correctly synthesizes AIG’s amortized cost and yield adjustment approach with BAC’s fair-value sensitivity, contrasting their differing risk exposures—AIG to cash flow and credit loss revisions, BAC to assumption volatility in Level 3 models. (4) The answer is semantically equivalent to the ground truth, adding useful quantitative detail not in the original (e.g., portfolio size, allowance amount, CPR/CDR ranges), enhancing precision without introducing error. The only reason for not scoring a 10 is the addition of specific numerical ranges and dollar amounts not present in the ground truth; while plausible and consistent, they go beyond the provided knowledge graph and could be seen as over-specific if not explicitly confirmed. However, since they do not contradict and improve clarity, a score of 9 is justified.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 508,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does Broadcom's valuation methodology for its developed technology in cybersecurity, which includes cloud security solutions, compare to Cisco's revenue recognition approach for its Cloud Security product category?",
      "original_answer": "Broadcom valued its developed technology in cybersecurity, including cloud security solutions, using the multiperiod excess earnings method under the income approach, which considers the present value of projected cash flows less charges for contributions from other assets. The economic useful life was determined based on the technology cycle and forecast cash flows. In contrast, Cisco recognizes revenue for its Cloud Security product ratably over the contract term as a single distinct performance obligation satisfied over time, particularly for SaaS arrangements. This highlights a difference in financial treatment—Broadcom focused on asset valuation through projected earnings, while Cisco emphasizes revenue recognition aligned with service delivery timelines.",
      "llm_answer": "Broadcom does not “recognize” the cyber‑security technology as revenue; it treats the developed technology (including cloud‑security solutions) as an intangible asset and values it with the **multiperiod excess‑earnings method** – a discounted‑cash‑flow income approach that estimates the present value of the future cash flows the technology will generate over its useful life【page_98】.  \n\nCisco, on the other hand, applies ASC 606 to its **Cloud Security** offerings (part of the End‑to‑End Security category), treating hardware and perpetual‑software as distinct performance obligations recognized up‑front, while term‑software licenses and SaaS are recognized **ratably over the contract term** as the service is delivered【page_75】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies Broadcom's use of the multiperiod excess earnings method for valuing developed cybersecurity technology, including cloud security, under the income approach, focusing on discounted future cash flows and useful life—matching the original answer. It also accurately describes Cisco's revenue recognition for Cloud Security: ratable recognition over the contract term for SaaS and term licenses under ASC 606, distinguishing them from upfront recognition for perpetual software and hardware. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes Broadcom’s asset valuation methodology (from its 10-K or similar) with Cisco’s revenue recognition policy (from its filing), comparing two different financial treatments across companies and contexts. The only minor shortcoming is that the original answer explicitly frames the contrast as 'asset valuation vs. revenue recognition,' while the LLM implies it but could make the conceptual distinction slightly more explicit. However, the substance is fully correct. (4) Contextual relevance is perfect—the response directly addresses the comparison asked, with precise, on-topic details from both companies’ financial reporting practices. Minor deduction in qualitative accuracy only for slightly less explicit framing of the conceptual contrast, but all facts and reasoning are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 440,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does the voting power disparity between Class A and Class B common stock at META compare to GOOGL's dual-class structure, particularly in relation to the number of shares outstanding and the potential influence of high-vote shares on corporate governance decisions?",
      "original_answer": "At META, Class A common stock has 2,189,898,148 shares outstanding with one vote per share, while Class B common stock has 343,761,117 shares outstanding, each with voting rights only in specified circumstances and tied to the conversion rate. This creates a concentrated voting structure where Class B shares can exert significant influence during specific corporate events. Similarly, GOOGL's Class B common stock has 10 votes per share, giving disproportionate voting power to holders of this class, although the rights of Class A and Class B are otherwise identical. Both companies use dual-class structures to maintain control with certain stakeholders, but META's Class B shares only gain enhanced voting rights under defined conditions, whereas GOOGL's Class B shares have consistently higher voting power. This difference affects how corporate governance decisions are influenced at each company.",
      "llm_answer": "Meta’s capital structure includes 2,189,898,148 Class A shares (one vote each) and 343,761,117 Class B shares (ten votes each) outstanding【page_1】—the B‑shares represent only about 14 % of the equity but command roughly 60 % of the total voting power (≈3.44 billion votes vs 2.19 billion from A‑shares). Alphabet’s dual‑class system gives its publicly‑traded Class A shares one vote and its Class C shares no votes, while a small, insider‑controlled pool of non‑traded Class B shares (ten votes each) holds the majority of voting rights【page_82】; the bulk of equity is represented by hundreds of millions of Class A and C shares (e.g., 73 million Class A and 306 million Class C shares repurchased in 2024)【page_82】. In both firms a minority of high‑vote shares wields disproportionate influence over corporate governance, but Meta’s high‑vote shares are publicly tradable, whereas Google’s are privately held.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual errors, particularly regarding the voting rights of META's Class B shares. According to the ground truth, META's Class B shares do not have ten votes per share but instead have voting rights only in specified circumstances and are tied to a conversion rate—this is a critical misrepresentation. The claim that Class B shares command ~60% of voting power is unsupported by the original answer and based on an incorrect assumption of 10 votes per share. For GOOGL, the LLM incorrectly refers to Class C shares (non-voting) and describes share repurchases (e.g., 73 million Class A and 306 million Class C repurchased in 2024), which are not mentioned in the original answer and appear fabricated or misattributed. (2) Quantitative inaccuracies include: (a) assigning 10 votes to META Class B shares (false), (b) calculating total votes (~3.44 billion from B-shares) based on this false premise, (c) introducing specific repurchase figures for GOOGL with no basis in the original answer. While the Class A share count for META (2,189,898,148) is correct, the Class B share count (343,761,117) is misinterpreted due to incorrect voting weight. (3) The multi-hop reasoning is partially sound in intent—comparing dual-class structures and influence on governance—but fails due to incorrect data synthesis. The observation that a minority of high-vote shares controls governance is valid, but the conclusion that Meta’s high-vote shares are publicly tradable (vs Google’s privately held) goes beyond the original answer and introduces unverified claims. (4) Contextual relevance is strong—the question is addressed directly with comparative analysis—but correctness is severely undermined by factual and quantitative errors. The core distinction in the original answer—that META’s Class B voting power is conditional while GOOGL’s is consistently higher—is entirely missed. Thus, while the structure and intent are appropriate, the factual foundation is flawed, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 545,
        "total_tokens": 2029
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does Coca-Cola FEMSA's bottling operations in Argentina impact both KO's net sales to equity method investees and CL's organic sales growth in Latin America, considering KO's contractual pricing model with its bottlers?",
      "original_answer": "Coca-Cola FEMSA's operations in Argentina contribute to KO's $14,471 million in net sales to equity method investees in 2021 through the incidence-based concentrate pricing model, where bottler pricing and package mix directly affect the concentrate prices charged by KO. As Coca-Cola FEMSA bottles in Argentina (federal capital of Buenos Aires and surrounding areas), this relationship supports KO's financial dependency on equity method investees. Meanwhile, CL reported a 7.0% net sales increase in Latin America in 2021, with Argentina being one of the key growth drivers. Specifically, CL's Oral Care, Personal Care, and Home Care segments in Argentina benefited from favorable market conditions that also likely supported Coca-Cola FEMSA's operations, creating parallel growth effects across both companies' financial performance in the region.",
      "llm_answer": "Coca‑Cola FEMSA’s bottling and distribution network in Argentina is part of KO’s equity‑method investees; the concentrates it buys under KO’s incidence‑based pricing model feed into the $14.5 billion of net sales to equity‑method investees reported for 2021 (up from $13.0 billion in 2020)【page_89】. Those Argentine operations also helped lift Colgate‑Palmolive’s Latin‑America segment, which posted an 8 % organic‑sales increase in 2021, led by Brazil, Mexico, Argentina and Colombia【page_40】—showing that KO’s contract pricing with its bottlers boosts both KO’s equity‑method revenue and CL’s organic growth in the region.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but has key factual inaccuracies. It correctly identifies Coca-Cola FEMSA as part of KO's equity-method investees and links its operations in Argentina to KO's net sales to those investees. It also correctly references the incidence-based pricing model. However, it misstates the net sales figure: the LLM says $14.5 billion (and references an increase from $13.0 billion in 2020), while the ground truth specifies $14,471 million (i.e., $14.471 billion) in 2021 — a close but not exact match. More critically, the LLM incorrectly states that Colgate-Palmolive (CL) reported an 8% organic sales increase in Latin America in 2021, while the ground truth reports 7.0%. This is a significant quantitative error. (2) The dollar amount is approximately correct but not precise; the 2020 comparison is not in the ground truth and thus unsupported. The 8% vs 7.0% discrepancy in CL’s organic growth is a clear error. (3) The multi-hop reasoning is partially sound: the model correctly connects KO’s pricing model with its equity-method revenue and attempts to link regional bottling activity to CL’s regional performance. However, the reasoning falters in asserting that KO’s contract pricing 'boosts' CL’s organic growth — the original answer notes parallel growth effects due to favorable market conditions in Argentina, not a causal link from KO’s pricing to CL’s performance. The LLM overstates the connection. (4) The contextual relevance is high as it addresses both KO and CL in the Latin American context and attempts the required synthesis. Qualitative accuracy is moderate due to correct entity identification and logical structure, but weakened by flawed reasoning. Quantitative accuracy is low due to incorrect percentages and unsupported year-over-year data. Correctness score is 6 due to mostly correct framework but significant factual errors in key metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 521,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does Abbott's investment in private equity funds, which are valued using NAV as a practical expedient, compare to Merck's use of NAV for measuring similar alternative investments, considering the typical redemption restrictions associated with these fund types?",
      "original_answer": "Abbott holds investments in private equity funds valued at NAV, with $555 million in unfunded commitments as of December 31, 2023, and these funds cannot be redeemed but will make distributions through liquidation over periods ranging from 2024 to 2033. These private equity funds are subject to NAV valuation practices consistent with those described in UPS's 10-K, where private equity funds typically have redemption restrictions until the end of the partnership term (10–15 years) and are valued at NAV adjusted for known cash flows. Merck similarly discloses NAV-based valuations for alternative investments, reporting $382 million in NAV-based assets in 2023, including private real estate and equity funds. Both companies rely on NAV as a practical expedient for illiquid alternative investments, but Abbott faces longer liquidation timelines and greater unfunded commitments compared to Merck's disclosed NAV-based portfolio.",
      "llm_answer": "Abbott values its private‑equity, private‑debt and real‑estate partnership interests at the most recent audited NAV (adjusted for cash‑flow activity) and explicitly notes that these interests are essentially illiquid – they cannot be redeemed until the partnership’s term ends (typically 10‑15 years) and are only exited via secondary‑market sales or eventual liquidation distributions【page_71†L1-L9】【page_89†L14-L22】. Merck also relies on a NAV practical‑expedient to measure its alternative‑investment holdings, but the excerpts provided (pages 108‑112) contain no specific discussion of redemption limits, suggesting that Merck’s approach is similarly based on NAV for illiquid funds, though the exact lock‑up terms are not disclosed.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that both Abbott and Merck use NAV as a practical expedient to value alternative investments and notes the illiquidity and typical 10–15 year redemption restrictions associated with private equity funds, citing Abbott's disclosures accurately regarding lack of redemption and exit via liquidation. However, it fails to include key quantitative data from the ground truth: Abbott's $555 million in unfunded commitments and Merck's $382 million in NAV-based assets as of 2023. These figures are central to the comparative aspect of the question and their omission significantly undermines the answer's completeness and quantitative accuracy. Additionally, while the LLM correctly infers that Merck does not disclose specific redemption terms, it misses the ground truth point that Abbott faces longer liquidation timelines (through 2033) and greater unfunded commitments compared to Merck—this comparative insight is a core part of the original answer and represents a multi-hop synthesis that the LLM fails to deliver. The reasoning is sound where present, and the contextual relevance is high, but the absence of specific numbers and the resulting weakened comparison reduces the correctness score. Semantic equivalence is partially met, but missing financial figures and comparative analysis prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 374,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does BlackRock's management of Separate Account Assets, which are legally segregated and not subject to general creditor claims, impact AIG's reporting of equal and offsetting Separate Account Liabilities tied directly to contract holder account balances?",
      "original_answer": "BlackRock discloses that its Separate Account Assets, which include equity securities, debt securities, money market funds, and derivatives, are legally segregated and not subject to general claims of creditors. These assets are held to fund individual and group pension contracts and are offset by equal and offsetting liabilities on BlackRock’s consolidated statements of financial condition. AIG reports Separate Account Liabilities that directly reflect the contract holder's account balance in these assets, and they are required to be equal and offsetting to the total Separate Account Assets. Therefore, any changes in the valuation or composition of BlackRock's Separate Account Assets would directly influence AIG’s liability reporting, as AIG must mirror these asset values in its liabilities to reflect the contract holders' beneficial interest.",
      "llm_answer": "BlackRock’s separate‑account assets are held in a legally segregated “BlackRock Life” entity and are expressly excluded from the claims of BlackRock’s general creditors, so they are recorded on BlackRock’s balance sheet together with an equal and offsetting liability (BlackRock 10‑K, p. 80). Because those assets are protected, AIG can present its separate‑account liabilities as the contract‑holder balances that are exactly equal to the underlying assets, resulting in offsetting separate‑account assets and liabilities on AIG’s balance sheet (AIG 10‑K, p. 232).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and conveys the core relationship between BlackRock's separate account assets and AIG's reporting of offsetting liabilities. (1) It correctly states that BlackRock’s separate account assets are legally segregated and not subject to general creditor claims, and that they are recorded with equal and offsetting liabilities on BlackRock’s balance sheet—this aligns with the ground truth. It also accurately notes that AIG reports separate account liabilities equal to contract holder balances, which mirror the asset values. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer, so quantitative accuracy is not compromised—score of 10 is justified. (3) The multi-hop reasoning is sound: the LLM connects BlackRock’s asset treatment to AIG’s liability reporting, recognizing the mirroring effect. However, it introduces a potentially inaccurate detail—'BlackRock Life'—which is not mentioned in the ground truth and may be fabricated or misattributed (no evidence that BlackRock uses a legal entity by that name for this purpose). This minor factual overreach reduces qualitative accuracy slightly. (4) The answer remains highly contextually relevant, directly addressing the impact of BlackRock’s asset treatment on AIG’s liability reporting. Despite the minor entity inaccuracy, the core logic and factual framework are correct, warranting a correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 400,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How does AbbVie's revenue recognition for Imbruvica sales in the U.S. reflect its cost-sharing arrangement with Janssen Biotech, and how does this compare to Johnson & Johnson's global commercialization strategy for the same drug?",
      "original_answer": "AbbVie recognizes 100% of Imbruvica sales in the U.S. as net revenue, while Janssen's share of profits is deducted as part of cost of products sold, indicating a co-exclusive commercialization model where AbbVie acts as the principal. Both companies share pre-tax profits and losses equally, with Janssen covering approximately 60% of development costs and AbbVie 40%. Meanwhile, Johnson & Johnson, through its subsidiary Janssen, holds exclusive rights to commercialize Imbruvica outside the U.S. and also shares pre-tax profits equally with AbbVie. This global division of commercial rights and cost-sharing creates a dual-market strategy where Janssen leverages its international infrastructure to drive global expansion of Imbruvica, while AbbVie leads in the domestic market.",
      "llm_answer": "AbbVie records all U.S. Imbruvica sales in its net‑revenue line, but the portion of profit that belongs to Janssen is booked as a cost of products sold – a direct result of the 60 %/40 % development‑cost split and the agreement to share pre‑tax profits equally (see AbbVie Note 6, page 68). By contrast, Johnson & Johnson’s Janssen unit holds the exclusive license to sell Imbruvica outside the United States and co‑exclusive rights in the U.S., and the drug is listed as a global product in J&J’s Innovative Medicine portfolio, reflecting a worldwide commercialization strategy (see J&J product list, page 8).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the 60%/40% development cost split (Janssen 60%, AbbVie 40%) and equal pre-tax profit sharing are accurately reported. There are no calculation errors. (2) The LLM correctly identifies that AbbVie recognizes 100% of U.S. sales as net revenue, with Janssen's profit share deducted in cost of products sold—this reflects proper understanding of revenue recognition under the co-exclusive model. It also correctly states Janssen’s exclusive rights outside the U.S. and co-exclusive role within it. (3) The multi-hop reasoning is sound: the answer synthesizes information about AbbVie’s financial reporting practices and J&J’s global commercialization strategy, linking them to the shared drug development and profit structure. (4) Minor omission: the original answer notes that Janssen covers ~60% of development costs while AbbVie covers ~40%, which the LLM mentions, but does not explicitly tie this cost imbalance to the equal profit split as a strategic nuance. Also, the LLM references 'Note 6, page 68' and 'J&J product list, page 8'—while plausible, these specific citations aren't part of the ground truth and slightly overreach, though they don't detract from factual accuracy. Overall, the answer is semantically equivalent and contextually precise, with only minor depth differences from the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 394,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How might a prolonged geopolitical conflict involving Taiwan impact both NVIDIA's supply chain execution and Apple's manufacturing operations, considering NVIDIA's dependency on foundry partners in Taiwan and Apple's reliance on manufacturing in the region?",
      "original_answer": "A prolonged geopolitical conflict involving Taiwan could severely disrupt NVIDIA's supply chain execution due to its dependency on foundry partners in the region, particularly for advanced GPU manufacturing. This could lead to production delays, inventory shortages, and an inability to meet customer demand, which NVIDIA has previously warned could damage customer relationships and reduce revenue. Similarly, Apple relies heavily on manufacturing operations in Taiwan, as part of its broader supply chain concentrated in the region. A disruption in Taiwan would likely delay product manufacturing and delivery, increase costs, and potentially force Apple to restructure its supply chain, which it has noted could be expensive and time-consuming. Both companies would face significant operational and financial risks due to their shared exposure to Taiwan's geopolitical stability.",
      "llm_answer": "A prolonged conflict over Taiwan could cut off the wafer capacity NVIDIA relies on from its Taiwanese foundry partners, creating longer lead‑times, higher component costs and inventory shortfalls that would strain its supply‑chain execution and earnings (NVDA 10‑K p.19; p.18). The same disruption would hit Apple’s highly concentrated manufacturing and assembly base in Taiwan, forcing production delays, higher logistics expenses and likely a costly shift to alternative suppliers or sites, jeopardizing product launches and margins (Apple 10‑K p.9; p.11).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. (1) All factual elements are correct: NVIDIA's dependency on Taiwanese foundries and the resulting risks to supply chain execution, lead times, costs, and earnings are accurately described, with correct reference to its 10-K (pp.18–19). Apple's concentrated manufacturing in Taiwan and the potential for production delays, increased costs, and costly supply chain restructuring are also correctly detailed, citing Apple’s 10-K (pp.9,11). (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer, so quantitative accuracy is not compromised—score reflects full compliance. (3) Multi-hop reasoning is sound: the model correctly synthesizes risks across two companies (NVIDIA and Apple), linking their shared geographic exposure in Taiwan to distinct but parallel operational and financial consequences. The use of specific 10-K page citations enhances credibility and alignment with source-based reasoning. (4) Minor deduction in qualitative accuracy due to slightly more concise phrasing than the original (e.g., 'cut off the wafer capacity' is a stronger claim than 'severely disrupt'), but the core meaning and risk implications remain consistent. Overall, the response is contextually precise, factually correct, and well-grounded in the source logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 384,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How does the use of pricing models for Level 2 fixed income investments by LMT compare to HON's use of pricing models for corporate bonds and government securities in terms of observable market data inputs and risk adjustments?",
      "original_answer": "LMT values its Level 2 fixed income investments using pricing models that rely on verifiable observable market data such as interest rates, yield curves, and credit spreads, or through bids from brokers and quoted prices of similar securities. In contrast, HON uses pricing models for corporate bonds, mortgage/asset-backed securities, and government securities that also incorporate observable inputs but may include unobservable adjustments for risks like credit and liquidity. This indicates that while both companies use pricing models involving market data, HON's valuations may involve more subjective risk-based adjustments not always present in LMT's Level 2 valuations.",
      "llm_answer": "Lockheed Martin’s Level 2 fixed‑income assets are valued with pricing models that depend on verifiable, observable market inputs – interest‑rate and yield‑curve data and credit‑spread levels – plus broker bids or quoted prices of comparable securities (Lockheed Martin 10‑K p. 88). Honeywell likewise uses pricing models, broker bids and comparable‑security quotes for corporate bonds and government securities, but it explicitly adjusts those valuations for non‑observable risks such as credit and liquidity risk (Honeywell 10‑K p. 111). In short, LMT’s models rely on observable market data, while Honeywell’s models incorporate additional risk‑adjustments beyond the observable inputs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the original answer. (1) It correctly identifies that LMT uses observable market data (interest rates, yield curves, credit spreads) and broker bids or comparable securities for valuing Level 2 fixed income investments, while HON uses similar observable inputs but adds unobservable risk adjustments for credit and liquidity. (2) There are no numeric values, dates, or financial figures in the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from both LMT and HON 10-K filings, comparing their use of pricing models and highlighting the key distinction—HON’s inclusion of unobservable risk adjustments absent in LMT’s approach. (4) The only minor shortcoming is that the LLM answer does not explicitly mention 'mortgage/asset-backed securities' as part of HON’s portfolio (included in the original answer), which slightly reduces completeness. However, the focus of the question is on corporate bonds and government securities, which are covered. Wording differs but semantic meaning and factual content align closely with the ground truth. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 380,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did the unfavorable foreign currency exchange rate impact from a stronger U.S. dollar affect Coca-Cola's (KO) Europe, Middle East and Africa segment in 2024, and how does this compare to the exposure risk described by Mondelez (MDLZ) under similar macroeconomic conditions?",
      "original_answer": "Coca-Cola (KO) reported that fluctuations in foreign currency exchange rates unfavorably impacted consolidated operating income by 11% in 2024, with a stronger U.S. dollar affecting several segments including Europe, Middle East and Africa. While the euro and British pound provided some offsetting benefit, the segment was still significantly affected by the stronger dollar. Mondelez (MDLZ) similarly noted that a stronger U.S. dollar relative to other functional currencies adversely affects its consolidated earnings and net assets, as the company translates non-U.S. dollar financials into U.S. dollars for reporting. Although KO quantified the impact (11% unfavorable), MDLZ emphasized the inherent unpredictability and volatility introduced by such currency movements, despite active hedging strategies.",
      "llm_answer": "Coca‑Cola said that a stronger U.S. dollar “unfavourably” hit its Europe, Middle East and Africa segment, trimming net‑operating‑revenue growth by roughly **‑16 %** and shaving about **‑15 %** off operating income for 2024 (KO p. 48‑52). Mondelez, by contrast, describes the same macro‑environment more generally: a stronger dollar “adversely affects our consolidated earnings and net assets,” and although it hedges a portion of its currency exposure, it cannot fully eliminate the volatility (MDLZ p. 63). Thus Coca‑Cola’s impact is quantified as a double‑digit decline in a specific segment, while Mondelez’s risk is framed as a broader earnings‑and‑asset exposure to a stronger dollar.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in the quantitative details. While the ground truth states that Coca-Cola reported an 11% unfavorable impact on consolidated operating income due to foreign exchange in 2024 (with the Europe, Middle East and Africa segment affected), the LLM incorrectly claims a -16% impact on net operating revenue and -15% on operating income for that segment specifically. These specific percentages (-16%, -15%) are not supported by the original answer and represent a substantial deviation. (2) The original answer does not provide segment-level quantification for EMEA, only a consolidated 11% impact; thus, attributing -15% or -16% to that specific segment is unsupported and incorrect. The citation of 'KO p. 48-52' adds false precision. (3) Qualitatively, the comparison with Mondelez is reasonably accurate: MDLZ does describe the stronger dollar as adversely affecting earnings and net assets, with hedging that doesn't eliminate volatility. The LLM correctly captures that KO quantified the impact while MDLZ discussed it more generally as a risk. This shows sound multi-hop reasoning in structure, though based on incorrect numbers. (4) Contextually, the answer is relevant and addresses both parts of the question—KO's impact and MDLZ's exposure—making the framing appropriate. However, the severe numerical inaccuracies severely undermine factual correctness, warranting a low quantitative accuracy score and a partial correctness score overall.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 412,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How does the $365 million in long-lived assets that AVGO reported in Taiwan for fiscal 2024 compare to the risk QCOM highlighted regarding its reliance on foundry partners in Taiwan for chipset supply, particularly in the context of geopolitical tensions involving China and Taiwan?",
      "original_answer": "AVGO reported $365 million in long-lived assets in Taiwan for fiscal 2024, indicating a significant operational presence in the region. Meanwhile, QCOM explicitly stated that its business depends on receiving consistent and reliable chipset supply from foundry partners in Taiwan, and a significant or prolonged geopolitical conflict involving China and Taiwan could severely limit or prevent this supply, materially impacting QCOM’s business. This highlights that both companies have substantial exposure to Taiwan, but while AVGO’s exposure is reflected in its asset base, QCOM’s risk is operational and supply chain-dependent, making them vulnerable to the same regional geopolitical tensions in different ways.",
      "llm_answer": "AVGO’s 2024 filing shows that $365 million of its $2.5 billion long‑lived asset base is located in Taiwan (AVGO 10‑K, page 91). In contrast, Qualcomm flags a strategic supply‑chain risk – its chipset production depends on Taiwanese foundry partners, and a China‑Taiwan conflict could sever that supply and cause a material adverse impact on its business (QCOM 10‑K, page 35). Thus, AVGO’s exposure is a specific $365 million asset figure, while Qualcomm’s concern is a broader operational vulnerability that could dwarf any single asset amount.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies AVGO's $365 million in long-lived assets in Taiwan for fiscal 2024, matching the ground truth. It also accurately reflects QCOM's risk disclosure regarding its reliance on Taiwanese foundries and the potential material adverse impact from geopolitical tensions. The $2.5 billion total long-lived asset figure is additional context not in the ground truth but does not contradict it and appears consistent with AVGO’s 10-K. (2) All numeric values—$365 million, reference to AVGO’s $2.5 billion asset base, and the characterization of QCOM’s risk—are factually accurate and properly attributed to the respective 10-K filings (page 91 and page 35). No calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (AVGO and QCOM), distinguishes between asset-based exposure (AVGO) and supply-chain operational risk (QCOM), and contextualizes both within geopolitical risks involving China and Taiwan. The conclusion that AVGO’s exposure is quantifiable in assets while QCOM’s is broader and potentially more impactful is logically derived and aligns with the ground truth. (4) The only minor shortcoming is that the LLM does not explicitly state that both companies are exposed to the same regional geopolitical risk 'in different ways'—a nuance emphasized in the original answer—though this is implied. Otherwise, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 412,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How does Apple's reliance on manufacturing operations in Taiwan for a majority of its product assembly impact its exposure to regional geopolitical risks compared to Microsoft's business operations in Greater China through its regional center in Singapore?",
      "original_answer": "Apple's reliance on manufacturing in Taiwan for a significant portion of its product assembly increases its exposure to regional geopolitical risks, particularly given that Taiwan is included in Apple's Greater China segment, which is subject to trade policies and disputes that could result in tariffs, sanctions, and other business restrictions. Microsoft operates in Greater China through its regional operations center in Singapore, which supports logistics and vendor management across the region. However, unlike Apple, Microsoft's operations are not heavily dependent on localized manufacturing, reducing its exposure to supply chain disruptions tied to geopolitical tensions. Apple's outsourced manufacturing in Asia, including Taiwan, makes it more vulnerable to interruptions from tariffs, export controls, and public health crises, while Microsoft's regional center in Singapore primarily supports administrative and logistics functions, which can be more easily adapted or relocated if necessary.",
      "llm_answer": "Apple’s supply chain is heavily concentrated in Taiwan – “substantially all of the Company’s manufacturing is performed … in Asia, including … Taiwan” and the 10‑K notes that “manufacturing or logistics in these locations … can be disrupted … by … armed conflict, political issues, or international trade disputes” (Apple 10‑K p. 9, 11). Because the assembly of most of its products depends on Taiwan, Apple is directly exposed to any cross‑strait or broader U.S.–China geopolitical tensions that could halt production or raise tariffs. In contrast, Microsoft’s Greater‑China business is managed from a “regional center in Singapore” that supports Japan, India, Greater China and the Asia‑Pacific region (Microsoft 10‑K p. 16), placing its operations in a politically stable third‑party hub and insulating it from the immediate local political shocks that affect Taiwan‑based manufacturing, though it still faces broader regional risks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual information is correct: Apple's reliance on manufacturing in Taiwan is accurately described, with proper citation to its 10-K noting risks from armed conflict, political issues, and trade disputes. Microsoft's regional center in Singapore is correctly identified as supporting Greater China and other regions, with operations based in a politically stable hub. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across Apple’s and Microsoft’s 10-K filings to compare their exposure to geopolitical risks based on operational structure—manufacturing dependency vs. administrative/logistics support. The LLM correctly infers that Apple’s supply chain concentration increases its vulnerability, while Microsoft’s Singapore-based center reduces direct exposure. (4) The only minor shortcoming is that the LLM answer does not explicitly mention that Apple classifies Taiwan under its 'Greater China' segment, which links it directly to trade policies affecting that region—a nuance present in the original answer. However, this does not undermine the overall correctness. Wording differs but semantic meaning and factual content are equivalent. Contextual relevance is perfect—the response directly addresses the comparative geopolitical risk exposure as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 431,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How did Nebraska's 2023 corporate tax rate reduction impact Union Pacific's deferred tax expense in relation to Boeing's exposure to federal appropriations delays as disclosed in their respective 10-K filings?",
      "original_answer": "Nebraska's 2023 corporate tax rate reduction contributed to a $114 million reduction in Union Pacific's deferred tax expense, as disclosed in their 2024 10-K filing. In contrast, Boeing highlighted in its 2024 10-K that delays in U.S. government appropriations, such as continuing resolutions or government shutdowns, could disrupt operations, delay new programs, and negatively impact revenue. While Union Pacific benefited from state-level tax legislation, Boeing faces regulatory and funding risks tied to federal legislation, which could impair its ability to execute contracts or deliver commercial airplanes.",
      "llm_answer": "Union Pacific disclosed that the 2023 Nebraska corporate‑tax rate reduction (together with similar cuts in Iowa, Kansas and Arkansas) produced a $114 million reduction in its deferred tax expense for the year. By contrast, Boeing’s 10‑K warns that delays or lapses in U.S. federal appropriations could disrupt its government‑contract business and cash‑flows, representing a risk exposure rather than a concrete tax‑benefit impact.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $114 million reduction in Union Pacific's deferred tax expense is correctly stated, and the reference to Nebraska's 2023 tax rate reduction is accurate. The LLM adds context about similar cuts in Iowa, Kansas, and Arkansas, which is factually consistent with Union Pacific's 2024 10-K and does not contradict the ground truth—it provides additional detail without distorting the core fact. (2) The comparison to Boeing's exposure to federal appropriations delays is correctly framed as a risk factor, consistent with Boeing's 2024 10-K disclosures. While the LLM does not explicitly mention 'continuing resolutions or government shutdowns' or impacts on commercial airplane delivery, it captures the essential risk to government contracts and cash flows, which is the core of Boeing's disclosure. (3) Multi-hop reasoning is sound: the model correctly synthesizes state-level tax impacts (Union Pacific) versus federal funding risks (Boeing), addressing the comparative structure of the question. (4) Entity accuracy is strong—correct companies, correct fiscal context (2023 events reflected in 2024 filings), and correct financial terminology (deferred tax expense, appropriations delays). The only minor shortcoming is slightly less detail on Boeing’s specific operational risks (e.g., program delays, revenue impact), which slightly reduces qualitative completeness. However, the core contrast—tax benefit vs. funding risk—is clearly and correctly conveyed. Wording differs but semantic equivalence is maintained.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 439,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How might the expiration timelines of specific Enbrel-related patents in the U.S. influence MRK's strategic focus on maintaining patent protection for its own products, given the competitive dynamics in the biopharmaceutical industry?",
      "original_answer": "The expiration timelines for Enbrel-related patents in the U.S.—including the Fusion protein and pharmaceutical compositions patent expiring on 11/22/2028, the DNA encoding fusion protein and methods of making fusion protein patent on 4/24/2029, and the formulations and methods of preparing formulations patent on 10/19/2037—suggest a phased decline in AMGN's exclusivity for this product. This gradual patent erosion likely reinforces MRK's emphasis on actively protecting its own patents, as outlined in its 2024 10-K, where it states that loss of patent protection typically leads to generic substitutes and reduced sales. MRK acknowledges that political and regulatory pressures to encourage early approval of generics could further exacerbate this risk, making robust patent defense a strategic imperative to maintain market position and profitability in the face of increasing biosimilar competition.",
      "llm_answer": "Enbrel’s U.S. patent portfolio runs out in three waves—its core fusion‑protein claim expires 11 Nov 2028, the DNA‑encoding claim on 24 Apr 2029 and the formulation claim on 19 Oct 2037 (see MRK 10‑K Patents table, p. 11). Because the 10‑K stresses that loss of patent protection “promptly” invites generic or biosimilar competition and that “the Company’s patents may not prevent the emergence of generic competition” (p. 33) and that “any event that adversely affects … loss of patent protection … could have a material adverse effect” (p. 31), MRK is likely to sharpen its focus on extending and defending patents for its own high‑value assets (e.g., Prolia/XGEVA, Keytruda) and accelerating new‑product pipelines to offset the revenue pressure that Enbrel’s 2028‑2037 expirations will create in a highly competitive biopharma market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all Enbrel-related patent expiration dates—11/22/2028, 4/24/2029, and 10/19/2037—matching the ground truth exactly, with only minor formatting differences (e.g., '11 Nov 2028' vs '11/22/2028'), which are semantically equivalent. All dates are accurately attributed to the correct patent types (fusion protein, DNA encoding, formulation). (2) Quantitative accuracy is perfect: no calculations are required, and all dates are correct. (3) The reasoning is sound and reflects multi-hop synthesis: the model correctly infers that the phased expiration of Enbrel patents creates competitive dynamics that would influence MRK’s strategic behavior, and it supports this by citing MRK’s own 10-K language about the risks of patent loss, generic competition, and material adverse effects. It further extends the logic to MRK’s likely strategic response—defending high-value assets like Keytruda and accelerating pipelines—which is a reasonable inference aligned with the ground truth’s emphasis on 'robust patent defense as a strategic imperative.' (4) The only minor shortcoming is that the LLM answer cites the MRK 10-K as the source of the Enbrel patent dates, whereas in reality, Enbrel patents would be disclosed in AMGN’s filings, not MRK’s. This is a subtle but important entity/source error, though the dates themselves are correct. This prevents a perfect 10 on qualitative accuracy. Otherwise, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 419,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How has AMD's revenue from operations in Taiwan compared to Apple's revenue contribution from Taiwan (as part of Greater China) in 2022, and what does this suggest about their relative market presence in the region?",
      "original_answer": "In 2022, AMD reported $2,091 million in revenue from operations in Taiwan. Apple, on the other hand, reported $74,200 million in net sales from the Greater China region, which includes Taiwan, China mainland, and Hong Kong. Since Taiwan is only a subset of Apple's Greater China segment, and no specific breakdown is provided for Taiwan's contribution within that region, we cannot directly compare the absolute revenue from Taiwan between the two companies. However, AMD's $2,091 million in Taiwan revenue represents a significant portion of its regional operations, whereas Apple's revenue in the broader Greater China region dwarfs AMD's exposure. This suggests that while Taiwan is a meaningful market for AMD, Apple's market presence and revenue scale in the broader Greater China region, including Taiwan, is substantially larger.",
      "llm_answer": "AMD’s sales to customers in Taiwan were about **$2.1 billion** (AMD 10‑K, page 78). Apple’s Greater China segment – which includes Taiwan – generated roughly **$74.2 billion** in net sales in 2022 (Apple 10‑K, page 52, note that “China includes Hong Kong and Taiwan”). Thus Apple’s revenue from the region is more than thirty‑five times AMD’s Taiwan sales, indicating a far larger market presence for Apple in that market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports AMD's 2022 revenue from Taiwan as $2.1 billion (matching the ground truth $2,091 million, with acceptable rounding). Apple's Greater China net sales are accurately cited as $74.2 billion, consistent with the original answer. The comparison stating Apple's revenue is 'more than thirty-five times' AMD's Taiwan sales is mathematically sound (74,200 / 2,091 ≈ 35.5). (2) All numeric values are correct and properly attributed to the respective 10-K filings. Minor rounding ($2.1B vs $2,091M) is acceptable and common in financial reporting. (3) The reasoning correctly acknowledges that Apple's figure covers Greater China (including Taiwan), preventing a direct one-to-one comparison, and infers relative market presence appropriately. It synthesizes data from two companies and filings correctly. (4) The answer addresses both parts of the question: the revenue comparison and the implication about market presence. It omits the explicit caveat that Taiwan's exact contribution within Greater China is unknown (a minor omission in qualitative nuance), but still avoids claiming a direct comparison, preserving factual integrity. Overall, the answer is factually accurate, contextually relevant, and logically sound, warranting a high score with only slight room for added nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 371,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How does Alphabet's repurchase of Class C shares, which carry no voting rights, enable different capital allocation flexibility compared to Netflix's share repurchase strategy under its uniform voting rights structure?",
      "original_answer": "Alphabet's repurchase of Class C shares, which carry no voting rights, allows the company to return capital to shareholders while preserving insider control through the retention of higher-vote Class A and B shares. In 2023, Alphabet repurchased $62.2 billion of Class A and Class C shares, with an additional $36.3 billion remaining available under the repurchase authorization. In contrast, Netflix's capital stock carries uniform voting rights — one vote per share — meaning any significant share repurchase could potentially dilute voting control among existing shareholders. This structural difference implies that Netflix may need to be more cautious in its repurchase activity to avoid unintended shifts in governance, unlike Alphabet which can execute larger buybacks without affecting its core governance structure.",
      "llm_answer": "Alphabet can buy back its non‑voting Class C stock, which “has no voting rights” (p. 81), and the repurchase program is run “taking into account the economic cost and prevailing market conditions, including the relative trading prices and volumes of the Class A and Class C shares” (p. 81). Because the company can target the cheaper, non‑voting shares, it can return cash while preserving voting control and shift capital between the two classes as market conditions dictate. Netflix, by contrast, has only one class of common stock in which “the holders of each share of common stock shall be entitled to one vote per share” (p. 61) and its repurchase authority is a single‑class program that “depends on the Company’s stock price, general economic, business and market conditions, and alternative investment opportunities” (p. 62), so any buy‑back reduces both cash and voting power together, offering less flexibility to separate capital return from control considerations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Alphabet's ability to repurchase non-voting Class C shares preserves insider voting control via Class A and B shares, while Netflix’s uniform voting structure means buybacks reduce both capital and voting power proportionally. The explanation of strategic flexibility in capital allocation is sound. (2) Quantitative accuracy is perfect: although the LLM answer does not explicitly mention the $62.2 billion repurchased or $36.3 billion remaining authorization from the original answer, it does not make any numerical claims, so omission does not constitute error—these figures were context in the ground truth but not essential to the conceptual comparison asked. The LLM correctly cites page references (e.g., p. 81, p. 61) indicating proper sourcing. (3) Multi-hop reasoning is strong: the model correctly synthesizes structural differences in share classes between Alphabet and Netflix and links them to implications for capital allocation and governance. It accurately contrasts dual-class vs. uniform voting systems and explains how repurchase strategies interact with control preservation. (4) Semantic equivalence is achieved—wording differs but meaning aligns closely with the original. The only minor limitation is the lack of specific dollar figures from Alphabet’s 2023 repurchase program, which slightly reduces completeness but does not impair correctness. Overall, the response is contextually precise, logically coherent, and factually sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 433,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How does MET's exposure to non-agency pass-through mortgage-backed securities with $1,699 million in NQM and Alt-A loans compare to AIG's liquidity risk from mortgage assets, particularly in light of MET's $1,294 million in unrealized losses on pass-through securities versus AIG's concerns about valuing illiquid mortgage-related investments?",
      "original_answer": "MET holds $12,567 million in pass-through mortgage-backed securities, including $1,699 million in NQM and Alt-A loans categorized under non-agency RMBS, with $1,294 million in unrealized losses in 2024. These pass-through securities are directly secured by pools of mortgage loans, including lower-quality segments like NQM and Alt-A that carry elevated credit risk. AIG, meanwhile, faces liquidity risk from its mortgage and loan portfolio, particularly due to its holdings of less liquid assets like private equity, hedge funds, mortgage loans, and real estate. AIG explicitly warns that adverse market conditions or valuation volatility in these assets could lead to material losses if sold in stressed environments. Thus, while MET's exposure is more specifically defined and marked-to-market with known unrealized losses, AIG's risk lies in the uncertain valuation and potential illiquidity of its broader mortgage-linked investments, which could realize even greater losses under unfavorable market conditions.",
      "llm_answer": "MET’s RMBS portfolio includes $1.7 billion of non‑agency pass‑through securities (the NQM and Alt‑A segment) and it has already booked $1.3 billion of unrealized losses on its overall pass‑through holdings (MET RMBS table, p. 88). AIG’s filing, however, flags a broader liquidity risk – it warns that its mortgage‑related assets are illiquid and may be difficult to value or sell in a stressed market, but it does not disclose a comparable dollar‑amount loss (AIG liquidity discussion, pp. 20‑21).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core comparison between MET and AIG as required by the question. (1) Quantitatively, the LLM correctly reports MET's $1.7 billion (rounded from $1,699 million) in non-agency pass-through securities (NQM and Alt-A loans) and $1.3 billion (rounded from $1,294 million) in unrealized losses—both figures are within acceptable rounding and formatting variations ($1.7B = $1,700M ≈ $1,699M; $1.3B = $1,300M ≈ $1,294M). The original answer specifies the total RMBS portfolio as $12,567 million, which the LLM omits, but this is not directly asked in the question and does not impair the core comparison. (2) The LLM correctly notes that AIG does not disclose a comparable dollar amount for losses, aligning with the ground truth that AIG emphasizes valuation uncertainty and liquidity risk without quantifying losses. (3) The reasoning is sound: it contrasts MET’s marked-to-market, quantified unrealized losses with AIG’s broader liquidity and valuation concerns, correctly identifying that AIG’s risk stems from illiquidity and uncertain pricing rather than disclosed losses. (4) Entities (MET, AIG), metrics (unrealized losses, non-agency RMBS, NQM/Alt-A), and context (2024 implied by source data) are accurate. The only minor shortcoming is the omission of MET’s total RMBS portfolio size, which provides context but is not essential to the direct comparison asked. Wording differs but semantic meaning matches. Thus, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 420,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How did the revenue contribution from beverage operations in the Asia Pacific region compare between Coca-Cola (KO) and PepsiCo (PEP) in 2021, based on their regional and product segment reporting?",
      "original_answer": "In 2021, Coca-Cola (KO) generated $4,682 million in third-party beverage revenue from its Asia Pacific (APAC) operations. PepsiCo (PEP) reported that 20% of its total revenue in the APAC region came from beverage operations, though the exact dollar amount is not disclosed. This indicates that while KO's APAC beverage revenue is directly quantifiable for 2021, PEP's APAC beverage revenue would require further calculation based on total regional revenue to determine the precise figure.",
      "llm_answer": "Coca‑Cola’s Asia Pacific segment produced **$5.3 billion** of net operating revenue in 2021, which is essentially all beverage revenue【page_124】. PepsiCo’s APAC division reported **$4.6 billion** of net revenue, but only **≈20 %** of that was from beverages – about **$0.9 billion**【page_73】【page_73】. Thus Coca‑Cola’s beverage revenue in Asia Pacific was roughly six‑times larger than PepsiCo’s in the same year.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Coca-Cola's 2021 third-party beverage revenue in APAC was $4,682 million ($4.682 billion), but the LLM reports $5.3 billion, which is incorrect. For PepsiCo, the LLM claims total APAC revenue was $4.6 billion and that 20% of it ($0.9 billion) came from beverages. However, the ground truth states that while PepsiCo reported 20% of APAC revenue came from beverages, the exact dollar amount was not disclosed — meaning any calculation of $0.9 billion is speculative and not supported by the data. (2) The numbers are quantitatively inaccurate: $5.3B vs $4.682B for KO and fabricated $0.9B for PEP’s beverage revenue. The 20% figure for PEP is correct, but applying it to a claimed $4.6B regional total introduces unsupported precision. (3) The multi-hop reasoning is flawed — the model incorrectly assumes PepsiCo’s total APAC revenue and performs a calculation not justified by the source data. It also fails to acknowledge the uncertainty or need for additional data to derive PEP’s beverage revenue, as highlighted in the original answer. (4) Despite these errors, the answer is contextually relevant — it addresses the comparison between KO and PEP in APAC beverage operations in 2021 and attempts proper synthesis. However, due to major quantitative and qualitative inaccuracies, especially in reporting false figures and making unsupported calculations, the correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 411,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How does Gilead's revenue-sharing structure with Merck for long-acting HIV products compare to Merck's royalty obligations to BMS and Ono for Keytruda sales, and what implications does this have for Merck's profitability from both partnerships?",
      "original_answer": "Gilead and Merck share global product revenues equally for long-acting HIV products until $2.0 billion (oral) or $3.5 billion (injectable) in net sales are surpassed, after which Gilead's share increases to 65%. Meanwhile, Merck pays BMS and Ono royalties of 6.5% through 2023 and 2.5% from 2024–2026 on global Keytruda sales, with BMS receiving 75% of those payments. In 2023, Merck recorded $212 million in alliance revenue from its collaboration with BMS on Reblozyl, which includes a 20–24% sales royalty. These structures indicate that Merck both shares in revenue from joint development (with Gilead) and pays significant royalties (to BMS and Ono), which directly affects its net profitability from these partnerships depending on the scale of product sales.",
      "llm_answer": "Gilead and Merck agreed to split global product revenue 50/50 (with Merck’s share falling to 35 % of any sales above the $2 bn oral‑product or $3.5 bn injectable‑product thresholds) and Merck will fund only 40 % of development and commercialization costs 【page_76】. In contrast, Merck must pay a royalty of 6.5 % of all Keytruda sales (allocated 75 % to BMS and 25 % to Ono) that cost the company about $1.2 bn in 2023 and will drop to 2.5 % after 2023 【page_90】. Thus, the HIV collaboration could be more profitable for Merck because it receives a sizable revenue share while bearing a smaller cost share, whereas the Keytruda royalty is a large, fixed‑percentage expense that erodes Merck’s margin on its flagship immunotherapy, albeit with a lower rate in future years.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a key error in describing Merck's revenue share after the sales thresholds. The original answer states that Gilead's share increases to 65% (i.e., Merck drops to 35%) after $2.0B (oral) or $3.5B (injectable) in net sales, which the LLM correctly notes. However, the LLM incorrectly implies that Merck’s revenue share is 35% of *all* sales above the threshold, rather than only on sales exceeding the threshold—a nuance not fully clarified. This could mislead on financial impact. (2) Quantitatively, most numbers are accurate: $2.0B/$3.5B thresholds, 6.5% royalty through 2023, dropping to 2.5% in 2024–2026, and 75%/25% split between BMS/Ono are correct. However, the LLM claims Merck paid ~$1.2B in Keytruda royalties in 2023, which is not in the original answer and cannot be verified from the provided ground truth (no total royalty dollar amount was given). This is an unsupported addition. Also, the original mentions $212M in Reblozyl alliance revenue (from BMS), which the LLM omits entirely. (3) The multi-hop reasoning is sound: the model correctly contrasts Merck as a revenue sharer (with Gilead) vs. a royalty payer (to BMS/Ono) and draws a logical conclusion about profitability implications. It accurately identifies the dual role of Merck in different partnerships. (4) The answer is contextually relevant and addresses both parts of the comparison question. Despite missing the Reblozyl detail and adding an unverified $1.2B figure, the core comparison and implications for profitability are well-reasoned and semantically aligned with the original. Hence, correctness is reduced to 7 due to quantitative overreach, but qualitative and contextual scores remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 475,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How does BAC's investment in CDOs, which contain embedded credit default swaps that transfer risk through tranche structures, compare to AIG's $75 million loss from embedded derivatives in 2024, considering the role of credit events in triggering losses for both institutions?",
      "original_answer": "BAC invests in CDOs, which are hybrid instruments containing embedded derivatives where credit protection has been sold to the issuer. These structures pass credit event losses from junior tranches to more senior ones, exposing investors like BAC to cascading risk. AIG, in turn, reported a $75 million loss from embedded derivatives in 2024, which includes similar instruments like credit default swaps tied to reference entities. A credit event in the underlying reference entity would directly impact both BAC’s CDO value and AIG’s derivative exposure, linking their financial risks through the same type of structured credit mechanism.",
      "llm_answer": "BAC’s CDO holdings, which embed credit‑default swaps that shift loss to the most junior tranches, give the bank a **maximum loss exposure of about $1.1 billion (consolidated) and $952 million (unconsolidated) as of Dec 31 2024** – the amount that includes the notional of the related derivative contracts【page_130】.  \nAIG, on the other hand, recorded a **$75 million loss from embedded derivatives in 2024**【page_144】.  \nIn both cases a credit event (e.g., a default of the reference entity) can trigger the loss, but BAC’s potential exposure runs in the billions, whereas AIG’s actual loss from such events was only $75 million.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in reasoning and context but introduces specific quantitative figures not present in the original ground truth, which undermines full factual accuracy. (1) The original answer does not specify BAC’s exposure as $1.1 billion (consolidated) or $952 million (unconsolidated); these numbers, while possibly accurate in the source document, are not part of the verified ground truth provided, making their inclusion a deviation. The AIG $75 million loss is correctly cited and matches the original. (2) The quantitative accuracy is partially compromised because the BAC exposure figures are added detail not confirmed by the ground truth, and no mention of 'maximum loss exposure' or notional amounts appears in the original. While such data may exist in the cited pages (e.g., page 130), the ground truth does not include them, so the LLM goes beyond the verified answer. (3) Qualitatively, the reasoning is sound: it correctly identifies CDOs with embedded CDSs, tranche-based risk transfer, and the role of credit events in triggering losses for both BAC and AIG. It appropriately contrasts potential exposure (BAC) versus realized loss (AIG), which enhances understanding. (4) Contextual relevance is high—the answer directly addresses the comparison, the role of credit events, and the structural similarities in risk mechanisms. However, the addition of unverified dollar figures lowers the correctness and quantitative accuracy scores. The core multi-hop synthesis (linking BAC’s CDO structure to AIG’s derivative losses via credit events) is logically and factually coherent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 438,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "What specific roles does Citibank, N.A. hold in both 3M's May 2023 Five-Year Credit Agreement and Caterpillar's September 2022 credit facilities, and how do these roles differ in terms of administrative responsibilities across the two agreements?",
      "original_answer": "In 3M’s May 2023 Five-Year Credit Agreement, Citibank, N.A. serves as an administrative agent and joint lead arranger alongside JPMorgan Chase Bank, N.A., with responsibilities including coordination of the lending group and oversight of borrowing procedures. In Caterpillar’s September 2022 credit facilities, Citibank, N.A. acts as the Agent for both the 3-Year and 5-Year Facilities, and also as the Local Currency Agent through Citibank Europe plc, UK Branch, and Japan Local Currency Agent in coordination with MUFG Bank, Ltd. These roles differ in that Citibank holds multiple layered responsibilities in Caterpillar’s structure, including cross-border coordination, while at 3M it shares leadership with another bank without such international scope.",
      "llm_answer": "Citibank, N.A. is named as the **administrative agent** on 3M’s May 2023 Five‑Year Credit Agreement (exhibit 10.29) 【page_114】. In Caterpillar’s September 2022 credit facilities, Citibank, N.A. is listed as both the **agent** and the **Local Currency Agent** in the Credit Agreement and its Local‑Currency Addendum 【page_128】. Thus, Citibank’s role for 3M is limited to general loan administration, whereas for Caterpillar it also carries the added responsibility of handling local‑currency administration for the facility.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Citibank, N.A.'s role as administrative agent in 3M’s May 2023 Five-Year Credit Agreement and as agent and Local Currency Agent in Caterpillar’s September 2022 facilities, which aligns with the ground truth. The dates and entity names are accurate. However, the LLM omits key details present in the original answer: it does not mention that Citibank, N.A. served as a joint lead arranger alongside JPMorgan Chase Bank, N.A. in the 3M agreement, which is a significant part of its role. Additionally, the LLM fails to note that Citibank Europe plc, UK Branch, and MUFG Bank, Ltd. are involved in the local currency coordination for Caterpillar, particularly the Japan Local Currency Agent role. (2) There are no numerical values to calculate or verify, so quantitative accuracy is perfect. (3) The multi-hop reasoning is partially sound—information is correctly pulled from both agreements, but the synthesis is incomplete. The comparison between the two roles lacks depth, particularly regarding the 'layered responsibilities' and 'cross-border coordination' emphasized in the ground truth. The conclusion that Citibank’s role at 3M is 'limited to general loan administration' oversimplifies its joint lead arranger role. (4) The answer is contextually relevant and addresses the core question, but the lack of specificity on administrative scope and international coordination reduces qualitative accuracy. The correctness score reflects accurate core facts but meaningful omissions in role complexity and structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 429,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "How does the use of option contracts by KO to hedge foreign currency exposure compare with PEP's foreign exchange risk management strategy, given the impact of these instruments on their respective foreign currency liabilities?",
      "original_answer": "KO uses option contracts as part of its derivative strategy to hedge foreign currency exchange rate risk, aiming to mitigate the impact of currency fluctuations on its financial performance. These contracts are designated as cash flow hedges and affect KO's foreign currency liabilities by deferring gains and losses in AOCI until the hedged transactions occur. Similarly, PEP actively manages foreign exchange risk through derivatives, including option and forward contracts, which are also used to hedge forecasted transactions and firm commitments. PEP reported that foreign exchange movements unfavorably impacted net revenue by 1.5 percentage points in 2024, highlighting the importance of these hedges. Both companies rely on option contracts to manage foreign currency liabilities, but KO specifically emphasizes the deferral of mark-to-market impacts in AOCI, while PEP focuses on offsetting exposure from its significant international operations (44% of revenue).",
      "llm_answer": "KO’s 2024 filing says it “enters into forward contracts and purchases foreign‑currency options and collars (principally euro, British pound and Japanese yen)” as part of a cash‑flow hedging program 【page_83】.  The fair‑value of those option‑based contracts is reflected in its foreign‑currency liabilities – $14 million on accounts payable and $39 million on other non‑current liabilities for designated hedges (and $86 million and $12 million for non‑designated contracts) 【page_82】.  \n\nPepsiCo, by contrast, manages FX risk through “foreign‑exchange derivative contracts” and cross‑currency swaps, without mentioning options 【page_42】【page_43】, and the effect shows up as net foreign‑exchange gains/losses on its currency‑denominated assets and liabilities (e.g., a $63 million loss on assets & liabilities and a $72 million loss on non‑designated contracts in 2024) 【page_43】.  Thus KO uses explicit option contracts that produce modest, line‑item liability adjustments, whereas PepsiCo relies on broader forward‑/swap‑type derivatives whose impact is recorded as overall FX gains or losses rather than specific liability fair‑value offsets.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and misrepresents key aspects of both companies' foreign exchange risk management strategies, particularly regarding PEP's use of options. (1) The ORIGINAL ANSWER confirms that PEP uses both option and forward contracts, but the LLM incorrectly states that PEP does not mention options and relies only on forward and swap-type derivatives. This is a major error in entity and strategy identification. (2) The LLM cites specific dollar amounts for KO’s foreign-currency liabilities related to designated and non-designated hedges ($14M, $39M, $86M, $12M), which are not present in the original answer and cannot be verified against the ground truth; these figures may be extracted correctly from the filing but are not part of the known truth used to generate the original answer, making their accuracy uncertain. (3) The claim that PEP recorded a $63M loss on assets & liabilities and $72M loss on non-designated contracts in 2024 is not supported by the original answer, which only states that FX movements negatively impacted net revenue by 1.5 percentage points—this is a different metric and context. (4) The reasoning is partially sound in comparing how each company reflects hedge impacts (liability fair value vs. income statement gains/losses), but it fails the multi-hop synthesis by incorrectly contrasting KO’s use of options with PEP’s alleged non-use, when both use options. (5) While the LLM attempts to address the comparison of hedging strategies and their impact on liabilities, it draws an incorrect distinction due to missing PEP’s use of options, undermining the core conclusion. Wording and structure are relevant and clear, hence moderate contextual relevance, but qualitative and quantitative accuracy suffer from unsupported numbers and strategic misrepresentation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1549,
        "completion_tokens": 496,
        "total_tokens": 2045
      },
      "error": null
    },
    {
      "question_id": 183,
      "question": "How does the use of discounted cash flow models by GE in assessing goodwill impairment risk compare with LMT's application of DCF in valuing Level 3 fixed income investments, particularly in terms of sensitivity to discount rate assumptions and projected cash flow estimates?",
      "original_answer": "GE uses a discounted cash flow (DCF) approach as part of its annual goodwill impairment testing, relying on cash flow forecasts, terminal value assumptions, and discount rates to estimate fair value. The company performs sensitivity analyses due to the material impact that changes in these assumptions could have on impairment determinations. Similarly, LMT applies DCF models to value certain Level 3 fixed income investments when observable market data is unavailable, using projected annuity payments and discount rates as key inputs. Both companies depend on forward-looking cash flow projections and discount rate assumptions, making their valuations sensitive to shifts in economic conditions or interest rate environments. However, GE’s DCF use is tied to internal strategic and operational planning, while LMT’s is externally focused on asset valuation within its pension fund investments.",
      "llm_answer": "GE says that goodwill fair‑value is estimated with a discounted‑cash‑flow (DCF) model that uses its strategic and operating‑plan cash‑flow forecasts and a terminal‑value assumption, and that “we perform sensitivity analyses on key estimates and assumptions” – meaning the valuation is explicitly tested for changes in the discount rate and the projected cash‑flow amounts (GE 10‑K p. 17). Lockheed Martin, by contrast, applies a DCF approach only to Level 3 fixed‑income assets, where the valuation hinges on “projected annuity payments and the discount rate applied to those payments,” but the filing does not describe any formal sensitivity testing of those inputs (LMT 10‑K p. 89). Thus GE’s DCF impairment analysis is framed around explicit sensitivity to discount‑rate and cash‑flow assumptions, whereas LMT’s DCF valuation simply relies on those inputs without disclosed sensitivity analysis.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. It correctly identifies that GE uses DCF models for goodwill impairment testing, incorporating cash flow forecasts, terminal value, and discount rates, and explicitly performs sensitivity analyses on these inputs—this matches the original answer's emphasis on GE’s sensitivity testing due to material impacts. The LLM accurately cites GE’s 10-K (p. 17) as the source, which supports the claim. For LMT, the answer correctly states that DCF is used for Level 3 fixed income investments, relying on projected annuity payments and discount rates, consistent with the ground truth. It also correctly notes that LMT does not disclose formal sensitivity testing, which is a valid distinction from GE and supported by the absence of such language in LMT’s 10-K (p. 89). The comparison effectively highlights that both companies use forward-looking cash flows and discount rates—making valuations sensitive to assumptions—but differ in whether sensitivity analysis is formally disclosed. The only minor shortcoming is that the original answer adds contextual nuance: GE’s DCF is tied to internal strategic planning, while LMT’s is externally focused on pension fund assets. This layer of internal vs. external purpose is missing in the LLM answer, slightly reducing qualitative completeness. However, all factual elements—entities, methods, inputs, and disclosure differences—are correct. No numerical inaccuracies exist, as the response avoids specific numbers (appropriately, since none were required). The reasoning is sound, multi-hop synthesis across two companies and use cases is accurate, and the response is fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 464,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 184,
      "question": "How does the voting power distribution in CMCSA's Class A and Class B common stock compare to GOOGL's structure, given the repurchase activity and voting rights differences?",
      "original_answer": "In CMCSA, holders of Class A common stock collectively hold 66 2/3% of the combined voting power, while Class B common stock (held entirely by Brian L. Roberts) holds 33 1/3%, with each Class B share carrying 15 votes. In contrast, GOOGL's Class A shares carry 1 vote each, while Class B shares have 10 votes per share, giving disproportionate voting power to Class B holders in both companies. Additionally, GOOGL repurchased $62.2 billion of Class A and Class C shares in 2023, which could affect ownership concentration and voting dynamics, though CMCSA does not disclose such repurchase volumes for Class A shares directly.",
      "llm_answer": "Comcast’s voting power is split between its publicly‑traded Class A shares, which carry one vote each and represent roughly two‑thirds of the combined voting rights, and a single Class B share that has 15 votes and accounts for about one‑third of voting power; the 2023 repurchase program was limited to Class A shares, shrinking the pool of low‑voting stock. Alphabet’s structure gives Class A shares one vote, Class B shares ten votes (held by insiders and not repurchased), and Class C shares no votes, and its buy‑back program has focused on the publicly‑traded Class A and non‑voting Class C shares, leaving voting control firmly in the hands of the high‑voting Class B stock.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor differences in precision. (1) Quantitatively, the LLM correctly states that CMCSA's Class A shares represent roughly two-thirds (66 2/3%) of voting power and Class B holds one-third (33 1/3%), with Class B having 15 votes per share. It correctly notes that GOOGL Class B shares have 10 votes and Class A have 1 vote, and that GOOGL repurchased Class A and Class C shares in 2023. However, the exact repurchase amount of $62.2 billion is omitted, which slightly reduces quantitative accuracy. (2) The LLM correctly identifies that CMCSA's repurchase program was limited to Class A shares, though the original answer notes that CMCSA does not disclose repurchase volumes directly—this nuance is missing but does not materially distort the facts. (3) The multi-hop reasoning is sound: the model correctly compares voting structures across both companies and links repurchase activity to ownership concentration and voting dynamics. (4) Entity accuracy is strong—CMCSA and GOOGL are correctly identified, share classes and their voting rights are accurate, and the years align. (5) The answer is semantically equivalent to the original, with slightly more interpretive language (e.g., 'shrinking the pool of low-voting stock') that enhances clarity without introducing error. The omission of the $62.2B figure prevents a perfect score, but all other elements are correct and well-synthesized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 410,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 184,
      "question": "How does the 8.2% increase in Turkey's total cigarette market, driven by increased in-bound tourism, impact PM's business performance in comparison to CL's operational footprint in the same country?",
      "original_answer": "The 8.2% growth in Turkey's total cigarette market, attributed to the easing of pandemic-related measures and increased in-bound tourism (particularly by Turkish expatriates), positively contributed to PM's net revenues and shipment volumes in the region. PM reported favorable volume/mix and pricing variances in Turkey, which were key contributors to its Middle East & Africa regional performance. Meanwhile, CL operates manufacturing and warehousing facilities in Turkey as part of its global Oral, Personal and Home Care product segment, indicating a significant operational presence in the country. Therefore, while PM benefits from increased consumer activity linked to tourism, CL maintains a physical and ongoing business infrastructure in Turkey, suggesting differing but regionally aligned exposure to the country's economic dynamics.",
      "llm_answer": "The 8.2 % rise in Turkey’s total cigarette market – spurred by higher in‑bound tourism – translated into a 17.2 % jump in PMI’s shipment volume in the country and a gain in market share as adult smokers up‑traded to Marlboro and Parliament (PM 10‑K p. 56‑57). By contrast, CL’s presence in Turkey is limited to a single manufacturing/distribution site (CL 10‑K p. 22‑23), so the market‑size boost yields only a modest, indirect effect on CL’s results versus PMI’s pronounced volume and share gains.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The 17.2% jump in PMI's shipment volume in Turkey is not present in the original answer or ground truth; the original only states that PM benefited from favorable volume/mix and pricing variances without specifying a percentage. This fabricated statistic severely undermines quantitative accuracy. Additionally, the claim that adult smokers 'up-traded to Marlboro and Parliament' and that PMI gained market share is not supported by the original answer, which does not mention specific brands or market share gains. (2) The reference to 'PM 10-K p. 56-57' and 'CL 10-K p. 22-23' implies specific sourcing, but these citations are not verifiable from the provided ground truth and introduce unconfirmed details. The original answer notes CL operates manufacturing and warehousing facilities in Turkey, while the LLM downplays this as a 'single' site, which contradicts the characterization of CL's presence as 'significant' in the ground truth. (3) The multi-hop reasoning is partially sound in structure—comparing PM's market-driven revenue gains to CL's operational footprint—but fails in execution due to incorrect data and oversimplification. The LLM incorrectly frames CL's exposure as 'modest' and 'indirect,' whereas the original emphasizes CL's ongoing infrastructure, suggesting stable operational significance regardless of cigarette market fluctuations. (4) Contextual relevance is high because the answer attempts to compare PM and CL in Turkey with respect to market dynamics. However, correctness score is low due to major quantitative and qualitative inaccuracies that distort the actual business impacts. While the direction of reasoning (PM benefits from consumption, CL from operations) aligns with the original, the specific claims and numbers are not factually supported, leading to a misleading conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 513,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How might geopolitical tensions involving Taiwan impact both NVIDIA's ability to secure timely supply from its foundry partners and Qualcomm's operations in the region, given their shared dependency on Taiwanese manufacturing infrastructure?",
      "original_answer": "NVIDIA faces risks related to its dependency on foundry partners, particularly in Taiwan, where it relies on timely production capacity to meet customer demand. If geopolitical tensions involving Taiwan disrupt operations, NVIDIA may not be able to secure sufficient supply to fulfill orders on time, which could damage customer relationships and lead to revenue loss. Similarly, Qualcomm explicitly states that its business depends on receiving consistent chipset supply from foundry partners in Taiwan, and a significant or prolonged conflict involving Taiwan could severely limit or prevent this supply, materially impacting its business. Both companies are exposed to the same regional risk due to their reliance on Taiwanese manufacturing infrastructure, amplifying the cross-company impact of geopolitical instability in the region.",
      "llm_answer": "Both companies flag that a flare‑up over Taiwan would jeopardize the chip supply they get from Taiwanese fabs. NVIDIA says that geopolitical tensions with China‑Taiwan could impair its ability to obtain timely wafer capacity from its foundry partners (e.g., TSMC), forcing longer lead‑times, premium pricing and possible product shortages (NVDA 10‑K pp. 15‑17). Qualcomm likewise warns that a conflict involving Taiwan could severely limit or stop the flow of chipset components from its Taiwan‑based foundry and assembly partners, disrupting its operations and revenue (QCOM 10‑K pp. 33‑35).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All key factual elements are correct: both NVIDIA and Qualcomm are correctly identified as reliant on Taiwanese foundries (e.g., TSMC), and the risks from geopolitical tensions involving Taiwan are accurately described. The LLM correctly states that NVIDIA could face impaired wafer capacity, longer lead times, premium pricing, and product shortages, citing its 10-K (pp. 15–17), which matches known disclosures. Similarly, Qualcomm’s risk of severely limited or halted chipset supply is accurately reported with correct citation (QCOM 10-K pp. 33–35). (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in a traditional sense—however, the absence of incorrect numbers and the precise referencing of document sections support a score of 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes risks across two companies, linking their shared dependency on Taiwanese manufacturing infrastructure and the amplifying effect of regional instability. The only minor shortcoming is that the LLM does not explicitly state that this shared dependency 'amplifies the cross-company impact'—a point emphasized in the original answer—though the implication is clearly present. (4) The answer is fully contextually relevant, directly addressing how geopolitical tensions could impact both companies’ supply chains through their reliance on the same regional manufacturing base. Wording differs slightly but maintains semantic equivalence. Overall, this is a strong, factually correct response with only a slight omission of synthesis language, justifying a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 477,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How has the application of ASU 2020-04 impacted FDX's exposure to LIBOR-related contract modifications, and how does this compare to MMM's financial treatment of hedging relationships affected by reference rate reform?",
      "original_answer": "FDX has not experienced any material effect from reference rate reform, including ASU 2020-04, as of May 31, 2024, although it continues to monitor contracts that may be affected by LIBOR discontinuation. In contrast, MMM actively manages its hedging relationships, including those affected by reference rate changes, and reported $9 million in losses related to interest rate contracts in 2023, indicating active financial impact and accounting treatment under the ASU 2020-04 framework. This suggests that while FDX has not yet seen significant financial effects, MMM has recognized tangible impacts in its hedging activities tied to reference rate reform.",
      "llm_answer": "FedEx says that, after applying the optional expedients in ASU 2020‑04, the reference‑rate reform has produced “no material effect on our financial condition, results of operations, or cash flows” – essentially eliminating any material LIBOR‑related exposure (FDX 10‑K p. 93). In contrast, 3M’s LIBOR‑based interest‑rate swaps were re‑structured to reference SOFR and remain designated as fair‑value hedges, so the mark‑to‑market gains or losses on those hedges are recognized in earnings (interest expense) rather than OCI (3M 10‑K p. 75). This means FedEx’s exposure is neutral, while 3M reflects the reform directly in its earnings through hedge accounting.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly states that FDX has experienced no material effect from reference rate reform, including ASU 2020-04, citing its 10-K (p. 93), which matches the original answer's claim about FDX's lack of material impact as of May 31, 2024. (2) For MMM (3M), the LLM accurately describes the restructuring of LIBOR-based swaps to SOFR and the continued use of fair-value hedge accounting, with gains/losses recognized in earnings (interest expense), citing the 10-K (p. 75). While the original answer mentions a specific $9 million loss in 2023 for MMM, the LLM answer does not include this figure—this is a minor omission but does not distort the overall financial treatment or conclusion. (3) The multi-hop reasoning is sound: the model correctly contrasts FDX’s neutral exposure due to expedients under ASU 2020-04 with MMM’s active hedge accounting that flows through earnings, demonstrating proper synthesis across two companies and their respective accounting treatments. (4) All entities (FDX, MMM, ASU 2020-04, SOFR, LIBOR), financial concepts (hedge accounting, fair-value hedges, mark-to-market), and document sources are correct and contextually appropriate. The only reason for not scoring a 10 is the missing $9 million loss figure from MMM’s 2023 results, which is a relevant quantitative detail present in the ground truth. However, since the qualitative explanation of MMM’s financial treatment remains accurate, the correctness score is 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 419,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How does the voting power distribution tied to CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, influence the governance structure compared to GOOGL's dual-class stock system where Class A and Class B shares have differential voting rights?",
      "original_answer": "CMCSA's Class B common stock, entirely owned by Brian L. Roberts, holds 33⅓% of the combined voting power with each share carrying 15 votes, creating a non-dilutable control mechanism. This contrasts with GOOGL's structure, where Class A shares (1 vote per share) and Class B shares (10 votes per share) allow insiders to maintain control while enabling broader public ownership. Both systems use dual-class structures to preserve founder/leadership control, but differ in the vote ratios and ownership concentration, with CMCSA's setup being more concentrated and structurally rigid due to the non-dilutable nature of Class B shares.",
      "llm_answer": "Comcast’s governance is anchored by the 9.44 million Class B shares that are **100 % owned by Brian L. Roberts**; each Class B share carries multiple votes (10‑15 per share) and represents roughly one‑third of the company’s total voting power, giving Roberts a non‑dilutable, decisive say over director elections and other matters (see CMCSA Item 5, p. 31; Note 11, p. 82). Alphabet’s dual‑class system, by contrast, issues **Class A shares with one vote** and **Class B shares with ten votes** (and a non‑voting Class C), with the high‑vote Class B stock held by founders and insiders, so control is retained by a small insider group while public investors hold low‑vote or non‑voting shares (see GOOGL Note 11, p. 82; share‑count table, p. 84). Thus, both firms concentrate voting power, but Comcast’s is concentrated in a single individual, whereas Google’s is spread among its insider shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth, with only minor imprecision in vote count details. (1) Quantitatively, the LLM states that each CMCSA Class B share carries '10-15 votes', while the ground truth specifies exactly '15 votes'. This is a slight inaccuracy, though the overall voting power (one-third) and ownership (100% by Brian L. Roberts) are correct. The '33⅓%' in the original is accurately reflected as 'roughly one-third'. For GOOGL, the LLM correctly identifies 1 vote for Class A and 10 for Class B, matching the ground truth. (2) The answer is complete, addressing both CMCSA's concentrated control via Roberts and GOOGL's insider group control, fulfilling the comparative multi-hop requirement. (3) Entities (CMCSA, GOOGL, Brian L. Roberts, Class A/B shares) are correctly identified, and the reasoning correctly contrasts ownership concentration (single individual vs. insider group) and control mechanisms. (4) The LLM synthesizes governance implications well, noting non-dilutable control and decisive influence, though it omits the explicit term 'non-dilutable' in the CMCSA description (it does mention 'non-dilutable' in the context of Roberts’ influence, so the concept is present). Semantic equivalence is strong, with only minor variation in vote count precision affecting full accuracy. Contextual relevance is perfect—directly addresses governance influence through voting power distribution.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 404,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How does Amgen's remaining repatriation tax payment schedule under the 2017 Tax Act compare with Eli Lilly's cash payment obligations for the same tax provision as of December 31, 2023?",
      "original_answer": "Amgen has remaining scheduled repatriation tax payments under the 2017 Tax Act, which it is paying over an eight-year period beginning in 2018. Similarly, Eli Lilly made the election to pay the Toll Tax over the same eight-year period, with its future cash payments extending through 2025. Both companies are managing their obligations under the same regulatory framework introduced by the 2017 Tax Act, though the specific amounts differ based on their foreign earnings and individual tax calculations.",
      "llm_answer": "Amgen’s filing (Amgen 10‑K pages 153‑157) does not disclose any remaining “Toll‑Tax” (repatriation‑tax) payment schedule under the 2017 Tax Act, whereas Eli Lilly’s filing (LLY 10‑K page 92) shows a total liability of $1.427 billion, broken out as $634.2 million due in 2024 and $792.8 million due in 2025 as of December 31 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains partially correct quantitative information about Eli Lilly's remaining cash payment obligations under the 2017 Tax Act, stating a total liability of $1.427 billion with $634.2 million due in 2024 and $792.8 million due in 2025 as of December 31, 2023. These figures sum correctly ($634.2M + $792.8M = $1.427B), so the quantitative accuracy for Eli Lilly is correct. However, the LLM incorrectly states that Amgen’s 10-K does not disclose any remaining Toll Tax payment schedule, which contradicts the ground truth indicating that Amgen is making payments over an eight-year period beginning in 2018. The ground truth confirms that Amgen has a scheduled payment plan under the same provision, even if specific annual breakdowns are not disclosed. Therefore, the LLM’s claim of no disclosure is factually incorrect or at least misleading—absence of detailed annual schedule does not equate to no obligation or no schedule. This undermines the qualitative accuracy and reasoning, especially in the multi-hop comparison between Amgen and Eli Lilly. While both companies are subject to the same eight-year framework (2018–2025), the LLM fails to recognize Amgen’s ongoing obligation, leading to an incomplete and imbalanced comparison. The contextual relevance is fair because it addresses the core question about payment schedules and cites correct sources, but the failure to acknowledge Amgen’s structured payment plan results in a significant factual gap. Overall, the answer is partially accurate on numbers for Lilly but fundamentally flawed in reasoning and completeness regarding Amgen, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 448,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 186,
      "question": "How does the risk of biosimilar competition following loss of exclusivity for Amgen's biologics compare to Bristol Myers Squibb's exposure, given the differing regulatory pathways and product portfolios in the U.S. and EU?",
      "original_answer": "Amgen's reliance on biologics such as 'Erbitux, Cyramza, Trulicity, Taltz, and Emgality' is at risk due to the potential entry of biosimilars, which could occur after 12 years of regulatory data protection in the U.S. However, litigation and expedited review processes like IPR could weaken patent protection and accelerate biosimilar entry. Similarly, Bristol Myers Squibb faces biosimilar threats to its biologics including 'Opdivo, Yervoy, Orencia, Reblozyl, and Empliciti,' with regulatory data protection lasting 12 years in the U.S., but also faces earlier generic competition in the EU under the '8+2+1' regime, where biosimilars can enter after 8 years of data exclusivity. Both companies are exposed to rapid revenue declines upon loss of exclusivity, but the timing and competitive intensity differ based on regional regulatory frameworks and the complexity of biosimilar development.",
      "llm_answer": "Amgen notes that loss of exclusivity for its biologics “may or may not result in the near‑term entry of competitor versions (i.e., biosimilars) due to many factors, including development timelines, manufacturing challenges, and uncertainties regarding the regulatory pathways” (see Amgen 10‑K p. 25) and that in the U.S. a biosimilar cannot be approved until 12 years after the innovator’s BLA, while in the EU the “8+2+1” regime can allow a generic‑type filing after eight years (Amgen 10‑K p. 9). By contrast, Bristol‑Myers Squibb’s portfolio contains a broad set of biologic therapies (e.g., Abecma, Zeposia, Breyanzi, Inrebic, Onureg) (BMS 10‑K p. 7) and, given the same U.S. BPCIA filing window after four years and the EU’s earlier data‑protection expiry, the company is more directly exposed to biosimilar competition once exclusivity ends. Thus Amgen’s biosimilar risk is more uncertain and potentially delayed, whereas BMS faces a higher and more immediate exposure to biosimilar entry.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies key regulatory timelines: 12 years of data protection in the U.S. under the BPCIA and the EU's '8+2+1' regime allowing biosimilar applications after 8 years. These quantitative elements are accurate and align with the ground truth, earning a solid score on quantitative accuracy. However, there are significant factual inaccuracies in entity identification. The LLM incorrectly lists Amgen’s biologics as including 'Erbitux, Cyramza, Trulicity, Taltz, and Emgality'—none of which are Amgen products (Erbitux is Eli Lilly/ImClone, Cyramza is Lilly, Trulicity is Lilly, Taltz and Emgality are Eli Lilly). Similarly, the LLM attributes Abecma, Breyanzi, and others to Bristol Myers Squibb correctly, but fails to mention the key BMS biologics highlighted in the ground truth (Opdivo, Yervoy, Orencia, Reblozyl, Empliciti), which are central to the multi-hop comparison. The reasoning about differing exposure—Amgen facing more uncertainty and delay, BMS more immediate risk—is partially sound and contextually relevant, especially in contrasting U.S. and EU pathways. However, the flawed product portfolios undermine the qualitative accuracy and overall correctness. The synthesis across regulatory frameworks is reasonable, but the failure to correctly map products to companies weakens the multi-hop logic. Thus, while the structural reasoning and regulatory facts are on track, the core factual foundation is compromised, leading to a mid-range correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 410,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 187,
      "question": "How does Medtronic's exposure to Medicaid reimbursement policies compare to AbbVie's pricing pressures under the IRA, particularly in relation to their respective product portfolios and revenue risks?",
      "original_answer": "Medtronic faces increased price sensitivity from Medicaid reimbursement limitations, which affects hospitals' purchasing behavior and creates a need for competitively priced medical devices. AbbVie, on the other hand, is directly impacted by the Inflation Reduction Act (IRA), which allows the U.S. Department of Health and Human Services to set government prices for certain drugs like Imbruvica (selected in 2023 for pricing starting in 2026) and Vraylar and Linzess (selected in 2025 for pricing starting in 2027), potentially accelerating revenue erosion before patent expiration. While both companies face healthcare cost-containment pressures, Medtronic’s Medicaid exposure affects device pricing strategies, whereas AbbVie must navigate IRA-driven government pricing that could apply to more high-revenue products in the future.",
      "llm_answer": "Medtronic’s reimbursement risk is tied to possible changes in Medicaid (and other government‑payor) policies that could lower the amount it receives for its medical‑device and therapy portfolio, but because its sales are broadly distributed across many product lines, any reimbursement cut would affect revenue in a relatively diffuse way (see MDT page 15). AbbVie, by contrast, faces direct price‑cap pressure from the Inflation Reduction Act, which allows the government to set ceiling prices for single‑source drugs—including its top‑selling biologics and small‑molecule medicines that together account for roughly 47 % of 2024 net revenue (Humira, Skyrizi, Rinvoq, etc.)—making the IRA‑driven pricing reforms a concentrated threat to its earnings (see ABBV pages 19 & 17).",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the core contrast between Medtronic's Medicaid reimbursement exposure and AbbVie's IRA-driven pricing pressures, with accurate entity identification and strong multi-hop reasoning. It correctly identifies Medtronic's diffuse risk due to broad product portfolio exposure and AbbVie's concentrated risk from the IRA affecting high-revenue drugs. However, there are minor quantitative inaccuracies: the claim that AbbVie's top products (Humira, Skyrizi, Rinvoq, etc.) account for 'roughly 47% of 2024 net revenue' is not present in the original answer and cannot be verified against the ground truth, which does not include any percentage figures. This introduces a specific numerical claim absent from the source, reducing quantitative accuracy. The original answer instead emphasizes that Imbruvica, Vraylar, and Linzess are subject to IRA pricing (with specific selection and implementation years), but the LLM omits these drug names and the timeline details (e.g., Imbruvica selected in 2023 for 2026 pricing). While the LLM correctly identifies IRA price caps as a threat to AbbVie, it misses the forward-looking risk that more high-revenue products could be added in the future, as stated in the original. Despite these omissions and the unverified 47% figure, the qualitative reasoning and contextual relevance remain strong, with the answer addressing the comparative risk structure and policy mechanisms accurately at a conceptual level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 405,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How does the $2.7 billion in unfunded commitments to private equity funds held by UPS compare to General Dynamics' use of NAV for valuing its Level 1 plan assets, given both companies rely on NAV as a practical expedient for alternative investments?",
      "original_answer": "UPS reports $2.7 billion in unfunded commitments to private equity and similar funds as of December 31, 2024, with contributions expected over 3 to 6 years. These investments are valued using NAV as a practical expedient due to the lack of readily determinable fair value. Similarly, General Dynamics (GD) uses NAV for its Level 1 plan assets, which include commingled equity and fixed-income funds valued using a unit price or NAV. Both companies rely on NAV for valuation, but UPS's private equity commitments carry longer redemption restrictions (10–15 year terms), whereas GD's NAV-based assets are generally redeemable monthly or quarterly. This suggests UPS has a less liquid exposure to NAV-based investments compared to GD.",
      "llm_answer": "UPS discloses that it has roughly $2.7 billion of unfunded commitments to private‑equity, private‑debt and real‑estate limited‑partnership interests that will be funded over the next three‑to‑six years (UPS 10‑K, p. 93). In contrast, General Dynamics does not report a comparable unfunded commitment; instead it values its existing Level 1 plan assets – such as hedge‑fund and commingled‑fund holdings – at the reported NAV as a practical expedient, reflecting current market‑based values rather than future cash outlays (GD 10‑K, p. 91‑95).  Thus, UPS’s $2.7 billion is a future funding obligation, whereas GD’s NAV usage is a valuation method for already‑funded assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $2.7 billion unfunded commitment by UPS is correctly stated, including the 3-to-6-year funding horizon, matching the original answer. General Dynamics' use of NAV for Level 1 plan assets is also accurately described, with correct references to commingled and hedge funds. (2) All numbers and timeframes are correct; no calculation errors. Format variations (e.g., 'three-to-six years' vs '3 to 6 years') are acceptable and semantically equivalent. (3) The reasoning correctly distinguishes between UPS's future funding obligations (unfunded commitments) and GD's use of NAV as a valuation method for already-funded assets, which is a key multi-hop insight. The LLM captures the core contrast: UPS has future cash outflows tied to illiquid private investments, while GD uses NAV for current valuation of more liquid fund holdings. (4) The only minor omission is that the original answer adds specific detail about redemption terms—UPS’s 10–15 year lockups versus GD’s monthly/quarterly redeemability—which the LLM does not mention. This contextual nuance about liquidity differences strengthens the original answer but is not critical to the main comparison. Otherwise, the LLM demonstrates strong entity accuracy (UPS, GD, NAV, Level 1 assets), correct use of financial terminology, and appropriate sourcing logic from 10-Ks. The answer is contextually precise and directly responsive to the comparative question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 414,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How does CMCSA's issuance of Class B Common Stock in 2024 influence its shareholder voting rights structure, and how does this compare to META's dual-class framework as disclosed in their respective filings?",
      "original_answer": "CMCSA issued 9,444,375 shares of Class B Common Stock in 2024, which, as per the governance structure outlined in V_10k_2024.pdf, carries no voting rights except in limited circumstances such as exiting the core payments business or specific merger scenarios. This creates a tiered voting rights system where Class A shareholders maintain full voting control. Similarly, META's filing reveals a dual-class structure with Class A and Class B common stock, where Class A stockholders have full voting rights while Class B stockholders generally do not, except in defined events like a merger. Both companies thus concentrate voting power among a subset of shareholders, reinforcing control while allowing for differentiated capital structures.",
      "llm_answer": "CMCSA’s 2024 issuance of Class B (and Class C) common stock adds a non‑voting tier – holders of those shares cannot vote on most corporate matters and only vote on limited items such as certain mergers, exits from the core payments business, or charter amendments, leaving voting control essentially with the Class A shareholders (CMCSA 10‑K p. 90). By contrast, Meta’s filing describes a dual‑class system in which public Class A shares carry one vote per share while the founder‑controlled Class B shares carry ten votes per share, concentrating voting power with insiders (Meta 10‑K p. 2). Thus, CMCSA’s new Class B shares dilute ownership without granting voting rights, whereas Meta’s Class B shares provide enhanced voting authority.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several correct elements but introduces significant inaccuracies in the qualitative comparison, particularly regarding META's dual-class structure. (1) Quantitatively, the LLM correctly identifies CMCSA's issuance of non-voting Class B stock in 2024 and references the correct limited voting triggers (e.g., merger, exit from core payments business), though it omits the specific number of shares issued (9,444,375) from the ground truth. This is a minor omission, not a factual error. (2) However, the LLM incorrectly describes META’s dual-class structure: it states that Meta’s Class B shares have 10 votes per share and are founder-controlled, while Class A has 1 vote—this contradicts the ground truth, which states that Class A shareholders have full voting rights and Class B generally do not, except in defined events like a merger. The ground truth does not mention differential voting multiples (e.g., 10:1), nor does it specify that Meta’s Class B shares carry enhanced voting power. Instead, both companies are described as restricting voting rights for Class B shares. The LLM inverts the structure for Meta, claiming Class B has superior voting rights, which is not supported by the provided ground truth. (3) The multi-hop reasoning is partially sound—comparing CMCSA and Meta’s voting structures—but the synthesis is flawed due to the misrepresentation of Meta’s framework. (4) Contextually, the answer is relevant and well-structured, addressing both companies and the impact on voting rights. However, the core comparison is misleading. Thus, while the CMCSA portion is largely accurate, the Meta characterization undermines the correctness, warranting a score of 6. Quantitative accuracy is high (8) due to correct context and no numerical errors (though missing the exact share count). Qualitative accuracy is low (5) due to the critical misrepresentation of Meta’s voting structure. Contextual relevance remains strong (9) as the response directly engages the question’s framework.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 542,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How might the IRA's Medicare price-setting provisions impact revenue erosion timelines for Amgen's products that rely on federal reimbursement, especially in light of AbbVie's experience with Imbruvica and Vraylar being selected for government pricing starting in 2026 and 2027?",
      "original_answer": "The IRA's Medicare price-setting provisions could accelerate revenue erosion for Amgen's products that depend on federal reimbursement by imposing government-determined prices as early as nine or thirteen years post-FDA approval, depending on whether the product is a small molecule or biologic. This mirrors AbbVie's experience where Imbruvica was selected for price setting in 2026 and Vraylar and Linzess in 2027, leading to potential revenue declines before patent expiration. Amgen, which also relies heavily on Medicare reimbursement, faces similar risk as these policies reduce pricing flexibility and increase downward pressure on profitability.",
      "llm_answer": "The IRA requires Medicare to set a ceiling price and impose inflation‑penalty rebates for the first 10 drugs in 2026 and an additional 15 drugs in 2027, so Amgen warns that any of its products that rely on federal reimbursement could see lower government‑set prices and higher rebates that compress margins and cause revenue to erode earlier than it would from patent loss alone. AbbVie’s filing shows the same effect in practice—Imbruvica will be subject to government‑set pricing starting in 2026 and Vraylar in 2027, which it says will accelerate revenue erosion before intellectual‑property protection expires—suggesting Amgen could experience a comparable shift in erosion timelines for any of its drugs selected under the IRA.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor differences in emphasis. (1) Quantitatively, the LLM correctly identifies that Imbruvica is subject to government pricing starting in 2026 and Vraylar in 2027, matching the original answer. It also correctly references the IRA's rollout—10 drugs in 2026 and 15 in 2027—which aligns with known provisions of the Inflation Reduction Act, though the original answer does not specify these numbers. This additional detail is factually correct and enhances the response. (2) The LLM accurately identifies the relevant companies (Amgen, AbbVie), products (Imbruvica, Vraylar), and timelines (2026, 2027), with no entity errors. (3) The multi-hop reasoning is sound: it connects AbbVie’s experience under the IRA to Amgen’s exposure by drawing a parallel in revenue erosion risk due to government-set pricing, even before patent expiration. The synthesis across firms and policies is logical and well-supported. (4) Semantically, the LLM captures the key implication: IRA provisions may accelerate revenue erosion for federally reimbursed drugs. The only minor shortcoming is that the original answer specifies the 9- or 13-year post-approval timeline for small molecules vs biologics under the IRA, which the LLM omits. This is a relevant structural detail about the law’s mechanism, but its absence does not invalidate the overall correctness. The LLM focuses instead on the practical outcome (earlier erosion than patent loss), which is consistent. Thus, the answer is factually strong, contextually relevant, and well-reasoned, warranting a 9/10 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 453,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 190,
      "question": "How does the number of securities remaining available for future issuance under equity compensation plans approved by security holders at Colgate-Palmolive compare to the total remaining available securities disclosed by Procter & Gamble, based on their respective disclosures?",
      "original_answer": "Colgate-Palmolive reported 37,028,000 securities remaining available under equity compensation plans approved by security holders, while Procter & Gamble disclosed a total of 133,185,995 remaining available securities across both Stock Options/SARs and RSUs/PSUs under the same category of approved plans. This indicates PG has a significantly larger pool of available securities for future issuance compared to CL.",
      "llm_answer": "Colgate‑Palmolive reports that 37,028 thousand securities (about 37 million) remain available for future issuance under equity‑compensation plans approved by security holders【page_61】.  Procter & Gamble discloses that 119 million securities are still available for future issuance under its equity‑compensation plans【page_69】.  Thus, P&G’s pool of available shares is roughly three times the size of Colgate‑Palmolive’s.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Colgate-Palmolive's available securities as 37,028,000 (rounded to 37 million), which matches the ground truth. However, it reports Procter & Gamble's total remaining available securities as 119 million, which is incorrect—the ground truth is 133,185,995. This is a significant numerical discrepancy of over 14 million shares. (2) The calculation and comparison are based on inaccurate data: stating that P&G’s pool is 'roughly three times' Colgate’s is misleading. Using correct figures: 133.2M / 37.0M ≈ 3.6x, while 119M / 37M ≈ 3.2x—so the ratio is somewhat accurate but still skewed due to incorrect input. (3) The multi-hop reasoning is sound in structure—comparing available securities under shareholder-approved plans across two companies—but fails in execution due to incorrect sourcing for P&G. The LLM likely missed aggregating across P&G’s plan categories (Stock Options/SARs and RSUs/PSUs) or pulled outdated/wrong data. (4) Despite the reasoning framework being correct and contextually relevant, the quantitative inaccuracy significantly undermines the factual correctness, warranting a moderate score of 6. The answer is partially right but contains a major factual error in a core number.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 350,
        "total_tokens": 1592
      },
      "error": null
    },
    {
      "question_id": 190,
      "question": "How does the joint commercialization of BMY's biologics in Taiwan compare with MRK's strategic spin-off of its biosimilars business, given Taiwan's regulatory requirement for local clinical trial data for biologics registration?",
      "original_answer": "BMY jointly commercializes biologics like Opdivo and Yervoy in Taiwan with Ono, where BMS handles supply and both parties share development costs and profits. This suggests a collaborative, market-access-focused strategy in Taiwan, which requires local clinical trial data for biologics registration. In contrast, MRK spun off its biosimilars business into Organon, signaling a strategic retreat from the biosimilars segment, which faces increasing global competition and regulatory complexity, including in markets like Taiwan that require additional local data for registration. Thus, while BMY maintains a direct and collaborative presence in Taiwan's biologics market, MRK has opted to divest its biosimilars portfolio, potentially avoiding the added burden of meeting such regulatory requirements in markets requiring local trials.",
      "llm_answer": "BMS’s Taiwan strategy relies on a partnership with Ono – the two companies co‑develop and co‑commercialize biologics such as Opdivo/Yervoy in Taiwan, sharing supply, development costs and profits while still having to generate the local bridging trial data that Taiwan requires for biologics registration (Amgen 10‑K p. 22). In contrast, Merck has removed its biosimilars from the core business by spinning them off into the independent Organon company (Merck 10‑K p. 3), allowing the new entity to meet Taiwan’s local‑data requirement (and other regulatory demands) on its own rather than through a joint‑venture arrangement.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies BMS's (BMY's) joint commercialization strategy in Taiwan with Ono for biologics like Opdivo and Yervoy, including shared development costs, profits, and supply responsibilities. It accurately notes Taiwan's requirement for local clinical trial data (referred to as 'bridging trials'), which aligns with the ground truth. The contrast with MRK (Merck) spinning off its biosimilars business into Organon is also factually correct. However, the LLM incorrectly implies that Organon, post-spin-off, is expected to meet Taiwan’s local data requirements independently, suggesting a continued regulatory burden on the spun-off entity. The ground truth emphasizes MRK’s strategic retreat *from* the biosimilars segment, implying avoidance of such burdens altogether—this nuance is slightly misrepresented. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored 10 by default as no inaccuracies exist. (3) The multi-hop reasoning is largely sound: the model connects BMY’s collaborative market-access strategy in Taiwan with regulatory requirements and contrasts it with MRK’s structural divestiture. However, the reasoning slightly mischaracterizes the implication of the spin-off—portraying Organon as still responsible for meeting Taiwan’s rules, rather than recognizing that MRK has exited this responsibility entirely, which weakens the qualitative accuracy. (4) Contextual relevance is perfect: all information provided directly addresses the comparison between BMY’s collaborative approach and MRK’s strategic divestiture in the context of Taiwan’s regulatory environment. Minor reasoning flaw prevents a 9–10 correctness score, but core facts are accurate, warranting an 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 489,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 191,
      "question": "How does AAPL's 2022 revenue contribution from Taiwan, as part of its Greater China segment, compare to ADBE's operational presence in the same region?",
      "original_answer": "AAPL reported $74,200 million in net sales for its Greater China segment in 2022, which includes Taiwan among other regions. ADBE maintains a local field office in Taiwan as part of its global operations, indicating a direct market presence. While AAPL's exposure to Taiwan is embedded within its broader Greater China revenue, ADBE's operational footprint in Taiwan suggests a more targeted geographic strategy in the region.",
      "llm_answer": "Apple’s 2022 net‑sales for the Greater China segment – which the filing says “includes Hong Kong and Taiwan” – were $74.2 billion【page_52】.  Adobe’s 10‑K only notes that it has a local field office in Taiwan as part of its worldwide sales and support network【page_15】, so Adobe’s footprint there is limited to a sales/support location rather than a large revenue‑generating segment comparable to Apple’s multi‑billion‑dollar contribution.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $74.2 billion figure for AAPL's Greater China segment in 2022 is correct and matches the $74,200 million in the original answer (with acceptable unit conversion: $74.2 billion = $74,200 million). (2) The LLM correctly identifies that AAPL's revenue from Taiwan is embedded within its Greater China segment, which includes Taiwan and Hong Kong, and cites the correct context from the filing. (3) For ADBE, the LLM accurately states that Adobe has a local field office in Taiwan as part of its global sales and support network, reflecting a direct but limited operational presence—consistent with the original answer’s claim of a 'local field office' and 'targeted geographic strategy'. (4) The reasoning correctly contrasts AAPL’s significant revenue exposure (albeit aggregated) with ADBE’s operational but non-revenue-specific footprint, capturing the multi-hop comparison between revenue contribution and operational presence. (5) Minor deduction in qualitative accuracy due to slightly less nuanced phrasing than the original (e.g., not explicitly stating that ADBE’s presence suggests a 'more targeted strategy'), but the semantic meaning and factual content are equivalent. All entities (AAPL, ADBE, 2022, Taiwan, Greater China) and their relationships are correctly identified and synthesized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 385,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 191,
      "question": "How do CMCSA and META differ in terms of the voting control concentration between Class A and Class B common stockholders, and what implications does this have for shareholder influence in corporate governance decisions?",
      "original_answer": "CMCSA's Class A common stockholders hold 66 2/3% of the combined voting power, while Class B stockholders (led by Brian L. Roberts) hold 33 1/3%, with each Class B share carrying 15 votes. In contrast, META's Class B common stock, though not publicly traded, holds significant voting rights, but the specific voting power percentage is not disclosed. However, META's Class A shares are publicly traded under the ticker META, and as of December 31, 2023, there were only 23 stockholders of record for Class B shares, indicating concentrated control. This means CMCSA maintains a structured balance of voting power, while META's control is more opaque and concentrated among fewer Class B holders.",
      "llm_answer": "CMCSA’s dual‑class structure gives Class A shareholders roughly two‑thirds (≈66 %) of the combined voting power, while the single Class B holder (Brian L. Roberts) controls the remaining one‑third (≈33 %) through 15‑vote shares【page_33】. By contrast, META’s Class B shares are not listed and are held by only 23 record owners (versus 3,098 Class A holders), concentrating voting power in a small insider group and giving them a disproportionate influence over corporate decisions【page_57】. Thus, Comcast’s public shareholders retain a majority voice in governance, whereas Meta’s insiders dominate voting, limiting ordinary shareholders’ ability to affect board elections and other governance matters.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and percentages are correct: CMCSA's Class A has approximately 66 2/3% voting power and Class B has 33 1/3%, with each Class B share carrying 15 votes — the LLM correctly rounds these to 'two-thirds' and 'one-third', which is acceptable and common. The statement that there are 23 record holders of META Class B shares matches the ground truth as of December 31, 2023. (2) The LLM correctly identifies Brian L. Roberts as the sole (or single) Class B holder for CMCSA, consistent with the ground truth's emphasis on his leadership of Class B stockholders. (3) For META, while the exact percentage of voting power held by Class B is not disclosed in either answer, the LLM appropriately notes the concentration of control among 23 record holders without fabricating a figure, and correctly states that Class B shares are not publicly traded. (4) The reasoning and synthesis across both companies are sound: the contrast between CMCSA’s structured, majority-public voting balance and META’s insider-dominated governance is clearly and correctly articulated. (5) The implication for shareholder influence — that CMCSA public shareholders retain majority voice while Meta insiders dominate decisions — is a valid interpretation supported by the data. The only minor shortcoming is that the LLM implies Brian L. Roberts is the *only* Class B holder at CMCSA, whereas the ground truth says Class B is 'led by' him, leaving room for other minor holders. This slight overstatement prevents a perfect 10 but does not materially distort the conclusion. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 468,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 191,
      "question": "How do LLY and MRK benefit differently from pediatric exclusivity provisions in the U.S. and EU regulatory frameworks?",
      "original_answer": "LLY benefits from pediatric exclusivity in the U.S. by receiving an additional six months of exclusivity added to data protection, orphan drug exclusivity, or non-expired patents. MRK, on the other hand, benefits in the U.S. through an additional six months of market exclusivity added to Orange Book-listed patents and regulatory data exclusivity, and in the EU through an additional six months added to the Supplementary Protection Certificate (SPC) term. This difference in application highlights how the U.S. framework ties pediatric exclusivity to both patents and data protection, while the EU framework applies it only to the SPC term.",
      "llm_answer": "Lilly’s filing only describes the generic pediatric‑exclusivity rule – in the U.S. a six‑month extension can be tacked onto its data‑protection term (and, for non‑biologics, onto any remaining patents or orphan‑drug exclusivity) and, in the EU, the same six months is added to a product’s SPC term【page_6】. Merck’s filing spells out the same six‑month boost but notes that it is added to the patent term for Orange‑Book‑listed patents and to the data‑exclusivity term for both small‑molecule and biologic products in the U.S., and it actually flags at least one product as “eligible for six months pediatric market exclusivity,” meaning Merck can apply the six‑month SPC extension in the EU as well【page_14】【page_15】.  In short, Lilly’s benefit is described as a potential, broad‑based extension, while Merck already has a specific product qualifying for the six‑month pediatric exclusivity in both the U.S. and EU.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in terms of factual content and accurately reflects the differences in how LLY and MRK benefit from pediatric exclusivity in the U.S. and EU. The quantitative elements (six-month extensions in both jurisdictions) are correctly stated and consistent with the ground truth. The U.S. framework is accurately described as applying the six-month exclusivity to data protection, patents (for non-biologics), and orphan drug exclusivity, and the EU mechanism correctly tied to SPC extensions. The mention of Orange Book-listed patents for Merck aligns with the original answer.\n\nHowever, the LLM introduces a nuance not present in the ground truth: that Merck 'already has a specific product qualifying' for pediatric exclusivity while Lilly's is 'potential' or 'broad-based.' This distinction about current vs. potential application is not supported in the original answer, which focuses on structural differences in how the two companies' filings describe the regulatory frameworks, not on whether exclusivity has actually been applied to specific products. This adds an interpretive layer that goes beyond the provided ground truth, slightly reducing qualitative accuracy.\n\nThe core multi-hop reasoning—comparing LLY and MRK across U.S. and EU frameworks—is sound and contextually relevant. The answer correctly synthesizes that the U.S. allows pediatric exclusivity to extend both patents and data protection, while the EU applies it only to SPCs. Despite the minor overinterpretation regarding product-specific eligibility, the key factual and structural comparisons are accurate, warranting a high correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 451,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 192,
      "question": "How does the change in EMR's foreign currency liabilities from 2023 to 2024 compare with the scale of LMT's foreign currency hedge exposure, and what might this indicate about their respective foreign exchange risk management strategies?",
      "original_answer": "EMR's foreign currency liabilities decreased from $22 billion in 2023 to $20 billion in 2024, a $2 billion reduction, while LMT maintained $7.5 billion in outstanding foreign currency hedges at the end of 2024. This indicates that LMT is proactively hedging a significant portion of its foreign exchange exposure, whereas EMR appears to be reducing its overall foreign currency liability position rather than necessarily increasing hedging activity. The use of option contracts by LMT suggests a strategy focused on offsetting earnings volatility from exchange rate fluctuations, while EMR's declining liabilities may reflect either reduced international operations or a shift in risk management approach.",
      "llm_answer": "EMR’s foreign‑currency liabilities – essentially its euro‑denominated debt – fell from about **$1.606 billion in 2023 to $1.137 billion in 2024**, a drop of roughly **$0.47 billion** (see EMR 10‑K, page 60). Lockheed Martin, by contrast, reports **foreign‑currency hedge notional amounts of $7.5 billion at year‑end 2024 (up from $6.5 billion in 2023)** (see LMT 10‑K, page 52). The modest reduction in EMR’s exposure versus LMT’s multi‑billion‑dollar hedge program indicates that EMR’s FX risk is relatively limited and managed mainly through its debt structure, while LMT maintains a far larger, systematic hedging program to cover a broad base of foreign‑currency risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies in key financial figures. According to the ground truth, EMR's foreign currency liabilities decreased from $22 billion in 2023 to $20 billion in 2024, a $2 billion reduction. However, the LLM incorrectly reports this as falling from $1.606 billion to $1.137 billion, a drop of only $0.47 billion—off by an order of magnitude. This severe numerical error undermines the entire analysis. While the LMT hedge exposure of $7.5 billion in 2024 is correctly reported, the LLM adds an unsupported claim that it was $6.5 billion in 2023, which is not present in the original answer and cannot be verified from the provided truth. (2) Calculations are internally consistent within the LLM’s incorrect numbers (e.g., $1.606B - $1.137B ≈ $0.47B), but since the base values are wrong, the comparison is invalid. The ground truth does not mention LMT’s 2023 hedge value, so introducing $6.5B is an unsupported addition. (3) The multi-hop reasoning is structurally sound—comparing liability reduction vs. active hedging—but based on false premises. The conclusion that EMR manages risk via debt structure has some alignment with the original interpretation, but the scale of EMR’s liability is so misstated that the comparison to LMT’s $7.5B hedge program becomes misleading. The original answer emphasizes EMR reducing liabilities as a strategy versus LMT’s proactive hedging; the LLM attempts similar logic but with incorrect data. (4) Contextual relevance is fair—the response addresses both companies, the time frame, and attempts to infer risk management strategies. However, due to the critical error in EMR’s liability figures, the qualitative and quantitative accuracy scores are low. A correctness score of 3 reflects that while the structure and intent are partially correct, the core data is factually wrong, leading to a misleading comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 515,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 192,
      "question": "How does the $3.6 billion in dividends paid by AENB to AXP in 2023 relate to the leverage ratio requirements that both AENB and WFC are subject to under federal banking regulations?",
      "original_answer": "The $3.6 billion in dividends paid by AENB to AXP in 2023 is directly tied to AENB's compliance with leverage ratio requirements, as AENB must consider the impact of such distributions on its regulatory capital ratios. AENB, as a subsidiary bank of AXP, is subject to federal banking regulations that restrict dividend payments if they would cause the bank to fall short of required leverage ratios. Similarly, WFC, as a large bank holding company, is also subject to leverage and supplementary leverage ratio requirements under Basel III and FRB rules, which constrain its ability to make capital distributions like dividends. Therefore, both AENB and WFC must ensure that any dividend payments comply with these leverage constraints, making the $3.6 billion distribution by AENB a function of its ability to maintain required capital levels under the same type of regulatory framework that governs WFC.",
      "llm_answer": "The $3.6 billion dividend that AENB paid to its parent American Express in 2023 reduces the bank’s Tier 1 capital, and because AENB – like every FDIC‑insured depository institution – must keep its Tier 1 leverage ratio above the regulator‑mandated minimum (the Federal Reserve’s 4 % floor) the payout is constrained by that requirement【page_67】.  Wells Fargo faces the same leverage‑ratio ceiling – the FRB requires large BHCs and their banks to maintain a minimum leverage (and supplementary‑leverage) ratio and to factor that limit into any dividend plan – so both AENB’s $3.6 billion dividend and any Wells Fargo dividend must be sized to preserve compliance with the leverage‑ratio rules【page_4】【page_5】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $3.6 billion dividend amount and the 2023 timeframe match the original answer. The mention of the 4% Tier 1 leverage ratio floor is consistent with federal regulatory standards, even if the exact percentage isn't in the ground truth — it is a correct factual addition supported by Basel III and FRB rules. (2) The answer correctly identifies the entities: AENB (American Express National Bank), AXP (American Express), and WFC (Wells Fargo), and accurately describes their regulatory environments. (3) The reasoning is sound and reflects proper multi-hop synthesis: it connects AENB’s dividend payout to its impact on regulatory capital (Tier 1 capital and leverage ratio), explains that such payouts are constrained by federal requirements, and draws a parallel to WFC’s similar constraints under the same regulatory framework (FRB, Basel III). This mirrors the original answer’s core logic. (4) The only minor shortcoming is that the LLM specifies the 'Tier 1 leverage ratio' and '4% floor' with more precision than the original, which speaks to regulatory expectations but doesn’t contradict them. While this detail enhances clarity, the original answer remains more general, so the LLM slightly exceeds rather than misstates. Overall, the answer is factually correct, contextually relevant, and synthesizes across entities and regulations appropriately, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 415,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 193,
      "question": "How does the geographic distribution of Microsoft's pre-tax income ($62.9B U.S. and $44.9B foreign in fiscal 2024) influence its exposure to the OECD's Pillar Two Model Rules, and how does this compare to Qualcomm's expected impact under the same Global Minimum Tax framework given their similar fiscal year 2025 implementation timeline?",
      "original_answer": "Microsoft's geographic distribution of pre-tax income shows significantly higher earnings in the U.S. ($62.9B) compared to foreign jurisdictions ($44.9B), which may reduce its exposure to the Pillar Two Model Rules since these rules target multinational enterprises with operations in low-tax jurisdictions. Microsoft notes it does not expect a material impact from Pillar Two. Similarly, Qualcomm acknowledges the global minimum tax framework will apply to them starting in fiscal 2025 and also states they do not expect a material impact on their financial statements, suggesting both companies anticipate minimal disruption from the same regulatory framework.",
      "llm_answer": "Microsoft’s fiscal‑2024 pre‑tax earnings were about $62.9 billion in the United States and $44.9 billion abroad, but the company notes that it “does not have material operations in jurisdictions with tax rates lower than the Pillar Two minimum” and therefore does not expect a material increase to its global tax cost when the OECD Pillar Two rules apply beginning in fiscal 2025 (MSFT 10‑K Item 7, p. 47). Qualcomm makes a parallel statement – it also says the 15 % global minimum tax (Pillar Two) “will apply … beginning in fiscal 2025” but “we do not currently expect this to materially impact our consolidated financial statements” (QCOM 10‑K, p. 43). Thus, despite Microsoft’s sizable foreign earnings mix, both firms anticipate only limited exposure to the Pillar Two framework.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitative accuracy: The pre-tax income figures for Microsoft ($62.9B U.S., $44.9B foreign) are correctly reported, and the fiscal 2025 implementation timeline for Pillar Two is accurately stated for both Microsoft and Qualcomm. No calculations are required, but the synthesis of relative exposure based on geographic earnings is logically sound. (2) Completeness: The answer addresses both parts of the multi-hop question—Microsoft’s exposure based on income distribution and comparison with Qualcomm’s expected impact—citing both companies’ disclosures. (3) Entity accuracy: Correct company names (Microsoft, Qualcomm), tickers (MSFT, QCOM), financial metrics (pre-tax income), and timeframes (fiscal 2024 for Microsoft income, fiscal 2025 for Pillar Two applicability) are used. (4) Reasoning: The logic is strong—despite Microsoft’s significant foreign earnings, the key point is the absence of material operations in low-tax jurisdictions, which aligns with the Pillar Two targeting mechanism. Qualcomm’s parallel disclosure is correctly compared, showing both expect no material impact. (5) Semantic equivalence: The LLM conveys the same conclusion as the ground truth—that both companies anticipate minimal disruption from Pillar Two—with added specificity from 10-K references (page numbers, exact phrasing), enhancing credibility without deviating from the truth. Minor wording differences (e.g., 'abroad' vs 'foreign') do not affect meaning. All information is contextually relevant and precisely aligned with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 442,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 193,
      "question": "How does WMT's $37.2 billion in unrecorded purchase obligations expose the company to financial risks that aren't captured by the VAR models used by peers like MDLZ?",
      "original_answer": "WMT has $37.2 billion in unrecorded purchase obligations as of January 31, 2025, which includes firm commitments for inventory, utility purchases, and capital expenditures. These obligations are legally binding but are not reflected on the balance sheet. However, according to DIS's 10-K filing, VAR models — like the one used by MDLZ — exclude forecasted transactions and firm commitments when estimating financial risk exposure. MDLZ's VAR model specifically uses a parametric delta-gamma approximation technique based on interest rate, currency, and commodity price movements to estimate potential one-day losses, but does not include firm commitments in its calculations. This means that while WMT has significant off-balance sheet obligations, companies using VAR models like MDLZ do not incorporate these types of commitments into their risk assessments, leaving WMT potentially more exposed to market volatility that isn't captured through standard VAR modeling practices.",
      "llm_answer": "Walmart’s $37.2 billion of “unrecorded purchase obligations” – legally‑binding firm commitments for inventory, utilities, capital‑expenditure, software licences and service contracts (with $15.9 billion due within a year) – represent a sizable cash‑outflow exposure that could strain liquidity, affect credit ratings and increase borrowing costs if the obligations cannot be met on schedule【page_45】.  By contrast, Mondelēz’s VAR model only measures market‑risk losses under normal‑market, one‑day, 95 %‑confidence assumptions and explicitly excludes firm commitments, anticipated transactions and other contractual cash‑flow items from the calculation【page_66】【page_65】.  Consequently, the cash‑flow risk embedded in Walmart’s purchase‑obligation portfolio is not captured by the VAR‑based risk metrics that peers such as MDLZ rely on.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $37.2 billion unrecorded purchase obligations are correctly stated, and the breakdown including $15.9 billion due within a year is consistent with typical disclosures (though this specific split wasn't in the original answer, it does not contradict it and may reflect additional detail from the source). The fiscal date (January 31, 2025) is implied as current in context and not contradicted. (2) The entity identification is correct: WMT (Walmart) and MDLZ (Mondelēz) are accurately referenced, and the use of DIS's 10-K in the original answer to support VAR exclusions is effectively mirrored by the LLM citing MDLZ’s own filing to confirm exclusion of firm commitments—this is semantically equivalent and valid. (3) The multi-hop reasoning is sound: the LLM correctly links WMT’s off-balance sheet obligations to the limitations of VAR models used by peers like MDLZ, noting that these models exclude firm commitments and forecasted transactions. It accurately describes MDLZ’s VAR methodology (parametric delta-gamma approximation under normal market conditions, one-day horizon, 95% confidence) as per the original context. (4) The conclusion—that WMT’s cash-flow risks are not captured by VAR-based metrics—is logically derived and matches the original answer’s core insight. The only minor gap is the absence of explicit mention of 'interest rate, currency, and commodity price movements' as risk factors in MDLZ’s model, though the reference to 'market-risk losses' under VAR implies them. Overall, the answer is factually correct, well-reasoned, and contextually complete, warranting a high score with only slight deduction for not fully enumerating the risk factors in the VAR model.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 484,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 193,
      "question": "How does UNH's use of interest rate swaps to manage exposure to floating-rate liabilities compare with AMGN's use of similar instruments in relation to their respective $1.4 billion repayments of the 3.625% 2024 Notes?",
      "original_answer": "UNH uses interest rate swaps as part of its broader strategy to manage exposure to market interest rate fluctuations on both assets and liabilities, including $27 billion of floating-rate financial liabilities as of December 31, 2024. AMGN, on the other hand, specifically entered into interest rate swap contracts to convert fixed-rate coupons to floating-rate SOFR-based coupons, with $1.4 billion of such swaps maturing in 2024 in connection with the repayment of the 3.625% 2024 Notes. While both companies use interest rate swaps, UNH's application is broader in scope across its balance sheet, whereas AMGN's use is directly tied to specific debt instruments like the 3.625% 2024 Notes that were fully repaid in 2024.",
      "llm_answer": "UnitedHealth Group uses interest‑rate swaps as a broad‑based hedging tool – the company maintains a portfolio of swaps (about $6.7 billion of notional amount) that are designated as fair‑value hedges and convert fixed‑rate coupons on its long‑term debt into floating‑rate, SOFR‑based coupons, thereby matching a portion of its floating‑rate assets and liabilities【page_38】. Amgen, on the other hand, tied its swaps to a specific debt repayment: the $1.4 billion of interest‑rate swap contracts that matured in 2024 were used to hedge the $1.4 billion repayment of its 3.625 % 2024 Notes, and the company then entered into new $1.4 billion swaps for its 5.25 % 2033 Notes at SOFR + 1.8%【page_148】【page_149】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly affect correctness, particularly in quantitative details and entity-specific facts. (1) Quantitative Accuracy: The LLM states UNH has $6.7 billion in notional amount of interest rate swaps, but the ground truth indicates UNH has $27 billion in floating-rate liabilities (not swaps) as of December 31, 2024—this is a major discrepancy. The LLM incorrectly frames UNH’s swaps as converting fixed to floating, while the ground truth describes UNH’s use as managing exposure across both assets and liabilities more broadly, not specifically tied to debt conversion. For AMGN, the LLM correctly identifies the $1.4 billion swap maturity in 2024 linked to the 3.625% Notes repayment, which aligns with the original answer. However, the mention of new $1.4 billion swaps for the 5.25% 2033 Notes at SOFR + 1.8% is extraneous and not responsive to the question about the 2024 Notes repayment. (2) Completeness: The LLM addresses both companies and their use of swaps, but misrepresents UNH’s strategy and adds irrelevant forward-looking detail about AMGN’s 2033 Notes. The core comparison—UNH’s broad balance sheet use vs. AMGN’s specific instrument-level hedging—is partially captured but distorted by incorrect figures. (3) Entity Accuracy: Companies (UNH, AMGN), the 3.625% 2024 Notes, SOFR, and the $1.4 billion amount are correctly identified. The years (2024) and debt instruments are accurate. (4) Reasoning: The multi-hop reasoning is partially sound—comparing scope of swap usage between two firms—but flawed due to incorrect characterization of UNH’s program. The LLM implies UNH uses swaps to convert fixed to floating on debt, which contradicts the ground truth that UNH manages exposure across $27B of floating-rate liabilities (not fixed-to-floating conversions). (5) Semantic Equivalence: While the intent to contrast broad vs. specific use is present, the factual foundation is weak due to incorrect numbers and misattribution of strategy. The answer introduces details not in the original (e.g., new 2033 swaps) and omits key context about UNH’s broader risk management. Thus, despite relevant structure and some correct elements, the quantitative and strategic inaccuracies reduce overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 606,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 194,
      "question": "How does the potential acceleration of AMD's 3.924% Senior Notes Due 2032 in the event of an 'Event of Default' compare with Oracle's exposure to similar default-triggered obligations under their Revolving Credit Agreement, particularly in terms of debt repayment structure and maturity conditions?",
      "original_answer": "AMD's 3.924% Senior Notes Due 2032 could be accelerated upon an Event of Default, which would require AMD to repay $1.0 billion in aggregate principal issued in 2022, plus accrued interest. Oracle, under its Revolving Credit Agreement, also faces potential acceleration if an Event of Default occurs, with the full $6.0 billion facility becoming due unless terminated earlier. Unlike AMD's notes, which are unsecured senior obligations, Oracle's Revolving Facility allows borrowing, prepayment, and reborrowing until March 8, 2027, with interest rates tied to credit ratings. Both companies face significant financial obligations upon default, but Oracle's structure allows more flexibility in managing short-term liquidity.",
      "llm_answer": "AMD’s 3.924 % senior notes due 2032 are unsecured, fixed‑rate bonds that would be accelerated – requiring the entire principal and any accrued interest to be paid immediately – if an “event of default” occurs (AMD 10‑K, p. 79). By contrast, Oracle’s $6 billion revolving credit facility does not have a single bond maturity; any amounts drawn become due on March 8, 2027 (or earlier if the facility is terminated at Oracle’s request) and are accelerated to that maturity date only if an event of default occurs (Oracle 10‑K, p. 88). Thus AMD faces instant repayment of a specific 2032 note, while Oracle’s default exposure would force repayment of any outstanding revolving‑credit borrowings on a preset 2027 date rather than immediately.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: AMD's $1.0 billion 3.924% Senior Notes Due 2032 would be accelerated upon Event of Default, requiring immediate repayment of principal and accrued interest. Oracle's $6.0 billion Revolving Credit Agreement would also accelerate upon default, with outstanding amounts due by March 8, 2027, or earlier termination. These numbers, dates, and dollar amounts are all correctly reported, with acceptable formatting variations (e.g., $6 billion = $6.0 billion). (2) Quantitative accuracy is perfect: the $1.0 billion and $6.0 billion figures, the 3.924% rate, and the 2027 maturity date are all correct. (3) The multi-hop reasoning is sound—comparing AMD’s fixed-maturity unsecured notes with Oracle’s revolving facility structure shows understanding of different debt instruments and default consequences. The LLM correctly notes that Oracle’s repayment is due on a preset date (2027) rather than immediately upon default, which aligns with the ground truth’s emphasis on Oracle’s facility allowing reborrowing until maturity. (4) The only minor omission is that the LLM does not explicitly mention Oracle’s interest rates being tied to credit ratings, a detail present in the original answer. Additionally, while the LLM correctly states Oracle’s repayment would be due on March 8, 2027, it could have clarified that the full facility becomes due upon default, not just drawn amounts—though this is implied. Despite these small gaps, the core comparison of repayment structure and maturity conditions is accurate and well-reasoned. Semantic equivalence is strong, and the answer is fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 464,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 195,
      "question": "How does the $31.0 billion of trust assets under reinsurance agreements at GE, which are subject to strict investment guidelines, compare to General Dynamics' $191 million in marketable securities held in trust as of December 31, 2021, in terms of investment policy and risk exposure?",
      "original_answer": "GE holds $31.0 billion in trust assets associated with reinsurance contracts and is subject to strict investment guidelines that include limitations on asset class concentration, issuer exposure, and duration variances, with a focus on diversification and credit quality while considering risk-based capital requirements. These trust assets are managed to support insurance liabilities and are reviewed periodically for asset allocation changes, including the potential inclusion of non-traditional asset classes. In contrast, General Dynamics held $191 million in marketable securities in trust as of December 31, 2021, governed by an investment policy that restricts purchases to investment-grade fixed-income securities with a maximum maturity of five years, indicating a more conservative and short-duration approach. This highlights a significant difference in scale and investment strategy between the two companies' trust asset management, with GE facing broader credit, interest rate, and reinvestment risks due to the larger and more diverse asset base.",
      "llm_answer": "GE’s run‑off insurance trusts contain about **$31 billion** of assets that are held by an independent trustee and are governed by “strict investment guidelines, including limitations on asset‑class concentration, single‑issuer exposures, asset‑liability duration variances, and other factors to meet credit‑quality, yield, liquidity and diversification requirements” 【page_50】. These guidelines allow a diversified mix that includes investment‑grade debt, private‑equity, senior secured loans and infrastructure, exposing the portfolio to **credit, interest‑rate and equity risk** 【page_48】.  \n\nGeneral Dynamics, by contrast, held **$191 million** of marketable securities in trust at year‑end 2021, and its investment policy “allows for purchases of fixed‑income securities with an investment‑grade rating and a maximum maturity of up to five years” 【page_52】, so the exposure is far smaller and limited to short‑duration, investment‑grade bonds, implying a **much narrower, lower‑risk profile**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key factual elements: GE's $31.0 billion in trust assets under reinsurance agreements and General Dynamics' $191 million in marketable securities as of December 31, 2021. The dollar amounts are accurate and properly attributed to the respective companies and timeframes. (2) Quantitative accuracy is perfect—both figures match the ground truth exactly, with acceptable formatting variations ($31 billion = $31.0 billion; $191 million is consistent). The date (year-end 2021) is correctly implied for General Dynamics. (3) The multi-hop reasoning is sound: the model synthesizes investment policies across two different companies from distinct contexts—GE’s broader, diversified approach allowing private equity, loans, and infrastructure with associated credit, interest rate, and equity risks, versus General Dynamics’ narrow policy limited to investment-grade fixed-income securities with a maximum five-year maturity. This correctly reflects the contrast in risk exposure and investment strategy. (4) The LLM captures the core qualitative differences in investment policy and risk profile, though it omits minor contextual details present in the original answer—such as GE’s consideration of risk-based capital requirements and periodic review for non-traditional asset classes. However, these omissions do not detract from the essential correctness or the comparative insight. Wording differs but semantic meaning and factual content are equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy due to slight incompleteness in nuance, but full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1549,
        "completion_tokens": 459,
        "total_tokens": 2008
      },
      "error": null
    },
    {
      "question_id": 195,
      "question": "How do the observable market data inputs used in Lockheed Martin's fixed income pricing models compare to the inputs used in PayPal's derivative valuations, given both institutions rely on Level 2 pricing methodologies?",
      "original_answer": "Lockheed Martin's fixed income investments categorized as Level 2 are valued using pricing models that incorporate verifiable observable market data such as interest rates, yield curves at commonly quoted intervals, and credit spreads. Similarly, PayPal values a majority of its derivative instruments using pricing models that consider observable inputs like currency rates, interest rate yield curves, option volatility, and equity prices. Both institutions rely on Level 2 methodologies, indicating a shared dependence on observable market factors to determine fair value, although applied to different asset classes—fixed income for Lockheed Martin and derivatives for PayPal.",
      "llm_answer": "Lockheed Martin’s fixed‑income models are Level 2 because they are driven by verifiable market data such as current interest‑rate levels, yield‑curve points, credit‑spread levels and broker or dealer quotes for comparable bonds or swaps. PayPal’s derivative valuations are also Level 2, but they use observable inputs that span multiple markets – FX rates, interest‑rate yield curves, equity prices and option‑volatility surfaces – in addition to any relevant yield‑curve data. Thus, while both firms rely on Level 2 pricing, Lockheed’s inputs are fixed‑income‑market specific, whereas PayPal’s inputs are broader, reflecting currency, equity and volatility market data.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Lockheed Martin uses observable inputs like interest rates, yield curves, credit spreads, and broker quotes for Level 2 fixed income pricing; PayPal uses FX rates, interest rate curves, equity prices, and option volatility for Level 2 derivative valuations. These match the original answer. (2) There are no numeric values requiring calculation, so quantitative accuracy is perfect. (3) The multi-hop reasoning is sound—correctly comparing Level 2 methodologies across two different companies and asset classes (fixed income vs. derivatives), identifying both commonalities (reliance on observable inputs) and differences (scope of markets). (4) The LLM adds slightly more detail (e.g., 'option volatility surfaces', 'broker or dealer quotes') not in the original but consistent with plausible SEC filing language, which enhances clarity without introducing error. Only minor deduction from 10 is due to slight rephrasing emphasis—original highlights 'shared dependence on observable market factors', which LLM implies but doesn't explicitly state—but this does not affect factual correctness. Overall, high accuracy, completeness, and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 355,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 196,
      "question": "How does the sensitivity of AVGO's fixed rate senior notes to interest rate changes compare to the impact of CSCO's interest rate swap on their fixed-rate debt, given both companies' exposure to market interest rate fluctuations?",
      "original_answer": "AVGO's $56.3 billion in fixed rate senior notes as of November 3, 2024, would see a $1.7 billion change in fair value with a 50 basis point interest rate shift, while CSCO has an interest rate swap with a notional amount of $0.5 billion that converts a portion of its fixed-rate debt to floating, offsetting changes in fair value due to interest rate movements. CSCO’s swap specifically hedges a senior note due in fiscal 2025, whereas AVGO uses treasury rate lock contracts to hedge anticipated future debt issuances, indicating differing hedging strategies despite both managing interest rate risk on fixed-rate debt.",
      "llm_answer": "Broadcom’s (AVGO) fixed‑rate senior notes are highly sensitive to market rates – a 50‑basis‑point move would alter the fair value of the notes by about $1.7 billion (2024) or $1.4 billion (2023). Cisco (CSCO) instead uses a $0.5 billion interest‑rate swap that is accounted for as a fair‑value hedge; the swap’s gain or loss “substantially offsets” the change in fair value of the hedged portion of its fixed‑rate notes, effectively neutralizing the rate‑risk for that slice of debt. Thus AVGO’s exposure is un‑hedged and materially larger, while Cisco’s swap mitigates the impact on a relatively small, hedged portion of its fixed‑rate debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth with only minor differences. (1) Quantitatively, the LLM correctly states AVGO's $1.7 billion fair value change (as of 2024) due to a 50 bps interest rate shift and CSCO's $0.5 billion notional swap. It adds a correct but extra detail about a $1.4 billion impact in 2023, which is not in the original but does not contradict it. (2) The entity identification (AVGO, CSCO), financial instruments (fixed-rate senior notes, interest rate swap), and hedging mechanisms are accurate. (3) The reasoning correctly contrasts AVGO’s sensitivity (unhedged, large exposure) with CSCO’s use of a fair-value hedge that offsets rate risk on a portion of debt. The LLM infers correctly that CSCO’s swap 'substantially offsets' fair value changes, aligning with the ground truth’s 'offsetting changes.' (4) The only minor omission is that the original specifies CSCO’s swap hedges a senior note due in fiscal 2025, and AVGO uses treasury rate locks for *future* debt issuances—details not included in the LLM answer. However, the core multi-hop comparison of sensitivity and hedging strategy is sound. Wording differs but meaning is semantically equivalent. No calculation errors. Thus, the answer earns a 9 for correctness—excellent but not fully complete on contextual hedging timing and purpose details.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 381,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 196,
      "question": "How does BMY's joint research and commercialization obligations with Pfizer under the Eliquis alliance compare to Pfizer's financial commitments in its collaboration with Beam for in vivo base editing programs, particularly in terms of upfront payments and potential milestone obligations?",
      "original_answer": "BMY and Pfizer share joint research and commercialization responsibilities under the Eliquis alliance, with Pfizer receiving co-exclusive license rights in exchange for an upfront payment and potential milestone payments, which are being amortized over BMY’s co-promotion obligation period. Separately, Pfizer paid Beam $300 million upfront upon entering their collaboration for in vivo base editing programs and may pay up to an additional $1.05 billion in development, regulatory, and commercial milestone payments across three targets, for a total potential deal value of $1.35 billion. This shows that Pfizer’s financial commitment to Beam could significantly exceed its initial payments under the Eliquis alliance, depending on development progress and milestone achievements.",
      "llm_answer": "BMY’s Eliquis alliance is framed as a true partnership – BMS and Pfizer share a joint executive committee and jointly carry out the research, development, distribution, sales and marketing of Eliquis, with profits and losses split equally and no specific cash payment disclosed for the alliance 【page_84】【page_86】. By contrast, Pfizer’s collaboration with Beam is largely financial: Pfizer paid a $300 million upfront fee and, if it licenses all three targets, Beam could receive up to $1.05 billion in development, regulatory and commercial milestones (potential total consideration of $1.35 billion) 【page_76】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all numbers are correct: the $300 million upfront payment and up to $1.05 billion in potential milestones (total $1.35 billion) for the Pfizer-Beam collaboration are accurately reported. The absence of a disclosed upfront payment for the BMY-Pfizer Eliquis alliance is correctly noted. (2) The LLM correctly contrasts the nature of the two collaborations: the Eliquis alliance as a joint, co-commercialized partnership with shared responsibilities and equal profit/loss split, versus the Pfizer-Beam deal as a more traditional licensing arrangement with significant financial commitments. (3) Multi-hop reasoning is sound—information is synthesized across two distinct collaborations involving Pfizer with different partners (BMY and Beam), correctly comparing structure and financial terms. (4) The only minor shortcoming is that the original answer notes Pfizer made an upfront and milestone payments in Eliquis that are being amortized over BMY’s co-promotion period—a detail omitted in the LLM response. However, the LLM’s emphasis on the lack of disclosed cash payment aligns with available transparency and does not contradict the ground truth. Wording differs but semantic meaning and factual content are equivalent. Contextual relevance is excellent, directly addressing the comparison in obligations and financial commitments.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 398,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How do Texas Instruments' accounting practices for lease extension and termination options compare with Cisco's treatment of similar provisions in their customer financing arrangements, particularly regarding the impact on long-term liabilities and revenue recognition?",
      "original_answer": "Texas Instruments accounts for lease extension and termination options by recognizing lease assets and liabilities based on the present value of lease payments when it is reasonably certain they will be exercised, using their incremental borrowing rate. This affects long-term liabilities on their balance sheet. Cisco, on the other hand, includes similar extension and termination provisions in its customer financing arrangements, which are primarily collateralized and affect the timing of revenue recognition. Cisco also defers revenue on arrangements involving guarantees until the risk is removed. Both companies incorporate these options into their financial reporting, but with different implications: TXN affects liability valuation, while CSCO affects revenue timing and credit exposure.",
      "llm_answer": "Texas Instruments includes any extension or non‑termination option that it is “reasonably certain” to exercise in the lease term, so the present value of those additional payments is added to the right‑of‑use asset and lease liability and the expense is recognized on a straight‑line basis over the (extended) term【page_35】.  \n\nCisco, by contrast, treats similar options in its customer‑financing leases as part of a guarantee arrangement: it records a liability for the fair‑value of the guarantee and defers the related revenue, recognizing that revenue only when the guarantee is removed rather than expanding the lease liability itself【page_52】.  \n\nThus, TI’s practice inflates long‑term lease liabilities directly, whereas Cisco’s practice creates a separate guarantee liability and deferred‑revenue balance, affecting long‑term liabilities in a different way and delaying revenue recognition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Texas Instruments' (TI) accounting practice: including lease extension/termination options in the lease term when 'reasonably certain' to be exercised, capitalizing the present value of payments into right-of-use assets and lease liabilities, which increases long-term liabilities. This matches the original answer's description of TXN's impact on liability valuation. (2) For Cisco, the LLM correctly states that similar options in customer financing arrangements are treated as part of a guarantee arrangement, with a recorded liability at fair value and deferred revenue recognized only upon removal of the guarantee. This accurately reflects CSCO's revenue timing and credit exposure treatment. (3) The multi-hop reasoning is sound: the model synthesizes distinct accounting treatments across two companies and correctly contrasts their impacts—TI on lease liabilities, Cisco on revenue deferral and separate liability recognition. (4) Minor deduction in qualitative accuracy due to slightly narrower framing—original answer notes Cisco’s arrangements are 'primarily collateralized' and emphasizes 'credit exposure,' which the LLM omits. However, this does not undermine the core correctness. No numeric inaccuracies; all descriptions are semantically equivalent to the ground truth. Contextual relevance is perfect—directly addresses all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 403,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How does Disney's 73% stake in National Geographic influence the content differentiation strategy on Disney+, and what implications does this have for subscriber acquisition costs relative to YouTube's content licensing model?",
      "original_answer": "Disney's 73% stake in National Geographic allows it to integrate National Geographic-branded programming directly into Disney+ as a top-level tile within the interface, providing exclusive access to content that is not subject to third-party licensing fees (chunk 1 and chunk 2). This vertical integration reduces dependency on external content providers and lowers long-term content acquisition costs. In contrast, YouTube, as a digital video service competitor, relies more heavily on licensed and third-party content, which may involve ongoing licensing expenditures (chunk 3). This structural advantage could give Disney+ a cost edge in subscriber acquisition by leveraging proprietary content like National Geographic to attract and retain users at a lower marginal cost than YouTube.",
      "llm_answer": "Disney’s 73 % ownership of National Geographic (see DMED description 【page_78】) allows the company to feature National Geographic’s documentary and science titles as a dedicated tile on Disney+ (see Disney+ Services description 【page_12】), giving the streaming service exclusive, high‑value content that sets it apart from rivals. Because this programming is owned rather than licensed, Disney can attract new subscribers with lower incremental content‑licensing spend, whereas YouTube’s Premium and TV services depend on licensing third‑party programming (see Google’s note that YouTube non‑advertising revenue comes from YouTube Premium and YouTube TV subscriptions 【page_7】), which raises its subscriber‑acquisition costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Disney's 73% stake in National Geographic is accurately stated, and the integration of National Geographic as a top-level tile on Disney+ is correctly described. The contrast with YouTube’s reliance on licensed content is valid and supported by the reference to YouTube Premium and YouTube TV. (2) Quantitative accuracy is perfect: the 73% ownership figure is correct, and no other numerical data (dates, dollar amounts) are present or required. (3) Multi-hop reasoning is sound—LLM correctly synthesizes information across Disney’s ownership, content integration on Disney+, cost implications of owned vs. licensed content, and competitive comparison with YouTube. The only minor shortcoming is that the answer implies YouTube TV and YouTube Premium are direct competitors to Disney+ in the same content space, which is partially true but slightly less precise—the primary cost comparison should focus on content acquisition models rather than service types. Still, the core logic that licensed content increases subscriber acquisition costs is correctly inferred. (4) The answer is contextually relevant, directly addressing both parts of the question: content differentiation strategy and implications for subscriber acquisition costs. Wording differs from the original but maintains semantic equivalence. No factual errors—only a slight nuance in competitive framing prevents a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 412,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How does the impact of regulatory exclusivity expiration timelines on BMY's biologic products compare to MRK's experience with Januvia family market exclusivity delays, considering the role of regulatory exclusivity in extending market protection beyond patent terms?",
      "original_answer": "BMY's biologic products, such as Opdivo and Yervoy, benefit from 12 years of regulatory exclusivity in the U.S., which prevents the FDA from approving biosimilars until 12 years after initial approval. This regulatory exclusivity can extend beyond patent terms and provide additional market protection. In contrast, MRK's Januvia family of products saw their key U.S. patent expire in January 2023, but due to favorable court rulings and settlement agreements on a later-expiring salt-form patent, MRK expects to maintain market exclusivity until May 2026 for Januvia and Janumet and July 2026 for Janumet XR. This shows that while BMY relies on the standard 12-year biologic exclusivity framework, MRK was able to extend market exclusivity for its chemical products through litigation and secondary patents, highlighting different strategies and outcomes tied to regulatory exclusivity mechanisms.",
      "llm_answer": "BMS’s biologics are shielded by a statutory 12‑year “regulatory exclusivity” that can outlast any patent term, so the company’s earliest estimated market‑exclusivity dates for products such as Opdivo (2028 U.S.), Yervoy (2025 U.S.) and Reblozyl (2031 U.S.) extend well beyond the underlying patents (BMY p. 7; BMY p. 9). In contrast, Merck’s Januvia/Janumet family – a chemical small‑molecule – relies on later‑expiring patents and settlement‑driven extensions that push U.S. market exclusivity to May 2026 (Januvia/Janumet) and July 2026 (Janumet XR) despite the original patent lapsing in 2023 (MRK p. 58). Thus, BMS’s biologic exclusivity is a fixed, longer‑duration regulatory block, whereas Merck’s small‑molecule protection is a case‑by‑case patent‑driven delay that still benefits from regulatory exclusivity but for a shorter horizon.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: BMY's biologics have 12 years of regulatory exclusivity (e.g., Opdivo ~2028, Yervoy ~2025, Reblozyl ~2031), which is statutory and can extend beyond patent terms. MRK's Januvia/Janumet exclusivity extends to May 2026 and July 2026 despite the 2023 patent expiration due to secondary patents and settlements. These dates and mechanisms match the original answer. (2) Quantitative accuracy is perfect: all years (2023, 2025, 2026, 2028, 2031) are correctly cited or reasonably inferred; no calculation errors. (3) Multi-hop reasoning is sound: the model correctly contrasts BMY’s reliance on fixed biologic regulatory exclusivity with MRK’s use of patent litigation and settlements for small molecules, highlighting different regulatory and IP strategies. (4) The only minor shortcoming is that the original answer explicitly notes the 12-year exclusivity starts from initial approval, which the LLM implies but does not state verbatim. Also, the LLM adds Reblozyl, not mentioned in the original, but this is a valid example and does not detract from accuracy. Wording differs but semantic meaning and factual content are equivalent. Contextual relevance is excellent—directly addresses the comparison of exclusivity mechanisms and timelines.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 373,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How does MetLife's issuance of 40,000 shares of Series F preferred stock, with redemption terms tied to a 'rating agency event,' intersect with AIG's exposure to financial risks from potential rating downgrades, particularly given AIG's acknowledgment that a downgrade could limit its ability to write new business and impair customer retention?",
      "original_answer": "MetLife has issued 40,000 shares of Series F preferred stock, which includes a redemption clause triggered by a 'rating agency event'—defined as a change in rating criteria that lowers equity credit assigned to such securities. This creates a financial contingency for MetLife should credit agencies revise their treatment of these instruments. Similarly, AIG acknowledges in its 10-K that a downgrade in its Insurer Financial Strength ratings could materially impair its ability to write new business and retain customers. Therefore, both companies face strategic and operational risks tied to rating agency actions, with MetLife facing potential redemption obligations and AIG facing direct business constraints due to a potential loss of creditworthiness.",
      "llm_answer": "MetLife’s 40,000 shares of 4.75 % Series F preferred stock can be redeemed by MetLife at $25.50 per share (plus accrued dividends) within 90 days of a “rating‑agency event,” i.e., any downgrade or change in equity credit by a rating agency (MetLife 10‑K, p. 264; issuance shown on p. 260). AIG explicitly states that a downgrade of its insurer‑strength or credit ratings could curtail its ability to write new business and impair customer retention (AIG 10‑K, p. 85). Consequently, a rating‑agency downgrade would simultaneously trigger MetLife’s redemption obligation—potentially draining capital—and exacerbate AIG’s operational and financial pressures, linking both companies’ exposure to rating‑agency risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and terms are correct: MetLife issued 40,000 shares of Series F preferred stock, the redemption price is $25.50 per share plus accrued dividends, and the 90-day redemption window after a 'rating-agency event' is accurately cited. The reference to MetLife’s 10-K pages 260 and 264 and AIG’s 10-K page 85 adds precision. (2) The answer correctly identifies the definition of a 'rating-agency event' as a change in equity credit or downgrade, consistent with the ground truth’s focus on reduced equity credit. (3) The multi-hop reasoning is sound: it connects MetLife’s contingent redemption obligation to AIG’s operational risks from rating downgrades, highlighting the shared exposure to rating agency actions. (4) The LLM slightly extends the original answer by suggesting that a downgrade could 'simultaneously' trigger MetLife’s redemption and worsen AIG’s pressures—this is a reasonable inference but not explicitly stated in the ground truth, which treats the companies’ risks as parallel rather than interactive. This minor interpretive leap prevents a perfect 10 on qualitative accuracy. Otherwise, entity names (MetLife, AIG), financial instruments (Series F preferred stock), and risks (customer retention, new business limitations) are correctly identified. The answer is fully contextually relevant, addressing both the financial mechanism and strategic implications for both firms.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 411,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 198,
      "question": "How does the use of matrix pricing for U.S. Government Securities differ between LMT's portfolio as of December 31, 2021, and UPS's valuation methodology for similar assets, based on their respective Level 2 classifications?",
      "original_answer": "LMT reported $121 million in U.S. Government Securities as of December 31, 2021, which were classified under Level 2 inputs, indicating they were valued using matrix pricing or similar methods when broker quotes were unavailable. UPS also utilized matrix pricing for Level 2 marketable securities, including U.S. government debt, though the specific amount was not disclosed. Both companies rely on matrix pricing as a fallback when direct market data is not available, aligning with the broader accounting policy described by MO, which lists matrix pricing as a standard valuation technique for government securities when broker quotes are absent.",
      "llm_answer": "LMT’s 2021 investment note places its U.S. government securities in the Level 2 tier of the fair‑value hierarchy and values them with observable inputs – broker quotes, matrix pricing, yield‑curve and index data when a quoted price is not available (LMT 10‑K pp. 107‑111). UPS, by contrast, classifies its U.S. government securities as Level 1 and values them at quoted market prices; matrix‑pricing is reserved for its Level 2 assets such as corporate bonds and asset‑backed securities (UPS 10‑K pp. 89‑90). Thus, matrix pricing is applied to U.S. government securities in LMT’s portfolio but not in UPS’s, reflecting the different level‑2 classifications.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding UPS's valuation methodology. The ground truth states that UPS *does* use matrix pricing for U.S. government securities classified as Level 2, but the LLM incorrectly claims that UPS classifies its U.S. government securities as Level 1 and does not apply matrix pricing to them. This misrepresents the core comparison. While LMT’s use of matrix pricing for Level 2 U.S. government securities is correctly described, the contrasting claim about UPS is false according to the original answer. (2) Quantitatively, the LLM does not contradict the $121 million figure for LMT (though it doesn’t mention it), and no incorrect numbers are introduced. However, it fails to note that UPS did not disclose a specific amount, which is a minor omission. The absence of numerical errors keeps quantitative accuracy moderate. (3) The multi-hop reasoning is flawed: the model incorrectly infers that because UPS uses matrix pricing for other Level 2 assets (e.g., corporate bonds), it does *not* use it for government securities—this contradicts the ground truth, which explicitly states UPS *does* use matrix pricing for U.S. government debt in Level 2. The synthesis across companies is therefore invalid. (4) Contextual relevance is fair because the answer addresses the right documents, valuation techniques, and hierarchy levels, but the conclusion is factually reversed on a key point. Due to the major error in the comparative analysis—the central point of the question—the correctness score is low despite some accurate elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 443,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 198,
      "question": "How does PM's use of market inputs for derivative valuations compare to MDLZ's approach for its real estate fund investments, given the differing levels of observability in their respective valuation models?",
      "original_answer": "PM values its derivative contracts using standard valuation models based on readily observable market inputs such as foreign exchange spot rates, interest rate differentials, and maturity dates. In contrast, MDLZ values its real estate fund investments using the present value of future cash flows, relying on unobservable inputs like projected operating performance and local market conditions. While PM's approach falls under Level 1 or 2 fair value measurements due to the use of observable data, MDLZ's real estate fund valuations are categorized as Level 3 due to the reliance on unobservable inputs that cannot be corroborated by market data.",
      "llm_answer": "PMI values its foreign‑exchange, interest‑rate and commodity derivatives with standard pricing models that rely on readily observable market data—spot rates, yield‑curve differentials, volatilities and futures prices—and therefore classifies the contracts as Level 2 fair‑value measurements (see PM pages 128‑129). In contrast, MDLZ values its real‑estate fund holdings using appraisal‑based discounted‑cash‑flow models that depend on unobservable inputs such as local market conditions, projected operating performance and cash‑flow estimates, placing those assets in the less‑observable Level 3 tier of the fair‑value hierarchy (see MDLZ pages 104‑103). Thus PMI’s valuations are driven by observable market inputs, while MDLZ’s real‑estate fund valuations rely on more subjective, non‑observable assumptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: PM (PMI) uses observable market inputs like spot rates, yield-curve differentials, and futures prices for derivative valuations, classifying them as Level 2. MDLZ uses unobservable inputs such as projected operating performance and local market conditions for its real estate fund investments, placing them in Level 3. These classifications and input types match the original answer. (2) There are no numeric values requiring calculation, but the qualitative financial concepts (Level 2 vs Level 3, observable vs unobservable inputs) are correctly interpreted and consistently applied. (3) The multi-hop reasoning—comparing PM's derivative valuation approach to MDLZ's real estate fund valuation method across differing observability levels—is sound and well-synthesized. The LLM correctly identifies the contrast in valuation hierarchies and the rationale behind them. (4) Minor point: the LLM references 'MDLZ pages 104-103' which is a typo (page numbers reversed), but this does not affect factual correctness. Also, the original answer mentions Level 1 or 2 for PM, while LLM specifies Level 2—this is still accurate as derivatives are typically Level 2 when models are used, even if inputs are observable. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 400,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 198,
      "question": "How does MetLife's repayment strategy for its junior subordinated debentures compare to AIG's obligations under the AIGLH-issued junior subordinated debentures, particularly in terms of liquidity constraints and deferral provisions?",
      "original_answer": "MetLife has provisions allowing it to defer interest payments on its junior subordinated debentures under certain conditions, which in turn triggers dividend stopper provisions. Additionally, MetLife is subject to replacement capital covenants that require it to raise specified replacement securities before repaying, redeeming, or purchasing the debentures. In contrast, AIG's obligations under the AIGLH-issued junior subordinated debentures include specific maturities such as $54 million of 8.5% debentures due in 2030, $142 million of 8.125% debentures due in 2046, and $31 million of 7.57% debentures due in 2045, all of which are guaranteed by AIG Parent. However, AIG does not guarantee any of the borrowings of AIGLH post-distribution of debentures, indicating a different liquidity risk profile compared to MetLife's structured repayment and deferral constraints.",
      "llm_answer": "MetLife’s junior‑subordinated debentures are “flexible” – the company may elect to defer interest (subject to trigger‑event tests) and, under replacement‑capital covenants, can only redeem or repurchase the notes after it has received cash proceeds from the sale of specified replacement securities; any elective deferral also activates dividend‑stopper provisions, so repayment is tightly linked to MetLife’s available liquidity (MetLife 10‑K p.130‑131, p.129). In contrast, AIG’s AIGLH junior‑subordinated debentures are ordinary guaranteed obligations with fixed maturities (e.g., $54 m due 2030, $142 m due 2046, $31 m due 2045) and are not subject to elective deferral or replacement‑capital restrictions, with AIG relying on its credit facilities for liquidity rather than tying repayment to such covenants (AIG 10‑K p.288‑290).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All quantitative details are correct: the dollar amounts ($54M due 2030, $142M due 2046, $31M due 2045), interest rates (8.5%, 8.125%, 7.57%), and maturities align with the original answer. Format variations (e.g., 'm' for million) are acceptable. (2) The answer addresses all parts of the question: it compares MetLife’s deferral provisions and replacement capital covenants with AIG’s fixed-maturity, guaranteed debentures, highlighting differences in liquidity constraints and deferral capabilities. (3) Entity accuracy is strong: both MetLife and AIG/AIGLH are correctly identified, with proper attribution of debenture structures and guarantees. (4) Multi-hop reasoning is sound—information is synthesized across both companies’ 10-Ks, and the contrast in repayment strategies and liquidity implications is logically presented. The only minor shortcoming is that the LLM omits the explicit statement that AIG does not guarantee AIGLH borrowings post-distribution, which slightly weakens the completeness of the liquidity risk comparison. However, the implication is captured through the contrast in covenant structures. Wording differs but semantic meaning is equivalent. Overall, the answer is factually correct, well-structured, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 371,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 199,
      "question": "How does NVIDIA's competitive positioning against Samsung in the SoC and GPU markets influence Intel's strategic challenges in scaling its IFS Foundry Services, particularly given Intel's historical manufacturing delays and competitive pressures?",
      "original_answer": "NVIDIA competes with Samsung in the SoC and GPU markets, which are critical to automotive, gaming, and accelerated computing applications. Samsung is also a key competitor to Intel's IFS Foundry Services, which Intel established as part of its IDM 2.0 strategy to become a major foundry provider. Intel highlights that IFS must compete with established players like Samsung on multiple fronts including time-to-market, process performance, and ecosystem support. However, Intel's history of manufacturing delays, such as the setbacks with its 10nm and Intel 4 (formerly 7nm) process technologies, creates a disadvantage compared to Samsung's mature foundry capabilities. These delays have already impacted Intel's product competitiveness and gross margins, and could hinder IFS's ability to attract customers in a market where timely access to advanced processes is critical. Therefore, NVIDIA's competitive pressure on Samsung indirectly affects Intel's ability to scale IFS, as Samsung remains a dual threat both in end-product markets and in the underlying manufacturing ecosystem.",
      "llm_answer": "NVIDIA lists Samsung as one of its principal rivals in both the high‑performance SoC and GPU segments 【NVDA 10‑K pp 13‑15】, underscoring that Samsung already offers advanced‑node silicon that can meet the same workloads NVIDIA targets.  Intel’s IDM 2.0 “IFS” foundry business must therefore compete not only with TSMC but also with Samsung’s mature, high‑density processes 【INTC 10‑K p 54】—a task made harder by Intel’s own history of node‑rollout delays (10 nm and the Intel 4 defect‑mode) that have let Samsung and TSMC pull ahead on performance, power‑efficiency and capacity 【INTC 10‑K p 55】.  Consequently, NVIDIA’s strong competitive stance against Samsung amplifies Intel’s strategic challenge: to scale IFS it must close the technology‑gap and improve time‑to‑market, or risk losing customers like NVIDIA to Samsung’s more advanced and reliable foundry services.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: NVIDIA competes with Samsung in SoC and GPU markets; Samsung is a competitor to Intel's IFS Foundry Services; Intel faces challenges due to manufacturing delays (10nm and Intel 4); these delays have allowed Samsung and TSMC to gain an edge in process technology. The citations to the 10-K filings (NVDA pp 13–15, INTC p 54–55) are plausible and contextually appropriate. (2) There are no numeric values, dates, or calculations in the question or answer that require verification—thus, quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the model correctly links NVIDIA vs. Samsung competition → Samsung’s foundry strength → Intel’s IFS facing competition from Samsung → Intel’s historical delays weakening its position → implications for IFS’s ability to attract customers like NVIDIA. The only minor shortcoming is that the answer slightly overemphasizes TSMC (not mentioned in the original question or ground truth) which, while contextually relevant, shifts focus from the core Samsung-Intel-NVIDIA dynamic. However, this does not detract significantly from accuracy. (4) The answer is semantically equivalent to the original, with slightly more emphasis on TSMC and a forward-looking risk to losing 'customers like NVIDIA'—a reasonable inference, though not explicitly stated in the ground truth. Overall, the response is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 417,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 199,
      "question": "Given that Alphabet repurchased $62.0 billion in Class A and Class C shares in 2024, how does the difference in voting rights between Class A and Class B shares at both Alphabet and Comcast impact their respective share repurchase strategies, particularly in light of Comcast's concentrated ownership of Class B shares by a single individual?",
      "original_answer": "Alphabet's share repurchase strategy in 2024 focused on Class A and Class C shares, with $62.0 billion repurchased, while maintaining the balance between voting classes since Class B shares automatically convert to Class A upon sale. This preserves the concentrated voting power of Class B holders. Similarly, Comcast's Class B shares, which carry 15 votes per share and represent 33⅓% of the combined voting power, are entirely owned by Brian L. Roberts. This concentrated ownership influences Comcast's repurchase strategy, as repurchases of Class A shares increase the relative voting power of the Class B shares. Both companies manage their share structures to maintain governance control while returning capital to shareholders.",
      "llm_answer": "Alphabet’s 2024 $62 bn buy‑back was limited to its one‑vote Class A and non‑voting Class C shares, leaving the 10‑vote Class B shares (held mainly by insiders) untouched, which preserves the founders’ control (GOOGL Note 11, p. 82).  Comcast follows the same logic: its repurchase program targets only Class A and Class C stock, while the 15‑vote Class B shares—entirely owned by Brian L. Roberts—are excluded, keeping his concentrated voting power intact (Comcast Holders table, p. 31; repurchase summary, p. 68).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dollar amounts are correct: the $62.0 billion repurchase by Alphabet in 2024 is accurately stated, and the voting rights (10 votes for Alphabet Class B, 15 votes for Comcast Class B) match the context. The exclusion of Class B shares from repurchases is correctly noted. (2) The answer correctly identifies that Alphabet’s repurchase was limited to Class A and Class C shares, preserving insider control due to Class B's superior voting rights—consistent with the ground truth. It also correctly states that Comcast excludes Class B shares (owned entirely by Brian L. Roberts) from repurchases, thereby maintaining his concentrated voting power. (3) The multi-hop reasoning is sound: the model synthesizes information across both companies, correctly comparing how dual-class structures influence share repurchase strategies to preserve governance control. (4) Minor deduction in qualitative accuracy because the LLM mentions '10-vote Class B shares' for Alphabet, while the ground truth does not explicitly state the vote ratio (though this is publicly known and likely correct); however, since the ground truth does not include that specific number, its inclusion introduces a detail not confirmed in the reference. Otherwise, the reasoning, entity identification (Alphabet, Comcast, Brian L. Roberts), and contextual relevance are excellent. The answer fully addresses the impact of voting rights on repurchase strategies at both firms.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 424,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 199,
      "question": "How does Amgen's focus on NSCLC therapies compare with Bristol Myers Squibb's recent FDA approval of Opdivo Qvantig in terms of administration method and potential market expansion for adult solid tumor indications?",
      "original_answer": "Amgen's 2024 disclosures highlight its strategic focus on NSCLC therapies, indicating a strong commitment to oncology innovation. Meanwhile, Bristol Myers Squibb's FDA approval in December 2024 for Opdivo Qvantig enables subcutaneous administration for most previously approved adult solid tumor indications of Opdivo, either as monotherapy, maintenance therapy, or in combination with chemotherapy or cabozantinib. This administration route offers a more convenient alternative to traditional intravenous delivery, potentially expanding market access and improving patient adherence. The combination of Amgen’s ongoing NSCLC development and BMS’s subcutaneous innovation in Opdivo Qvantig reflects divergent strategies in addressing the same therapeutic area, with BMS leveraging delivery mechanism improvements to enhance market positioning in solid tumor oncology.",
      "llm_answer": "Amgen’s NSCLC pipeline centers on oral small‑molecule inhibitors – Krazati for KRAS‑mutated disease and Augtyro for ROS1‑positive disease – and an IV‑administered chemotherapy (Abraxane) that is also used in NSCLC【page_5】. By contrast, Bristol‑Myers Squibb’s newly approved Opdivo Qvantig is a subcutaneous injection of nivolumab + hyaluronidase, converting a traditionally IV‑only immunotherapy into a more convenient route and positioning it to expand across most adult solid‑tumor indications【page_44】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses the core aspects of the question. (1) It correctly identifies Amgen's focus on NSCLC therapies through specific agents—Krazati (for KRAS-mutated NSCLC) and Augtyro (for ROS1-positive NSCLC)—and notes the use of IV-administered Abraxane, aligning with Amgen's oncology strategy. It accurately contrasts this with Bristol Myers Squibb's Opdivo Qvantig, correctly identifying its subcutaneous administration via nivolumab + hyaluronidase as a shift from traditional IV delivery. (2) There are no numeric values, dates, or financial figures in the LLM answer, but the absence of the December 2024 FDA approval date—mentioned in the ground truth—is a minor omission. However, the approval itself is implied through the reference to 'newly approved,' so this does not significantly detract from factual accuracy. (3) The multi-hop reasoning is sound: the model synthesizes Amgen’s NSCLC pipeline with BMS’s delivery innovation, contrasting administration methods (oral/small molecule vs. subcutaneous biologic) and correctly inferring implications for market expansion in solid tumors. (4) The answer captures the divergent strategic approaches—Amgen advancing targeted therapies for molecular subsets of NSCLC, while BMS improves patient convenience and market positioning via administration route. The only minor gap is not explicitly stating that Opdivo Qvantig covers 'most previously approved adult solid tumor indications,' though this is partially captured. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth with high qualitative and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 453,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 201,
      "question": "Given CMCSA's non-dilutable 33 1/3% voting power protection for Class B shares and the conversion mechanism to Class A shares, how does this structure limit GOOGL's influence despite its stake in Class A common stock?",
      "original_answer": "CMCSA's capital structure protects 33 1/3% of the voting power through Class B shares, which cannot be diluted by additional issuances of common stock. Each Class B share converts on a 1:1 basis into Class A shares, but this conversion is subject to restrictions. Meanwhile, GOOGL holds a stake in Class A common stock, which carries voting rights that could otherwise influence corporate decisions. However, due to CMCSA's structural protections, even if all Class B shares were converted to Class A, the non-dilutable voting safeguard would still preserve the 33 1/3% voting control, limiting GOOGL’s ability to shift governance outcomes through its Class A stake alone.",
      "llm_answer": "CMCSA’s charter locks 33 ⅓ % of all voting power in the Class B shares and bars that block from being diluted; the Class B shares can be converted share‑for‑share into Class A, but the conversion only moves shares into the Class A pool and does not change the overall split (CMCSA 10‑K p. page_91). Since Class A stock carries one vote per share and together can command only the remaining 66 ⅔ % of votes (Alphabet 10‑K p. page_81), any stake GOOGL holds in Class A common stock is capped at that voting ceiling, preventing it from gaining control despite its equity ownership.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all numbers are correct: 33 1/3% and 66 2/3% voting splits are accurately reported, and the 1:1 conversion mechanism is correctly described. Format variations (e.g., 33 1/3% vs 33 ⅓ %) are acceptable. (2) The answer correctly explains that Class B shares are non-dilutable and that their conversion to Class A does not alter the overall voting power distribution, which aligns with the ground truth. (3) The reasoning is sound: it identifies that GOOGL’s Class A stake is limited to the 66 2/3% voting pool, thus capping its influence despite equity ownership—this captures the multi-hop logic involving CMCSA’s capital structure and GOOGL’s position. (4) Minor deduction in qualitative accuracy because the LLM does not explicitly state that the 33 1/3% protection persists *even if all Class B shares convert*, which is a key nuance in the original answer. However, the implication is present via 'does not change the overall split.' Citations to 10-K pages are a bonus but not required. Overall, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 331,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 201,
      "question": "How does the 13.2% increase in South Africa's total tobacco market volume, partly offset by higher illicit trade prevalence, affect both PEP's merger-related socioeconomic obligations and MO's illicit trade risk exposure in their respective international operations?",
      "original_answer": "The 13.2% increase in South Africa's total tobacco market volume, which was partly offset by higher illicit trade prevalence, directly impacts both companies through different mechanisms. For PEP, this market dynamic influences the scope and cost of their socioeconomic program obligations in South Africa, which are explicitly included in their merger and integration charges. For MO, the increased prevalence of illicit trade associated with this market growth contributes to the illicit trade risks outlined in their filings, which they state can lead to lost sales, brand dilution, and potential legal or regulatory actions against their distribution channels.",
      "llm_answer": "The 13.2% rebound in South Africa’s total tobacco market (PM 10‑K p. 56) – although partly offset by a higher estimated prevalence of illicit trade – amplifies the scale of PepsiCo’s merger‑related socioeconomic commitments tied to its Pioneer Foods acquisition (PEP 10‑K pp. 113‑115), which require roughly 8.8 bn ZAR (≈ $0.5 bn) for employee ownership, agricultural, education and development programs over the next five years. The same rise in illicit‑trade activity raises Altria’s exposure to illicit‑trade risk in its international operations (MO 10‑K p. 42), potentially eroding sales, prompting stricter regulation and increasing the need for anti‑illicit‑trade measures.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in entity identification and quantitative claims. It incorrectly attributes the socioeconomic obligations to PepsiCo (PEP) instead of PEP (PepsiCo) in the context of a Pioneer Foods acquisition, which is factually incorrect—PepsiCo did not acquire Pioneer Foods. The correct entity is likely British American Tobacco (BAT) or another tobacco firm, not PepsiCo, which is a food and beverage company. Similarly, 'Altria' is used instead of 'MO' (Altria Group), but this is a known synonym, so partially acceptable. However, the $0.5bn (8.8 bn ZAR) figure and its linkage to PEP’s merger obligations are not supported by the ground truth, which mentions no specific monetary value. This number is fabricated or misattributed. (2) The 13.2% market increase and mention of higher illicit trade are correctly noted and align with the original answer. However, the citation of PM 10-K p.56, PEP 10-K pp.113–115, and MO 10-K p.42 cannot be verified here, but the core issue is the misattribution of the socioeconomic spending to PEP (PepsiCo), which operates in a different sector. (3) The multi-hop reasoning fails because it synthesizes incorrect entity mappings: linking PepsiCo to tobacco market dynamics and merger obligations in South Africa is fundamentally flawed. The original answer refers to PEP in the context of a tobacco-related merger, which likely refers to a different company (possibly a ticker confusion). MO’s illicit trade risk exposure is correctly described in qualitative terms (lost sales, regulation, anti-illicit measures), which matches the ground truth. (4) Correctness score is low due to major entity and numerical inaccuracies, despite some contextual alignment. Quantitative accuracy is poor due to unsupported figures. Qualitative accuracy is moderate because the conceptual linkage of illicit trade to risk is correct, but the PEP-side reasoning is invalid. Contextual relevance is high as the structure and intent of the answer follow the question closely.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 551,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 203,
      "question": "How do the legal risks associated with securities litigation in Slack's IPO compare to Meta's exposure from its privacy-related lawsuits, particularly in terms of procedural outcomes and potential financial liabilities?",
      "original_answer": "Slack faced securities litigation related to its IPO, where a motion to dismiss was partially granted and partially denied in 2020, followed by a Ninth Circuit reversal in 2025 that led to the dismissal of the complaint with prejudice, significantly reducing its legal exposure. In contrast, Meta faced a $725 million settlement in a consumer privacy class action, which was approved in 2023, and continues to face ongoing litigation and regulatory scrutiny, including a $5.0 billion FTC penalty paid in 2020 and pending appeals in several state attorney general cases. Unlike Slack's litigation, which was ultimately dismissed, Meta's legal challenges have resulted in substantial financial liabilities and ongoing regulatory constraints.",
      "llm_answer": "Slack’s securities‑law suits stemming from its IPO have been largely resolved in its favor – after a cascade of district‑court, Ninth‑Circuit and Supreme‑Court rulings, the Ninth Circuit ordered the complaint dismissed “with prejudice” on Feb 10 2025, leaving only a still‑pending class‑certification motion and no disclosed monetary exposure【page_91】. By contrast, Meta’s privacy‑related litigation has already generated sizable liabilities (a $725 million consumer‑privacy settlement, a $5 billion FTC penalty, and a €1.2 billion GDPR fine) and the company continues to accrue “significant amounts for loss contingencies” for ongoing class actions, FTC proceedings and European regulator actions that could add further material costs【page_112】【page_113】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: Slack's IPO-related securities litigation was dismissed with prejudice by the Ninth Circuit on February 10, 2025, which aligns with the original answer’s mention of a 2025 reversal leading to dismissal with prejudice. The procedural outcome is accurately summarized, including the partial denial of the motion to dismiss in 2020 and ultimate resolution in Slack’s favor. For Meta, the $725 million consumer privacy settlement (approved in 2023), the $5.0 billion FTC penalty (paid in 2020), and ongoing regulatory scrutiny including European actions (e.g., €1.2 billion GDPR fine mentioned in LLM but not in original) are correctly reported. The LLM adds a detail not in the original (the GDPR fine), which is factually accurate and enhances completeness without introducing error. (2) Quantitative accuracy is excellent: all dollar amounts ($725 million, $5 billion, €1.2 billion) and the 2025 date are correct; no calculation errors. Format variations are acceptable and clear. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes procedural outcomes and financial liabilities across two companies, contrasting resolved vs. ongoing exposure. It distinguishes Slack’s lack of monetary exposure from Meta’s material liabilities, capturing the core comparison. (4) Minor deduction in qualitative accuracy due to mentioning Supreme Court involvement, which is not in the original and may be misleading—no indication in ground truth that the Supreme Court ruled on this matter; the Ninth Circuit reversal appears to be the final step. Otherwise, entity names, years, and legal/financial terms are accurate. Contextual relevance is perfect—the response directly addresses procedural outcomes and financial liabilities as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 496,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 203,
      "question": "How does the difference in vesting timelines for RSU awards between PM and WMT affect the recognition period of compensation costs, given PM's $160 million in unrecognized RSU costs and WMT's shift from 25% annual vesting to 8% quarterly vesting?",
      "original_answer": "PM has $160 million in unrecognized compensation costs from non-vested RSU awards, which are expected to be recognized over a weighted-average period of seventeen months, typically over three years or upon specific events like death, disability, or reaching age 58. This vesting schedule aligns with PM's policy where RSU awards generally vest on the third anniversary of the grant date. In contrast, WMT shifted its vesting schedule for RSU awards in fiscal 2023 to an 8% quarterly vesting rate over three years, down from a previous 25% annual vesting rate over four years. This change in WMT's vesting schedule accelerates the recognition of compensation costs earlier in the vesting period compared to PM’s structure. As a result, WMT’s updated vesting approach leads to a more evenly distributed cost recognition over the three-year period, whereas PM's cost recognition is more back-loaded due to its cliff-vesting structure tied to specific events or the three-year anniversary.",
      "llm_answer": "PM’s RSU awards vest only on the third anniversary of the grant, so the $160 million of unrecognized RSU compensation is amortized over the typical three‑year restriction period but, in practice, is expected to be recognized over a weighted‑average of about 17 months 【page_110】. By contrast, Walmart moved its RSU vesting from a 25 % annual schedule (four‑year period) to roughly 8 % each quarter over three years, which front‑loads the expense and shortens the average recognition period compared with the prior annual vesting 【page_66】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth with only minor omissions. (1) Quantitative accuracy is perfect: the $160 million unrecognized cost, 17-month weighted-average recognition period, three-year vesting for PM, Walmart's shift from 25% annual over four years to 8% quarterly over three years are all correctly stated. The 8% quarterly equates to ~32% annually, which over three years aligns with full vesting, and this change is correctly interpreted as front-loading expenses. (2) The answer correctly identifies both companies (PM and WMT), the relevant RSU policies, and the fiscal context (WMT's change in fiscal 2023, though not explicitly dated in the LLM answer, is implied). (3) Reasoning is sound: the contrast between PM’s cliff-vesting (leading to back-loaded cost recognition) and WMT’s new quarterly vesting (leading to earlier, more even recognition) is logically explained. The LLM correctly infers that WMT’s change shortens the average recognition period and front-loads expense, which aligns with the ground truth. (4) The only minor omission is that the original answer notes PM’s vesting can also occur upon specific events (death, disability, age 58), which the LLM does not mention. This contextual nuance affects the 'why' behind the 17-month average versus three years but does not invalidate the overall correctness. The LLM captures the essential multi-hop comparison: different vesting structures → different cost recognition patterns. Thus, the answer is semantically equivalent in outcome and reasoning, warranting a 9/10 on correctness and qualitative accuracy, with full marks for quantitative accuracy and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 461,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 204,
      "question": "How does the $620 million unrecognized tax benefit risk at Boeing compare to Lockheed Martin's assessment of Pillar 2's impact, given the OECD's global minimum tax framework and differing implementation timelines across jurisdictions?",
      "original_answer": "Boeing identifies a $620 million risk in unrecognized tax benefits related to federal tax matters under audit, with Pillar 2's global minimum tax of 15% potentially applying to its worldwide operations, though it expects minimal impact due to lack of material operations in low-tax jurisdictions. Meanwhile, Lockheed Martin also anticipates no material impact from Pillar 2 on its effective tax rate or consolidated results, despite the framework's phased implementation starting in 2024 and 2025. This assessment is complicated by the OECD's Pillar 2 model rules, which, while providing a framework, allow for varied national adoption timelines and potential modifications to domestic tax incentives, as noted by General Electric's evidence.",
      "llm_answer": "Boeing says that, because of audit uncertainty, it could see a $620 million change to its unrecognized tax‑benefit balance over the next 12 months 【page_75】, and notes that the OECD’s Pillar 2 global‑minimum‑tax rules are not expected to materially raise its overall tax cost 【page_75】.  By contrast, Lockheed Martin, which also operates under the same OECD Pillar 2 framework (with some jurisdictions applying parts of the rules in 2024 and others in 2025), states that Pillar 2 “is not expected to have a material impact on our effective tax rate or our consolidated results” 【page_36】.  In short, Boeing quantifies a specific $620 million audit‑related tax‑benefit risk, whereas Lockheed Martin’s view of Pillar 2 is a qualitative, no‑material‑impact assessment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: Boeing's $620 million unrecognized tax benefit risk is accurately reported, and there are no incorrect figures or miscalculations. The mention of Pillar 2 implementation in 2024 and 2025 matches the context of phased rollout. (2) The LLM correctly identifies both companies—Boeing and Lockheed Martin—and their respective assessments of Pillar 2’s impact, capturing the key distinction: Boeing quantifies a specific audit-related risk ($620M) while noting minimal expected impact from Pillar 2, whereas Lockheed Martin provides a qualitative 'no material impact' assessment. (3) The reasoning is sound and reflects proper multi-hop synthesis: it contrasts Boeing’s specific financial exposure (unrecognized tax benefits under audit) with Lockheed Martin’s forward-looking, principle-based evaluation of Pillar 2, under the same OECD framework but with jurisdictional timing differences. (4) The only minor shortcoming is that the LLM omits a brief reference to General Electric’s evidence about national adoption variability affecting the assessment, which adds contextual nuance present in the original answer. However, this does not detract significantly from the core comparison between Boeing and Lockheed Martin. Wording differs but semantic meaning and factual content are equivalent. Thus, the answer is factually complete, contextually relevant, and logically structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 411,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 204,
      "question": "How will the implementation of ASU No. 2023-07 impact the way PepsiCo reports its newly reorganized segments starting in Q1 2025, and how does this align with Altria's adoption timeline and disclosure requirements under the same standard?",
      "original_answer": "PepsiCo will recast its historical segment reporting beginning in Q1 2025 to reflect its new organizational structure, which includes combining FLNA and QFNA into PepsiCo Foods North America and reorganizing international food businesses into Latin America Foods, EMEA, and Other International Foods. This aligns with ASU No. 2023-07, which requires incremental disclosures of disaggregated expense information by reportable segment. Altria adopted the standard in 2024 and included expanded disclosures in Note 17, with interim requirements to be implemented starting Q1 2025. Thus, both companies are aligning with the new standard's timeline for retrospective application and enhanced reporting beginning in 2025.",
      "llm_answer": "PepsiCo’s adoption of ASU 2023‑07 means that, beginning in the first quarter of 2025, the company will restate its historical segment data and present its newly‑aligned reportable segments (PepsiCo Foods North America, International Beverages Franchise, EMEA, Latin America Foods and Other International Foods) with the expanded foot‑note and disaggregated expense disclosures required by the update 【page 7】. Altria already adopted the same ASU in connection with its 2024 annual statements (see the adoption note on page 62) and therefore will also furnish the incremental segment information and meet the interim‑reporting disclosure requirements, putting its timeline and reporting obligations in step with PepsiCo’s Q1 2025 rollout.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all dates and timelines are correct: PepsiCo's implementation in Q1 2025 and Altria's 2024 adoption with interim requirements starting Q1 2025 are accurately reflected. There are no numerical inaccuracies. (2) The answer correctly identifies that ASU No. 2023-07 requires restatement of historical segment data and enhanced disaggregated expense disclosures, which matches the standard’s requirements. (3) Entity accuracy is strong: both PepsiCo and Altria are correctly named with proper context around their adoption timelines. The new segments—PepsiCo Foods North America, EMEA, Latin America Foods, Other International Foods—are accurately listed, though the LLM adds 'International Beverages Franchise', which is not mentioned in the original answer and may be an overinference or mislabeling; this is a minor discrepancy but does not undermine the core correctness. (4) Multi-hop reasoning is sound: the model correctly synthesizes that both companies are aligning with the standard’s retrospective application and enhanced disclosure requirements, even though Altria adopted earlier, with full interim compliance starting in Q1 2025. (5) Semantic equivalence is high—the LLM conveys the same key message: PepsiCo will restate historical data in Q1 2025 under ASU 2023-07, Altria adopted in 2024, and both meet the same interim disclosure timeline starting 2025. The only minor issue is the inclusion of an unverified segment name, which slightly affects qualitative accuracy but not overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 438,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 204,
      "question": "How does the expiration timeline of Merck's MK-7962 (sotatercept) patent protection in the U.S. compare to Pfizer's broader patent strategy for biologics, especially considering potential extensions in both portfolios?",
      "original_answer": "Merck's MK-7962 (sotatercept) has a base U.S. patent expiration of 2027, with potential additional protection extending to 2037 if patent term extensions (PTEs) are granted. This reflects a strategy of relying on both initial and extended patent coverage for biologics. Pfizer also leverages PTEs and supplementary protection certificates (SPCs), particularly in Europe, to extend exclusivity beyond basic patent expirations. Both companies utilize regulatory exclusivity and patent filings to maximize product lifecycle management, though Pfizer explicitly notes variability in extension outcomes due to external factors.",
      "llm_answer": "Merck’s sotatercept (MK‑7962) is slated to lose its core U.S. compound patent in 2027, but method‑use patents on treating pulmonary arterial hypertension push protection out to 2037 and the product will also receive 12 years of data‑exclusivity once approved 【page_16†L1-L5】【page_16†L6-L9】. Pfizer’s biologics strategy, by contrast, leans on a broader suite of core and method patents and routinely pursues patent‑term extensions of up to five years (PTE) plus the statutory 12‑year data‑exclusivity for biologics, allowing it to extend market protection well beyond the basic patent expiry 【page_13†L1-L7】【page_13†L8-L12】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key dates and numbers are correct: Merck's base patent expiration in 2027 and extended protection to 2037 are accurately reported, as is the mention of 12 years of data exclusivity for biologics. Pfizer’s use of up to five years of patent-term extensions (PTEs) and 12-year data exclusivity is consistent with standard regulatory frameworks. (2) The answer correctly identifies that Merck’s extended protection to 2037 comes from method-use patents (specifically for pulmonary arterial hypertension), which is a more detailed and accurate explanation than the ground truth’s general reference to PTEs—this additional specificity is factually sound and enhances the answer. (3) The multi-hop reasoning is strong: the model synthesizes information about Merck’s specific drug timeline and compares it to Pfizer’s broader biologics strategy, correctly identifying common tools (PTEs, data exclusivity) and strategic similarities, while noting differences in approach. (4) The only minor deviation from the ground truth is that the original answer emphasizes Pfizer’s use of SPCs in Europe, which the LLM omits; however, the LLM focuses on U.S. strategy (implied by the question’s focus on U.S. patent timelines) and still captures the essence of Pfizer’s extension tactics. Overall, the answer is semantically equivalent, factually precise, and contextually appropriate, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 411,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 205,
      "question": "How do cost overruns under fixed-price contracts impact both Lockheed Martin's financial performance and GE's operational execution, given the sensitivity of these contracts to inflationary pressures and project complexity?",
      "original_answer": "Lockheed Martin reported cumulative reach-forward losses of $270 million and $280 million on two fixed-price contracts as of December 31, 2023, with potential for additional losses if cost overruns continue. These contracts are especially vulnerable to inflation, as noted in RTX's 10-K, which stated that rising material and labor costs can lead to losses on fixed-price contracts when overruns occur. Similarly, GE's operational execution is negatively impacted by cost overruns, particularly in large-scale projects such as those in its Power and Renewable Energy segments, where delays or technical issues can lead to contractual penalties and joint liability in consortiums. This highlights how both companies face significant financial and operational risks stemming from fixed-price contract structures under current economic and project execution conditions.",
      "llm_answer": "Lockheed Martin notes that if the estimated total cost to finish a fixed‑price contract exceeds the contract’s price, it must record a “reach‑forward” loss, which directly reduces earnings and operating profit (LMT 10‑K p.62‑65). GE warns that rising material, labor and component costs – especially on complex, fixed‑price aerospace contracts – can create losses and, because many contracts are intricate, can trigger penalties, delivery delays and margin pressure that hurt its operational execution (GE 10‑K p.34‑32).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the financial impact of cost overruns on Lockheed Martin through 'reach-forward' losses and links inflationary pressures to fixed-price contracts for GE, which aligns with the question's focus. However, it omits the specific quantitative data from the ground truth: Lockheed Martin's actual cumulative reach-forward losses of $270 million and $280 million as of December 31, 2023. These figures are critical for quantitative accuracy and were not mentioned at all. Additionally, the LLM incorrectly cites GE’s 10-K page range as 'p.34-32', which is invalid (page numbers in reverse), suggesting potential fabrication or misquotation. (2) The absence of exact dollar amounts and dates significantly undermines quantitative accuracy. While the LLM correctly describes the mechanism of reach-forward losses and cost pressures, the lack of specific figures from the knowledge graph (e.g., $270M, $280M, year-end 2023) means the answer fails to meet the standard for full factual precision. (3) The multi-hop reasoning is partially sound: the model connects fixed-price contracts to financial and operational risks for both companies and references inflation and complexity. However, it does not incorporate the cross-company synthesis involving RTX’s 10-K (which discusses inflation sensitivity in fixed-price contracts), nor does it mention GE’s Power and Renewable Energy segments or consortium liabilities, weakening the qualitative depth. (4) Contextual relevance is high because the answer addresses both financial performance (Lockheed) and operational execution (GE) under fixed-price contracts and inflation. The reasoning framework is appropriate, but missing specifics and incorrect citations reduce overall correctness. Thus, the answer is partially correct but lacks key data and contains minor factual errors, warranting a score of 6/10 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 519,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 207,
      "question": "How does MDLZ's use of commodity futures for raw material price risk compare with COST's disclosure of Level 1 financial liabilities in terms of fair value measurement and derivative instrument exposure?",
      "original_answer": "MDLZ actively uses commodity futures to hedge against price risk for raw materials like cocoa, sugar, and wheat, with these instruments classified as Level 1 financial liabilities measured at fair value based on quoted market prices. In contrast, COST disclosed that it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis as of August 28, 2022, indicating no direct exposure to exchange-traded commodity futures like those used by MDLZ. This highlights a strategic difference in derivative usage and fair value exposure between the two companies.",
      "llm_answer": "MDLZ explicitly uses commodity futures and options to hedge the price of raw‑material inputs (e.g., cocoa, wheat, sugar, oils) and records those contracts at fair value, with a material portion measured using Level 1 inputs (e.g., $161 million of commodity contracts in 2021 were valued from quoted market prices)【page_94】【page_111】. Costco, by contrast, discloses that it held no Level 1 financial assets or liabilities in 2022, indicating it has no exchange‑traded commodity‑future exposure and its derivative positions are limited to Level 2 instruments such as forward foreign‑exchange contracts【page_51】. This shows MDLZ’s active, Level 1‑measured commodity‑future hedging versus Costco’s absence of Level 1 derivative liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies MDLZ's use of commodity futures for hedging raw materials (cocoa, wheat, sugar, oils) and their classification as Level 1 financial liabilities based on quoted market prices. It also accurately states that COST held no Level 1 financial assets or liabilities in 2022, indicating no exchange-traded commodity futures exposure. (2) The dollar amount of $161 million for MDLZ's Level 1 commodity contracts in 2021 is consistent with the source data (though not in the ground truth, it is plausible and cited to specific pages). The only minor deviation is the absence of COST's exact fiscal date (August 28, 2022), but '2022' is sufficiently accurate. (3) The multi-hop reasoning is sound: the model correctly contrasts MDLZ’s active Level 1 derivative usage with COST’s lack thereof, highlighting a strategic difference in risk management and fair value exposure. (4) The answer is semantically equivalent to the original, with slightly more detail (e.g., mention of options and foreign exchange contracts), enhancing clarity without introducing error. The contextual relevance is perfect, directly addressing fair value measurement and derivative exposure as required. Minor deduction in quantitative accuracy only because the $161M figure, while likely correct, is not in the ground truth and could not be verified against it.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 393,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 208,
      "question": "What is the total number of UPS Class A shares that are convertible into Class B shares, and how does this compare to the assets held in Lockheed Martin's nonqualified pension trust as of December 31, 2024?",
      "original_answer": "As of December 31, 2024, there were 4.6 billion UPS Class A shares that are fully convertible into Class B shares. Lockheed Martin reported $658 million in assets held in a separate trust for its nonqualified defined benefit pension plans as of the same date.",
      "llm_answer": "UPS’s charter authorizes 4.6 billion Class A shares, and every one of those shares is fully convertible into Class B shares (see UPS 10‑K, Note 12, “as of December 31 2024, there were 4.6 billion Class A shares… fully convertible into Class B shares”). Lockheed Martin reported that its non‑qualified pension trust held $658 million of assets at December 31 2024 (see Lockheed Martin 10‑K, Note 9, “we have set aside certain assets totaling $658 million… as of December 31 2024”).  \n\nThus, UPS has billions of convertible shares (4.6 billion), whereas Lockheed Martin’s non‑qualified pension trust contains assets of roughly $658 million—a far smaller dollar amount compared with the massive share count.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitative accuracy: The numbers provided—4.6 billion UPS Class A shares and $658 million in Lockheed Martin's nonqualified pension trust assets—are exactly correct and match the original answer. The date (December 31, 2024) is also correctly cited. Format variations (e.g., '4.6 billion' vs '4.6 billion') are consistent and acceptable. (2) Completeness: The answer addresses both parts of the multi-part question—first, the number of convertible UPS shares, and second, the comparison with Lockheed Martin’s pension trust assets. (3) Entity accuracy: Both companies (UPS and Lockheed Martin), the financial instruments (Class A and Class B shares, nonqualified pension trust), and the time period (December 31, 2024) are correctly identified. (4) Reasoning: The multi-hop synthesis across two separate 10-K filings is sound. The comparison, while qualitative (billions vs. millions), is logically valid and highlights the scale difference appropriately, even without a precise dollar-value conversion. (5) Semantic equivalence: The LLM conveys the same factual content as the original answer, with added citation references (Note 12 and Note 9) that enhance credibility. Wording differs slightly but meaning is preserved. No factual errors, omissions, or misinterpretations.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 376,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 209,
      "question": "How does the sensitivity of AVGO's fixed rate senior notes to interest rate changes compare to CSCO's use of interest rate swaps in managing similar debt exposure, given the specific fair value impacts and hedging strategies outlined?",
      "original_answer": "AVGO's fixed rate senior notes are highly sensitive to interest rate changes, with a 50 basis point increase in rates causing a $1.7 billion decline in fair value as of November 3, 2024. In contrast, CSCO actively manages this risk using an interest rate swap with a $0.5 billion notional amount, which converts fixed interest payments on a portion of its senior notes to floating rates based on SOFR, thereby offsetting changes in the fair value of the hedged debt. This indicates that while AVGO faces significant exposure due to the size of its unhedged fixed-rate debt ($56.3 billion), CSCO employs targeted hedging strategies to mitigate similar risks on its smaller fixed-rate debt base.",
      "llm_answer": "AVGO’s fixed‑rate senior notes are highly interest‑rate‑sensitive – a 50‑basis‑point move would swing the aggregate fair value of the notes by about $1.7 billion (2024) and $1.4 billion (2023), even though the change would not affect interest expense【page_49】. Cisco, by contrast, has entered into a $0.5 billion interest‑rate swap (fair‑value hedge) that converts the fixed‑rate note to a floating SOFR‑based rate, and the swap’s gain‑or‑loss is recorded in interest expense and “substantially offsets” the fair‑value impact of market‑rate changes on the hedged portion of its senior debt【page_92】【page_89】. Thus, AVGO’s exposure is measured in billions of dollars and left un‑hedged, whereas Cisco actively neutralizes a comparable exposure through swaps.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Quantitatively, all key numbers are correct: AVGO's $1.7 billion fair value impact (2024) and $1.4 billion (2023) are accurately reported, with the most recent figure aligning with the ground truth's November 3, 2024 date. The $0.5 billion notional amount for CSCO's interest rate swap is correct. (2) The explanation of CSCO's hedging strategy—using a fair-value hedge to convert fixed-rate payments to floating based on SOFR—is factually sound and matches the original. The statement that the swap's gains/losses 'substantially offset' the fair value changes is consistent with the ground truth's 'offsetting changes' language. (3) The multi-hop reasoning is strong: the model correctly contrasts AVGO's large unhedged exposure ($56.3 billion in ground truth) with CSCO's targeted hedging, even though the LLM does not explicitly state AVGO's total debt amount. This is a minor omission but does not undermine the core comparison. (4) The LLM adds useful context not in the ground truth—such as the 2023 sensitivity and the accounting treatment (impact on interest expense)—which enhances accuracy without introducing error. Wording differs slightly (e.g., 'neutralizes' vs 'mitigates'), but semantic meaning is equivalent. The only reason for not scoring 10 is the omission of AVGO's total fixed-rate debt figure ($56.3 billion), which provides important scale context. However, the characterization of AVGO's exposure as 'billions' and 'unhedged' still conveys the essential contrast. All other elements are factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 449,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 209,
      "question": "How do PM and MDLZ differ in their application of the parametric delta-gamma approximation technique within their VAR models to estimate one-day loss under normal market conditions?",
      "original_answer": "PM applies the parametric delta-gamma approximation technique by observing interest rate and forward currency rate movements primarily over the preceding quarter for determining VAR at year-end, and over each of the four preceding quarters for average, high, and low VAR amounts during the year. MDLZ also uses the parametric delta-gamma method but extends its parameter estimation to include commodity price movements, in addition to interest rates and currencies. Furthermore, MDLZ observes movements over the prior quarter for year-end VAR calculations and across each of the four prior quarters for average VAR amounts, similar to PM, but explicitly accounts for the non-linear behavior of currency and commodity options in its computation.",
      "llm_answer": "PM’s VAR model applies a parametric delta‑gamma approximation only to the **observed inter‑relationships between interest‑rate movements and foreign‑currency rates**, using those relationships to estimate the one‑day fair‑value loss on its interest‑rate‑ and currency‑sensitive derivatives.  \n\nMDLZ’s VAR model also uses a parametric delta‑gamma technique, but it **generates expected‑return distributions for interest rates, currencies and commodity prices (including option‑valuation adjustments)** and then applies those distributions to calculate VAR for its fixed‑income, currency‑exchange and commodity portfolios (affecting both fair‑value and pre‑tax earnings).  \n\nThus, PM limits the technique to interest‑rate‑currency linkages for fair‑value risk, while MDLZ extends it to a broader set of risk factors—including commodities—and to both fair‑value and earnings impacts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core differences between PM and MDLZ in their use of the parametric delta-gamma approximation within VAR models. (1) It correctly identifies that PM applies the technique to interest-rate and foreign-currency rate inter-relationships, while MDLZ extends it to include commodity prices. This aligns with the ground truth, which notes MDLZ includes commodity price movements and accounts for non-linear behavior of currency and commodity options. (2) There are no numeric values (e.g., percentages, dollar amounts, time periods) in the question or ground truth that are misrepresented—the timeframes (prior quarter for year-end, four prior quarters for average/high/low) are not explicitly mentioned in the LLM answer, but the omission does not distort the factual comparison. (3) The multi-hop reasoning is sound: the model correctly synthesizes that PM focuses narrowly on fair-value risk from interest rates and currencies, while MDLZ broadens the scope to commodities and considers impacts on both fair value and pre-tax earnings, which reflects an accurate qualitative distinction. (4) The LLM answer does not explicitly mention MDLZ's accounting for the non-linear behavior of options, which is a minor omission from the ground truth, but it does imply more sophisticated modeling via 'expected-return distributions' and 'option-valuation adjustments'. Overall, the answer is semantically equivalent and factually correct with only slight incompleteness on technical modeling nuances. Hence, a high score of 9 is warranted.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 431,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 209,
      "question": "How does Medtronic's emphasis on increasing global patient access to its therapies compare with Amgen's challenges in maintaining patient affordability under pressure from payers like Express Scripts, particularly in light of Express Scripts' role in negotiating deeper discounts that limit access to Amgen's products such as Repatha?",
      "original_answer": "Medtronic aims to expand global patient access to its therapies by leveraging its product pipeline and local presence, as stated in its 2024 10-K. In contrast, Amgen faces significant challenges in ensuring patient affordability for products like Repatha due to increasing payer pressure, particularly from large PBMs such as Express Scripts. Express Scripts, as part of the top six integrated health plans and PBMs controlling 94% of U.S. pharmacy prescriptions, utilizes Rebate Management Organizations to negotiate deeper discounts, which in turn leads to formulary restrictions and higher out-of-pocket costs for patients. This dynamic negatively affects Amgen's product sales and patient access, especially for Medicare patients who abandon prescriptions due to high co-pays, despite Amgen's efforts to lower the list price of Repatha. Therefore, while Medtronic's strategy positively impacts patient access, Amgen's ability to maintain access is constrained by the market power of entities like Express Scripts.",
      "llm_answer": "Medtronic’s 10‑K stresses that its mission is to get life‑saving therapies into the hands of patients worldwide, using its local presence and scale to broaden adoption of its products across more than 150 countries (see page 6). Amgen, by contrast, reports that U.S. payers—particularly large PBMs such as Express Scripts—are demanding deeper discounts and rebates that have forced net‑price cuts on Repatha and limited patients’ ability to afford and access the drug (see page 37). Thus, Medtronic is actively expanding global patient access, while Amgen is wrestling with payer‑driven pricing pressure that can curtail access to its therapies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core contrast between Medtronic's proactive expansion of global patient access and Amgen's challenges with payer-driven pricing pressures, particularly from Express Scripts. (1) All entities are correct: Medtronic, Amgen, Express Scripts, and Repatha are accurately identified. The reference to Medtronic’s local presence and scale aligns with the ground truth’s mention of 'product pipeline and local presence' in its 2024 10-K. (2) There are no numeric values (e.g., percentages, dollar amounts, formulary coverage stats) in either the original or LLM answer, so quantitative accuracy is not compromised—no errors in numbers or calculations. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes that Medtronic is expanding access globally while Amgen faces U.S.-specific access barriers due to PBM negotiating power. The LLM mentions 'deeper discounts and rebates' leading to 'net-price cuts' and 'limited patient access,' which reflects the ground truth’s explanation involving formulary restrictions and high out-of-pocket costs. (4) The only minor omission is that the LLM does not mention the specific impact on Medicare patients or prescription abandonment due to co-pays, which is a contextual detail present in the original. It also omits the fact that six PBMs control 94% of U.S. prescriptions and the role of Rebate Management Organizations—details that enrich the explanation of market power. However, these omissions do not undermine the central factual accuracy or logical comparison. The answer remains semantically equivalent in its core claims and is contextually fully relevant. Thus, the correctness score is 9 due to high accuracy with slight incompleteness in supporting detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 478,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 210,
      "question": "How does Alphabet's share repurchase strategy prioritize certain stock classes relative to their conversion rights, and what might this imply about potential voting control considerations given that Class A shares are also publicly traded by another major corporation?",
      "original_answer": "Alphabet repurchased $62.2 billion of Class A and Class C shares in 2023, with $36.3 billion remaining available under the repurchase authorization as of December 31, 2023. Notably, Class B common stock—which carries 10 votes per share—can be converted to Class A shares at the stockholder's option or automatically upon sale or transfer. The company has focused repurchases on Class A and Class C shares rather than Class B, preserving the weighted voting power associated with Class B shares. Meanwhile, Class A common stock is also publicly traded by Comcast Corporation (CMCSA), suggesting Class A shares may represent a broader market standard for voting equity that could be strategically maintained for governance purposes.",
      "llm_answer": "Alphabet’s buy‑back program is directed only at its publicly‑traded Class A and non‑voting Class C shares, while the 10‑vote Class B shares— which can be converted at any time into Class A—are left untouched (Note 11 and Share Repurchases, page 81). By reducing the number of Class A shares on the market, Alphabet preserves the concentration of voting power in the high‑vote Class B stock, a strategy that further limits external voting influence from other holders of Class A stock (such as the Class A shares listed by Comcast, page 1 of CMCSA 10‑K).",
      "correctness_score": 9,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Alphabet's share repurchases target Class A and Class C shares while excluding Class B shares, which carry 10 votes per share and can be converted into Class A shares. It accurately describes the strategic implication of preserving voting power concentration in Class B shares by not repurchasing them. It also correctly notes that Class A shares are publicly traded by Comcast (CMCSA), linking this to broader governance considerations. However, the LLM omits the specific dollar amounts from the original answer: $62.2 billion repurchased in 2023 and $36.3 billion remaining authorization as of December 31, 2023. These quantitative details are material to full completeness. (2) While the reasoning and entity identification are sound—correctly referencing Alphabet, Class A/B/C shares, conversion rights, and Comcast’s Class A shares—the absence of exact figures reduces quantitative accuracy. The LLM does not contradict any numbers; it simply fails to include them. (3) The multi-hop reasoning is excellent: the model synthesizes information about share classes, voting rights, repurchase strategy, conversion mechanics, and external trading of Class A shares by another corporation (Comcast), drawing a logical conclusion about voting control preservation. This demonstrates strong qualitative and contextual understanding. (4) The correctness score is 9 because the core factual and inferential content is accurate and well-reasoned, but the omission of key financial figures prevents a perfect score. Quantitative accuracy is 8 due to missing numbers, while qualitative accuracy and contextual relevance are 10 as the logic, entities, and implications are fully aligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 478,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 210,
      "question": "How might UnitedHealth Group's formulary restrictions on high-cost biologics, as demonstrated by Repatha's access challenges, impact Eli Lilly's ability to maintain revenue growth for its biologic therapies given their dependence on patient access?",
      "original_answer": "UnitedHealth Group, as one of the top six integrated health plans and PBMs controlling 94% of U.S. pharmacy prescriptions, has significant leverage to impose formulary restrictions and require prior authorization for high-cost biologics. This is exemplified by the access limitations placed on Repatha, which resulted in reduced patient affordability and use despite price reductions. Eli Lilly acknowledges that its revenue prospects for biologics are directly affected by patient access issues, including payer restrictions such as prior authorization and formulary exclusions. Given the concentration of payer power and the precedent set by Repatha’s access challenges, Eli Lilly’s ability to maintain revenue growth for its biologic therapies may be significantly constrained if similar restrictions are applied to its products.",
      "llm_answer": "UnitedHealth Group’s step‑therapy, prior‑authorization and other formulary limits on high‑cost biologics—exemplified by the reduced patient uptake and deeper discounts Amgen had to offer for Repatha (Amgen 10‑K p.37‑38)—show how payer‑driven restrictions can choke sales of expensive biologics. Eli Lilly’s 10‑K repeatedly warns that its biologic revenues are highly dependent on coverage, reimbursement and patient access, and that payer actions that impose tighter formularies, larger rebates or narrower reimbursed populations could materially curb its growth (Lilly 10‑K p.35‑36, 26‑27). Thus, UnitedHealth’s formulary restrictions could similarly limit Lilly’s biologic uptake, force deeper price concessions and undermine the company’s ability to maintain revenue growth for its biologic therapies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: UnitedHealth Group's formulary restrictions (e.g., prior authorization, step therapy) on high-cost biologics are accurately described, with Repatha cited as a valid example. Eli Lilly’s dependence on patient access and the risk to revenue growth from payer restrictions are correctly attributed to disclosures in its 10-K. (2) There are no numeric values, percentages, dates, or financial figures in either the question or answers that require verification—thus, quantitative accuracy is not compromised. The references to page numbers in the 10-Ks (e.g., Amgen p.37–38, Lilly p.35–36, 26–27) are plausible and contextually appropriate, though minor page variations would not affect correctness. (3) Multi-hop reasoning is sound: the model correctly links UnitedHealth’s payer power and precedent with Repatha to potential impacts on Eli Lilly’s biologic therapies, synthesizing cross-company and cross-document implications. (4) The LLM adds slightly more detail than the original (e.g., mentioning 'deeper discounts' and 'narrower reimbursed populations'), but these are consistent with and supported by Lilly’s 10-K disclosures. The only reason for not scoring a 10 is that the answer slightly overemphasizes price concessions compared to the original’s focus on access constraints broadly, though this is a nuance rather than an error. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 428,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 211,
      "question": "How does Oracle's use of its $3.0 billion commercial paper program compare with Cisco's treatment of its $9.0 billion in senior fixed-rate notes, particularly in light of their shared exposure to short-term debt financing mechanisms?",
      "original_answer": "Oracle maintains a $3.0 billion commercial paper program, which allows it to issue unsecured short-term promissory notes under a private placement exemption. As of May 31, 2022, Oracle had no outstanding commercial paper notes. Cisco, on the other hand, had $9.0 billion in principal amount of senior fixed-rate notes outstanding as of July 30, 2022, which rank at par with any commercial paper notes it may issue in the future under its short-term debt financing program. Cisco also uses interest rate swaps to convert fixed interest rates on $1.5 billion of these notes to floating rates based on LIBOR. This indicates that while Oracle actively manages short-term liquidity through a flexible commercial paper facility, Cisco has a larger, more structured long-term debt profile with embedded risk management through interest rate hedging.",
      "llm_answer": "Oracle’s $3 billion commercial‑paper program is essentially a standby liquidity source – it gives the company the ability to issue unsecured short‑term notes, but no commercial‑paper notes were outstanding at the reporting date (May 31 2022)【page_91】. Cisco, by contrast, has $9 billion of senior fixed‑rate notes on its balance sheet (with $600 million of commercial‑paper currently issued) and actively uses its short‑term debt program for general corporate purposes, showing a much larger existing debt exposure that includes both long‑ and short‑term borrowing【page_89】. Thus, while both firms have short‑term financing mechanisms, Oracle’s program is unused, whereas Cisco’s senior notes represent a substantial, ongoing debt commitment.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but introduces a significant factual error regarding Cisco's commercial paper. The ground truth states that Cisco had $9.0 billion in senior fixed-rate notes outstanding and mentions its future commercial paper would rank at par with these notes, but it does not state that Cisco had $600 million of commercial paper currently issued. This figure is fabricated and not supported by the original answer, which does not specify any current commercial paper issuance by Cisco. This is a major quantitative inaccuracy. Oracle's zero outstanding commercial paper as of May 31, 2022, is correctly reported. The $9 billion senior notes for Cisco and the $3 billion program for Oracle are accurately cited. (2) The date for Oracle (May 31, 2022) is correct; Cisco's date in the original is July 30, 2022, but the LLM does not mention this date, which is a minor omission. The $1.5 billion interest rate swap converting fixed to floating rates based on LIBOR — a key differentiator in risk management strategy — is entirely omitted, weakening the qualitative comparison. (3) The multi-hop reasoning is partially sound: the model correctly identifies that both companies have short-term debt mechanisms and contrasts Oracle’s unused facility with Cisco’s larger debt profile. However, it mischaracterizes Cisco’s actual short-term debt usage by inventing a $600M commercial paper issuance, leading to flawed synthesis. The original emphasizes Cisco’s use of interest rate swaps for risk management, which the LLM fails to mention, missing a critical dimension of the comparison. (4) The contextual relevance is high because the response addresses the core contrast in debt financing strategies. Qualitative accuracy is moderate due to correct framing but missing key details. Quantitative accuracy is low due to the false $600M figure. Correctness score is 6 because while core facts about Oracle and Cisco’s note programs are right, the invented commercial paper amount and omission of hedging practices significantly undermine full accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 563,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 211,
      "question": "How does the extension of ASU 2022-06's optional hedging relief until 2024 impact FedEx's and Caterpillar's management of LIBOR-related interest rate risk in their respective derivative instruments?",
      "original_answer": "ASU 2022-06 extends the optional expedients and exceptions for accounting related to reference rate reform, including LIBOR, until December 31, 2024. FedEx, which references this ASU, continues to monitor its contracts and hedging relationships affected by LIBOR, though it has not yet experienced a material impact. Caterpillar, which actively uses interest rate contracts as part of its risk management strategy, benefits from the extended relief by maintaining flexibility in accounting for LIBOR-based hedging relationships without disruption. The extension allows both companies to continue transitioning away from LIBOR without immediate accounting complications, supporting consistent treatment of derivative instruments tied to legacy rates.",
      "llm_answer": "The FASB’s decision to extend the optional hedging relief in ASU 2022‑06 through December 31 2024 means that both companies can keep their existing LIBOR‑referenced interest‑rate derivatives in place under the same hedge‑accounting treatment. FedEx notes that the ASU “provides optional expedients…for contracts…that reference the London Interbank Offered Rate (‘LIBOR’)” and that it “continues to monitor our contracts…for potential application of these ASUs” with no material effect to its results 【page_93】. Caterpillar’s risk‑management policy likewise relies on “fixed‑to‑floating, floating‑to‑fixed and floating‑to‑floating interest‑rate contracts” that are designated as fair‑value or cash‑flow hedges to manage benchmark‑rate risk 【page_75】; the extended relief lets those LIBOR‑linked hedges remain effective without having to remeasure, reclassify or unwind them, thereby limiting earnings volatility and operational impact.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: ASU 2022-06 extends optional hedging relief until December 31, 2024 — matching the original answer’s date. This is correctly cited as applying to both FedEx and Caterpillar. (2) Quantitative accuracy is perfect: the date 'December 31, 2024' is correctly stated, and no financial figures are misreported. Format and precision are consistent with the source. (3) Multi-hop reasoning is sound: the answer synthesizes information across both companies — correctly noting FedEx’s monitoring stance with no material impact (supported by page 93 citation) and Caterpillar’s active use of interest rate contracts under hedge accounting (page 75 citation). It logically connects the extension to continued hedge accounting treatment, avoidance of remeasurement, and reduced earnings volatility. (4) The answer captures all elements of the original: the purpose of ASU 2022-06, its impact on LIBOR transition, and company-specific risk management approaches. Wording differs but meaning is preserved, including the benefit of avoiding disruption in accounting for derivative instruments. Citations enhance credibility and traceability. No omissions or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 357,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "How does Boeing's use of Citibank, N.A. as administrative agent in its Five-Year Credit Agreement compare with Caterpillar's engagement of Citibank in its multi-facility credit agreements in terms of syndication structure and amendment activity in 2022 and 2023?",
      "original_answer": "Boeing's Five-Year Credit Agreement, dated October 30, 2019, and amended on August 25, 2022, involved Citibank, N.A. as administrative agent alongside JPMorgan Chase Bank, N.A. as syndication agent, with both also serving as joint lead arrangers and joint book managers. Caterpillar, on the other hand, had Citibank, N.A. acting as agent in both its 3-Year and 5-Year Facilities dated September 1, 2022, with additional roles for Citibank Europe plc and MUFG Bank, Ltd. in local currency management. Both companies saw Citibank play a central role in structuring and managing credit facilities, but Caterpillar’s agreements included more complex international components, while Boeing’s amendment in 2022 was a singular update to its existing agreement.",
      "llm_answer": "Boeing’s five‑year credit agreement names Citibank N.A. as the administrative agent and JPMorgan Chase Bank N.A. as the syndication agent, with both banks acting as joint lead arrangers and book‑managers; the company amended its 2019 five‑year agreement in August 2022 (Amendment No. 1) and then executed a new five‑year agreement in August 2023 【page_126†L1-L4】【page_125†L9-L13】. Caterpillar’s multi‑facility 364‑day credit facilities list Citibank N.A. only as the agent (with Citibank Europe and MUFG as local‑currency agents) and do not designate a separate syndication agent, and amendment activity appears in 2023 through a Local‑Currency Addendum to the 2023 facility and a Japan Local‑Currency Addendum to the 2022 facility, with no distinct 2022 amendment disclosed 【page_128†L1-L9】【page_128†L10-L13】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that impact correctness, particularly around dates and amendment activity, though it captures some correct structural elements. (1) Quantitatively, the original answer states Boeing's Five-Year Credit Agreement was dated October 30, 2019, and amended on August 25, 2022. The LLM incorrectly claims Boeing executed a *new* five-year agreement in August 2023, which is not supported by the ground truth and represents a significant factual error. The ground truth does not mention any 2023 agreement or second amendment for Boeing. (2) For Caterpillar, the LLM claims amendment activity in 2023 via addenda to the 2022 and 2023 facilities, but the original answer does not specify amendment activity in 2022 or 2023—only that the facilities were dated September 1, 2022. The mention of a '2023 facility' and specific addenda (Japan Local-Currency Addendum) introduces details not present in the ground truth, suggesting overinference or hallucination. (3) Structurally, the LLM correctly identifies Citibank, N.A.'s role as administrative agent for Boeing and joint roles with JPMorgan, aligning with the original. It also correctly notes Citibank Europe plc and MUFG Bank, Ltd. involvement in local currency roles for Caterpillar. However, the claim that Caterpillar’s facilities 'do not designate a separate syndication agent' is plausible but not confirmed in the ground truth, which does not discuss this detail. (4) The reasoning partially supports the comparison: both banks use Citibank centrally, and Caterpillar's structure is more internationally complex—this aligns with the original. But the LLM introduces unverified details (new 2023 Boeing agreement, specific 2023 addenda) that undermine quantitative and qualitative accuracy. While the answer addresses syndication structure and amendment activity as required, the inclusion of unsupported events reduces correctness. Semantic equivalence is partially achieved in structure description but breaks down on key dates and events.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 547,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "How does the dual-class stock structure at META, which gives Class B shareholders disproportionate voting control, compare to CMCSA's dual-class framework in terms of potential impact on investor confidence, especially given CMCSA's Class B to Class A conversion mechanism?",
      "original_answer": "META's dual-class stock structure gives Class B shareholders, such as Mark Zuckerberg, disproportionate voting control, which could make its Class A common stock less attractive to some investors. This is due to reduced corporate governance protections and potential conflicts of interest. Similarly, CMCSA has a dual-class framework where Class B common stockholders hold 33⅓% of the voting power, and each share of Class B stock is convertible, share for share, into Class A stock. The conversion mechanism in CMCSA could allow for shifts in voting control, much like META's structure, though CMCSA's Class B shares currently represent a much smaller total quantity (9,444,375 issued and outstanding). This structural similarity may affect investor confidence in both companies, especially if control remains concentrated in a minority of shareholders.",
      "llm_answer": "Meta’s dual‑class system gives its ten‑vote Class B shares a controlling majority of voting power (the Class B holders control the outcome of all shareholder votes as long as they represent just 9.1 % of the total shares) and therefore limits other investors’ ability to influence corporate matters, a feature that can weigh on investor confidence【page_49】. Comcast’s structure, by contrast, allocates only one‑third of the total voting power to its 15‑vote Class B shares (the other two‑thirds belong to Class A) and makes those Class B shares convertible share‑for‑share into Class A, a mechanism that can dilute the concentrated block over time and is generally viewed as less likely to undermine confidence than Meta’s more dominant voting arrangement【page_91】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core structural differences between META and CMCSA's dual-class frameworks and their implications for investor confidence, showing sound qualitative reasoning and contextual relevance. It accurately notes CMCSA's Class B shares have 33⅓% voting power (aligned with ground truth) and the share-for-share convertibility into Class A, which is a key differentiator from META. However, there are quantitative inaccuracies: the claim that META's Class B holders control votes with only 9.1% of total shares is not in the original answer and cannot be verified from the provided ground truth; similarly, the 'ten-vote' and '15-vote' classifications for META and CMCSA shares are absent from the original and potentially incorrect (the ground truth does not specify vote multiples). The original mentions CMCSA's Class B shares are convertible and quantifies them as 9,444,375 outstanding, which the LLM omits. While the LLM captures the comparative impact on investor confidence—correctly suggesting CMCSA's conversion mechanism may dilute control over time and thus be less confidence-eroding than META's entrenched control—the unsupported numerical specifics reduce quantitative accuracy. The reasoning is logically sound and synthesizes a meaningful comparison, but the addition of unverified vote multiples and ownership percentages introduces factual errors not present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 393,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "What was The Coca-Cola Company's net sales to equity method investees in 2021, and which regions does Coca-Cola FEMSA specifically cover in its bottling and distribution operations?",
      "original_answer": "The Coca-Cola Company's net sales to equity method investees in 2021 were $14,471 million. Coca-Cola FEMSA operates in several countries including Mexico (central, southeast, and northeast), Guatemala, Nicaragua, Costa Rica, Panama, Colombia, Venezuela, Brazil (parts of São Paulo, Minas Gerais, Mato Grosso do Sul, Paraná, Santa Catarina, parts of Rio Grande do Sul, Goiás, and Rio de Janeiro), Argentina (Buenos Aires and surrounding areas), and Uruguay.",
      "llm_answer": "The Coca‑Cola Company recorded net sales to equity‑method investees of **$14.471 billion in 2021**. Coca‑Cola FEMSA’s bottling and distribution operations span **Mexico (central, southeast and northeast regions), Guatemala, Nicaragua, Costa Rica, Panama, Colombia, Venezuela, Brazil (São Paulo, Minas Gerais, Mato Grosso do Sul, Paraná, Santa Catarina and parts of Rio Grande do Sul, Goiás and Rio de Janeiro), Argentina (Buenos Aires and surrounding areas) and Uruguay**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the net sales amount of $14,471 million is accurately reported as $14.471 billion, which is a valid and equivalent representation (14,471 million = 14.471 billion). (2) The regions covered by Coca-Cola FEMSA are listed completely and correctly: Mexico (central, southeast, northeast), Guatemala, Nicaragua, Costa Rica, Panama, Colombia, Venezuela, Brazil (with correct partial coverage in specified states), Argentina (Buenos Aires and surrounding areas), and Uruguay—all match the original answer. (3) The multi-hop reasoning is sound: the answer correctly synthesizes financial data (net sales to equity-method investees) from The Coca-Cola Company's 2021 financials and combines it with operational geographic data from Coca-Cola FEMSA’s business segments. (4) All entities—The Coca-Cola Company, equity-method investees, Coca-Cola FEMSA, and the listed countries/regions—are accurately identified and contextually relevant. There are no factual errors, omissions, or misstatements. The wording differs slightly but maintains full semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 325,
        "total_tokens": 1565
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "How does the decline in Remicade sales due to biosimilar competition impact Merck's overall immunology segment revenue, and how does this compare to AbbVie's exposure to biosimilar pressures on biologics like Humira?",
      "original_answer": "Merck's Remicade sales declined by 9% in 2021 and 20% in 2020 due to biosimilar competition in Europe, where it lost market exclusivity in 2015. This decline directly affected its immunology segment, which includes Remicade and Simponi, both impacted by biosimilar pressures. In 2021, Remicade generated $299 million in international sales, contributing to the overall decline in the segment. AbbVie, on the other hand, faces similar biosimilar threats, particularly with Humira, which is now facing direct biosimilar competition in Europe and other countries. Unlike Merck, AbbVie continues to invest heavily in biologics infrastructure and emphasizes patent protection and regulatory exclusivity to delay biosimilar entry, particularly in the U.S. market.",
      "llm_answer": "Merck’s immunology segment fell from $1.168 billion in 2020 to $1.124 billion in 2021 – a $44 million (≈3.8 %) decline driven largely by Remicade, whose sales slipped 9 % from $330 million to $299 million as biosimilars ate into volume and price (see Merck 10‑K p. 61 & p. 141). By contrast, AbbVie’s flagship biologic Humira, a multi‑billion‑dollar blockbuster, is now confronting direct biosimilar competition in Europe and upcoming U.S. entry (see AbbVie 10‑K p. 13 & p. 15), exposing the company to a far larger revenue risk than Merck’s modest $31 million Remicade loss.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the decline in Remicade sales (9% in 2021, from $330M to $299M) and links it to biosimilar competition, which aligns with the ground truth. It also accurately notes AbbVie's exposure to biosimilar pressure on Humira in Europe and upcoming U.S. entry. However, the ground truth mentions a 20% decline in Remicade sales in 2020, which the LLM omits, reducing completeness. (2) The $44 million decline in immunology revenue is correctly calculated ($1.168B to $1.124B), and the 9% drop in Remicade sales from $330M to $299M is accurate. However, the LLM refers to a '$31 million Remicade loss'—this appears to be a miscalculation or misstatement, as the actual decline is $31 million ($330M - $299M), but labeling it as a 'loss' in isolation without context may misrepresent the scale relative to segment revenue. This is a minor quantitative inaccuracy. (3) The multi-hop reasoning is strong: the model connects Remicade’s sales decline to Merck’s immunology segment performance and compares it to AbbVie’s broader exposure via Humira. It correctly infers that Humira represents a larger revenue risk, which is logically sound given its blockbuster status, even if exact Humira revenue figures are not provided. (4) The answer is contextually excellent—directly addresses both parts of the question, uses correct entities (Merck, AbbVie, Remicade, Humira), correct years (2020–2021), and cites 10-K pages plausibly. The omission of the 2020 20% decline and the slight mischaracterization of the $31M figure prevent a top score, but core facts and synthesis are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 443,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 213,
      "question": "How did Honeywell's investment in Garrett's Series B Preferred Stock, originally tied to indemnification agreements, impact its long-term receivables after the partial redemptions in late 2021, and what was the remaining present value of the unredeemed shares as of December 31, 2021?",
      "original_answer": "Honeywell received $375 million and 834.8 million shares of Garrett's Series B Preferred Stock as part of the resolution of indemnification and tax matters agreements following Garrett's emergence from bankruptcy. The Series B Preferred Stock was subject to mandatory redemptions, with the First Partial Redemption of $211 million completed on December 28, 2021, and a planned Second Partial Redemption of $200 million in early 2022. As of December 31, 2021, the present value of the remaining mandatory redemptions of the Series B Preferred Stock was $423 million, which was included in Honeywell’s long-term receivables and investments.",
      "llm_answer": "Honeywell’s settlement of the Garrett indemnity and tax‑matters agreements with Series B Preferred Stock turned the original receivable into an investment that now sits in “Investments and long‑term receivables” at $423 million after Garrett’s $211 million first partial redemption on December 28 2021【page_103】.  Under the Second Amendment, the present‑value of the shares that remain un‑redeemed after that redemption was projected to be $207 million as of December 31 2021【page_102】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key quantitative figures. While it correctly identifies the $211 million first partial redemption on December 28, 2021, and notes the impact on long-term receivables, it incorrectly states the present value of the unredeemed shares as $207 million as of December 31, 2021, whereas the ground truth is $423 million. This is a major discrepancy that undermines the core of the answer. Additionally, the mention of a 'Second Amendment' and its associated $207 million figure does not align with the original answer, which states the remaining present value after the first redemption was $423 million, with a planned $200 million second redemption in early 2022. (2) Number verification: The $375 million cash and 834.8 million shares detail from the original settlement is missing in the LLM answer, reducing completeness. The $211 million first redemption date (Dec 28, 2021) is correct. However, the claimed $207 million present value is factually wrong—ground truth is $423 million. (3) Multi-hop reasoning: The LLM correctly links Honeywell’s investment to the resolution of indemnification agreements and recognizes the impact on long-term receivables, showing some synthesis. However, it fails to accurately track the financial outcome post-redemption, indicating a breakdown in reasoning or data sourcing. The reference to 'page_102' and 'page_103' suggests document grounding but with incorrect extraction. (4) Correctness score is 4 due to partial factual accuracy (correct redemption event and general categorization in receivables) but major error in the key present value figure. Quantitative accuracy is low (3) due to the incorrect $207M vs $423M. Qualitative accuracy is moderate (5) as the conceptual framework is sound but flawed in execution. Contextual relevance is high (8) as the answer addresses the right entities, timeline, and financial categories.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 523,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 213,
      "question": "How does the voting power distribution in CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, relate to the repurchase activity and voting structure of GOOGL's Class A and Class B common stock, given the interplay between their respective share classes and repurchase programs?",
      "original_answer": "In CMCSA, Class B common stock has 15 votes per share and represents 33 1/3% of the combined voting power, which is entirely owned by Brian L. Roberts. This structure ensures concentrated voting control despite broader share repurchases of Class A stock. Similarly, GOOGL’s Class A shares carry one vote each, while Class B shares have 10 votes per share, and the company repurchased $62.2 billion of Class A and Class C shares in 2023, with $36.3 billion remaining under the repurchase authorization. These repurchases primarily affect the float of lower-vote shares, preserving the relative control of insiders who hold Class B stock. Thus, both companies maintain dual-class structures that insulate control while using share repurchases to manage capital allocation.",
      "llm_answer": "Comcast’s Class B stock – wholly owned by Brian L. Roberts – carries 15 votes per share and accounts for about one‑third (33 ⅓ %) of the company’s total voting power, while the 2023 repurchase program was limited to Class A shares (262 million shares repurchased) and therefore does not dilute Roberts’ voting block【page_33†L13-L20】【page_33†L31-L38】. Alphabet’s dual‑class system gives its Class B shares ten votes each and is held by insiders, and its $62 billion repurchase effort in 2023 targeted only Class A (one‑vote) and Class C (non‑voting) shares, leaving the high‑voting Class B stock untouched and preserving insider control【page_81†L1-L8】【page_81†L13-L20】. Both companies use dual‑class structures to concentrate voting power, but Comcast’s owner directly controls the voting‑rich Class B, whereas Google’s repurchases are structured to avoid affecting the voting‑dominant Class B holdings.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all key numbers are correct: CMCSA's Class B has 15 votes per share and 33 1/3% voting power, entirely held by Brian L. Roberts; GOOGL repurchased $62 billion in 2023 (consistent with the $62.2 billion in the original, with minor rounding acceptable); $36.3 billion remaining authorization is not mentioned in the LLM answer, which is a minor omission but does not detract significantly. The 262 million Class A shares repurchased by CMCSA is an additional detail not in the original but plausibly correct and contextually relevant. (2) The dual-class structures are correctly described: GOOGL Class A (1 vote), Class B (10 votes, insider-held), and repurchases limited to Class A and C (non-voting), preserving insider control. (3) Multi-hop reasoning is sound: the answer successfully connects CMCSA’s voting structure and repurchase behavior to GOOGL’s analogous strategy, highlighting how both use repurchases of low-vote shares to maintain insider control. (4) The only minor gap is the absence of the exact $36.3 billion remaining authorization for GOOGL, but the core financial figure ($62.2B vs $62B) is acceptably rounded. Wording differs but semantic meaning matches: 'preserving insider control' and 'does not dilute Roberts’ voting block' effectively convey the same insight as the original. Thus, the answer is factually correct, complete in all major aspects, and contextually excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 410,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 213,
      "question": "How does the Value-at-Risk (VAR) calculation methodology under normal market conditions used by MDLZ compare to PM's approach, particularly in terms of the time horizon for observing interest rate and currency movements and the confidence interval applied?",
      "original_answer": "Both MDLZ and PM use a VAR model that assumes normal market conditions and applies a 95% confidence interval with a one-day holding period. However, MDLZ observes interest rate, currency exchange, and commodity price movements over the prior quarter for point-in-time VAR calculations and over each of the four prior quarters for average VAR amounts. Similarly, PM observes interest rate and forward currency rate movements primarily over the preceding quarter for point-in-time VAR and over each of the four preceding quarters for average, high, and low VAR amounts. This indicates a largely consistent methodology between the two companies, with both relying on quarterly historical data for risk estimation under normal market conditions.",
      "llm_answer": "MDLZ’s VAR model assumes normal market conditions, a one‑day holding period and a **95 % confidence interval**, with the parameters for interest‑rate, currency‑exchange and commodity‑price returns estimated from **movements observed over the prior quarter** (and from each of the four prior quarters when calculating average VAR)【page_64】. Philip Morris uses an identical framework – normal market conditions, a one‑day horizon and a **95 % confidence interval** – and derives its interest‑rate and forward‑currency return parameters from **movements observed primarily over the preceding quarter** (and from each of the four preceding quarters for average, high and low VAR)【page_81】. Thus, both companies employ the same confidence level and a similar one‑quarter observation window for the underlying rate and currency movements.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: both MDLZ and PM use a 95% confidence interval and a one-day holding period under normal market conditions. (2) The time horizons for observing interest rate and currency movements are correctly stated: both companies use the prior quarter for point-in-time VAR (MDLZ: 'prior quarter', PM: 'preceding quarter') and each of the four prior quarters for average VAR (PM also includes high and low, which is consistent with the original answer). (3) The multi-hop reasoning—comparing two companies' VAR methodologies across time horizons and confidence levels—is sound and correctly synthesizes information from both sources. (4) Minor wording differences (e.g., 'preceding' vs 'prior') do not affect meaning. All entities (MDLZ, PM, VAR components) are correctly identified. No factual, numerical, or interpretive errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 275,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does Apple's reliance on China Mainland for manufacturing, as a component of its Greater China segment, compare with Microsoft's operational footprint in Greater China, particularly in terms of regional support infrastructure and localized product offerings?",
      "original_answer": "Apple relies heavily on China Mainland for manufacturing, which is a key part of its Greater China segment that also includes Hong Kong and Taiwan. This reliance exposes Apple to risks such as trade tensions, tariffs, and supply chain disruptions. Microsoft operates in Greater China through its regional operations center in Singapore, which supports Japan, India, Greater China, and Asia-Pacific. Microsoft also localizes many of its products to reflect local languages and conventions, modifying user interfaces and translating text to better serve the region. Both companies are significantly engaged in Greater China, but Apple's exposure is more supply-chain intensive while Microsoft's is more focused on localized customer engagement and regional support infrastructure.",
      "llm_answer": "Apple’s Greater China segment is tightly linked to its supply‑chain, with “substantially all” of its hardware “performed … by outsourcing partners located primarily in Asia, including China mainland” (Apple 10‑K p. 11; also p. 9) – i.e., the region is a core manufacturing hub for its products. Microsoft, by contrast, does not manufacture in Greater China; instead it runs a regional operations center in Singapore that “supports … Greater China” for order processing, vendor management and logistics, and it “localizes many of our products to reflect local languages and conventions” (Microsoft 10‑K p. 16). Thus Apple’s presence is a manufacturing‑centric reliance on China mainland, while Microsoft’s footprint is a support‑infrastructure and product‑localization model for the region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Apple's reliance on China Mainland for manufacturing through outsourcing partners, citing the 10-K (p. 11 and p. 9), and contrasts this with Microsoft's non-manufacturing role in Greater China. The characterization of Microsoft’s regional operations center in Singapore supporting Greater China is factually correct and cited (10-K p. 16). (2) There are no numerical values, dates, or financial metrics in the question or answers that require verification—thus, quantitative accuracy is not applicable but no errors exist. (3) The multi-hop reasoning is sound: the model synthesizes information from two different companies’ 10-K filings to compare supply-chain vs. support/localization footprints in Greater China. The only minor shortcoming is that the original answer mentions Microsoft localizes products by modifying user interfaces and translating text, while the LLM answer summarizes this more generally as 'localizes many of our products'—slightly less detail but still semantically equivalent. (4) The answer is fully contextually relevant, addressing both companies’ operational models in Greater China with appropriate distinctions in infrastructure and localization. The use of direct citations enhances credibility. No factual errors; minor deduction in qualitative accuracy due to slightly less elaboration on product localization details.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 401,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does UPS's use of pricing models for foreign currency derivatives (classified as Level 2) contrast with GE's use of Level 3 valuation techniques in its insurance and pension liabilities, particularly regarding the role of unobservable inputs?",
      "original_answer": "UPS primarily uses pricing models with observable inputs like yield curves and exchange rates for its foreign currency derivatives, which are classified as Level 2 due to reliance on market-observable data. In contrast, GE employs Level 3 valuation techniques—such as discounted cash flow (DCF) methodologies—for certain insurance and pension liabilities, where significant unobservable assumptions are required. This distinction highlights that while UPS’s derivatives are grounded in active market data, GE’s long-duration insurance contracts and postretirement benefit obligations require internal modeling with assumptions not corroborated by market data, resulting in a higher degree of estimation uncertainty.",
      "llm_answer": "UPS values its foreign‑currency derivatives with pricing models that draw mainly on market‑observable data—such as yield curves, spot and forward rates—so the contracts are placed in Level 2, where unobservable inputs are not material. By contrast, GE measures certain insurance and pension liabilities using Level 3 techniques that depend on significant unobservable assumptions (e.g., mortality, discount‑rate and cash‑flow forecasts), meaning the fair‑value estimates rely heavily on management‑derived inputs. This creates a clear split: UPS’s valuations are driven by observable market inputs, while GE’s rely on subjective, unobservable inputs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: UPS uses observable inputs (yield curves, spot/forward rates) for foreign currency derivatives classified as Level 2, with no material use of unobservable inputs. GE uses Level 3 techniques involving significant unobservable assumptions (e.g., mortality, discount rates, cash flow forecasts) for insurance and pension liabilities. These points align precisely with the original answer. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in a numerical sense—however, the absence of any incorrect numbers or miscalculations supports a perfect score here. (3) The multi-hop reasoning is sound: the model correctly contrasts two companies (UPS and GE), two valuation levels (Level 2 vs Level 3), and the role of observable vs unobservable inputs across different financial instruments (derivatives vs insurance/pension liabilities). The synthesis across entities and concepts is accurate and logical. (4) The only minor shortcoming is that the LLM answer does not explicitly mention 'discounted cash flow (DCF) methodologies'—a specific technique named in the original answer—but it does refer to 'cash-flow forecasts' and 'management-derived inputs,' which captures the essence. This slight omission prevents a perfect 10 on qualitative accuracy. Overall, the answer is semantically equivalent, contextually precise, and factually correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 423,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does Coca-Cola's reliance on Swire Beverages for distribution in Hong Kong compare to Colgate-Palmolive's operational performance in the same market, given both companies' reported activities in the region?",
      "original_answer": "Coca-Cola relies on Swire Beverages for distribution in Hong Kong, where Swire is one of Coca-Cola's top bottling partners, contributing to a significant portion of Coca-Cola’s non-U.S. unit case volume, which totaled 83% of worldwide volume in 2021. In the same region, Colgate-Palmolive reported $2,867 million in Asia Pacific net sales in 2021, with growth led by the Greater China region, particularly in Oral Care categories such as toothpaste and manual toothbrushes. While Coca-Cola’s distribution strategy in Hong Kong is managed through its bottler partner, Colgate-Palmolive directly manages its operations and achieved 3.0% organic sales growth in Asia Pacific, driven by volume increases and cost savings. This comparison highlights differing market strategies—Coca-Cola through a key bottling partner versus Colgate-Palmolive through direct brand growth—within the same geographic region.",
      "llm_answer": "Coca‑Cola’s presence in Hong Kong is handled through Swire Beverages – one of its five largest independent bottlers that “has bottling and distribution operations … Hong Kong” (KO 10‑K p. 7). Colgate‑Palmolive, on the other hand, reports Hong Kong activity as part of its Asia‑Pacific segment, which saw net sales rise 6 % to $2.867 billion and operating profit rise 9 % to $844 million in 2021, with organic growth driven by the Greater China region (including Hong Kong) (CL 10‑K p. 42). Thus, Coca‑Cola depends on a specific bottling partner for distribution, whereas Colgate‑Palmolive’s performance in the market is reflected in broader regional growth.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Coca-Cola's reliance on Swire Beverages in Hong Kong and Colgate-Palmolive's inclusion of Hong Kong in its Asia-Pacific segment. The financial figures for Colgate-Palmolive are accurate: $2.867 billion in net sales (equivalent to $2,867 million in the original answer) and $844 million in operating profit. The 6% net sales increase and 9% operating profit increase are correctly reported, as is the mention of 3.0% organic growth being driven by Greater China, though the LLM does not explicitly state the 3.0% figure, instead referring to 'organic growth' generally. (2) Quantitatively, all numbers match the ground truth when accounting for format variations (e.g., $2.867 billion = $2,867 million). However, the LLM omits Coca-Cola’s 83% non-U.S. unit case volume figure, which is a key part of the original answer and relevant to assessing the scale of its international (and by implication, Hong Kong) operations. This omission reduces completeness. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information from both companies’ 10-Ks, contrasting Coca-Cola’s partner-based distribution model with Colgate-Palmolive’s direct regional performance reporting. It appropriately infers that Colgate’s growth in Greater China includes Hong Kong, which is consistent with the original answer. However, it does not explicitly compare the operational strategies as directly or draw the same conclusion about differing market strategies, making the synthesis slightly less complete. (4) The answer is contextually relevant and well-structured, citing specific 10-K pages and using correct entity names (Swire Beverages, Asia-Pacific segment). The qualitative accuracy is high but not perfect due to the missing 83% non-U.S. volume context and the slightly less explicit comparison of strategic models. Overall, the answer is factually strong and relevant, with only minor omissions affecting completeness and depth of comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 538,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does BAC's investment in CDOs, which contain embedded derivatives, compare to JPM's valuation methodology for similar structured notes with embedded derivatives, particularly in terms of risk exposure and modeling techniques?",
      "original_answer": "BAC invests in CDOs that are part of its broader involvement with VIEs, and while the Corporation does not consolidate these vehicles, it recognizes maximum loss exposure tied to the value of its investment balances. These CDOs are linked to embedded derivatives, as noted in the context of hybrid instruments where credit protection has been sold to the issuer, exposing the investor to credit events. JPM, on the other hand, explicitly discloses that structured notes with embedded derivatives are valued using discounted cash flow analyses and models such as Black-Scholes or simulation models, depending on the derivative features. JPM also adjusts valuations for its own credit risk (DVA), indicating a more detailed and model-driven approach to managing the risk of these instruments. This comparison highlights differing approaches to both risk exposure and valuation transparency in handling similar financial products.",
      "llm_answer": "Bank of America lists its CDO holdings in the “Other Credit Contracts” line of its investment‑securities note and describes them as hybrid instruments that contain embedded derivatives and are subject to credit‑event risk – the principal may not be repaid in full if a reference entity defaults, with fair‑value disclosed under the firm’s general Level 2/3 measurement approach but without a detailed valuation model (see BAC 10‑K p. 109). JPMorgan, however, values comparable structured notes by running discounted‑cash‑flow analyses that explicitly price the embedded derivative using option‑pricing models such as Black‑Scholes or simulation techniques, then adjusts the result for its own credit risk (DVA), and classifies the instruments at Level 2 or 3 (see JPM 10‑K p. 185‑186). Thus, JPM’s approach is more model‑driven and transparent about the inputs and credit‑risk adjustments, whereas BAC’s disclosure focuses on the credit‑event exposure and provides only a high‑level fair‑value classification.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original ground truth. (1) All factual elements are correct: BAC's CDOs are described as hybrid instruments with embedded derivatives and credit-event risk, consistent with the knowledge graph; JPM's use of discounted cash flow models, Black-Scholes, or simulation techniques is accurately reported, as is the DVA adjustment and Level 2/3 classification. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—score reflects full compliance where applicable. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across BAC and JPM filings, contrasting BAC’s high-level fair-value disclosure without detailed modeling against JPM’s explicit, model-driven approach. The mention of specific 10-K pages (p. 109 for BAC, pp. 185–186 for JPM) adds verifiability and reflects precise sourcing. (4) The only minor limitation is that the LLM answer does not explicitly mention BAC’s exposure through VIEs or the concept of maximum loss exposure tied to investment balances—this contextual nuance from the original answer is omitted but does not undermine the core comparison on risk exposure and modeling. Otherwise, the semantic meaning, entity accuracy (BAC, JPM, CDOs, structured notes, embedded derivatives), and qualitative insights (transparency, model usage, credit risk adjustments) are fully preserved. The response is directly relevant and thoroughly addresses the comparative aspect of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 433,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 215,
      "question": "How does the voting structure of CMCSA's Class B Common Stock compare to NFLX's common stock voting rights, given the specific limitations outlined in CMCSA's disclosure?",
      "original_answer": "CMCSA's Class B Common Stock has limited voting rights, only allowing votes on specific matters such as exiting the core payments business, certain consolidation or merger transactions, or amendments to the certificate of incorporation, and votes are calculated by multiplying shares held by the applicable conversion rate. In contrast, NFLX grants one vote per share on all matters to be voted upon by stockholders, providing more generalized voting power. CMCSA's disclosure also indicates that Class B Common Stock was issued and outstanding as of 2023, reinforcing the structured governance framework in place.",
      "llm_answer": "CMCSA’s Class B common stock is essentially non‑voting; the 10‑K notes that holders of Class B shares have no voting rights except on a narrow set of matters such as a decision to exit the core payments business, certain merger or acquisition transactions, and amendments to the certificate of incorporation. By contrast, Netflix’s common stock provides each share with one vote on all shareholder matters, giving it full voting power.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the core differences in voting rights between CMCSA's Class B Common Stock and NFLX's common stock. It correctly identifies that CMCSA’s Class B shares have limited voting rights only on specific matters such as exiting the core payments business, certain mergers, or charter amendments, while NFLX provides one vote per share on all matters. The statement that CMCSA’s Class B is 'essentially non-voting' is a reasonable interpretation of the limited rights described in the ground truth. The LLM omits the detail about votes being calculated via a conversion rate based on shares held, which is a minor but notable omission affecting completeness. It also does not mention that Class B shares were outstanding as of 2023, which reinforces the governance structure—this is a small missing contextual point but does not undermine the overall correctness. There are no numerical inaccuracies (quantitative accuracy is perfect), and the entities (CMCSA, NFLX) and their respective voting structures are correctly identified. The reasoning is sound and synthesizes the multi-hop comparison appropriately. Wording differs slightly but maintains semantic equivalence. Hence, a high score is warranted with only a slight deduction for missing technical details.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 362,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 215,
      "question": "How does the treatment of embedded derivatives within CDOs by Morgan Stanley compare to JPMorgan Chase's valuation methodology for similar instruments, given their respective involvement in structured note products?",
      "original_answer": "Morgan Stanley treats CDOs as hybrid instruments containing embedded derivatives, where credit protection has been sold to the issuer of the note, and if there is a credit event of a reference entity, the principal balance of the note may not be repaid in full. JPMorgan Chase, on the other hand, values structured notes using discounted cash flow analyses that consider the embedded derivative features through models like Black-Scholes or simulation models, with adjustments for the Firm's own credit risk (DVA). Both firms recognize the complexity and risk associated with these instruments, but differ in how they disclose and value the embedded derivatives within their portfolios.",
      "llm_answer": "Morgan Stanley reports that its CDO and CLN holdings are “hybrid instruments containing embedded derivatives” and that the resulting interests are recorded as **trading assets measured at fair value** (see MS 10‑K p. 109 & 127).  JPMorgan Chase, on the other hand, values “structured notes” – which also embed derivatives – by **discounted‑cash‑flow analyses that incorporate option‑pricing or simulation models (e.g., Black‑Scholes) and adjust for the firm’s own credit risk**, classifying them in Level 2 or 3 of the fair‑value hierarchy (see JPM 10‑K p. 187).  Thus, Morgan Stanley relies on a fair‑value measurement of the underlying securities, whereas JPMorgan Chase applies a more explicit, model‑driven valuation that explicitly prices the embedded derivative component.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Morgan Stanley's treatment of CDOs as hybrid instruments with embedded derivatives, recorded at fair value as trading assets, citing specific page numbers from the 10-K (pp. 109 & 127), which matches the qualitative description in the original answer. (2) It accurately describes JPMorgan Chase’s methodology using discounted cash flow analyses incorporating option-pricing models like Black-Scholes and simulation models, with adjustments for the firm’s own credit risk (DVA implied through 'adjust for the firm’s own credit risk'), and correctly notes classification in Level 2 or 3 of the fair value hierarchy, citing p. 187 of the JPM 10-K. (3) The comparison between Morgan Stanley’s fair-value measurement of the whole instrument versus JPMorgan’s model-driven, component-level pricing of embedded derivatives is logically sound and reflects the core distinction in the original answer. (4) Minor deduction in qualitative accuracy because the LLM does not explicitly mention 'credit protection sold to the issuer' or the risk of non-repayment upon a credit event for Morgan Stanley, which are key elements in the original answer’s explanation of the economic substance. However, these are contextual nuances rather than factual errors. All entities, methodologies, and disclosures are correctly attributed. No numerical inaccuracies; all information is semantically equivalent and contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 414,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 216,
      "question": "How does Abbott's exposure to intellectual property risks, particularly regarding patent enforcement, intersect with AbbVie's legal actions through its subsidiary Forest Laboratories Holdings Limited to protect the exclusivity of Vraylar, and what implications does this have for both companies' pharmaceutical revenue streams?",
      "original_answer": "Abbott faces significant risks related to the expiration or loss of intellectual property protection, which could reduce future revenues and operating income. In parallel, AbbVie's subsidiary Forest Laboratories Holdings Limited is actively involved in patent enforcement litigation concerning Vraylar (cariprazine), seeking to prevent generic competition from companies like Sun Pharmaceutical and Aurobindo Pharma. This litigation, initiated in the U.S. District Court for the District of Delaware in December 2019, aims to preserve market exclusivity for Vraylar, a key pharmaceutical product. If successful, the enforcement of these patents would protect AbbVie’s revenue from Vraylar. However, if generic versions are allowed to enter the market, both companies could face competitive pressure—Abbott due to its reliance on strong IP protections and AbbVie through reduced exclusivity for Vraylar—highlighting the interplay between IP enforcement and pharmaceutical revenue sustainability.",
      "llm_answer": "Abbott notes that “the expiration or loss of intellectual‑property protection… could reduce Abbott’s future revenues and operating income” and that “a successful claim of patent or other intellectual‑property infringement could subject Abbott to significant damages or an injunction preventing the manufacture, sale or use of affected Abbott products” (Abbott 10‑K Item 1A, pp. 12‑14). In contrast, AbbVie states that it is pursuing patent‑enforcement actions through its subsidiary Forest Laboratories Holdings Limited to protect the exclusivity of Vraylar, a move designed to block generic competition and preserve Vraylar’s contribution to AbbVie’s pharmaceutical revenue (AbbVie 10‑K, p. 113). Thus, while Abbott’s revenue stream is vulnerable to any weakening of its own IP rights, AbbVie is actively using litigation to safeguard a key drug’s market exclusivity, underscoring that both companies’ earnings depend heavily on the ability to secure and enforce patent protection.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: Abbott's exposure to IP risks is accurately described with direct citation to its 10-K, and AbbVie's patent enforcement actions through Forest Laboratories Holdings Limited to protect Vraylar are correctly stated. (2) There are no numeric values, dates, or calculations in the LLM answer that conflict with the ground truth; while the original answer mentions the December 2019 litigation filing, the LLM omits this date but does not misstate any timing—this is a minor omission, not an error. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across Abbott and AbbVie, linking their respective IP-related risks and actions, and draws a valid conclusion about the shared dependence on patent protection for revenue sustainability. (4) Semantic equivalence is maintained: though the LLM does not name the generic competitors (Sun Pharmaceutical, Aurobindo Pharma) or the specific court, it captures the core dynamic—AbbVie’s litigation to block generics and preserve revenue. The answer is contextually precise, directly addressing the intersection of IP risks and implications for revenue. The only reason for not scoring a 10 is the omission of minor but specific details present in the ground truth that slightly enhance completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1539,
        "completion_tokens": 381,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 216,
      "question": "How does Citigroup's use of foreign currency forwards and cross-currency swaps in its net investment hedging strategy compare to Morgan Stanley's reliance on VaR models for managing market risk exposure in trading portfolios?",
      "original_answer": "Citigroup utilizes foreign currency forwards, cross-currency swaps, and options to hedge foreign exchange risk on equity investments in non-U.S.-dollar subsidiaries, recording changes in fair value in CTA within AOCI under ASC 815. In contrast, Morgan Stanley employs Value-at-Risk (VaR) models as a key risk management tool to estimate aggregate market risk exposure across trading portfolios, incorporating diversification and hedging effects, while acknowledging VaR's limitations in capturing extreme market events or liquidity constraints. Southern Company Gas, which connects the two entities, also uses weather derivative instruments and other risk management tools to mitigate weather-related revenue volatility in its gas marketing services segment, demonstrating a broader industry application of risk management frameworks.",
      "llm_answer": "Citigroup’s net‑investment hedging is an instrument‑specific program: it uses foreign‑currency forwards, cross‑currency swaps, options and foreign‑currency‑denominated debt to offset the translation risk of its non‑U.S.‑dollar subsidiaries, with the fair‑value changes of those hedges recorded in foreign‑currency translation adjustment (CTA) within AOCI (see C_10k_2024 p.153). Morgan Stanley, by contrast, manages market‑risk exposure primarily through a Value‑at‑Risk (VaR) framework—supplemented by stress‑testing and scenario analysis—that quantifies the aggregate risk of its trading portfolios rather than relying on specific hedging instruments (see MS_10k_2024 pp.58‑60). Thus, Citigroup focuses on targeted currency‑hedge instruments for net‑investment risk, while Morgan Stanley leans on a statistical VaR model to monitor overall trading‑book risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: Citigroup uses foreign currency forwards, cross-currency swaps, options, and foreign-currency-denominated debt to hedge net investment risk in non-U.S.-dollar subsidiaries, with fair value changes recorded in CTA within AOCI under ASC 815—this matches the original answer, with slight expansion (debt instruments) that are consistent with typical hedging practices and do not contradict the ground truth. Morgan Stanley’s use of VaR models as a primary tool for measuring aggregate market risk in trading portfolios, supplemented by stress testing and scenario analysis, is accurately described and correctly contrasts with Citigroup’s instrument-specific approach. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a traditional sense; however, the citation of page numbers (p.153, pp.58–60) does not affect factual correctness as they are likely accurate within the source documents and not part of the core factual claim. (3) Multi-hop reasoning is sound: the model correctly synthesizes contrasting risk management strategies across two firms—Citigroup’s accounting-focused, hedging-instrument-based approach vs. Morgan Stanley’s statistical, portfolio-level risk modeling—answering the comparative question effectively. (4) The only minor shortcoming is that the LLM omits the mention of Southern Company Gas as a connecting entity and broader industry context, which was included in the original answer. However, this detail is tangential to the core comparison between Citigroup and Morgan Stanley, so the omission does not significantly detract from correctness. The answer remains semantically equivalent in substance and superior in clarity. Thus, the correctness score is 9 (not 10) due to this partial omission in completeness, though all directly relevant content is accurate and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 536,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 217,
      "question": "How does Colgate-Palmolive's use of option contracts to hedge foreign exchange risk compare to Walmart's exposure through firm commitments, given the impact of these financial instruments on their respective cash flow stability?",
      "original_answer": "Colgate-Palmolive utilizes option contracts as part of its foreign exchange risk management strategy, hedging portions of its foreign currency purchases and firm commitments with contracts valued using observable market rates, aiming to minimize earnings volatility from currency fluctuations. These contracts, with a typical duration of no more than 12 months, are aligned with the company's policy of matching derivative terms to underlying exposures. In contrast, Walmart reports $37.2 billion in unrecorded purchase obligations as of January 31, 2025, including $15.9 billion due within one year, which includes firm commitments for inventory, utilities, and capital expenditures. These obligations are legally binding and expose Walmart to cash flow risks if market conditions change. The impact of Colgate's use of option contracts is to stabilize the U.S. dollar equivalent value of foreign currency transactions, while Walmart lacks such financial instrument protections on its firm commitments, leaving it more exposed to market volatility affecting its cash flow stability.",
      "llm_answer": "Colgate‑Palmolive relies on option contracts (along with forwards and swaps) to hedge its foreign‑currency exposures, and the gains or losses from those cash‑flow hedges “did not have a material impact on the Company’s Consolidated Financial Statements” (Colgate‑Palmolive 10‑K p. 90‑92). In contrast, Walmart’s cash‑flow picture is shaped by large “firm commitments for inventory and utility purchases” that are listed as material purchase obligations and must be funded directly from operating cash flow (Walmart 10‑K p. 45, 43). Thus, Colgate‑Palmolive’s hedging strategy dampens FX‑related cash‑flow volatility, whereas Walmart’s exposure to firm commitments creates a direct, un‑hedged cash‑outflow that can affect its cash‑flow stability.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core contrast between Colgate-Palmolive's use of option contracts (and other derivatives) to hedge foreign exchange risk and Walmart's exposure through un-hedged firm commitments, accurately reflecting the impact on cash flow stability. The qualitative reasoning is sound and aligns with the ground truth: Colgate’s strategy reduces FX-related volatility, while Walmart’s lack of hedging on firm commitments increases cash flow risk. (2) However, the LLM answer omits specific quantitative details present in the ground truth: Walmart’s total unrecorded purchase obligations of $37.2 billion as of January 31, 2025, and the $15.9 billion due within one year. These figures are critical for full quantitative accuracy and were not mentioned, though the general concept of large obligations is conveyed. (3) The multi-hop reasoning is strong—correctly synthesizing information across two companies’ 10-K filings, identifying Colgate’s hedging instruments and their limited impact on financials, and contrasting with Walmart’s direct funding obligations. The use of citations (e.g., page numbers) adds credibility, though exact figures from Walmart’s filing are missing. (4) The answer is contextually highly relevant and semantically close to the original, with only the absence of precise dollar amounts preventing a top score. Wording differences (e.g., 'dampens FX-related cash-flow volatility' vs 'stabilize the U.S. dollar equivalent value') are acceptable as they convey equivalent meaning. Thus, correctness is high but not complete due to missing key numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 443,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 217,
      "question": "How does the adoption timeline of ASU No. 2023-07 for segment reporting differ between TMO and CVS, and what specific disclosures were required by each company as a result of this new standard?",
      "original_answer": "TMO adopted ASU No. 2023-07 for its 2024 annual report and applied it retrospectively, resulting in increased disclosures in Note 11. CVS adopted the standard on January 1, 2024, for fiscal year reporting and is required to provide additional disclosures related to its reportable segments, including the CODM's title, how the CODM uses segment operating results, and alignment of interim reporting with annual requirements, as detailed in Note 19. Both companies applied the standard retrospectively to prior periods, but TMO implemented it specifically for the 2024 annual report while CVS also aligned it with interim reporting requirements starting after December 15, 2024.",
      "llm_answer": "- Thermo Fisher Scientific said the new ASU 2023‑07 became effective with its 2024 annual report and will apply to all interim periods thereafter on a retrospective basis (2024 annual report + subsequent interim periods)【page_44】.  The company therefore added “significant segment expenses” and chief‑operating‑decision‑maker (CODM) information to its segment‑reporting note (Note 11)【page_44】.  \n\n- CVS Health adopted the same update on January 1 2024 for its FY 2024 filing, but the standard will not be effective for interim periods until fiscal years beginning after December 15 2024, also with retrospective application【page_133】.  CVS’s disclosures now include the CODM’s title and role, how the CODM uses segment results, the amount of significant segment expenses, the total of other items in segment operating results and a qualitative description of those other items (see Note 19)【page_132】【page_133】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: TMO (Thermo Fisher Scientific) adopted ASU No. 2023-07 for its 2024 annual report with retrospective application, and added disclosures in Note 11 including significant segment expenses and CODM information. CVS adopted the standard on January 1, 2024, for fiscal year 2024, with interim applicability starting after December 15, 2024, also applied retrospectively, with expanded disclosures in Note 19. (2) Quantitative accuracy is perfect: dates (January 1, 2024; December 15, 2024), years (2024), and document references (Note 11, Note 19) are all correct. (3) Multi-hop reasoning is sound—differences in adoption timelines (annual vs. interim applicability) are correctly identified and contrasted between the two companies. (4) The only minor shortcoming is that the LLM does not explicitly state that both companies applied the standard retrospectively to prior periods, though it mentions 'retrospective basis,' which implies this. Also, the original answer emphasizes TMO’s implementation being specific to the 2024 annual report while CVS aligned with interim reporting requirements—this nuance is present but slightly less emphasized in the LLM version. However, the core meaning and factual content are semantically equivalent. Wording differences do not affect factual correctness. All entities (TMO, CVS, ASU 2023-07, Note 11, Note 19, CODM) are accurately referenced.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 408,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "What was the impact of the Philippines' corporate income tax rate reduction on ACN's 2021 effective tax rate, and how does this compare to AMD's disclosure of tax reform effects in the same period?",
      "original_answer": "ACN benefited from the Philippines' corporate income tax rate reduction enacted in Q1 2021, which favorably impacted its 2021 effective tax rate of 21.8%, partially offsetting other unfavorable tax factors like GILTI-related foreign tax credit limitations. In contrast, AMD reported no impact from the Tax Reform Act in 2021, as shown by the $0 value in their tax provision table for that line item, indicating different exposure or geographic applicability of the reform.",
      "llm_answer": "The Philippines corporate‑income‑tax cut only modestly softened the rise in the 2021 effective tax rate – the rate rose 0.1 percentage point to 21.8%, and the increase was “partially offset by the corporate income tax rate reduction in the Philippines (enacted in the first quarter of 2021)”【page_94】. In AMD’s 2021 filing, the Tax Reform Act shows a dash (no amount) for 2021, indicating that the company reported no tax‑reform impact on its 2021 tax provision or effective tax rate【page_74】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all key facts are correct: the Philippines' tax rate reduction was enacted in Q1 2021, ACN's 2021 effective tax rate was 21.8%, and the reduction partially offset other unfavorable tax factors. The mention of a 0.1 percentage point increase in the rate aligns with the context, though the ground truth does not explicitly state the prior year's rate or the magnitude of change—this is a minor addition not contradicted by the source. AMD's disclosure showing no tax reform impact in 2021 is correctly interpreted from the dash (implying $0) in their tax provision table. (2) The numbers, dates, and percentages are accurate or reasonably inferred. Format and phrasing differences (e.g., 'dash' vs '$0 value') are semantically equivalent. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across ACN and AMD filings, comparing the impact of tax reforms across geographies and entities. (4) The only minor gap is that the LLM does not explicitly name GILTI-related foreign tax credit limitations as the unfavorable factor partially offset by the Philippines rate cut—this detail is present in the ground truth and adds specificity. However, the core conclusion about partial offsetting is preserved. Overall, the answer is factually correct, well-reasoned, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 394,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does Honeywell's use of pricing models for valuing fixed income investments in its pension plans compare to 3M's valuation methodology, particularly in terms of reliance on observable versus unobservable inputs?",
      "original_answer": "Honeywell values its fixed income investments using pricing models, broker bids, or discounted cash flows, incorporating adjustments for credit and liquidity risks when necessary. 3M similarly uses pricing models that rely on observable inputs like interest rates and yield curves for Level 2 fixed income investments, while Level 3 investments depend on unobservable inputs such as projected annuity payments and discount rates. Both companies apply discounted cash flow techniques in certain cases and disclose the use of NAV practical expedients for certain fund types, though 3M explicitly categorizes its fixed income investments by valuation hierarchy levels, whereas Honeywell focuses on the nature of the valuation adjustments made.",
      "llm_answer": "Honeywell values its pension‑plan fixed‑income holdings with pricing models that draw on verifiable market data—interest‑rate curves, observable yields and credit spreads—and also uses broker bids or quoted prices, adding adjustments for credit‑ and liquidity‑risk factors that are not directly observable. 3M’s approach is similar: corporate bonds, ABS and CMOs are priced using yields on comparable issuers or discounted‑cash‑flow models that rely on observable inputs, with additional adjustments for unobservable credit and liquidity risks. Thus, both companies base the bulk of the valuation on observable market inputs, but each adds unobservable risk adjustments; Honeywell emphasizes pricing‑model and bid data, while 3M stresses comparable‑yield and DCF methods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: both Honeywell and 3M use pricing models for fixed income investments in their pension plans, relying primarily on observable inputs (e.g., interest rates, yield curves) for Level 2 assets, with unobservable adjustments for credit and liquidity risks—consistent with the original answer. The LLM correctly identifies that both companies apply adjustments involving unobservable inputs, even if not explicitly referencing 'Level 3' categorization. (2) There are no numeric values, dates, or financial figures in the question or ground truth, so quantitative accuracy is not compromised; all descriptive metrics are correctly represented. (3) The multi-hop reasoning is sound: the LLM synthesizes information across two companies and compares their methodologies, correctly identifying similarities (use of observable inputs, unobservable adjustments) and subtle differences in emphasis (Honeywell on pricing models/broker bids, 3M on comparable yields and DCF). (4) The only minor shortcoming is that the LLM does not explicitly mention 3M’s formal categorization of investments by valuation hierarchy levels (Level 2 vs Level 3), which is a detail present in the original answer. However, it implicitly captures this by referencing observable vs unobservable inputs. It also omits the point about NAV practical expedients, though this is a secondary detail. Overall, the answer is semantically equivalent and contextually precise, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 431,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does the voting power distribution tied to Class B common stock conversion mechanisms at CMCSA compare with the share repurchase strategy for Class A and Class C shares at GOOGL, given the differing impacts on equity structure and shareholder control?",
      "original_answer": "At CMCSA, Class B common stockholders control 33 1/3% of the voting power, which is non-dilutable and convertible share-for-share into Class A common stock, while the voting power of Class A shares depends on the total number of Class A and Class B shares outstanding. This structure ensures continued influence by Class B holders. In contrast, GOOGL has repurchased $62.2 billion of Class A and Class C shares in 2023, with an additional $36.3 billion remaining under the repurchase authorization. These repurchases reduce the number of outstanding shares, increasing the proportional ownership of remaining shareholders, including those holding Class B shares, which carry 10 votes per share. Since Class B shares automatically convert to Class A upon sale or transfer, these repurchases indirectly influence the balance of voting control by reducing the total pool of shares subject to Class A voting calculations. Thus, while CMCSA’s structure protects Class B voting power through fixed percentages and conversion rules, GOOGL’s equity control dynamics are shaped by aggressive repurchases that affect the relative ownership and voting influence of remaining shareholders.",
      "llm_answer": "Comcast’s Class B shares carry 15 votes each and, in aggregate, represent about one‑third of the company’s voting power – a block that is expressly non‑dilutable and can be converted share‑for‑share into Class A stock, preserving that voting‑power concentration even as the equity base shifts (CMCSA Note 12, p. 91). Alphabet, by contrast, is repurchasing and retiring its Class A (one‑vote) and Class C (no‑vote) shares, reducing the total number of shares outstanding but leaving the voting rights per share unchanged (GOOGL Note 11, p. 81). Thus, Comcast’s conversion mechanism locks in a fixed voting‑power slice that can affect control, whereas Google’s buy‑back mainly contracts the equity structure without altering the distribution of voting authority.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general contrast between CMCSA's voting structure and GOOGL's repurchase strategy but contains significant quantitative inaccuracies and omits key details. (1) Quantitative Accuracy: The claim that CMCSA Class B shares carry '15 votes each' is incorrect — the ground truth states they hold 33 1/3% of total voting power collectively, not per share, and does not specify individual vote count per share. This is a major factual error. Additionally, the LLM omits GOOGL’s specific repurchase figures: $62.2 billion executed and $36.3 billion remaining authorization in 2023 — critical numbers that are absent from the response. (2) Completeness: While the answer addresses the core idea of CMCSA protecting voting power via conversion and GOOGL reducing shares via buybacks, it fails to mention the automatic conversion of GOOGL Class B to Class A upon sale, which is a key control mechanism. It also does not explain how repurchases indirectly affect voting influence by shrinking the share base, particularly benefiting Class B holders with superior voting rights. (3) Entity Accuracy: Companies (CMCSA, GOOGL) and share classes are correctly identified, and the references to financial notes (though fabricated page numbers) suggest plausible sourcing. (4) Reasoning: The multi-hop logic is partially sound — the model correctly contrasts structural voting protection vs. repurchase-driven ownership concentration — but the flawed vote count per share undermines the reasoning foundation. (5) Semantic Equivalence: The overall narrative direction aligns with the ground truth, but due to missing numbers and incorrect vote allocation, the factual substance is compromised. The answer is contextually relevant and frames the comparison appropriately, warranting moderate scores in qualitative and relevance dimensions despite quantitative deficiencies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 506,
        "total_tokens": 2017
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does Altria's exposure to FCTC-driven advertising restrictions, as outlined in its 2022 10-K, compare to Philip Morris International's experience with implemented advertising bans in markets like Australia and Russia, and what implications does this have for their respective international marketing strategies?",
      "original_answer": "Altria acknowledges in its 2022 10-K that while the U.S. is a signatory to the FCTC, it is not a party to the agreement, and therefore FCTC-driven advertising restrictions have limited direct regulatory impact in the U.S. However, the document notes that the FCTC has called for and influenced advertising bans globally. In contrast, Philip Morris International (PMI) reports that in markets like Australia and Russia, governments have already banned the display of tobacco products at the point of sale, which severely restricts visibility and marketing potential. These bans align with FCTC guidelines recommending the prohibition of all forms of communication with adult smokers. Given that Altria's primary market remains the U.S., where such bans are not yet widespread, its international marketing strategy is less constrained compared to PMI, which operates more heavily in FCTC-compliant markets where advertising and product visibility restrictions are already enforced. This divergence suggests that PMI must adapt more aggressively to restrictive advertising environments, while Altria faces more potential future risk if the U.S. adopts similar FCTC-aligned policies.",
      "llm_answer": "Altria’s 2022 10‑K notes that the WHO Framework Convention on Tobacco Control (FCTC) is driving a wave of proposals that could impose “substantial restrictions on the manufacture, marketing, distribution and sale of tobacco products” (Altria p. 39), but the company stresses that the outcome of those proposals is uncertain and it currently faces only the indirect risk of future advertising limits. In contrast, Philip Morris International reports that outright advertising and display bans are already in force in several markets – for example, “Australia and Russia” have banned point‑of‑sale displays and other marketing communications (PMI p. 42). Consequently, PMI must structure its international marketing around compliance‑driven, non‑traditional channels and product‑innovation strategies, whereas Altria’s international marketing retains more flexibility today but must remain ready to adjust if FCTC‑driven restrictions become binding.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Altria, while not bound by the FCTC, acknowledges its influence in driving global advertising restrictions, citing its 2022 10-K and referencing the 'substantial restrictions' language (p. 39), which matches the original context. It accurately contrasts this with Philip Morris International (PMI), noting that Australia and Russia have implemented point-of-sale display bans, citing PMI's report (p. 42), consistent with the ground truth. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification—only qualitative disclosures from 10-Ks—so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (Altria and PMI), two regulatory environments (U.S. vs. international), and two stages of policy implementation (proposed/indirect vs. implemented/direct). The conclusion about differing marketing strategy implications—PMI adapting to compliance-driven models while Altria retains flexibility but faces future risk—is logically derived and semantically equivalent to the original. (4) The only minor shortcoming is that the LLM omits explicit mention that the U.S. is a signatory but not a party to the FCTC, a nuance present in the ground truth that clarifies the legal distinction. However, the core message about limited current impact and future risk is preserved. Wording differs slightly but meaning is equivalent. Contextual relevance is excellent, directly addressing all parts of the multi-faceted question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1573,
        "completion_tokens": 453,
        "total_tokens": 2027
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does Goldman Sachs' competitive disadvantage to JPMorgan in cryptocurrency offerings, influenced by Dodd-Frank compliance burdens, compare with Morgan Stanley's exposure to regulatory risks in emerging markets that could impact its cross-border cryptocurrency-related financial activities?",
      "original_answer": "Goldman Sachs faces a competitive disadvantage compared to JPMorgan due to Dodd-Frank compliance burdens that restrict its ability to offer cryptocurrencies and digital assets, as stated in its 2024 10-K filing. JPMorgan, as a competitor, offers these products, giving it a strategic edge in evolving financial markets. Meanwhile, Morgan Stanley's 2024 10-K highlights exposure to regulatory risks in emerging markets, where uncertain and rapidly changing laws could hinder its ability to structure and enforce cryptocurrency-related transactions across borders. Both firms face regulatory constraints, but Goldman Sachs' limitations are self-imposed due to U.S. regulatory frameworks, while Morgan Stanley's risks stem from external geopolitical and legal environments in foreign jurisdictions.",
      "llm_answer": "Goldman Sachs says that because the Dodd‑Frank Act imposes proprietary‑trading bans, higher fees and extra compliance costs on U.S.‑based banks, it cannot (or chooses not to) offer crypto and digital‑asset products that rivals such as JPMorgan can provide more freely【page_13】. Morgan Stanley, on the other hand, highlights that its cross‑border activities – including any crypto‑related services – are exposed to the uncertain, sometimes conflicting regulatory regimes of emerging‑market jurisdictions, where sanctions, AML, anti‑corruption and other local rules can impede or invalidate transactions【page_24】. Thus, GS’s disadvantage is driven by stricter domestic regulation that limits product availability, whereas MS’s risk is external, stemming from regulatory volatility in foreign markets that could disrupt its crypto‑related operations abroad.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Goldman Sachs' competitive disadvantage due to Dodd-Frank compliance burdens is accurately described, with proper attribution to U.S. regulatory constraints limiting its cryptocurrency offerings compared to JPMorgan. Morgan Stanley's exposure to regulatory risks in emerging markets affecting cross-border crypto activities is also correctly detailed, emphasizing external legal and geopolitical uncertainties. (2) There are no numeric values, dates, or calculations in the question or answers that require verification; both responses reference the 2024 10-K filings implicitly through context, which matches the ground truth. Format and semantic use of information are consistent and acceptable. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two different firms (Goldman Sachs and Morgan Stanley), identifies distinct sources of regulatory risk (domestic vs. foreign), and contrasts their implications for cryptocurrency-related activities. The reasoning correctly distinguishes between self-imposed/structural limitations (Goldman) and external operational risks (Morgan Stanley). (4) The only minor shortcoming is the lack of explicit mention that JPMorgan 'offers these products' as a direct competitive advantage, though it is implied by saying rivals can provide them 'more freely.' This slight omission prevents a perfect 10 on qualitative accuracy, but the core meaning remains intact. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 442,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 219,
      "question": "How does the adoption of ASU 2022-04 impact the disclosure requirements for supplier finance obligations at both 3M and GE, particularly in terms of the roll-forward information introduced in 2024?",
      "original_answer": "The adoption of ASU 2022-04 requires companies like 3M and GE to disclose key terms, balance sheet presentation, and the confirmed amount outstanding under supplier finance programs. For 3M, this includes a $0.3 billion balance in confirmed invoices as of December 31, 2024, with $1.5 billion of invoices confirmed and paid during the year. GE adopted the standard on January 1, 2023, and in line with the ASU's phased requirements, began providing the annual roll-forward information in 2024. This roll-forward requirement, applicable prospectively from January 1, 2024, aligns both companies' disclosures to include changes in confirmed invoice balances over the reporting period, enhancing transparency in their accounts payable disclosures.",
      "llm_answer": "Both 3M and GE adopted ASU 2022‑04 on 1 January 2023, which adds a new annual disclosure for any supplier‑finance programs – the key terms, the balance‑sheet presentation, the confirmed amount outstanding at period‑end and, for the first time, a “roll‑forward” of the obligation. The standard requires the roll‑forward to be presented prospectively beginning in 2024; 3M’s Note 16 already shows this for 2024 (≈ $0.3 bn of confirmed invoices at year‑end, with $1.5 bn of invoices confirmed and $1.5 bn paid during the year), and GE’s supply‑chain finance note now must include a comparable roll‑forward of its obligations (though the specific figures are not shown in the excerpt). In both cases the adoption had no material impact on the financial statements, but it expands disclosure to track the movement of supplier‑finance balances year‑over‑year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: $0.3 billion year-end balance and $1.5 billion confirmed and paid during the year for 3M match the original answer. The adoption date of January 1, 2023, is accurate for GE, and the prospective roll-forward requirement starting in 2024 is correctly noted. (2) The LLM correctly states that both companies adopted ASU 2022-04 on January 1, 2023—this is consistent with GE’s adoption; while the original answer does not explicitly state 3M’s adoption date, it is reasonable to infer alignment given the 2024 disclosures. (3) The multi-hop reasoning is sound: the LLM synthesizes the new disclosure requirements (key terms, balance sheet presentation, confirmed amounts, roll-forward) and applies them correctly to both companies, noting the enhanced transparency and lack of material impact on financials. (4) The only minor gap is that the original answer emphasizes GE began providing the roll-forward in 2024 'in line with the ASU’s phased requirements,' which the LLM mentions implicitly but could have made more explicit. However, this does not detract significantly from the accuracy. Wording differs but semantic meaning is equivalent. All parts of the question—impact on disclosure, roll-forward, both companies, 2024 timing—are addressed thoroughly and correctly.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 384,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 219,
      "question": "How does MDT's geographic revenue concentration in 'Other Countries' expose it to similar regulatory and reimbursement challenges as those impacting AMGN's drug pricing strategies in international markets?",
      "original_answer": "MDT reports $32.251 billion in net sales from 'Total other countries, excluding Ireland' in fiscal 2024, which represents the majority of its revenue outside the U.S. This significant international exposure subjects MDT to regulatory environments where governments increasingly control healthcare costs through reimbursement and coverage limitations. As outlined in the DHR filing, these limitations include direct price controls, reference pricing, and mandatory licensing, which tie reimbursement to outcomes and constrain revenue potential. Similarly, AMGN notes that many countries outside the U.S. apply price controls, therapeutic-reference pricing, and volume caps, which limit both pricing and market access for its biologics. Both companies face parallel pressures from global payers seeking cost predictability and imposing narrower coverage criteria, despite operating in different healthcare sectors.",
      "llm_answer": "Medtronic’s 2024 net‑sales table shows that “Total other countries, excluding Ireland” generated $32.3 billion – essentially the bulk of its non‑U.S. revenue (page 105). Amgen explicitly warns that in most non‑U.S. markets governments use price‑controls, health‑technology assessments, reference‑pricing and restrictive reimbursement rules that shape its drug‑pricing strategies (pages 18‑17). Because Medtronic’s earnings are similarly concentrated in those overseas markets, it faces comparable regulatory and reimbursement pressures that can limit pricing flexibility, coverage and profitability.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the revenue figure is reported as $32.3 billion versus the ground truth $32.251 billion — a negligible rounding difference (likely due to reporting precision), which is acceptable under format variation rules. The fiscal year (2024) and geographic segment ('Total other countries, excluding Ireland') are correctly identified. (2) The answer correctly identifies both MDT's and AMGN's exposure to international regulatory and reimbursement challenges, citing price controls, reference pricing, and restrictive reimbursement rules — aligning with the ground truth's mention of direct price controls, therapeutic-reference pricing, and volume caps. (3) Multi-hop reasoning is sound: it connects MDT's revenue concentration to regulatory pressures in the same markets where AMGN operates, despite different healthcare sectors, and correctly infers parallel challenges. (4) Minor omission: the LLM does not explicitly mention 'mandatory licensing' or 'tying reimbursement to outcomes' as detailed in the DHR filing, nor does it reference the specific page numbers from the AMGN filing (though it cites pages 18–17, likely a typo for 17–18). However, these are minor contextual details that do not undermine the overall correctness. Wording differs but semantic meaning and factual content are equivalent. Contextual relevance is perfect — directly addresses the comparative exposure question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 411,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 219,
      "question": "How does the combined capital buffer requirement above the minimum risk-based capital ratios for SCHW and JPM compare, considering their respective application of countercyclical and capital conservation buffers?",
      "original_answer": "SCHW is subject to a stress capital buffer of 2.5% and a capital conservation buffer of 2.5%, with the countercyclical capital buffer at 0%, resulting in a total buffer requirement of 5.0% above the minimum risk-based capital ratios. JPM, on the other hand, applies a fixed capital conservation buffer of 2.5% and a stress capital buffer (SCB) of 2.9%, with the countercyclical buffer also at 0%, leading to a total buffer requirement of 5.4% above the minimum. Therefore, JPM has a slightly higher combined buffer requirement than SCHW due to its higher SCB. This comparison reflects how both firms are subject to similar regulatory buffer frameworks, but with firm-specific SCB and CCyB determinations.",
      "llm_answer": "SCHW’s total buffer above the minimum risk‑based ratios is 5.0 % (2.5 % stress‑capital buffer + 2.5 % capital‑conservation buffer, with a 0 % counter‑cyclical buffer)【page_122】.  \nJPM’s total buffer is 5.4 % (2.9 % SCB + 2.5 % capital‑conservation buffer, also with a 0 % counter‑cyclical buffer)【page_291】.  \nThus, JPM’s combined buffer is roughly 0.4 percentage‑point higher than SCHW’s.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all percentages are accurate: SCHW's 2.5% stress capital buffer + 2.5% capital conservation buffer = 5.0% total buffer, and JPM's 2.9% SCB + 2.5% capital conservation buffer = 5.4% total buffer, with both having 0% countercyclical buffer. The difference of 0.4 percentage points is correctly implied. (2) The answer is complete, addressing both firms' buffer components and the comparative outcome. (3) Entities (SCHW, JPM, SCB, capital conservation buffer, countercyclical buffer) are correctly identified and applied. (4) The reasoning is sound: it synthesizes multi-hop information (different buffer types across two firms) and draws the correct conclusion that JPM has a higher combined buffer due to its higher SCB. (5) The semantic meaning is equivalent to the original answer, with only minor formatting differences (e.g., 'counter-cyclical' vs 'countercyclical') that do not affect accuracy. The inclusion of page references adds contextual support without detracting from correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 309,
        "total_tokens": 1599
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 600,
    "successful_evaluations": 600,
    "failed_evaluations": 0,
    "average_correctness_score": 7.82,
    "average_quantitative_accuracy": 8.49,
    "average_qualitative_accuracy": 8.01,
    "average_contextual_relevance": 9.45,
    "score_distribution": {
      "excellent": 383,
      "good": 85,
      "fair": 98,
      "poor": 34
    }
  },
  "original_experiment_metadata": {
    "model": "gpt-oss-120b-reasoning",
    "experiment": "e3_page_window_distract",
    "pattern": "qualitative_3hop_cross_company_type1",
    "total_questions": 600,
    "successful": 600,
    "failed": 0,
    "elapsed_seconds": 15564.65,
    "timestamp": "2026-02-02T19:59:50.395018"
  }
}